Citrus Sinensis ID: 005257
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 705 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9U1 | 686 | L-type lectin-domain cont | yes | no | 0.940 | 0.966 | 0.622 | 0.0 | |
| O49445 | 681 | Probable L-type lectin-do | no | no | 0.924 | 0.957 | 0.541 | 0.0 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.836 | 0.875 | 0.429 | 1e-140 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.829 | 0.864 | 0.424 | 1e-140 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.831 | 0.856 | 0.445 | 1e-139 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.834 | 0.871 | 0.445 | 1e-137 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.826 | 0.871 | 0.425 | 1e-136 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.853 | 0.899 | 0.418 | 1e-135 | |
| Q96285 | 661 | L-type lectin-domain cont | no | no | 0.836 | 0.892 | 0.398 | 1e-126 | |
| Q9M9E0 | 656 | L-type lectin-domain cont | no | no | 0.838 | 0.900 | 0.439 | 1e-126 |
| >sp|Q9S9U1|LRK71_ARATH L-type lectin-domain containing receptor kinase VII.1 OS=Arabidopsis thaliana GN=LECRK71 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 831 bits (2146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/689 (62%), Positives = 522/689 (75%), Gaps = 26/689 (3%)
Query: 23 ISAVDFVFNGFN--SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYV 80
ISA+DF+FNGFN SSN+SL+G AT+ES+ILTLTN T+F GRALY I TK P +S V
Sbjct: 18 ISAIDFIFNGFNDSSSNVSLFGIATIESKILTLTNQTSFATGRALYNRTIRTKDPITSSV 77
Query: 81 YPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGV 140
PFSTSFIF MAPYK L GHG+VFLF P GI G++ AQHLGLFN TN+GN SNH+FGV
Sbjct: 78 LPFSTSFIFTMAPYKNTLPGHGIVFLFAPSTGINGSSSAQHLGLFNLTNNGNPSNHIFGV 137
Query: 141 EFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFK 200
EFDVF NQEF+DID NHVGIDVNSL SV ++ +GYW DD FK
Sbjct: 138 EFDVFANQEFSDIDANHVGIDVNSLHSVYSNTSGYW----------------SDDGVVFK 181
Query: 201 ELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260
LKLN+G+NYQVWIDY D +N+TM AG RPK PLLS LNLS V+EDEM+VGFTAAT
Sbjct: 182 PLKLNDGRNYQVWIDYRDFVVNVTMQVAGKIRPKIPLLSTSLNLSDVVEDEMFVGFTAAT 241
Query: 261 GQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIVA 320
G+LV+SHKILAWSFSN+ FSLS LIT+GLPSFVLPKDSI K+K F+ + + ++
Sbjct: 242 GRLVQSHKILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVFVLVLICFLVVAL 301
Query: 321 VVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKV 380
V L +++++ RAR+R MEDWE+EYWPHRI Y+EIE+ TKGF E+NVIG+GGNGKV
Sbjct: 302 VGLVLFAVVRKRLERARKRALMEDWEMEYWPHRIPYEEIESGTKGFDEKNVIGIGGNGKV 361
Query: 381 YKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440
YKG+L+GG E+AVKRIS E+ G R F+AEISSLGRLKH++LV LRGWCK+E GS MLV
Sbjct: 362 YKGLLQGGVVEVAVKRISQESSDGMREFVAEISSLGRLKHRNLVSLRGWCKKEVGSFMLV 421
Query: 441 YDYMENGSLDKWIFQCDGSM-MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
YDYMENGSLD+WIF+ D + LSCEERIR+LK VA+G+LYLHEGWE KVLHRDIK+SNV
Sbjct: 422 YDYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKVLHRDIKASNV 481
Query: 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
LLD++M RL DFGLAR+HGH Q TTRVVGT GYLAPEV +GRASTQTDVF +GIL+
Sbjct: 482 LLDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKTGRASTQTDVFAYGILV 541
Query: 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE--DEVERVLHLGLL 617
LEV+ GRRPIEEGK L++ VW LM +G++L+ LD ++ G E DE ERVL LGLL
Sbjct: 542 LEVMCGRRPIEEGKKPLMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEAERVLQLGLL 601
Query: 618 CAYPDPRARPTMRQVVKVLEGKIEAGIENE-TEDMDAYLLQQVKSKDMWANYSRSFGYGY 676
CA+PDP RP+MRQVV+V EG E E +ED+++++L ++ S+ SR F YG
Sbjct: 602 CAHPDPAKRPSMRQVVQVFEGDKAEIFEAESSEDVESWMLMKMGSR----GSSREFWYGS 657
Query: 677 ATHPTFHDIRQSNSYSMSLSWSNTIMEGR 705
++HPT IR + SW+++I+EGR
Sbjct: 658 SSHPTIEQIRLQSLSVSLSSWNSSILEGR 686
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49445|LRK72_ARATH Probable L-type lectin-domain containing receptor kinase VII.2 OS=Arabidopsis thaliana GN=LECRK72 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/694 (54%), Positives = 504/694 (72%), Gaps = 42/694 (6%)
Query: 22 SISAVDFVFNG-FNSSNLSLYGTATVES--RILTLTNSTTFTIGRALYPSKIPTKRPNSS 78
S + ++F++N F ++N L G ATV+S ILTLTN TTF+IGR LYPS+I ++S
Sbjct: 20 STTGIEFIYNSNFTTTNTLLLGNATVKSPPSILTLTNQTTFSIGRGLYPSRINASSSSAS 79
Query: 79 YVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVF 138
+ PF+TSFIF+MAP+K + GHG F+F+PF A+ +QHLGLFN TN+G+ ++ +F
Sbjct: 80 PL-PFATSFIFSMAPFKHLSPGHGFAFVFLPFSETSAASSSQHLGLFNFTNNGDPNSRIF 138
Query: 139 GVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKS 198
VEFDVF NQEFNDI++NHVG+DVNSLTSV++ AG++ G D +
Sbjct: 139 AVEFDVFANQEFNDINDNHVGVDVNSLTSVASETAGFY---------------GGRDGQR 183
Query: 199 FKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258
F ELKLN+G+NYQ WI++ S IN+TM A ++P RPL+S+PLNL+GVL D+M+VGFTA
Sbjct: 184 FTELKLNSGENYQAWIEFNGSAINVTMARASSRKPIRPLISIPLNLTGVLLDDMFVGFTA 243
Query: 259 ATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFII 318
+TGQLV+SH+IL+WSFSN+ FS+ + LIT LPSF L DS+ KSKGFIAGV+ G + ++
Sbjct: 244 STGQLVQSHRILSWSFSNSNFSIGDALITRNLPSFKLSGDSVLKSKGFIAGVSSGVVLLV 303
Query: 319 VAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNG 378
+ L ++++R RR R ++EDWE EYWPHR+ Y+++ ATKGFS+EN+IG GGN
Sbjct: 304 SVIGLLCFYVVRR--RRQRLEGDVEDWETEYWPHRVQYKDVLEATKGFSDENMIGYGGNS 361
Query: 379 KVYKGVLEGGGAEIAVKRI---SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435
KVY+GVLE G E+AVKRI E+ G T FLAE+SSLGRL+HK++VGL+GW K+
Sbjct: 362 KVYRGVLE--GKEVAVKRIMMSPRESVGATSEFLAEVSSLGRLRHKNIVGLKGWSKKGGE 419
Query: 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495
SL+L+Y+YMENGS+DK IF C+ ML+ EER+RV++D+A+G+LYLHEGWE KVLHRDIK
Sbjct: 420 SLILIYEYMENGSVDKRIFDCN--EMLNWEERMRVIRDLASGMLYLHEGWETKVLHRDIK 477
Query: 496 SSNVLLDKEMNGRLGDFGLARMHGHG-QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFG 554
SSNVLLDK+MN R+GDFGLA++ ++ STT VVGT GY+APE+ +GRAS QTDV+
Sbjct: 478 SSNVLLDKDMNARVGDFGLAKLQNTSKEMVSTTHVVGTAGYMAPELVKTGRASAQTDVYS 537
Query: 555 FGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHL 614
FG+ +LEV+ GRRPIEEG+ +VE +W LM + K++D LD R++A G F +EVE L +
Sbjct: 538 FGVFVLEVVCGRRPIEEGREGIVEWIWGLMEKDKVVDGLDERIKANGVFVVEEVEMALRI 597
Query: 615 GLLCAYPDPRARPTMRQVVKVLE-GK-IEAGIENETEDMDAYLLQQVKSKDMWANYSRSF 672
GLLC +PDPR RP MRQVV++LE G+ +E G E E LL++VKS +Y
Sbjct: 598 GLLCVHPDPRVRPKMRQVVQILEQGRLVEDGGEREIS-----LLERVKS-----SYLLET 647
Query: 673 GYG-YATHPTFHDIRQSNSYSMSLSWSNTIMEGR 705
G G HPTF D+ S+SYS S ++I+ GR
Sbjct: 648 GEGSRQQHPTFQDVWNSSSYSNSFQTYDSILHGR 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1286), Expect = e-140, Method: Compositional matrix adjust.
Identities = 272/633 (42%), Positives = 399/633 (63%), Gaps = 43/633 (6%)
Query: 22 SISAVDFVFNGFN--SSNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSS 78
S +++F +N F+ +N+S+ G ATV S IL LT+ T + G A Y I K +
Sbjct: 23 SSQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPND 82
Query: 79 YVYPFSTSFIFAMAPYKGV--LAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
V FST+F+ + Y G+ ++GHG+ F P + A +Q+LGLF+ TN+GN +NH
Sbjct: 83 TVSSFSTTFVIGI--YSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDTNH 140
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
+ VEFD N EF+D ++NHVGI++NSLTSV + GYW D+
Sbjct: 141 ILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYW-----------------DEI 183
Query: 197 KSFKELKLNNGKNYQVWIDYAD--SFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
F L L + K QVW+DY D + I++TM G +P++ L+SV +LS V +MY+
Sbjct: 184 NQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYL 243
Query: 255 GFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSF--VLPK--DSIFKSKGFIAGV 310
GF+AATG ++ H + WSF K + L S +P F V P +K++ + +
Sbjct: 244 GFSAATGYVLSEHFVFGWSFM-VKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSL 302
Query: 311 TVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEEN 370
+ + +V+++ F+++R+++ A EE EDWE E+ +R+ ++++ ATKGF +++
Sbjct: 303 LLIPVLFVVSLIFLVRFIVRRRRKFA---EEFEDWETEFGKNRLRFKDLYYATKGFKDKD 359
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
++G GG G+VY+GV+ EIAVKR+S+E+ G + F+AEI S+GR+ H++LV L G+C
Sbjct: 360 LLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYC 419
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+R + L+LVYDYM NGSLDK+++ C + L ++R V+ VA+G+ YLHE WE+ V+
Sbjct: 420 RR-RDELLLVYDYMPNGSLDKYLYDCP-EVTLDWKQRFNVIIGVASGLFYLHEEWEQVVI 477
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRDIK+SNVLLD E NGRLGDFGLAR+ HG TTRVVGT GYLAP+ +GRA+T T
Sbjct: 478 HRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTAT 537
Query: 551 DVFGFGILILEVLSGRRPIE-----EGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
DVF FG+L+LEV GRRPIE + LV+ V+ ++G +LDA D L + +D+
Sbjct: 538 DVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSV--YDQ 595
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
EVE VL LGLLC++ DP+ RPTMRQV++ L G
Sbjct: 596 REVETVLKLGLLCSHSDPQVRPTMRQVLQYLRG 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 267/629 (42%), Positives = 402/629 (63%), Gaps = 44/629 (6%)
Query: 26 VDFVFNGFNS--SNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYP 82
++F +NGF+ +++SL G ATV +L LTN++ G A +I K + V
Sbjct: 25 LNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDSQNGNVSS 84
Query: 83 FSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEF 142
FST+F+FA+ L+GHG+ F+ P G+ A +Q++GLFN +N+GN +NH+F VEF
Sbjct: 85 FSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDTNHIFAVEF 144
Query: 143 DVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKEL 202
D ++ EF D ++NHVGID+N L S + AGY DD F+ L
Sbjct: 145 DTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYR-----------------DDHDKFQNL 187
Query: 203 KLNNGKNYQVWIDYADSF--INITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260
L + K QVWIDY + I++T+ +P++PL+S +LS +L ++MYVGF++AT
Sbjct: 188 SLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSAT 247
Query: 261 GQLVESHKILAWSF----SNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLF 316
G ++ H ++ WSF SLS+ LP F + S F + G+ + L
Sbjct: 248 GSVLSEHFLVGWSFRLNGEAPMLSLSK---LPKLPRFEPRRISEF----YKIGMPLISLS 300
Query: 317 IIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGG 376
+I +++ + ++++RK++ EE++DWE E+ +R ++E+ ATKGF E++++G GG
Sbjct: 301 LIFSIIFLAFYIVRRKKKY---EEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGG 357
Query: 377 NGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436
G+VY+G+L E+AVKR+SH++ G + F+AEI S+GR+ H++LV L G+C+R +G
Sbjct: 358 FGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRR-RGE 416
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L+LVYDYM NGSLDK+++ + L ++R ++K VA+G+ YLHE WE+ V+HRD+K+
Sbjct: 417 LLLVYDYMPNGSLDKYLYN-NPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKA 475
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFG 556
SNVLLD + NGRLGDFGLAR++ HG TT VVGT+GYLAPE +GRA+T TDV+ FG
Sbjct: 476 SNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFG 535
Query: 557 ILILEVLSGRRPIEEGKPN-----LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV 611
+LEV+SGRRPIE + LVE V+ L ++G +++A D +L G+D +EVE V
Sbjct: 536 AFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKL-GSSGYDLEEVEMV 594
Query: 612 LHLGLLCAYPDPRARPTMRQVVKVLEGKI 640
L LGLLC++ DPRARP+MRQV++ L G +
Sbjct: 595 LKLGLLCSHSDPRARPSMRQVLQYLRGDM 623
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 280/629 (44%), Positives = 388/629 (61%), Gaps = 43/629 (6%)
Query: 27 DFVFNGFN--SSNLSLYGTATV-ESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPF 83
DF F GF S NL+L G A + + + LT T IG A Y I K + F
Sbjct: 25 DFSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVNRALSF 84
Query: 84 STSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFD 143
STSF AM P L GHGL F P ++G+ +Q+LGL N ++ N S+H F VEFD
Sbjct: 85 STSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLN-SSRVNFSSHFFAVEFD 143
Query: 144 VFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELK 203
++ EF DI++NHVGID+NS+ S + AGY+ N T KEL
Sbjct: 144 TVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTK-----------------KELF 186
Query: 204 LNNGKNYQVWIDYADSFINITM-VEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQ 262
L+ G+ Q WIDY + + + + ++PK LLS ++LS VL DEMYVGF+A+TG
Sbjct: 187 LDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGL 246
Query: 263 LVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKS----KGFIAGVTV-GGLFI 317
L SH IL W+F+ +S E + LPS SI K + I GV++ L I
Sbjct: 247 LASSHYILGWNFN-----MSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLI 301
Query: 318 IVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGN 377
+V SLF++ R+ ++ + +E+WEL++ PHR +Y+E++ AT GF ++ ++G GG
Sbjct: 302 FAVLVAASLFVV----RKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGF 357
Query: 378 GKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437
GKVYKG L G +AVKRISHE+ G R F++E+SS+G L+H++LV L GWC+R + L
Sbjct: 358 GKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRR-RDDL 416
Query: 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497
+LVYD+M NGSLD ++F + ++L+ ++R +++K VA+G+LYLHEGWE+ V+HRDIK++
Sbjct: 417 LLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAA 476
Query: 498 NVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGI 557
NVLLD EMNGR+GDFGLA+++ HG TRVVGT GYLAPE+ SG+ +T TDV+ FG
Sbjct: 477 NVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGA 536
Query: 558 LILEVLSGRRPIEEGK-PN---LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLH 613
++LEV GRRPIE P +V+ VW G + D +D RL G FDE+EV V+
Sbjct: 537 VLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRL--NGEFDEEEVVMVIK 594
Query: 614 LGLLCAYPDPRARPTMRQVVKVLEGKIEA 642
LGLLC+ P RPTMRQVV LE + +
Sbjct: 595 LGLLCSNNSPEVRPTMRQVVMYLEKQFPS 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1255), Expect = e-137, Method: Compositional matrix adjust.
Identities = 280/629 (44%), Positives = 396/629 (62%), Gaps = 41/629 (6%)
Query: 22 SISAVDFVFN-GFNS-SNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSS 78
S +++F +N GFN ++LS+ G TV +L LTN+T G A Y I K +
Sbjct: 21 SSQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNG 80
Query: 79 YVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVF 138
V FSTSF+FA+ +L+GHG+ F+ P + +Q++GLFN N+GN +NHVF
Sbjct: 81 TVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHVF 140
Query: 139 GVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKS 198
VE D + EFND ++NHVGID+NSL SV + AGYW D++
Sbjct: 141 AVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYW-----------------DEKGQ 183
Query: 199 FKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
FK L L + K QVW+DY + I++TM +P RPL++ +LS VL +MYVGF
Sbjct: 184 FKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGF 243
Query: 257 TAATGQLVESHKILAWSFS-NTKFSLSEELITSGLPSFVLPK-DSIFKSKGFIAGVTVGG 314
++ATG ++ H IL WSF N K + L S LP LP+ + S+ + G+ +
Sbjct: 244 SSATGSVLSEHYILGWSFGLNEK---APPLALSRLPK--LPRFEPKRISEFYKIGMPLIS 298
Query: 315 LFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGV 374
LF+I + + ++++R+++ A E EE E E+ +R ++++ ATKGF E+ ++G
Sbjct: 299 LFLIFSFIFLVCYIVRRRRKFAEELEEWE---KEFGKNRFRFKDLYYATKGFKEKGLLGT 355
Query: 375 GGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434
GG G VYKGV+ G EIAVKR+SHE+ G + F+AEI S+GR+ H++LV L G+C+R +
Sbjct: 356 GGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRR-R 414
Query: 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494
G L+LVYDYM NGSLDK+++ + L+ ++RI+V+ VA+G+ YLHE WE+ V+HRD+
Sbjct: 415 GELLLVYDYMPNGSLDKYLYNTP-EVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDV 473
Query: 495 KSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFG 554
K+SNVLLD E+NGRLGDFGLAR++ HG TT VVGT+GYLAPE +GRA+ TDVF
Sbjct: 474 KASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFA 533
Query: 555 FGILILEVLSGRRPIEEGKPN-----LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVE 609
FG +LEV GRRPIE + LV+ V+ L +G +L A D + ++ DE EVE
Sbjct: 534 FGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSE--CDEKEVE 591
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
VL LGLLC++ DPRARP+MRQV+ L G
Sbjct: 592 MVLKLGLLCSHSDPRARPSMRQVLHYLRG 620
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 264/621 (42%), Positives = 381/621 (61%), Gaps = 38/621 (6%)
Query: 27 DFVFNGFNSSNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFST 85
+F FNG+ N G A S+ ++ LTNS+ F+ G Y S + K + V FST
Sbjct: 27 EFGFNGYLYDN---SGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVSSFST 83
Query: 86 SFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVF 145
+F+FA+ L GHGL F+ P G+ ++ +Q+LGLFN TN+G+ SNH+ VEFD F
Sbjct: 84 TFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTF 143
Query: 146 KNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLN 205
+NQEF+D+D NHVGID+NSL+S A AGY+ DD+ +FK ++L
Sbjct: 144 QNQEFDDMDNNHVGIDINSLSSEKASTAGYYE----------------DDDGTFKNIRLI 187
Query: 206 NGKNYQVWIDYADSF--INITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQL 263
N K Q WI+Y S +N+T+ + +PK PLLS+ +LS L D MYVGFT+ATG+L
Sbjct: 188 NQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRL 247
Query: 264 VESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVG--GLFIIVAV 321
SH IL W+F + + S LP LP+DS S I +++ L I+V +
Sbjct: 248 RSSHYILGWTFKLN--GTASNIDISRLPK--LPRDSRSTSVKKILAISLSLTSLAILVFL 303
Query: 322 VLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVY 381
+ + +KRK + E +EDWE+++ PHR Y+++ ATKGF ++G GG GKVY
Sbjct: 304 TISYMLFLKRK----KLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVY 359
Query: 382 KGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441
KG L +IAVK++SH++ G R F+AEI+++GRL+H +LV L G+C+R KG L LVY
Sbjct: 360 KGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRR-KGELYLVY 418
Query: 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501
D M GSLDK+++ L +R +++KDVA+G+ YLH W + ++HRDIK +NVLL
Sbjct: 419 DCMPKGSLDKFLYH-QPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLL 477
Query: 502 DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILE 561
D MNG+LGDFGLA++ HG T+ V GT GY++PE+ +G+AST +DVF FGIL+LE
Sbjct: 478 DDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLE 537
Query: 562 VLSGRRPIEEGKPNLVEMV---WELMV-QGKLLDALDARLRAKGGFDEDEVERVLHLGLL 617
+ GRRP+ + EMV W L + +L +D R++ + E++V VL LGL
Sbjct: 538 ITCGRRPVLPRASSPSEMVLTDWVLDCWEDDILQVVDERVKQDDKYLEEQVALVLKLGLF 597
Query: 618 CAYPDPRARPTMRQVVKVLEG 638
C++P RP+M V++ L+G
Sbjct: 598 CSHPVAAVRPSMSSVIQFLDG 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 273/652 (41%), Positives = 397/652 (60%), Gaps = 50/652 (7%)
Query: 8 LLFSLLLSIF-LSF------ESISAVDFVFNGFNS--SNLSLYGTATVESR-ILTLTNST 57
+ F L +IF LSF S +DF +NGF +++S+ G AT+ +L LTN+T
Sbjct: 1 MFFIKLFTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTNTT 60
Query: 58 TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGAT 117
+ G A Y I K + V FST+F+FA+ + + HG+ F+ P + +
Sbjct: 61 MQSTGHAFYTKPIRFKDSPNGTVSSFSTTFVFAI--HSQIPIAHGMAFVIAPNPRLPFGS 118
Query: 118 EAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWP 177
Q+LGLFN TN+GN NHVF VE D N EFND + NHVGID+NSL SV + AGYW
Sbjct: 119 PLQYLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYW- 177
Query: 178 DNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKR 235
D+ F L L + K QVW+D+ I++TM G +P++
Sbjct: 178 ----------------DENDQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRK 221
Query: 236 PLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSF----SNTKFSLSEELITSGLP 291
PL+S+ +LS VL +M+VGF++ATG +V +L WSF +LS+ LP
Sbjct: 222 PLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGWSFGVNGEAQPLALSK---LPRLP 278
Query: 292 SFVLPKDSIFKSKGFIAGVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWP 351
+ L +++ + L + ++ F++KR+++ A EE+EDWE E+
Sbjct: 279 VWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVRFIMKRRRKFA---EEVEDWETEFGK 335
Query: 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAE 411
+R+ ++++ ATKGF ++N++G GG G VYKG++ EIAVKR+S+E+ G + F+AE
Sbjct: 336 NRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAE 395
Query: 412 ISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVL 471
I S+G++ H++LV L G+C+R + L+LVYDYM NGSLDK+++ + L ++R +V+
Sbjct: 396 IVSIGQMSHRNLVPLVGYCRR-RDELLLVYDYMPNGSLDKYLYNSP-EVTLDWKQRFKVI 453
Query: 472 KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVG 531
VA+ + YLHE WE+ V+HRD+K+SNVLLD E+NGRLGDFGLA++ HG TTRVVG
Sbjct: 454 NGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVG 513
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-----LVEMVWELMVQ 586
T GYLAP+ +GRA+T TDVF FG+L+LEV GRRPIE + LV+ V+ ++
Sbjct: 514 TWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWME 573
Query: 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
+LDA D L ++ +D+ EVE VL LGLLC++ DP ARPTMRQV++ L G
Sbjct: 574 ANILDAKDPNLGSE--YDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRG 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96285|LRK55_ARATH L-type lectin-domain containing receptor kinase V.5 OS=Arabidopsis thaliana GN=LECRK55 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 257/645 (39%), Positives = 389/645 (60%), Gaps = 55/645 (8%)
Query: 6 KPLLFSLLLSIFLS----FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTI 61
+P+L L L++F + F S +V FNG+ TLTN+T T
Sbjct: 10 QPILV-LFLTLFYNSHGYFVSQGSVGIGFNGY-----------------FTLTNTTKHTF 51
Query: 62 GRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQH 121
G+A + K ++ + FS +F FA+ P HG+ F+ P G+ GA+ Q+
Sbjct: 52 GQAFENEHVEIKNSSTGVISSFSVNFFFAIVPEHNQQGSHGMTFVISPTRGLPGASSDQY 111
Query: 122 LGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQT 181
LG+FN+TN+G +SN+V +E D+ K++EF DID+NHVGI++N L SV++ +AGY+
Sbjct: 112 LGIFNKTNNGKASNNVIAIELDIHKDEEFGDIDDNHVGININGLRSVASASAGYY----- 166
Query: 182 DSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDYA--DSFINITMVEAGMKRPK-RPLL 238
D + SFK+L L + + ++ I Y+ D +N+T+ A + P +PLL
Sbjct: 167 -----------DDKDGSFKKLSLISREVMRLSIVYSQPDQQLNVTLFPAEIPVPPLKPLL 215
Query: 239 SVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKD 298
S+ +LS L ++MY+GFTA+TG + H ++ W + EL LP + PK
Sbjct: 216 SLNRDLSPYLLEKMYLGFTASTGSVGAIHYLMGWLVNGVIEYPRLELSIPVLPPY--PKK 273
Query: 299 SIFKSKGFIA-GVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQ 357
+ ++K +A +TV VA + +F ++ K + +E +E+WE++Y PHR Y+
Sbjct: 274 TSNRTKTVLAVCLTVSVFAAFVASWIGFVFYLRHK----KVKEVLEEWEIQYGPHRFAYK 329
Query: 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR 417
E+ ATKGF E+ ++G GG G+VYKG L G AEIAVKR SH++ G FLAEIS++GR
Sbjct: 330 ELFNATKGFKEKQLLGKGGFGQVYKGTLPGSDAEIAVKRTSHDSRQGMSEFLAEISTIGR 389
Query: 418 LKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
L+H +LV L G+C R K +L LVYDYM NGSLDK++ + + L+ E+R R++KDVA
Sbjct: 390 LRHPNLVRLLGYC-RHKENLYLVYDYMPNGSLDKYLNRSENQERLTWEQRFRIIKDVATA 448
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
+L+LH+ W + ++HRDIK +NVL+D EMN RLGDFGLA+++ G T++V GT GY+A
Sbjct: 449 LLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFDPETSKVAGTFGYIA 508
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIE----EGKPNLVEMVWELMVQGKLLDAL 593
PE +GRA+T TDV+ FG+++LEV+ GRR IE E + LV+ + EL GK+ DA
Sbjct: 509 PEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEEYLVDWILELWENGKIFDAA 568
Query: 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
+ +R + + +VE VL LG+LC++ RP M V+++L G
Sbjct: 569 EESIRQEQ--NRGQVELVLKLGVLCSHQAASIRPAMSVVMRILNG 611
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9E0|LRKS1_ARATH L-type lectin-domain containing receptor kinase S.1 OS=Arabidopsis thaliana GN=LECRKS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1163), Expect = e-126, Method: Compositional matrix adjust.
Identities = 278/633 (43%), Positives = 399/633 (63%), Gaps = 42/633 (6%)
Query: 22 SISAVDFVFNGF----NSSNLSLYGTATVESRILTLTN-STTFTIGRALYPSK---IPTK 73
S SA+DF++N F N +++ L + VES +++L N S + GR YP K IP
Sbjct: 26 SSSAIDFLYNSFSSVTNRTDVILIEDSRVESTVISLINDSDPLSFGRVFYPQKLTIIPDP 85
Query: 74 RPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLF-NRTNDGN 132
N + + FSTSF+F++ P G GL F+ A +Q+ GLF N T N
Sbjct: 86 TRNPTRLSSFSTSFVFSILPDISTSPGFGLCFVLSNSTSPPNAISSQYFGLFTNATVRFN 145
Query: 133 SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGT 192
+ + VEFD +N E NDID+NHVGID+N++ S ++ AGY+ +S +G
Sbjct: 146 AP--LLAVEFDTGRNSEVNDIDDNHVGIDLNNIESTTSVTAGYY----------DSVNG- 192
Query: 193 GDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSV--PLNLSGVL 248
SF + NG N + WID+ + IN+++ G+ RP+RP L+ P+ ++ +
Sbjct: 193 -----SFVRFNMRNGNNVRAWIDFDGPNFQINVSVAPVGVLRPRRPTLTFRDPV-IANYV 246
Query: 249 EDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIA 308
+MY GF+A+ E+ +ILAWS S+T E+ T+ LP F L S S G IA
Sbjct: 247 SADMYAGFSASKTNWNEARRILAWSLSDT--GALREINTTNLPVFFLENSSSSLSTGAIA 304
Query: 309 GVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSE 368
G+ +G + + VA++ +LI +K R E EE+E+WELE+WPHR +Y+E+ AAT+ FS
Sbjct: 305 GIVIGCV-VFVALIGFGGYLIWKKLMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSN 363
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+ ++G GG GKVY+G+L +EIAVK ++H++ G R F+AEISS+GRL+HK+LV +RG
Sbjct: 364 DRLLGSGGFGKVYRGILSNN-SEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRG 422
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
WC+R K LMLVYDYM NGSL++WIF M R +V+ DVA G+ YLH GW++
Sbjct: 423 WCRR-KNELMLVYDYMPNGSLNQWIFDNPKEPM-PWRRRRQVINDVAEGLNYLHHGWDQV 480
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
V+HRDIKSSN+LLD EM GRLGDFGLA+++ HG +TTRVVGT+GYLAPE+ S+ +
Sbjct: 481 VIHRDIKSSNILLDSEMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTE 540
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPN---LVEMVWELMVQGKLLDALDARLRAKGGFDE 605
+DV+ FG+++LEV+SGRRPIE + LV+ V +L G+++DA D R+R++ E
Sbjct: 541 ASDVYSFGVVVLEVVSGRRPIEYAEEEDMVLVDWVRDLYGGGRVVDAADERVRSECETME 600
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
EVE +L LGL C +PDP RP MR++V +L G
Sbjct: 601 -EVELLLKLGLACCHPDPAKRPNMREIVSLLLG 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 705 | ||||||
| 255536803 | 728 | kinase, putative [Ricinus communis] gi|2 | 0.977 | 0.946 | 0.742 | 0.0 | |
| 356549325 | 684 | PREDICTED: L-type lectin-domain containi | 0.957 | 0.986 | 0.714 | 0.0 | |
| 359496168 | 947 | PREDICTED: L-type lectin-domain containi | 0.965 | 0.719 | 0.734 | 0.0 | |
| 147854730 | 761 | hypothetical protein VITISV_003876 [Viti | 0.965 | 0.894 | 0.733 | 0.0 | |
| 356555321 | 679 | PREDICTED: L-type lectin-domain containi | 0.939 | 0.974 | 0.704 | 0.0 | |
| 224125344 | 681 | predicted protein [Populus trichocarpa] | 0.939 | 0.972 | 0.710 | 0.0 | |
| 147815100 | 1793 | hypothetical protein VITISV_005356 [Viti | 0.941 | 0.370 | 0.726 | 0.0 | |
| 126143480 | 697 | lectin-receptor like protein kinase 3 [N | 0.964 | 0.975 | 0.679 | 0.0 | |
| 224105545 | 675 | predicted protein [Populus trichocarpa] | 0.926 | 0.967 | 0.704 | 0.0 | |
| 357446605 | 687 | LRR receptor-like serine/threonine-prote | 0.961 | 0.986 | 0.677 | 0.0 |
| >gi|255536803|ref|XP_002509468.1| kinase, putative [Ricinus communis] gi|223549367|gb|EEF50855.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1070 bits (2768), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/710 (74%), Positives = 601/710 (84%), Gaps = 21/710 (2%)
Query: 1 MKNHPKP---LLFSLLLSIFL-SFESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNS 56
MK H KP LL +L+SI L + I A DFV+NGFNSS+L LYG A +ESRIL+LTN
Sbjct: 1 MKKHQKPPRFLLVLVLVSIILFCQQPILATDFVYNGFNSSSLLLYGYAVIESRILSLTNE 60
Query: 57 TTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGA 116
TTFTIGRALYPSKI TK PNSSYVYPFSTSFIFAMAPYK VL GHGLVF+FVP GI+G
Sbjct: 61 TTFTIGRALYPSKIRTKDPNSSYVYPFSTSFIFAMAPYKNVLPGHGLVFIFVPIAGIEGT 120
Query: 117 TEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYW 176
T AQ+LGLFNRTNDGN +NHV G+EFDVF NQEFNDI++NHVGIDVNSLTS A AGYW
Sbjct: 121 TTAQNLGLFNRTNDGNPNNHVLGIEFDVFSNQEFNDINDNHVGIDVNSLTSRFAEDAGYW 180
Query: 177 PDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRP 236
D++ SS +D KSFK LKLNNG+NYQVWIDYADS INITM G +RP RP
Sbjct: 181 LDDRRSSS---------EDMKSFKRLKLNNGENYQVWIDYADSLINITMAPVGTRRPSRP 231
Query: 237 LLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLP 296
LL+V ++LSG+ E+EMYVGFTA+TG+LVESHKILAWSFSN+ FSLS+ LIT GLPSFVLP
Sbjct: 232 LLNVSIDLSGIFEEEMYVGFTASTGRLVESHKILAWSFSNSDFSLSDRLITVGLPSFVLP 291
Query: 297 KDSIFKSKGFIAGVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITY 356
K S F+SKGFIAG T G +IV+ L +LF I+RKQR+ARER ++E+WELEYWPHRITY
Sbjct: 292 KGSFFRSKGFIAGATAGSFVVIVSAALITLFFIRRKQRKARERADIEEWELEYWPHRITY 351
Query: 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLG 416
QEIEAATKGFSEENVIG+GGNGKVYKGVL GG AE+AVKRISHENDG R FLAEISSLG
Sbjct: 352 QEIEAATKGFSEENVIGIGGNGKVYKGVLPGG-AEVAVKRISHENDG-MREFLAEISSLG 409
Query: 417 RLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
RLKH++LVGLRGWCK+EKGS MLVYDY+ENGSLDK +F CD S MLSCEERIR+LKDVA+
Sbjct: 410 RLKHRNLVGLRGWCKKEKGSFMLVYDYLENGSLDKRVFDCDESKMLSCEERIRILKDVAS 469
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
GVLYLHEGWE +VLHRDIK+SNVLLDK+M G++GDFGLARMH HGQVASTTRVVGTVGYL
Sbjct: 470 GVLYLHEGWESRVLHRDIKASNVLLDKDMKGKIGDFGLARMHSHGQVASTTRVVGTVGYL 529
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596
APEV SGRAS+QTDVFGFG+LILEV+ GRRPIEEGK LVE+VW+ M++G+LLDALD R
Sbjct: 530 APEVVRSGRASSQTDVFGFGVLILEVICGRRPIEEGKQPLVELVWQSMMRGQLLDALDPR 589
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLL 656
++A+GGFDE+EVERVLHLGLLC YPD RPTMRQVVK+LEGK EA E ETEDMDAYLL
Sbjct: 590 IKARGGFDEEEVERVLHLGLLCGYPDASVRPTMRQVVKILEGKNEAN-ETETEDMDAYLL 648
Query: 657 QQVKSKDMWANYSRSFGYGYATHPTFHDIRQSNSYSMSLSWSNT-IMEGR 705
Q V SK+MW +YS+ GY++HPTF DIRQS+ SMSLSW+N+ I++GR
Sbjct: 649 QYVNSKEMWLDYSQRL--GYSSHPTFEDIRQSS--SMSLSWTNSVIVDGR 694
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549325|ref|XP_003543044.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1011 bits (2613), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/697 (71%), Positives = 581/697 (83%), Gaps = 22/697 (3%)
Query: 9 LFSLLLSIFLSFESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPS 68
L S+LLSI F S A+DFVFNGFNSS + L+G ATV+SRILTLT+ F++GRALY
Sbjct: 10 LPSILLSILFLFNSTCAIDFVFNGFNSSEVLLFGNATVDSRILTLTHQQRFSVGRALYNK 69
Query: 69 KIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRT 128
KIPTK+PNSS VYPFSTSFIFAMAP++ L GHGLVF+F P GI+G + AQHLGLFN T
Sbjct: 70 KIPTKKPNSSRVYPFSTSFIFAMAPFEDTLPGHGLVFIFTPVTGIQGTSSAQHLGLFNLT 129
Query: 129 NDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNS 188
N+GNSSNHVFGVEFDVF+NQEF+DID NHVGID+NSL S +H AGYWPD
Sbjct: 130 NNGNSSNHVFGVEFDVFQNQEFDDIDANHVGIDINSLKSYVSHDAGYWPDGA-------- 181
Query: 189 NSGTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVL 248
+KSFKEL LN+G+NYQVWIDY DS+IN+TM GMKRP RPLL+V LNLS V
Sbjct: 182 -------DKSFKELTLNSGENYQVWIDYEDSWINVTMAPVGMKRPSRPLLNVSLNLSQVF 234
Query: 249 EDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIA 308
EDEM+VGFT+ATGQLVESHKIL WSFSN KFSLS+ELIT+GLPSFVLPKDSIFKSKGF+A
Sbjct: 235 EDEMFVGFTSATGQLVESHKILGWSFSNEKFSLSDELITTGLPSFVLPKDSIFKSKGFVA 294
Query: 309 GVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSE 368
G TVG F+I +VL +LFLI+RK+ + R+R EMEDWELEYWPHR+TY+EIEAATKGFSE
Sbjct: 295 GFTVGVFFVICLLVLLALFLIQRKREKERKRMEMEDWELEYWPHRMTYEEIEAATKGFSE 354
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
ENVIGVGGNGKVYKGVL GG E+AVKRISHENDG R FLAE+SSLGRLK ++LVGLRG
Sbjct: 355 ENVIGVGGNGKVYKGVLRGG-VEVAVKRISHENDG-LREFLAEVSSLGRLKQRNLVGLRG 412
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
WCK++ G+ +L+YDYMENGSLDK +F CD S MLS E+RIR+LKDVA VLYLHEGWE K
Sbjct: 413 WCKKDVGNFLLIYDYMENGSLDKRVFDCDESKMLSYEDRIRILKDVAFAVLYLHEGWEDK 472
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
V+HRDIK+SNVLLDK+MNGRLGDFGLARMH HGQVASTT++VGTVGY+APEVF +GRAST
Sbjct: 473 VVHRDIKASNVLLDKDMNGRLGDFGLARMHSHGQVASTTKLVGTVGYMAPEVFKTGRAST 532
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608
QTDV+ FGILILEVL GRRP+EEGKP LVE +W+LMVQG++ ALD RLRAKG F+ E+
Sbjct: 533 QTDVYMFGILILEVLCGRRPLEEGKPPLVEWIWQLMVQGQVECALDERLRAKGEFNVQEM 592
Query: 609 ERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANY 668
ERV+HLGLLCAYP+P+ RPTMRQVV VLEGK E ++E E+MD YLLQQ+KS+D+ + Y
Sbjct: 593 ERVMHLGLLCAYPEPKTRPTMRQVVNVLEGKNEVE-DSEIENMDTYLLQQLKSRDILSEY 651
Query: 669 SRSFGYGYATHPTFHDIRQSNSYSMSLSWSNTIMEGR 705
S+ F Y +HPTF DIR S+ SMSL+WS +++EGR
Sbjct: 652 SQYF--SYTSHPTFQDIRLSS--SMSLTWSESVVEGR 684
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496168|ref|XP_002270216.2| PREDICTED: L-type lectin-domain containing receptor kinase VII.1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/686 (73%), Positives = 580/686 (84%), Gaps = 5/686 (0%)
Query: 20 FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSY 79
F S SA DFVFNGFNSS++ LYG A +ESR+LTLTN T+F IGRALYPSKIP K PNSS
Sbjct: 267 FGSASAEDFVFNGFNSSDMLLYGVADIESRVLTLTNQTSFAIGRALYPSKIPAKSPNSSD 326
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V PFSTSFIF++APY+ +L GHG+VFLF P GI+GAT +QHLG NRTNDGNS+NHVFG
Sbjct: 327 VVPFSTSFIFSIAPYEDILPGHGIVFLFAPVTGIEGATSSQHLGFLNRTNDGNSTNHVFG 386
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
V+FDVFKN+EF DI +NHVGI+VNSLTS+SAH AGYWPDN SSG ++S +DEKSF
Sbjct: 387 VKFDVFKNEEFGDISDNHVGINVNSLTSMSAHEAGYWPDNGKISSGGGNSSSE-EDEKSF 445
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
K L+LNNGKNYQVWIDY D IN+TM AG RP+RPLLSV LNLS V D+MYVGFTAA
Sbjct: 446 KRLQLNNGKNYQVWIDYMDFHINVTMAVAGKTRPQRPLLSVALNLSDVFLDDMYVGFTAA 505
Query: 260 TGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIV 319
TG+LVESH+ILAWSFSN+ FSLS ELITSGLPSFV PK SIF+SKGFIAG+TVG F +V
Sbjct: 506 TGRLVESHRILAWSFSNSNFSLSSELITSGLPSFVPPKKSIFQSKGFIAGITVGVFFCVV 565
Query: 320 AVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGK 379
+ S FLI+ K+ RAR RE ME+WELEYWPHRIT+QEIEAAT GFSEENVIG GGNGK
Sbjct: 566 FCSVFSWFLIRWKRLRARRREGMEEWELEYWPHRITHQEIEAATNGFSEENVIGTGGNGK 625
Query: 380 VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439
VYKGVLEGG AEIAVKRISHEND G R F+AEISSLGRLKH+ LV LRGWCKRE GS ML
Sbjct: 626 VYKGVLEGG-AEIAVKRISHENDQGMREFVAEISSLGRLKHRCLVSLRGWCKRENGSFML 684
Query: 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
VYDYMENGSLDK +F+C+ S +LS ++RIRVLKDVA+GVLYLHEGWE KVLHRDIK+SNV
Sbjct: 685 VYDYMENGSLDKRVFECEESKLLSFKDRIRVLKDVASGVLYLHEGWESKVLHRDIKASNV 744
Query: 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
LLD++MNGRLGDFGLARMHGH +V STTRVVGTVGYLAPEV +GRAS QTDVFGFG+LI
Sbjct: 745 LLDRDMNGRLGDFGLARMHGHDKVGSTTRVVGTVGYLAPEVIRTGRASAQTDVFGFGVLI 804
Query: 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
LEVL GRRP+EEGK +L++ VWELM++G+L+ ALD RLR++G DE+EVE+VLHLGLLC
Sbjct: 805 LEVLCGRRPMEEGKQHLIDWVWELMMKGELVLALDERLRSRGELDEEEVEKVLHLGLLCT 864
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679
YPDP ARPTMRQVVK+LEG E E+E E+MDAYLL+ V+SK MW+ YS +FG G +H
Sbjct: 865 YPDPSARPTMRQVVKILEGGNEV-CESEGEEMDAYLLESVRSKSMWSKYSHTFGRG--SH 921
Query: 680 PTFHDIRQSNSYSMSLSWSNTIMEGR 705
PTF D RQS + SMS+SWS+ I++GR
Sbjct: 922 PTFEDFRQSLASSMSMSWSDAILDGR 947
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147854730|emb|CAN78607.1| hypothetical protein VITISV_003876 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2557), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/686 (73%), Positives = 579/686 (84%), Gaps = 5/686 (0%)
Query: 20 FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSY 79
F S SA DFVFNGFNSS++ LYG A +ESR+LTLTN T+F IGRALYPSKIP K PNSS
Sbjct: 18 FGSASAEDFVFNGFNSSDMLLYGVADIESRVLTLTNQTSFAIGRALYPSKIPAKSPNSSD 77
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V PFSTSFIF++APY+ +L GHG+VFLF P GI+GAT +QHLG NRTNDGNS+NHVFG
Sbjct: 78 VVPFSTSFIFSIAPYEDILPGHGIVFLFAPVTGIEGATSSQHLGFLNRTNDGNSTNHVFG 137
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
V+FDVFKN+EF DI +NHVGI+VNSLTS+SAH AGYWPDN SSG ++S +DEKSF
Sbjct: 138 VKFDVFKNEEFGDISDNHVGINVNSLTSMSAHEAGYWPDNGKISSGGGNSSSE-EDEKSF 196
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
K L+LNNGKNYQVWIDY D IN+TM AG RP+RPLLSV LNLS V D+MYVGFTAA
Sbjct: 197 KRLQLNNGKNYQVWIDYMDFHINVTMAVAGKTRPQRPLLSVALNLSDVFLDDMYVGFTAA 256
Query: 260 TGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIV 319
TG+LVESH+ILAWSFSN+ FSLS ELITSGLPSFV PK SIF+SKGFI G+TVG F +V
Sbjct: 257 TGRLVESHRILAWSFSNSNFSLSSELITSGLPSFVPPKKSIFQSKGFIXGITVGVFFCVV 316
Query: 320 AVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGK 379
+ S FLI+ K+ RAR RE ME+WELEYWPHRIT+QEIEAAT GFSEENVIG GGNGK
Sbjct: 317 FCSVFSWFLIRWKRLRARRREGMEEWELEYWPHRITHQEIEAATNGFSEENVIGTGGNGK 376
Query: 380 VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439
VYKGVLEGG AEIAVKRISHEND G R F+AEISSLGRLKH+ LV LRGWCKRE GS ML
Sbjct: 377 VYKGVLEGG-AEIAVKRISHENDQGMREFVAEISSLGRLKHRCLVSLRGWCKRENGSFML 435
Query: 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
VYDYMENGSLDK +F+C+ S +LS ++RIRVLKDVA+GVLYLHEGWE KVLHRDIK+SNV
Sbjct: 436 VYDYMENGSLDKRVFECEESKLLSFKDRIRVLKDVASGVLYLHEGWESKVLHRDIKASNV 495
Query: 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
LLD++MNGRLGDFGLARMHGH +V STTRVVGTVGYLAPEV +GRAS QTDVFGFG+LI
Sbjct: 496 LLDRDMNGRLGDFGLARMHGHDKVGSTTRVVGTVGYLAPEVIRTGRASAQTDVFGFGVLI 555
Query: 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
LEVL GRRP+EEGK +L++ VWELM++G+L+ ALD RLR++G DE+EVE+VLHLGLLC
Sbjct: 556 LEVLCGRRPMEEGKQHLIDWVWELMMKGELVLALDERLRSRGELDEEEVEKVLHLGLLCT 615
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679
YPDP ARPTMRQVVK+LEG E E+E E+MDAYLL+ V+SK MW+ YS +FG G +H
Sbjct: 616 YPDPSARPTMRQVVKILEGGNEV-CESEGEEMDAYLLESVRSKSMWSKYSHTFGRG--SH 672
Query: 680 PTFHDIRQSNSYSMSLSWSNTIMEGR 705
PTF D RQS + SMS+SWS+ I++GR
Sbjct: 673 PTFEDFRQSLASSMSMSWSDAILDGR 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555321|ref|XP_003545982.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2514), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/686 (70%), Positives = 565/686 (82%), Gaps = 24/686 (3%)
Query: 20 FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSY 79
F S A+DFVFNGFNSS + L+G AT++SRILTLT+ +F++GRALY KIP K+PNSSY
Sbjct: 18 FNSACAIDFVFNGFNSSEVLLFGNATIDSRILTLTHQQSFSVGRALYKEKIPAKKPNSSY 77
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
VYPFS SFIFAMAP++ L GHGLVF+F P GI G + AQHLGLFN TN+GNSSNHVFG
Sbjct: 78 VYPFSISFIFAMAPFEDTLPGHGLVFIFTPITGIHGTSSAQHLGLFNLTNNGNSSNHVFG 137
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
VEFDVF+NQEF+DI+ NHVGID+NSL S +H AGYWPD GD KSF
Sbjct: 138 VEFDVFQNQEFDDINANHVGIDINSLKSYVSHDAGYWPDG-------------GD--KSF 182
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
KEL LN+G+NYQVWIDY DS++N+TM GMKRP RPL +V LNLS V EDEM+VGFT+A
Sbjct: 183 KELALNSGENYQVWIDYEDSWVNVTMAPVGMKRPSRPLFNVSLNLSQVFEDEMFVGFTSA 242
Query: 260 TGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIV 319
TGQLVESHKIL WSFSN FSLS+ELIT GLPSFVLPKDSIFKSKG +AG TVG F++
Sbjct: 243 TGQLVESHKILGWSFSNENFSLSDELITIGLPSFVLPKDSIFKSKGLVAGFTVGVFFVVC 302
Query: 320 AVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGK 379
+VL +LFLI+RK+ + R+R EMEDWELEYWPHR+ Y+EIEAATKGFSEENVIGVGGNGK
Sbjct: 303 LLVLLALFLIQRKRVKERKRLEMEDWELEYWPHRMAYEEIEAATKGFSEENVIGVGGNGK 362
Query: 380 VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439
VYKGVL GG E+AVKRISHENDG R FLAE+SSLGRLK ++LVGLRGWCK++ G+ +L
Sbjct: 363 VYKGVLRGG-VEVAVKRISHENDG-LREFLAEVSSLGRLKQRNLVGLRGWCKKDVGNFLL 420
Query: 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
+YDYMEN SLDKW+F CD S MLS E+RIR+LKDVA VLYLHEGWE KV+HRDIK+SNV
Sbjct: 421 IYDYMENRSLDKWVFDCDESKMLSYEDRIRILKDVAFAVLYLHEGWEAKVVHRDIKASNV 480
Query: 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
LLDK+MNGRLGDFGLARMH H QVASTT++VGTVGY+APEV +GRASTQTDV+ FGILI
Sbjct: 481 LLDKDMNGRLGDFGLARMHSHDQVASTTKLVGTVGYMAPEVIKTGRASTQTDVYMFGILI 540
Query: 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
LEVL GRRP+EEGK LVE +W+LMVQG++ ALD RLRAKG F+ E+ERV+HLGLLCA
Sbjct: 541 LEVLCGRRPLEEGKSPLVEWIWQLMVQGQVECALDERLRAKGDFNVQEMERVMHLGLLCA 600
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679
YP+P+ARPTMRQVV VLEGK E ++E E+MD YLLQQ+KS+D+ + YS+ F Y +H
Sbjct: 601 YPEPKARPTMRQVVNVLEGKNEVD-DSEIENMDTYLLQQLKSRDILSEYSQYF--SYTSH 657
Query: 680 PTFHDIRQSNSYSMSLSWSNTIMEGR 705
PTF DIR S+ SMSL+WS +EGR
Sbjct: 658 PTFQDIRHSS--SMSLTWSE--VEGR 679
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125344|ref|XP_002329782.1| predicted protein [Populus trichocarpa] gi|222870844|gb|EEF07975.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/694 (71%), Positives = 571/694 (82%), Gaps = 32/694 (4%)
Query: 9 LFSLLLSIFLSFESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPS 68
L SLLL I L + ISA+DFVFNGFNSS++SLYG+A +ESRILTLTN T+F IGRAL+P+
Sbjct: 10 LVSLLLPIILFLQPISAIDFVFNGFNSSSVSLYGSAIIESRILTLTNQTSFQIGRALFPT 69
Query: 69 KIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRT 128
KIPTK PNSS+V+PFSTSFIFAMAPYK VL GHGLVFLFVPF GI+G++ AQ+LG N T
Sbjct: 70 KIPTKAPNSSFVHPFSTSFIFAMAPYKNVLPGHGLVFLFVPFTGIQGSSSAQNLGFLNFT 129
Query: 129 NDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNS 188
N +S NH+ G+EFDVF N+EF+D+++NHVGIDVNSLTS+ A AGYWPDN SS N+
Sbjct: 130 NGNSSDNHMLGIEFDVFANEEFSDMNDNHVGIDVNSLTSIKAADAGYWPDNSRSSSNENT 189
Query: 189 NSGTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVL 248
+ +D SFKE LNNGKNYQVWIDY DS IN+TM AGMKRP RPLL+V LNLS V
Sbjct: 190 ---SDEDSNSFKEQDLNNGKNYQVWIDYEDSIINVTMAPAGMKRPTRPLLNVSLNLSDVF 246
Query: 249 EDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIA 308
EDEMYVGFT++TG LVE+HKILAWSFSN+ FSLSE LIT+GLPSFVLPKD ++SK FIA
Sbjct: 247 EDEMYVGFTSSTGLLVENHKILAWSFSNSNFSLSERLITTGLPSFVLPKDPFYRSKVFIA 306
Query: 309 GVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSE 368
G TVGG+ + REEMEDWELEYWPH++ YQEIEAATKGFSE
Sbjct: 307 GATVGGVLL---------------------REEMEDWELEYWPHQVRYQEIEAATKGFSE 345
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
ENVIG+GGNGKVYKGVL GG EIAVKRISHENDG R FLAEISSLGRLKH+SLVGLRG
Sbjct: 346 ENVIGIGGNGKVYKGVLPGG-TEIAVKRISHENDG-MREFLAEISSLGRLKHRSLVGLRG 403
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
WCKRE+G MLVYDYMENGSL+K +F CD S MLSCEERIR+LKDVA+ +LYLHEGW+ +
Sbjct: 404 WCKRERGVFMLVYDYMENGSLEKRVFDCDESKMLSCEERIRILKDVASALLYLHEGWDSQ 463
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
VLHRDIK+SNVLLDK+MNGRLGDFGLAR+HGHGQV STTRVVGT+GY+APEV SGRAS
Sbjct: 464 VLHRDIKASNVLLDKDMNGRLGDFGLARVHGHGQVPSTTRVVGTIGYMAPEVVRSGRASA 523
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG-GFDEDE 607
+TDVFGFG+LILEV+ GRRPIEEG+P L+E VW+LM+QG+ L ALD RL+A+G FDE E
Sbjct: 524 RTDVFGFGVLILEVMCGRRPIEEGQPPLLESVWQLMMQGQSLYALDERLKARGEQFDEGE 583
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWAN 667
VER+LHLGLLCAYPD + RPTMRQVVKV+EG E E E+EDMDA LLQQ+KSKD W++
Sbjct: 584 VERMLHLGLLCAYPDSKGRPTMRQVVKVMEGNNELS-EIESEDMDACLLQQMKSKDFWSS 642
Query: 668 YSRSFGYGYATHPTFHDIRQSNSYSMSLSWSNTI 701
+ S G +HPTF +IR+ +S SMSLSWSNT+
Sbjct: 643 LNSSHG----SHPTFDEIRRHHSSSMSLSWSNTM 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815100|emb|CAN76892.1| hypothetical protein VITISV_005356 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2482), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/669 (72%), Positives = 558/669 (83%), Gaps = 5/669 (0%)
Query: 20 FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSY 79
F SAVDFVFNGFNSS++ LYG A +ESR LTLTN T F IGRALYPSK+P K PNSS+
Sbjct: 18 FRLASAVDFVFNGFNSSDMLLYGVADIESRFLTLTNHTRFAIGRALYPSKVPAKSPNSSH 77
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V PFSTSFIF+MAPYK ++ GHG+VFLF P GI+G T AQ+LG N TN+GNS NHVFG
Sbjct: 78 VVPFSTSFIFSMAPYKDMIPGHGIVFLFAPVTGIEGTTSAQNLGFLNHTNNGNSINHVFG 137
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
V FDVF+N+EF+DI NHVGI+VNSLTS+SAH AGYWPDN SSG ++S +DEKSF
Sbjct: 138 VXFDVFQNEEFDDISNNHVGINVNSLTSMSAHEAGYWPDNXKISSGGGNSSSE-EDEKSF 196
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
K L+LNNGKNYQVWIDY D +N+TM EAG RP+RPLLSV LNLS V D+MYVGFTAA
Sbjct: 197 KRLQLNNGKNYQVWIDYLDLHLNVTMAEAGKTRPQRPLLSVALNLSDVFLDDMYVGFTAA 256
Query: 260 TGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIV 319
TG+LVESH+ILAWSFSN+ FSLS ELITSGLPSFV PK SIF+SKGFI G+TVG F +V
Sbjct: 257 TGRLVESHRILAWSFSNSNFSLSSELITSGLPSFVPPKKSIFQSKGFIXGITVGVFFCVV 316
Query: 320 AVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGK 379
+ S FLI+ K+ RAR RE ME+WELEYWPHRIT+QEIEAAT GFSEENVIG GGNGK
Sbjct: 317 FCSVFSWFLIRWKRLRARRREGMEEWELEYWPHRITHQEIEAATNGFSEENVIGTGGNGK 376
Query: 380 VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439
VYKGVLEGG AEIAVKRISHEND G R F+AEISSLGRLKH+ LV LRGWCKRE GS ML
Sbjct: 377 VYKGVLEGG-AEIAVKRISHENDQGMREFVAEISSLGRLKHRCLVSLRGWCKRENGSFML 435
Query: 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
VYDYMENGSLDK +F+C+ S +LS ++RIRVLKDVA+GVLYLHEGWE VLHRDIK+SNV
Sbjct: 436 VYDYMENGSLDKRVFECEESXJLSFKDRIRVLKDVASGVLYLHEGWESXVLHRDIKASNV 495
Query: 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
LLDK+MNGRLGDFGLARMHGH +V STTRVVGTVGYLAPEV +GRAS QTDVFGFG+LI
Sbjct: 496 LLDKDMNGRLGDFGLARMHGHDKVGSTTRVVGTVGYLAPEVIRTGRASAQTDVFGFGVLI 555
Query: 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
LEVL GRRP+EEGKP+L++ +WELM +G+L+ ALD RLR++G DE+EVE+VLHLGLLC
Sbjct: 556 LEVLCGRRPMEEGKPHLIDWLWELMRKGELVLALDERLRSRGELDEEEVEKVLHLGLLCT 615
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679
YPDP ARPTMRQVVK+LEG+ E E+E E+MD YLL+ ++SK MW+ Y +FG G +H
Sbjct: 616 YPDPSARPTMRQVVKILEGRNEV-CESEGEEMDVYLLESMRSKSMWSKYPHTFGRG--SH 672
Query: 680 PTFHDIRQS 688
PT D RQS
Sbjct: 673 PTXEDFRQS 681
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|126143480|dbj|BAF47279.1| lectin-receptor like protein kinase 3 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2458), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/690 (67%), Positives = 561/690 (81%), Gaps = 10/690 (1%)
Query: 17 FLSFESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPN 76
F +S+SA+DFVFNGF S++SL+G AT+ES ILTLTN +TF+IGRAL+PSKI TK PN
Sbjct: 17 FSCIQSVSAIDFVFNGFKPSDISLFGIATIESGILTLTNDSTFSIGRALHPSKIVTKAPN 76
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
SS V PFS SFIFAMAP+K L GHG+VFLFVP GI G T +Q+LG N TN+GN NH
Sbjct: 77 SSQVLPFSASFIFAMAPFKDRLPGHGIVFLFVPQTGIDGTTSSQNLGFLNFTNNGNPDNH 136
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VFGVEFDVFKNQEFNDI++NHVGIDVNSL SV AH AGYWPD S S +E
Sbjct: 137 VFGVEFDVFKNQEFNDINDNHVGIDVNSLASVFAHEAGYWPDKYNKFSDDGSL-----NE 191
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
+SF+ LKLNNG+NYQVWIDYAD IN+TM GMKRPK+PLL PLNLS V E+EMYVGF
Sbjct: 192 ESFETLKLNNGRNYQVWIDYADFQINVTMAPIGMKRPKQPLLDFPLNLSQVFEEEMYVGF 251
Query: 257 TAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLF 316
TA+TG L + HKILAWSFSN+ FS+S+ LIT GLPSF LPKD + +SKGFIAG+TV LF
Sbjct: 252 TASTGDLAQGHKILAWSFSNSNFSISDALITQGLPSFELPKDPVHRSKGFIAGMTVSLLF 311
Query: 317 IIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGG 376
++V + SLFLIKR +R REREEMEDWELEYWPHRI+YQEI+AATKGF++ENVIG+GG
Sbjct: 312 LVVVTAVVSLFLIKRNRRMKREREEMEDWELEYWPHRISYQEIDAATKGFADENVIGIGG 371
Query: 377 NGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436
NGKVYKGVL G +E+AVKRISHE+ G R FLAEISSLGRLKH++LV LRGWCK+++ S
Sbjct: 372 NGKVYKGVL-AGSSEVAVKRISHESSEGARQFLAEISSLGRLKHRNLVSLRGWCKKDRRS 430
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L+LVYDYMENGSLDK +F+CD + MLS E+RIR+LKDVA+GVLYLHEGWE KVLHRDIK+
Sbjct: 431 LILVYDYMENGSLDKTLFECDETNMLSFEDRIRILKDVASGVLYLHEGWEAKVLHRDIKA 490
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFG 556
SNVLLDK+MN RLGDFGLARMH HGQVA+TTRVVGTVGYLAPE +GRASTQTDVFG+G
Sbjct: 491 SNVLLDKDMNARLGDFGLARMHDHGQVANTTRVVGTVGYLAPEFVKTGRASTQTDVFGYG 550
Query: 557 ILILEVLSGRRPI-EEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLG 615
+L+LEV+ GRRPI EEGKP L++ +WELM +G+L++A D RLR F+E+E RVL LG
Sbjct: 551 VLVLEVMCGRRPIEEEGKPPLLDWLWELMRRGELINAFDRRLRTSQDFNEEEALRVLQLG 610
Query: 616 LLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYG 675
++CA DP+ RPTMRQVVK E EA E+E EDMD YLL+ ++S M +N+S S +G
Sbjct: 611 MICASLDPKGRPTMRQVVKFFERNSEAD-ESEAEDMDVYLLETLRSNTMLSNFSLSLSHG 669
Query: 676 YATHPTFHDIRQSNSYSMSLSWSNTIMEGR 705
+HPTF +IR+ S SMS+SW+N++++GR
Sbjct: 670 --SHPTFEEIREGLSSSMSISWTNSLVDGR 697
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105545|ref|XP_002333803.1| predicted protein [Populus trichocarpa] gi|222838541|gb|EEE76906.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/686 (70%), Positives = 561/686 (81%), Gaps = 33/686 (4%)
Query: 21 ESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYV 80
+ ISA+DFVFNGFNSS++SLYG+A +ESRILTLTN T+F IGRALYP+KIPTK PNSS+V
Sbjct: 22 QPISAIDFVFNGFNSSSVSLYGSAIIESRILTLTNQTSFQIGRALYPTKIPTKAPNSSFV 81
Query: 81 YPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGV 140
YPFSTSFIFAM PYK VL GHGL FLFVPF I+ + AQ+LG NRTN S +H+ G+
Sbjct: 82 YPFSTSFIFAMVPYKNVLPGHGLAFLFVPFTSIQSSISAQYLGFLNRTNGNRSDDHLLGI 141
Query: 141 EFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFK 200
EFDVF N+EF+D+++NHVGIDVN+LTS+ A AGYWPDN SS N+ + +D SFK
Sbjct: 142 EFDVFANEEFSDMNDNHVGIDVNTLTSIKAADAGYWPDNSRSSSNENT---SDEDSNSFK 198
Query: 201 ELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260
E LNNGKNYQVWIDY DS IN+TM AGMKRP RPLL+V LNLS V EDEMYVGFT++T
Sbjct: 199 EQDLNNGKNYQVWIDYEDSIINVTMAPAGMKRPTRPLLNVSLNLSDVFEDEMYVGFTSST 258
Query: 261 GQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIVA 320
G LVE+HKILAWSFSN+ FSLSE LIT+GLPSFVLPKD ++SK FIAG TVGG+ +
Sbjct: 259 GLLVENHKILAWSFSNSNFSLSERLITTGLPSFVLPKDPFYRSKVFIAGATVGGVLL--- 315
Query: 321 VVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKV 380
REEMEDWELEYWPH++ YQEIEAATKGFSEENVIG+GGNGKV
Sbjct: 316 ------------------REEMEDWELEYWPHQVRYQEIEAATKGFSEENVIGIGGNGKV 357
Query: 381 YKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440
YKGVL GG EIAVKRISHENDG R FLAEISSLGRLKH+SLVGLRGWCKRE+G MLV
Sbjct: 358 YKGVLPGG-TEIAVKRISHENDG-MREFLAEISSLGRLKHRSLVGLRGWCKRERGVFMLV 415
Query: 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
YDYMENGSL+K +F CD S MLSCEERIR+LKDVA+ +LYLHEGW+ +VLHRDIK+SNVL
Sbjct: 416 YDYMENGSLEKRVFDCDESKMLSCEERIRILKDVASALLYLHEGWDSQVLHRDIKASNVL 475
Query: 501 LDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560
LDK+MNGRLGDFGLAR+HGHGQV STTRVVGT+GY+APEV SGRAS +TDVFGFG+LIL
Sbjct: 476 LDKDMNGRLGDFGLARVHGHGQVPSTTRVVGTIGYMAPEVVRSGRASARTDVFGFGVLIL 535
Query: 561 EVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG-GFDEDEVERVLHLGLLCA 619
EV+ GRRPIEEG+P L+E VW+LM+QG+ L ALD RL+A+G FDE EVER+LHLGLLCA
Sbjct: 536 EVMCGRRPIEEGQPPLLESVWQLMMQGQSLYALDERLKARGEQFDEGEVERMLHLGLLCA 595
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679
YPD + RPTMRQVVKV+EG E E E+ED+DA LLQQ+KS D+W+++S +H
Sbjct: 596 YPDSKGRPTMRQVVKVMEGNNELS-EIESEDLDACLLQQMKSTDLWSSHSSH-----GSH 649
Query: 680 PTFHDIRQSNSYSMSLSWSNTIMEGR 705
PTF +IR+ +S SMSLSWSNT +EGR
Sbjct: 650 PTFDEIRRHHSSSMSLSWSNTTVEGR 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357446605|ref|XP_003593578.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] gi|355482626|gb|AES63829.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/700 (67%), Positives = 579/700 (82%), Gaps = 22/700 (3%)
Query: 9 LFSLLLS---IFLSFESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRAL 65
L+ LLLS FL F SISA+DF+FNGFNSSN+ L+G AT++S+ILTLT+ +F++GRAL
Sbjct: 7 LYLLLLSTTIFFLLFNSISAIDFIFNGFNSSNVLLFGNATIDSQILTLTHQQSFSVGRAL 66
Query: 66 YPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLF 125
YP KIPTK NSSYVYPFSTSFIF+MAP++ L GHGLVF+F P GI+G + AQHLGLF
Sbjct: 67 YPKKIPTK--NSSYVYPFSTSFIFSMAPFEDTLPGHGLVFIFTPVKGIEGTSSAQHLGLF 124
Query: 126 NRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSG 185
N +N+GNS+NHVFGVEFDVF NQEFNDI+ NHVGID+NSL SV +H G+W D++
Sbjct: 125 NLSNNGNSNNHVFGVEFDVFMNQEFNDINANHVGIDINSLNSVVSHDVGFWVDDEK---- 180
Query: 186 SNSNSGTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLS 245
+ ++ F++L LNNG+NYQVWIDY DS IN+T+ + GMKRP RPLL+V LNLS
Sbjct: 181 -------SEKDQIFEKLVLNNGENYQVWIDYKDSLINVTIAKLGMKRPIRPLLNVSLNLS 233
Query: 246 GVLEDEMYVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKG 305
V EDEM+VGFT++TGQLVESHKILAWSFSN FSLS+EL+TSGLPSFVLP DSIFKSKG
Sbjct: 234 DVFEDEMFVGFTSSTGQLVESHKILAWSFSNANFSLSDELVTSGLPSFVLPNDSIFKSKG 293
Query: 306 FIAGVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKG 365
F+AG +VG FII +VL LFLI++K++ ++R EMEDWELEYWPHR+TY+EIEA+TKG
Sbjct: 294 FVAGFSVGVFFIICVLVLLVLFLIQKKRKIDKKRSEMEDWELEYWPHRMTYEEIEASTKG 353
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
FSE+NVIGVGGNGKVYKGVL GG IAVK ISHEN+G R FLAE+S+LGRLK ++LVG
Sbjct: 354 FSEKNVIGVGGNGKVYKGVLRGG-VVIAVKHISHENNG-MREFLAEVSTLGRLKQRNLVG 411
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
LRGWCK+ G+ +LVY+YMENGSLDK +F CD S ML+ E+RIR++KDVA VLYLHEGW
Sbjct: 412 LRGWCKKNAGNFLLVYEYMENGSLDKRVFDCDESKMLNFEDRIRIIKDVAHAVLYLHEGW 471
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
E KV+HRDIK+SNVLLDK+MNG+LGDFGLARM HGQVASTT++VGTVGY+APEV +GR
Sbjct: 472 EVKVVHRDIKASNVLLDKDMNGKLGDFGLARMQDHGQVASTTKLVGTVGYMAPEVIKTGR 531
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
AST TDV+ FGILILEV+ GRRP+EEGKP+LVE VW+LMVQG+L++ALD RLR KG F E
Sbjct: 532 ASTHTDVYMFGILILEVMCGRRPLEEGKPSLVEFVWKLMVQGELVNALDQRLRDKGEFSE 591
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMW 665
E+ER+LHLGLLCAYP+P++RPTMRQVV +LEGK E E+E E+MD+YLLQQ+KS+D+
Sbjct: 592 QELERLLHLGLLCAYPEPKSRPTMRQVVNILEGKNEGVEESEIENMDSYLLQQLKSRDIL 651
Query: 666 ANYSRSFGYGYATHPTFHDIRQSNSYSMSLSWSNTIMEGR 705
A YS+ F YA+HPTF DI + S S +WS ++++GR
Sbjct: 652 AEYSQYF--SYASHPTFQDIGHFS--STSFTWSGSLVQGR 687
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 705 | ||||||
| TAIR|locus:2138381 | 686 | AT4G04960 [Arabidopsis thalian | 0.936 | 0.962 | 0.587 | 4.4e-203 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.614 | 0.641 | 0.423 | 3.3e-117 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.607 | 0.625 | 0.437 | 1.4e-116 | |
| TAIR|locus:2149795 | 688 | LECRKA4.2 "lectin receptor kin | 0.849 | 0.870 | 0.377 | 3.8e-101 | |
| TAIR|locus:2149810 | 691 | LECRKA4.3 "lectin receptor kin | 0.828 | 0.845 | 0.369 | 3.2e-97 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.824 | 0.862 | 0.372 | 3.7e-96 | |
| TAIR|locus:2097613 | 693 | AT3G08870 [Arabidopsis thalian | 0.831 | 0.845 | 0.371 | 2.6e-95 | |
| TAIR|locus:2080407 | 626 | AT3G59750 [Arabidopsis thalian | 0.585 | 0.659 | 0.387 | 1.6e-94 | |
| TAIR|locus:2097533 | 659 | AT3G59740 [Arabidopsis thalian | 0.753 | 0.805 | 0.380 | 9e-93 | |
| TAIR|locus:2083986 | 715 | AT3G53380 [Arabidopsis thalian | 0.478 | 0.471 | 0.407 | 3.3e-91 |
| TAIR|locus:2138381 AT4G04960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1965 (696.8 bits), Expect = 4.4e-203, P = 4.4e-203
Identities = 404/688 (58%), Positives = 485/688 (70%)
Query: 25 AVDFVFNGFN--SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYP 82
A+DF+FNGFN SSN+SL+G AT+ES+ILTLTN T+F GRALY I TK P +S V P
Sbjct: 20 AIDFIFNGFNDSSSNVSLFGIATIESKILTLTNQTSFATGRALYNRTIRTKDPITSSVLP 79
Query: 83 FSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEF 142
FSTSFIF MAPYK L GHG+VFLF P GI G++ AQHLGLFN TN+GN SNH+FGVEF
Sbjct: 80 FSTSFIFTMAPYKNTLPGHGIVFLFAPSTGINGSSSAQHLGLFNLTNNGNPSNHIFGVEF 139
Query: 143 DVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKSFKEL 202
DVF NQEF+DID NHVGIDVNSL SV ++ +GYW D+ FK L
Sbjct: 140 DVFANQEFSDIDANHVGIDVNSLHSVYSNTSGYWSDDGVV----------------FKPL 183
Query: 203 KLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQ 262
KLN+G+NYQVWIDY D +N+TM AG RPK PLLS LNLS V+EDEM+VGFTAATG+
Sbjct: 184 KLNDGRNYQVWIDYRDFVVNVTMQVAGKIRPKIPLLSTSLNLSDVVEDEMFVGFTAATGR 243
Query: 263 LVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTVGGLFIIVAVV 322
LV+SHKILAWSFSN+ FSLS LIT+GLPSFVLPKDSI K+K F+ V V F++VA+V
Sbjct: 244 LVQSHKILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVF-VLVLICFLVVALV 302
Query: 323 LCSLF-LIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXXXXXXXXXXXX 381
LF +++ YWPHRI Y+EIE+ TKGF E+
Sbjct: 303 GLVLFAVVRKRLERARKRALMEDWEMEYWPHRIPYEEIESGTKGFDEKNVIGIGGNGKVY 362
Query: 382 XXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441
L+GG E+AVKRIS E+ G R F+AEISSLGRLKH++LV LRGWCK+E GS MLVY
Sbjct: 363 KGLLQGGVVEVAVKRISQESSDGMREFVAEISSLGRLKHRNLVSLRGWCKKEVGSFMLVY 422
Query: 442 DYMENGSLDKWIFQCDGSMM-LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
DYMENGSLD+WIF+ D + LSCEERIR+LK VA+G+LYLHEGWE KVLHRDIK+SNVL
Sbjct: 423 DYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKVLHRDIKASNVL 482
Query: 501 LDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560
LD++M RL DFGLAR+HGH Q TTRVVGT GYLAPEV +GRASTQTDVF +GIL+L
Sbjct: 483 LDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKTGRASTQTDVFAYGILVL 542
Query: 561 EVLSGRRPIEEGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDE--DEVERVLHLGLLC 618
EV+ GRRPIEEGK L++ VW LM +G+ G E DE ERVL LGLLC
Sbjct: 543 EVMCGRRPIEEGKKPLMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEAERVLQLGLLC 602
Query: 619 AYPDPRARPTMRQVVKVLEG-KIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYA 677
A+PDP RP+MRQVV+V EG K E +ED+++++L ++ S+ SR F YG +
Sbjct: 603 AHPDPAKRPSMRQVVQVFEGDKAEIFEAESSEDVESWMLMKMGSRGS----SREFWYGSS 658
Query: 678 THPTFHDIRQXXXXXXXXXXXNTIMEGR 705
+HPT IR ++I+EGR
Sbjct: 659 SHPTIEQIRLQSLSVSLSSWNSSILEGR 686
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
Identities = 191/451 (42%), Positives = 268/451 (59%)
Query: 196 EKS-FKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252
EK FK L L + K QVW+DY + I++TM +P RPL++ +LS VL +M
Sbjct: 180 EKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDM 239
Query: 253 YVGFTAATGQLVESHKILAWSFS-NTKFSLSEELITSGLPSFVLPKDSIFK-SKGFIAGV 310
YVGF++ATG ++ H IL WSF N K + L S LP LP+ + S+ + G+
Sbjct: 240 YVGFSSATGSVLSEHYILGWSFGLNEK---APPLALSRLPK--LPRFEPKRISEFYKIGM 294
Query: 311 TVGGLFIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEX 370
+ LF+I + + ++++ + +R ++++ ATKGF E+
Sbjct: 295 PLISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKE---FGKNRFRFKDLYYATKGFKEKG 351
Query: 371 XXXXXXXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+ G EIAVKR+SHE+ G + F+AEI S+GR+ H++LV L G+C
Sbjct: 352 LLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYC 411
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+R +G L+LVYDYM NGSLDK+++ + L+ ++RI+V+ VA+G+ YLHE WE+ V+
Sbjct: 412 RR-RGELLLVYDYMPNGSLDKYLYNTP-EVTLNWKQRIKVILGVASGLFYLHEEWEQVVI 469
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRD+K+SNVLLD E+NGRLGDFGLAR++ HG TT VVGT+GYLAPE +GRA+ T
Sbjct: 470 HRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMAT 529
Query: 551 DVFGFGILILEVLSGRRPIE---EGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDEDE 607
DVF FG +LEV GRRPIE E + + W + K DE E
Sbjct: 530 DVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKE 589
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638
VE VL LGLLC++ DPRARP+MRQV+ L G
Sbjct: 590 VEMVLKLGLLCSHSDPRARPSMRQVLHYLRG 620
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 195/446 (43%), Positives = 271/446 (60%)
Query: 200 KELKLNNGKNYQVWIDYADSFINITM-VEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258
KEL L+ G+ Q WIDY + + + + ++PK LLS ++LS VL DEMYVGF+A
Sbjct: 183 KELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSA 242
Query: 259 ATGQLVESHKILAWSF--SNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTV-GGL 315
+TG L SH IL W+F S FSLS + +PS + + K + I GV++ L
Sbjct: 243 STGLLASSHYILGWNFNMSGEAFSLSLPSLPR-IPSSIKKRKK--KRQSLILGVSLLCSL 299
Query: 316 FIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXXXXXX 375
I +V SLF+++ + PHR +Y+E++ AT GF ++
Sbjct: 300 LIFAVLVAASLFVVRKVKDEDRVEEWELD----FGPHRFSYRELKKATNGFGDKELLGSG 355
Query: 376 XXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435
L G +AVKRISHE+ G R F++E+SS+G L+H++LV L GWC+R +
Sbjct: 356 GFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRR-RD 414
Query: 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495
L+LVYD+M NGSLD ++F + ++L+ ++R +++K VA+G+LYLHEGWE+ V+HRDIK
Sbjct: 415 DLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIK 474
Query: 496 SSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGF 555
++NVLLD EMNGR+GDFGLA+++ HG TRVVGT GYLAPE+ SG+ +T TDV+ F
Sbjct: 475 AANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAF 534
Query: 556 GILILEVLSGRRPIEEGK-PN---LVEMVWELMVQGKXXXXXXXXXXXKGGFDEDEVERV 611
G ++LEV GRRPIE P +V+ VW G G FDE+EV V
Sbjct: 535 GAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRL--NGEFDEEEVVMV 592
Query: 612 LHLGLLCAYPDPRARPTMRQVVKVLE 637
+ LGLLC+ P RPTMRQVV LE
Sbjct: 593 IKLGLLCSNNSPEVRPTMRQVVMYLE 618
|
|
| TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1003 (358.1 bits), Expect = 3.8e-101, P = 3.8e-101
Identities = 242/641 (37%), Positives = 357/641 (55%)
Query: 27 DFVFNGF--NSSNLSLYGTATVE-SRILTLTNSTTFTIGRALYPSKIPTKRPNSSY---- 79
+F+F GF N SN+ G AT++ +L LT+ + G + Y + N+S
Sbjct: 25 EFIFRGFSGNQSNIVTTGAATIKLDGLLRLTDRNSNVTGTSFYHKPVRLLETNTSSTNST 84
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
+ FSTSF+F + P G G F P GA AQ+LGL N+ NDGNS+NHVF
Sbjct: 85 IRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPDRTGAESAQYLGLLNKANDGNSTNHVFA 144
Query: 140 VEFDVFKN-QEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKS 198
VEFD + ++ D NH+G++ NSLTS Y+ DN+ + +
Sbjct: 145 VEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQEPVVYY-DNE---------------DPN 188
Query: 199 FKE-LKLNNGKNYQVWIDY--ADSFINITMVEAGMK-RPKRPLLSVPL-NLSGVLEDEMY 253
KE L +G + +DY +N+T+ A +K RP RPL+S P+ LS ++++EMY
Sbjct: 189 RKEDFPLQSGDPIRAILDYDGPTQTLNLTVYPANLKSRPVRPLISRPVPKLSQIVQEEMY 248
Query: 254 VGFTAATGQLVES-HKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVT- 311
VGFTAATG+ S H ++ WSFS+ L+E+ T L P + K +G+ + V
Sbjct: 249 VGFTAATGRDQSSAHYVMGWSFSSGGDLLTED--TLDLLELPRPPPNTAKKRGYNSQVLA 306
Query: 312 -VGGLFIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEX 370
+ L + ++L LF + PHR+ Y+++ AAT GF E
Sbjct: 307 LIVALSGVTVILLALLFFFVMYKKRLQQGEVLEDWEINH-PHRLRYKDLYAATDGFKENR 365
Query: 371 XXXXXXXXXXXXXXLEGGGAE-IAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
L ++ IAVK+I+ + G R F+AEI SLGRL+HK+LV L+GW
Sbjct: 366 IVGTGGFGTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKNLVNLQGW 425
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQC--DGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
CK +K L+L+YDY+ NGSLD ++ ++LS R ++ K +A+G+LYLHE WEK
Sbjct: 426 CK-QKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLYLHEEWEK 484
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
V+HRDIK SNVL++ +MN RLGDFGLAR++ G ++TT VVGT+GY+APE+ +G++S
Sbjct: 485 VVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPELARNGKSS 544
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDEDE 607
+ +DVF FG+L+LE++SGRRP + G L + V EL +G+ G+D E
Sbjct: 545 SASDVFAFGVLLLEIVSGRRPTDSGTFFLADWVMELHARGEILHAVDPRLGF--GYDGVE 602
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG-IENE 647
L +GLLC + P +RP+MR V++ L G + I+N+
Sbjct: 603 ARLALVVGLLCCHQRPTSRPSMRTVLRYLNGDDDVPEIDND 643
|
|
| TAIR|locus:2149810 LECRKA4.3 "lectin receptor kinase a4.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 233/630 (36%), Positives = 345/630 (54%)
Query: 27 DFVFNGF--NSSNLSLYGTATVESR-ILTLTNSTTFTIGRALY--PSKIPTKRPNSSYVY 81
+F+F+GF N S + + G +T+ S +L LT+ + +G A Y P ++ ++ V
Sbjct: 29 EFIFHGFKGNQSEIHMQGDSTITSNGLLRLTDRNSDVVGTAFYHKPVRLLDSNSTNTTVR 88
Query: 82 PFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVE 141
FSTSFIF + G G F P A Q++GL N NDGNSSNHVF VE
Sbjct: 89 SFSTSFIFIIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGNSSNHVFAVE 148
Query: 142 FDVFKNQEFNDIDE---NHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKS 198
FD Q F D NH+G++ NSL+S Y+ +N +K
Sbjct: 149 FDTV--QGFKDGTNRIGNHIGLNFNSLSSDVQEPVAYFNNNDS--------------QK- 191
Query: 199 FKELKLNNGKNYQVWIDY--ADSFINITMVEAGMK-RPKRPLLS--VPLNLSGVLEDEMY 253
+E +L +G+ QV++DY +N+T+ + +P+ PL+S VP LS ++ DEM+
Sbjct: 192 -EEFQLVSGEPIQVFLDYHGPTKTLNLTVYPTRLGYKPRIPLISREVP-KLSDIVVDEMF 249
Query: 254 VGFTAATGQLVES--HKILAWSF-SNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGV 310
VGFTAATG+ +S H ++ WSF S + L+ L S LP P + K +G+ V
Sbjct: 250 VGFTAATGRHGQSSAHYVMGWSFASGGEHPLAAMLDISQLPP---PPPNKAKKRGYNGKV 306
Query: 311 T--VGGLFIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSE 368
+ L +++++L LFL + PHR Y+++ AT+GF E
Sbjct: 307 IALIVALSTVISIMLVLLFLFMMYKKRMQQEEILEDWEIDH-PHRFRYRDLYKATEGFKE 365
Query: 369 EXXXXXXXXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+ +IAVK+I+ + G R F+AEI SLGRL+HK+LV L+G
Sbjct: 366 NRVVGTGGFGIVYRGNIRSSSDQIAVKKITPNSMQGVREFVAEIESLGRLRHKNLVNLQG 425
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCD--GSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
WCK + L+L+YDY+ NGSLD ++ +LS R ++ K +A+G+LYLHE WE
Sbjct: 426 WCKH-RNDLLLIYDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLLYLHEEWE 484
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+ V+HRD+K SNVL+D +MN RLGDFGLAR++ G + TT VVGT+GY+APE+ +G +
Sbjct: 485 QIVIHRDVKPSNVLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPELARNGNS 544
Query: 547 STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDED 606
S+ +DVF FG+L+LE++SGR+P + G + + V EL G+ G+DE
Sbjct: 545 SSASDVFAFGVLLLEIVSGRKPTDSGTFFIADWVMELQASGEILSAIDPRLGS--GYDEG 602
Query: 607 EVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E L +GLLC + P +RP MR V++ L
Sbjct: 603 EARLALAVGLLCCHHKPESRPLMRMVLRYL 632
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
Identities = 235/631 (37%), Positives = 341/631 (54%)
Query: 28 FVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYV-YPFSTS 86
FV+ F +++L L G A L LTN+T G A Y IP K SS + FST
Sbjct: 30 FVYYDFRNADLELDGMANTNHGPLHLTNNTNTGTGHAFY--NIPIKFTASSLSSFSFSTE 87
Query: 87 FIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQ-HLGLFNRTNDGNSSNHVFGVEFDVF 145
F+FA+ P + GHG+ F+ P ++ A +LG+FNR ND ++ H+F VE D
Sbjct: 88 FVFAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDTN 147
Query: 146 KNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKSFKELKLN 205
+N E D N VGID+NS+ SV + A Y+ + K+ L L
Sbjct: 148 QNSESFDKGGNDVGIDINSIVSVESADASYFNARKG---------------KNIS-LPLA 191
Query: 206 NGKNYQVWIDY--ADSFINITMVE-----------AGMKRPKRPLLSVPLNLSGVLEDEM 252
+GK+ VWIDY + +N+T+ + +PK PLLS +NLS + + M
Sbjct: 192 SGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETM 251
Query: 253 YVGFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTV 312
YVGF+ +TG + + IL WSF +E L S L S P F K + G T+
Sbjct: 252 YVGFSGSTGSIKSNQYILGWSFKQG--GKAESLDISRL-SNPPPSPKRFPLKE-VLGATI 307
Query: 313 GGL-FIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXX 371
+ F+ + ++ +L K Y P R +++ + ATKGF E
Sbjct: 308 STIAFLTLGGIV---YLYKKKKYAEVLEQWEKE----YSPQRYSFRILYKATKGFRENQL 360
Query: 372 XXXXXXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
L G +IAVKR+ H+ + G + ++AEI+S+GRL+HK+LV L G+C+
Sbjct: 361 LGAGGFGKVYKGILPSG-TQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCR 419
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
R KG L+LVYDYM NGSLD ++F + L+ +R+ ++K VA+ +LYLHE WE+ VLH
Sbjct: 420 R-KGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLH 478
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RDIK+SN+LLD ++NG+LGDFGLAR H G TRVVGT+GY+APE+ + G +T TD
Sbjct: 479 RDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTD 538
Query: 552 VFGFGILILEVLSGRRPIEEGKPN--LVEMVWELMVQGKXXXXXXXXXXXKGGFDEDEVE 609
V+ FG ILEV+ GRRP++ P ++ + W GK F +E +
Sbjct: 539 VYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASC-GKRDALTDTVDSKLIDFKVEEAK 597
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640
+L LG+LC+ +P RP+MRQ+++ LEG +
Sbjct: 598 LLLKLGMLCSQINPENRPSMRQILQYLEGNV 628
|
|
| TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 2.6e-95, P = 2.6e-95
Identities = 234/630 (37%), Positives = 344/630 (54%)
Query: 28 FVFNGF--NSSNLSLYGTATVE--SRILTLTNSTTFTIGRALYPSKIPTKR-PNSS--YV 80
F F GF N +++ G +T++ + +L LTN G A Y I + NSS V
Sbjct: 36 FTFIGFKENQTDIQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLRELTNSSDIKV 95
Query: 81 YPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGV 140
FSTSF+F + P G G F P GA AQ+LGL NRTN+GN SNHVF V
Sbjct: 96 CSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNRTNNGNPSNHVFAV 155
Query: 141 EFDVFKN-QEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKSF 199
EFD + ++ D NH+G++ N+L+S Y+ E
Sbjct: 156 EFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYYD-----------------TEDRK 198
Query: 200 KELKLNNGKNYQVWIDYADSF--INITMVEAGMK-RPKRPLLSVPLN-LSGVLEDEMYVG 255
++ +L +G+ +V IDY S +N+T+ ++ +PK+PL+S ++ LS +++DEMYVG
Sbjct: 199 EDFQLESGEPIRVLIDYDGSSETLNVTIYPTRLEFKPKKPLISRRVSELSEIVKDEMYVG 258
Query: 256 FTAATGQLVES-HKILAWSFSNT-KFSLSEELITSGLPSFVLPKDSIFKSKGFIAGVTV- 312
FTAATG+ S H ++ WSFS+ + +++ L S LP P + KG+ + V V
Sbjct: 259 FTAATGKDQSSAHYVMGWSFSSCGENPMADWLEISRLP----PPPRLSNKKGYNSQVIVL 314
Query: 313 -GGLFIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXX 371
L I+ V+L LF+ Y PHR Y+++ ATK F E
Sbjct: 315 IVALSIVTLVLLVLLFIFVMYKRRIQEEDTLEDWEIDY-PHRFRYRDLYLATKKFKESEI 373
Query: 372 XXXXXXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
L G IAVK+I+ + G R F+AEI SLGRL HK+LV L+GWCK
Sbjct: 374 IGTGGFGIVYRGNLSSSGP-IAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCK 432
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCD--GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
K L+L+YDY+ NGSLD ++Q ++L + R ++K +A+G+LYLHE WE+ V
Sbjct: 433 H-KNELLLIYDYIPNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIV 491
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQ 549
+HRD+K SNVL+D++MN +LGDFGLAR++ G + TT++VGT+GY+APE+ +G+ ST
Sbjct: 492 VHRDVKPSNVLIDEDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTA 551
Query: 550 TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDEDEVE 609
+DVF FG+L+LE++ G +P L + V E G F+ E +
Sbjct: 552 SDVFAFGVLLLEIVCGNKPTNAENFFLADWVMEFHTNGGILCVVDQNLGSS--FNGREAK 609
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639
L +GLLC + P+ RP+MR V++ L G+
Sbjct: 610 LALVVGLLCCHQKPKFRPSMRMVLRYLNGE 639
|
|
| TAIR|locus:2080407 AT3G59750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 1.6e-94, Sum P(2) = 1.6e-94
Identities = 167/431 (38%), Positives = 250/431 (58%)
Query: 216 YADSFINITMVEAGMK-RPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSF 274
+ D +N+T+ A + P++PLLS+ +LS +EMY G+TA+TG + H +L+ S+
Sbjct: 156 HPDQQLNVTLFPAEIPVPPRKPLLSLNRDLSPYFLEEMYYGYTASTGSIGAFHYMLS-SY 214
Query: 275 SNTKFSLS--EELITSGLPSFVLPKDSIFKSKGFIAG-VTVGGLFIIVAVVLCSLFLIKX 331
+ K E ++ LP + PK S ++K +A +T+ + VA +C +F +
Sbjct: 215 ATPKVENPTWEFIVVPTLPPY--PKKSSDRTKKILAVCLTLAVFAVFVASGICFVFYTRH 272
Query: 332 XXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXXXXXXXXXXXXXXXLEGGGAE 391
Y PHR Y+E+ ATK F E+ L G AE
Sbjct: 273 KKVKEVLEEWEIQ----YGPHRFAYKELLNATKDFKEKQLLGKGGFGQVFKGTLPGSNAE 328
Query: 392 IAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDK 451
IAVKR SH++ G FLAEIS++GRL+H +LV L G+C R K +L LVYD+ NGSLDK
Sbjct: 329 IAVKRTSHDSRQGMSEFLAEISTIGRLRHPNLVRLLGYC-RHKENLYLVYDFTPNGSLDK 387
Query: 452 WIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511
++ + + L+ E+R +++KDVA+ +L+LH+ W + ++HRDIK +NVL+D EMN R+GD
Sbjct: 388 YLDRNENQERLTWEQRFKIIKDVASALLHLHQEWVQIIIHRDIKPANVLIDHEMNARIGD 447
Query: 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
FGLA+++ G T+RV GT GY+APE+ +GRA+T TDV+ FG+++LEV+ GRR IE
Sbjct: 448 FGLAKLYDQGLDPQTSRVAGTFGYIAPELLRTGRATTSTDVYAFGLVMLEVVCGRRMIER 507
Query: 572 GKPN----LVEMVWELMVQGKXXXXXXXXXXXKGGFDEDEVERVLHLGLLCAYPDPRARP 627
P LV+ + EL GK + + E+E +L LGLLCA+ RP
Sbjct: 508 RAPENEEVLVDWILELWESGKLFDAAEESIRQEQ--NRGEIELLLKLGLLCAHHTELIRP 565
Query: 628 TMRQVVKVLEG 638
M V+++L G
Sbjct: 566 NMSAVMQILNG 576
|
|
| TAIR|locus:2097533 AT3G59740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 9.0e-93, P = 9.0e-93
Identities = 216/568 (38%), Positives = 331/568 (58%)
Query: 83 FSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEF 142
FS + IF + P HG+ F+F P G+ GA+ Q+LG+FN TN+G +SN+V +E
Sbjct: 67 FSFNIIFGIVPEHKQQGSHGMAFVFSPTRGLPGASPDQYLGIFNETNNGKASNNVIAIEL 126
Query: 143 DVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQXXXXXXXXXXXXXXXEKSFKEL 202
D+ K++EF DID+NHVGI++N LTSV++ +AGY+ D + +FK+L
Sbjct: 127 DIRKDEEFGDIDDNHVGININGLTSVASASAGYYDDE----------------DGNFKKL 170
Query: 203 KLNNGKNYQVWIDYA--DSFINITMVEAGMK-RPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
L + K ++ I Y+ D +N+T++ A + P++ LLS+ +LS +E Y+GFTA+
Sbjct: 171 SLISTKVMRLSIVYSHTDKQLNVTLLPAEISVPPQKSLLSLNRDLSPYFLEETYLGFTAS 230
Query: 260 TGQLVESHKILAWSFSNTKFSLSEEL-ITSGLPSFVLPKDSIFKSKGFIAG-VTVGGLFI 317
TG + + ++ +S+ + +L + LP + PK S +++ +A +T+
Sbjct: 231 TGSIGALYYVMQFSYEEGVIYPAWDLGVIPTLPPY--PKKSYDRTRRILAVCLTLAVFTA 288
Query: 318 IVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEAATKGFSEEXXXXXXXX 377
+VA + +F ++ PHR +Y+E+ ATKGF E+
Sbjct: 289 LVASGIGFVFYVRHKKVKEVLEEWEIQNG----PHRFSYKELFNATKGFKEKQLLGKGGF 344
Query: 378 XXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437
L G AEIAVKR SH++ G FLAEIS++GRL+H +LV L G+CK K +L
Sbjct: 345 GQVYKGMLPGSDAEIAVKRTSHDSRQGMSEFLAEISTIGRLRHPNLVRLLGYCKH-KENL 403
Query: 438 MLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494
LVYD+M NGSLD+ + + + L+ E+R +++KDVA +L+LH+ W + ++HRDI
Sbjct: 404 YLVYDFMPNGSLDRCLTRSNTNENQERLTWEQRFKIIKDVATALLHLHQEWVQVIVHRDI 463
Query: 495 KSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFG 554
K +NVLLD MN RLGDFGLA+++ G T+RV GT+GY+APE+ +GRA+T TDV+
Sbjct: 464 KPANVLLDHGMNARLGDFGLAKLYDQGFDPQTSRVAGTLGYIAPELLRTGRATTSTDVYA 523
Query: 555 FGILILEVLSGRRPIE----EGKPNLVEMVWELMVQGKXXXXXXXXXXXKGGFDEDEVER 610
FG+++LEV+ GRR IE E + LV+ + EL GK + + E+E
Sbjct: 524 FGLVMLEVVCGRRLIERRAAENEAVLVDWILELWESGKLFDAAEESIRQEQ--NRGEIEL 581
Query: 611 VLHLGLLCAYPDPRARPTMRQVVKVLEG 638
VL LGLLCA+ RP M V+++L G
Sbjct: 582 VLKLGLLCAHHTELIRPNMSAVLQILNG 609
|
|
| TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 3.3e-91, Sum P(3) = 3.3e-91
Identities = 144/353 (40%), Positives = 200/353 (56%)
Query: 302 KSKGFIAGVTVGGLFIIVAVVLCSLFLIKXXXXXXXXXXXXXXXXXXYWPHRITYQEIEA 361
++ G IAGV G F + A+ +LF + P +Y+E++A
Sbjct: 313 ENPGTIAGVVTAGAFFL-ALFAGALFWVYSKKFKRVERSDSFASEIIKAPKEFSYKELKA 371
Query: 362 ATKGFSEEXXXXXXXXXXXXXXXLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHK 421
TK F+E L G +AVKR SH + FL+E+S +G L+H+
Sbjct: 372 GTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLSELSIIGSLRHR 431
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL 481
+LV L+GWC EKG ++LVYD M NGSLDK +F+ L + R ++L VA+ + YL
Sbjct: 432 NLVRLQGWC-HEKGEILLVYDLMPNGSLDKALFE--SRFTLPWDHRKKILLGVASALAYL 488
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H E +V+HRD+KSSN++LD+ N +LGDFGLAR H + T GT+GYLAPE
Sbjct: 489 HRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGTMGYLAPEYL 548
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEG----------KPNLVEMVWELMVQGKXXX 591
+GRAS +TDVF +G ++LEV+SGRRPIE+ PNLVE VW L +GK
Sbjct: 549 LTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGLYKEGKVSA 608
Query: 592 XXXXXXXXKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGI 644
+G FDE E+ RVL +GL C++PDP RPTMR VV++L G+ + +
Sbjct: 609 AADSRL--EGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEADVPV 659
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9S9U1 | LRK71_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6226 | 0.9404 | 0.9664 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 705 | |||
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 2e-90 | |
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 6e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-27 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 2e-90
Identities = 119/255 (46%), Positives = 151/255 (59%), Gaps = 27/255 (10%)
Query: 24 SAVDFVFNGF-NSSNLSLYGTATV-ESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVY 81
S V F +NGF N SNL+L G ATV + +L LTN T + GRALY I ++ V
Sbjct: 1 STVSFNYNGFSNVSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTGKVA 60
Query: 82 PFSTSFIFAMAPY-KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGV 140
FSTSF+FA+ K G GL F P GA+ +LGLFN +N+GNSSNH+ V
Sbjct: 61 SFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 141 EFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFK 200
EFD F N EFNDID+NHVGIDVNS+ SV++ +A SF
Sbjct: 121 EFDTFLNPEFNDIDDNHVGIDVNSIISVASESA------------------------SFV 156
Query: 201 ELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260
L LN+GK QVWIDY S +++ A +PKRPLLS ++LS VL + +YVGF+A+T
Sbjct: 157 PLDLNSGKPIQVWIDYDGSSKRLSVTLAYPNKPKRPLLSASVDLSTVLPEWVYVGFSAST 216
Query: 261 GQLVESHKILAWSFS 275
G ESH +L+WSFS
Sbjct: 217 GGATESHYVLSWSFS 231
|
Length = 231 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 6e-87
Identities = 117/259 (45%), Positives = 154/259 (59%), Gaps = 31/259 (11%)
Query: 26 VDFVFNGFNS--SNLSLYGTATVESR-ILTLTNST--TFTIGRALYPSKIPTKRPNSSYV 80
+ F FNGF+S SNL+L G AT+ S L LTN T ++GRALY + + V
Sbjct: 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKV 60
Query: 81 YPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGV 140
FSTSF F++ P L G GL F P + A+ +LGLFN +N+GNSSNH+ V
Sbjct: 61 ASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 141 EFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFK 200
EFD F+N EF D D+NHVGIDVNSL SV AGYW D+
Sbjct: 121 EFDTFQNPEFGDPDDNHVGIDVNSLVSV---KAGYWDDD--------------------- 156
Query: 201 ELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258
KL +GK Q WIDY + +++T+ +G+ +PK+PLLS P++LS VL +E+YVGF+A
Sbjct: 157 GGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSA 216
Query: 259 ATGQLVESHKILAWSFSNT 277
+TG L E H IL+WSFS+
Sbjct: 217 STGLLTELHYILSWSFSSN 235
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G G VYK +G G +AVK + E + EI L RL H ++V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+K L LV +Y E G L ++ + G LS +E ++ + G+ YLH
Sbjct: 66 AF-EDKDHLYLVMEYCEGGDLFDYLSR-GGP--LSEDEAKKIALQILRGLEYLHS---NG 118
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR-AS 547
++HRD+K N+LLD+ ++ DFGLA+ + TT VGT Y+APEV G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607
+ DV+ G+++ E+L+G +P G+ L ++ +L+ + L L
Sbjct: 178 PKVDVWSLGVILYELLTG-KPPFSGENILDQL--QLIRRI-----LGPPLEFDEPKWSSG 229
Query: 608 VERVLHL--GLLCAYPDPRARPTMRQVVK 634
E L L DP RPT ++++
Sbjct: 230 SEEAKDLIKKCLN--KDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 27/273 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLV 424
+ +G G GKVY + G +A+K I + R L EI L +LKH ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHE 483
L ++ L LV +Y E G L + + G + E+ R L+ + + + YLH
Sbjct: 61 RLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKR-GRL---SEDEARFYLRQILSALEYLHS 115
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
K ++HRD+K N+LLD++ + +L DFGLAR G+ +T VGT Y+APEV
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLG 170
Query: 544 GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603
D++ G+++ E+L+G+ P G L+E+ ++ + + K +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-PGDDQLLEL-FKKIGKPKPPF-----PPPEWDI 223
Query: 604 DEDEVERVLHL--GLLCAYPDPRARPTMRQVVK 634
+ L LL DP R T + ++
Sbjct: 224 SPE----AKDLIRKLLV--KDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRGWC 430
+G GG G VY + G ++A+K I E+ L EI L +L H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ ++ L LV +Y E GSL + + +G LS +E +R+L + G+ YLH ++
Sbjct: 61 E-DENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 491 HRDIKSSNVLLDKEMNGR--LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRAS 547
HRD+K N+LLD + NG+ L DFGL+++ + T VGT Y+APEV G S
Sbjct: 115 HRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYS 172
Query: 548 TQTDVFGFGILILE 561
++D++ G+++ E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 369 ENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSL 423
+G G G+VYKG L+G G E+AVK + + FL E + +L H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L G C E+ L +V +YME G L ++ + LS + + +A G+ YL
Sbjct: 64 VKLLGVC-TEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLES 120
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
K +HRD+ + N L+ + + ++ DFGL+R + ++APE
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 544 GRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
G+ ++++DV+ FG+L+ E+ + G +P G N V E + G L
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEE--VLEYLKNGYRLPQPPN------- 227
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E+ ++ L C DP RPT ++V++L
Sbjct: 228 -CPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHENDGGTRA-FLAEISSLGRLKHKSL 423
+G G G+VYKG L+G G E+AVK + + FL E + +L H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L G C E+ LM+V +YM G L ++ + LS + + +A G+ YL
Sbjct: 64 VKLLGVC-TEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLES 121
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV--ASTTRVVGTVGYLAPEVF 541
K +HRD+ + N L+ + + ++ DFGL+R ++ + ++APE
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
G+ ++++DV+ FG+L+ E+ + G P G N V E + +G L K
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP-YPGMSN--AEVLEYLKKGYRLP--------K 225
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E+ +++ L C DP RPT ++V++L
Sbjct: 226 PPNCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 9e-39
Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 370 NVIGVGGNGKVYKGVLEGGGA---EIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVG 425
+G G G+VYKG L+G E+AVK + + R FL E + +L H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWI------FQCDGSMMLSCEERIRVLKDVAAGVL 479
L G C E+ L LV +YME G L ++ F LS ++ + +A G+
Sbjct: 61 LLGVC-TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYL 536
YL KK +HRD+ + N L+ +++ ++ DFGL+R G + ++
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT--GGKLPIRWM 174
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595
APE G ++++DV+ FG+L+ E+ + G P + E ++L+ L
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-------LSNE-----EVLEYLRK 222
Query: 596 RLR-AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
R K + DE+ ++ L C DP RPT ++V+ LE
Sbjct: 223 GYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 77/275 (28%), Positives = 134/275 (48%), Gaps = 31/275 (11%)
Query: 371 VIGVGGNGKVYKGVL----EGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVG 425
+G G G+VYKG L EG ++AVK + R FL E S + +L H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C + L +V +YM G L ++ + L+ ++ +++ +A G+ YL
Sbjct: 66 LLGVCTQG-EPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLES-- 120
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG---QVASTTRVVGTVGYLAPEVFS 542
K +HRD+ + N L+ + + ++ DFGL+R + ++ + ++APE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIKWMAPESLK 177
Query: 543 SGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
G+ ++++DV+ FG+L+ E+ + G +P G N E V EL+ G L +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSN--EEVLELLEDGYRLPRPE------- 227
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
DE+ ++ L C DP RPT ++V+ L
Sbjct: 228 -NCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
++G G G VY + + G +AVK +S +++ A EI L L+H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 428 GWCKR--EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC----EERIRVL-KDVAAGVLY 480
G +R EK +L + +Y+ GSL S++ E IR + + G+ Y
Sbjct: 66 G-SERDEEKNTLNIFLEYVSGGSL--------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR-VVGTVGYLAPE 539
LH ++HRDIK +N+L+D + +L DFG A+ G + T V GT ++APE
Sbjct: 117 LHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRP 568
V D++ G ++E+ +G+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT--RAFLAEISSLGRLKHKSLVGLR 427
++IG G G VYKG+ G +A+K+IS E ++ + EI L LKH ++V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
G SL ++ +Y ENGSL + I + + V G+ YLHE +
Sbjct: 66 G-SIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHE---Q 118
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
V+HRDIK++N+L K+ +L DFG+A + VVGT ++APEV AS
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKP 574
T +D++ G ++E+L+G P + P
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNP 204
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 68/223 (30%), Positives = 114/223 (51%), Gaps = 21/223 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRG- 428
IG G G+VYK + G +A+K+I +E +G + EI L +L+H ++V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 429 WCKREKGSLMLVYDYME---NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
+ KGS+ +V++YM+ G LD + + + +K + G+ YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDS------PEVKFTESQIKCYMKQLLEGLQYLHS-- 118
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEV-FSS 543
+LHRDIK SN+L++ + +L DFGLAR T RV+ T+ Y PE+ +
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 544 GRASTQTDVFGFGILILEVLSGRRPIEEGK--PNLVEMVWELM 584
R + D++ G ++ E+ G +PI +G +E ++EL
Sbjct: 177 TRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFELC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F IG GG G+VYK + G E+A+K I E+ + EI L + KH ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEG 484
G +K L +V ++ GSL + + ++ E +I V K++ G+ YLH
Sbjct: 62 YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL---TESQIAYVCKELLKGLEYLHS- 116
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRVVGTVGYLAPEVF 541
++HRDIK++N+LL + +L DFGL+ Q++ T +VGT ++APEV
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLS-----AQLSDTKARNTMVGTPYWMAPEVI 169
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEE 571
+ + D++ GI +E+ G+ P E
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 11/220 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ IG G GKVY + G +K I S+ ++ L E+ L +L H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLH 482
+ EKG L +V +Y + G L + I + EE+I + + YLH
Sbjct: 62 IKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVF 541
+K+LHRDIK N+ L +LGDFG+++ + +A T VVGT YL+PE+
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELC 175
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMV 580
+ + ++D++ G ++ E+ + + P E E L +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ IG G +G+VYK G E+A+K++ + EI + KH ++V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVD 79
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLHEG 484
L +V +YM+ GSL I Q M E +I V ++V G+ YLH
Sbjct: 80 YYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN---EPQIAYVCREVLQGLEYLHS- 134
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
+ V+HRDIKS N+LL K+ + +L DFG A + + VVGT ++APEV
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRK 191
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ D++ GI+ +E+ G P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 69/199 (34%), Positives = 108/199 (54%), Gaps = 15/199 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKHKSLVGLRGWC 430
IG G G V G G ++AVK + ++D +AFLAE S + L+H +LV L G
Sbjct: 14 IGKGEFGDVMLGDYRG--QKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ L +V +YM GSL ++ + G +++ +++ DV G+ YL E K +
Sbjct: 70 -LQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRD+ + NVL+ +++ ++ DFGLA+ GQ + V T APE + ST++
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 551 DVFGFGILILEVLS-GRRP 568
DV+ FGIL+ E+ S GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 100/362 (27%), Positives = 178/362 (49%), Gaps = 36/362 (9%)
Query: 287 TSGLPSFVLPKDSIFKSKG--FIAGVTVGGLFIIVAVVLCSLFLIKRKQRRAREREEMED 344
TSGLP P + K+ F T+G F+++A+V I+ + +R E ED
Sbjct: 613 TSGLP----PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENED 667
Query: 345 --WELEYWPHR----ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS 398
WEL+++ + IT +I ++ K EENVI G G YKG G + VK I+
Sbjct: 668 GTWELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN 724
Query: 399 HENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG 458
N +EI+ +G+L+H ++V L G C+ EKG+ L+++Y+E +L + +
Sbjct: 725 DVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGA-YLIHEYIEGKNLSEVLRN--- 776
Query: 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518
LS E R ++ +A + +LH V+ ++ +++D + L R+
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLS 827
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE---EGKPN 575
G + + T+ + Y+APE + + ++D++GFG++++E+L+G+ P + +
Sbjct: 828 LPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887
Query: 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635
+VE L +D +R +++E+ V++L L C DP ARP V+K
Sbjct: 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947
Query: 636 LE 637
LE
Sbjct: 948 LE 949
|
Length = 968 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/257 (28%), Positives = 102/257 (39%), Gaps = 39/257 (15%)
Query: 22 SISAVDFVFNGFNSSNLSLYGTATV--ESRILTLTNSTTFTIGRALYPSKIPTKRPNSSY 79
S++ +F N N SN L G+AT+ +S +L LT T G A Y + I
Sbjct: 2 SLNFSNFSNN--NQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS------ 53
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
F+T+F F + KG G+ F+ A G +
Sbjct: 54 -KDFTTTFKFYL-GTKGTNGADGIAFVLQN-----DPAGALGGGGGGGGLGYGGIGNSVA 106
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
VEFD +KN + ND + NH+ IDVN + +A A S GS S
Sbjct: 107 VEFDTYKNDDNNDPNGNHISIDVNGNGNNTALAT---------SLGSASLPNGT------ 151
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVE-AGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258
G + V I Y D N V +++P++L + + Y GFTA
Sbjct: 152 -----GLGNEHTVRITY-DPTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTA 205
Query: 259 ATGQLVESHKILAWSFS 275
+TG L H IL WSF+
Sbjct: 206 STGGLTNLHDILNWSFT 222
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 82/278 (29%), Positives = 145/278 (52%), Gaps = 32/278 (11%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLV 424
E VIG G G+V +G L+ G + +A+K + + +D FL E S +G+ H +++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G + + +M++ +YMENGSLDK++ + DG + + + +L+ +A+G+ YL E
Sbjct: 69 RLEGVVTKSR-PVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSE- 124
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVG---TVGYLAPEVF 541
+HRD+ + N+L++ + ++ DFGL+R + TT+ G + + APE
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAI 180
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
+ + ++ +DV+ FGI++ EV+S G RP W++ Q ++ A++ R
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP-----------YWDMSNQ-DVIKAVEDGYRLP 228
Query: 601 GGFDEDEVERVLH-LGLLCAYPDPRARPTMRQVVKVLE 637
D L+ L L C D RPT Q+V L+
Sbjct: 229 PPMDCPS---ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSL 423
+ + +G G G VYK + G +A+K R+ +E +G L EIS L LKH ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA----AGVL 479
V L + L LV++Y + L K++ + G + ++K + G+
Sbjct: 61 VKLLDVI-HTERKLYLVFEYCDM-DLKKYLDKRPGPL------SPNLIKSIMYQLLRGLA 112
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
Y H +LHRD+K N+L++++ +L DFGLAR G T VV T+ Y APE
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168
Query: 540 V-FSSGRASTQTDVFGFGILILEVLSGR 566
+ S ST D++ G + E+++G+
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 38/272 (13%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRGW 429
V+G G +G VYK + G A+K+I + D R L E+ +L + +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSM---MLSCEERIRVLKDVAAGVLYLHEGWE 486
+E G + +V +YM+ GSL + + G + +L+ + + + G+ YLH +
Sbjct: 68 FYKE-GEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAY-----IARQILKGLDYLHT--K 118
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV-----VGTVGYLAPEVF 541
+ ++HRDIK SN+L++ + ++ DFG+++ V T VGTV Y++PE
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK------VLENTLDQCNTFVGTVTYMSPERI 172
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
S D++ G+ +LE G+ P P +ELM + D L A+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQA--ICDGPPPSLPAEE 227
Query: 602 GFDE--DEVERVLHLGLLCAYPDPRARPTMRQ 631
E D + L DP+ RP+ +
Sbjct: 228 FSPEFRDFISACLQ-------KDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 78/278 (28%), Positives = 140/278 (50%), Gaps = 27/278 (9%)
Query: 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA----FLAEISSLGRLKHKS 422
+++ VIG G G+V++G+L+ G + I G T FL+E S +G+ H +
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
++ L G + K M++ +YMENG+LDK++ DG S + + +L+ +AAG+ YL
Sbjct: 68 IIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYLS 124
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG--YLAPEV 540
+ +HRD+ + N+L++ + ++ DFGL+R+ + T G + + APE
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
+ + ++ +DV+ FGI++ EV+S G RP W++ +++ A++ R
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP-----------YWDMSNH-EVMKAINDGFRL 229
Query: 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
D V L L C D RP +V +L+
Sbjct: 230 PAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 73/286 (25%), Positives = 136/286 (47%), Gaps = 32/286 (11%)
Query: 370 NVIGVGGNGKVYKGVLE----GGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLV 424
+G G GKV + G ++AVK ++H + R+ F EI L L H+++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 425 GLRGWCKREKG-SLMLVYDYMENGSLDKWI----FQCDGSMMLSCEERIRVLKDVAAGVL 479
+G C++ G SL L+ +Y+ +GSL ++ Q + +L +I G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI------CKGMD 123
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLA 537
YL ++ +HRD+ + N+L++ E ++ DFGLA++ + + G + + A
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV---WELMVQGKLLDALD 594
PE + + S+ +DV+ FG+ + E+ + P + + M+ M+ +LL+ L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 595 --ARL-RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL R DE V L LC +P+ RP+ ++ +++
Sbjct: 241 EGERLPRPPSCPDE-----VYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 24/284 (8%)
Query: 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKH- 420
+ +G G G+VY +A+K ++ + FL EI L L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
++V L +++GSL LV +Y++ GSL+ + + LS E + +L + + + Y
Sbjct: 58 PNIVKLYD-FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMN-GRLGDFGLAR-----MHGHGQVASTTRVVGTVG 534
LH K ++HRDIK N+LLD++ +L DFGLA+ A + VGT G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 535 YLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMVWELMVQGKLL 590
Y+APEV AS+ +D++ GI + E+L+G P E E + +++++
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ +L L DP+ R + +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLA---KDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F +G G G VYK + + G +A+K + + + + EIS L + +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC-----EERIR-VLKDVAAGVL 479
G + L +V +Y GS+ D +M EE I +L G+
Sbjct: 63 YYG-SYFKNTDLWIVMEYCGAGSV------SD--IMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGY 535
YLH K +HRDIK+ N+LL++E +L DFG++ GQ+ T V+GT +
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS-----GQLTDTMAKRNTVIGTPFW 165
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
+APEV + + D++ GI +E+ G+ P + P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 86/272 (31%), Positives = 134/272 (49%), Gaps = 31/272 (11%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G V G + G ++AVK I +ND +AFLAE S + +L+H +LV L G
Sbjct: 11 LQTIGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
EKG L +V +YM GSL ++ + G +L + ++ DV + YL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGRA 546
+HRD+ + NVL+ ++ ++ DFGL + AS+T+ G V + APE +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEALREKKF 176
Query: 547 STQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
ST++DV+ FGIL+ E+ S GR P + L ++V + +G +DA D
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVE-KGYKMDAPDGC--------- 224
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
V + C + D RP+ Q+ + LE
Sbjct: 225 --PPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 83/282 (29%), Positives = 145/282 (51%), Gaps = 31/282 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLV 424
E VIG G G+V +G L+ G +A+K + S + R FL+E S +G+ H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G + + +M++ ++MENG+LD ++ Q DG + + + +L+ +AAG+ YL E
Sbjct: 69 HLEGVVTKSR-PVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLSE- 124
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST-TRVVG---TVGYLAPEV 540
+HRD+ + N+L++ + ++ DFGL+R T T +G + + APE
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
+ + ++ +DV+ +GI++ EV+S G RP W++ Q +++A++ R
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP-----------YWDMSNQ-DVINAIEQDYRL 230
Query: 600 KGGFDEDEVERVLH-LGLLCAYPDPRARPTMRQVVKVLEGKI 640
D LH L L C D ARP Q+V L+ I
Sbjct: 231 PPPMD---CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHK 421
F VIG G GKV A+K ++ G R L E L L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 422 SLVGLR-GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVL 479
LV L + E + LV D + G L + Q + EE+++ + ++ +
Sbjct: 61 FLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALE 114
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
YLH K ++HRDIK N+LLD++ + + DF +A + TT GT GY+APE
Sbjct: 115 YLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPE 169
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
V S D + G+ E L G+RP
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFL-AEISSLGRLKHKSLVGLR 427
IG G G V K + G + K I + N + L +E++ L LKH ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 428 GWCK-REKGSLMLVYDYMENGSLDKWIFQC--DGSMMLSCEER--IRVLKDVAAGVLYLH 482
R +L +V +Y E G L + I +C + + EE R+L + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI---EEEFIWRILTQLLLALYECH 122
Query: 483 EGWEKK--VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
+ VLHRD+K +N+ LD N +LGDFGLA++ GH + T VGT Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQ 181
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIE 570
+ ++D++ G LI E+ + P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 83/280 (29%), Positives = 144/280 (51%), Gaps = 29/280 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLV 424
E VIG G G+V G L+ G +A+K + + + R FL+E S +G+ H +++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G + K +M+V +YMENGSLD ++ + DG + + + +L+ +A+G+ YL
Sbjct: 69 HLEGVVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYLS-- 123
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFS 542
+ +HRD+ + N+L++ + ++ DFGL+R+ A+ T G + + APE +
Sbjct: 124 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 543 SGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ ++ +DV+ +GI++ EV+S G RP WE+ Q ++ A++ R
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP-----------YWEMSNQ-DVIKAIEEGYRLPA 230
Query: 602 GFDEDEVERVLH-LGLLCAYPDPRARPTMRQVVKVLEGKI 640
D LH L L C D RP Q+V +L+ I
Sbjct: 231 PMD---CPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
F N IG G G V+K V + A+K+I S N + E L +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 424 VGLRGW-CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYL 481
+ R + +KG L +V +Y ENG L K + G + E+++ R + G+ +L
Sbjct: 62 I--RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL--PEDQVWRFFIQILLGLAHL 117
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H KK+LHRDIKS N+ LD N ++GD G+A++ + T +VGT YL+PE+
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELC 173
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIE 570
+ ++DV+ G+++ E +G+ P +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 66/199 (33%), Positives = 111/199 (55%), Gaps = 15/199 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+IG G G V +G E G ++AVK I + D +AFL E + + +L HK+LV L G
Sbjct: 13 IIGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
L +V + M G+L ++ + G ++S + ++ DVA G+ YL KK++
Sbjct: 69 LHN--GLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLV 122
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRD+ + N+L+ ++ ++ DFGLAR+ G +++ V + APE + S+++
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKL--PVKWTAPEALKHKKFSSKS 178
Query: 551 DVFGFGILILEVLS-GRRP 568
DV+ +G+L+ EV S GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 372 IGVGGNGKVYKGV-LEGGGAEI--AVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLR 427
+G G G V KGV L G E+ AVK + E G + FL E S + +L H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
G CK E LMLV + G L K++ + + +S + + VA G+ YL K
Sbjct: 63 GVCKGE--PLMLVMELAPLGPLLKYLKK-RREIPVS--DLKELAHQVAMGMAYLES---K 114
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGR 545
+HRD+ + NVLL ++ DFG++R G G G + + APE + G+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 546 ASTQTDVFGFGILILEVLS-GRRPIEEGK-PNLVEMV 580
S+++DV+ +G+ + E S G +P E K ++ M+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 73/243 (30%), Positives = 119/243 (48%), Gaps = 45/243 (18%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGL--- 426
+G G G+VYK G +A+K+I +E DG L EI L +LKH ++V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 427 ----RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV--------LKDV 474
KR++GS+ +V YM++ D S +L +++ + +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH----------DLSGLLE-NPSVKLTESQIKCYMLQL 124
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-------MHGHGQVAST- 526
G+ YLHE +LHRDIK++N+L+D + ++ DFGLAR G T
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 527 --TRVVGTVGYLAPE-VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL--VEMVW 581
T +V T Y PE + R +T D++G G + E+ + RRPI +GK ++ + +++
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKSDIDQLHLIF 240
Query: 582 ELM 584
+L
Sbjct: 241 KLC 243
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKS 422
+ E + +G G G V K L+ G A+K I+ N + L E+ K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 423 LVGLRGWCKREK-GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVL 479
+V G E S+ + +Y E GSLD + RI +VL +A VL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSI-----YKKVKKRGGRIGEKVLGKIAESVL 115
Query: 480 ----YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGY 535
YLH +K++HRDIK SN+LL ++ +L DFG++ + + T GT Y
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFY 169
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE-EGKPNLV 577
+APE S +DV+ G+ +LEV R P EG+P L
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
IG G G V+ G ++A+K I E F+ E + +L H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
E+ + LV+++ME+G L ++ G S E + + DV G+ YL V+H
Sbjct: 70 -ERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESS---NVIH 123
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD+ + N L+ + ++ DFG+ R Q S+T V + +PEVFS + S+++D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 552 VFGFGILILEVLS-GRRPIE 570
V+ FG+L+ EV S G+ P E
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 10/207 (4%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F+ E +G G G+V++G L +A+K + ++ + F E+ +L RL+HK L+
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L C + + ++ + ME GSL ++ +G + L I + VA G+ YL E
Sbjct: 67 LFAVCSVGE-PVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEE-- 122
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG-QVASTTRVVGTVGYLAPEVFSSG 544
+ +HRD+ + N+L+ +++ ++ DFGLAR+ ++S ++ + APE S G
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 545 RASTQTDVFGFGILILEVLS-GRRPIE 570
ST++DV+ FGIL+ E+ + G+ P
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 41/275 (14%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRG 428
+G G +G V K + G +AVK I E + + L E+ L + +VG G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL----YLHEG 484
G + + +YM+ GSLDK + + G + ERI L +A VL YLHE
Sbjct: 67 AFYNN-GDISICMEYMDGGSLDKILKEVQGRI----PERI--LGKIAVAVLKGLTYLHE- 118
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ----VASTTRVVGTVGYLAPEV 540
+ K++HRD+K SN+L++ +L DFG++ GQ +A T VGT Y+APE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTF--VGTSSYMAPER 170
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELM---VQGKLLDALDAR 596
S ++D++ G+ ++E+ +GR P N + ++EL+ V
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY--PPENDPPDGIFELLQYIVNE------PPP 222
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
G F D + V LC DPR RP+ ++
Sbjct: 223 RLPSGKFSPDFQDFV----NLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 71/206 (34%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G VYK + G +A+K+I E++G + L EI L L H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEGWEKK 488
R KG L LV+++M+ L K I E I+ L + G+ + H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRAS 547
+LHRD+K N+L++ E +L DFGLAR G V T V T Y APE+ S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGK 573
T D++ G + E+LS RRP+ GK
Sbjct: 178 TPVDIWSVGCIFAELLS-RRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G GKV + G A+K + + L E + L R+ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEK 487
+ + + L LV +Y G L + + S EER R ++ + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFS-EERARFYAAEIVLALEYLHS---L 112
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
+++RD+K N+LLD + + +L DFGLA+ + T GT YLAPEV
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 548 TQTDVFGFGILILEVLSGRRP 568
D + G+L+ E+L+G+ P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 60/232 (25%), Positives = 114/232 (49%), Gaps = 27/232 (11%)
Query: 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRISHENDGGTRA-FLAE 411
EI + F EE +G G GKVYKG L G +A+K + + + F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 412 ISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQ-------------CDG 458
+ L+H ++V L G C +E+ + ML ++Y+ +G L +++ +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-M 517
L C + + + +AAG+ YL +HRD+ + N L+ + + ++ DFGL+R +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
+ ++ + V ++ PE G+ +T++D++ FG+++ E+ S G +P
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 34/264 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT---RAFLAEISSLGRLKHKSLVGLRG 428
+G G G+V++G+ +AVK + GT + FLAE + +L+H L+ L
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
C E+ + +V + M+ GSL +++ Q L + I + VA+G+ YL +
Sbjct: 69 VCTLEE-PIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QN 123
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD+ + NVL+ + ++ DFGLAR+ + + + APE R S
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 549 QTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA--RLRAKGGFDE 605
++DV+ FGIL+ E+++ GR P + M ++L +D R+ G
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP------------YPGMTNAEVLQQVDQGYRMPCPPG--- 228
Query: 606 DEVERVLH-LGLLCAYPDPRARPT 628
+ L+ + L C DP RPT
Sbjct: 229 --CPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 66/281 (23%), Positives = 134/281 (47%), Gaps = 33/281 (11%)
Query: 372 IGVGGNGKVYKGVLEG-----GGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLVG 425
+G G G VY+G+ +G +A+K ++ + + FL E S + +V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWI-------FQCDGSMMLSCEERIRVLKDVAAGV 478
L G + + ++V + M G L ++ G + ++ I++ ++A G+
Sbjct: 74 LLGVVSTGQPT-LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLA 537
YL KK +HRD+ + N ++ +++ ++GDFG+ R ++ + + V ++A
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596
PE G +T++DV+ FG+++ E+ + +P +G N E V + ++ G LD
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSN--EEVLKFVIDGGHLD----- 241
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
E+ +++L L +C +P+ RPT ++V L+
Sbjct: 242 ------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 74/231 (32%), Positives = 108/231 (46%), Gaps = 36/231 (15%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA---EISSLGRLKHKSLVGL 426
N IG G GKVY V G +AVK I + D + E+ L LKH +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 427 RGW-CKREKGSLMLVYDYME---NGSLDKWIFQCDGSMMLSCEERIRVL-KDVAAGVLYL 481
G REK VY +ME G+L++ + +L E IRV + G+ YL
Sbjct: 65 YGVEVHREK-----VYIFMEYCSGGTLEEL---LEHGRILD-EHVIRVYTLQLLEGLAYL 115
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNG--RLGDFGLARMHGHGQVASTTRVVGTVG---YL 536
H ++HRDIK +N+ LD NG +LGDFG A + V G Y+
Sbjct: 116 HS---HGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 537 APEVFSSGRASTQ---TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584
APEV + G+ D++ G ++LE+ +G+RP E ++ +++M
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE-----LDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 371 VIGVGGNGKV----YKGVLEGGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVG 425
V+G G GKV Y +G G +AVK + E + + EI+ L L H+++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 426 LRGWCKREKG-SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+G C + G L L+ +Y+ GSL ++ + L+ + + + + G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS- 125
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFS 542
+ +HRD+ + NVLLD + ++GDFGLA+ G R G V + A E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV---WELMVQGKLLDALDARLRA 599
+ S +DV+ FG+ + E+L+ + EM+ M +L++ L+ +R
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
++ + V L C + + RPT R ++ +L+
Sbjct: 244 PC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKHKSLVGL 426
+G G VYK + G +A+K+I DG L EI L LKH +++GL
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK--DVAA-------G 477
K ++ LV+++ME L+K I +++ VL D+ + G
Sbjct: 68 LD-VFGHKSNINLVFEFME-TDLEKVI-----------KDKSIVLTPADIKSYMLMTLRG 114
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
+ YLH W +LHRD+K +N+L+ + +L DFGLAR G T +VV T Y A
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 538 PEVFSSGRA-STQTDVFGFGILILEVLSGRRPI 569
PE+ R D++ G + E+L R P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 21/221 (9%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLRG 428
VIGVG VY + ++A+KRI E + L E+ ++ + H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 429 WCK-REKGSLMLVYDYMENGS-LD--KWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLH 482
+ L LV Y+ GS LD K + G +E I VLK+V G+ YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL-----DEAIIATVLKEVLKGLEYLH 119
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL-ARMHGHGQVASTTR--VVGTVGYLAPE 539
+HRDIK+ N+LL ++ + ++ DFG+ A + G R VGT ++APE
Sbjct: 120 S---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 540 VFSSGRASTQ-TDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
V D++ FGI +E+ +G P + P V M
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM 217
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 21/265 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G V+ G G ++A+K I E F+ E + +L H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGK-IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
+++ + +V +YM NG L ++ + G L E + + DV + YL +H
Sbjct: 70 KQR-PIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES---NGFIH 123
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD+ + N L+ ++ ++ DFGLAR Q S+ V + PEVF R S+++D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 552 VFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV 611
V+ FG+L+ EV S + E N V E + G L +L EV +
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRLY--RPKLAPT------EVYTI 233
Query: 612 LHLGLLCAYPDPRARPTMRQVVKVL 636
++ C + P RP ++++ L
Sbjct: 234 MY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 79/269 (29%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWC 430
IG G G+V+ G L +AVK +A FL E L + H ++V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+K + +V + ++ G ++ + +G L +E I+++++ AAG+ YL K +
Sbjct: 63 T-QKQPIYIVMELVQGGDFLTFL-RTEGPR-LKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT-VGYLAPEVFSSGRASTQ 549
HRD+ + N L+ ++ ++ DFG++R G AST + V + APE + GR S++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 550 TDVFGFGILILEVLS-GRRPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAKGGFDEDE 607
+DV+ FGIL+ E S G P NL + E + QG L E
Sbjct: 177 SDVWSFGILLWEAFSLGAVPY----ANLSNQQTREAIEQGVRLPC-----------PELC 221
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVL 636
+ V L C DP RP+ V + L
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G VYKG + G +A+K+I E+ +G + EIS L L+H ++V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
+E L L+++++ L K++ + E L + G+L+ H ++V
Sbjct: 68 LMQES-RLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRV 122
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF-SSGRAST 548
LHRD+K N+L+D + +L DFGLAR G T VV T+ Y APEV S R ST
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYST 181
Query: 549 QTDVFGFGILILEVLSGRRPIEEG 572
D++ G + E+ + ++P+ G
Sbjct: 182 PVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
IG G G VYKGVL+G E+AVK R FL E L + H ++V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNT-EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+K + +V + + GSL ++ + + + ++ +++ D AAG+ YL K +
Sbjct: 62 V-QKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLES---KNCI 115
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHG--QVASTTRVVGTVGYLAPEVFSSGRAST 548
HRD+ + N L+ + ++ DFG++R G V+ + + + + APE + GR ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTS 174
Query: 549 QTDVFGFGILILEVLSG 565
++DV+ +GIL+ E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 57/198 (28%), Positives = 109/198 (55%), Gaps = 9/198 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G+V+ G G ++A+K + + AFLAE + + +L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGH-TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
+E + ++ +YMENGSL ++ +G L+ + I + +A G+ ++ K +H
Sbjct: 72 QE--PIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD++++N+L+ + + ++ DFGLAR+ + + + + APE + G + ++D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 552 VFGFGILILEVLS-GRRP 568
V+ FGIL+ E+++ GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 33/283 (11%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAE-----IAVKRISHENDGGTRA-FLAEISSLGRLKHKSL 423
+G G G+VY+G+ G + +AVK + + FL E + + H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC----DGSMMLSCEERIRVLKDVAAGVL 479
V L G E+ ++ + M G L ++ + + L+ ++ + +DVA G
Sbjct: 72 VRLIGVS-FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGR---LGDFGLAR-MHGHGQVASTTRVVGTVGY 535
YL E +HRDI + N LL + GR + DFG+AR ++ R + + +
Sbjct: 131 YLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALD 594
+ PE F G +++TDV+ FG+L+ E+ S G P G+ N + V E + G
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-PGRTN--QEVMEFVTGG------- 237
Query: 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL G V + C P RP +++ ++
Sbjct: 238 GRLDPPKGCP----GPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA--FLAEISSLGRLKHKSL 423
+ IG G G V + G ++A+K+I H D T A L E+ L KH ++
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 424 VGLRGWCKREKGSLM----LVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGV 478
+ +R R G+ +V D ME+ L I D + EE IR L + G+
Sbjct: 67 IAIRD-ILRPPGADFKDVYVVMDLMES-DLHH-IIHSDQPLT---EEHIRYFLYQLLRGL 120
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRVVGTVGY 535
Y+H V+HRD+K SN+L++++ R+GDFG+AR T V T Y
Sbjct: 121 KYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 536 LAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
APE+ S +T D++ G + E+L GRR + GK
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 47/291 (16%)
Query: 371 VIGVGGNGKVYKGVLEGGGAE-----IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLV 424
+G G GKV+ G E +AVK + R F E L +H+++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKW---------IFQCDGSMM--LSCEERIRVLKD 473
G C ++V++YME+G L+K+ + S M L+ + +++
Sbjct: 72 KFYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT--RVVG 531
+A+G++YL + +HRD+ + N L+ ++ ++GDFG++R V +T RV G
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182
Query: 532 T----VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586
+ ++ PE + +T++DV+ FG+++ E+ + G++P G N E V E + Q
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSN--EEVIECITQ 239
Query: 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
G+LL R + E V + L C DP+ R ++ + + L+
Sbjct: 240 GRLLQ------RPRTCPSE-----VYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 37/230 (16%)
Query: 361 AATKGFSE---ENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSL 415
+A K SE N IG G G VYK + G A+K I +HE D R EI L
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEIL 126
Query: 416 GRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA 475
+ H ++V G + ++ ++M+ GSL+ G+ + + V + +
Sbjct: 127 RDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQIL 178
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVG 531
+G+ YLH + ++HRDIK SN+L++ N ++ DFG++R+ +A T VG
Sbjct: 179 SGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI-----LAQTMDPCNSSVG 230
Query: 532 TVGYLAPEVFSS--------GRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T+ Y++PE ++ G A D++ G+ ILE GR P G+
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAG---DIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 77/273 (28%), Positives = 133/273 (48%), Gaps = 36/273 (13%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-----RAFLAEISSLGRLKHKSLVGL 426
+G G G VY+G+ G AVK +S +DG T + EI+ L +L+H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVL-KDVAAGVLYLHEGW 485
G +RE+ +L + + + GSL K + + GS E IR+ + + G+ YLH+
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAK-LLKKYGSFP---EPVIRLYTRQILLGLEYLHD-- 120
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV---ASTTRVVGTVGYLAPEVF- 541
+ +HRDIK +N+L+D +L DFG+A+ QV + G+ ++APEV
Sbjct: 121 -RNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
G D++ G +LE+ +G+ P + + V V+++ + K L + L +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKI-GRSKELPPIPDHLSDEA 231
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+D + L C DP RPT ++++
Sbjct: 232 ---KDFI-------LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G+V+ G G ++AVK + AFL E + +L+H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
E+ + +V +YM GSL ++ +G L + + + +A G+ YL + +H
Sbjct: 72 EEE-PIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLES---RNYIH 126
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD+ + N+L+ + + ++ DFGLAR+ + + + + APE + GR + ++D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 552 VFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR-AKGGFDEDEVE 609
V+ FGIL+ E+++ GR P + M ++L+ ++ R + +E+
Sbjct: 187 VWSFGILLTEIVTYGRVP------------YPGMTNREVLEQVERGYRMPRPPNCPEELY 234
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVLE 637
++ L C DP RPT + LE
Sbjct: 235 DLM---LQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G G+VYK + G +A+K R+ +E +G + EI L +L H+++V L+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 428 GWC---------KREKGSLMLVYDYMEN---GSLDKWIFQCDGSMMLSCEERIR-VLKDV 474
K++KG+ LV++YM++ G L+ ++ E+ I+ +K +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-------GLVHFSEDHIKSFMKQL 125
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534
G+ Y H+ K LHRDIK SN+LL+ + +L DFGLAR++ + T V T+
Sbjct: 126 LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 535 YLAPE-VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
Y PE + R DV+ G ++ E+ + ++PI + L ++
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G GG G+V ++ G A K++ + G + L E L ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ K L LV M G L I+ G L E I + G+L+LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+++RD+K NVLLD + N RL D GLA G+ + T+ GT GY+APE+ S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSY 173
Query: 549 QTDVFGFGILILEVLSGRRPIEEGK 573
D F G I E+++GR P ++ K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 11/193 (5%)
Query: 391 EIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
++A+K I +E F+ E + +L H LV L G C ++K L +V ++MENG L
Sbjct: 30 KVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIVTEFMENGCLL 87
Query: 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510
++ Q G LS + + + +DV G+ YL +HRD+ + N L+ ++
Sbjct: 88 NYLRQRQGK--LSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVS 142
Query: 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPI 569
DFG+ R + S++ V + PEVF+ + S+++DV+ FG+L+ EV + G+ P
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
Query: 570 EEGKPNL--VEMV 580
E+ K N VEM+
Sbjct: 203 EK-KSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 35/285 (12%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
V+G G G V K + G +A+K + S +++ + L E+ L +L+H+++V L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+R KG L LV++Y+E L+ G L + + + + Y H
Sbjct: 68 AFRR-KGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHS---HN 120
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVF-SSGRA 546
++HRDIK N+L+ + +L DFG AR + T V T Y APE+
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179
Query: 547 STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM--------VQGKLLDALDARLR 598
DV+ G ++ E+L G P+ G + ++ ++ + +L + + R
Sbjct: 180 GKPVDVWAIGCIMAELLDG-EPLFPGD-SDIDQLYLIQKCLGPLPPSHQELFSS-NPRFA 236
Query: 599 AKGGFDEDEVERVLH----------LGLL--CAYPDPRARPTMRQ 631
+ + E + L L C DP+ R T +
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKHKSLVGLRGWC 430
+G G VYKG G +A+K I + + GT + EIS + LKH+++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 431 KREKGSLMLVYDYMENGSLDKWI----FQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
E LMLV++YM+ L K++ + ++LK G+ + HE
Sbjct: 68 HTEN-KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLK----GIAFCHE--- 118
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+VLHRD+K N+L++K +L DFGLAR G + VV T+ Y AP+V R
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRT 177
Query: 547 -STQTDVFGFGILILEVLSGRRPIEEGKPN 575
ST D++ G ++ E+++G RP+ G N
Sbjct: 178 YSTSIDIWSVGCIMAEMITG-RPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEIS 413
YQ++E IG G G VYK + G +A+K+I E++G + EIS
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS 50
Query: 414 SLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLK 472
L L H ++V L E L LV++++ + L K++ + + I+ L
Sbjct: 51 LLKELNHPNIVRLLDVVHSEN-KLYLVFEFL-DLDLKKYMDSSPLTGL--DPPLIKSYLY 106
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT 532
+ G+ Y H +VLHRD+K N+L+D+E +L DFGLAR G T VV T
Sbjct: 107 QLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-T 162
Query: 533 VGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPI 569
+ Y APE+ R ST D++ G + E+++ RRP+
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLK----- 419
F+ IG G G+VYK + + +A+K I E + EI L + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 420 --HKSLVGLRGWCKREKGS-LMLVYDYMENGSLDKWIFQCDGSMMLSC---EERIR-VLK 472
+ S + KGS L ++ +Y GS ++ E I +L+
Sbjct: 63 KYYGSFL---------KGSKLWIIMEYCGGGSC--------LDLLKPGKLDETYIAFILR 105
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR---- 528
+V G+ YLHE E K+ HRDIK++N+LL +E + +L DFG++ GQ+ ST
Sbjct: 106 EVLLGLEYLHE--EGKI-HRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNT 157
Query: 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT ++APEV + D++ GI +E+ G P
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 70/231 (30%), Positives = 118/231 (51%), Gaps = 26/231 (11%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSL 423
F + N IG G G VY+ G +A+K++ +N DG + L EI+ L L+H ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 424 VGLR----GWCKREKGSLMLVYDYMEN--GSLDKWIFQCDGSMMLSCEERIRVL-KDVAA 476
V L+ G + S+ LV +Y E SL D E +++ L +
Sbjct: 69 VELKEVVVG---KHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLR 119
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ YLHE + ++HRD+K SN+LL + ++ DFGLAR +G T +VV T+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175
Query: 537 APEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP--NLVEMVWELM 584
APE+ +T D++ G ++ E+L+ +P+ GK ++++ +L+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQLDLIIQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLV 424
E ++G G G++ +G L+ +A+ + + +D R FLAE +LG+ H ++V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE- 483
L G R ++M+V +YM NG+LD ++ + +G L + + +L +A+G+ YL E
Sbjct: 70 RLEGVITR-GNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEM 126
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
G+ +H+ + + VL++ ++ ++ F + + +T V + APE
Sbjct: 127 GY----VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 544 GRASTQTDVFGFGILILEVLS-GRRP 568
S+ +DV+ FGI++ EV+S G RP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTR-----AFLAEISSLGRLKH 420
+IG G G+VY + G +AVK++ + A +EI +L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC----EERIR-VLKDVA 475
++V G + + L + +Y+ GS+ GS + + E+ +R + V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSI--------GSCLRTYGRFEEQLVRFFTEQVL 118
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG--HGQVASTTRVVGTV 533
G+ YLH K +LHRD+K+ N+L+D + ++ DFG+++ + + + + G+V
Sbjct: 119 EGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSV 174
Query: 534 GYLAPEVFSSGRA--STQTDVFGFGILILEVLSGRRP 568
++APEV S S + D++ G ++LE+ +GRRP
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG-----TRAFLAEISSLGRLKHKSLVGL 426
+G G G+VY G E+AVK++ + D A EI L L+H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
G C R+ +L + +YM GS+ + G++ + + + + GV YLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYT--RQILEGVEYLHS--- 122
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFG----LARMHGHGQVASTTRVVGTVGYLAPEVFS 542
++HRDIK +N+L D N +LGDFG L + G + V GT +++PEV S
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEVIS 180
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
+ DV+ G ++E+L+ + P E +
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G V+K +A+KR+ ++D G + L EI L LKHK++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWEK 487
+K L LV++Y + L K+ C+G + + ++LK G+ + H
Sbjct: 68 LHSDK-KLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK----GLAFCHS---H 118
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRA 546
VLHRD+K N+L++K +L DFGLAR G V + V T+ Y P+V F +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 547 STQTDVFGFGILILEVLSGRRPIEEGK 573
ST D++ G + E+ + RP+ G
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-18
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 25/268 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G+V+ G G +A+K + AFL E + +L+H+ LV L
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
E + +V +YM GSL ++ + + L + + + +A+G+ Y+ +H
Sbjct: 72 EE--PIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD++++N+L+ + + ++ DFGLAR+ + + + + APE GR + ++D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVER 610
V+ FGIL+ E+ + GR P + MV ++LD ++ R E
Sbjct: 186 VWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPC---PPECPE 230
Query: 611 VLH-LGLLCAYPDPRARPTMRQVVKVLE 637
LH L C +P RPT + LE
Sbjct: 231 SLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 81/299 (27%), Positives = 125/299 (41%), Gaps = 73/299 (24%)
Query: 370 NVIGVGGNGKVYKGVL---EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVG 425
VIG G G VY G L +G AVK ++ D FL E + H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD-------VAAGV 478
L G C +GS ++V YM++G L +I E +KD VA G+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGM 111
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR---------MHGHGQVASTTRV 529
YL KK +HRD+ + N +LD+ ++ DFGLAR +H H
Sbjct: 112 EYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--- 165
Query: 530 VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
V ++A E + + +T++DV+ FG+L+ WELM +G
Sbjct: 166 ---VKWMALESLQTQKFTTKSDVWSFGVLL---------------------WELMTRGAP 201
Query: 590 ----LDA-------LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+D+ L R + + D + V+ L C +P P RPT ++V +E
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM---LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRG- 428
VIG G GKVYK + G +A+K + D E + L + H ++ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEI-KEEYNILRKYSNHPNIATFYGA 71
Query: 429 WCKR----EKGSLMLVYDYMENGS---LDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLY 480
+ K+ L LV + GS L K + + + EE I +L++ G+ Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK---EEWIAYILRETLRGLAY 128
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
LHE KV+HRDIK N+LL K +L DFG++ T +GT ++APEV
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYWMAPEV 184
Query: 541 FSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ + DV+ GI +E + +GKP L +M
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIE-------LADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 66/271 (24%), Positives = 132/271 (48%), Gaps = 23/271 (8%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
++ +G G G+VY+GV + +AVK + E+ FL E + + +KH +LV L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
C RE ++ ++M G+L ++ +C+ ++ + + +++ + YL + K
Sbjct: 70 VCTREP-PFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KN 124
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD+ + N L+ + ++ DFGL+R+ + + + APE + + S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 549 QTDVFGFGILILEVLS-GRRPIEEGKPNL-VEMVWELMVQGKLLDALDARLRAKGGFDED 606
++DV+ FG+L+ E+ + G P P + + V+EL+ +G ++ R +G
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEKGYRME------RPEGC---- 230
Query: 607 EVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+V L C +P RP+ ++ + E
Sbjct: 231 -PPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 61/244 (25%), Positives = 117/244 (47%), Gaps = 23/244 (9%)
Query: 391 EIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
E+ + R+S + R L EI L L+H +++ + +L++ +Y G+L
Sbjct: 32 EVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAYYNHFM-DDNTLLIEMEYANGGTLY 87
Query: 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510
I + G + E + L + + V Y+H+ +LHRDIK+ N+ L K +LG
Sbjct: 88 DKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLG 143
Query: 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
DFG++++ G + T VVGT Y++PE+ + + ++D++ G ++ E+L+ +R +
Sbjct: 144 DFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
Query: 571 EGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMR 630
N + +V +++ QG + E+ ++H DP RPT
Sbjct: 203 --ATNPLNLVVKIV-QG-------NYTPVVSVYSS-ELISLVH---SLLQQDPEKRPTAD 248
Query: 631 QVVK 634
+V+
Sbjct: 249 EVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF----LAEISSLGRLKHKSLVGLR 427
IG G G+V+K + +A+K++ EN+ F L EI L LKH+++V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 77
Query: 428 GWCK-------REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
C+ R KGS LV+++ E+ D + ++ + E +V+K + G+ Y
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS----TTRVVGTVGYL 536
+H K+LHRD+K++N+L+ K+ +L DFGLAR + + T RVV T+ Y
Sbjct: 135 IHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190
Query: 537 APEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEG 572
PE+ R D++G G ++ E+ + R PI +G
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--TRAFLAEISSLGRLKHKSLVGLRG 428
IG G GK+Y + +K I A E+ L ++KH ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+E G L +V +Y + G L K I + G ++ S ++ + ++ G+ ++H+ +K
Sbjct: 67 -SFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 489 VLHRDIKSSNVLLDKE-MNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+LHRDIKS N+ L K M +LGDFG+AR ++ ++A T VGT YL+PE+ +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPY 179
Query: 547 STQTDVFGFGILILEVLSGRRPIE 570
+ +TD++ G ++ E+ + + P E
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL 423
K ++ IG G +G VY + G E+A+K+++ + + EI + KH ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 424 VG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVL 479
V L + ++ L +V +Y+ GSL + + +G + C E ++ L+
Sbjct: 79 VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE------- 129
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRDIKS N+LL + + +L DFG Q +T +VGT ++APE
Sbjct: 130 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPE 185
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRP 568
V + + D++ GI+ +E++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 371 VIGVGGNGKVYKGV----LEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVG 425
V+G G G VYKGV E +A+K + E + L E + + H +V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM----MLSCEERIRVLKDVAAGVLYL 481
L G C + L+ M G L ++ ++ +L+ +I A G+ YL
Sbjct: 74 LLGICLSS--QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ---VASTTRVVGTVGYLAP 538
E K+++HRD+ + NVL+ + ++ DFGLA++ + A +V + ++A
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMAL 180
Query: 539 EVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKP 574
E + ++DV+ +G+ + E+++ G +P EG P
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPY-EGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR----AFLAEISSLGRLKHKSLVGL 426
V+G G G V+ + + +K+I E T+ A E L L H +++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
+K +LM+V +Y G+L ++I Q + +L + +L +L LH
Sbjct: 65 YENFLEDK-ALMIVMEYAPGGTLAEYI-QKRCNSLLDEDT---ILHFFVQILLALHHVHT 119
Query: 487 KKVLHRDIKSSNVLLDK-EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
K +LHRD+K+ N+LLDK +M ++GDFG++++ A T VVGT Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKP 177
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM--VQGKLLDALDARLRAKGGF 603
+ ++D++ G ++ E+ S +R E NL +V ++M + D LR
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAA--NLPALVLKIMSGTFAPISDRYSPDLRQL--- 232
Query: 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVV 633
+ +L+L DP RP + Q++
Sbjct: 233 ----ILSMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 21/266 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G+V+ G G ++AVK + +FL E + +L+H LV L
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
E + +V +YM GSL ++ +G L + + VAAG+ Y+ +H
Sbjct: 72 EE--PIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD++S+N+L+ + ++ DFGLAR+ + + + + APE GR + ++D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV 611
V+ FGIL+ E+++ R G N V E + +G R+ E +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNN--REVLEQVERG-------YRMPCPQDCPISLHELM 236
Query: 612 LHLGLLCAYPDPRARPTMRQVVKVLE 637
L C DP RPT + LE
Sbjct: 237 LQ----CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
+G G V+KG + +A+K R+ HE +G + E+S L LKH ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
+K SL LV++Y++ L +++ C G++M +I L + G+ Y H +KV
Sbjct: 73 VHTDK-SLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKI-FLYQILRGLAYCHR---RKV 125
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRAST 548
LHRD+K N+L+++ +L DFGLAR + VV T+ Y P+V S ST
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 549 QTDVFGFGILILEVLSGR 566
Q D++G G + E+ SGR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G V G G ++A+K I E F+ E + +L H+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQ-YDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
+++ + +V +YM NG L ++ + + + + KDV G+ YL K+ +H
Sbjct: 70 KQR-PIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIH 123
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD+ + N L+D + ++ DFGL+R + S+ V + PEV + S+++D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 552 VFGFGILILEVLS-GRRPIE 570
V+ FG+L+ EV S G+ P E
Sbjct: 184 VWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 62/222 (27%), Positives = 112/222 (50%), Gaps = 12/222 (5%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT--RAFLAEISSLGRLKHKSLVGLRG 428
V+G G G+V G + +K+++ N +A E L +LKH ++V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ E G L +V + E G L + + G ++ + + +A + YLHE K
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHE---KH 122
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
+LHRD+K+ NV L + ++GD G+AR + +AST ++GT Y++PE+FS+ +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
++DV+ G + E+ + + N +V+ + ++GKL
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRI-IEGKL 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G GKVYK + G A K I E++ F+ EI L KH ++VGL
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-AY 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEGWEKKVL 490
+ L ++ ++ + G+LD + + + + E +IR V + + + +LH KV+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLT---EPQIRYVCRQMLEALNFLHS---HKVI 125
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGL-ARMHGHGQVASTTRVVGTVGYLAPEV-----FSSG 544
HRD+K+ N+LL + + +L DFG+ A+ Q T +GT ++APEV F
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 545 RASTQTDVFGFGILILEVLSGRRPIEEGKP 574
+ D++ GI ++E+ P E P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 35/273 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT---RAFLAEISSLGRLKHKSLVGLRG 428
+G G G+V+ G G ++A+K + GT AFL E + +L+H LV L
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
E + +V ++M GSL ++ + DG L + + + +A G+ Y+
Sbjct: 69 VVSEE--PIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIER---MN 122
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD++++N+L+ + ++ DFGLAR+ + + + + APE GR +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 549 QTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA--RLRAKGGFDE 605
++DV+ FGIL+ E+++ GR P + MV ++L+ ++ R+ G E
Sbjct: 183 KSDVWSFGILLTELVTKGRVP------------YPGMVNREVLEQVERGYRMPCPQGCPE 230
Query: 606 DEVERVLH-LGLLCAYPDPRARPTMRQVVKVLE 637
LH L LC DP RPT + LE
Sbjct: 231 S-----LHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 36/233 (15%)
Query: 365 GFSEENVIGVGGNGKVYKGVLEGG--GAEIAVKRI---SHENDGGTRAFLAEISSLGRLK 419
+ E IG G G+VYK + G G E A+K+ + G +++ EI+ L LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 420 HKSLVGLRGWC-KREKGSLMLVYDYMENGSLDKW----------IFQCDGSMMLSCEERI 468
H+++V L + S+ L++DY E+ D W SM+ S
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKS----- 112
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL--DKEMNGR--LGDFGLARMHGH--GQ 522
+L + GV YLH W VLHRD+K +N+L+ + G +GD GLAR+
Sbjct: 113 -LLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQT-DVFGFGILILEVLSGRRPIEEGKP 574
+A VV T+ Y APE+ R T+ D++ G + E+L+ PI +G+
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 21/219 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLK---H 420
+ E IG G G VYK G +A+K R+ +G + L EI+ L +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 421 KSLVGLRGWC-----KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDV 474
++V L C RE L LV+++++ L ++ +C + E I+ +++ +
Sbjct: 61 PNIVRLLDVCHGPRTDREL-KLTLVFEHVDQ-DLATYLSKCPKPGL--PPETIKDLMRQL 116
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534
GV +LH +++HRD+K N+L+ + ++ DFGLAR++ ++A T+ VV T+
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLW 171
Query: 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
Y APEV +T D++ G + E L RRP+ G
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G GG G+V ++ G A K++ + G + L E L ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ K L LV M G L I+ G I + G+ +LH+ ++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQ---RR 115
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+++RD+K NVLLD N R+ D GLA G+ GT GY+APEV
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 549 QTDVFGFGILILEVLSGRRPIEEGK 573
D F G + E+++GR P + K
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G VYK IA+K R+ E++G + EIS L ++H ++V L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWEK 487
EK L LV++Y++ L K D S + R+ L + G+ Y H
Sbjct: 70 VHSEK-RLYLVFEYLDL-DLKK---HMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---H 121
Query: 488 KVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+VLHRD+K N+L+D+ N +L DFGLAR G T VV T+ Y APE+ R
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180
Query: 547 -STQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
ST D++ G + E+++ ++P+ G + E+
Sbjct: 181 YSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDEL 213
|
Length = 294 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 23/228 (10%)
Query: 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR 417
E E E V+G G G VY IA+K I + + EI+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 418 LKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD-----KWIFQCDGSMMLSCEERIRVLK 472
LKH+++V G E G + + + GSL KW G + + + I K
Sbjct: 62 LKHRNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKW-----GPLKDNEQTIIFYTK 115
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG--RLGDFGLA-RMHGHGQVASTTRV 529
+ G+ YLH+ +++HRDIK NVL++ +G ++ DFG + R+ G T
Sbjct: 116 QILEGLKYLHD---NQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTET--F 169
Query: 530 VGTVGYLAPEVFSSGRA--STQTDVFGFGILILEVLSGRRP-IEEGKP 574
GT+ Y+APEV G D++ G I+E+ +G+ P IE G+P
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 56/189 (29%), Positives = 103/189 (54%), Gaps = 12/189 (6%)
Query: 391 EIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
EI + ++S + +R E++ L +KH ++V + E G+L +V DY E G L
Sbjct: 32 EINISKMSPKEREESRK---EVAVLSNMKHPNIVQYQE-SFEENGNLYIVMDYCEGGDLY 87
Query: 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510
K I G ++ ++ + + + ++H+ +K+LHRDIKS N+ L K+ +LG
Sbjct: 88 KKINAQRG-VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLG 143
Query: 511 DFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569
DFG+AR ++ ++A T +GT YL+PE+ + + ++D++ G ++ E+ + +
Sbjct: 144 DFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201
Query: 570 EEGK-PNLV 577
E G NLV
Sbjct: 202 EAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 67/267 (25%), Positives = 131/267 (49%), Gaps = 47/267 (17%)
Query: 392 IAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDK 451
+AVK + + F E L L+H+ +V G C + L++V++YM++G L+K
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-DGDPLIMVFEYMKHGDLNK 96
Query: 452 WI---------------FQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
++ Q G + LS + + + +A+G++YL + +HRD+ +
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIASQIASGMVYLAS---QHFVHRDLAT 151
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTT--RVVG----TVGYLAPEVFSSGRASTQT 550
N L+ + ++GDFG++R V ST RV G + ++ PE + +T++
Sbjct: 152 RNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 551 DVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVE 609
DV+ FG+++ E+ + G++P + V E + QG++L+ R+ K +D
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTE---VIECITQGRVLER--PRVCPKEVYD----- 256
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVL 636
+ LG C +P+ R ++++ K+L
Sbjct: 257 --IMLG--CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 45/222 (20%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISH------ENDGGTRAFLAEISSLGRLKHKSLV 424
+G G Y+ G +AVK++++ E + A EI + RL H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLS----CEERI--RVLKDVAAGV 478
+ G E L ++M GS+ S +LS +E + + + G+
Sbjct: 67 RMLG-ATCEDSHFNLFVEWMAGGSV---------SHLLSKYGAFKEAVIINYTEQLLRGL 116
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVASTT--------RV 529
YLHE +++HRD+K +N+L+D R+ DFG A ++A+ ++
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAA-----ARLAAKGTGAGEFQGQL 168
Query: 530 VGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRP 568
+GT+ ++APEV GR+ DV+ G +I+E+ + + P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSC---DVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 389 GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC-KREKGSLMLVYDYMENG 447
G +AVK++ H R F EI L L+H ++V +G C + +L LV +Y+ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 448 SLDKWIFQ----CDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK 503
SL ++ + D +L +I G+ YL K+ +HRD+ + N+L++
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQI------CKGMEYLGS---KRYVHRDLATRNILVES 143
Query: 504 EMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGRASTQTDVFGFGILILE 561
E ++GDFGL ++ + R G + + APE + + S +DV+ FG+++ E
Sbjct: 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 562 VLS----GRRPIEEGKPNLVEMVWELMVQGKLLDAL--DARLRAKGGFDEDEVERVLHLG 615
+ + P E + M+ L++ L + RL A G E+ ++
Sbjct: 204 LFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGC-PAEIYAIM--- 259
Query: 616 LLCAYPDPRARPTMRQVVKVLE 637
C DP RP+ ++ +E
Sbjct: 260 KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G VYK + G +A+K R+ E +G + EIS L L H ++V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
E L LV++++ + L K++ S + L + G+ + H +V
Sbjct: 68 IHTEN-KLYLVFEFL-HQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHS---HRV 121
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR-AST 548
LHRD+K N+L++ E +L DFGLAR G V + T V T+ Y APE+ + ST
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 549 QTDVFGFGILILEVLSGR 566
D++ G + E+++ R
Sbjct: 181 AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/197 (30%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRGWC 430
+G G V+KG + +A+K I E++ G + E+S L LKH ++V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
E+ L LV++Y+++ L +++ C G++M +I + + + G+ Y H+ +K+L
Sbjct: 73 HTER-CLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQ-LLRGLSYCHK---RKIL 125
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRASTQ 549
HRD+K N+L++++ +L DFGLAR + VV T+ Y P+V S ST
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 550 TDVFGFGILILEVLSGR 566
D++G G ++ E+ +GR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 66/241 (27%), Positives = 122/241 (50%), Gaps = 34/241 (14%)
Query: 372 IGVGGNGKV-----YKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGL 426
+G G GKV Y E +AVK + +D + F E L L+H+ +V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWI--FQCDGSMM--------LSCEERIRVLKDVAA 476
G C E L++V++YM++G L+K++ D +M L+ + + + + +AA
Sbjct: 73 YGVCV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT--RVVG--- 531
G++YL + +HRD+ + N L+ + + ++GDFG++R V ST RV G
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTM 183
Query: 532 -TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKL 589
+ ++ PE + +T++DV+ G+++ E+ + G++P + N V E + QG++
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQGRV 240
Query: 590 L 590
L
Sbjct: 241 L 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
+G G VYKG + +A+K R+ HE +G + E+S L LKH ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEKK 488
EK SL LV++Y++ L +++ C S+ + +++ L + G+ Y H +K
Sbjct: 73 IHTEK-SLTLVFEYLDK-DLKQYLDDCGNSINM---HNVKLFLFQLLRGLNYCHR---RK 124
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRAS 547
VLHRD+K N+L+++ +L DFGLAR + VV T+ Y P++ S S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 548 TQTDVFGFGILILEVLSGR 566
TQ D++G G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVGLRG 428
+G G VYKG + G +A+K I E++ G F A E S L LKH ++V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEK 487
+K +L LV++Y++ L +++ C G + + +R+ L + G+ Y H+ +
Sbjct: 71 IIHTKK-TLTLVFEYLDT-DLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCHQ---R 122
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT---RVVGTVGYLAPEVF-SS 543
+VLHRD+K N+L+ + +L DFGLAR V S T VV T+ Y P+V S
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAK---SVPSKTYSNEVV-TLWYRPPDVLLGS 178
Query: 544 GRASTQTDVFGFGILILEVLSGR 566
ST D++G G + E+ +GR
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 55/260 (21%)
Query: 370 NVIGVGGNGKVYKG----VLEGGGAEI--AVKRISH-ENDGGTRAFLAEISSLGRLKHKS 422
N +G G G+VY+G +L G I AVK + D + FL E + H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWI----FQCDGSMMLSCEERIRVLKDVAAGV 478
+V L G C ++ + ME G L ++ + G +L+ +E + + DVA G
Sbjct: 61 IVKLLGVC-LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGR-----LGDFGLAR---------MHGHGQVA 524
+YL + +HRD+ + N L+ ++ +GDFGLAR G G +
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175
Query: 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPI-------------E 570
V ++APE G+ +TQ+DV+ FG+L+ E+L+ G++P
Sbjct: 176 -------PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
Query: 571 EGK----PNLVEMVWELMVQ 586
G+ N + +++LM
Sbjct: 229 GGRLQKPENCPDKIYQLMTN 248
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 60/217 (27%), Positives = 114/217 (52%), Gaps = 31/217 (14%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIA-----VKRISHENDGGTRAFLAEISSLGRL-KHKS 422
E+VIG G G+V + +++ G ++ +K + END R F E+ L +L H +
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKLGHHPN 64
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKW-----IFQCDGSM--------MLSCEERIR 469
++ L G C+ +G L + +Y G+L + + + D + L+ ++ ++
Sbjct: 65 IINLLGACE-NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 470 VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV 529
DVA G+ YL E K+ +HRD+ + NVL+ + + ++ DFGL+R G+ +
Sbjct: 124 FASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKT 176
Query: 530 VG--TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS 564
+G V ++A E + +T++DV+ FG+L+ E++S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G +G V+K G +A+K+++ G L EI +L +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
+LV +YM L + + D L + ++ + GV Y+H +
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRAST 548
+HRD+K +N+L+ + ++ DFGLAR+ + + V T Y APE+ + + +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 549 QTDVFGFGILILEVLSGR 566
D++ G + E+L+G
Sbjct: 181 GVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G G+VY G E+AVK++ S E A EI L L+H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 426 LRGWCKR--EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
G C R E+ L + +YM GS+ Q L+ R + + GV YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKD---QLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR------MHGHGQVASTTRVVGTVGYLA 537
++HRDIK +N+L D N +LGDFG ++ M G G V GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG----IKSVTGTPYWMS 177
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
PEV S + DV+ ++E+L+ + P E
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G G+VY G E+A K++ S E A EI L L+H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 426 LRGWCKREKG--SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
G C R++ +L + +YM GS+ + + G++ S + + + G+ YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRK--YTRQILEGMSYLHS 124
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR------MHGHGQVASTTRVVGTVGYLA 537
++HRDIK +N+L D N +LGDFG ++ M G G V GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG----IRSVTGTPYWMS 177
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
PEV S + DV+ G ++E+L+ + P E
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 66/270 (24%), Positives = 128/270 (47%), Gaps = 23/270 (8%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
E +G G G+V+ ++AVK + AFLAE + + L+H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH-TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+E + ++ ++M GSL ++ +GS + I +A G+ ++ + +
Sbjct: 69 VVTKE--PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQ---RN 122
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD++++N+L+ + ++ DFGLAR+ + + + + APE + G +
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 549 QTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607
++DV+ FGIL++E+++ GR P + M +++ AL+ R E+
Sbjct: 183 KSDVWSFGILLMEIVTYGRIP------------YPGMSNPEVIRALERGYRMPR--PENC 228
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
E + ++ + C P RPT + VL+
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ IG G G VYK G +A+K I E EIS L +H ++V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 426 LRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHE 483
G + +R+K L +V +Y GSL G LS E +I V ++ G+ YLHE
Sbjct: 65 YFGSYLRRDK--LWIVMEYCGGGSLQDIYQVTRGP--LS-ELQIAYVCRETLKGLAYLHE 119
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVGTVGYLAPE 539
+HRDIK +N+LL ++ + +L DFG++ Q+ +T +GT ++APE
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPE 171
Query: 540 VF---SSGRASTQTDVFGFGILILEVLSGRRP 568
V G + D++ GI +E+ + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL 423
K ++ IG G +G V+ + G E+A+K+I+ + + EI + LK+ ++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 424 VG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVL 479
V L + ++ L +V +Y+ GSL + + + + C E ++ L+
Sbjct: 79 VNFLDSFLVGDE--LFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALE------- 129
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRDIKS NVLL + + +L DFG Q +T +VGT ++APE
Sbjct: 130 FLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPE 185
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
V + + D++ GI+ +E++ G P P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G G+VY G E+AVK++ S E A EI L L H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 426 LRGWCKRE--KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
G C R+ + +L + ++M GS+ Q L+ + + + GV YLH
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR------MHGHGQVASTTRVVGTVGYLA 537
++HRDIK +N+L D N +LGDFG ++ + G G + V GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMS 177
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
PEV S + D++ G ++E+L+ + P E
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---GTRAFLAEISSLGRLKHKSLVGL 426
IG G G V V + G ++A+K+IS+ D R L EI L L+H++++GL
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI-LREIKLLRHLRHENIIGL 64
Query: 427 R---GWCKREK-GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----VLKDVAAG 477
E + +V + ME L K I L+ ++ I+ +L+ G
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKS---PQPLT-DDHIQYFLYQILR----G 115
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVASTTRVVGTVGY 535
+ YLH V+HRD+K SN+L++ + ++ DFGLAR + T V T Y
Sbjct: 116 LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 536 LAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPI 569
APE+ SS R + D++ G + E+L R+P+
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 10/211 (4%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F + V+G GG G+V + G A KR+ + G L E L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+V L + K +L LV M G L I+ G+ E + ++ G+ LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH 119
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+ ++RD+K N+LLD + R+ D GLA G+ S VGTVGY+APEV +
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLN 174
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ R + D +G G LI E++ G+ P K
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 81/294 (27%), Positives = 137/294 (46%), Gaps = 46/294 (15%)
Query: 372 IGVGGNGKVYKGVLEG-----GGAEIAVKRI---SHENDGGTRAFLAEISSLGRL-KHKS 422
+G G G+V K G + +AVK + + E D ++E+ + + KHK+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKN 77
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWI-------FQCDGSMMLSCEERIRVLKD-- 473
++ L G C +E G L +V +Y +G+L ++ EE + KD
Sbjct: 78 IINLLGVCTQE-GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT-QKDLV 135
Query: 474 -----VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTT 527
VA G+ +L KK +HRD+ + NVL+ ++ ++ DFGLAR +H TT
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586
V ++APE + Q+DV+ FG+L+ E+ + G P G P VE +++L+ +
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP--VEELFKLLKE 249
Query: 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640
G ++ K E + HL C + P RPT +Q+V+ L+ +
Sbjct: 250 GYRME--------KPQNCTQE---LYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 55/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G G+V+ G ++AVK + +AFL E + + L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNS-TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
+E+ + ++ +YM GSL ++ +G +L + I +A G+ Y+ K +H
Sbjct: 72 KEE-PIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RD++++NVL+ + + ++ DFGLAR+ + + + + APE + G + ++D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 552 VFGFGILILEVLS-GRRP 568
V+ FGIL+ E+++ G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 415 LGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKD 473
L ++KH ++V + + + G L +V +Y + G L + I G L E+ I +
Sbjct: 52 LAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKLQRGK--LFPEDTILQWFVQ 108
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTV 533
+ GV ++HE K+VLHRDIKS N+ L + +LGDFG AR+ A VGT
Sbjct: 109 MCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTP 164
Query: 534 GYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG 572
Y+ PE++ + + ++D++ G ++ E+ + + P +
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F + V+G GG G+V + G A K++ + G L E L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+V L + K +L LV M G L I+ G + ++ G+ LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+ +++++RD+K N+LLD + R+ D GLA GQ VGTVGY+APEV
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVK 174
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ R + D + G L+ E+++G+ P ++ K
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 66/282 (23%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 371 VIGVGGNGKVYKGVL---EGGGAEIAVKRISHENDGGT--RAFLAEISSLGRLKHKSLVG 425
++G G G V +G L +G ++AVK + + + FL+E + + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 426 LRGWC--KREKGSL---MLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAG 477
L G C + M++ +M++G L ++ L + ++ + D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT-VGYL 536
+ YL + +HRD+ + N +L ++M + DFGL++ G R+ V ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595
A E + ++++DV+ FG+ + E+ + G+ P G N +++ + G
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-PGVEN--HEIYDYLRHGN------- 232
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL+ ED ++ + L C DP+ RPT ++ +VLE
Sbjct: 233 RLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 42/293 (14%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEI--AVKRIS-HENDGGTRAFLAEISSLGRL-KHKSLV 424
++VIG G G+V K ++ G + A+KR+ + + R F E+ L +L H +++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKW-----IFQCDGSM--------MLSCEERIRVL 471
L G C+ +G L L +Y +G+L + + + D + LS ++ +
Sbjct: 72 NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 472 KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVG 531
DVA G+ YL + K+ +HRD+ + N+L+ + ++ DFGL+R GQ + +G
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
Query: 532 --TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGK 588
V ++A E + +T +DV+ +G+L+ E++S G P + M +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------YCGMTCAE 231
Query: 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641
L + L R + + D + V L C P RP+ Q++ L +E
Sbjct: 232 LYEKLPQGYRLEKPLNCD--DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 46/234 (19%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLK- 419
F +IG G V + E A+K ++ E + E L RL
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLNG 60
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI--FQCDGSMMLSCEERIRVLKDVAAG 477
H ++ L + +++ +L V +Y NG L ++I + L + + AA
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LD----EKCTRFYAAE 110
Query: 478 VL----YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV---- 529
+L YLH K ++HRD+K N+LLDK+M+ ++ DFG A++ + +
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 530 ---------------VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT Y++PE+ + A +D++ G +I ++L+G+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFL-AEISSLGRLKHKSLVGLRG 428
+GVGG G+V ++ A+K + H + G + + +E L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 429 WCKREKGSLML--------VYDYM-ENGSLDKWIFQ-CDGSMMLSCEERIRVLKDVAAGV 478
K +K ML ++ + + G D++ + ++L+ E
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFE------------- 107
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
YLH + +++RD+K N+LLD +L DFG A+ GQ T GT Y+AP
Sbjct: 108 -YLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAP 161
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRP 568
E+ + D + GIL+ E+L+GR P
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEI-----AVKRISHENDGGTRAFLAEISSLGRL-KHKSL 423
+VIG G G+V K ++ G + +K + ++D R F E+ L +L H ++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 58
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKW-----IFQCDGSM--------MLSCEERIRV 470
+ L G C+ +G L L +Y +G+L + + + D + LS ++ +
Sbjct: 59 INLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
DVA G+ YL + K+ +HRD+ + N+L+ + ++ DFGL+R GQ + +
Sbjct: 118 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTM 170
Query: 531 G--TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS 564
G V ++A E + +T +DV+ +G+L+ E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 57/225 (25%), Positives = 113/225 (50%), Gaps = 29/225 (12%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKR-----ISHENDGGTRAFLA----EISSLGRLKHK 421
+IG G G VY G+ G +AVK+ +S + R+ L EI+ L L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVL 479
++V G + L + +Y+ GS+ + + + EE + ++ + G+
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALL-----NNYGAFEETLVRNFVRQILKGLN 120
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR-----VVGTVG 534
YLH + ++HRDIK +N+L+D + ++ DFG+++ +++ T + G+V
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
++APEV + + D++ G L++E+L+G+ P P+ ++
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRGW 429
++G G G+V+KG L+ +AVK + + FL+E L + H ++V L G
Sbjct: 2 LLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
C ++ + +V + + G D F L ++ ++ D AAG+ YL K
Sbjct: 61 CT-QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQ 549
+HRD+ + N L+ + ++ DFG++R G +S+ + + APE + GR S++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 550 TDVFGFGILILEVLS 564
+DV+ +GIL+ E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAE--ISSLGRLKHKSLVG 425
V+G G GKV L+G AVK + + D + E + +L KH L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEG 484
L C + K L V +Y+ G L +F S E R R ++ G+ +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFD-EPRARFYAAEIVLGLQFLHE- 114
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
+ +++RD+K NVLLD E + ++ DFG+ + G +T+ GT Y+APE+ S
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 545 RASTQTDVFGFGILILEVLSGRRPIE 570
D + G+L+ E+L+G+ P E
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVGLRGW 429
+G G VYKG+ G +A+K IS + + G F A E S L LKH ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
K +L V++YM L +++ Q G + R+ + + + G+ Y+H + +
Sbjct: 72 I-HTKETLTFVFEYMHT-DLAQYMIQHPGGLH-PYNVRLFMFQ-LLRGLAYIHG---QHI 124
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF-SSGRAST 548
LHRD+K N+L+ +L DFGLAR ++ VV T+ Y P+V + S+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEM---VWELM 584
D++G G + +E+L G +P G ++ E +W ++
Sbjct: 184 ALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWTVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 42/282 (14%)
Query: 390 AEIAVKRISHENDGGTRAFLAEISSLGRL-----KHKSLVGLRGWCKREKGSLMLVYDYM 444
+AVK + D T LA++ S L KHK+++ L G C +E G L ++ +Y
Sbjct: 45 VTVAVKML---KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-GPLYVIVEYA 100
Query: 445 ENGSLDKWI---------FQCDGSMM----LSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
G+L +++ + D + + LS ++ + VA G+ YL ++ +H
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIH 157
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
RD+ + NVL+ ++ ++ DFGLAR +H T+ V ++APE + Q+
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 551 DVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVE 609
DV+ FGIL+ E+ + G P G P VE +++L+ +G +D +
Sbjct: 218 DVWSFGILMWEIFTLGGSPY-PGIP--VEELFKLLREGHRMDK-----------PSNCTH 263
Query: 610 RVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDM 651
+ L C + P RPT +Q+V+ L+ K+ A + E D+
Sbjct: 264 ELYMLMRECWHAVPTQRPTFKQLVEALD-KVLAAVSEEYLDL 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 71/266 (26%), Positives = 129/266 (48%), Gaps = 41/266 (15%)
Query: 392 IAVKRISHENDGGTRAFLAEISSLGRL-----KHKSLVGLRGWCKREKGSLMLVYDYMEN 446
+AVK + D T L+++ S + KHK+++ L G C ++ G L ++ +Y
Sbjct: 47 VAVKML---KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVLVEYASK 102
Query: 447 GSLDKWI---------FQCDGSMM----LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRD 493
G+L +++ + D + L+ ++ + VA G+ YL +K +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRD 159
Query: 494 IKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDV 552
+ + NVL+ ++ ++ DFGLAR +H TT V ++APE + Q+DV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 553 FGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV 611
+ FG+L+ E+ + G P G P VE +++L+ +G +D K E+ +
Sbjct: 220 WSFGVLLWEIFTLGGSPY-PGIP--VEELFKLLKEGHRMD--------KPANCTHELYMI 268
Query: 612 LHLGLLCAYPDPRARPTMRQVVKVLE 637
+ C + P RPT +Q+V+ L+
Sbjct: 269 MR---ECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL 423
K ++ IG G +G VY + G E+A+K+++ + + EI + K+ ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 424 VG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVL 479
V L + ++ L +V +Y+ GSL + + +G + C E ++ L
Sbjct: 79 VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALD------- 129
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRDIKS N+LL + + +L DFG Q +T +VGT ++APE
Sbjct: 130 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPE 185
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
V + + D++ GI+ +E++ G P P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKH---KSLVGL 426
+IG G G VY+G G +A+K I+ + + + E++ L +L+ ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC-EERIR--VLKDVAAGVLYLHE 483
G + L ++ +Y E GS+ M E+ ++++V + Y+H+
Sbjct: 68 YG-SYLKGPRLWIIMEYAEGGSVRTL-------MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYLAPE 539
V+HRDIK++N+L+ N +L DFG+A + + VGT ++APE
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVA-----ALLNQNSSKRSTFVGTPYWMAPE 171
Query: 540 VFSSGRA-STQTDVFGFGILILEVLSGRRP 568
V + G+ T+ D++ GI I E+ +G P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLA 410
I YQEI +G G G VYK +AVK I + + ++
Sbjct: 1 QDIQYQEI------------LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS 48
Query: 411 EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV 470
E+ L + ++G G E + + ++M+ GSLD + + RI V
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVEN-RISICTEFMDGGSLDVY-----RKIPEHVLGRIAV 102
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
V G+ YL W K+LHRD+K SN+L++ +L DFG++ + +A T V
Sbjct: 103 A--VVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKT--YV 154
Query: 531 GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT Y+APE S + +DV+ GI +E+ GR P
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL 423
K ++ IG G +G VY + G E+A+++++ + + EI + K+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 424 VG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVL 479
V L + ++ L +V +Y+ GSL + + +G + C E ++ L+
Sbjct: 80 VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE------- 130
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRDIKS N+LL + + +L DFG Q + + +VGT ++APE
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPE 186
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
V + + D++ GI+ +E++ G P P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 30/238 (12%)
Query: 372 IGVGGNGKVYKGV--LEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRG 428
+G G G V KGV + ++A+K + +EN+ R + E + +L + +V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
C+ E +LMLV + G L+K F ++ + ++ V+ G+ YL K
Sbjct: 63 VCEAE--ALMLVMEMASGGPLNK--FLSGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGRA 546
+HRD+ + NVLL + ++ DFGL++ G R G + + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 547 STQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWELMVQ 586
S+++DV+ +GI + E S G++P IE+GK ++ LM
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKD 233
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F V+G GG G+V + G A K++ + G L E L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+V L + K +L LV M G L I+ G+ + I ++ G+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR-VVGTVGYLAPEVF 541
+++++RD+K N+LLD + R+ D GLA G+ T R VGTVGY+APEV
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI 173
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
++ + + D +G G LI E++ G+ P + K
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 65/234 (27%), Positives = 114/234 (48%), Gaps = 33/234 (14%)
Query: 419 KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF-------------QCDGSMMLSCE 465
KHK+++ L G C ++ G L ++ +Y G+L +++ LS +
Sbjct: 82 KHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 466 ERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVA 524
+ + VA G+ YL KK +HRD+ + NVL+ ++ ++ DFGLAR +H
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWEL 583
TT V ++APE + Q+DV+ FG+L+ E+ + G P G P VE +++L
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP--VEELFKL 254
Query: 584 MVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ +G +D K +E+ ++ C + P RPT +Q+V+ L+
Sbjct: 255 LKEGHRMD--------KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKR-ISHENDGGTRAF-LAEISSLGRLKHKSLVGLRGW 429
IG G G V+K G +A+K+ + E+D + L EI L +LKH +LV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 430 CKREKGSLMLVYDYMEN---GSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEGW 485
+R K L LV++Y ++ L+K E I+ ++ V + H+
Sbjct: 69 FRR-KRKLHLVFEYCDHTVLNELEKNPRGVP-------EHLIKKIIWQTLQAVNFCHK-- 118
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+HRD+K N+L+ K+ +L DFG AR+ G T V T Y APE+
Sbjct: 119 -HNCIHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRAPELLV--- 173
Query: 546 ASTQ----TDVFGFGILILEVLSGRRPIEEGKPNL 576
TQ DV+ G + E+L+G +P+ GK ++
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDV 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 78/296 (26%), Positives = 137/296 (46%), Gaps = 47/296 (15%)
Query: 371 VIGVGGNGKVYKGV---LEG--GGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLV 424
+G G GKV K L+G G +AVK + + + R L+E + L ++ H ++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWI----------FQCDGSMMLSC----EERIRV 470
L G C ++ G L+L+ +Y + GSL ++ DG+ S +ER
Sbjct: 67 KLYGACSQD-GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 471 LKDV-------AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQ 522
+ D+ + G+ YL E K++HRD+ + NVL+ + ++ DFGL+R ++
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVW 581
++ V ++A E +TQ+DV+ FG+L+ E+++ G P P E ++
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---ERLF 239
Query: 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
L+ G ++ E+ E + +L L C +P RPT + K LE
Sbjct: 240 NLLKTGYRMER-----------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 32/274 (11%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLV 424
F++ IG G G+VYKG+ +A+K I E + EI+ L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 425 GLRGWCKREKGS-LMLVYDYMENGS-LDKWIFQCDGSMMLSCEER--IRVLKDVAAGVLY 480
R + KG+ L ++ +Y+ GS LD G + EE +L+++ G+ Y
Sbjct: 66 --RYYGSYLKGTKLWIIMEYLGGGSALD---LLKPGPL----EETYIATILREILKGLDY 116
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
LH E+K+ HRDIK++NVLL ++ + +L DFG+A Q+ T VGT ++APEV
Sbjct: 117 LHS--ERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEV 172
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
+ D++ GI +E+ G P + P M ++ L+ +
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIPKNSPPTLEGQYSKP 228
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
++ VE C DPR RPT ++++K
Sbjct: 229 F---KEFVEA-------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 372 IGVGGNGKVYK----GVLEGGGAEI-AVKRISHENDGGTRA-FLAEISSLGRLKHKSLVG 425
IG G G+V++ G+L + AVK + E +A F E + + H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCD-------------------GSMMLSCEE 466
L G C K + L+++YM G L++++ + LSC E
Sbjct: 73 LLGVCAVGK-PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 467 RIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVAS 525
++ + K VAAG+ YL E +K +HRD+ + N L+ + M ++ DFGL+R ++ +
Sbjct: 132 QLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
+ + ++ PE R +T++DV+ +G+++ E+ S G +P
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 18/227 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLV 424
F + + +G G G V+K + G +A K I E R + E+ L +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLH 482
G G + G + + ++M+ GSLD+ + + G + E+I +V V G+ YL
Sbjct: 67 GFYGAFYSD-GEISICMEHMDGGSLDQ-VLKKAGRI----PEQILGKVSIAVIKGLTYLR 120
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST--TRVVGTVGYLAPEV 540
E + K++HRD+K SN+L++ +L DFG++ GQ+ + VGT Y++PE
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 173
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587
S Q+D++ G+ ++E+ GR PI +E+++ V+G
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGT-----RAFLAEISSLG 416
TKG V+G G G VY G L G IAVK++ ++ E+ L
Sbjct: 3 TKG----EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 417 RLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM--MLSCEERIRVLKDV 474
LKH ++V G C + ++ + +++ GS+ I G + + C + K +
Sbjct: 58 SLKHVNIVQYLGTC-LDDNTISIFMEFVPGGSISS-ILNRFGPLPEPVFC----KYTKQI 111
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR------MHG-HGQVASTT 527
GV YLH V+HRDIK +NV+L +L DFG AR +HG H + +
Sbjct: 112 LDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569
GT ++APEV + ++D++ G + E+ +G+ P+
Sbjct: 169 H--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F V+G GG G+V + G A K++ + G L E L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVL---KDVAAGVL 479
+V L + K +L LV M G L I+ +M + R + ++ G+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFYAAEITCGLE 116
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
LH +++++RD+K N+LLD + R+ D GLA G+ VGTVGY+APE
Sbjct: 117 DLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR--VGTVGYMAPE 171
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
V + R + D +G G LI E++ G+ P + K
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
++G G G V K + G +A+K+ S ++ + + EI L +L+H++LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+R+K L LV++++++ LD +G L + L + G+ + H
Sbjct: 68 VFRRKK-RLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS---HN 120
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVF----SS 543
++HRDIK N+L+ + +L DFG AR + G+V T V T Y APE+
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKY 178
Query: 544 GRASTQTDVFGFGILILEVLSG 565
GRA D++ G L+ E+L+G
Sbjct: 179 GRA---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLR 427
N I G G VY+ + G +A+K++ E +G L EI+ L +L+H ++V ++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 428 GWCKREKGSLM----LVYDYMEN---GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
+ GS + +V +Y+E+ ++ E ++ + +GV +
Sbjct: 71 ---EVVVGSNLDKIYMVMEYVEHDLKSLME------TMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
LH+ W +LHRD+K+SN+LL+ ++ DFGLAR +G T VV T+ Y APE+
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPEL 177
Query: 541 -FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ ST D++ G + E+L+ ++P+ GK
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 16/136 (11%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L +V +++E G+L + ++ E+ V V + +LH + V+HRDIKS
Sbjct: 91 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKS 143
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTT----RVVGTVGYLAPEVFSSGRASTQTDV 552
++LL + +L DFG QV+ +VGT ++APEV S T+ D+
Sbjct: 144 DSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 553 FGFGILILEVLSGRRP 568
+ GI+++E++ G P
Sbjct: 199 WSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLV 424
F++ IG G G+V+KG+ +A+K I E + EI+ L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 425 GLRG-WCKREKGSLMLVY-------DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
G + K K +++ Y D + G D+ FQ +LK++
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--FQI-----------ATMLKEILK 112
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ YLH EKK+ HRDIK++NVLL ++ + +L DFG+A Q+ T VGT ++
Sbjct: 113 GLDYLHS--EKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWM 168
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
APEV ++ D++ GI +E+ G P + P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G GKVYK + GA A K I +++ ++ EI L H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVL-KDVAAGVLYLHEGWEKKVL 490
+ G L ++ ++ G++D + + D + E +I+V+ + + + YLH K++
Sbjct: 80 WD-GKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-----FSSGR 545
HRD+K+ NVLL + + +L DFG++ + + +GT ++APEV
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKP 574
+ D++ GI ++E+ P E P
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLV 424
F++ IG G G+V+KG+ +A+K I E + EI+ L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 425 GLRG-WCKREKGSLMLVY-------DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
G + K K +++ Y D +E G LD+ + +L+++
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-------------TQIATILREILK 112
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVGT 532
G+ YLH EKK+ HRDIK++NVLL + +L DFG+A GQ+ T VGT
Sbjct: 113 GLDYLHS--EKKI-HRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGT 164
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
++APEV ++ D++ GI +E+ G P E P
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 15/218 (6%)
Query: 372 IGVGGNGKVYKGVLE--GGGAEIAVKRISHENDGGT--RAFLAEISSLGRLKHKSLVGLR 427
+G G G V KG+ + +AVK + ++N+ L E + + +L + +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
G C+ E S MLV + E G L+K++ + + ++ + ++ V+ G+ YL E
Sbjct: 63 GICEAE--SWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGR 545
+HRD+ + NVLL + ++ DFGL++ G + + G V + APE + +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 546 ASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582
S+++DV+ FG+L+ E S G++P + K N V + E
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 70/292 (23%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 366 FSEENVIGVGGNGKVYKGVL---EGGGAEIAVKRISHENDGGT--RAFLAEISSLGRLKH 420
F+ ++G G G V + L +G ++AVK + + + FL E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 421 KSLVGLRGWC--KREKGSL---MLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLK 472
+++ L G R KG L M++ +M++G L ++ + L + +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG---QVASTTRV 529
D+A+G+ YL K +HRD+ + N +L++ M + DFGL++ G + +++
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 530 VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP---IEEGKPNLVEMVWELMV 585
V +LA E + +T +DV+ FG+ + E+++ G+ P +E + ++ ++
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLI 229
Query: 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+G RL+ D +E V L C P+P+ RP+ + + LE
Sbjct: 230 KGN-------RLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKHKSLVGLRGWC 430
+G G G VYK + G +A+K I E D + E+ L + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWEKK 488
E G++ + +YM+ GSLDK G E + R+ V G+ +L E E
Sbjct: 69 FIE-GAVYMCMEYMDAGSLDK--LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ-VASTTRV-VGTVGYLAPEVFSSGRA 546
++HRD+K +NVL++ +L DFG++ G VAS + +G Y+APE SG
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 547 ------STQTDVFGFGILILEVLSGRRP 568
+ Q+DV+ G+ ILE+ GR P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 17/216 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLV 424
+ + IG G G V + G ++A+K+IS E+ + L EI L R KH++++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 425 GLRGWCKREKGSLM----LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
G+ + +V + ME L K I + LS + L + G+ Y
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKY 121
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH--GHGQVASTTRVVGTVGYLAP 538
+H VLHRD+K SN+LL+ + ++ DFGLAR+ H T V T Y AP
Sbjct: 122 IHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 539 EV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
E+ +S + D++ G ++ E+LS RP+ GK
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 389 GAEIAVK--RISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445
G E+A+K R + RA F E + RL H ++V L + G L V++Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---D 502
+L + + DG+ L E R++ V + H + ++HRD+K N+++
Sbjct: 63 GRTL-REVLAADGA--LPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 503 KEMNGRLGDFGL------ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFG 556
+ ++ DFG+ R + TT V+GT Y APE + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 557 ILILEVLSGRRPIE 570
++ LE L+G+R ++
Sbjct: 177 LIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 29/234 (12%)
Query: 372 IGVGGNGKVYKGV-LEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLK---HKSLVG 425
IG G GKV+K L+ GG +A+KR+ +G + + E++ L L+ H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 426 LRGWCK-----REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVL 479
L C RE L LV+++++ L ++ + + + E I+ ++ + G+
Sbjct: 69 LFDVCTVSRTDRET-KLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLLRGLD 124
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRD+K N+L+ +L DFGLAR++ + T VV T+ Y APE
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPE 179
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593
V +T D++ G + E+ R+P+ G ++ ++ GK+LD +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL-------GKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G GG G+V + G A K+++ + G + E L ++ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER-IRVLKDVAAGVLYLHEGWEK 487
+ + K L LV M G L I+ D E R + +G+ +LH+ +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
++++RD+K NVLLD + N R+ D GLA GQ + T GT G++APE+
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQGEEYD 175
Query: 548 TQTDVFGFGILILEVLSGRRP 568
D F G+ + E+++ R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAE--ISSLGRLKHKSLVG 425
V+G G GKV L+G A+K + + D + E I +L KH L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEG 484
L C + K L V +Y+ G L +FQ S E R R +V +++LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHR- 114
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
V++RD+K N+LLD E + +L DFG+ + G +TT GT Y+APE+
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 545 RASTQTDVFGFGILILEVLSGRRPIE 570
D + G+L+ E+++G+ P E
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 70/274 (25%), Positives = 112/274 (40%), Gaps = 30/274 (10%)
Query: 371 VIGVGGNGKVYKGV---LEGGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGL 426
IG G G VY+GV E +AVK + R FL E + + H +V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
G + + +V + G L ++ S L I ++ + YL
Sbjct: 73 IGVI--TENPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAYLES--- 125
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQV-ASTTRVVGTVGYLAPEVFSSG 544
K+ +HRDI + NVL+ +LGDFGL+R + AS ++ + ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFR 183
Query: 545 RASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603
R ++ +DV+ FG+ + E+L G +P + K N V E G+ L
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGERLP-----------M 229
Query: 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ + L C DP RP ++ L
Sbjct: 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKR--ISHENDGGTRAFLAEISSLGRLKHKS 422
F +G G G VYK A+K + + + EI L + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 423 LVG-----LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAA 476
++ L G L +V +Y G L K I + L E+ I R+ +
Sbjct: 61 IISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ LHE +K+LHRD+KS+N+LL ++GD G++++ +A T +GT Y+
Sbjct: 115 GLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKT--QIGTPHYM 168
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
APEV+ S ++D++ G L+ E+ + P E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 53/221 (23%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 372 IGVGGNGKVYKG-----VLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGL 426
+G G GKV+ + E +AVK + ++ + F E L L+H+ +V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQ-------CDGSMMLSC-----EERIRVLKDV 474
G C E L++V++YM +G L++++ G ++ + + + +
Sbjct: 73 YGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT--RVVG- 531
A+G++YL +HRD+ + N L+ + + ++GDFG++R + ST RV G
Sbjct: 132 ASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 532 ---TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
+ ++ PE + +T++D++ FG+++ E+ + G++P
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
L E L +H L L+ + + K L V +Y+ G L F + S E+R
Sbjct: 43 LTESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRT 97
Query: 469 RVL-KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
R ++ + + YLH G K+++RD+K N++LDK+ + ++ DFGL + G A+
Sbjct: 98 RFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMK 153
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT YLAPEV D +G G+++ E++ GR P
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 53/169 (31%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 406 RAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI----FQCDGSMM 461
R F +H LV L C + + + V +Y G L I F ++
Sbjct: 51 RIFET----ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF 105
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHG 519
+ V G+ YLHE K+++RD+K N+LLD E ++ DFGL + M G
Sbjct: 106 YAAC--------VVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-G 153
Query: 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
G ST GT +LAPEV + + D +G G+LI E+L G P
Sbjct: 154 FGDRTST--FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-13
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 40/269 (14%)
Query: 395 KRISHENDGGTRAFLA---EISSLGRLKHKSLVGLRGWCKREKGSLML-------VYDYM 444
+ I+ G+RA + EI +LGRL H++++ + + E + M+ +Y +M
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
Query: 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504
+ + D W D ++ ++ ++K + V Y+H+ KK++HRDIK N+ L+ +
Sbjct: 254 YDEAFD-WK---DRPLL---KQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCD 303
Query: 505 MNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS 564
LGDFG A + A VGTV +PE+ + TD++ G+++L++LS
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
Query: 565 GRR-PIEEGKPN----LVEMVWELMV--------QGKLLDALDARLRAKGGFDEDEVERV 611
PI +G L++++ L V KL D +D+ G + R
Sbjct: 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423
Query: 612 LHLGLLCAYP-------DPRARPTMRQVV 633
L L YP D RP +++
Sbjct: 424 LGLPADFEYPLVKMLTFDWHLRPGAAELL 452
|
Length = 501 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLV 424
F + +G G G V K + G +A K I E R + E+ L +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 425 GLRG--WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI------RVLKDVAA 476
G G + E M ++M+ GSLD+ +L RI ++ V
Sbjct: 63 GFYGAFYSDGEISICM---EHMDGGSLDQ---------VLKKAGRIPENILGKISIAVLR 110
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ YL E + K++HRD+K SN+L++ +L DFG++ +A++ VGT Y+
Sbjct: 111 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS--FVGTRSYM 165
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569
+PE + Q+D++ G+ ++E+ GR PI
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 72/280 (25%), Positives = 133/280 (47%), Gaps = 31/280 (11%)
Query: 372 IGVGGNGKVYKGVLEG---GGAE--IAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVG 425
+G G G VY+G G AE +AVK ++ R FL E S + +V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWI--FQCD-----GSMMLSCEERIRVLKDVAAGV 478
L G + + +L +V + M +G L ++ + + G + +E I++ ++A G+
Sbjct: 74 LLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLA 537
YL+ KK +HRD+ + N ++ + ++GDFG+ R ++ + + V ++A
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
PE G +T +D++ FG+++ E+ S +G N E V + ++ G LD
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFVMDGGYLDQ----- 242
Query: 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
++ ERV L +C +P+ RPT ++V +L+
Sbjct: 243 ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 392 IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+AVK + + R FL EI + RLK+ +++ L G C + L ++ +YMENG L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-PLCMITEYMENGDLN 105
Query: 451 KWIFQ---------CDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501
+++ Q + +S + + +A+G+ YL +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV 162
Query: 502 DKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560
++ DFG++R ++ R V + ++A E G+ +T +DV+ FG+ +
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 561 EVLS 564
E+ +
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAE--ISSLGRLKHKSLVG 425
V+G G GKV L+ G AVK + + D + E I SL R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEG 484
L C + L V +++ G L +F S E R R ++ + +++LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHD- 114
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
K +++RD+K NVLLD E + +L DFG+ + ++T GT Y+APE+
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 545 RASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMV 580
D + G+L+ E+L G P E E + +L E +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRA-FLAEISSLGRLKHKS 422
F E IG G +VY+ G +A+K++ + D RA + EI L +L H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYL 481
++ E L +V + + G L + I L E+ + + + + + ++
Sbjct: 64 VIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H ++V+HRDIK +NV + +LGD GL R A+ + +VGT Y++PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ ++D++ G L+ E+ + + P K NL + K ++ D
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------KKIEQCDYPPLPSD 231
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635
+ E E+ ++++ +C PDP RP + V V
Sbjct: 232 HYSE-ELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + K L LV +Y+ G I G L + + + +V GV LH+ +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQ---RG 117
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
++HRDIK N+L+D+ + +L DFGL+R + VGT YLAPE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDK 172
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLV 577
+D + G +I E L G P P+ V
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRD 493
+ ++ + ++M+ GSLD+ I++ G + + +I V V G+ YL+ +++HRD
Sbjct: 75 ENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAV--AVVEGLTYLYN--VHRIMHRD 129
Query: 494 IKSSNVLLDKEMNGRLGDFGLARMHGHGQ----VASTTRVVGTVGYLAPEVFSSGRASTQ 549
IK SN+L++ +L DFG++ G+ +A T VGT Y++PE G+ + +
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVS-----GELINSIADT--FVGTSTYMSPERIQGGKYTVK 182
Query: 550 TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD-------ARLRAKGG 602
+DV+ GI I+E+ G+ P +LD L RL
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSN----IDDDGQDDPMGILDLLQQIVQEPPPRL-PSSD 237
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
F ED + V C DP RPT +Q+
Sbjct: 238 FPEDLRDFV----DACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRGWC 430
+G G G V K + G +A K I E R + E+ L +VG G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVL----YLHEG 484
+ G + + ++M+ GSLD+ +L +RI +L V+ VL YL E
Sbjct: 73 YSD-GEISICMEHMDGGSLDQ---------VLKEAKRIPEEILGKVSIAVLRGLAYLRE- 121
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST--TRVVGTVGYLAPEVFS 542
+ +++HRD+K SN+L++ +L DFG++ GQ+ + VGT Y++PE
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPI 569
S Q+D++ G+ ++E+ GR PI
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLG-RLKHKSLVGL 426
++G G GKV+ L+G A+K + + D + E L +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 427 RGWCK-REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
+C + K +L V +Y+ G L +F ++ G+ +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS-- 114
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
K +++RD+K N+LLD + + ++ DFG+ + + G A T GT Y+APE+ +
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQK 172
Query: 546 ASTQTDVFGFGILILEVLSGRRP 568
+T D + FG+L+ E+L G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 70/263 (26%), Positives = 126/263 (47%), Gaps = 35/263 (13%)
Query: 392 IAVKRISHENDGGTRAFLAEISSLGRL-----KHKSLVGLRGWCKREKGSLMLVYDYMEN 446
+AVK + D T L+++ S + KHK+++ L G C ++ G L ++ +Y
Sbjct: 50 VAVKML---KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASK 105
Query: 447 GSLDKWIFQCDGSMMLSCEERIRV------LKDVAAGVLYLHEGWE----KKVLHRDIKS 496
G+L +++ M + RV KD+ + + G E +K +HRD+ +
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165
Query: 497 SNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGF 555
NVL+ + ++ DFGLAR ++ TT V ++APE + Q+DV+ F
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 556 GILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHL 614
G+L+ E+ + G P G P VE +++L+ +G +D K +E+ ++
Sbjct: 226 GVLMWEIFTLGGSPY-PGIP--VEELFKLLKEGHRMD--------KPANCTNELYMMMR- 273
Query: 615 GLLCAYPDPRARPTMRQVVKVLE 637
C + P RPT +Q+V+ L+
Sbjct: 274 --DCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G G V ++A+K+I++ +N + L EI L L H++++ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 430 ----CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
+ + +VY+ M+ L + I S LS + L + G+ Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-DLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSA- 127
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSG 544
VLHRD+K SN+LL+ + ++ DFGLAR T VV T Y APE+ +
Sbjct: 128 --NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCS 184
Query: 545 RASTQTDVFGFGILILEVLSGRRPIEEGK 573
+T DV+ G + E+L GR+P+ GK
Sbjct: 185 EYTTAIDVWSVGCIFAELL-GRKPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 32/200 (16%)
Query: 392 IAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+AVK + +D FL E+ L RL ++ L G C + L ++ +YMENG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP-PLCMIMEYMENGDLN 107
Query: 451 KWI--------FQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502
+++ S LS + + +A+G+ YL +HRD+ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 503 KEMNGRLGDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVF 553
K ++ DFG++R + G R + ++A E G+ +T++DV+
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQG--------RAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 554 GFGILILEVLS--GRRPIEE 571
FG+ + E+L+ +P E
Sbjct: 217 AFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 8/148 (5%)
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
LVGL C + L LV +Y+ G L +F L E ++ + +LH
Sbjct: 58 LVGLHS-CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLH 113
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
E + +++RD+K NVLLD + + +L D+G+ + G G +T+ GT Y+APE+
Sbjct: 114 E---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIE 570
D + G+L+ E+++GR P +
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
H LVGL C + + L V +Y+ G L +F L E +++ +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
YLHE + +++RD+K NVLLD E + +L D+G+ + G +T+ GT Y+APE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPE 166
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
+ D + G+L+ E+++GR P +
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 66/264 (25%), Positives = 116/264 (43%), Gaps = 23/264 (8%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
IG G G V + G ++AVK++ E+ + H+++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-SY 88
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
L +V +++E G+L + ++ E+ V V + YLH + V+H
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RDIKS ++LL + +L DFG +V +VGT ++APEV S T+ D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 552 VFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV 611
++ GI+++E++ G P P L ++ D L R++ D +V V
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRIRDNLPPRVK-----DSHKVSSV 247
Query: 612 LHLGL-LCAYPDPRARPTMRQVVK 634
L L L +P R T +++++
Sbjct: 248 LRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF--------LAEISSLGRLK-HKS 422
+G G G VY + G +A+K++ + F L E+ SL +L H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYL 481
+V L+ RE L V++YME G+L + + G E IR ++ + G+ ++
Sbjct: 60 IVKLKE-VFRENDELYFVFEYME-GNLYQLMKDRKGKPF--SESVIRSIIYQILQGLAHI 115
Query: 482 HE-GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRVVGTVGYLA 537
H+ G+ HRD+K N+L+ ++ DFGLAR ++ S T V T Y A
Sbjct: 116 HKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRA 166
Query: 538 PEVF-SSGRASTQTDVFGFGILILEVLSGR 566
PE+ S S+ D++ G ++ E+ + R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 38/257 (14%)
Query: 371 VIGVGGNGKVYKGVL--EGGGAEIAVK-RISHENDG--GTRAFLAEISSLGRLKHKSLVG 425
V+G G G VYKG+ EG +I V +I +E G F+ E + + H LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCD---GSMMLSCEERIRVLKDVAAGVLYLH 482
L G C ++ LV M +G L ++ + GS +L + +A G++YL
Sbjct: 74 LLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE 126
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVF 541
E ++++HRD+ + NVL+ + ++ DFGLAR + G + + + ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRPIE----EGKPNLVEM-------------VWEL 583
+ + Q+DV+ +G+ I E+++ G +P + P+L+E V+ +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243
Query: 584 MVQGKLLDALDARLRAK 600
MV+ ++DA D+R + K
Sbjct: 244 MVKCWMIDA-DSRPKFK 259
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKH-KSLVG 425
+ IG G G V K + + G +AVKRI D + L ++ + R +V
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR----VLKDVAAGVL-- 479
G RE G + + M+ SLDK+ + + +L +A +
Sbjct: 68 FYGALFRE-GDCWICMELMDI-SLDKF------YKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 480 --YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ--VASTTRVVGTVGY 535
YL E E K++HRD+K SN+LLD+ N +L DFG++ G +A TR G Y
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAK-TRDAGCRPY 173
Query: 536 LAPE-VFSSGRAS--TQTDVFGFGILILEVLSGRRP 568
+APE + S R ++DV+ GI + EV +G+ P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGL-RGWC 430
IG G G V + G ++AVK + E+ + +H+++V + + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
E+ L ++ ++++ G+L + Q L+ E+ V + V + YLH + V+
Sbjct: 89 VGEE--LWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRDIKS ++LL + +L DFG V +VGT ++APEV S T+
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 551 DVFGFGILILEVLSGRRPIEEGKP 574
D++ GI+++E++ G P P
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 74/256 (28%), Positives = 105/256 (41%), Gaps = 31/256 (12%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSL-GRLKHKSLVGL 426
VIG G GKV + G AVK + + + +AE + L +KH LVGL
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEGW 485
+ + L V DY+ G L F E R R ++A+ + YLH
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS-- 114
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+++RD+K N+LLD + + L DFGL + G +T+ GT YLAPEV
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEG----------------KPNLVEMVWELMVQGKL 589
D + G ++ E+L G P KPN+ L+ +G L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLL-EGLL 231
Query: 590 LDALDARLRAKGGFDE 605
RL AK F E
Sbjct: 232 QKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 9/161 (5%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
L E L +H L L+ + + L V +Y G L F + S E+R
Sbjct: 43 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRA 97
Query: 469 RVL-KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
R ++ + + YLH EK V++RD+K N++LDK+ + ++ DFGL + G A+
Sbjct: 98 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMK 154
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT YLAPEV D +G G+++ E++ GR P
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRA-FLAEISSLGRLK 419
F E IG G VYK + G +A+K++ D R L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 420 HKSLVG-LRGWCKREKGSLMLVYDYMENGSLDKWI--FQCDGSMMLSCEERI--RVLKDV 474
H +++ L + E L +V + + G L + I F+ ++ ER + +
Sbjct: 61 HPNVIKYLASFI--ENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQL 115
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534
+ + ++H K+++HRDIK +NV + +LGD GL R A+ + +VGT
Sbjct: 116 CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171
Query: 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL----L 590
Y++PE + ++D++ G L+ E+ + + P K NL + + + +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIEKCDYPPLPA 230
Query: 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635
D LR L C PDP RP + V++V
Sbjct: 231 DHYSEELR--------------DLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 33/279 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAE-----IAVKRISHENDGGTR-AFLAEISSLGRL-KHKSL 423
+G G GKV + G +AVK + R A ++E+ + L H+++
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L G C G ++++ +Y G L ++ + L+ E+ + VA G+ +L
Sbjct: 102 VNLLGACTI-GGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVA-STTRVVGTVGYLAPEV 540
K +HRD+ + NVLL ++ DFGLAR M+ V R+ V ++APE
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR- 598
+ + ++DV+ +GIL+ E+ S G P P + V K + R
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPY----PG-------MPVDSKFYKLIKEGYRM 263
Query: 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
A+ E+ ++ C DP RPT +Q+V+++
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRI----SHENDGGTRAFLAEISSLGRLK-HKSLVGL 426
+G G G V+K + +A+K+I + D R F EI L L H ++V L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA-QRTF-REIMFLQELGDHPNIVKL 72
Query: 427 RGWCKREKGS-LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDV---------AA 476
K E + LV++YME L I R +L+DV
Sbjct: 73 LNVIKAENDKDIYLVFEYMET-DLHAVI-------------RANILEDVHKRYIMYQLLK 118
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVGT 532
+ Y+H G V+HRD+K SN+LL+ + +L DFGLAR + T V T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 533 VGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGR 566
Y APE+ S R + D++ G ++ E+L G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLK---HKSLVGL 426
IGVG G VYK G +A+K R+ DG + + E++ L RL+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 427 RGWCKREKG----SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYL 481
C + + LV+++++ L ++ + + + E I+ +++ G+ +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H ++HRD+K N+L+ +L DFGLAR++ Q+A T VV T+ Y APEV
Sbjct: 125 HA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC-QMALTPVVV-TLWYRAPEVL 179
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPI 569
+T D++ G + E+ R+P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 56/224 (25%), Positives = 113/224 (50%), Gaps = 27/224 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHENDGGTRA-FLAEISSLGRLKH 420
F EE +G GK+YKG L G + +A+K + N+ F E S + L H
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQ--------C----DGSMMLSCE--E 466
++V L G +E+ ML ++Y+ G L +++ C DG++ S + +
Sbjct: 67 PNIVCLLGVVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 467 RIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVAS 525
+ + +AAG+ YL + +H+D+ + N+L+ ++++ ++ D GL+R ++
Sbjct: 126 FLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
+ + + ++ PE G+ S+ +D++ FG+++ E+ S G +P
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 411 EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI-----FQCDGSMMLSCE 465
E L + H ++ L W + ++ L ++ +Y+ G L ++ F + + E
Sbjct: 51 EKRVLKEVSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 466 ERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525
+ + YLH K++++RD+K N+LLDKE + +L DFG A+
Sbjct: 110 --------IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK----LRDR 154
Query: 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585
T + GT YLAPEV S + D + GILI E+L G P + P ++E ++
Sbjct: 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKIL 211
Query: 586 QGKL 589
GKL
Sbjct: 212 AGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRA-FLAEISSLGRLKHKS 422
F E IG G +VY+ +A+K++ D R + EI L +L H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 423 LVG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLY 480
++ L + E L +V + + G L + I L E + + + + V +
Sbjct: 64 VIKYLDSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
+H ++V+HRDIK +NV + +LGD GL R A+ + +VGT Y++PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 177
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
+ ++D++ G L+ E+ + + P K NL + + ++ D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK-------IEQCDYPPLPT 230
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635
E E++ L +C YPDP RP + V ++
Sbjct: 231 ----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-12
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISH---ENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG GG G+VY +A+K+I EN + FL E L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 429 WCKREKGSLMLVYDYMENGSLD---KWIFQCDGSMMLSCEER------IRVLKDVAAGVL 479
C + + Y+E +L K ++Q + S+ E+ + + + A +
Sbjct: 70 ICS-DGDPVYYTMPYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG-----------------HGQ 522
Y+H K VLHRD+K N+LL + D+G A +
Sbjct: 128 YVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ ++VGT Y+APE AS TD++ G+++ ++L+ P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 19/141 (13%)
Query: 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL------HEGWEKKVLHR 492
LV DY G L + I S + R ++ AG+L++ H K ++HR
Sbjct: 116 LVLDYANAGDLRQEI--------KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167
Query: 493 DIKSSNVLLDKEMNGRLGDFGLARMHGH---GQVASTTRVVGTVGYLAPEVFSSGRASTQ 549
DIKS+N+LL +LGDFG ++M+ V T GT Y+APE++ S +
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPYYVAPEIWRRKPYSKK 225
Query: 550 TDVFGFGILILEVLSGRRPIE 570
D+F G+L+ E+L+ +RP +
Sbjct: 226 ADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 371 VIGVGGNGKVYKGVL--EGGGAEIAVKRISHENDGGTRAFLA---EISSLGRLKHKSLVG 425
++G G G V+KG+ EG +I V + ++ G + F + ++G L H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C SL LV GSL + Q S L + + +A G+ YL E
Sbjct: 74 LLGICP--GASLQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEE-- 127
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSG 544
+++HR++ + N+LL + ++ DFG+A ++ + + + ++A E G
Sbjct: 128 -HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 545 RASTQTDVFGFGILILEVLS-------GRRPIEEGKPNLVE 578
R + Q+DV+ +G+ + E++S G RP E P+L+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---LAEISSLGRLKHKSLVGLRG 428
I G G+V+ + G A+K I + L E L + + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEK 487
+ + K +L LV +Y+ G L + + GS+ E+ R+ + ++ + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLD---EDVARIYIAEIVLALEYLHS---N 112
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARM-------HGHGQVASTTRVVGTVGYLAPEV 540
++HRD+K N+L+D + +L DFGL+++ + + R+VGT Y+APEV
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRP 568
S D + G ++ E L G P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLG-RLKHKSLVGL 426
V+G G GKV L+G A+K + + D + E L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 427 RGWCK-REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEG 484
+C + K L V +Y+ G L +F S E R R ++ G+ +LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFD-EARARFYAAEIICGLQFLHKK 115
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
+++RD+K NVLLDK+ + ++ DFG+ + + +G+ ++T GT Y+APE+
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ + D + FG+L+ E+L G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 392 IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+AVK + + + R FL E+ L RLK +++ L G C E L ++ +YMENG L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDED-PLCMITEYMENGDLN 107
Query: 451 KWI----------------FQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494
+++ +S + V +A+G+ YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164
Query: 495 KSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVF 553
+ N L+ + + ++ DFG++R ++ R V + ++A E G+ +T +DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 554 GFGILILEVLS 564
FG+ + E+L
Sbjct: 225 AFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 54/201 (26%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 372 IGVGGNGKV----YKGVLEGGGAEIAVKRISHENDGGTRAFL-AEISSLGRLKHKSLVGL 426
+G G GKV Y + G ++AVK + E+ G A L EI L L H+++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 427 RGWCKREKG-SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
+G C + G + L+ +++ +GSL +++ + + L +++++ + G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGS-- 127
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR--VVGTVGYLAPEVFSS 543
++ +HRD+ + NVL++ E ++GDFGL + + T + + V + APE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 544 GRASTQTDVFGFGILILEVLS 564
+ +DV+ FG+ + E+L+
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/280 (21%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 372 IGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVG 425
+G G G VY+G+ +G +A+K ++ R FL E S + +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQC-------DGSMMLSCEERIRVLKDVAAGV 478
L G + + +L+++ + M G L ++ S ++ I++ ++A G+
Sbjct: 74 LLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLA 537
YL+ K +HRD+ + N ++ ++ ++GDFG+ R ++ + + V +++
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
PE G +T +DV+ FG+++ E+ + +G N E V +++G LLD D
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEGGLLDKPD--- 244
Query: 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ + + L +C +P+ RP+ +++ ++
Sbjct: 245 --------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLR 427
V+G G GKV L+G G AVK + + D + E L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 428 GWCKREKGSLMLVYDYMENGSL-----DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+ K L V +++ G L DK F + + E + G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE--------IVCGLQFLH 113
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+++RD+K NV+LD++ + ++ DFG+ + + G ++T GT Y+APE+
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQ 169
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP 568
+ + D + FG+L+ E+L G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 372 IGVGGNGKVYKGVLEGGGAE---IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGLR 427
+G G G V +G G + +AVK + + FL E + + L H++L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 428 GWCKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLS--CEERIRVLKDVAAGVLYLHEG 484
G LM+V + GSL D+ G ++S C+ +++ A G+ YL
Sbjct: 63 GVVLTH--PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES- 115
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ---VASTTRVVGTVGYLAPEVF 541
K+ +HRD+ + N+LL + ++GDFGL R + V V + APE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRP 568
+ S +DV+ FG+ + E+ + G P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G GKVYK + G +A+K R+ + +G L EIS L L + +R
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-VRLL 67
Query: 430 C------KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYL 481
K K SL LV++Y+++ L K++ + + + GV +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
H+ V+HRD+K N+L+DK+ ++ D GL R V S T + T+ Y APEV
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIVTLWYRAPEV 182
Query: 541 FSSGRA-STQTDVFGFGILILEVLSG 565
ST D++ G + E+
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
+G G GKVYK + G A K I +++ ++ EI L H ++V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVL-KDVAAGVLYLHEGWEKKVL 490
E +L ++ ++ G++D + + + + E +IRV+ K + YLHE K++
Sbjct: 73 YEN-NLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHE---NKII 125
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV-------VGTVGYLAPEVF-- 541
HRD+K+ N+L + + +L DFG++ A TR +GT ++APEV
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 542 --SSGRA-STQTDVFGFGILILEVLSGRRPIEEGKP 574
S R + DV+ GI ++E+ P E P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 33/235 (14%)
Query: 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHENDGGTRA-FLAE 411
EI +T F EE +G GKVYKG L G +A+K + + +G R F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 412 ISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCD-----GSM------ 460
RL+H ++V L G +E+ L +++ Y + L +++ GS
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQ-PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 461 --MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518
L + + ++ +AAG+ +L V+H+D+ + NVL+ ++N ++ D GL R
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFR-- 172
Query: 519 GHGQVASTTRVVGT----VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
A +++G + +++PE G+ S +D++ +G+++ EV S G +P
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 19/143 (13%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY------LHEGWEKKVL 490
L+L+ +Y G L+K I Q +E + ++ G+L+ L E +K++
Sbjct: 140 LLLIMEYGSGGDLNKQIKQ-------RLKEHLP-FQEYEVGLLFYQIVLALDEVHSRKMM 191
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHG---QVASTTRVVGTVGYLAPEVFSSGRAS 547
HRD+KS+N+ L +LGDFG ++ + VAS+ GT YLAPE++ R S
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS--FCGTPYYLAPELWERKRYS 249
Query: 548 TQTDVFGFGILILEVLSGRRPIE 570
+ D++ G+++ E+L+ RP +
Sbjct: 250 KKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 42/292 (14%)
Query: 365 GFSEENVIGVGGNGKVYKG-----VLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRL 418
E +G G G+V+ EGG + VK + D + F E+ +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 419 KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI------FQCDGSMMLSCEERIRVLK 472
HK++V L G C RE ++ +Y + G L +++ + LS ++++ +
Sbjct: 66 SHKNVVRLLGLC-REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR------MHGHGQVAST 526
+A G+ +L + +HRD+ + N L+ + ++ L++ +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMV 585
R +LAPE ST++DV+ FG+L+ EV + G P + E ++
Sbjct: 182 LR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY-------GLSDEEVL 228
Query: 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
L A L E R+ L C +P+ RP+ ++V L
Sbjct: 229 NR--LQAGKLELPVP----EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 63/279 (22%), Positives = 121/279 (43%), Gaps = 28/279 (10%)
Query: 372 IGVGGNGKVYKGVLEGG--GAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G GKV G G A + VK + + FL E+ L H +++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWE 486
C E +LV ++ G L ++ G + ++ + R+ +VA+G+L+LH+
Sbjct: 63 QCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSS-- 543
+H D+ N L +++ ++GD+GLA + + + +LAPE+
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 544 -----GRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
+ +++++ G+ + E+ + +P P+L + V +++ D +L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----PDLS----DEQVLKQVVREQDIKL 230
Query: 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
K D +R + C + DP RPT +V ++L
Sbjct: 231 -PKPQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 34/99 (34%), Positives = 59/99 (59%), Gaps = 6/99 (6%)
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV-VG 531
++A G+ +LH K +++RD+K NV+LD E + ++ DFG+ + + G TTR G
Sbjct: 109 EIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCG 163
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
T Y+APE+ + D + FG+L+ E+L+G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---LAEISSLG 416
E K F++ IG G G VY +A+K++S+ + + E+ L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 417 RLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA- 475
R+KH + + +G C + + LV +Y C GS E + L++V
Sbjct: 81 RIKHPNSIEYKG-CYLREHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEI 127
Query: 476 --------AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
G+ YLH ++HRDIK+ N+LL + +L DFG A + +
Sbjct: 128 AAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPAN 179
Query: 528 RVVGTVGYLAPEV---FSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT ++APEV G+ + DV+ GI +E L+ R+P
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 370 NVIGVGGNGKVYKGVL--EGGGAEIAV---KRISHENDGGTRAFLAEISSLGRLKHKSLV 424
+++ G G+++ G+L E G E V H ++ L E L L H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQC-----DGSMMLSCEERIRVLKDVAAGVL 479
+ C + ++Y YM G+L ++ QC + LS ++ + + +A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR----MHGHGQVASTTRVVGTVGY 535
YLH+ + V+H+DI + N ++D+E+ ++ D L+R M H + R V +
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR---PVKW 185
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKP 574
+A E + S+ +DV+ FG+L+ E+++ G+ P E P
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 372 IGVGGNGKVYKGVLEGGGAEI-AVKRIS----------HENDGGTRAFLAEISSLG-RLK 419
+G G G VYK + G + A+K I+ E D ++E++ + +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGV 478
H ++V E L +V D +E L + EERI + + +
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
YLH+ EK+++HRD+ +N++L ++ + DFGLA+ + T VVGT+ Y P
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSVVGTILYSCP 182
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598
E+ + + DV+ FG ++ ++ + + P N++ + K+++A+ L
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLA------TKIVEAVYEPLP 234
Query: 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
+ E V + C PD ARP + QV
Sbjct: 235 -----EGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 45/224 (20%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---LAEISSLGRLKH 420
K F++ IG G G VY +A+K++S+ + + E+ L +L+H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK------DV 474
+ + +G C + + LV +Y C GS + + V K ++
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEY------------CLGS----ASDILEVHKKPLQEVEI 117
Query: 475 AA-------GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
AA G+ YLH + +HRDIK+ N+LL + +L DFG A + V+
Sbjct: 118 AAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPAN 169
Query: 528 RVVGTVGYLAPEV---FSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT ++APEV G+ + DV+ GI +E L+ R+P
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 54/227 (23%), Positives = 103/227 (45%), Gaps = 40/227 (17%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKR-----ISHENDGGTR---------AFLAEISSL 415
+G G GKV K G +A+K+ IS++ + L E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 416 GRLKHKSLVGLRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDV 474
+KH++++GL + E + LV D M L K + D + L+ + +L +
Sbjct: 75 NEIKHENIMGLVDVYV--EGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQI 128
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS--------- 525
G+ LH+ + +HRD+ +N+ ++ + ++ DFGLAR +G+ +
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 526 -----TTRVVGTVGYLAPE-VFSSGRASTQTDVFGFGILILEVLSGR 566
T++VV T+ Y APE + + + D++ G + E+L+G+
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+G G VYKG + G +A+K I E +G + E S L LKH ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEKKV 489
K +L LV++Y+ L +++ + G + E +++ L + G+ Y+H+ + +
Sbjct: 73 -HTKETLTLVFEYVHT-DLCQYMDKHPGGLH---PENVKLFLFQLLRGLSYIHQ---RYI 124
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRAST 548
LHRD+K N+L+ +L DFGLAR + VV T+ Y P+V S ST
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 549 QTDVFGFGILILEVLSG 565
D++G G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGR-LKHKSLVGL 426
VIG G GKV + G AVK + + N + +AE + L + +KH LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGW 485
+ + L V D++ G L F E R R ++A+ + YLH
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS-- 114
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+++RD+K N+LLD + + L DFGL + G Q +TT GT YLAPEV
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 546 ASTQTDVFGFGILILEVLSGRRP 568
D + G ++ E+L G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 33/111 (29%), Positives = 64/111 (57%), Gaps = 5/111 (4%)
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT 532
+++ G+ +LH + +++RD+K NV+LD E + ++ DFG+ + H V + T GT
Sbjct: 109 EISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGT 164
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMVWE 582
Y+APE+ + D + +G+L+ E+L+G+ P + E + L + + E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
L E L +H L L+ + + L V +Y G L F + S E+R
Sbjct: 43 LTESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRA 97
Query: 469 RVL-KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
R ++ + + YLH V++RD+K N++LDK+ + ++ DFGL + G A+
Sbjct: 98 RFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 153
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT YLAPEV D +G G+++ E++ GR P
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRIS----HENDGGTRAFLAEISSLGRLKHKSLV 424
+ VIG G G V + G ++A+K+I+ H +D TR L EI L L+H +V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA-TR-ILREIKLLRLLRHPDIV 62
Query: 425 GLRGW----CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
++ +RE + +V++ ME+ L + I D L+ E L + + Y
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD---LTPEHHQFFLYQLLRALKY 118
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST--TRVVGTVGYLAP 538
+H V HRD+K N+L + + ++ DFGLAR+ + + T V T Y AP
Sbjct: 119 IHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 539 EVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGK 573
E+ S + + D++ G + EVL+G +P+ GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 54/211 (25%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 372 IGVGGNGKVYKGVL--EGGGAEIAVK--RISHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
+G G G V +G L + ++AVK +I+ FL+E + H +++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 428 GWC----KREK-GSLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVL 479
G C + E S +++ +M++G L ++ D L + ++ + D+A+G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT-VGYLAP 538
YL K +HRD+ + N +L++ MN + DFGL++ +G R+ V ++A
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 539 EVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
E + +T++DV+ FG+ + E+ + G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG-WC 430
IG G G VYK G A+K I E EI + KH ++V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+R+K L + ++ GSL I+ G LS + V ++ G+ YLH K +
Sbjct: 77 RRDK--LWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHS---KGKM 128
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS---SGRAS 547
HRDIK +N+LL + +L DFG++ +A +GT ++APEV + G +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS-AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKP 574
D++ GI +E+ + P+ + P
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 36/111 (32%), Positives = 64/111 (57%), Gaps = 5/111 (4%)
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT 532
++A G+ +LH K +++RD+K NV+LD E + ++ DFG+ + + V + T GT
Sbjct: 109 EIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGT 164
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMVWE 582
Y+APE+ + D + FG+L+ E+L+G+ P E E + L + + E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 8e-11
Identities = 55/172 (31%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
L E L ++H LV L G + + +L LV +Y+ G L + +
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDS-NLYLVMEYVPGGELFSHLRKSG----------- 96
Query: 469 RVLKDV----AAGVL----YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHG 519
R + V AA V+ YLH +++RD+K N+LLD + ++ DFG A R+ G
Sbjct: 97 RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153
Query: 520 HGQVASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRP 568
T + GT YLAPE+ S G+A D + GILI E+L+G P
Sbjct: 154 R-----TYTLCGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 372 IGVGGNGKVYKGVLEGGG--AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG- 428
+G G G VYK + G E A+K+I E G + + EI+ L LKH +++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 429 WCKREKGSLMLVYDYMEN-----------GSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
+ + L++DY E+ +K Q SM+ S +L + G
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS------LLYQILDG 120
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR----LGDFGLARMHGH--GQVASTTRVVG 531
+ YLH W VLHRD+K +N+L+ E R + D G AR+ +A VV
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 532 TVGYLAPEVFSSGRASTQT-DVFGFGILILEVLS 564
T Y APE+ R T+ D++ G + E+L+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG-WC 430
+G G G VYK G AVK I E EI + KH ++V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
REK L + +Y GSL I+ G LS + V ++ G+ YLH K +
Sbjct: 77 SREK--LWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAYLHS---KGKM 128
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS---SGRAS 547
HRDIK +N+LL + +L DFG+A +A +GT ++APEV + +G +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKP 574
D++ GI +E+ + P+ + P
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 10/161 (6%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
+ E L +H L L+ + + L V +Y G L F + + EER
Sbjct: 43 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERA 97
Query: 469 RVL-KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
R ++ + + YLH + V++RDIK N++LDK+ + ++ DFGL + G A+
Sbjct: 98 RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 153
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT YLAPEV D +G G+++ E++ GR P
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGR-LKHKSLVGL 426
VIG G GKV + G+ AVK + + +AE + L + LKH LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEGW 485
+ + L V DY+ G L F E R R +VA+ + YLH
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL-EPRARFYAAEVASAIGYLHS-- 114
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+++RD+K N+LLD + + L DFGL + G +T+ GT YLAPEV
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 546 ASTQTDVFGFGILILEVLSGRRP 568
D + G ++ E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISH---ENDGGTRAFLAEISSLGRLKH 420
K FS+ IG G G VY +A+K++S+ +++ + + E+ L +L+H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM--MLSCEERIRVLKDVAA-- 476
+ + RG C + + LV +Y C GS +L ++ ++AA
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 477 -----GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVG 531
G+ YLH ++HRD+K+ N+LL + +LGDFG A + +A VG
Sbjct: 122 HGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVG 173
Query: 532 TVGYLAPEV---FSSGRASTQTDVFGFGILILEVLSGRRP 568
T ++APEV G+ + DV+ GI +E L+ R+P
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 55/241 (22%), Positives = 109/241 (45%), Gaps = 22/241 (9%)
Query: 336 AREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVK 395
A E ++ +D L P + +E+ A+ G++ + G G+V+ G + +K
Sbjct: 41 ASESDDDDDDGLI--PTKQKAREV-VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLK 97
Query: 396 RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQ 455
G L E L + H S++ ++ + M++ Y S D + +
Sbjct: 98 I------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY----SSDLYTYL 147
Query: 456 CDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515
S L ++ + + K + G+ YLH ++++HRD+K+ N+ ++ +GD G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 516 RMHGHGQVASTTR--VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ V + + GTV APEV + + +++ D++ GI++ E+L+ I E
Sbjct: 205 QF----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260
Query: 574 P 574
P
Sbjct: 261 P 261
|
Length = 357 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 47/284 (16%)
Query: 372 IGVGGNGKVYKGVLE--------GGGAEIAVKR-ISHENDGGTRAFLAEISSLGRLKHKS 422
+G G +YKGVL G G E++V + + + AF S + +L HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
LV L G C R++ ++V +Y++ G LD ++ + ++ L ++ V K +A+ + YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 483 EGWEKKVLHRDIKSSNVLLDK-EMNG------RLGDFGLARMHGHGQVASTTRVVGTVGY 535
+KK++H ++ N+L+ + +N +L D G+ V S V + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPW 170
Query: 536 LAPEVFSSGRASTQT--DVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDA 592
+APE +G+AS D + FG +LE+ S G P+ K
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----------SEKER-- 217
Query: 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
+ + + + +L C DP RP+ R +++ L
Sbjct: 218 ---FYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGV 478
H LVGL C + + L V +++ G L +F L EE R +++ +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLP-EEHARFYSAEISLAL 109
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
+LHE + +++RD+K NVLLD E + +L D+G+ + G +T+ GT Y+AP
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIE 570
E+ D + G+L+ E+++GR P +
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L L+ DY+ G L ++Q + E +RV +A VL L + +++RDIK
Sbjct: 80 LHLILDYVNGGELFTHLYQREHFT----ESEVRVY--IAEIVLALDHLHQLGIIYRDIKL 133
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA--STQTDVFG 554
N+LLD E + L DFGL++ + GT+ Y+APEV G D +
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 555 FGILILEVLSGRRP 568
G+L E+L+G P
Sbjct: 194 LGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 41/137 (29%), Positives = 73/137 (53%), Gaps = 7/137 (5%)
Query: 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRD 493
+G L L+ D++ G L + +M + E+ L ++A + +LH +++RD
Sbjct: 70 EGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRD 123
Query: 494 IKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVF 553
+K N+LLD+E + +L DFGL++ + GTV Y+APEV + + D +
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWW 182
Query: 554 GFGILILEVLSGRRPIE 570
FG+L+ E+L+G P +
Sbjct: 183 SFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 10/211 (4%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
V+G G G V K + +A+K+ S EN+ L E+ L LK +++V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+R +G L LV++Y+E L+ +G I L + +H +
Sbjct: 68 AFRR-RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKND 120
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
++HRDIK N+L+ +L DFG AR G A+ T V T Y +PE+
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
D++ G ++ E LS +P+ G+ + ++
Sbjct: 181 AVDMWSVGCILGE-LSDGQPLFPGESEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 21/152 (13%)
Query: 432 REKGSLMLVYDYMENGSL----DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
++K +L LV +Y G L +++ Q D M + +A VL +H +
Sbjct: 71 QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFY--LAELVLAIHSVHQM 121
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFG-LARMHGHGQVASTTRVVGTVGYLAPEVFSS--- 543
+HRDIK NVL+D+ + +L DFG AR+ + V S VGT Y+APEV ++
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-VGTPDYIAPEVLTTMNG 180
Query: 544 ---GRASTQTDVFGFGILILEVLSGRRPIEEG 572
G + D + G++ E++ GR P EG
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 9/147 (6%)
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+VGL+ + + L LV DYM G L W Q +G E+R + +A VL L
Sbjct: 58 IVGLK-FSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFS---EDRAKFY--IAELVLALE 110
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+ +++RD+K N+LLD + L DFGL++ + +T GT YLAPEV
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLL 169
Query: 543 SGRAST-QTDVFGFGILILEVLSGRRP 568
+ T D + G+L+ E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
IG G G V ++ G +AVK++ E+ + +H+++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-SY 86
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
L +V +++E G+L + ++ E+ V V + LH + V+H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTD 551
RDIKS ++LL + +L DFG +V +VGT ++APE+ S + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 552 VFGFGILILEVLSGRRP 568
++ GI+++E++ G P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISH---ENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G VY +AVK++S+ + + + + E+ L +LKH + + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDV--AA-------GVL 479
C ++ + LV +Y C GS E + L++V AA G+
Sbjct: 89 -CYLKEHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
YLH ++HRDIK+ N+LL + +L DFG A + VGT ++APE
Sbjct: 136 YLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPE 187
Query: 540 V---FSSGRASTQTDVFGFGILILEVLSGRRP 568
V G+ + DV+ GI +E L+ R+P
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 14/183 (7%)
Query: 392 IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+AVK + + + R FL EI + RLK +++ L C L ++ +YMENG L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-TSDPLCMITEYMENGDLN 107
Query: 451 KWI----FQCDG----SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502
+++ Q + +S I + +A+G+ YL +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164
Query: 503 KEMNGRLGDFGLARMHGHGQVASTT-RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILE 561
K ++ DFG++R G R V + +++ E G+ +T +DV+ FG+ + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 562 VLS 564
+L+
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRG-W 429
IG G GKVYK + G+ AVK + +D AE + L L H ++V G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 430 CKREK---GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR------VLKDVAAGVLY 480
K +K G L LV + GS+ + + +L C +R+ +L G+ +
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
LH +++HRD+K +N+LL E +L DFG++ ++ T VGT ++APEV
Sbjct: 144 LHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEV 199
Query: 541 FSSGRA-----STQTDVFGFGILILEVLSGRRPIEEGKP 574
+ + + DV+ GI +E+ G P+ + P
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L L+ DY+ G + ++Q D E+ +R +L L + +++RDIK
Sbjct: 80 LHLILDYVSGGEMFTHLYQRDNF----SEDEVRFY--SGEIILALEHLHKLGIVYRDIKL 133
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF-SSGRASTQTDVFGF 555
N+LLD E + L DFGL++ + T GT+ Y+APE+ G D +
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193
Query: 556 GILILEVLSGRRPIE-EGKPN 575
GILI E+L+G P EG+ N
Sbjct: 194 GILIFELLTGASPFTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 16/137 (11%)
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT-RVVGTVGYLAP 538
YLH K +++RD+K N+LLD + + ++ DFG A+ +V T + GT YLAP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL--DALDAR 596
EV S D + G+L+ E ++G P + P ++E ++ G+L + D R
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKILAGRLKFPNWFDGR 241
Query: 597 LR--AKGGFDEDEVERV 611
R KG D +R+
Sbjct: 242 ARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 372 IGVGGNGKV----YKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLK-HKSLV 424
+G G G V E +A+K+I++ + L E+ L + HK++
Sbjct: 8 LGQGAYGIVCSARNAETSEE--ETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR------VLKDVAAGV 478
L G+ +Y Y E + + D ++ + + + + G+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEE-------LMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVAS-TTRVVGTVGY 535
Y+H VLHRD+K N+L++ + ++ DFGLAR G+ A T V T Y
Sbjct: 119 KYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 536 LAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
APE+ S + DV+ G ++ E+L GR+P+ +GK
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 372 IGVGGNGKVYKGVLEGG--GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG- 428
+G G G VYK + G + A+K+I E G + + EI+ L LKH +++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 429 WCKREKGSLMLVYDYMEN-----------GSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
+ + L++DY E+ +K Q M+ S +L + G
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS------LLYQILDG 120
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR----LGDFGLARMHGH--GQVASTTRVVG 531
+ YLH W VLHRD+K +N+L+ E R + D G AR+ +A VV
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 532 TVGYLAPEVFSSGRASTQT-DVFGFGILILEVLS 564
T Y APE+ R T+ D++ G + E+L+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVAST--TRVVGTVGYL 536
YL E + V+HRD+K SN+LLD N +L DFG++ R+ V S TR G Y+
Sbjct: 129 YLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAAYM 181
Query: 537 APEVF----SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592
APE + + + DV+ GI ++E+ +G+ P + K E V K+L
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQE 234
Query: 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
L GF D V LC D R RP R++++
Sbjct: 235 EPPSLPPNEGFSPDFCSFV----DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 7/85 (8%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFG-LARMHGHGQVASTTRVVGTVGYLAPEVFSS----- 543
+HRDIK NVLLDK + RL DFG R+ G V S VGT Y++PE+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMEDGK 182
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
GR + D + G+ + E+L G P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 49/211 (23%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 372 IGVGGNGKVYKGVLEGG--GAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G GKV G + G A++ VK + + FL E L+H +L+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWE 486
C E +LV ++ G L ++ C + +++ + R+ ++A G+L+LH+
Sbjct: 63 QCT-EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARM-HGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+H D+ N LL ++ ++GD+GL+ + + ++ + ++APE+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 546 A-------STQTDVFGFGILILEVLS-GRRP 568
+ +++V+ G+ I E+ G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 23/223 (10%)
Query: 366 FSEENVIGVGGNGKVYKG--VLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH-KS 422
F V+G G G+VYKG V G A I V ++ + + + EI+ L + H ++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRN 74
Query: 423 LVGLRG-WCKR----EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAA 476
+ G + K+ L LV ++ GS+ + G+ + E+ I + +++
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREILR 132
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ +LH KV+HRDIK NVLL + +L DFG++ V +GT ++
Sbjct: 133 GLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWM 188
Query: 537 APEVFSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKP 574
APEV + T D++ GI +E+ G P+ + P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 366 FSEENVIGVGGNGKVYKG--VLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH-KS 422
F ++G G G+VYKG V G A I V ++ + + + EI+ L + H ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64
Query: 423 LVGLRG-WCKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAA 476
+ G + K+ L LV ++ GS+ I G+ + EE I + +++
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILR 122
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ +LH+ KV+HRDIK NVLL + +L DFG++ V +GT ++
Sbjct: 123 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWM 178
Query: 537 APEVFSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKP 574
APEV + T D++ GI +E+ G P+ + P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 372 IGVGGNGKVYKGVL--------EGGGAEIAVKRISHENDGGTR----AFLAEISSLGRLK 419
+G G ++Y G+L +G E +K I D R AF S + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
HK +V L G C R+ ++M V +++E G LD +F S +L+ + +V K +A+ +
Sbjct: 63 HKHIVLLYGVCVRDVENIM-VEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHG---QVASTTRVVGTVGY 535
YL +K ++H ++ + N+LL +E ++G G F ++ G V S V + +
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIPW 174
Query: 536 LAPE-VFSSGRASTQTDVFGFGILILEV-LSGRRPIEEGK 573
+APE V S S D + FG + E+ +G P+++
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV------G 425
+G G NG V+ V +AVK+I + + L EI + RL H ++V G
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 426 LRGWCKREK-------GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAG 477
G E S+ +V +YME L + Q S EE R+ + G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLS-----EEHARLFMYQLLRG 126
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARM----HGHGQVASTTRVVGT 532
+ Y+H VLHRD+K +NV ++ E + ++GDFGLAR+ + H S V T
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--T 181
Query: 533 VGYLAPEVFSSGRASTQT-DVFGFGILILEVLSGR 566
Y +P + S T+ D++ G + E+L+G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 39/154 (25%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 411 EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGS-MMLSCEERIR 469
E L +L H ++V E+ + ++ +Y E LD + + + LS +
Sbjct: 52 EAQLLSKLDHPAIVKFHA-SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 470 VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTR 528
+ GV Y+H+ +++LHRD+K+ N+ L + ++GDFG++R + G +A+T
Sbjct: 111 WFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-- 164
Query: 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEV 562
GT Y++PE +++D++ G ++ E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/224 (25%), Positives = 111/224 (49%), Gaps = 22/224 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---GTRAFLAEISSLGRLKHKSLVGLRG 428
+G G G V + + G ++A+K++S RA+ E++ L ++H++++GL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLL- 80
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLS---CEERIRVL-KDVAAGVLYLHEG 484
+ + + D ++ L Q D ++ E++++ L + G+ Y+H
Sbjct: 81 ----DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K N+ ++++ ++ DFGLAR H T VV T Y APEV +
Sbjct: 137 ---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILNW 189
Query: 545 RASTQT-DVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587
QT D++ G ++ E+L+G + + +GK L ++ L V G
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTG 232
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L + D M G L + Q + S +E ++ G+ ++H + V++RD+K
Sbjct: 72 LCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKP 125
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGF 555
+N+LLD+ + R+ D GLA + ++ VGT GY+APEV G A + D F
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 556 GILILEVLSGRRPIEEGK 573
G ++ ++L G P + K
Sbjct: 183 GCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 43/119 (36%), Positives = 63/119 (52%), Gaps = 13/119 (10%)
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG--RLGDFG-LARMHGHGQVASTTRVV 530
+A VL +H + +HRDIK NVLLD MNG RL DFG +M+ G V S+ V
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFGSCLKMNQDGTVQSSV-AV 164
Query: 531 GTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584
GT Y++PE+ + G+ + D + G+ + E+L G P +LVE ++M
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY--AESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 10/138 (7%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L + D M G L + Q + S E ++ G+ ++H + V++RD+K
Sbjct: 72 LSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKP 125
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGF 555
+N+LLD+ + R+ D GLA + ++ VGT GY+APEV G A + D F
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 556 GILILEVLSGRRPIEEGK 573
G ++ ++L G P + K
Sbjct: 183 GCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 4/114 (3%)
Query: 457 DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA- 515
D S L E+ I + + + + YLH + ++HRD+K+ N+ LD+ N LGDFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233
Query: 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569
++ H GT+ +PE+ + +TD++ G+++ E+ +
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSS----G 544
+HRD+K N+LLDK + +L DFG +M +G V T VGT Y++PEV S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ D + G+ + E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 18/118 (15%)
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ YLH +LHRDIK N+L++ ++ DFGLAR+ + T+ V T Y
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 537 APEVFSSGRASTQT-DVFGFGILILEVLSGR------RPIEE--------GKPNLVEM 579
APE+ R T D++ G + E+L R PI++ G P+L M
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFLAEISSLGRLK-HKSLVGLRG 428
IG G GKV+K + + G++ AVK + H+ D AE + L L H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID---EEIEAEYNILKALSDHPNVVKFYG 82
Query: 429 -WCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR------VLKDVAAGV 478
+ K++ + L LV + GS+ + L ER+ +L + G+
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEALMGL 137
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVGTVG 534
+LH K +HRD+K +N+LL E +L DFG++ Q+ ST VGT
Sbjct: 138 QHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS-----AQLTSTRLRRNTSVGTPF 189
Query: 535 YLAPEVFSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKP 574
++APEV + + T DV+ GI +E+ G P+ + P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 50/285 (17%)
Query: 372 IGVGGNGKVYKGVLE--GGGAEIAVKRI-------SHENDGGTRAFLAEISSLGRLKHKS 422
+G G K++KG+ G E+ + SH N + +F S + +L HK
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN--YSESFFEAASMMSQLSHKH 60
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
LV G C S+M V +Y++ GSLD ++ + + +S ++ V K +A + +L
Sbjct: 61 LVLNYGVCVCGDESIM-VQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG---QVASTTRVVGTVGYLAPE 539
+K + H ++ + NVLL +E + + G+ ++ G V ++ + ++ PE
Sbjct: 118 ---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 540 VFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598
+ + S D + FG + E+ SG KP L ALD+ +
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGD-----KP---------------LSALDS--Q 212
Query: 599 AKGGFDEDE----VERVLHLGLL---CAYPDPRARPTMRQVVKVL 636
K F ED + L L C +P RP+ R +++ L
Sbjct: 213 KKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGH 520
L+ E+ I VA G+ +L +K +HRD+ + N+LL + ++ DFGLAR ++
Sbjct: 171 LTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579
+ ++APE +TQ+DV+ FG+L+ E+ S G P + N
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---- 283
Query: 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E Q +L D R+RA E+ R++ L C DP+ RPT +V++L
Sbjct: 284 --EEFCQ-RLKDG--TRMRAP-ENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKH-KSLVGLRGW 429
+G G G V K G +AVKRI + N + L ++ R V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL----YLHEGW 485
RE G + + + M+ SLDK+ + + E+ +L +A ++ YLH
Sbjct: 69 LFRE-GDVWICMEVMDT-SLDKFYKKVYDKGLTIPED---ILGKIAVSIVKALEYLHS-- 121
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA---STTRVVGTVGYLAPEVFS 542
+ V+HRD+K SNVL+++ +L DFG++ G + + T G Y+APE +
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 543 SGRASTQ----TDVFGFGILILEVLSGRRPIE 570
+DV+ GI ++E+ +GR P +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 65/267 (24%), Positives = 125/267 (46%), Gaps = 49/267 (18%)
Query: 350 WPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISH--ENDGGTRA 407
W Y++++ +G G G V + GA++A+K++ +++ +
Sbjct: 11 WEVPDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 408 FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKW--------IFQCD-G 458
E+ L +KH++++GL + + + SLD++ D G
Sbjct: 61 AYRELRLLKHMKHENVIGL-------------LDVFTPDLSLDRFHDFYLVMPFMGTDLG 107
Query: 459 SMM----LSCEERIRVL-KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513
+M LS E+RI+ L + G+ Y+H ++HRD+K N+ ++++ ++ DFG
Sbjct: 108 KLMKHEKLS-EDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163
Query: 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT-DVFGFGILILEVLSGRRPIEEG 572
LAR T VV T Y APEV + TQT D++ G ++ E+L+G +P+ +G
Sbjct: 164 LAR---QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKG 218
Query: 573 KPNLVEMVWELMVQGKLLDALDARLRA 599
+L +++ + V G +L++
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQS 245
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
LAE + L ++ +V L+ + + L LV ++ G L + Q +G LS R
Sbjct: 41 LAERTVLAQVNCPFIVPLK-FSFQSPEKLYLVLAFINGGELFHHL-QREGRFDLS---RA 95
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528
R A + L + V++RD+K N+LLD + + L DFGL +++ T
Sbjct: 96 RFY--TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN-MKDDDKTNT 152
Query: 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588
GT YLAPE+ + D + G+L+ E+L+G P + N+ EM ++
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD--ENVNEMYRKI----- 205
Query: 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPR 624
L LR GFD D + L +GLL P R
Sbjct: 206 ----LQEPLRFPDGFDRD--AKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHKS 422
+ + +G G G+V G ++A+K++S R + E+ L + H++
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHEN 75
Query: 423 LVGLRGWCKREKGSLMLVYD-YMENGSLDKWIFQCDGSMMLSCEERIRVL-KDVAAGVLY 480
++GL SL D Y+ + + LS ++ I+ L + G+ Y
Sbjct: 76 VIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQILRGLKY 133
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
+H ++HRD+K SN+ ++++ ++ DFGLAR T V T Y APE+
Sbjct: 134 IHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEI 186
Query: 541 FSSGRASTQT-DVFGFGILILEVLSGR 566
+ QT D++ G ++ E+L+G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 415 LGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-D 473
L +KH LVGL + + L V DY+ G L + Q + + E R R +
Sbjct: 50 LKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAE 104
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTV 533
+A+ + YLH +++RD+K N+LLD + + L DFGL + + +T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTP 160
Query: 534 GYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
YLAPEV D + G ++ E+L G P
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 371 VIGVGGNGKVYKGVLEGG---GAEIAVKRISH----ENDGGTRAFLAEISSLGRLKHKSL 423
V+G GG GKV++ G G A+K + N T AE + L +KH +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSL-----DKWIFQCDGSMMLSCEERIRVLKDVAAGV 478
V L + + G L L+ +Y+ G L + IF D + L +++ +
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--------LSEISLAL 113
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH-GQVASTTRVVGTVGYLA 537
+LH+ + +++RD+K N+LLD + + +L DFGL + H G V T GT+ Y+A
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMA 168
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
PE+ D + G L+ ++L+G P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 407 AFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEE 466
AF S + ++ H L + G C R ++M V +++E+G LD + + G + +
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIM-VEEFVEHGPLDVCLRKEKGRVPV--AW 118
Query: 467 RIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-------RLGDFGLARMHG 519
+I V + +A+ + YL +K ++H ++ + N+LL + +L D G+
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----S 171
Query: 520 HGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEV-LSGRRPIEEGKPNLV 577
++ R V + ++APE G + ST D + FG +LE+ G P++E P+
Sbjct: 172 FTALSREER-VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E +E K E + + L C +P RP+ R +++ L
Sbjct: 231 ERFYE----------------KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ Y+H V+HRD+K SN+L+++ + ++ DFGLAR+ T V T Y
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYR 172
Query: 537 APEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
APE+ + + + D++ G + E+L G +P+ GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 6/110 (5%)
Query: 457 DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516
DGS L+ + + VA G+ +L K +HRD+ + NVLL + ++ DFGLAR
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 517 --MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS 564
MH V+ + + V ++APE +T +DV+ +GIL+ E+ S
Sbjct: 286 DIMHDSNYVSKGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496
L L+ DY+ G L + Q +E ++ + +LH+ +++RDIK
Sbjct: 80 LHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKL 133
Query: 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA--STQTDVFG 554
N+LLD + L DFGL++ +V GT+ Y+AP++ G D +
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193
Query: 555 FGILILEVLSGRRP 568
G+L+ E+L+G P
Sbjct: 194 MGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHK 421
K + + IG G G V G +AVK++S T A A E+ L + HK
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 422 SLVGLRGWCKREKG-----SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
+++ L +K + LV + M+ +L + I M L E +L +
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI-----HMELDHERMSYLLYQMLC 134
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST----TRVVGT 532
G+ +LH ++HRD+K SN+++ + ++ DFGLAR A T T V T
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR------TACTNFMMTPYVVT 185
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSG 565
Y APEV D++ G ++ E++ G
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 372 IGVGGNGKV---YKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVGL 426
IG G G V Y +LE +A+K++S T A A E+ + + HK+++GL
Sbjct: 32 IGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 427 RGWCKREKG--SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+K VY ME +D + Q M L E +L + G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVME--LMDANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K SN+++ + ++ DFGLAR G + T V T Y APEV
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGM 200
Query: 545 RASTQTDVFGFGILILEVLSGR 566
D++ G ++ E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSS----G 544
+HRD+K N+LLDK + +L DFG +M+ G V T VGT Y++PEV S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ D + G+ + E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 30/199 (15%)
Query: 411 EISSLGRLKHKSLVG-LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER-- 467
E++ + LKHK++V + + + L ++ ++ + G L + I +C M EE
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAI 120
Query: 468 IRVLKDVAAGVLYLHEGWE----KKVLHRDIKSSNVLLD-------------KEMNGR-- 508
+ + + + + Y H + ++VLHRD+K N+ L +NGR
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 509 --LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS--TQTDVFGFGILILEVLS 564
+GDFGL++ G +A + VGT Y +PE+ S ++D++ G +I E+ S
Sbjct: 181 AKIGDFGLSKNIGIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 565 GRRPIEEGKPNLVEMVWEL 583
G+ P + N +++ EL
Sbjct: 239 GKTPFHKAN-NFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 457 DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516
+ S L ++ +R VA G+ +L K +HRD+ + NVLL ++ DFGLAR
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 517 --MHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEG 572
M+ V R+ V ++APE + Q+DV+ +GIL+ E+ S G+ P
Sbjct: 261 DIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY--- 315
Query: 573 KPN-LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
P LV + MV+ ++ F E+ ++ +C +P RPT Q
Sbjct: 316 -PGILVNSKFYKMVK-------RGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQ 364
Query: 632 VVKVLE 637
+ ++++
Sbjct: 365 ISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSS---- 543
++HRD+K N+LLDK + +L DFG +M G V T VGT Y++PEV S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGD 221
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
G + D + G+ + E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 490 LHRDIKSSNVLLDKEMNG--RLGDFG-LARMHGHGQVASTTRVVGTVGYLAPEVFSS--- 543
+HRDIK N+L+D MNG RL DFG ++ G V S+ VGT Y++PE+ +
Sbjct: 124 VHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMED 180
Query: 544 --GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584
G+ + D + G+ + E+L G P +LVE ++M
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFY--AESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA--FLAEISSLGRLKHKSLVGL--- 426
+G G G V G +AVK++S A E+ L +KH++++GL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 427 --RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
E + LV M G+ I +C L+ + ++ + G+ Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA 139
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K SN+ ++++ ++ DFGLAR H ++ T V T Y APE+ +
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM---TGYVATRWYRAPEIMLNW 192
Query: 545 RASTQT-DVFGFGILILEVLSGR 566
QT D++ G ++ E+L+GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 61/266 (22%), Positives = 116/266 (43%), Gaps = 46/266 (17%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK---RISHENDG--GTRAFLAEISSLGRLKHKSLVG 425
V+G G G VYKG+ G + + ++ EN + L E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C ++ LV M G L ++ + + ++ + +A G+ YL E
Sbjct: 74 LLGICL--TSTVQLVTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--------HGHGQVASTTRVVGTVGYLA 537
+++HRD+ + NVL+ + ++ DFGLAR+ H G + ++A
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP-------IKWMA 179
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEM 579
E R + Q+DV+ +G+ + E+++ G +P +E+G+ P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239
Query: 580 VWELMVQGKLLDALDARLRAKGGFDE 605
V+ +MV+ ++D+ + R R + DE
Sbjct: 240 VYMIMVKCWMIDS-ECRPRFRELVDE 264
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 28/107 (26%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTR-------------------- 528
+HRDIK N+L+D + + +L DFGL +M+
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 529 -------VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT Y+APEV + D + G+++ E+L G P
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 22/188 (11%)
Query: 457 DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516
+ + L E+ + VA G+ +L K +HRD+ + N+LL ++ DFGLAR
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 262
Query: 517 ---MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEG 572
+ V R+ V ++APE + + ++DV+ +GIL+ E+ S G P G
Sbjct: 263 DIRNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PG 319
Query: 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
P + ++++ +G + + + E+ ++ C DP RPT +Q+
Sbjct: 320 MP-VDSKFYKMIKEGYRMLSPE--------CAPSEMYDIMK---SCWDADPLKRPTFKQI 367
Query: 633 VKVLEGKI 640
V+++E ++
Sbjct: 368 VQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 71/323 (21%), Positives = 140/323 (43%), Gaps = 48/323 (14%)
Query: 366 FSEENVIGVGGNGKVYKG--VLEGGGAEI--AVKRISHEND-GGTRAFLAEISSLGRLKH 420
F + V+G G G VYKG + EG +I A+K + + L E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQ-----CDGSMMLSCEERIRVLKDVA 475
+ L G C ++ L+ M G L ++ + ++ C + +A
Sbjct: 69 PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ-------IA 119
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV---ASTTRVVGT 532
G+ YL E ++++HRD+ + NVL+ + ++ DFGLA++ G + A +V
Sbjct: 120 KGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--P 174
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----P 574
+ ++A E + Q+DV+ +G+ + E+++ G +P +E+G+ P
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
Query: 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDE-DEVERVLHLGLLCAYPDPRARPTMRQVV 633
V+ +MV+ ++DA D+R + + E ++ R L+ + P+
Sbjct: 235 ICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 293
Query: 634 KVLEGKIEAGIENETEDMDAYLL 656
E ++ + D D YL+
Sbjct: 294 FYRALMDEEDMD-DVVDADEYLI 315
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 40/231 (17%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLR 427
++G G G+V+ L+G G A+K + + + L E L L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLH-EGW 485
+ E L LV DY G L + + + G + EE R +V + YLH G
Sbjct: 68 ASFQTET-YLCLVMDYCPGGELFRLLQRQPGKCL--SEEVARFYAAEVLLALEYLHLLG- 123
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGL---------ARMHGHGQVASTTRV------- 529
+++RD+K N+LL + + L DF L + + + V
Sbjct: 124 ---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 530 ------------VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
VGT Y+APEV S + D + GIL+ E+L G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/85 (35%), Positives = 41/85 (48%), Gaps = 4/85 (4%)
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQT 550
HRD+K N L+D + +L DFGL++ G V VVG+ Y+APEV
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179
Query: 551 DVFGFGILILEVLSGRRPIEEGKPN 575
D + G ++ E L G P PN
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+++RD+K N+LLDK+ ++ DFG A++ T + GT Y+APE+ +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGK 207
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLV 577
D + GI I E+L G P +P L+
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 372 IGVGGNGKV---YKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVGL 426
IG G G V Y VL+ +A+K++S T A A E+ + + HK+++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 427 RGWCKREKG--SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+K VY ME +D + Q M L E +L + G+ +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVME--LMDANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K SN+++ + ++ DFGLAR G + T V T Y APEV
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGM 193
Query: 545 RASTQTDVFGFGILILEVL 563
D++ G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 18/183 (9%)
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGH 520
L+ E+ I VA G+ +L +K +HRD+ + N+LL + ++ DFGLAR ++
Sbjct: 176 LTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579
+ ++APE + Q+DV+ FG+L+ E+ S G P K + E
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE 290
Query: 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639
+ +G + A D + E+ + + L C + +P RPT ++V+ L
Sbjct: 291 FCRRLKEGTRMRAPD--------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 339
Query: 640 IEA 642
++A
Sbjct: 340 LQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDG--GTRAFLAEISSLGRLKHKSLVGL--- 426
+G G G V ++AVK++S R E+ L +KH++++GL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 427 --RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+ LV + M G+ I +C LS E ++ + G+ Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLM--GADLNNIVKCQK---LSDEHVQFLIYQLLRGLKYIHSA 137
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K SNV ++++ R+ DFGLAR T V T Y APE+ +
Sbjct: 138 ---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNW 190
Query: 545 RASTQT-DVFGFGILILEVLSGR 566
QT D++ G ++ E+L G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 74/267 (27%)
Query: 409 LAEISSLGRLK-HKSLVGLRGWCK----REKGSLMLV--------YDYMEN-------GS 448
L EI +L RL H +++ L + R+ G L LV Y+ ++
Sbjct: 45 LREIQALRRLSPHPNILRL---IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKR 101
Query: 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508
+ +++Q +LK + ++H + HRDIK N+L+ + +
Sbjct: 102 VKSYMYQ--------------LLK----SLDHMHR---NGIFHRDIKPENILIKDD-ILK 139
Query: 509 LGDFGLARMHGHGQVAST---TRVVGTVGYLAPE-VFSSGRASTQTDVFGFGILILEVLS 564
L DFG R + S T + T Y APE + + G + D++ G + E+LS
Sbjct: 140 LADFGSCR-----GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
Query: 565 GRRPIEEGKPNLVEMVWELM-VQGKLLDALDARLRAKGGFDED-------EVERVLH--- 613
P+ G N ++ + ++ V G + + R + + + ++L
Sbjct: 195 -LFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS 252
Query: 614 ------LGLLCAYPDPRARPTMRQVVK 634
L L AY DP R T +Q ++
Sbjct: 253 AEGLDLLKKLLAY-DPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGH 520
L+ E+ I VA G+ +L +K +HRD+ + N+LL + ++ DFGLAR ++
Sbjct: 170 LTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226
Query: 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579
+ ++APE +TQ+DV+ FG+L+ E+ S G P P V++
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PG-VQI 281
Query: 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
E +L + R+RA E + + L C + +P RPT ++V++L
Sbjct: 282 DEEFC--RRLKEG--TRMRAP----EYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 470 VLKDVAAGVLYLH-EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTT 527
V + + + + Y+H EG ++HRDIK+ NVL++ + LGDFG A G
Sbjct: 265 VARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILE 561
+ GTV APEV + + D++ G++I E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 29/178 (16%)
Query: 403 GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMML 462
GGT E L + H S++ L+G K + +++ Y D + + +
Sbjct: 128 GGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY----KTDLYCYLAAKRNIA 180
Query: 463 SCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA------- 515
C+ + + + V + YLHE +++HRDIK+ N+ ++ + LGDFG A
Sbjct: 181 ICD-ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 516 --RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
+ +G GT+ APE+ + D++ GI++ E+ + + E
Sbjct: 237 ANKYYGWA---------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH 420
+ K + N+IG G G VY+ + ++A+K++ + R E+ + L H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNH 118
Query: 421 KSLVGLRGWC------KREKGSLM---------LVYDYME-----NGSLDKWIFQCDGSM 460
+++ L+ + K EK + V+ YM+ N +L ++ +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK----- 173
Query: 461 MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHG 519
L + R L Y+H K + HRD+K N+L+D + +L DFG A+
Sbjct: 174 -LYSYQLCRALA-------YIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222
Query: 520 HGQVASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVE 578
GQ + + + Y APE+ + +T D++ G +I E++ G PI G+ ++ +
Sbjct: 223 AGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQ 279
Query: 579 MVWELMVQG 587
+V + V G
Sbjct: 280 LVRIIQVLG 288
|
Length = 440 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 372 IGVGGNGKVYKGVL--EGGGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G GKV + + G A + VK + ++ + FL + L+H +++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 429 WCKREKGSLMLVYDYMENGSL------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
C E +LV++Y E G L ++W + ++L R+ ++AAGV ++H
Sbjct: 63 QCV-EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMH 116
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVF 541
+ LH D+ N L ++ ++GD+G+ + + + + +LAPE+
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 542 SS--GR--ASTQT---DVFGFGILILEVL 563
G + QT +V+ G+ + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVASTTRVVG 531
VA G+ +L K +HRD+ + NVL+ + ++ DFGLAR M ++ + +
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS 564
+ ++APE + +T +DV+ FGIL+ E+ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 27/158 (17%)
Query: 429 WCKRE-KGSLMLVYDYMENG---SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+C E K L +V +Y+E G +L K I M R+ + V A + YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-----RMYFAETVLA-LEYLHN- 119
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH--------GHGQVASTTR------VV 530
++HRD+K N+L+ + +L DFGL+++ G + TR V
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 531 GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
GT Y+APEV D + GI++ E L G P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 44/179 (24%)
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
++K +L L+ +++ G + + + D LS E + + + +H+ +H
Sbjct: 71 QDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ---LGFIH 124
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLA------------RMHGHG------------------ 521
RDIK N+LLD + + +L DFGL R H
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 522 ------QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
Q+A +T VGT Y+APEVF + D + G+++ E+L G P P
Sbjct: 185 WKKNRRQLAYST--VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 371 VIGVGGNGKV---YKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVG 425
IG G G V Y V G +A+K++S T A A E+ + + HK+++G
Sbjct: 23 PIGSGAQGIVCAAYDTVT---GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 426 LRGWCKREKG--SLMLVYDYME--NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL 481
L +K VY ME + +L + I M L E +L + G+ +L
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-----QMDLDHERMSYLLYQMLCGIKHL 134
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H ++HRD+K SN+++ + ++ DFGLAR G T V T Y APEV
Sbjct: 135 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 189
Query: 542 SSGRASTQTDVFGFGILILEVLSGR 566
D++ G ++ E++ G
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 44/179 (24%)
Query: 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLH 491
++K +L L+ +++ G + + + D L+ EE + + + +H+ +H
Sbjct: 71 QDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ---LGFIH 124
Query: 492 RDIKSSNVLLDKEMNGRLGDFGLA------------RMHGHG------------------ 521
RDIK N+LLD + + +L DFGL R H
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 522 ------QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574
Q+A +T VGT Y+APEVF + D + G+++ E+L G P P
Sbjct: 185 WKRNRRQLAFST--VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
LH+ ++H DIK NVL D+ + L D+GL ++ G GT+ Y +P
Sbjct: 124 DLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----GTLDYFSP 175
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
E D + G+L E+L+G+ P +E +
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 371 VIGVG--GNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFL--AEISSLGRLKHKSLVGL 426
+IG V+ + +AVK+I+ ++ L EI + +L+H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 427 RGWCKREKGSLMLVYDYMENGS---LDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLH 482
L +V M GS L K F +G L E I +LKDV + Y+H
Sbjct: 65 VT-SFIVDSELYVVSPLMAYGSCEDLLKTHF-PEG---LP-ELAIAFILKDVLNALDYIH 118
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQ-----VASTTRVVGTVGYL 536
K +HR +K+S++LL + L + M HG+ V + +L
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 537 APEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEE 571
+PEV G + ++D++ GI E+ +G P ++
Sbjct: 176 SPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 32/116 (27%), Positives = 48/116 (41%), Gaps = 37/116 (31%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGL------------ARMHGH----------------- 520
+HRDIK N+LLD + + +L DFGL R+ H
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 521 GQVASTTR--------VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ + R VGT Y+APEVF + + D + G+++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 42/127 (33%)
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGL---------ARMHGHGQ------------------ 522
+HRDIK N+L+D++ + +L DFGL ++ + G
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 523 ----------VASTTRV-----VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRR 567
R VGT Y+APEV + D + G+++ E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 568 PIEEGKP 574
P P
Sbjct: 243 PFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 705 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.51 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.9 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.8 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.32 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.31 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.32 | |
| PLN02236 | 344 | choline kinase | 96.07 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.95 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.79 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.58 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.55 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.95 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.45 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.44 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=464.58 Aligned_cols=288 Identities=44% Similarity=0.782 Sum_probs=252.3
Q ss_pred CCcccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeee
Q 005257 350 WPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429 (705)
Q Consensus 350 ~~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 429 (705)
..+.|+|+|+..||++|+..+.||+|+||.||+|.+.++ ..||||++.....+..++|.+|+.++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 356799999999999999999999999999999999864 8899998876544315669999999999999999999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
|.+.+...+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 997433589999999999999999876554 7999999999999999999999999889999999999999999999999
Q ss_pred eeeccceecCC-CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCC----CccHHHHHHHHH
Q 005257 510 GDFGLARMHGH-GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG----KPNLVEMVWELM 584 (705)
Q Consensus 510 ~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~----~~~~~~~v~~~~ 584 (705)
+|||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+.. ...+++|++..+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999976554 22211111 7999999999999999999999999999999999999988743 335899999999
Q ss_pred HhCchhHHHHHhhhcCCCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 585 VQGKLLDALDARLRAKGGFDE-DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.++++.+.+|+++.. ..++. +++.++..++..|++.+|.+||+|.||++.|+....
T Consensus 298 ~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999864 34443 788999999999999999999999999999964433
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=430.65 Aligned_cols=228 Identities=50% Similarity=0.846 Sum_probs=206.7
Q ss_pred eeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC--CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCC
Q 005257 26 VDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST--TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAG 100 (705)
Q Consensus 26 ~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~--~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g 100 (705)
++|+|++|.. .+|+|+|+|.+. ++.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|.+.+...+|
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~g 80 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLGG 80 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCCC
Confidence 4799999976 799999999998 8999999998 8999999999999999999999999999999999987767789
Q ss_pred CceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCC
Q 005257 101 HGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQ 180 (705)
Q Consensus 101 ~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~ 180 (705)
|||||||+|+...+.+..|++|||++.++.+++.+++|||||||++|.+++||++||||||+|++.|..+. +|+.
T Consensus 81 dGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~---~~~~-- 155 (236)
T cd06899 81 DGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAG---YWDD-- 155 (236)
T ss_pred CeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceee---cccc--
Confidence 99999999987666678999999999887777889999999999999999999999999999999887653 3422
Q ss_pred CCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceeccccc
Q 005257 181 TDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258 (705)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsa 258 (705)
..+.|.+|+.++|||+| ..++|+|++...+..+|..|+++..+||+.+||++|||||||
T Consensus 156 -------------------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSa 216 (236)
T cd06899 156 -------------------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSA 216 (236)
T ss_pred -------------------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEe
Confidence 23347899999999999 478999999988777899999999999999999999999999
Q ss_pred ccccccccceeeeeeeccc
Q 005257 259 ATGQLVESHKILAWSFSNT 277 (705)
Q Consensus 259 stg~~~~~h~i~~wsf~~~ 277 (705)
|||...|.|+|++|+|+++
T Consensus 217 sTG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 217 STGLLTELHYILSWSFSSN 235 (236)
T ss_pred EcCCCcceEEEEEEEEEcC
Confidence 9999999999999999975
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=419.13 Aligned_cols=229 Identities=42% Similarity=0.712 Sum_probs=202.7
Q ss_pred eeeEEeCCC-CCCCeEEEcceEe-ecCcEEecCCCC-CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC--CCCCC
Q 005257 25 AVDFVFNGF-NSSNLSLYGTATV-ESRILTLTNSTT-FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY--KGVLA 99 (705)
Q Consensus 25 ~~~f~f~~f-~~~~~~~~g~a~~-~~~~l~lt~~~~-~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~--~~~~~ 99 (705)
+++|+|++| +..++++.|+|.+ .++.|+||++.. +++|||+|++||+|||+.+++++||+|+|+|.|... ....+
T Consensus 1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~ 80 (236)
T PF00139_consen 1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSNNG 80 (236)
T ss_dssp EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSSS-
T ss_pred CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCccC
Confidence 479999999 5689999999999 589999999988 999999999999999999999999999999999643 55678
Q ss_pred CCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCC
Q 005257 100 GHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDN 179 (705)
Q Consensus 100 g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~ 179 (705)
||||||||+|....+.++.|++||+++.++.+...++.|||||||++|++++||++||||||+|++.|..+++++++
T Consensus 81 ~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~--- 157 (236)
T PF00139_consen 81 GDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYY--- 157 (236)
T ss_dssp BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-------
T ss_pred CCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccccccccc---
Confidence 99999999999877777899999999988777778999999999999999999999999999999999888776654
Q ss_pred CCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccc
Q 005257 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFT 257 (705)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfs 257 (705)
......+.+|+.++|||+| ..++|.|++.... .+|..|+++..+||+.+|+++||||||
T Consensus 158 ------------------~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFs 218 (236)
T PF00139_consen 158 ------------------SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFS 218 (236)
T ss_dssp ------------------EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEE
T ss_pred ------------------ccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEE
Confidence 1256789999999999999 5579999998874 688889999999999999999999999
Q ss_pred cccccccccceeeeeeec
Q 005257 258 AATGQLVESHKILAWSFS 275 (705)
Q Consensus 258 astg~~~~~h~i~~wsf~ 275 (705)
||||...|.|.|++|+|+
T Consensus 219 asTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 219 ASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp EEESSSSEEEEEEEEEEE
T ss_pred eecCCCcceEEEEEEEeC
Confidence 999999999999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=386.90 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=215.0
Q ss_pred ccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 353 RITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 353 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
.++..|++. .+.||+|..|+|||+.++.+++.+|+|.+.... ....+++.+|++++++.+||+||+++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355556554 678999999999999999999999999996553 445678999999999999999999999998
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
.+...+.|+||||++|||++++...+ ++++..+-+|+.+|++||.|||+ +++||||||||+|||++..|.+||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecc
Confidence 73335999999999999999997643 69999999999999999999996 39999999999999999999999999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
||.+...... .....+||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+....+ .+
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~----------~~ 289 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI----------FE 289 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH----------HH
Confidence 9999877554 3345799999999999999999999999999999999999999998742211111 12
Q ss_pred HHHHhhh-cCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALDARLR-AKGGFDED-EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~l~-~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.++.... ..+..+.+ +.+++..++..|+++||.+||+++|++++
T Consensus 290 Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 LLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222221 11233333 66789999999999999999999999885
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=403.25 Aligned_cols=253 Identities=36% Similarity=0.584 Sum_probs=210.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeE-EEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAE-IAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~-vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
.+.||+|+||+||+|.+++ .. ||||++..... ...++|.+|+.+|.+++|||||+++|+|.+....++||||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 4459999999999999984 44 99999976532 2256899999999999999999999999874447899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeEEccCC-CeeeeeeccceecCCCCc
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK-VLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~~~~ 523 (705)
+|+|.++|+.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999875 23379999999999999999999998 67 99999999999999997 99999999998765432
Q ss_pred ceeeeeeccccCCCccccc--cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 524 ASTTRVVGTVGYLAPEVFS--SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
...+...||+.|||||++. ...++.|+|||||||++|||+||+.||..... .+........+. + .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~---------R--p 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGL---------R--P 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC---------C--C
Confidence 2233368999999999999 56899999999999999999999999987654 222222222221 1 3
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..+...+..++..||+.||..||++.+++..|+....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 3444577888999999999999999999999999986654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=395.26 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=213.5
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
..+.||+|.||.||.|.++. ...||+|.++.. ....++|++|+++|++|+|+|||+++|+|.. ++.++||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEEecccC
Confidence 36779999999999999985 357999998654 3455789999999999999999999999987 44799999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceee
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 527 (705)
+|.++|.... +..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+||||||...++......
T Consensus 287 sLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999998733 3479999999999999999999999 99999999999999999999999999999966655544433
Q ss_pred eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
...-+..|.|||.+..++++.|||||||||+||||+| |+.|+..... ..+ .+.++...+ -..+..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev---------~~~le~GyR--lp~P~~ 428 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEV---------LELLERGYR--LPRPEG 428 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHH---------HHHHhccCc--CCCCCC
Confidence 3344678999999999999999999999999999999 9999876542 222 334444333 234566
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 607 EVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
++..+.++|..||+.+|++|||++.+...|+....
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 88889999999999999999999999888876543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=366.02 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=215.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc-eEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS-LMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~~lV~ 441 (705)
+|.+.++||+|.||+|||+....+|..+|.|.++-. +....++...|+.+|++|+|||||+++++-..+++. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 366688899999999999999999999999999754 345567899999999999999999999965544555 89999
Q ss_pred eeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 442 DYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||+..|+|...++..+ ....+++..+++++.|++.||.++|+.+.+ -|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997643 344799999999999999999999986644 49999999999999999999999999999887
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .....+|||.||+||.+...+|+.||||||+||++|||+.-+.||.+.. + ..+.+.+.+|+...
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~-~~L~~KI~qgd~~~-------- 247 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--L-LSLCKKIEQGDYPP-------- 247 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--H-HHHHHHHHcCCCCC--------
Confidence 5543 3345799999999999999999999999999999999999999998762 2 23345555554321
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
-++......+..|+..|+.+||+.||+.-.+++.+..
T Consensus 248 --~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 --LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1124566789999999999999999995555554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=386.68 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=214.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.+|...+.||+|||+.||+++...+|+.||+|++.+. .....+...+||++.+.|+|||||++++++.+ .+..|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence 5688899999999999999999889999999999764 44566789999999999999999999998876 7899999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
.|+|++++|..++++. ..+++.+++.+++||+.||.|||+ ++|||||||-.|+||+++.++||+|||||.....
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999743 379999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
+..... ..+|||.|+|||++....++..+||||+||++|-|+.|++||+.... ......+... .
T Consensus 171 ~~Erk~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---kety~~Ik~~------------~ 234 (592)
T KOG0575|consen 171 DGERKK-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---KETYNKIKLN------------E 234 (592)
T ss_pred cccccc-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---HHHHHHHHhc------------C
Confidence 544443 47999999999999999999999999999999999999999986431 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+........+|+...|++||.+|||+.+|+.+
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22333445667889999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=399.09 Aligned_cols=269 Identities=30% Similarity=0.520 Sum_probs=227.7
Q ss_pred ccCHHHHHHHhCC---------CCcceEEeecCceEEEEEEEcCCC---eEEEEEEeccCC-chhHHHHHHHHHHhccCC
Q 005257 353 RITYQEIEAATKG---------FSEENVIGVGGNGKVYKGVLEGGG---AEIAVKRISHEN-DGGTRAFLAEISSLGRLK 419 (705)
Q Consensus 353 ~~~~~el~~at~~---------f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~ 419 (705)
.++|+|-..|-.. ..++++||.|.||.||+|.++..+ ..||||.++... ....++|+.|..||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 3566655444333 456789999999999999998655 579999998764 456789999999999999
Q ss_pred CCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 420 Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
||||++|.|+... ....+||.|||+||+|+.+|+++++ .+++.++.-++++||.||.||-+ .++|||||.++||
T Consensus 689 HPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 9999999999876 6678999999999999999998875 49999999999999999999998 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcceeeeeec--cccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVG--TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNL 576 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~ 576 (705)
|++.+..+|++||||+|...++.....+..-| +.+|.|||.+...+++.++||||||||+||+++ |.+||-+-.+
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-- 840 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 840 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence 99999999999999999886655333333333 578999999999999999999999999999887 9999865432
Q ss_pred HHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.++...++...+ ...+.+++..|.+|++.||++|-.+||.+.||+..|++++.
T Consensus 841 ----------QdVIkaIe~gyR--LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 841 ----------QDVIKAIEQGYR--LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ----------HHHHHHHHhccC--CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 123344444444 34567899999999999999999999999999999998876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=368.03 Aligned_cols=202 Identities=29% Similarity=0.520 Sum_probs=182.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
..+|...+.||+|+|++||+|+++.++..||||.+.+. .....+-...|+++|+.++|||||++++++.. ++.+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence 35678888899999999999999999999999999876 45556678899999999999999999998776 7799999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC------CCeeeeeecc
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE------MNGRLGDFGL 514 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~------~~~kL~DFGl 514 (705)
||||.+|+|.+||+..+ .+++.....++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998754 69999999999999999999999 999999999999999864 4589999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
||.+..+... ...+|++.|||||++..++|+.|+|+||.|++|||+++|+.||....
T Consensus 162 AR~L~~~~~a--~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPGSMA--ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCchhHH--HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9988755433 34799999999999999999999999999999999999999998644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=366.49 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=209.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-------hHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.+.|...+.||+|+||.|-+|+.+.+|+.||||++++.... ......+|+++|++|+|||||++++++.. ..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CC
Confidence 34577789999999999999999999999999999765211 12335799999999999999999999886 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDF 512 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DF 512 (705)
..|+|||||+||+|.+.+-.++ .+.+....-+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 7899999999999999997654 57888889999999999999999 999999999999999765 77999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCC---CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR---ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
|+|+..+.. ..+...+||+.|.|||++.+.. +..++|+||+|||||-+++|.+||.+..... -..+.+.+|++
T Consensus 324 GlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G~y 399 (475)
T KOG0615|consen 324 GLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKGRY 399 (475)
T ss_pred chhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcCcc
Confidence 999987644 3455689999999999997654 3458899999999999999999998643321 12334444443
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
... ........++.++++.++|..||++|||+.|++++=.
T Consensus 400 ~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 400 AFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 211 1223345678899999999999999999999998644
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=399.07 Aligned_cols=262 Identities=26% Similarity=0.467 Sum_probs=224.0
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.+.+....+.||+|.||+||+|...+ ....||||.++..... ..++|.+|++++..|+|||||+++|+|.+ ++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~ 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GD 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CC
Confidence 34455667889999999999998753 3467999999888666 78899999999999999999999999997 77
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC-------C----CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG-------S----MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~-------~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
.+++|+|||..|+|.++|..... . .+|+..+.+.|+.|||.||.||-+ +.+|||||..+|+|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccc
Confidence 89999999999999999975321 1 238999999999999999999998 999999999999999999
Q ss_pred CCeeeeeeccceecCCCCcceee-eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHH
Q 005257 505 MNGRLGDFGLARMHGHGQVASTT-RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~ 582 (705)
..+||+||||+|..-..+..... .-.-..+||+||.+..+++|++||||||||||||+++ |+.||.+... +.|.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe 716 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIE 716 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHH
Confidence 99999999999855433332211 2233689999999999999999999999999999999 9999987654 56677
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+++|.++ ..++.++..+..||..||+.+|.+||+++||-..|+...+
T Consensus 717 ~i~~g~lL-----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIRAGQLL-----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHcCCcc-----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 77777764 3466788899999999999999999999999999987655
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=372.03 Aligned_cols=279 Identities=25% Similarity=0.363 Sum_probs=217.3
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV~E 442 (705)
|+..++||+|.||.||||++..+|+.||+|++.... .+......+||.+|++|+||||++|.+...+. .+.+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 445667999999999999999999999999998764 44556678999999999999999999998875 468999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
||+. +|.-++... ...+++.++..+++|++.||+|||+ ++|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 199 YMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9987 888887542 3369999999999999999999998 999999999999999999999999999999988777
Q ss_pred cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
....+..+-|++|+|||++.+. .|+.++|+||.||||.||+.|+..|++..+
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--------------------------- 325 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--------------------------- 325 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH---------------------------
Confidence 6666667789999999999874 699999999999999999999999876432
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc-----cCCCCCcchhhHHHHHHhhccccccccccccccCC
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE-----AGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGY 676 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 676 (705)
++++-.|...|-.+.++--| ...+- ......+ .........+....++++..+.-.+|+.|.++..+
T Consensus 326 ------veQl~kIfklcGSP~e~~W~-~~kLP-~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 326 ------VEQLHKIFKLCGSPTEDYWP-VSKLP-HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred ------HHHHHHHHHHhCCCChhccc-cccCC-cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 22222333334333333222 00000 0000000 00000122344556777777888999999999999
Q ss_pred CCCCCcccc
Q 005257 677 ATHPTFHDI 685 (705)
Q Consensus 677 ~~hp~f~~~ 685 (705)
+.|+||..-
T Consensus 398 L~seyF~t~ 406 (560)
T KOG0600|consen 398 LQSEYFTTE 406 (560)
T ss_pred hcCcccccC
Confidence 999999433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=345.73 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=206.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hh-HHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GG-TRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+.|+...++|+|+||.|||++++++|+.||||++....+ .. .+--++||++|++|+|+|+|.++.+|.. +..++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence 357778899999999999999999999999999865432 33 3446899999999999999999999987 78999999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|||+. ++.+-|..... .++...+.+++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||.||.....
T Consensus 81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99987 44444554433 48899999999999999999998 99999999999999999999999999999988743
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ...+..+.|.+|+|||.+.+ ..|...+||||.||++.||++|.+.|++... +.+.......-|++...-...+...
T Consensus 155 g-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 G-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred c-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHHHHHHHHcccCHHHHHHhccC
Confidence 2 23455788999999999988 6799999999999999999999998876542 2222222233344332211111110
Q ss_pred CC-----------C------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 601 GG-----------F------DEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 601 ~~-----------~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+. . -+....-+++++..|++.||.+|++.+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 0 0122346889999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=339.25 Aligned_cols=281 Identities=26% Similarity=0.353 Sum_probs=224.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+|...++||+|.||.||+|++..+|+.||||+++... +.-....++||+.|++++|+||+.+++++.. ...+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence 45777889999999999999999999999999997653 2334567999999999999999999998876 77899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|||+. +|...++... ..++..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99976 9999997644 379999999999999999999998 99999999999999999999999999999998876
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
....+.. +-|.+|+|||.+.+ ..|+..+||||.||++.||+-|.+-|.+.. + .++
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-D--------------idQ-------- 210 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-D--------------IDQ-------- 210 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-h--------------HHH--------
Confidence 6554443 67999999999877 569999999999999999999876665432 1 122
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc-cccCCCC-CcchhhHHHHHHhhccccccccccccccCCCC
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK-IEAGIEN-ETEDMDAYLLQQVKSKDMWANYSRSFGYGYAT 678 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 678 (705)
+..+....-.+.|++-|.|.++-+..+-. .+..+.. -........++++.++..++|..|.++.++++
T Consensus 211 ----------L~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 211 ----------LSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ----------HHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 22333333445666666666655444322 1211111 23334455688999999999999999999999
Q ss_pred CCCcccc
Q 005257 679 HPTFHDI 685 (705)
Q Consensus 679 hp~f~~~ 685 (705)
||||...
T Consensus 281 ~~yf~~~ 287 (318)
T KOG0659|consen 281 HPYFKSL 287 (318)
T ss_pred chhhhcC
Confidence 9999853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.77 Aligned_cols=292 Identities=23% Similarity=0.345 Sum_probs=221.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHH-HHHHHHHHhccCC-CCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~-~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...++||.|.||.||+|+...+++.||||+++..-....+ .-++|++.|++|. ||||+++.+++.+.+..+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45677788999999999999999999999999999776444333 2388999999998 999999999998866699999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||+. +|.++++.+ +..+++.++..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+||||||....
T Consensus 89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 999965 999999876 3489999999999999999999998 9999999999999999999999999999997754
Q ss_pred CCcceeeeeeccccCCCccccc-cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFS-SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
. ...+..+.|++|+|||++. .+-|+.+.||||+|||++|+.+-++.|.+..+ .|.++... +.
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc------~V------- 225 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKIC------EV------- 225 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHH------HH-------
Confidence 3 3345678999999999975 46799999999999999999999988876542 22222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCCCCC
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~h 679 (705)
.+....+......+++..+--.-|..-|+- |..++. + ........+..+..|+|..|.++.+|+.|
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~------l~~L~p----~----~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSP------LKDLLP----N----ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCC------hHHhCc----c----cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222222223344444333334443331 111111 1 22233455566667999999999999999
Q ss_pred CCcccccccccc
Q 005257 680 PTFHDIRQSNSY 691 (705)
Q Consensus 680 p~f~~~~~~~~~ 691 (705)
|||...+.....
T Consensus 292 pffq~~~~~~~~ 303 (538)
T KOG0661|consen 292 PFFQVGRASGSS 303 (538)
T ss_pred cccccccccccc
Confidence 999888766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=353.69 Aligned_cols=243 Identities=28% Similarity=0.375 Sum_probs=205.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+.|+..++||+|+||+||+++.+++++.+|+|++++. .....+...+|..+|.+++||.||++.-.+.+ ...+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence 46789999999999999999999999999999999765 33456778999999999999999999987776 789999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|+||+.||.|..+|.+.. .+++..+.-++.+|+.||.|||+ .+||||||||+|||||++|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997543 69999999999999999999998 999999999999999999999999999998654
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+. ....+.+..+++
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k~---------- 242 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGKL---------- 242 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCcC----------
Confidence 4332 33448999999999999999999999999999999999999999987542 222233333331
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP 627 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 627 (705)
..++.-......+++...++.||++|-
T Consensus 243 -~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 112222345567888888999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.08 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=209.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-ceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG-SLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~lV~E 442 (705)
.++...+.||+|+||+||++....+|...|||.+...+....+.+.+|+.+|.+++|||||+++|......+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345667899999999999999998899999999877654446778999999999999999999997444333 6899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeeccceecCC-
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARMHGH- 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~~~~- 520 (705)
|+++|+|.+++.+.+. .|++..+..+.+||++||.|||+ ++||||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999987654 69999999999999999999998 99999999999999999 79999999999987653
Q ss_pred -CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 521 -GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 521 -~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... ....+++.........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~--------- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSL--------- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCC---------
Confidence 222234457899999999999854 3446999999999999999999999763 1111222121111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+.++........+++..|++.||++|||+.+++++.-
T Consensus 242 --P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 --PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 2344455667889999999999999999999998653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.70 Aligned_cols=243 Identities=26% Similarity=0.489 Sum_probs=204.6
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
+.+-||.|+.|.||+|++. ++.||||+++... ..+|+.|++|+||||+.+.|+|.. ...+|||||||+.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEEeeeccccc
Confidence 4678999999999999997 6889999885332 357899999999999999999987 67899999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceee
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 527 (705)
-|..+|+... .++......+.++||.||.|||. +.|||||||.-||||..+..+||+|||-++....- ....
T Consensus 198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkM 269 (904)
T KOG4721|consen 198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKM 269 (904)
T ss_pred cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhh
Confidence 9999997533 78999999999999999999998 99999999999999999999999999999876543 2334
Q ss_pred eeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHH
Q 005257 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~ 607 (705)
.++||..|||||++.+.+.++|+||||||||||||+||..||.+-+.. ..+|. -|. ..+. ...+..+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIwG---VGs------NsL~--LpvPstc 336 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIWG---VGS------NSLH--LPVPSTC 336 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--eeEEe---ccC------Cccc--ccCcccC
Confidence 589999999999999999999999999999999999999999763321 11111 010 0111 2345677
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 608 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
++.+.-|+++||+..|..||++++++.+|+-..+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 8889999999999999999999999999984433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=361.48 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=209.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
..++|...++||+|+||.||+|.+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999852 334679999987543 23456789999999999 8999999999988766
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC--------------------------------------------------------
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG-------------------------------------------------------- 458 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 458 (705)
+.+++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 678999999999999999975321
Q ss_pred ---CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeecccc
Q 005257 459 ---SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVG 534 (705)
Q Consensus 459 ---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~ 534 (705)
...+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1247888999999999999999998 99999999999999999999999999999865332211 1122345678
Q ss_pred CCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHH
Q 005257 535 YLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLH 613 (705)
Q Consensus 535 y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~ 613 (705)
|+|||++.+..++.++|||||||++|||++ |..||...... +.....+..+.. ...+......+.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~l~~ 308 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDGTR-----------MRAPENATPEIYR 308 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcCCC-----------CCCCCCCCHHHHH
Confidence 999999998899999999999999999997 99999764321 112222222211 1112233456889
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 614 LGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 614 l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
++..||+.||++|||+.++++.|+..++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.57 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=212.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+.+.....++||+|-||.|.++.... +..||||.++... ....++|.+|+++|.+|+||||+.++|+|.. ++.+++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHH
Confidence 33456677899999999999999874 6899999998763 4556899999999999999999999999997 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
+|||++|+|.++|...... .+......+|+.|||.||+||.+ .++|||||.++|||+|.++++||+|||++|..-.
T Consensus 614 ~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999876433 24566778899999999999999 9999999999999999999999999999995544
Q ss_pred CCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHh--hCCCCCCCCCcc-HHHHHHHHHHhCchhHHHHHh
Q 005257 521 GQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL--SGRRPIEEGKPN-LVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 521 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ell--tG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~ 596 (705)
+.. ....+.+-+.+|||||.+..+++++++|||+||+.+||++ |...||...... .++........+. ...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-~~~---- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-RQV---- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC-cce----
Confidence 433 3333456688999999999999999999999999999974 588999764321 1111111111111 111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
....+.-++..++++++.||..|-++||+++++...|++.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223445667889999999999999999999999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=365.87 Aligned_cols=265 Identities=27% Similarity=0.447 Sum_probs=211.9
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
++.++..+.+...+.||+|.||+||+|.+.+ .||||++... ..+..+.|++|+.++++-||.||+-+.|||..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 4455555556678899999999999999975 3999999876 45678899999999999999999999999985
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
..+.||+.+|+|.+|+.+|+..+. .|...+.+.|+.|||+|+.|||. ++|||||||..||+|.+++.+||+||||
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CceeeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 345999999999999999987553 69999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCC-CcceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 515 ARMHGHG-QVASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 515 a~~~~~~-~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
+..-..- ........-|...|||||+++. .+|+..+||||||||+|||+||..||..... +.+.-.+.+|.+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRGYLM 611 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecccccC
Confidence 8543211 1111122346788999999965 4689999999999999999999999984322 2221222333211
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ++ ......+.+.+.+|+..||..++++||.+.+|+..|+.+..
T Consensus 612 p----d~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 P----DL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c----cc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 11 11234566788999999999999999999999998886665
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=358.79 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=215.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
..|....+||+|+.|.||.+....+++.||||++........+-+++|+.+|+..+|+|||.++.-+.. ++.+|.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEee
Confidence 357778889999999999999999999999999987766666778999999999999999999998876 5789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
|++|+|.+.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.+|++||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999998643 58999999999999999999998 9999999999999999999999999999988876654
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
. ....+||+.|||||++....|.+|.||||||++++||+-|.+||-...+ ...++-....|.. . ...
T Consensus 425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAlyLIa~ng~P------~----lk~ 491 (550)
T KOG0578|consen 425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNGTP------K----LKN 491 (550)
T ss_pred c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHHHHhhcCCC------C----cCC
Confidence 3 3447999999999999999999999999999999999999999987543 2222222223321 1 122
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.++..+||+.|+++||++.|++++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33445678899999999999999999999984
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=338.07 Aligned_cols=299 Identities=23% Similarity=0.258 Sum_probs=223.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~lV 440 (705)
++|+..+.|++|.||.||+|+++.+++.||+|+++.+.. .-.-.-++||.+|.+.+|||||.+..+..- .-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 346778899999999999999999999999999987642 223346899999999999999999887652 23568999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||+. +|..++...+ +++...+...++.|+++|++|||. .-|+|||||++|+|+...|.+||+||||||.++.
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 9999998765 379999999999999999999998 9999999999999999999999999999999987
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .+..+-|.+|+|||.+.+. .|++..|+||+|||+.||+++++.|.+..+ .++++..++.
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---------------~dQl~~If~l 293 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---------------IDQLDKIFKL 293 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---------------HHHHHHHHHH
Confidence 6443 4556779999999999874 699999999999999999999998887553 2333333333
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCCCCC
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATH 679 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~h 679 (705)
.+......+..+..+-.+ +-..+|.- -...|++.++... ..+.-.+++.....++|..|.++.++|.|
T Consensus 294 lGtPte~iwpg~~~lp~~----k~~~f~~~--pyn~lr~kF~~~~------lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 294 LGTPSEAIWPGYSELPAV----KKMTFSEH--PYNNLRKKFGALS------LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hCCCccccCCCccccchh----hccccCCC--Cchhhhhhccccc------cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 233333322222221110 00011110 0122333332111 12333455666777999999999999999
Q ss_pred CCcccccccccccccce
Q 005257 680 PTFHDIRQSNSYSMSLS 696 (705)
Q Consensus 680 p~f~~~~~~~~~~~~~~ 696 (705)
+||.+.......++=-+
T Consensus 362 ~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 362 EYFRETPLPIDPSMFPT 378 (419)
T ss_pred cccccCCCCCChhhcCC
Confidence 99999777666554433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=385.78 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=214.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-----eEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++....+.||+|.||.||.|...+.. ..||||.+++. +.+...+|++|..+|++++|||||+++|+|.+ ...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCC
Confidence 345566788999999999999986432 45999999876 45567899999999999999999999999998 778
Q ss_pred eEEEEeeCCCCChhHHHHhcCC----CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG----SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
.+|++|||++|+|..+|++... ...|+..+++.++.|||+|+.||++ +++|||||.++|+||+....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEccc
Confidence 8999999999999999987521 2369999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCC-CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 513 GLARMHGH-GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 513 Gla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
||||.+.. +.........-...|||||.+..+.++.|+|||||||+|||++| |..||...+.. .+...+.+|.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLDVLEGG-- 921 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHHHHhCC--
Confidence 99994333 22222222233568999999999999999999999999999999 99999875541 2223222222
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
| -+.+..+++.+.+++..||+.+|++||++..+++.+.....
T Consensus 922 -----R----L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 -----R----LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -----c----cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1 23455677889999999999999999999999998776554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=396.14 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=214.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
..|...+.||+|+||.||+|....++..||||++...... ..+|++++++++||||++++++|.. ....++||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeC
Confidence 4577889999999999999999888999999998644321 2346889999999999999999986 5678999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.++++ .++|.++.+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.+......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999995 38999999999999999999997666899999999999999999888875 6665433221
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCC---CccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG---KPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~---~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
....||+.|||||++.+..++.++|||||||++|||++|+.||... .....+|+............+|+.+...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1236789999999999999999999999999999999999998642 2345566554444444444455555433
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+.++...+.+++.+||+.||++||+|.|+++.|+...+
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 44566778889999999999999999999999999997765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.46 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=209.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+.|...+.||.|..++||+|+....++.||||++..+.- ...+.+.+|+..|+.++||||++.+..|.. +..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEee
Confidence 4578889999999999999999999999999999987643 336889999999999999999999998776 77999999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
.||.+||+.+.++..-.. .+.+..+..|++++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999764333 59999999999999999999998 99999999999999999999999999987544332
Q ss_pred Cccee---eeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 522 QVAST---TRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 522 ~~~~~---~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
..... ...+||+.|||||++.. ..|+.|+||||||+..+||++|..||....+ .+.....+ ++......-..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tL-qn~pp~~~t~~ 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTL-QNDPPTLLTSG 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHh-cCCCCCccccc
Confidence 22221 44689999999999643 4699999999999999999999999986543 12222222 22211110000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+. .+-.......+.+++..|++.||++|||+.++++.
T Consensus 257 ~~--~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LD--KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CC--hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00 00011223478899999999999999999999873
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.48 Aligned_cols=287 Identities=22% Similarity=0.341 Sum_probs=221.0
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEecc--CCchhHHHHHHHHHHhccCCCCCcceeeeeeee----cc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR----EK 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~--~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~ 434 (705)
.....|...+.||+|+||.|..+.+..+|+.||||++.. ......++-++|+++|+.++|+||+.++.++.. .-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344566667899999999999999999999999999973 345567788999999999999999999998764 23
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
+.+|+|+|+|+ .+|...++... .|+...+.-++.|+++||.|+|+ .+|+||||||+|+|++.+..+||+||||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 56899999994 59999997543 59999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCC-CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 515 ARMHGHG-QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 515 a~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
||..... .....+..+.|.+|+|||++.. ..|+...||||.||++.||++|+..|.+.+. .++
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~---------------v~Q 236 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY---------------VHQ 236 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch---------------HHH
Confidence 9987543 2233466788999999999754 6799999999999999999999999987542 122
Q ss_pred HHHhhhcCCCCCHHHHHHHH-----HHHHHcCCCCCCCC-CCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhcccccc
Q 005257 593 LDARLRAKGGFDEDEVERVL-----HLGLLCAYPDPRAR-PTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWA 666 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~-----~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (705)
+...+...+..+++....+. ..+..+ |... -++.++ .........++++++..++
T Consensus 237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl----p~~p~~~f~~~---------------fp~a~p~AidLlekmL~fd 297 (359)
T KOG0660|consen 237 LQLILELLGTPSEEDLQKIRSEKARPYIKSL----PQIPKQPFSSI---------------FPNANPLAIDLLEKMLVFD 297 (359)
T ss_pred HHHHHHhcCCCCHHHHHHhccHHHHHHHHhC----CCCCCCCHHHH---------------cCCCCHHHHHHHHHHhccC
Confidence 22222222333443332222 222222 2111 111111 1233455678888899999
Q ss_pred ccccccccCCCCCCCccccccc
Q 005257 667 NYSRSFGYGYATHPTFHDIRQS 688 (705)
Q Consensus 667 ~~~r~~~~~~~~hp~f~~~~~~ 688 (705)
|..|.++.+|+.||||......
T Consensus 298 P~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 298 PKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred ccccCCHHHHhcChhhhhhcCC
Confidence 9999999999999999766543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.85 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=208.1
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC----Cc-hhHHHHHHHHHHhccCC-CCCcceeeeeeeecc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE----ND-GGTRAFLAEISSLGRLK-HKSLVGLRGWCKREK 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~----~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~ 434 (705)
....+|...+.||+|+||+|+.|.+..+++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.. .
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-P 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-C
Confidence 3456889999999999999999999999999999977654 11 23455678999999999 9999999999887 5
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeec
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFG 513 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFG 513 (705)
..+++||||+.+|+|.+++.+.+ ++.+.+...++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 56999999999999999998722 68999999999999999999998 999999999999999999 999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCC-CC-ccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGR-AS-TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++.... . ....+..+.
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~-l~~ki~~~~--- 239 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--N-LYRKIRKGE--- 239 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--H-HHHHHhcCC---
Confidence 999874 2222334469999999999999876 75 8899999999999999999999874321 1 111122221
Q ss_pred HHHHhhhcCCCCCHHH-HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 592 ALDARLRAKGGFDEDE-VERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..++... ...+..++..|+.+||.+|+++.+++.
T Consensus 240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1222222 567889999999999999999999995
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.46 Aligned_cols=282 Identities=22% Similarity=0.313 Sum_probs=210.5
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC----ceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG----SLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----~~~lV 440 (705)
.|...+++|.|+||.||+|+...+++.||||++-...+. --+|+++|++++|||||+++-++....+ .+.+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466788999999999999999999999999998654332 2369999999999999999988763222 46789
Q ss_pred EeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccceec
Q 005257 441 YDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMH 518 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla~~~ 518 (705)
|||||. +|..+++.. ..+..++...+.-+..||++||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 999998752 223368888899999999999999998 999999999999999966 89999999999998
Q ss_pred CCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
..+... .....|+.|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|.+.+.. +++...+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---------------dQL~eIi 239 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---------------DQLVEII 239 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---------------HHHHHHH
Confidence 776654 34567999999999977 56999999999999999999999999875421 1111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccC
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPD--PRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYG 675 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 675 (705)
+.-+....++.. |++++ -.+=|..... - ..+......+...++++.+...++|..|.++.+
T Consensus 240 k~lG~Pt~e~I~--------~mn~~y~~~~~p~ik~~---~------~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 240 KVLGTPTREDIK--------SMNPNYTEFKFPQIKAH---P------WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred HHhCCCCHHHHh--------hcCcccccccCcccccc---c------ceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 111333333221 22211 1111111100 0 000112233455667777778899999999999
Q ss_pred CCCCCCccccccc
Q 005257 676 YATHPTFHDIRQS 688 (705)
Q Consensus 676 ~~~hp~f~~~~~~ 688 (705)
+++||||+++|..
T Consensus 303 ~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 303 ALAHPFFDELRDP 315 (364)
T ss_pred HhcchhhHHhhCc
Confidence 9999999999955
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.58 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=213.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|...+.||+|+|++|++|+.+.+++.+|||++.+. .....+-...|-.+|.+| .||.|++|+--+.+ +..+|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~sLY 150 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EESLY 150 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-ccceE
Confidence 45678899999999999999999999999999998654 223344567899999999 89999999988876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++|+|.++|.+.+ .|++...+.++.+|+.||+|||+ +|||||||||+|||||+|+++||.|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998764 69999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCcc----------e--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 519 GHGQVA----------S--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 519 ~~~~~~----------~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
...... . ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+.+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---------
Confidence 543221 1 1458999999999999999999999999999999999999999988765321
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.+.+.....+++..++.+.+|+.+.+..||.+|++.+||.++
T Consensus 296 ------FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ------FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111122244555666788899999999999999999988875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.21 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=213.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|.||+||||+.+.+.+.||+|.+.+.. +.+.+.+.+|++++++|+||||+.+++|+.. ..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence 46778889999999999999999999999999997653 3456778999999999999999999999986 78999999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+.| +|..+|.+.. .++++.+..++.++..||.|||+ .+|+|||+||.|||++.++.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99976 9999997654 69999999999999999999999 99999999999999999999999999999987664
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. ...+...|||.|||||++.+++|+..+|+||+||++||+.+|++||.... + .+.+...+....
T Consensus 154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i-------------~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--I-------------TQLVKSILKDPV 217 (808)
T ss_pred c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--H-------------HHHHHHHhcCCC
Confidence 3 34566889999999999999999999999999999999999999996532 1 222233333334
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.++......+..++.-.+.+||.+|-+..+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 4455666778888888999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.00 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=203.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++.+++|+||+++.+.+.. ++..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEE
Confidence 3677899999999999999999899999999986542 2234467899999999999999999998876 66899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|..++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 80 e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 80 TIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999988865432 268999999999999999999998 99999999999999999999999999999875433
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh-cC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR-AK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~-~~ 600 (705)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||......... +.++..+. ..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~~ 221 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR------------EEVDRRVKEDQ 221 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH------------HHHHHHhhccc
Confidence 21 23357899999999999999999999999999999999999999865432110 11111111 01
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
..++......+.+++..||+.||++||+ +.+++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1223334467889999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=354.63 Aligned_cols=260 Identities=29% Similarity=0.424 Sum_probs=210.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCC----eEEEEEEecc---CCchhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISH---ENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~---~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
..++....++||+|+||.||+|.+...+ ..||||..+. .......+|++|.++|+.++|||||+++|++.. +
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-~ 233 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-E 233 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-C
Confidence 3344555689999999999999987542 2389999875 246678899999999999999999999999987 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
..++||||+|+||+|+++|.+.+. .++..++..++.+.|.||+|||+ +++|||||.++|+|++.++.+||+||||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccc
Confidence 789999999999999999988664 59999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
++....-.. ......-+..|+|||.+..+.++.++|||||||++||+.+ |..||.+.... .+...+..
T Consensus 309 s~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~------- 377 (474)
T KOG0194|consen 309 SRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVK------- 377 (474)
T ss_pred ccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHh-------
Confidence 886531111 1101123678999999999999999999999999999998 88899875431 12222211
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+ ...+...+..+..++..||..+|++||+|.++.+.|+....
T Consensus 378 -~~~r--~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 378 -NGYR--MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred -cCcc--CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1111 22333556677888889999999999999999999987665
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.01 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=220.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+....++||-|.||.||.|+++.....||||.++. +....++|+.|..+|+.++|||+|+|+|+|.. +...|||+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEfM 345 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEFM 345 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEecc
Confidence 34557899999999999999999889999999854 45567899999999999999999999999987 66899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
.+|+|.+||++++.. .++...++.++.||+.||.||.. +++|||||.++|+|+.++..+|++||||+|++..+...
T Consensus 346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999998765 67888889999999999999998 99999999999999999999999999999998766544
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......-...|.|||.+....++.|+|||+|||+||||.| |..||.+.+- ..|..++.+ ..+. +-
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LLEk---------gyRM--~~ 487 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLLEK---------GYRM--DG 487 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHhc---------cccc--cC
Confidence 3332333678999999999999999999999999999998 9999987542 233333333 3332 23
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+..|++.+.+|++.||+.+|.+||++.|+-+.++.++.
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 55677889999999999999999999999999987765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=346.08 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=199.9
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
+.||+|+||.||++....+++.||||+++.. .......+.+|+.++++++||||+++++++.. .+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 4699999999999999999999999998754 23344568899999999999999999998876 6789999999999
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 80 GELFFHLSRER---VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99999987543 68999999999999999999998 999999999999999999999999999987532221 122
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ..++..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~~~------------~~~p~~ 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEE------------IRFPRT 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCC------------CCCCCC
Confidence 3467999999999999889999999999999999999999999764321 1111111111 122333
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
....+.+++..||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 446688999999999999999 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.07 Aligned_cols=259 Identities=17% Similarity=0.311 Sum_probs=205.8
Q ss_pred cccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh---HHHHHHHHHHhccCCCCCcceeee
Q 005257 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG---TRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 352 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
+.++++++. ......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++||||+++++
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344555552 23346799999999999998 47899999997653322 467889999999999999999999
Q ss_pred eeee--c-cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC
Q 005257 429 WCKR--E-KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505 (705)
Q Consensus 429 ~~~~--~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~ 505 (705)
++.+ + ...+++||||+++|+|.+++.+.. .+++....+++.|++.||.|||+ ..+++||||||+|||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCC
Confidence 8865 2 346899999999999999997543 68999999999999999999997 24788999999999999999
Q ss_pred CeeeeeeccceecCCCCcceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHH
Q 005257 506 NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWEL 583 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~ 583 (705)
.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... + +...
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~-~~~~ 233 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--E-IYDL 233 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--H-HHHH
Confidence 99999999998654322 12467899999999976 67999999999999999999999999864321 1 1111
Q ss_pred HHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 584 MVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 584 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
+..+.. + ...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 i~~~~~--------~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 234 IINKNN--------S--LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHhcCC--------C--CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111110 0 112224556789999999999999999999999999854
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.50 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=206.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|+..+.||+|+||.||+|.+. ..+..||+|.++.... ...+.+.+|+.++.+++||||+++++++.. ++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcE
Confidence 346788999999999999999875 3467899999876533 345678999999999999999999998876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999976432 68999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-------- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFR-------- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC--------
Confidence 3222111112334678999999998999999999999999999775 99999764421 11112222111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+...+..+.+++..||+.+|++||++.++.+.|+..
T Consensus 227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112334456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.29 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=203.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEE
Confidence 4688899999999999999999999999999998653 22345678999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999997543 68899999999999999999998 9999999999999999999999999999987643
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+..+..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~----------- 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKILAGRL----------- 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCc-----------
Confidence 22 235799999999999998899999999999999999999999976442 112222222211
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
.++......+.+++..||+.||.+||+ +++++.+
T Consensus 233 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112223346788999999999999997 5766654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.48 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=202.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcC----------------CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCccee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG----------------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGL 426 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l 426 (705)
++|...++||+|+||.||+|.+.. ++..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467889999999999999998642 34579999987653 3345679999999999999999999
Q ss_pred eeeeeeccCceEEEEeeCCCCChhHHHHhcCC----------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 005257 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDG----------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490 (705)
Q Consensus 427 ~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 490 (705)
++++.. .+..++||||+++|+|.+++..... ...+++.++.+++.|++.||.|||+ .+|+
T Consensus 85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 85 LGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 999876 5678999999999999999865321 1247889999999999999999998 9999
Q ss_pred ecCCCCCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh--CCC
Q 005257 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS--GRR 567 (705)
Q Consensus 491 HrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt--G~~ 567 (705)
||||||+|||++.++.+||+|||+++........ ......++..|||||++..+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 1222345788999999988899999999999999999986 566
Q ss_pred CCCCCCcc-HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 568 PIEEGKPN-LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 568 Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
||...... ....+......... ... ...+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGR------QVY--LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccc------ccc--ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77653321 11111111111000 000 1112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.13 Aligned_cols=264 Identities=27% Similarity=0.364 Sum_probs=201.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc--CCCCCcceeeeeeeec---cCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR--LKHKSLVGLRGWCKRE---KGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~---~~~~~ 438 (705)
...+..++||+|+||.||||.+. ++.||||++. .+..+.|.+|-++.+. ++|+||+++++.-... ...++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34556778999999999999996 5899999985 3455677777776554 5899999999965431 23789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW------EKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
||+||.+.|+|.+||..+ .++|.+..+|+..+++||+|||++. +++|+|||||++|||+..|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999753 6999999999999999999999764 678999999999999999999999999
Q ss_pred ccceecCCCCcce-eeeeeccccCCCccccccCC------CCccccEEEEehhHHHHhhCCCCCCC--------------
Q 005257 513 GLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGR------ASTQTDVFGFGILILEVLSGRRPIEE-------------- 571 (705)
Q Consensus 513 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~------~s~ksDVwS~Gvvl~ElltG~~Pf~~-------------- 571 (705)
|||..+..+.... ....+||.+|||||++.+.- .-.+.||||+|.|||||+++-.-+..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999887655433 23368999999999997632 23578999999999999985332211
Q ss_pred CCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 572 GKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 572 ~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.....+.++..+...+....+..... ....+..+.+.+..||..||+.|-|+.=+.+.+..+..
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~-----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWR-----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhh-----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111223444444333222211111111 12346778999999999999999999999888876654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.21 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=212.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
..|...++||+|.||.||||.+..+++.||+|++..+. ....+++.+|+.+|..++++||.+++|.+.. +..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHH
Confidence 35667789999999999999999999999999998763 4456788999999999999999999998776 778999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
||.+|++.+.|.... .+.+..+.-|++++..||.|||. .+.+|||||+.|||+..+|.+||+|||++-......
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999996433 45888888899999999999998 999999999999999999999999999998776655
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
... ..++||+.|||||++....|+.|+||||||++.+||++|.+|+..-.+. +++-.+.+... +.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------rvlflIpk~~P--P~ 230 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------RVLFLIPKSAP--PR 230 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------eEEEeccCCCC--Cc
Confidence 444 5589999999999999889999999999999999999999999865541 11122222211 22
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+++..|++.||+.||++.+++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 333556678999999999999999999999884
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=335.74 Aligned_cols=264 Identities=23% Similarity=0.274 Sum_probs=203.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 46888999999999999999999999999999987542 3345678899999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||++++.+..+... . ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99998777655432 2 258999999999999999999998 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh----
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL---- 597 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l---- 597 (705)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..........+.+........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCHHHHHhhhccc
Confidence 333333457899999999998888999999999999999999999999764321 111000001111111000000
Q ss_pred -------hcC-------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 -------RAK-------GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 -------~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ..+.......+.+++..|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 00001123568999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.47 Aligned_cols=246 Identities=25% Similarity=0.297 Sum_probs=203.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ +..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence 36888999999999999999999889999999986432 2345668899999999999999999998775 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999997543 68999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+.
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~------------ 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAGK------------ 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------
Confidence 2 22357899999999999888999999999999999999999999765421 1122222221
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
..++......+.+++..||+.||.+||+ +.+++++
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1222233456789999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=319.87 Aligned_cols=237 Identities=26% Similarity=0.363 Sum_probs=203.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||.|+||+|.+++.+.++..+|+|++++.. ..+.+...+|..+|+.+.||.++++.+-|.+ ...+++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEE
Confidence 35677889999999999999999999999999997653 3455678899999999999999999998876 7789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||.+||.|..+|++.+ ++++...+-++.||+.||+|||+ ..|++|||||+|||||.+|.+||.|||.|+....
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999998755 79999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. +-..+|||.|+|||++....+..++|.|||||++|||+.|..||....+ ....+.+.++++
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v----------- 258 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKV----------- 258 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcc-----------
Confidence 2 5568999999999999999999999999999999999999999987654 233444444432
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCC
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRAR 626 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~R 626 (705)
.++......+.+|+...++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3444444556777777777777777
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.32 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=212.0
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|...+.||.|+-|.|..|++..+|+.+|||++.+. .......+.+||-+|+-|.|||++++++++.. +.++|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEE
Confidence 55678899999999999999999999999999766 23345668899999999999999999998775 779999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|.|.++|...+ ++++.+..+++.||+.|+.|||. .+|+||||||+|+|||..+++||+|||+|.+..++.
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999997654 69999999999999999999998 999999999999999999999999999998876655
Q ss_pred cceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... ..||++.|.|||++.+.+| ..++||||+|||||.|++|+.||+++.- ..+..+++.|.+
T Consensus 167 lLe--TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G~f------------ 229 (786)
T KOG0588|consen 167 LLE--TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRGVF------------ 229 (786)
T ss_pred ccc--ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcCcc------------
Confidence 443 3599999999999999887 6899999999999999999999986542 333444444432
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.+.....+..+|+..++..||+.|-|++||+++
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2334445667889999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=341.81 Aligned_cols=243 Identities=23% Similarity=0.296 Sum_probs=197.5
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||.||+|.+..+++.||+|++... .......+.+|+.++.+++||||+++++++.. .+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 69999999999999989999999998643 23445678899999999999999999998875 678999999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 80 LFHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999997533 58999999999999999999998 999999999999999999999999999998543222 12234
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+ ...++....
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~~~~------------~~~~~~~~~ 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKILQE------------PLRFPDGFD 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHHHcC------------CCCCCCcCC
Confidence 57999999999999989999999999999999999999999764321 111111111 122233344
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..+.+++..||+.||++||++..+.+.|+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 56789999999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.32 Aligned_cols=288 Identities=26% Similarity=0.351 Sum_probs=216.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCC-cceeeeeeeeccC-----c
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKS-LVGLRGWCKREKG-----S 436 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~-----~ 436 (705)
.|...++||+|+||+||+|+.+.+|+.||+|++....+ .....-.+|+.++++|+|+| |+.+++++..+.. .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 35556679999999999999999999999999987644 23455689999999999999 9999999987543 8
Q ss_pred eEEEEeeCCCCChhHHHHhcCCC-CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGS-MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
+++|+||++. +|.+++...... ..++...+..++.|++.||+|||+ ++|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999965 999999876532 357778999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
+...-.... .+..++|.+|+|||++.+. .|+...||||+||++.||++++..|.+..+ .+++.
T Consensus 168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---------------~~ql~ 231 (323)
T KOG0594|consen 168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---------------IDQLF 231 (323)
T ss_pred HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---------------HHHHH
Confidence 977644433 3345789999999999886 699999999999999999999888887653 11122
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhcccccccccccccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGY 674 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 674 (705)
...+..+..+.+.++.+..+...=. ...+++..+.+...+... .....+.+..+..+++..|.+++
T Consensus 232 ~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~------------~~~~~dll~~~L~y~p~~R~Sa~ 297 (323)
T KOG0594|consen 232 RIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKL------------DPDGIELLSKLLQYDPAKRISAK 297 (323)
T ss_pred HHHHHcCCCCccCCCCccccccccc--cCcCCCCccchHHhcccc------------CccHHHHHHHHhccCcccCcCHH
Confidence 2222112223222222222221111 111222233333333211 12344566667779999999999
Q ss_pred CCCCCCCccccc
Q 005257 675 GYATHPTFHDIR 686 (705)
Q Consensus 675 ~~~~hp~f~~~~ 686 (705)
.++.||||.+..
T Consensus 298 ~al~h~yf~~~~ 309 (323)
T KOG0594|consen 298 GALTHPYFSELP 309 (323)
T ss_pred HHhcChhhcccc
Confidence 999999998875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.13 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=199.2
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
+.||+|+||.||++....+++.||+|++... .......+.+|+++++.++||||+++++++.. ++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 4699999999999999999999999999754 23345678899999999999999999998875 6789999999999
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
|+|..++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 80 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 80 GELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99998886533 68999999999999999999998 999999999999999999999999999987543221 122
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ..++..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~~------------~~~p~~ 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMED------------IKFPRT 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccCC------------ccCCCC
Confidence 3357999999999999889999999999999999999999999764321 1111111111 112223
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
....+.+++..||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 345678899999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.92 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=209.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.+|...+.||+|++|.||+|.....++.||+|++... ....+++.+|++++++++||||++++++|.. ++..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEe
Confidence 3477788999999999999999988999999998643 3345778999999999999999999998876 6688999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999976443 368999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... +..+.....+ .. ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~---------~~--~~ 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKG---------YR--ME 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC---------CC--CC
Confidence 22222234568999999988899999999999999999998 9999875432 1222222211 11 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2233456788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.80 Aligned_cols=243 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
+.||+|+||.||++....++..||+|+++.. .......+.+|+++++.++||||+++++.+.. .+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 4699999999999999989999999998754 23345667889999999999999999998876 6789999999999
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99998886543 68999999999999999999998 9999999999999999999999999999875322221 22
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ..++..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~~~~------------~~~p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEE------------IRFPRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCC------------CCCCCC
Confidence 2357899999999999889999999999999999999999999764421 1111111111 112233
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
....+.+++..||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 345678999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.95 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=205.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++..++||||+++++++.. .+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence 46888999999999999999999889999999987542 2345678899999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999996543 68999999999999999999998 9999999999999999999999999999976543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+..... .+.....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~--~~~~~~~-- 222 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKE--TLQRPVY-- 222 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhccc--cccCCCC--
Confidence 223357899999999999889999999999999999999999999764421 11111111100 0000000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..|+..+|++||++.+++++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=317.69 Aligned_cols=203 Identities=29% Similarity=0.412 Sum_probs=168.6
Q ss_pred CCCeEEEcceEee--cCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCC
Q 005257 35 SSNLSLYGTATVE--SRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHG 112 (705)
Q Consensus 35 ~~~~~~~g~a~~~--~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~ 112 (705)
..++.++|+|.+. ++.|+||++..+++|+++|++||++| ++|+|+|+|.|.+.. ..+||||||+|+|...
T Consensus 13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~ 84 (223)
T cd01951 13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPA 84 (223)
T ss_pred hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCC
Confidence 3689999999998 78999999999999999999999998 679999999998865 5689999999999866
Q ss_pred CCCCCCC--CcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccc--cccccccCCCCCCCCCCCC
Q 005257 113 IKGATEA--QHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVS--AHAAGYWPDNQTDSSGSNS 188 (705)
Q Consensus 113 ~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~--~~~~~~~~~~~~~~~~~~~ 188 (705)
.+.+..| ++||+ ...++.+||||||++|.+++||+.||||||+|+..|.. ..++++..
T Consensus 85 ~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~----------- 146 (223)
T cd01951 85 GALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSAS----------- 146 (223)
T ss_pred CccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceee-----------
Confidence 5555555 78887 35578999999999999888999999999999997641 11111110
Q ss_pred CCCCCCCccccceeecCCCcceEEEEEec--CceEEEEEEEccCCCCCCCceeeeecCccccccceeccccccccccccc
Q 005257 189 NSGTGDDEKSFKELKLNNGKNYQVWIDYA--DSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVES 266 (705)
Q Consensus 189 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~--~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~ 266 (705)
.+....+|+.++|||+|+ .++|.|++..... |..+.++.++||+..++++||||||||||...+.
T Consensus 147 -----------~~~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~ 213 (223)
T cd01951 147 -----------LPNGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNL 213 (223)
T ss_pred -----------CCCccCCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcce
Confidence 011122388999999994 6888888875543 6778999999999999999999999999999999
Q ss_pred ceeeeeeecc
Q 005257 267 HKILAWSFSN 276 (705)
Q Consensus 267 h~i~~wsf~~ 276 (705)
|.|++|+|++
T Consensus 214 h~V~~wsf~~ 223 (223)
T cd01951 214 HDILNWSFTS 223 (223)
T ss_pred eEEEEEEecC
Confidence 9999999974
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=349.16 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=205.0
Q ss_pred HhCCCCcceEEeecCceEEEEEEE-----cCCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVL-----EGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
..++|+..+.||+|+||.||+|+. .+++..||||+++... ....+.+.+|+.++..+ +||||++++++|.. .
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~ 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-G 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-C
Confidence 345788899999999999999974 3456789999986543 33456789999999999 89999999999876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC--------------------------------------------------------
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG-------------------------------------------------------- 458 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 458 (705)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 688999999999999999865321
Q ss_pred ----------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 459 ----------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 459 ----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
...+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247889999999999999999998 999999999999999999999999999998664332
Q ss_pred cce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 523 VAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 523 ~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+..+. +
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~---------~-- 335 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKEGY---------R-- 335 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHhCc---------c--
Confidence 211 111234667999999999899999999999999999998 88888654321 11112222211 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+......+.+++..||+.||++||++.|+++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011112235688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.44 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=202.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCC-eEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGG-AEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.++..++||||+++++++.. .+.+++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEE
Confidence 46888999999999999999876554 68999998643 23345678899999999999999999998876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997543 68999999999999999999998 999999999999999999999999999998754
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||....+. .....+..+.
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~----------- 244 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEGI----------- 244 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcCC-----------
Confidence 32 23357999999999999888999999999999999999999999865431 1122222221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
..++......+.+++..|++.||++|+ ++++++++
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112222334578899999999999995 88888764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.13 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=207.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|+..+.||+|+||.||++.+..++..+|+|.+..... ...+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEe
Confidence 4678899999999999999999999999999999876533 345679999999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999997543 58999999999999999999997 246999999999999999999999999999765432
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH-HHHhC-------------
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE-LMVQG------------- 587 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~-~~~~~------------- 587 (705)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....+
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 223468999999999998889999999999999999999999997543211111000 00000
Q ss_pred -----------------chhHHHHHhhhcC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 588 -----------------KLLDALDARLRAK--GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 588 -----------------~~~~~id~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+..+...... ..........+.+++.+||+.||++|||+.+++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0001111110000 000112345789999999999999999999998864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=331.09 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=197.0
Q ss_pred cceEEeecCceEEEEEEEc----CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 368 EENVIGVGGNGKVYKGVLE----GGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
..+.||.|.||.||+|.+. ..+..|+||.++.... ...+.|.+|++.+++++||||++++|+|.. .+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccc
Confidence 3578999999999999998 3457899999965433 347889999999999999999999999985 667999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.++|..... ..+++.++.+|+.|++.||.|||+ .+++|+||+++||++++++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999988622 269999999999999999999998 899999999999999999999999999998773322
Q ss_pred c-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 523 V-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 523 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||..... ..+...+.++..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~----------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQR----------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEE-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccc-----------
Confidence 2 11222356789999999988889999999999999999999 7889876532 112222233222
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+..+...+..++..||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112233456688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.24 Aligned_cols=262 Identities=25% Similarity=0.423 Sum_probs=205.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
..++|+..+.||+|+||.||+|+... ++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.. .
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~ 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-G 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-C
Confidence 34578889999999999999998643 33579999997543 33356688999999999 89999999998876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC--------------------------------------------------------
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG-------------------------------------------------------- 458 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 458 (705)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 688999999999999999864311
Q ss_pred -----------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce-e
Q 005257 459 -----------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS-T 526 (705)
Q Consensus 459 -----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~-~ 526 (705)
...+++.++++++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1247889999999999999999998 999999999999999999999999999998654432211 1
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
....++..|||||++.+..++.++|||||||++|||++ |+.||...... .........+ .. ...+.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~~~~~~---------~~--~~~~~ 338 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMVKRG---------YQ--MSRPD 338 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHHHHHcc---------cC--ccCCC
Confidence 12234668999999988899999999999999999997 99999754321 1111111111 11 11111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.....+.+++..||+.||++||++.++++.|++.+
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 22356889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.86 Aligned_cols=256 Identities=25% Similarity=0.477 Sum_probs=207.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCC-----eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
+|+..+.||+|+||.||+|.....+ ..||+|.+..... .....|.+|+.++.+++||||+++++++.. ....+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCceE
Confidence 5777889999999999999986554 6799999865433 345678999999999999999999998875 56789
Q ss_pred EEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC
Q 005257 439 LVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~ 505 (705)
++|||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999976421 1358899999999999999999998 9999999999999999999
Q ss_pred CeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHH
Q 005257 506 NGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWEL 583 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~ 583 (705)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543221 12223456788999999988889999999999999999998 99999764421 12222
Q ss_pred HHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 584 MVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 584 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
+..+.. ...+...+..+.+++..||+.||.+||++.++++.|+.
T Consensus 239 i~~~~~-----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQL-----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc-----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222211 12234456788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.81 Aligned_cols=302 Identities=21% Similarity=0.261 Sum_probs=219.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-C-----CCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-H-----KSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-H-----pniv~l~g~~~~~~~~~~ 438 (705)
+|.+.+.||+|.||.|.||.+..+++.||||+++.. ..-.++-..|+.+|..|+ | -|+|++++++.. ++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-cccee
Confidence 788999999999999999999999999999999654 334455677999999997 4 389999998886 88999
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC--CCeeeeeeccce
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE--MNGRLGDFGLAR 516 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~--~~~kL~DFGla~ 516 (705)
||+|.+.. +|.++|+.++-+ .++...++.++.||+.||..||+ .+|||+||||+||||.+- ..+||+|||.++
T Consensus 265 iVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999965 999999887655 69999999999999999999998 999999999999999754 369999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH-HhCchhH-HHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM-VQGKLLD-ALD 594 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~-~~~~~~~-~id 594 (705)
.....-. ..+.++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+ .+.+...+ ..|.... .++
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne--~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE--YDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH--HHHHHHHHHHhCCCCHHHHH
Confidence 7654332 45778999999999999999999999999999999999877776553 22222221 1222111 222
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc--CC------CCCcc-hhhHHHHHHhhccccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA--GI------ENETE-DMDAYLLQQVKSKDMW 665 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~--~~------~~~~~-~~~~~~~~~~~~~~~~ 665 (705)
..-+....++ .+......|-..+-.+-+...++.+.+...... .| +.... ..+..+.++++.+..|
T Consensus 414 ~~~~~~kff~-----~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 414 TAKKAHKFFT-----SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred hccccceehh-----ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 2111111111 101111113322211111222333322211110 11 11112 3456678999999999
Q ss_pred cccccccccCCCCCCCccc
Q 005257 666 ANYSRSFGYGYATHPTFHD 684 (705)
Q Consensus 666 ~~~~r~~~~~~~~hp~f~~ 684 (705)
+|..|.++.+++.||||+.
T Consensus 489 dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTG 507 (586)
T ss_pred CchhcCCHHHHhcCccccc
Confidence 9999999999999999983
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=341.12 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=205.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||+||+|....+++.||||+++.. .....+.+.+|++++..++||||+++++++.. ++.+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 4688899999999999999999988999999998754 22445678899999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999765 268999999999999999999998 9999999999999999999999999999986654
Q ss_pred CC----------------------------cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 521 GQ----------------------------VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 521 ~~----------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 11223357899999999999999999999999999999999999999865
Q ss_pred CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 005257 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-MRQVVKV 635 (705)
Q Consensus 573 ~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 635 (705)
... . .+..+.... ..+. ..........+.+++..|+. ||.+||+ +.+++++
T Consensus 234 ~~~--~-~~~~i~~~~------~~~~--~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ--E-TYNKIINWK------ESLR--FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH--H-HHHHHhccC------Cccc--CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 421 1 111111100 0000 00011134567888899997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.57 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=207.1
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
...++|+....||+|+||.||+|+-+++|..+|+|++++. ...+.+..++|-.+|...+.|.||+|+-.+.+ ...+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYL 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCee
Confidence 3557899999999999999999999999999999999876 34567788999999999999999999988776 7899
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
||||||++||++..+|...+ .|++.....++.+++.|+.-||. .|+|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999997654 79999999999999999999998 9999999999999999999999999999842
Q ss_pred cCC----------------------CCcc-----e-------------------eeeeeccccCCCccccccCCCCcccc
Q 005257 518 HGH----------------------GQVA-----S-------------------TTRVVGTVGYLAPEVFSSGRASTQTD 551 (705)
Q Consensus 518 ~~~----------------------~~~~-----~-------------------~~~~~gt~~y~APE~~~~~~~s~ksD 551 (705)
+.. .... . ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 210 0000 0 01258999999999999999999999
Q ss_pred EEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC---C
Q 005257 552 VFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP---T 628 (705)
Q Consensus 552 VwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s 628 (705)
.||||||+|||+.|.+||....+. ..|..+...+. .+. .........+..+|+..|+. ||++|- .
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~------~l~--fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRE------TLK--FPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhh------hcc--CCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999999886652 33333322211 111 11112233667788888877 999995 5
Q ss_pred HHHHHH
Q 005257 629 MRQVVK 634 (705)
Q Consensus 629 ~~evl~ 634 (705)
+.||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 666665
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.59 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=198.2
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
+.||+|+||.||++....+++.||+|++... .......+.+|++++..++||||+++.+++.. .+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 4699999999999999989999999998754 22345667889999999999999999998776 6789999999999
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
|+|..++.... .+++.++..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 80 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 80 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 99998886533 68999999999999999999995 26999999999999999999999999999875432221 22
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~~------------~~~p~~ 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEE------------IRFPRT 218 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcCC------------CCCCCC
Confidence 3357999999999999889999999999999999999999999764321 1111111111 112223
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
....+.+++..||+.||++|+ ++.+++++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 345678899999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.53 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=215.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+++|+|+||.++..+++.++..+++|++.... ....+...+|+.++++++|||||.+.+.+..++..++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999999999999999999997653 3445577899999999999999999998887444499999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
+|++||+|.+.+.+.+ +..++++.+..++.|++.|+.|||+ ..|+|||||+.|||++.+..+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998766 3479999999999999999999998 99999999999999999999999999999998776
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... ...++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.. ..+ ..+.++ .. .
T Consensus 160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~Li-~ki~~~---------~~--~ 224 (426)
T KOG0589|consen 160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--ELI-LKINRG---------LY--S 224 (426)
T ss_pred hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--HHH-HHHhhc---------cC--C
Confidence 532 33479999999999999999999999999999999999999999875421 111 111111 10 3
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+..++..|++.+|+.||++.+++..
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3455667788999999999999999999999885
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.05 Aligned_cols=202 Identities=28% Similarity=0.484 Sum_probs=173.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|...++||+|+||.||+|....++..||+|+++.... .....+.+|+.++++++||||+++++++.. ++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence 468889999999999999999998999999999875432 334567899999999999999999998876 568899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++ +|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9975 99998865432 57899999999999999999998 999999999999999999999999999997654322
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
.. .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223467999999999865 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.48 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=208.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
++|+..+.||+|+||.||+|...+ +++.||+|+++... ....+.+.+|+.++.++ +||||++++++|...+..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997543 34789999987543 23346788999999999 899999999998876778
Q ss_pred eEEEEeeCCCCChhHHHHhcCC----------------------------------------------------------
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG---------------------------------------------------------- 458 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 458 (705)
+++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 9999999999999999864321
Q ss_pred CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCC
Q 005257 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLA 537 (705)
Q Consensus 459 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~A 537 (705)
...+++..+.+++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++........ ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999998 99999999999999999999999999999865433221 1222355778999
Q ss_pred ccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 005257 538 PEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGL 616 (705)
Q Consensus 538 PE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~ 616 (705)
||++.+..++.++|||||||++|||++ |+.||...... +.....+..+.. ...+......+.+++.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKEGTR-----------MRAPEYATPEIYSIML 310 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhccCC-----------CCCCccCCHHHHHHHH
Confidence 999999999999999999999999998 99998753221 111122222111 1112233456889999
Q ss_pred HcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 617 LCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 617 ~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+||+.+|++||++.|++++|+..++
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999997665
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=332.13 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=199.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|...+.||+|+||.||+|....+++.||||++..... .....+.+|+.+++.++||||+++++++.. +...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence 4678999999999999999999998899999999875432 234567889999999999999999998876 66899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||++ ++|.+++..... .+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9996 688888765432 58899999999999999999998 99999999999999999999999999999754322
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHH-------
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDA------- 592 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~------- 592 (705)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .+....... .+.....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhCCCChhhccchhh
Confidence 21 1223468999999999865 45788999999999999999999999764321 111111110 0000000
Q ss_pred ---HH-HhhhcCCCCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 ---LD-ARLRAKGGFDE-------DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 ---id-~~l~~~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+ .+......... .....+.+++..|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00000000000 012457789999999999999999999873
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.32 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=204.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||+||++....+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 46888999999999999999999999999999987542 2345668899999999999999999998775 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999976532 68999999999999999999998 9999999999999999999999999999987655
Q ss_pred CCcceeeeeeccccCCCccccc------cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 521 GQVASTTRVVGTVGYLAPEVFS------SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... .. ...+.....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~-~~~i~~~~~----- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KT-YNNIMNFQR----- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HH-HHHHHcCCC-----
Confidence 4433334457899999999986 456789999999999999999999999765421 11 111111100
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+. ..........+.+++..|++ +|.+||++.+++++
T Consensus 227 -~~~--~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 -FLK--FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -ccC--CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 00011234567788888997 99999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.36 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=207.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|+..+.||+|+||.||+|.+... ...||||.++... .....+|.+|+.++++++||||+++++++.. .+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEE
Confidence 5688899999999999999998643 4579999987553 3345678999999999999999999998876 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++..... .+++.++++++.|++.||.|||+ ++|+|+||||+||++++++.+||+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976443 68999999999999999999998 999999999999999999999999999998775
Q ss_pred CCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 520 HGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 520 ~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-------- 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYR-------- 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCC--------
Confidence 22221 1112234678999999998889999999999999999998 9999865432 111222221110
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+......+.+++..||+.+|++||++.++++.|+..
T Consensus 227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111233456789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.08 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=205.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.. .+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEec
Confidence 467888999999999999999764 5679999876433 345789999999999999999999998765 6678999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++...... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999764332 68999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||++....++.++|||||||++|||++ |+.||...... .....+..+. . ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~---------~--~~ 224 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGY---------R--MP 224 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCC---------C--CC
Confidence 22222345678999999988889999999999999999998 99999754321 1111111111 0 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
........+.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=334.45 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=196.6
Q ss_pred eEEeecCceEEEEEEEc---CCCeEEEEEEeccC----CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 370 NVIGVGGNGKVYKGVLE---GGGAEIAVKRISHE----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+.||+|+||.||++... .+++.||||.++.. .......+.+|+.+++.++||||+++++++.. ++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence 57999999999999864 46789999998653 22334567889999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++.+.. .+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999986543 57888999999999999999998 999999999999999999999999999987543322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+. ..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~~------------~~ 218 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGK------------LN 218 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCC------------CC
Confidence 2 223357899999999999888999999999999999999999999764421 1111121111 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
.+......+.+++..||+.||++|| ++.+++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 2223345678999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.11 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=210.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|+...+++.||||.++.. .......+.+|++++++++||||+++++++.. .+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence 4688899999999999999999988999999987643 23344578999999999999999999998876 6688999
Q ss_pred EeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
+||+++|+|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999999886432 22358899999999999999999998 999999999999999999999999999998764
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........+.. ..+......
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~--------- 226 (267)
T cd08228 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-QKIEQCDYP--------- 226 (267)
T ss_pred chhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH-HHHhcCCCC---------
Confidence 33221 1234678899999999888899999999999999999999999976543322221 111111100
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..........+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223446789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.56 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=194.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++++.++|+||+++++++.. .+.+++||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecC
Confidence 3446789999999999999998899999999865433 345678999999999999999999998876 67899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|.... ...+..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 45677888999999999999998 9999999999999999999999999999987643321
Q ss_pred eeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 525 STTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
......||..|+|||++.. ...+.++|||||||++|||++|+.||................. ..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----------~~ 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----------SQ 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----------cC
Confidence 1233578999999998743 2345689999999999999999999974332111111111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..||+.||++||++.|++++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 012223345678899999999999999999999885
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.36 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=200.1
Q ss_pred CCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccC----CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 365 GFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHE----NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~----~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
+|+..+.||+|+||.||++... .+++.||+|++... .....+.+..|++++..+ +||||+++++++.. .+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence 4778899999999999999874 46789999998643 223345678899999999 59999999987765 678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+++||||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 899999999999999997543 58999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCc-cHHHHHHHHHHhCchhHHHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-~~~~~v~~~~~~~~~~~~id 594 (705)
..............||+.|||||++.+. .++.++|||||||++|||++|+.||..... .....+...+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--------
Confidence 6544433334456799999999999765 478899999999999999999999964322 111111111111
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
....++......+.+++..||+.||++|| ++++++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11222233445678899999999999999 67777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=334.74 Aligned_cols=257 Identities=21% Similarity=0.375 Sum_probs=205.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.+|+..+.||+|+||.||+|++..+++ .||+|.++... ....+++.+|+.+++.++||||++++++|.. ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCce
Confidence 468889999999999999999865554 48999986543 3456788999999999999999999999875 3568
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+++||+++|+|.+++.+... .+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999976443 58899999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCccee-eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVAST-TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~------- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGER------- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhCCCC-------
Confidence 54332211 11234678999999998899999999999999999997 99999764321 11111111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+...+..++..||+.+|++||++.+++..|.....
T Consensus 230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11112234567889999999999999999999999886644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=334.71 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=197.0
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|....+++.||||+++.. .....+.+..|.+++..+ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 3699999999999999988999999998754 233455678899988866 79999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999999886543 58999999999999999999998 9999999999999999999999999999976432222 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+. ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~~~------------~~~p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILHDD------------VLYPV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCC------------CCCCC
Confidence 23457899999999999889999999999999999999999999865421 1122222211 11122
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARP-------TMRQVVKV 635 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 635 (705)
.....+.+++..|++.||++|| ++.+++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2335678899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.96 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=199.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc----CceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~~ 438 (705)
+|+..+.||+|+||.||+|....++..||||++... .......+.+|++++++++||||+++++++.... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999999989999999998643 2234457889999999999999999999875422 3479
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||++ ++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68998886533 58999999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCc--ceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHH----------
Q 005257 519 GHGQV--ASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWEL---------- 583 (705)
Q Consensus 519 ~~~~~--~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~---------- 583 (705)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11233578999999999865 57899999999999999999999999764321 11111110
Q ss_pred -HHhCchhHHHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 584 -MVQGKLLDALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 584 -~~~~~~~~~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+........+. .+....... +.....+.+++..||+.||++||++.|++++
T Consensus 234 ~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHH-hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111000110 000000000 0123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=326.14 Aligned_cols=247 Identities=22% Similarity=0.397 Sum_probs=210.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+|++.+.||+|.||.|-+++....|+.||||.+++. +.++.-.+.+||++|+.|+||||++++.++.. ++.+.|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvivM 132 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVIVM 132 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEEEE
Confidence 566678899999999999999889999999998765 34555678999999999999999999998876 78999999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||..+|.|++|+..++ .|++.+...+++||..|+.|+|. ++++|||||.+|||||+|+++||+||||+.++...
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999997655 69999999999999999999998 99999999999999999999999999999988665
Q ss_pred CcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .+.++|++.|.+||++.+.+| .+.+|-|||||+||-|+.|..||++.+.. .+...+..|..
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~GaY----------- 270 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRGAY----------- 270 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcccc-----------
Confidence 44 345799999999999999887 58899999999999999999999875421 11122222322
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
..++.+....-|++|++..+|++|.|+.+|..+-
T Consensus 271 --rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 --REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2233445567789999999999999999998864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=324.10 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=206.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..+.||+|++|.||+|.+.. ++.||+|.++... ...+++.+|+.++++++||||+++++++.. .+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeee
Confidence 4568889999999999999999764 5779999986543 345678999999999999999999998876 668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999976542 368999999999999999999998 999999999999999999999999999998765332
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.. ... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---------~~~--~ 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVDQ---------GYR--M 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc---------CCC--C
Confidence 222221223457999999988899999999999999999999 99998754321 11111111 111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1223345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.27 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=203.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+|+..++||+|+||.||++....+++.||||++.... ......+.+|+.++++++||||+++++.+.. ++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence 4778899999999999999998889999999986532 2233557889999999999999999998876 56899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999998875432 268999999999999999999998 99999999999999999999999999999876433
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||........ +.+.. .+... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~---------~~~~~---~ 221 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER---------RVKED---Q 221 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH---------Hhhhc---c
Confidence 22 1234789999999999888899999999999999999999999986432111 11111 11110 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
..++......+.+++..||+.||++|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 223334456788999999999999999 77777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.37 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=196.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-CCeEEEEEEeccCC--chhHHHHHHHHHHhccC---CCCCcceeeeeeee----c
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHEN--DGGTRAFLAEISSLGRL---KHKSLVGLRGWCKR----E 433 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~----~ 433 (705)
++|...+.||+|+||.||+|.+.. ++..||+|+++... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999999853 46889999886542 22334566777776665 69999999998852 2
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
...+++||||++ ++|.+++...... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 6999998764433 58999999999999999999998 999999999999999999999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhC---ch
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQG---KL 589 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~---~~ 589 (705)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+.+..... ..
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 998765432 223457899999999998888999999999999999999999999764321 111111110000 00
Q ss_pred hHHH---HHhhhcCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 590 LDAL---DARLRAKGG-----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 590 ~~~i---d~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+ ...+..... ........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000000 00112355789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.28 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=209.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
..+|...++||.|+||.||+|.... +..+|+|.+..........+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEe
Confidence 4567788999999999999999987 78899999977666567789999999999999999999998876 668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+... ..+++.++..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999976543 368999999999999999999998 999999999999999999999999999997664332
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+. .... .
T Consensus 159 ~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---------~~~~--~ 223 (261)
T cd05148 159 YLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---------AGYR--M 223 (261)
T ss_pred ccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---------hCCc--C
Confidence 211 12345678999999988889999999999999999998 89999754321 1111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+....+.+.+++.+||+.||++|||++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1223445678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=352.09 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=206.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCC-CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGG-GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++||||+++++++.. ++.++|||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEEC
Confidence 488899999999999999998776 78899998765555555678889999999999999999999876 6789999999
Q ss_pred CCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 444 MENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 444 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
+++|+|.++|.+. .....+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 223368999999999999999999998 999999999999999999999999999998765432
Q ss_pred c-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 V-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+ +......+.. .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~-~~~~~~~~~~-----------~ 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--RE-IMQQVLYGKY-----------D 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HH-HHHHHHhCCC-----------C
Confidence 2 123345799999999999988999999999999999999999999975432 11 1111111111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..+......+.+++..||+.||++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112233456889999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.13 Aligned_cols=242 Identities=24% Similarity=0.390 Sum_probs=193.7
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+..+++.||||+++... ....+.+..|..++..+ +||||+++++++.. +..+++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999999999999999987542 23344566677777654 89999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999999886543 58999999999999999999998 999999999999999999999999999998653322 22
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+... ...++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~------------~~~~~~ 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILND------------RPHFPR 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcC------------CCCCCC
Confidence 33457999999999999888999999999999999999999999764421 111111111 122223
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMR-QVVK 634 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 634 (705)
.....+.+++..||+.||++||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3345678899999999999999975 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.89 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=197.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.|...+.||+|+||+||+|.+..+++.||||++... .....+.+.+|++++.+++||||+++++.+.+ .+.+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence 578889999999999999999999999999999654 23345678999999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999997543 58899999999999999999998 99999999999999999999999999997543110
Q ss_pred Cc----------------------------------------------ceeeeeeccccCCCccccccCCCCccccEEEE
Q 005257 522 QV----------------------------------------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGF 555 (705)
Q Consensus 522 ~~----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~ 555 (705)
.. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123579999999999988889999999999
Q ss_pred ehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHH--cCCCCCCCCCCHHHHH
Q 005257 556 GILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL--CAYPDPRARPTMRQVV 633 (705)
Q Consensus 556 Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl 633 (705)
||++|||++|+.||....... ........... ........++ ..+.+++.+ |+.++|..||++.+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~--~~~~i~~~~~~-----~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTE--TQLKVINWENT-----LHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHH--HHHHHHccccc-----cCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999997654321 11111100000 0011001122 334455544 6677888899999998
Q ss_pred HH
Q 005257 634 KV 635 (705)
Q Consensus 634 ~~ 635 (705)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.30 Aligned_cols=240 Identities=24% Similarity=0.356 Sum_probs=193.6
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||++....+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 4699999999999999999999999999754 233455678899888777 89999999998776 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999998886543 68999999999999999999998 9999999999999999999999999999975432221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC------ccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK------PNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~------~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+++.+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------- 221 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------- 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------
Confidence 234578999999999999899999999999999999999999995311 111222222222211
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
..++......+.+++..||+.||++||++
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 12233344567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.66 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=210.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
-++|+..+.||+|-||.||.|+.+.++-.||+|++.+. ..+..+++.+|+++-+.|+||||+++++++.+ ....||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEE
Confidence 35688899999999999999999999999999998654 23345678999999999999999999999987 668999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
++||.++|+|...|...... .+++.....++.|+|.||.|+|. ++||||||||+|+|++..+.+||+|||-+....
T Consensus 100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999854433 68899999999999999999998 999999999999999999999999999987644
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
. ......+||..|.+||...+..++..+|+|++|++.||++.|.+||...... .....+. +.
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~------------k~ 237 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIR------------KV 237 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHH------------Hc
Confidence 2 2334579999999999999999999999999999999999999999764321 1111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+-.++........+++..|+..+|.+|.+..|++.+
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122334455678899999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.41 Aligned_cols=245 Identities=26% Similarity=0.359 Sum_probs=195.6
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHH---hccCCCCCcceeeeeeeeccCceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISS---LGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~---l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
|...+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+++ ++.++||||+++++++.. ++..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 567889999999999999999899999999997542 2234556666655 467789999999998875 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|..++.. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988753 268999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... .......|++.|||||.+.+..++.++|||||||++|||++|+.||...... .+...+..+.
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~----------- 217 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVNDE----------- 217 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC-----------
Confidence 222 1223467999999999999889999999999999999999999999764421 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
..++......+.+++.+||+.||.+|| ++.++++
T Consensus 218 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112223345678899999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=323.19 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=201.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||++.++. +..+|+|.+... ....+++.+|+.++++++||||+++++++.. +...++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEc
Confidence 347778899999999999998864 567999987643 2335678999999999999999999998876 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999875432 58999999999999999999998 9999999999999999999999999999986543332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +. .....++.. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~-~~~i~~~~~-----------~~ 221 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EV-VEMISRGFR-----------LY 221 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHHHHCCCC-----------CC
Confidence 22222345678999999988889999999999999999999 89999764421 11 111221111 01
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.+......+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1122345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.00 Aligned_cols=286 Identities=18% Similarity=0.241 Sum_probs=214.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..+.||+|+||.||++.+..+++.||+|... .+.+.+|++++++|+||||+++++++.. +...++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEe
Confidence 357999999999999999999999999999999753 2456889999999999999999998876 668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
++. ++|..++.... .+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 164 ~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 68888886532 58999999999999999999998 899999999999999999999999999997543322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-----HHHHHHHHHHhCchhHHHHHhh
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-----LVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-----~~~~v~~~~~~~~~~~~id~~l 597 (705)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+ ..+...+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l----------~~i~~~~ 306 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI----------KLIIRRS 306 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH----------HHHHHHh
Confidence 22333467999999999999889999999999999999999999887543210 00000 0000000
Q ss_pred hc-CCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccc
Q 005257 598 RA-KGGFD---EDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFG 673 (705)
Q Consensus 598 ~~-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 673 (705)
.. ...++ ......+..-...+....|..||....+.. .+..+.+++.++..++|..|.++
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE----------------LPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhh----------------hhhhHHHHHHHHhcCChhhCCCH
Confidence 00 00011 111122222223344556777776554332 12234556777888999999999
Q ss_pred cCCCCCCCccccccc
Q 005257 674 YGYATHPTFHDIRQS 688 (705)
Q Consensus 674 ~~~~~hp~f~~~~~~ 688 (705)
.+++.||||.++...
T Consensus 371 ~elL~hp~f~~~~~~ 385 (391)
T PHA03212 371 EALLDFAAFQDIPDP 385 (391)
T ss_pred HHHhcChhhccCCCC
Confidence 999999999876543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=334.47 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=193.9
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.++.+++.||||++... .....+.+..|..++..+ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999999989999999998653 233456678888888876 69999999998765 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999999887543 68999999999999999999998 9999999999999999999999999999875432221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+. ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~------------~~~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDE------------VVYPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCC------------CCCCC
Confidence 23357999999999999888999999999999999999999999765421 1222222221 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
.....+.+++..|++.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.35 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=195.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCC-cceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS-LVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~~lV 440 (705)
+|+..+.||+|+||.||+|....+++.||||++... .....+.+..|.+++..++|++ |+++++++.. .+.+++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence 477889999999999999999988999999998753 2344567888999999997654 6777776654 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999986543 58999999999999999999998 9999999999999999999999999999875322
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~------------ 217 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIMEHN------------ 217 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCC------------
Confidence 22 1233457999999999999989999999999999999999999999765421 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
..++......+.+++..||+.||.+||+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12222334567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.33 Aligned_cols=255 Identities=21% Similarity=0.246 Sum_probs=203.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
..++|...+.||+|+||.||++....+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence 456788999999999999999999999999999998643 22334557889999999999999999997765 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998642 47888899999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccC----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSG----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ....+..+..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~-~~~~i~~~~~----- 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G-TYSKIMDHKN----- 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--H-HHHHHHcCCC-----
Confidence 54333223345799999999998653 4789999999999999999999999865421 1 1111111100
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 635 (705)
.+. ..........+.+++..|++.+|.+ ||++.+++++
T Consensus 265 -~~~--~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -SLT--FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -cCC--CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0001123456788999999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.49 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=200.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|....+++.||||++... .......+.+|+.++..++||||+++++++.. ++.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 4688899999999999999999999999999999653 22344567889999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999997543 68999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCcc-------------------------------------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHh
Q 005257 521 GQVA-------------------------------------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL 563 (705)
Q Consensus 521 ~~~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ell 563 (705)
.... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999889999999999999999999
Q ss_pred hCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Q 005257 564 SGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT---MRQVVKV 635 (705)
Q Consensus 564 tG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 635 (705)
+|+.||...... +.. ..+.... ..+. ........+.+.+++..|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~~--~~~-~~i~~~~------~~~~--~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQ--ETY-RKIINWK------ETLQ--FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHH--HHH-HHHHcCC------CccC--CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999765431 111 1111110 0000 00011123456777788886 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.51 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=194.1
Q ss_pred eEEeecCceEEEEEEE---cCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 370 NVIGVGGNGKVYKGVL---EGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~---~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+.||+|+||.||++.. ..+++.+|+|++.... ......+..|++++++++||||+++++++.. .+.+++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence 5799999999999876 3568899999987542 2234567789999999999999999998876 67899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|.+++.+.. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999986532 68999999999999999999998 9999999999999999999999999999986543322
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ....+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~~~------------~~~~p 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMILKA------------KLGMP 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHHcC------------CCCCC
Confidence 233467899999999998888999999999999999999999999764321 111111111 11222
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
......+.+++..||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 233456788999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.52 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=201.6
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
+....++|+..+.||+|+||.||++.+..+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~ 116 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DK 116 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CC
Confidence 334557899999999999999999999999999999998642 22334567899999999999999999998875 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 899999999999999998542 47889999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccC----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSG----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
...............||+.|||||++.+. .++.++||||+||++|||++|+.||..... .... ..+.....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--~~~~-~~i~~~~~-- 264 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--VGTY-SKIMDHKN-- 264 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--HHHH-HHHHhCCc--
Confidence 87654333233346799999999998653 378899999999999999999999976542 1111 11111100
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 635 (705)
.+. ..........+.+++..|+..++.+ ||++.|++++
T Consensus 265 ----~~~--~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ----SLN--FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----ccC--CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0011122455677788888755543 8899998885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.04 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=207.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...+.||+|++|.||+|....+++.|++|.+... .....+++.+|++++++++|||++++++.+.. ++..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence 467788999999999999999989999999998643 34456788999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999976532 368999999999999999999998 999999999999999999999999999998765433
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .........+.. ..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~-----------~~ 220 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKIIRGVF-----------PP 220 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC-----------CC
Confidence 22 2234688999999999988899999999999999999999999976542 111111111111 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 222345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.11 Aligned_cols=238 Identities=26% Similarity=0.335 Sum_probs=190.8
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHH-HhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEIS-SLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
++||+|+||.||+|.+..+++.||+|++.... ......+.+|.. +++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999999899999999986532 223345556654 5788999999999998765 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 80 GGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999998886532 58899999999999999999998 999999999999999999999999999987532222 12
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+ ....+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~------------~~~~~~ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHK------------PLQLPG 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHhcC------------CCCCCC
Confidence 23457899999999999888999999999999999999999999765321 111111111 112233
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMR 630 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~ 630 (705)
.....+.+++.+|++.||.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3445688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=343.44 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=207.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCCc-hhHHHHHHHHHHhccCC-CCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHEND-GGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~ 435 (705)
.++|...++||+|+||.||+|.+... +..||||++..... ...+.+.+|++++++++ ||||++++++|.. .+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CC
Confidence 56788899999999999999987432 35799999975433 34567999999999996 9999999999876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC---------------------------------------------------------
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG--------------------------------------------------------- 458 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 458 (705)
..+|||||+++|+|.++|.+...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 89999999999999999875321
Q ss_pred ------------------------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 459 ------------------------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 459 ------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
...+++.++++++.|++.||.|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 1247888999999999999999998 9999999999999999
Q ss_pred cCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHH
Q 005257 503 KEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMV 580 (705)
Q Consensus 503 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v 580 (705)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 9999999999999865432221 1222356788999999988889999999999999999997 99998753221 111
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+. . ...+......+.+++.+||+.||++||++.++.+.|+...+
T Consensus 350 ~~~~~~~~---------~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKIKSGY---------R--MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHhcCC---------C--CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 12222111 1 11223345678899999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.38 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=196.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+|...+.||+|+||.||+|....+++.||||++.... ....+.+..|..++..+ +|++|+++++++.. .+.+++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence 4778899999999999999999889999999987542 23345567788888877 57888889887765 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999886543 58999999999999999999998 9999999999999999999999999999975432
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~------------ 217 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHN------------ 217 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------
Confidence 221 223457899999999999999999999999999999999999999765421 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
..++......+.+++..|++.||++|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 12233344667899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.97 Aligned_cols=238 Identities=26% Similarity=0.322 Sum_probs=191.3
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHH-HhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEIS-SLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||+||+|.+..+++.||||++.... ....+++.+|.. +++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 46999999999999999999999999986532 223345556655 5678999999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999999986533 68999999999999999999998 999999999999999999999999999987543222 22
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+..+. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~------------~~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNILNKP------------LRLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHHcCC------------CCCCC
Confidence 3345799999999999998999999999999999999999999976432 11111111111 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMR 630 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~ 630 (705)
.....+.+++..|++.||.+||+++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2345678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.01 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=209.2
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
+...++|+..+.||+|+||.||++..... ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34456788899999999999999998643 3789999987542 33456789999999999 89999999998876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
++..+++|||+++|+|..++.... ....+++..+++++.|++.||.|||+ .+|+||||||+||
T Consensus 88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni 163 (293)
T cd05053 88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV 163 (293)
T ss_pred -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence 668999999999999999996531 22368999999999999999999998 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~ 577 (705)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 99999999999999998765432211 122234678999999988889999999999999999998 9999875432
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
..+......+. . ...+......+.+++..||+.||++|||+.++++.|+..+
T Consensus 241 ~~~~~~~~~~~---------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELFKLLKEGY---------R--MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHcCC---------c--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11122222111 1 1122334567889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.44 Aligned_cols=256 Identities=23% Similarity=0.428 Sum_probs=206.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|...+.||+|+||.||+|.... ++..||||.++..... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCe
Confidence 457778899999999999998753 3578999998765444 46789999999999999999999999876 5789
Q ss_pred EEEEeeCCCCChhHHHHhcCC-----------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 438 MLVYDYMENGSLDKWIFQCDG-----------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
++||||+++++|.+++..... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975421 2358899999999999999999998 89999999999999999999
Q ss_pred eeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 99999999976533221 11222345788999999999999999999999999999998 99998754321 111222
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..+.. ...+......+.+++..||+.||++||++.|+++.|+
T Consensus 238 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRL-----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 22211 1112234467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=337.42 Aligned_cols=203 Identities=26% Similarity=0.348 Sum_probs=176.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||++....+++.||||+++... ......+.+|+.++.+++||||+++++.+.+ ...+++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence 46888999999999999999999899999999986532 2334567889999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999997543 68999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCC
Q 005257 521 GQV----------------------------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR 566 (705)
Q Consensus 521 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~ 566 (705)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999989999999999999999999999
Q ss_pred CCCCCCC
Q 005257 567 RPIEEGK 573 (705)
Q Consensus 567 ~Pf~~~~ 573 (705)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.12 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||++.+..+++.||||+++.. .....+.+.+|..++..+ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 4699999999999999999999999999754 223455688899999998 79999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.+.. .+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999998886532 69999999999999999999998 999999999999999999999999999987432211 12
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC------ccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK------PNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~------~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....++..+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 221 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------- 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-----------
Confidence 234579999999999999899999999999999999999999996321 111222222222211
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPT------MRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 634 (705)
...+......+.+++..|++.||.+||+ +.++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122223456788999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.41 Aligned_cols=258 Identities=21% Similarity=0.421 Sum_probs=204.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
++++|+..+.||+|+||.||+|.+.. .+..||+|++.... .....++.+|+.+++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 46778999999999999999998752 35679999886443 2345678999999999999999999998875 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC-------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG-------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
..++||||+++|+|.+++.+... ...+++..++.++.|++.||.|||+ .+++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 88999999999999999975321 1246788999999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++......... .....+++.|||||.+.+..++.++|||||||++|||++ |..||...... ........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~~~ 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFVME 236 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence 99999987654322211 112345778999999988889999999999999999999 78888754321 11121212
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+.. ...+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111 1122234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.04 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=203.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|+..+.||+|+||.||+|.+..+++ .+++|.+..... ...+++..|+..+.+++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccE
Confidence 356778899999999999999876665 478888754332 33467888999999999999999999875 34678
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+++||+++|+|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999976433 58999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||....... ..+.+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~------ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEKGERL------ 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcC------
Confidence 433221 1223456788999999988899999999999999999998 999997654321 11122222111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..+...+..++..||..+|++|||+.|+++.|.....
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111223456788999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.85 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=195.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+|...+.||+|+||.||++....+++.||||++.... ....+.+.+|++++.+++||||+++++.+.. ++.+++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEE
Confidence 6888999999999999999999999999999986432 2334668899999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997543 58899999999999999999998 99999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeeeeeccccCCCccccccCCCCccccEEEEehhH
Q 005257 522 Q------------------------------------------VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559 (705)
Q Consensus 522 ~------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl 559 (705)
. .......+||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001235799999999999998999999999999999
Q ss_pred HHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q 005257 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP---TMRQVVKV 635 (705)
Q Consensus 560 ~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~ 635 (705)
|||++|+.||...... +.. ..+...... ......... ...+.+++..|+ .+|.+|+ ++.+++++
T Consensus 235 yell~G~~Pf~~~~~~--~~~-~~i~~~~~~----~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPA--ETQ-LKVINWETT----LHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHH--HHH-HHHhccCcc----ccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999865431 111 111111000 000000112 234455555554 4999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.61 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=209.8
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
+.....++|...+.||+|+||+||+|....+++.||||++... .......+.+|+.++..++|+|++++...+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444567999999999999999999999989999999998654 33445678899999999999999998876643211
Q ss_pred -------ceEEEEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 436 -------SLMLVYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 436 -------~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
.+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999997532 23368999999999999999999998 999999999999999999999
Q ss_pred eeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 508 RLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 508 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~~ 259 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLA 259 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc
Confidence 9999999987653322 122345799999999999998999999999999999999999999976432 111111111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.. ...+......+.+++..||+.||.+||++.+++++
T Consensus 260 ~~~-----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY-----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 11223345678899999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=336.52 Aligned_cols=301 Identities=23% Similarity=0.320 Sum_probs=226.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|+..++||+|+||.||++.+..++..+|+|.+..... .....+.+|+++++.++||||++++++|.. ++.+++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEE
Confidence 4678999999999999999999998899999998876533 345678999999999999999999999887 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999997543 58899999999999999999997 247999999999999999999999999998765332
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.................+.....
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES--------- 225 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc---------
Confidence 1 1234689999999999988899999999999999999999999976443211111110011111000
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc-CCCCCcchhhHHHHHHhhccccccccccccccCCCCCC
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA-GIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATHP 680 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~hp 680 (705)
............|....|..||++.. .+........ .+..........+.+++.++..++|..|.+..+++.||
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 226 ----ETSPRPRPPGRPLSSYGPDSRPPMAI-FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred ----ccCcccCCccchhhhhcccccccccH-HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 00011112233455567899998742 2222222111 11111222345577888899999999999999999999
Q ss_pred Cccccc
Q 005257 681 TFHDIR 686 (705)
Q Consensus 681 ~f~~~~ 686 (705)
||....
T Consensus 301 ~~~~~~ 306 (333)
T cd06650 301 FIKRSE 306 (333)
T ss_pred HHhcCc
Confidence 997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.14 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=206.0
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc--CCCCCcceeeeeeeeccC---c
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR--LKHKSLVGLRGWCKREKG---S 436 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~~~---~ 436 (705)
..++....+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.++.+. |||+||+.+++.-..+.+ .
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456778899999999999999998 788999998533 34567777777766 499999999986543232 5
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG-----WEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
++||.+|.+.|||.|||.. ..++....++++..+|.||++||.+ .++.|.|||||+.|||+..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 8999999999999999964 3799999999999999999999954 368899999999999999999999999
Q ss_pred eccceecCCCCcc---eeeeeeccccCCCccccccC------CCCccccEEEEehhHHHHhhC----------CCCCCC-
Q 005257 512 FGLARMHGHGQVA---STTRVVGTVGYLAPEVFSSG------RASTQTDVFGFGILILEVLSG----------RRPIEE- 571 (705)
Q Consensus 512 FGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~Gvvl~ElltG----------~~Pf~~- 571 (705)
+|||......... .....+||.+|||||++... ..-..+||||||.|+||++.. +.||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876654221 12346899999999999653 123468999999999999862 356654
Q ss_pred --CCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 572 --GKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 572 --~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+++. +.|++--..+.+.+.+.. ...+.+.+..+.++++.||..+|..|-|+-.+.+.|.++.+
T Consensus 440 Vp~DPs~-----eeMrkVVCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSF-----EEMRKVVCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCH-----HHHhcceeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22322 222332233333333332 22355778899999999999999999999999999987664
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.05 Aligned_cols=242 Identities=23% Similarity=0.404 Sum_probs=194.6
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+..+++.||||+++... ....+.+..|..++..+ +||||+++++++.. ++.+++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 46999999999999999989999999987542 23345567788888764 89999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 80 GGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999997532 58899999999999999999998 9999999999999999999999999999875432221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+. ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~------------~~~~~ 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRMDN------------PCYPR 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------CCCCc
Confidence 23467999999999999889999999999999999999999999764421 1111111111 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMR-QVVK 634 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 634 (705)
.....+.+++..||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2335678899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.03 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=194.4
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+..+++.||+|+++... ....+.+..|..++..+ +||||+++++++.. ++.+++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 46999999999999999999999999987542 23445667788888754 89999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05620 80 GGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R 152 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence 999999886532 58999999999999999999998 9999999999999999999999999999875332221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+. ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~~------------~~~~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVDT------------PHYPR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------CCCCC
Confidence 33467999999999999989999999999999999999999999765421 1122221111 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMR-QVV 633 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 633 (705)
.....+.+++..||+.||++||++. ++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.03 Aligned_cols=259 Identities=23% Similarity=0.425 Sum_probs=209.5
Q ss_pred CCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+|...+.||+|+||.||+|.... ++..+++|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 84 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIM 84 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEE
Confidence 46778899999999999998642 346799999876665566789999999999999999999998876 667899
Q ss_pred EEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975321 2258999999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.+.+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 999999999765433211 1223456788999999988889999999999999999998 99998764431 122222
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+... ......+..+.+++.+||+.+|++||++.++++.|+....
T Consensus 239 ~~~~~~-----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 TQGRVL-----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred hCCCCC-----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 222221 1122334678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.91 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=197.3
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||+||++.+..+++.+|+|++.... ....+.+..|+++++.++||||+++.+++.. +...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 699999999999999899999999986542 2234567889999999999999999988765 678999999999999
Q ss_pred hhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceee
Q 005257 449 LDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527 (705)
Q Consensus 449 L~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 527 (705)
|..++.... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 998886532 23368999999999999999999998 99999999999999999999999999999866543322 23
Q ss_pred eeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+.....++..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RILNDSVTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH------------hhcccCCCCccc
Confidence 35789999999999999999999999999999999999999976432111 11111 111111122334
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
....+.+++..||+.||++|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.03 Aligned_cols=260 Identities=23% Similarity=0.447 Sum_probs=209.3
Q ss_pred CCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.+|...+.||+|+||.||++... .++..+|+|.+........+.+.+|+.++.+++||||+++++++.. .+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence 45778899999999999999852 3456799999876666667789999999999999999999998876 67889
Q ss_pred EEEeeCCCCChhHHHHhcC----------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 439 LVYDYMENGSLDKWIFQCD----------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
+||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999997532 12258999999999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~~ 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQ 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc
Confidence 999999986543221 11122345778999999988889999999999999999998 8999875432 112222233
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.... .+......+.+++..||++||.+|||+.++.+.|+....
T Consensus 238 ~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQ-----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCcCC-----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 22111 111233568999999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=304.40 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=212.5
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec----cCc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGS 436 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~ 436 (705)
...++|.+.+.||+|||+-||.+..-.++..+|+|++.....++.+..++|++..++++|||++++++++..+ +..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4457899999999999999999998888999999999888878888999999999999999999999987642 235
Q ss_pred eEEEEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.||+++|+..|+|.+.+...+. +..+++.+++.|+.++++||.+||+ ...++.||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999987543 3379999999999999999999998 2335999999999999999999999999998
Q ss_pred eecCCCCcc--------eeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH
Q 005257 516 RMHGHGQVA--------STTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 516 ~~~~~~~~~--------~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~ 584 (705)
+...-.-.. ....-..|..|+|||.+. +...++++|||||||+||+|+.|..||+.. .
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~-----------~ 245 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI-----------Y 245 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH-----------h
Confidence 754321110 011124588999999984 456789999999999999999999999641 1
Q ss_pred HhCc-hhHHHHH-hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 585 VQGK-LLDALDA-RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 585 ~~~~-~~~~id~-~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.+|. +.-++.. .+.... .....+.+.+++.+|++.||.+||+..+++..++.++
T Consensus 246 ~~GgSlaLAv~n~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 246 QQGGSLALAVQNAQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hcCCeEEEeeeccccccCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1222 2111111 111111 1125678999999999999999999999999887543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=317.83 Aligned_cols=257 Identities=23% Similarity=0.433 Sum_probs=203.5
Q ss_pred CCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-----
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG----- 435 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 435 (705)
|...+.||+|+||.||+|.+..+ +..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678899999999999998653 3789999987542 3345678999999999999999999998865332
Q ss_pred ceEEEEeeCCCCChhHHHHhcC---CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCD---GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
..++++||+++|+|..++.... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 3789999999999999986532 22368999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 513 GLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 513 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~~- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRHGNR- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCC-
Confidence 9998764432211 111234678999999988889999999999999999999 88888654321 11122222111
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+......+.+++..||+.||++||++.|+++.|+..
T Consensus 234 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112234456789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.18 Aligned_cols=257 Identities=24% Similarity=0.434 Sum_probs=202.8
Q ss_pred CCcceEEeecCceEEEEEEEcCCCe--EEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-----cCc
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGA--EIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KGS 436 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 436 (705)
|...+.||+|+||.||+|.+..++. .+|+|.++.. .....+.+.+|+++++.++||||++++++|... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457889999999999999876664 6999988654 344567889999999999999999999987532 124
Q ss_pred eEEEEeeCCCCChhHHHHhcC---CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 437 LMLVYDYMENGSLDKWIFQCD---GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
.+++|||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885321 22358999999999999999999998 999999999999999999999999999
Q ss_pred cceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 514 LARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 514 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~- 233 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNRL- 233 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCC-
Confidence 998764432211 112245678999999998889999999999999999999 8889865432 1222223222211
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..+......+.+++..||++||++|||+.++++.|+..
T Consensus 234 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223445688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.14 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=197.9
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||+||+|.+..+++.||||+++.. .......+..|++++..+ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999999988999999998754 233455678899998888 79999999998776 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.+.. .+++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++....... .
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 80 GGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999999886543 68999999999999999999998 9999999999999999999999999999875322221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+. ..++.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~~~~------------~~~~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILEDE------------VRYPR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCC------------CCCCC
Confidence 2335789999999999998999999999999999999999999976442 11112221111 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTM-----RQVVKV 635 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 635 (705)
.....+.+++..||+.||.+||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 334568899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.88 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=203.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEe
Confidence 457788999999999999998764 56799999865433 3467999999999999999999999774 4567899999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++...... .+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999764332 58999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +. .+.+. .... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~-~~~~~---------~~~~--~~ 223 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EV-LEQVE---------RGYR--MP 223 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HH-HHHHH---------cCCC--CC
Confidence 22222345678999999988889999999999999999999 88898654321 11 11111 1111 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.+......+.+++.+|++++|++|||+.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 233445678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.58 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=197.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc----CceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~~ 438 (705)
+|+..+.||+|+||.||++.+..+++.||||++... .....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999999888999999998653 2234567899999999999999999999887532 2689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5788877543 268999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchh------
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLL------ 590 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~------ 590 (705)
............+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.+........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 54433333345678999999998764 4789999999999999999999999765431 111111111000000
Q ss_pred ----HHHHHhhhcCC------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 ----DALDARLRAKG------GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ----~~id~~l~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+........ .......+.+.+++..|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 0111123456778888888888888888887764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.51 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=198.9
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
+.||+|+||.||+|++..+++.+|+|.+.... ......+.+|++++++++||||++++++|.. +...++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence 36999999999999998889999999876543 3345679999999999999999999999876 668899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee-e
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST-T 527 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~ 527 (705)
|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......... .
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999996543 258999999999999999999998 9999999999999999999999999999876443221111 1
Q ss_pred eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
...++..|+|||.+.++.++.++|||||||++|||++ |..||...... .... .+..... ...+..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~---------~~~~~~~--~~~~~~ 220 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE---------AIEQGVR--LPCPEL 220 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH---------HHHcCCC--CCCccc
Confidence 1122456999999988889999999999999999998 88888653321 1111 1111111 122333
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
....+.+++.+|++.+|++||++.++.+.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.24 Aligned_cols=255 Identities=27% Similarity=0.352 Sum_probs=204.7
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------------hhHHHHHHHHHHhccCCCCCccee
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------------GGTRAFLAEISSLGRLKHKSLVGL 426 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------------~~~~~~~~Ei~~l~~l~Hpniv~l 426 (705)
..-++|...+.||+|.||.|-+|+...+++.||||++.+... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345789999999999999999999999999999999865411 123578999999999999999999
Q ss_pred eeeeee-ccCceEEEEeeCCCCChhHHHHhcCCCCc-ccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 427 RGWCKR-EKGSLMLVYDYMENGSLDKWIFQCDGSMM-LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 427 ~g~~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
+.+..+ ..+.+|||+|||..|.+... ..... ++..+.+++++++..||.|||. ++||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 997753 24579999999998887542 22224 9999999999999999999999 999999999999999999
Q ss_pred CCeeeeeeccceecCCCC----cceeeeeeccccCCCccccccCC----CCccccEEEEehhHHHHhhCCCCCCCCCccH
Q 005257 505 MNGRLGDFGLARMHGHGQ----VASTTRVVGTVGYLAPEVFSSGR----ASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~ 576 (705)
|++||+|||.+.....+. .......+|||.|||||...++. .+.+.||||+||.||.|+.|+.||.+...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999998763221 11223368999999999987743 36789999999999999999999986432
Q ss_pred HHHHHHHHHhCchhHHHHHhhhcCCCCC--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 577 VEMVWELMVQGKLLDALDARLRAKGGFD--EDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
++..++.......++ ++..+.+.+|++.+|.+||+.|-+..+|..+..
T Consensus 325 -------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 -------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 122222222222222 245678899999999999999999999988764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.48 Aligned_cols=241 Identities=25% Similarity=0.300 Sum_probs=192.3
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHH-HhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEIS-SLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||+||+|....+++.+|+|++... .....+.+..|.. +++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 4699999999999999989999999998654 2233455666665 4677999999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999998886533 68999999999999999999998 999999999999999999999999999987532221 12
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ..+.+..+. ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~-~~~~~~~~~------------~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--E-MYDNILHKP------------LVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--H-HHHHHHcCC------------ccCCC
Confidence 23457999999999999989999999999999999999999999764421 1 111111111 11112
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVV 633 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl 633 (705)
.....+.+++..|++.+|.+||++++.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2345677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.23 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=205.2
Q ss_pred HHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeee
Q 005257 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR 432 (705)
Q Consensus 356 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 432 (705)
..++....++|...+.||+|+||.||++.+..+++.+|+|++... .....+.+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445666678999999999999999999999999999999998642 22334567889999999999999999998875
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
+..+++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 -DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 67899999999999999998642 47888999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccC----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSG----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
|+++.............+||+.|||||++... .++.++|||||||++|||++|+.||..... .... ..+....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~-~~i~~~~ 263 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTY-SKIMNHK 263 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--HHHH-HHHHcCC
Confidence 99987654333333346799999999998653 378999999999999999999999976442 1111 1111110
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKVL 636 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 636 (705)
. .+. ..........+.+++..|+..++.+ ||++.+++++.
T Consensus 264 ~------~~~--~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 N------SLT--FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C------ccc--CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 000 0011123456778888899744433 77888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.01 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=174.5
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.|...++||+|+||+||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++.+.. ++.+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence 5788999999999999999999999999999986532 2345678899999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999997543 58899999999999999999998 99999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeeeeeccccCCCccccccCCCCccccEEEE
Q 005257 522 Q----------------------------------------------VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGF 555 (705)
Q Consensus 522 ~----------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~ 555 (705)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122479999999999998899999999999
Q ss_pred ehhHHHHhhCCCCCCCCC
Q 005257 556 GILILEVLSGRRPIEEGK 573 (705)
Q Consensus 556 Gvvl~ElltG~~Pf~~~~ 573 (705)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.93 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=209.6
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
..-++|...++||+|.||+|+++..+.+++.+|||.+++. .+.+.+....|.+++... +||.++.++..+.. +.+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCe
Confidence 3456789999999999999999999999999999999876 345567778888887777 59999999996665 889
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+++||||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++||+||||-+|||||.+|.+||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999544332 2369999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... ..+.+++||+.|||||++.+..|+..+|.|||||+||||+.|..||.++++. +..|..
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI 580 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSI 580 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Confidence 654222 2456689999999999999999999999999999999999999999987652 344555
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
+.....|+.....+...++...+..+|++|--+
T Consensus 581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 555566677777888999999999999999765
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.25 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=205.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...++||+|+||.||+|.+.++ ..||+|+++... ...+.+.+|++++++++||||+++++.+. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEE
Confidence 34688899999999999999988765 469999987533 23467899999999999999999999764 456799999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++.+... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 81 YMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred cCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999975432 258999999999999999999998 999999999999999999999999999998765443
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........++..|+|||+..+..++.++|||||||++|||++ |+.||...... ........+ .. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~---------~~--~ 222 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERG---------YR--M 222 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhcC---------CC--C
Confidence 322223346778999999988889999999999999999999 88888654321 111111111 00 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
....+....+.+++..|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12334567789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.45 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=204.5
Q ss_pred CCCCcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~ 438 (705)
++|+..+.||+|+||.||++.. ..++..||+|++........+.+.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999985 346789999998776666677899999999999999999999987532 34689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++++|.+++.+... .+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999965432 58999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCccee--eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc----hhHH
Q 005257 519 GHGQVAST--TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK----LLDA 592 (705)
Q Consensus 519 ~~~~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~----~~~~ 592 (705)
........ ....++..|+|||++.+..++.++|||||||++|||++|..|+....... ...+.... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF----MRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh----hhhcccccccccchHH
Confidence 44322111 11123456999999988889999999999999999999887764322111 11111110 0000
Q ss_pred HHHhhhcC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 593 LDARLRAK--GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 593 id~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
+...+... ..........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 10111100 11122344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=336.81 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=197.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||++....+++.||||++... .....+.+.+|++++.+++||||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 4688899999999999999999999999999998643 22345678899999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999997543 68899999999999999999998 9999999999999999999999999999964321
Q ss_pred CCcc----------------------------------------------eeeeeeccccCCCccccccCCCCccccEEE
Q 005257 521 GQVA----------------------------------------------STTRVVGTVGYLAPEVFSSGRASTQTDVFG 554 (705)
Q Consensus 521 ~~~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS 554 (705)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001246999999999999889999999999
Q ss_pred EehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHH
Q 005257 555 FGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR---PTMRQ 631 (705)
Q Consensus 555 ~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~e 631 (705)
|||++|||++|+.||...... +. ...+.... ..+.... .......+.+++..|+. +|.+| |++.+
T Consensus 234 lGvil~elltG~~Pf~~~~~~--~~-~~~i~~~~------~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--ET-YRKIINWR------ETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--HH-HHHHHccC------CccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999999764431 11 11111100 0010000 01123456778888887 66665 59988
Q ss_pred HHHH
Q 005257 632 VVKV 635 (705)
Q Consensus 632 vl~~ 635 (705)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.91 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=211.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||.||+|....+++.||+|.++.. .....+.+.+|++++++++|+|++++++.+.. .+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence 5788899999999999999999988999999988643 22345678999999999999999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|||+++++|.+++.... ....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999987532 23368999999999999999999998 999999999999999999999999999998654
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
..... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||........+.. +....+..
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~---------- 225 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEKCDY---------- 225 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH-hhhhcCCC----------
Confidence 33221 2235688999999999888899999999999999999999999976543322211 11111111
Q ss_pred CCCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 600 KGGFDE-DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 600 ~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+. .....+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11112 3456788999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.16 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=209.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.+|+..+.||+|++|.||++....++..+|||.+.... .....++.+|+.+++.++||||+++++++.. ++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence 35777889999999999999998889999999886532 2344678999999999999999999998876 6688999
Q ss_pred EeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999987532 23368999999999999999999998 999999999999999999999999999987664
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
..... .....|+..|+|||++.+..++.++||||||+++|||++|..||........... ....... ..
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~--------~~- 226 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEQCD--------YP- 226 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-hhhhcCC--------CC-
Confidence 33221 2234688999999999888899999999999999999999999975443211111 1111000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..........+.+++.+||+.+|++|||+.+|++.+.++
T Consensus 227 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 -PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123456788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.07 Aligned_cols=256 Identities=23% Similarity=0.407 Sum_probs=203.2
Q ss_pred CCCCcceEEeecCceEEEEEEEc----CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE----GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|+..+.||+|+||.||+|... ..+..||+|.+.... ......+.+|+.++++++||||+++++++.. +...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceE
Confidence 35677899999999999999863 345789999987543 3344678999999999999999999998876 66889
Q ss_pred EEEeeCCCCChhHHHHhcCC--------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 439 LVYDYMENGSLDKWIFQCDG--------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
+||||+++++|.+++..... ...+++.+++.++.|++.||.|||+ ++++||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999999864321 2258899999999999999999998 999999999999999999
Q ss_pred CCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHH
Q 005257 505 MNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~ 582 (705)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999976543321 11222345678999999988889999999999999999998 9889865432 11122
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
....+.. ...+......+.+++.+||++||++||++.++.+.|.
T Consensus 238 ~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 238 MVRKRQL-----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCc-----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 2222111 1122233467888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.32 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=216.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC----CCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG----GGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
.+.....++||.|-||.||+|++.. ....||||..+.. .....+.|+.|..+|+.++||||++++|+|.+ ...
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~ 465 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPM 465 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cce
Confidence 3344556789999999999999743 2356999988775 34557889999999999999999999999974 578
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+||||.++-|.|..||..++. .|+......++.||+.||+|||+ ..+|||||.++|||+.+...+||+||||+|.
T Consensus 466 WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999987665 58999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.............-+..|||||.+.-..++.++|||-|||++||++. |..||.+-... .|...+.+|+ |
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---DVI~~iEnGe-------R 610 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---DVIGHIENGE-------R 610 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---ceEEEecCCC-------C
Confidence 88766555444444778999999999999999999999999999987 99999864321 0111122221 1
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...++.|+..+..|+.+||..+|.+||.+.|+...|....+
T Consensus 611 ----lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 ----LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 34567788899999999999999999999999999987765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.32 Aligned_cols=259 Identities=25% Similarity=0.324 Sum_probs=211.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeee-eeec-----cCc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGW-CKRE-----KGS 436 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~-~~~~-----~~~ 436 (705)
.++++.+.|.+|||+.||.+.+...+..+|+|++-..++...+...+||++|+.|+ |||||.+++. .... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 34567889999999999999999887999999998888888999999999999997 9999999993 2211 236
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
++|.||||.+|+|-+++..+-.. .|++.++++|+.|+++|+++||. ++.+|||||||-+||||..+++.||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 78999999999999999875544 59999999999999999999997 56789999999999999999999999999986
Q ss_pred ecCCCCc-ce-------eeeeeccccCCCcccc---ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 517 MHGHGQV-AS-------TTRVVGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 517 ~~~~~~~-~~-------~~~~~gt~~y~APE~~---~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
..-.... .. .....-|+-|+|||++ .+...++|+|||+|||+||-||....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 4332211 00 0012348899999997 4678999999999999999999999999875321
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..... -...+.+...+..|+..||++||++||++.|++..+-.+..
T Consensus 265 -----aIlng~Y~--~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 -----AILNGNYS--FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----eEEecccc--CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 11111211 11124678899999999999999999999999998876654
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=317.64 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=201.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+|...+.||+|+||.||+|...+ +..+|+|.+.... ....++.+|+.++.+++||||++++++|.. ....++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcC
Confidence 46778899999999999998764 4569999886432 334679999999999999999999998875 56789999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|.+++..... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999976433 58999999999999999999998 99999999999999999999999999999866443322
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+......+.. ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~-----------~~~ 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQGLR-----------LYR 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhcCCC-----------CCC
Confidence 2222345678999999988889999999999999999998 99998754321 11112222111 111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+......+.+++..||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1223467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.64 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=207.8
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
|++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++|+||+++++++.. ++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 80 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFF 80 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEE
Confidence 345667788888899999999999999988899999999877766677889999999999999999999998876 6788
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeeccce
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLAR 516 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~ 516 (705)
++|+||+++++|.+++.........++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999999764322122788899999999999999998 99999999999999986 6789999999997
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCC--CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
....... ......|++.|+|||++.... ++.++||||||+++|||++|+.||........ ..+...
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~---------- 225 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVG---------- 225 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhh----------
Confidence 6543222 122345789999999986643 78999999999999999999999975332111 000000
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+....+.+..++.+||+.+|++||++.+++..
T Consensus 226 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 -MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0001122333445678899999999999999999998863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.39 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=210.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC----CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
..++|...+.||+|+||.||+|.+.. .+..|++|++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678889999999999999999875 35789999886543 34456789999999999999999999998876678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCC-----CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGS-----MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
.++++||+++++|.+++...... ..+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999764322 368999999999999999999998 9999999999999999999999999
Q ss_pred eccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCch
Q 005257 512 FGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 512 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+. + .......+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~-~~~~~~~~~- 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--E-MAAYLKDGY- 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--H-HHHHHHcCC-
Confidence 99998654332211 112345678999999988889999999999999999999 99999764321 1 111111111
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ..........+.+++.+||+.||++|||+.++++.|+....
T Consensus 237 --------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 --------R--LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------C--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 01112234568899999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=324.99 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe--EEEEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA--EIAVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|+..+.||+|+||.||+|....++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++.. .+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence 468889999999999999999876654 4788888643 334556789999999999 79999999998876 667899
Q ss_pred EEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
|+||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 9999999999999975321 1258899999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||...... .+.+...
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~~~ 232 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 232 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh
Confidence 9999999986432211 1111123557999999988889999999999999999997 99999764321 1111111
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ... ...+......+.+++..||+.+|.+||++.++++.|+....
T Consensus 233 ~---------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 233 Q---------GYR--MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred c---------CCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111 11122344568899999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.30 Aligned_cols=257 Identities=29% Similarity=0.519 Sum_probs=205.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCe---EEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGA---EIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|+..+.||+|+||.||+|....++. .+|+|.+.... ....+++.+|++++.+++|||++++.+++.. .+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcE
Confidence 3467788999999999999999875543 79999986553 3445679999999999999999999998876 66889
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999997543 268999999999999999999998 99999999999999999999999999999866
Q ss_pred CCCCcceee--eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 519 GHGQVASTT--RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 519 ~~~~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
......... ....+..|+|||++....++.++|||||||++|||++ |+.||...... + ....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~-~~~~i~~~-------- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--E-VMKAINDG-------- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--H-HHHHHhcC--------
Confidence 433221111 1123457999999988889999999999999999997 99999654321 1 11222111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.. .....+....+.+++.+||+.+|++||++.++++.|++.
T Consensus 227 -~~--~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FR--LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 112223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.65 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=204.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.+++|...+.||+|++|.||+|.+.. .+..||+|.+..... .....|.+|+.++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence 35678889999999999999999976 678899998865433 334579999999999999999999998876 56
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC----CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---Cee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG----SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM---NGR 508 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~---~~k 508 (705)
..++||||+++++|.+++..... ...+++.++++++.||+.||.|||+ .+++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceE
Confidence 78999999999999999976432 1258999999999999999999998 8999999999999998754 589
Q ss_pred eeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTG 236 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence 99999998663322111 112233568999999988899999999999999999997 99999764321 11111111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
. .+ ...+......+.+++.+||+.+|++||++.++++.|+
T Consensus 237 ~---------~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 G---------GR--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C---------Cc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11 1222334467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.51 Aligned_cols=242 Identities=25% Similarity=0.311 Sum_probs=192.0
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHH-HhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEIS-SLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|.. +++.++||||+++++++.. .+.+++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 46999999999999999889999999986532 222344555544 5678899999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 80 GGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999999987533 57888899999999999999998 9999999999999999999999999999975432221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. ...+.... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~-~~~i~~~~------------~~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EM-YDNILNKP------------LQLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HH-HHHHHhCC------------cCCCC
Confidence 33457999999999999989999999999999999999999999764421 11 11111110 11222
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.....+.+++..|++.||.+||++.+.+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 33456788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.51 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=204.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-----hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-----GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...+.||+|++|.||++....+++.+|+|.+..... ...+.+.+|++++++++||||+++++++.. +...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence 578899999999999999999988899999998864321 234578899999999999999999998876 56899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++..
T Consensus 81 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999987543 58899999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCccee--eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVAST--TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
........ ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~--------- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQP--------- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHHHhccC---------
Confidence 43221111 2345788999999999888999999999999999999999999754321 1111111100
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ....+......+.+++..||..+|++||++.+++++
T Consensus 224 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 T--NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C--CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 012233445678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=321.12 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|+..+.||+|+||.||++....+++.||||.+.... ....+.+.+|+.++++++|+|++++++.+.. ++..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEE
Confidence 677889999999999999999999999999986542 2223567889999999999999999998876 668999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999999865433 268999999999999999999998 999999999999999999999999999997654332
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||................ .... ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~------~~ 223 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-----KEVQ------EE 223 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-----hhhh------hh
Confidence 2 122468999999999998899999999999999999999999997643221111111100 0000 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
+.......+.+++..||+.||++||| +.|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12223456789999999999999999 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.01 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=205.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+|+..+.||+|+||.||++....+++.+|+|.++.. .....+.+.+|+.++++++||||+++++.+.. ++.++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence 467789999999999999999989999999998654 33445678899999999999999999998875 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.+++...... .+++..+..++.|++.||.|||+ ++++|+||||+||++++++.++|+|||+++.......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999988654332 58999999999999999999998 9999999999999999999999999999986644322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... .....+.. ...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~-~~~~~~~~-----------~~~ 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NLI-LKVCQGSY-----------KPL 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HHH-HHHhcCCC-----------CCC
Confidence 122356889999999998888999999999999999999999999764321 111 11111111 112
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++.+||+.||++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.16 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=203.4
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeec-----c
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE-----K 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~-----~ 434 (705)
.+++.|+..+.||+|+||.||+|....+++.||+|++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999999899999999986543 3456788999999998 799999999988653 2
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
..+++||||+++++|.+++..... ..+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 357999999999999999976433 268999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ....... ..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--~~~~~~~-~~- 232 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLIPR-NP- 232 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--HHHHHhc-CC-
Confidence 986543222 223357899999999986 3357889999999999999999999996543211 0000000 00
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. ..........+.+++.+||+.+|.+||++.+++++
T Consensus 233 -------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 -------AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -------CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 11112234568899999999999999999998763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.50 Aligned_cols=264 Identities=27% Similarity=0.418 Sum_probs=203.4
Q ss_pred CcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEEE
Q 005257 367 SEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLMLV 440 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~lV 440 (705)
...+.||+|+||+||++.. ..++..||+|.++.... .....+.+|++++++++||||++++++|.... ..+++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 34577899999876533 34567889999999999999999999886533 357899
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++... .+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999642 48999999999999999999998 9999999999999999999999999999986654
Q ss_pred CCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH---HhCchhHHHHH
Q 005257 521 GQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM---VQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~---~~~~~~~~id~ 595 (705)
..... .....++..|+|||.+....++.++|||||||++|||++|+.|+........+...... ....+.+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 32211 11123466799999998888999999999999999999999998654322111110000 00111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
... ...+......+.+++..||+++|++||+++++++.|+..
T Consensus 240 ~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111 112333456789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.06 Aligned_cols=250 Identities=29% Similarity=0.452 Sum_probs=200.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+|+..+.||+|+||.||+|.++. +..+|+|.+.... .....+.+|+++++.++||||+++++++.. .+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecC
Confidence 46778899999999999998864 5679999885432 234578899999999999999999998875 66889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 82 ANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999976443 68999999999999999999998 99999999999999999999999999999865432221
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... + .......+ .. ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~-~~~~~~~~---------~~--~~~ 222 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--E-VVESVSAG---------YR--LYR 222 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--H-HHHHHHcC---------Cc--CCC
Confidence 1111223457999999998899999999999999999999 89998754321 1 11111111 11 111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 223456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.65 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=206.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||++....+++.+|+|++.... ....+.+.+|++++++++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999999889999999986542 34456789999999999999999999877654556899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++.++..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999976433 268999999999999999999998 999999999999999999999999999998764332
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. ......|++.|+|||++.+..++.++|||||||+++||++|+.||..... .... ..+..+.. ..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~-~~~~~~~~-----------~~ 221 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLV-YRIIEGKL-----------PP 221 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHH-HHHHhcCC-----------CC
Confidence 2 22335688999999999988899999999999999999999999975432 1111 11112211 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+......+.+++.+|++++|++||++.+++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 233445678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.82 Aligned_cols=257 Identities=23% Similarity=0.422 Sum_probs=206.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.++..++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCC
Confidence 35678889999999999999998643 3789999986543 3445678999999999999999999998876 578
Q ss_pred eEEEEeeCCCCChhHHHHhcCC-------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG-------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 8999999999999999975321 2247899999999999999999998 99999999999999999999999
Q ss_pred eeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhC
Q 005257 510 GDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 510 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~~ 237 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVIDG 237 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHhcC
Confidence 99999976543321 12222356789999999988889999999999999999998 99998754321 111222121
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.. ...+......+.+++..||+.+|++|||+.++++.|+
T Consensus 238 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GH-----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC-----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 1122233567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=323.12 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=206.0
Q ss_pred CCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
+|+..+.||+|+||.||+|.... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.|.. ++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence 46778899999999999998743 235799998875543 345678999999999999999999998876 66789
Q ss_pred EEEeeCCCCChhHHHHhcC---------------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 005257 439 LVYDYMENGSLDKWIFQCD---------------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~ 497 (705)
+++||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 9999999999999986431 11358899999999999999999998 99999999999
Q ss_pred CeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCcc
Q 005257 498 NVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPN 575 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~ 575 (705)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999865332211 1122345678999999988889999999999999999998 9999975432
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+++....+ .. ...+......+.+++..||+++|++||++.++++.|++++.
T Consensus 236 --~~~~~~~~~~---------~~--~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 --ERLFNLLKTG---------YR--MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHHHhCC---------CC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2222322221 11 11122334578899999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=316.80 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=198.0
Q ss_pred EEeecCceEEEEEEE--cCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 371 VIGVGGNGKVYKGVL--EGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~--~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
.||+|+||.||+|.+ ..++..+|+|+++... ....+++.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 589999999999975 3567889999986543 234567899999999999999999999875 4467899999999
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce-
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS- 525 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~- 525 (705)
|+|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999996532 58999999999999999999998 999999999999999999999999999998765433221
Q ss_pred -eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 526 -TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 526 -~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .....+..+.. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~~~~-----------~~~ 219 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIESGER-----------MEC 219 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCCC-----------CCC
Confidence 111234578999999988889999999999999999998 99999764321 11122222211 122
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
+......+.+++.+||+.||++||++.+|.+.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=327.14 Aligned_cols=242 Identities=22% Similarity=0.379 Sum_probs=194.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV 440 (705)
+|+..+.||+|+||+||+|....+++.||+|++... .....+.+..|..++..+. |++|+++.+++.. .+.+++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 367789999999999999999999999999998754 2334456788999998886 4667778776655 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999986543 68999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+.
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~------------ 217 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIMEHN------------ 217 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------
Confidence 221 223356899999999999888999999999999999999999999765421 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
..++......+.+++..|++.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12223344567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.29 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=194.1
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||+||+|....+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence 46999999999999999999999999997542 23456688999999888 69999999997765 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 80 GGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 999998886533 68999999999999999999998 9999999999999999999999999999975332221 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc----cHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP----NLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~----~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.....+.... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------~ 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------------I 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------------C
Confidence 2346799999999999998999999999999999999999999964211 11222222222111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMR 630 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 630 (705)
..+......+.+++..|++.||.+||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12223345678899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.68 Aligned_cols=256 Identities=24% Similarity=0.283 Sum_probs=197.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||++....+++.||+|++... .....+.+.+|+.++..++|+||+++++++.. ++.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence 4688899999999999999999999999999998642 22345568899999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999965332 58999999999999999999998 9999999999999999999999999999976654
Q ss_pred CCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
..........||+.|||||++.. ..++.++|||||||++|||++|+.||..... .+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~---- 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEHFQ---- 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCccc----
Confidence 43333333579999999999863 4578899999999999999999999976432 111111111110000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCA--YPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~ 635 (705)
+ ..........+.+++..|+ ..++..||++.+++++
T Consensus 229 -~---~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -F---PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -C---CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0001112344566666654 4445558899988876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.35 Aligned_cols=249 Identities=31% Similarity=0.438 Sum_probs=202.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++...++..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46778899999999999999875 678999988643 33567899999999999999999999876656788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.+... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 82 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 999999999976443 258999999999999999999998 9999999999999999999999999999876433221
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+. ...+..+ .. ..
T Consensus 158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~-~~~~~~~---------~~--~~ 219 (256)
T cd05082 158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV-VPRVEKG---------YK--MD 219 (256)
T ss_pred ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHH-HHHHhcC---------CC--CC
Confidence 2234668999999988889999999999999999997 9999865332 111 1111111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 223345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=318.82 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=203.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|....+++.||+|++..........+.+|+.++.+++||||+++++.+.. ++..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeC
Confidence 468889999999999999999988899999999976655556678899999999999999999998876 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999986533 68999999999999999999998 9999999999999999999999999999986643221
Q ss_pred ceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 524 ASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+. +... .+...... .+...
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--~~~~-~~~~~~~~---~~~~~-- 232 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALF-LMSKSNFQ---PPKLK-- 232 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--hhhe-eeecCCCC---CCCCc--
Confidence 122346889999999884 345788999999999999999999998643321 0000 00000000 00000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
........+.+++..||+.+|++||++.++++.|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=330.19 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=205.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
.++|+..+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|+.++.++ +||||++++++|...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 357888999999999999999853 356789999997543 33456788999999999 68999999998877667
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC---------------------------------------------------------
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG--------------------------------------------------------- 458 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 458 (705)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 78999999999999999865321
Q ss_pred -------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc-ceeeeee
Q 005257 459 -------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV-ASTTRVV 530 (705)
Q Consensus 459 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~ 530 (705)
...+++.++.+++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1247888999999999999999998 9999999999999999999999999999976532211 1111234
Q ss_pred ccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHH
Q 005257 531 GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVE 609 (705)
Q Consensus 531 gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~ 609 (705)
++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......+..+.. ...+.....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~ 309 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR-----------MRAPDYTTP 309 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCC-----------CCCCCCCCH
Confidence 5678999999988889999999999999999997 99998754321 111122222211 001111234
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 610 RVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 610 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+.+++..||+.+|++||++.++++.|+...+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 67899999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.12 Aligned_cols=254 Identities=28% Similarity=0.497 Sum_probs=204.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..++||+|+||.||+|... +++.||+|.+.... ....++.+|+.++++++|||++++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEE
Confidence 456888999999999999999876 46789999986443 34568999999999999999999998764 456899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999876443 368999999999999999999998 999999999999999999999999999998765333
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........++..|+|||++....++.++||||||+++|||++ |+.||...... + ....+..+ .. .
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~-~~~~~~~~---------~~--~ 222 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--E-VIQNLERG---------YR--M 222 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--H-HHHHHHcC---------CC--C
Confidence 222222345678999999988889999999999999999999 99999754321 1 11111111 11 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+......+.+++.+||+.+|++||++++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122234578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.11 Aligned_cols=245 Identities=28% Similarity=0.406 Sum_probs=195.0
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||.||++..+.+++.+|+|++.... ....+.+..|++++++++||||+++.+++.. +...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 699999999999999999999999986431 2233456679999999999999999998765 678999999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... ....
T Consensus 80 L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 80 LKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9998865433 258999999999999999999998 999999999999999999999999999998765432 2233
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHHHHHhhhcCCCCCHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAKGGFDEDE 607 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~id~~l~~~~~~~~~~ 607 (705)
..|+..|+|||++.+..++.++||||+||++|||++|+.||........ ..+........ .. ......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~---~~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------VK---FEHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc--------cc---cccccC
Confidence 4689999999999888899999999999999999999999975432111 11111111110 00 001123
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 608 VERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 608 ~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+.+++..||+.||++||+++|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 456789999999999999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.94 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=205.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC----------------eEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG----------------AEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVG 425 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~----------------~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 425 (705)
.++|+..+.||+|+||.||++.+...+ ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 356888999999999999999876533 568999987553 345678899999999999999999
Q ss_pred eeeeeeeccCceEEEEeeCCCCChhHHHHhcCC--------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 005257 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG--------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497 (705)
Q Consensus 426 l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~ 497 (705)
++++|.. ++..++++||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+
T Consensus 84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9998876 5788999999999999999976431 1258999999999999999999998 99999999999
Q ss_pred CeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh--CCCCCCCCCc
Q 005257 498 NVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS--GRRPIEEGKP 574 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt--G~~Pf~~~~~ 574 (705)
||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999999865433221 1223456788999999988889999999999999999998 6777765332
Q ss_pred cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 575 ~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
...+...... ......... ...+......+.+++.+||+.||++||++.|+++.|+
T Consensus 240 ---~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ---QQVIENAGHF--FRDDGRQIY--LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHHhc--ccccccccc--CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111110 000000000 1112223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=321.33 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=202.6
Q ss_pred CCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
|...+.||+|+||.||+|....+ +..||||+++..... ..+.+.+|+.++..++||||+++++++.. ....++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCceEE
Confidence 55677899999999999987543 578999999755433 34668899999999999999999999876 567899
Q ss_pred EEeeCCCCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999985321 12258889999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||..... ....+.+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 999999998865433221 1222345778999999988889999999999999999998 8888865432 1122222
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..+.. ...+.+....+.+++..||+.+|++||++.++++.|+
T Consensus 240 ~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 240 RNRQV-----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HcCCc-----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 22211 1223345567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.51 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=198.1
Q ss_pred EEeecCceEEEEEEEc--CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 371 VIGVGGNGKVYKGVLE--GGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~--~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.||+|+||.||+|.+. +.+..||+|++..... ...+.+.+|+.++++++||||++++++|. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence 3899999999999875 4456799999876543 33467899999999999999999999875 45789999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee-
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST- 526 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~- 526 (705)
+|.+++..... .+++.++.+++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999875332 68999999999999999999998 9999999999999999999999999999986543322111
Q ss_pred -eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 527 -TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 527 -~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+...+..+.. ...+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~-----------~~~~ 220 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR-----------LDCP 220 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC-----------CCCC
Confidence 11223578999999988889999999999999999996 99999764321 11222222211 1223
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+...+.+++..||+.+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 3445678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.05 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=202.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|++|.||+|.+..+ ..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEc
Confidence 4577888999999999999998754 469999875432 34567899999999999999999998774 4567899999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999976433 258999999999999999999998 9999999999999999999999999999987644332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||...+..++.++|||||||++|||++ |+.||...... .....+..+ .. ..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~---------~~--~~ 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVERG---------YR--MP 223 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---------CC--CC
Confidence 22222345678999999988889999999999999999999 89998764321 111111111 00 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.+......+.+++.+||++||++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=323.73 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=202.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe--EEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA--EIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|+..+.||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.. ++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceE
Confidence 467888999999999999999876664 46888776432 34456788999999999 89999999998876 668999
Q ss_pred EEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
||||+++++|.+++..... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975421 1258899999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... + ......
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~-~~~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E-LYEKLP 237 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--H-HHHHHh
Confidence 9999999986432111 1111234667999999988889999999999999999998 99999654321 1 111111
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+ .. ...+......+.+++.+||+.+|++||++.++++.|+...+
T Consensus 238 ~~---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 238 QG---------YR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred cC---------Cc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11 11112234567899999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.77 Aligned_cols=250 Identities=28% Similarity=0.403 Sum_probs=200.3
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|+..+.||+|+||+||+|.+..+++.+|+|.+.... ......+.+|++++++++|+|++++.+.+.. ++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence 667789999999999999999899999999986542 2233557889999999999999999988776 668999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999998876433 269999999999999999999998 999999999999999999999999999997654322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ +.+......+ ..
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~------------~~ 222 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET------------EE 222 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc------------cc
Confidence 1 1234789999999999888899999999999999999999999976543211 1111111110 01
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVK 634 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 634 (705)
.+.......+.+++..|++.||++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122233456788999999999999999 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=319.28 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=205.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
.++|...++||+|+||+||+|.+..++. .||+|.++.... ...+++.+|+.++..++||||++++++|.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCc
Confidence 3567888999999999999999866655 489999875533 345678999999999999999999999874 456
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++++||+++|+|.+++..... .+++.+++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999999976432 58999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~------ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGER------ 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCc------
Confidence 65332211 111234678999999988889999999999999999998 899987543211 1111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++||++.++++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 230 -----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11122344568899999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.42 Aligned_cols=256 Identities=22% Similarity=0.415 Sum_probs=204.8
Q ss_pred CCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...++||+|+||.||++... .++..+|+|.+..........+.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceE
Confidence 45677889999999999999753 3456899999877666667789999999999999999999998876 66789
Q ss_pred EEEeeCCCCChhHHHHhcCC------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 439 LVYDYMENGSLDKWIFQCDG------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
++|||+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence 99999999999999975431 1258899999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... +. ....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~-~~~~ 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EA-IECI 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HH-HHHH
Confidence 9999999997654322111 122345678999999988889999999999999999998 89998654321 11 1111
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..+. . ...+......+.+++.+||+.||++||++.++++.|+
T Consensus 238 ~~~~---------~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 TQGR---------E--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCc---------c--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 0 1112233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.34 Aligned_cols=287 Identities=21% Similarity=0.343 Sum_probs=222.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... ....++.+|+.+++.++||||++++++|.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCc
Confidence 3457778899999999999999876664 578998865433 234478899999999999999999998864 346
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++++||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 789999999999999875432 58899999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~------ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLEKGER------ 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCCC------
Confidence 6433221 1122345678999999988889999999999999999997 89998754321 11122222111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccC
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYG 675 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 675 (705)
...+..+...+..++..||..+|++||++.++++.|+..... ......+.+..+.....
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~----------------~~~~~~~~~~~~~~~~~ 288 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD----------------PQRYLVIQGDDRMKLPS 288 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc----------------hhhheeeccCCcCCCCC
Confidence 111122345678899999999999999999999998854331 11224477788888888
Q ss_pred CCCCCCccccc
Q 005257 676 YATHPTFHDIR 686 (705)
Q Consensus 676 ~~~hp~f~~~~ 686 (705)
..+||||....
T Consensus 289 ~~~~~~~~~~~ 299 (303)
T cd05110 289 PNDSKFFQNLL 299 (303)
T ss_pred CchhhHHhccc
Confidence 89999997644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.01 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=203.5
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCe---EEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGA---EIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.|+..+.||+|+||.||+|.+..++. .||||.+... .....++|..|+.+++.++||||+++++++.. +...++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEE
Confidence 46778999999999999999876554 6999998765 33456789999999999999999999998865 6678999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976432 58999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcce--eeeee--ccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 521 GQVAS--TTRVV--GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~--~~~~~--gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
..... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||...... .+...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-------- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-------- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC--------
Confidence 32211 11111 1457999999998899999999999999999886 99999764321 111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.. ...+.+.+..+.+++..||+.+|++||++.+++..|+..
T Consensus 228 -~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -YR--LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -Cc--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 111233456688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.18 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=199.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||++....+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.. .+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 4688899999999999999999989999999998642 22334567889999999999999999998875 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999976432 58999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+.. ..+.....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~-~~i~~~~~------ 225 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETY-GKIMNHEE------ 225 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--HHHH-HHHHcCCC------
Confidence 43333334579999999999865 4678899999999999999999999976432 1111 11111100
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 635 (705)
++.. .....+..+.+.+++..|+..++++ |+++++++++
T Consensus 226 ~~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 0011123456777888887755543 4677777664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.00 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=206.8
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCC-CCCcceeeeeeeec
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLK-HKSLVGLRGWCKRE 433 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~ 433 (705)
...++|...+.||+|+||.||+|++.+ .++.||||+++.... ...+.+.+|+++|.++. ||||+++++.|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 344567778999999999999999643 456899999976532 33457899999999997 9999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------------------------------------------------
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG------------------------------------------------------- 458 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 458 (705)
.+..++||||+++|+|.+++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 5688999999999999999975421
Q ss_pred ----------------------------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 005257 459 ----------------------------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSN 498 (705)
Q Consensus 459 ----------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~N 498 (705)
...+++.++++++.|++.||.|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 1246788899999999999999998 999999999999
Q ss_pred eEEccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccH
Q 005257 499 VLLDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNL 576 (705)
Q Consensus 499 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~ 576 (705)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~- 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence 9999999999999999986543221 11222356788999999988889999999999999999998 88998653321
Q ss_pred HHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
+.....+..+. + ...+......+.+++..||+.+|++||+++++++.|+..+
T Consensus 349 -~~~~~~~~~~~---------~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -EQFYNAIKRGY---------R--MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHHHcCC---------C--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222111 1 1112223467889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.51 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=213.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch---hHHHHHHHHHHhccCC-CCCcceeeeeeeeccCce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---GTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~ 437 (705)
....|...+.||+|.||.||+++.+.+|+.+|+|.+.+.... ....+.+|+.+|+++. ||||+.+.+.+.. ...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeE
Confidence 345678889999999999999999999999999999776432 3468899999999998 9999999999886 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC----CCeeeeeec
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE----MNGRLGDFG 513 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~----~~~kL~DFG 513 (705)
++|||++.||.|.+.+... .+++.+...++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999765 29999999999999999999999 999999999999999643 479999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........ ...+..++.
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~---~~~i~~~~~---- 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI---FLAILRGDF---- 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---HHHHHcCCC----
Confidence 9998876 3345568999999999999989999999999999999999999999987653211 113333332
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.-...+-......+.+++..|+..||.+|+++.+++++
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122233446778899999999999999999999985
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.74 Aligned_cols=268 Identities=22% Similarity=0.355 Sum_probs=203.5
Q ss_pred CCCcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~ 438 (705)
.|...+.||+|+||.||++.. ..++..||+|.++... ....+.+.+|+.+++.++|||++++.+++... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999985 3457889999987553 33456799999999999999999999988764 35689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++++|.+++.+... .+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999865432 58999999999999999999998 99999999999999999999999999999866
Q ss_pred CCCCcc--eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch---hHHH
Q 005257 519 GHGQVA--STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL---LDAL 593 (705)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~---~~~i 593 (705)
...... ......++..|+|||++.+..++.++|||||||++|||++++.|.........+.......+... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 443221 11224567789999999888899999999999999999998776533211110000000000000 0001
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..... ..........+.+++..||+.+|++||++.++++.|+..
T Consensus 240 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10000 111223456799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.65 Aligned_cols=248 Identities=30% Similarity=0.471 Sum_probs=199.9
Q ss_pred eEEeecCceEEEEEEEcCCC---eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGG---AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
++||+|+||.||+|++...+ ..+|+|.+..... ...+++.+|++++++++||||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence 46999999999999876544 7899999875543 34567899999999999999999999875 456799999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999997643 68999999999999999999998 999999999999999999999999999998664433221
Q ss_pred e--eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 526 T--TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 526 ~--~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+......+.. ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~~-----------~~ 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGER-----------LP 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCc-----------CC
Confidence 1 11223567999999988889999999999999999998 99999764321 11222222211 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.+......+.+++.+||+++|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2223346788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.11 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=197.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...++||+|+||.||++.++.+++.+|+|++... .....+.+.+|+.++..++|+||+++++.+.. .+.+++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence 4688899999999999999999999999999998642 22334558889999999999999999998875 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999976432 58999999999999999999998 9999999999999999999999999999976544
Q ss_pred CCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 521 GQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.... +.....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~~~-i~~~~~------ 225 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGK-IMNHKE------ 225 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHHHH-HhCCCc------
Confidence 3333333457999999999986 34688999999999999999999999976432 122111 111100
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAY--PDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~ 635 (705)
+... ..........+.+++..|+. +++..||++.+++++
T Consensus 226 ~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 00011223456667777664 444457899988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.52 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=203.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+|+..+.||+|+||.||++....++..||+|.+... .......+.+|++++.+++||||+++++.+.. .+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEee
Confidence 577788999999999999999988999999988754 33345678999999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|..++........+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764323368999999999999999999996 2589999999999999999999999999997653322
Q ss_pred ceeeeeeccccCCCccccccC------CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG------RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.................+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD--------- 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---------
Confidence 1224678899999998554 34889999999999999999999997543211111111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+......+.+++.+||+.+|++||++.+++..
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 022333456778899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.44 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=200.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|...+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.++++++||||+++++++.. ++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEe
Confidence 568889999999999999999998899999999875532 234567889999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++ +|.+++..... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9975 88888865432 58899999999999999999998 999999999999999999999999999997654322
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH-------
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL------- 593 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i------- 593 (705)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+..... ....+..
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TPTEETWPGISSND 236 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhhhcchh
Confidence 21 122467899999999865 46899999999999999999999999765421 1111111110 0000000
Q ss_pred ---HHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 ---DARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 ---d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+....... .........+.+++..|++.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000 0001123457899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.23 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=204.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCC---eEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGG---AEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+|...+.||+|+||.||+|.+..++ ..+|+|.++... ....+.+.+|+.++.+++||||+++++++.. ++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence 45778899999999999999886433 479999886543 3345678999999999999999999998875 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++..... .+++.++..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999976432 58999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceee--eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 520 HGQVASTT--RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 520 ~~~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
........ ...++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+.++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~-------- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY-------- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC--------
Confidence 43221111 1223567999999998889999999999999999886 99999764321 1111121110
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
. .......+..+.+++..|++.+|++||++.++++.|+..
T Consensus 227 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -R--LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -c--CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 111223345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.49 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=204.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.+++|+..+.||+|+||.||+|..++ .+..||+|.+..... .....+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 45678999999999999999997652 245799998864432 234568899999999999999999998876 56
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC-------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG-------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
..++||||+++|+|.+++.+... ...+++..+.+++.|++.||.|||+ ++|+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 78999999999999999975321 2346778899999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~ 236 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFVMD 236 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc
Confidence 9999999865432221 1122245678999999988889999999999999999998 78888653321 11111111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
+.. ...+......+.+++.+|++.||++||++.++++.|+...
T Consensus 237 ~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGY-----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCC-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111 1112233467899999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.32 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=205.4
Q ss_pred hCCCCcceEEeecCceEEEEEEE-----cCCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVL-----EGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||++.. ...+..||||+++... ....+.+.+|+.+++++ +||||+++++.|.. .+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CC
Confidence 35688899999999999999985 2345689999987553 33456789999999999 79999999998876 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||+++|+|.+++...... .+++.++..++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 889999999999999999754332 48999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 516 RMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 516 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +........+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~------ 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEG------ 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcC------
Confidence 865433221 1112345678999999988889999999999999999998 99998754321 1111111111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.. ...+......+.+++..||+++|++||++.|+++.|+..
T Consensus 261 ---~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---YR--MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---Cc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 111122345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.60 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=197.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccC---CCCCcceeeeeeeec----cC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRL---KHKSLVGLRGWCKRE----KG 435 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~~----~~ 435 (705)
+|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999999999999999987542 22234566777777665 699999999987532 34
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||+++ +|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999974 89888876443 258999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id 594 (705)
+....... .....||..|+|||++.+..++.++||||+||++|||++|+.||...... ....+........ .....
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~ 232 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDDWP 232 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC-hhhCc
Confidence 87643321 22356899999999998888999999999999999999999999754321 1111111110000 00000
Q ss_pred Hhhh-------cC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLR-------AK-----GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~-------~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... .. ....+...+.+.+++..|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 00011233567899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.85 Aligned_cols=241 Identities=24% Similarity=0.408 Sum_probs=190.1
Q ss_pred eEEeecCceEEEEEEEcCC------------CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 370 NVIGVGGNGKVYKGVLEGG------------GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~------------~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
+.||+|+||.||+|+.... ...|++|.+..........+.+|+.++..++||||++++++|.. +...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence 3689999999999986422 23689998866555556688999999999999999999999876 5678
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC-------eeee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN-------GRLG 510 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~-------~kL~ 510 (705)
++||||+++|+|..++..... .+++..+++++.|++.||+|||+ ++|+||||||+|||++.++. +|++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999998865332 58999999999999999999998 99999999999999987664 8999
Q ss_pred eeccceecCCCCcceeeeeeccccCCCccccc-cCCCCccccEEEEehhHHHHh-hCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFS-SGRASTQTDVFGFGILILEVL-SGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 511 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~Gvvl~Ell-tG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......... ....+.
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~ 225 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEGQ 225 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhcC
Confidence 99998754322 2245788999999986 466899999999999999997 588887653321110 011110
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
. .........+.+++..||+.||++||++.++++.|+
T Consensus 226 --------~----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 --------C----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --------c----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 011112356789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.86 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=197.4
Q ss_pred eEEeecCceEEEEEEEcCCCe--EEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGA--EIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~--~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+.+++. .+++|.++... ....+.+.+|++++.++ +||||++++++|.. .+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence 368999999999999987664 57888886443 34556789999999999 89999999998876 667899999999
Q ss_pred CCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 446 NGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 446 ~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
+|+|.+++.... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 999999997532 11258899999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
|+++...... .......+..|+|||++....++.++|||||||++|||++ |..||...... ........+
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~---- 227 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQG---- 227 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHHhCC----
Confidence 9986332111 1111223567999999988889999999999999999997 99999654321 111111111
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.. ...+......+.+++..||+.+|.+|||+.++++.|+.++
T Consensus 228 -----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 -----YR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----CC--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 1112223456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.39 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=196.5
Q ss_pred eEEeecCceEEEEEEEcC---CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEG---GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+.. ....||+|++.... ....+.+.+|+.+++.++|||+++++++|...++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 34679999885433 34567889999999999999999999988765667899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc--
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV-- 523 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~-- 523 (705)
+|+|.+++.+... .+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999975432 46788889999999999999998 9999999999999999999999999999975533211
Q ss_pred -ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhC-CCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 524 -ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSG-RRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 524 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG-~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.......++..|+|||.+.+..++.++|||||||++|||++| ..||..... .+.. .....+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~-~~~~~~~~-----------~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDIT-VYLLQGRR-----------L 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH-HHHhcCCC-----------C
Confidence 111123457789999999888899999999999999999995 455544321 1111 11111110 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
..+...+..+.+++..||+++|++||++.++++.|+...
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 112223457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.41 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=202.0
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
|+..+.||+|+||.||+|....++..+++|.+........+.+.+|+++++.++|||++++++.+.. ++..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecC
Confidence 4556789999999999999998899999999976666667789999999999999999999998876 678899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+++|..++.+.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999999886533 268999999999999999999998 9999999999999999999999999999876533221 2
Q ss_pred eeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 526 TTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.....|+..|+|||++. +..++.++|||||||++|||++|+.||...... +.+.... .+.. +.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~-~~~~-----~~---- 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIA-KSEP-----PT---- 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHh-hcCC-----CC----
Confidence 22346899999999984 345788999999999999999999998764321 1111111 1100 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+......+.+++..||+.+|++||++.+++++-
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111222345688999999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.93 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=197.5
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCC------CCcceeeeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH------KSLVGLRGWCK 431 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H------pniv~l~g~~~ 431 (705)
++...+++|...++||+|+||+||+|.+..+++.||||+++... ...+++..|+.++++++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999999889999999986432 233455667777766654 45888888887
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC------
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM------ 505 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~------ 505 (705)
.+...+++|||++ +++|.+++.+.. .+++.++..|+.||+.||.|||+ +.+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence 6667889999998 678988886543 68999999999999999999996 25999999999999998765
Q ss_pred ----------CeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc
Q 005257 506 ----------NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN 575 (705)
Q Consensus 506 ----------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~ 575 (705)
.+||+|||++..... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 223468999999999999999999999999999999999999999764421
Q ss_pred -HHHHHHHHHHhCchhHHH-------------HHhhhcCCCCC---------------HHHHHHHHHHHHHcCCCCCCCC
Q 005257 576 -LVEMVWELMVQGKLLDAL-------------DARLRAKGGFD---------------EDEVERVLHLGLLCAYPDPRAR 626 (705)
Q Consensus 576 -~~~~v~~~~~~~~~~~~i-------------d~~l~~~~~~~---------------~~~~~~l~~l~~~Cl~~dP~~R 626 (705)
....+.. ..|.+...+ +.......... ......+.+|+..||+.||++|
T Consensus 352 ~~~~~i~~--~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 352 EHLHLMEK--TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred HHHHHHHH--HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 1111100 011111100 00000000000 0112457799999999999999
Q ss_pred CCHHHHHHH
Q 005257 627 PTMRQVVKV 635 (705)
Q Consensus 627 Ps~~evl~~ 635 (705)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999973
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.18 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=202.6
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHH--HHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR--AFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~--~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|+..+.||+|+||+||++....+++.+|+|++......... ...+|+.++++++||||+++++++.. +...++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence 45678999999999999999999999999999876543322 34569999999999999999999887 7788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... .+++.++..++.|+++||.+||+ .+++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 80 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp ETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccccccc---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cc
Confidence 99999999997332 68999999999999999999999 9999999999999999999999999999986421 22
Q ss_pred ceeeeeeccccCCCccccc-cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFS-SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++..|+|||++. +..++.++||||+|+++|||++|+.||................... ..... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~----~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----LPSSS----Q 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----HHHHT----T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----ccccc----c
Confidence 2333457899999999998 7889999999999999999999999998652111111111111111 11111 0
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+++..||+.||++||++.+++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011113788999999999999999999998863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.08 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=198.6
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
++||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++||||++++++|.. .+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCc
Confidence 36899999999999876 578899999876543 234578999999999999999999999876 567899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++..... .+++..+..++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||+++............
T Consensus 79 L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9999865432 58899999999999999999998 999999999999999999999999999997654332222222
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~ 607 (705)
..++..|+|||++.+..++.++||||||+++||+++ |..||...... ........+. . ...+...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~---------~--~~~~~~~ 219 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGY---------R--MSCPQKC 219 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC---------C--CCCCCCC
Confidence 234677999999988889999999999999999998 99999754321 1111111111 1 1122234
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 608 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
...+.+++.+|++.+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.04 Aligned_cols=203 Identities=26% Similarity=0.345 Sum_probs=176.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||.||++....+++.||||+++.. .......+.+|+.++..++||||+++++.+.. ++.+++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 3688899999999999999999999999999998643 23345678889999999999999999998875 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999997543 68999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCC
Q 005257 521 GQV----------------------------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR 566 (705)
Q Consensus 521 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~ 566 (705)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012347999999999999989999999999999999999999
Q ss_pred CCCCCCC
Q 005257 567 RPIEEGK 573 (705)
Q Consensus 567 ~Pf~~~~ 573 (705)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.61 Aligned_cols=250 Identities=31% Similarity=0.504 Sum_probs=205.6
Q ss_pred eEEeecCceEEEEEEEcCC---CeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGG---GAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|..... +..|++|.++..... ..+.+.+|++++..++|+|++++++++.. +...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 4699999999999999865 889999999766443 36789999999999999999999998886 778999999999
Q ss_pred CCChhHHHHhcCC------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 446 NGSLDKWIFQCDG------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 446 ~gsL~~~L~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
+++|.+++..... ...+++.+++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||.++...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999976521 2479999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 520 HGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 520 ~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.... .......++..|+|||.+....++.++||||+||++|||++ |..||..... ..+.+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-------- 225 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYR-------- 225 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC--------
Confidence 4321 12223457889999999988889999999999999999999 6999976532 122222222111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
...+......+.+++..||+.+|++|||+.++++.|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1223334567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.00 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=206.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+++ +..+|||.+.... ...+++.+|+.++++++||||+++++++.. ....++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEe
Confidence 4678889999999999999999864 5779999986433 345779999999999999999999998865 567899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++...... .+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999765433 68999999999999999999998 899999999999999999999999999998765432
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+..+ .. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~---------~~--~ 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERG---------YR--M 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC---------CC--C
Confidence 222222334678999999998889999999999999999998 9999965432 1111111111 11 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1122235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.29 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=206.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.+|+..+.||+|++|.||+|+...++..||+|.+........+.+.+|+.+++.++|||++++++.+.. ....++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecc
Confidence 578889999999999999999988899999999977665566788999999999999999999998876 6689999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.+. .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999998542 57899999999999999999998 9999999999999999999999999999876543322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....+. .........+.. . ...
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~~~------~----~~~ 238 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTP------E----LQN 238 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCCCC------C----CCC
Confidence 1 12346889999999998888999999999999999999999999764431 111111111100 0 111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++.+||..+|++||++.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 22344568889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.69 Aligned_cols=262 Identities=20% Similarity=0.290 Sum_probs=195.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec-------c
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-------K 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-------~ 434 (705)
..++|...+.||+|+||.||+|....+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999999889999999885432 2345799999999999999998876421 1
Q ss_pred CceEEEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-Ceeeeee
Q 005257 435 GSLMLVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDF 512 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DF 512 (705)
..+++||||+++ +|.+++... .....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 777776542 223368999999999999999999998 9999999999999999664 6999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCch-
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKL- 589 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~- 589 (705)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.... +.+...+. .+..
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence 99986644322 223578999999999865 46899999999999999999999999765421 11111111 1110
Q ss_pred hHHH---HHhhh-----cC------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 LDAL---DARLR-----AK------GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ~~~i---d~~l~-----~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+.+ .+... .. ..++......+.+++..||+.||.+|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 00000 00 00111223568899999999999999999999864
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.81 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=208.4
Q ss_pred cCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
+.++.+..+.++|+..+.||+|+||.||++....+++.+|+|++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455667778899999999999999999999999889999999875432 2345688899999999 69999999998752
Q ss_pred ----ccCceEEEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 433 ----EKGSLMLVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 433 ----~~~~~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 235689999999999999988642 223368999999999999999999998 999999999999999999999
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
||+|||+++........ .....|++.|+|||++.. ..++.++|||||||++|||++|+.||...... .....
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALFK 240 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHhh
Confidence 99999999866433222 223468999999999853 45788999999999999999999999764321 11000
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+. ...+ ..+......+..++.+||+.||++||++.|+++.+
T Consensus 241 -~~~~~-----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 -IPRNP-----PPTL----HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -ccccC-----CCcc----cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 0000 01111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.96 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=201.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCC--------------CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGG--------------GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~--------------~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
++|+..+.||+|+||.||++...+. ...||+|.++... ......+.+|++++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788899999999999999987542 2359999987543 334567999999999999999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCC---------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDG---------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
++.. ....++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 85 VCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9876 6788999999999999999965321 1247889999999999999999998 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh--CCCCCCCCCcc-
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS--GRRPIEEGKPN- 575 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt--G~~Pf~~~~~~- 575 (705)
++++++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432211 1122345678999999988889999999999999999988 56677653321
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
......+.... ...... ...+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~------~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRN------QGRQIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhh------cccccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111110000 000000 1112223467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.44 Aligned_cols=249 Identities=32% Similarity=0.473 Sum_probs=205.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEe
Confidence 46788899999999999999875 68899999976544 56789999999999999999999998876 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++...... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999765432 68999999999999999999998 9999999999999999999999999999986633222
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
...++..|+|||.+..+.++.++||||||+++|||++ |+.||...... .+......+ .. ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~---------~~--~~ 219 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVEKG---------YR--ME 219 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhcC---------CC--CC
Confidence 2234668999999988889999999999999999997 99998754321 111111111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 122345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.78 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=204.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+.|+..+.||+|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++|||++++++.+.. ++..++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEec
Confidence 467888999999999999999998899999999987766677889999999999999999999998876 6689999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|..++.+... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999988765432 58999999999999999999998 9999999999999999999999999999875433221
Q ss_pred ceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 524 ASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
......+++.|+|||++. ...++.++|||||||++|||++|+.||...... ... ......... .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~-~~~~~~~~~-----~-- 234 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVL-LKIAKSEPP-----T-- 234 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHH-HHHhcCCCc-----c--
Confidence 223356889999999985 345688999999999999999999998754321 111 111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.+|++||++.++++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 --LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01122234567889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.57 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=204.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|+..+.||+|+||.||++.... ++..||+|++..... ...+++.+|+.++++++||||++++++|.. +..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCc
Confidence 4578889999999999999998753 567899999875533 345679999999999999999999998876 567
Q ss_pred eEEEEeeCCCCChhHHHHhcCC-------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG-------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~ 497 (705)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 8999999999999999974321 1247889999999999999999998 99999999999
Q ss_pred CeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCcc
Q 005257 498 NVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPN 575 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~ 575 (705)
||++++++.+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765432211 1112234677999999988889999999999999999997 88888654321
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+ .......+... ..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 240 --~-~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 --E-VIYYVRDGNVL-----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --H-HHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11222222211 112234467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.39 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=201.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC----------------CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG----------------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVG 425 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 425 (705)
.++|+..+.||+|+||.||++.... ++..+|+|++.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3568889999999999999986432 34579999987543 334578999999999999999999
Q ss_pred eeeeeeeccCceEEEEeeCCCCChhHHHHhcCC--------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 005257 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG--------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497 (705)
Q Consensus 426 l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~ 497 (705)
+++++.. .+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+ .+++||||||+
T Consensus 84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR 159 (296)
T ss_pred EEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence 9998876 5678999999999999999976321 1247888999999999999999998 99999999999
Q ss_pred CeEEccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh--CCCCCCCCCc
Q 005257 498 NVLLDKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS--GRRPIEEGKP 574 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt--G~~Pf~~~~~ 574 (705)
|||++.++.++|+|||+++......... .....++..|+|||....+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999998654332211 122334678999999888889999999999999999998 6778865332
Q ss_pred c-HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 575 N-LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 575 ~-~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
. ............ ..... ...+..+...+.+++.+||+.||++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQ------GRQVY--LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhc------ccccc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111000000000 00000 1112234467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.05 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=204.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||+|+||.||++.+..++..+|+|.+..... ....++.+|++++.+++||||+++++.|.. ++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence 368889999999999999999998999999999875533 344568899999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999997642 68999999999999999999997 3589999999999999999999999999987653322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hC--------------
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QG-------------- 587 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~-------------- 587 (705)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................ ..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123468899999999988889999999999999999999999986543211111110000 00
Q ss_pred ------chhHHHHHhhhcC-CCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 588 ------KLLDALDARLRAK-GGF-DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 588 ------~~~~~id~~l~~~-~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+..+...... ... .......+.+++.+||+.+|++||++.++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000111100000 000 011334688999999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.94 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=207.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEc-------CCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE-------GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
.++|...+.||+|+||.||+|... ..+..||+|.+.... ....+++.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456788899999999999999752 234579999886542 34457899999999999 89999999998876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
....++||||+++|+|.+++.+... ...+++.++..++.|++.||.|||+ .+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 6688999999999999999976421 1357889999999999999999998 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~ 578 (705)
+++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~ 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---H
Confidence 9999999999999998765432221 222345678999999988889999999999999999998 7888865321 2
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
........+.. ...+......+.+++..||+++|++||++.++++.|+....
T Consensus 247 ~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 22222222211 11122345678889999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=326.93 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=200.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----- 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----- 434 (705)
..++|...+.||+|+||.||++.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999998889999999987542 334567889999999999999999999875322
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++||||+++ +|...+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 67666632 47889999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cc-----
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GK----- 588 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~----- 588 (705)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....+.. +.
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 98654322 22335789999999999988899999999999999999999999976432 1111111000 00
Q ss_pred -------hhHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 -------LLDALDARLR----------------AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 -------~~~~id~~l~----------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....++.... ............+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 0000111123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.91 Aligned_cols=249 Identities=22% Similarity=0.411 Sum_probs=201.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch---------hHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~---------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
+|.....||+|++|.||+|....+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence 366778999999999999999888899999988654221 23568899999999999999999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 8899999999999999996542 58899999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcc-----eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 516 RMHGHGQVA-----STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 516 ~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
+........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~---- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKI-GE---- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHH-hc----
Confidence 866532111 112245788999999998888999999999999999999999999764321 111100 00
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.. ....+......+.+++.+||++||++||++.++++
T Consensus 227 -----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NA--SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cC--CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 12223344567889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.72 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=205.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.+... ...||||...... ....+.+.+|+.++++++||||++++++|.. ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence 4577889999999999999987543 3569999887654 3456689999999999999999999998864 45789
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++..... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 58999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
...........++..|+|||.+....++.++|||||||++|||++ |+.||...... +.. ..+..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~-~~~~~~~~--------- 226 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVI-GRIENGER--------- 226 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHH-HHHHcCCc---------
Confidence 443222222334568999999988889999999999999999986 99999765421 111 11111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
...+......+.+++.+|+..+|++||++.++++.|+...
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 227 --LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122234467889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.26 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=199.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..++||+|+||.||+|.+..+++.||+|.+... .....+++.+|++++.+++||||+++++.+.. .+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEe
Confidence 3577789999999999999999888999999998655 23345678999999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 99999997653 47888999999999999999998 999999999999999999999999999998654322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............... ...+...... ..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~-~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-----LQCIVDEDPP-VL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-----HHHHhccCCC-CC
Confidence 22357899999999999888999999999999999999999999642211000000000 0000000000 00
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+++..||+.+|++||++++++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111233567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.94 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=189.1
Q ss_pred EEeecCceEEEEEEEcCC------------------------CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCccee
Q 005257 371 VIGVGGNGKVYKGVLEGG------------------------GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGL 426 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~------------------------~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l 426 (705)
.||+|+||.||+|.+..+ ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986321 24589998866555556778999999999999999999
Q ss_pred eeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-
Q 005257 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM- 505 (705)
Q Consensus 427 ~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~- 505 (705)
+++|.. ....++||||+++|+|..++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEe-CCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999986 6688999999999999999865432 68999999999999999999998 9999999999999997644
Q ss_pred ------CeeeeeeccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHh-hCCCCCCCCCccHH
Q 005257 506 ------NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVL-SGRRPIEEGKPNLV 577 (705)
Q Consensus 506 ------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~Ell-tG~~Pf~~~~~~~~ 577 (705)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998644222 12356788999998865 56899999999999999995 69999876433211
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
... ..... ..+......+.+++..||+.+|++||++.++++.|.
T Consensus 231 ~~~------------~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERF------------YEKKH----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH------------HHhcc----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 11111 111112246788999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=325.03 Aligned_cols=294 Identities=21% Similarity=0.239 Sum_probs=211.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----- 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----- 434 (705)
..++|+..+.||+|+||.||++.+..+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999988999999998654 2334567889999999999999999999876422
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
..+++||||+++ +|...+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 357999999975 66666532 47889999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +. +..+ .
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~--~~-~~~~---------~ 235 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI--DQ-WNKV---------I 235 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HH-HHHH---------H
Confidence 97643322 123357899999999999989999999999999999999999999865321 11 1110 0
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR-PTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFG 673 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 673 (705)
..+ +....+....+...........|..+ .+..++..... .+ ............+.+++.++..++|..|.++
T Consensus 236 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 309 (359)
T cd07876 236 EQL---GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWI--FP-SESERDKLKTSQARDLLSKMLVIDPDKRISV 309 (359)
T ss_pred Hhc---CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccc--cc-cccccccccchhHHHHHHHHhccCcccCCCH
Confidence 011 12222222223222222222233222 12222111100 00 0000011123445677788888999999999
Q ss_pred cCCCCCCCccc
Q 005257 674 YGYATHPTFHD 684 (705)
Q Consensus 674 ~~~~~hp~f~~ 684 (705)
.+++.||||..
T Consensus 310 ~e~l~hp~~~~ 320 (359)
T cd07876 310 DEALRHPYITV 320 (359)
T ss_pred HHHhcCchhhh
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.85 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|....+++.+++|.+........+.+.+|+.++++++||||+++++.+.. +..++++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeC
Confidence 578889999999999999999988889999999987666667889999999999999999999998776 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999987642 268999999999999999999998 9999999999999999999999999999876543221
Q ss_pred ceeeeeeccccCCCccccccC---CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG---RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....+.. .... ........ ..
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-~~~~~~~~---~~---- 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-ISKSNFPP---PK---- 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhccCCC---cc----
Confidence 12235688899999999776 78999999999999999999999997644211 1100 11110000 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..........+.+++.+||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.36 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=205.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...++||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence 47888999999999999999999889999999987542 2335679999999999999999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCC--------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 441 YDYMENGSLDKWIFQCDG--------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
|||+++|+|.+++..... ...+++..+++++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEec
Confidence 999999999999864211 1246678889999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCc-----------------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc
Q 005257 513 GLARMHGHGQV-----------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN 575 (705)
Q Consensus 513 Gla~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~ 575 (705)
|+++....... ......+||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986621110 0111246999999999999989999999999999999999999999763321
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHhccc
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-TMRQVVKVLEGKIE 641 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 641 (705)
. .. ......... ... ...+.+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus 238 k--i~----~~~~i~~P~--~~~----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 K--IS----YRDVILSPI--EVA----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h--hh----hhhhccChh--hcc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00 000000000 000 0112345678899999999999995 67777777776654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.03 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=204.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||.||+|....++..+++|.++.... .+++.+|++++++++||||+++++++.. +...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEec
Confidence 578888999999999999999998889999999865432 6789999999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999986543 268999999999999999999998 8999999999999999999999999999986654322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. .. . .+..........
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~-~---------~~~~~~~~~~~~ 221 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AI-F---------MIPNKPPPTLSD 221 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hh-h---------hhccCCCCCCCc
Confidence 2223457899999999988889999999999999999999999997643210 00 0 000000000111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+......+.+++..||+.+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2233456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.69 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=205.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
.+|...+.||+|+||.||++.... ....||+|.++... ....+++.+|++++.++ +||||++++++|.. +
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-C
Confidence 467889999999999999998642 22469999887543 34467899999999999 89999999999876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
+..++++||+++|+|.+++.+.. ....+++.++..++.|++.||.|||+ ++++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 68899999999999999997532 12358899999999999999999998 999999999999999
Q ss_pred ccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHH
Q 005257 502 DKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~ 579 (705)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||..... +.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence 99999999999999865432211 1122234567999999988889999999999999999998 8888865432 11
Q ss_pred HHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 580 v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....+..+.. ...+......+.+++..||+.+|++||++.++++.|+....
T Consensus 245 ~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 LFKLLKEGHR-----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHcCCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1222221111 11222334578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=325.89 Aligned_cols=295 Identities=19% Similarity=0.205 Sum_probs=213.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-----c
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----K 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~ 434 (705)
..++|...+.||+|+||.||++.+...++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999988999999998754 233456788999999999999999999977532 2
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 77776642 47889999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. ..
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~-~~----------- 236 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQW-NK----------- 236 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHH-HH-----------
Confidence 98654322 223357899999999999989999999999999999999999999765421 111 11
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR-PTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFG 673 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 673 (705)
.+...+...++....+...+..+....|... .++.++.. .................+.+++..+...+|..|.++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~ 312 (364)
T cd07875 237 -VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP---DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312 (364)
T ss_pred -HHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCc---cccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence 1111122223333333333333322222211 12221111 110000001111123456678888889999999999
Q ss_pred cCCCCCCCcccc
Q 005257 674 YGYATHPTFHDI 685 (705)
Q Consensus 674 ~~~~~hp~f~~~ 685 (705)
.+++.||||...
T Consensus 313 ~e~L~hp~~~~~ 324 (364)
T cd07875 313 DEALQHPYINVW 324 (364)
T ss_pred HHHhcCcccccc
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=307.18 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=207.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|+||.||.+....+++.+++|++... .....+++.+|+.++++++|+||+++++++.. .+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence 478889999999999999999989999999998654 34456778999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+... ..+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999976532 368999999999999999999998 899999999999999999999999999998765433
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.... +..+.. ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~-~~~~~~-----------~~ 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVK-IVQGNY-----------TP 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHcCCC-----------CC
Confidence 2 22335689999999999888889999999999999999999999976432 111111 111211 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
........+.+++..||+.+|++||++.++++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1223345688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.95 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=188.2
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC---CCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL---KHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
||+|+||+||+|....+++.||||++.... ......+..|..++.++ +||||++++.++.. ....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 699999999999999999999999986432 22334455677777665 69999999998876 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|..++.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 80 GGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred CChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999999886533 68999999999999999999998 9999999999999999999999999999875432221 2
Q ss_pred eeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 526 TTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..+.. ++. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~------~~~-----~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFGKV------RFP-----K 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcCCC------CCC-----C
Confidence 2345799999999998764 479999999999999999999999976432 112222222211 010 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPT----MRQVVK 634 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 634 (705)
......+.+++..||+.||++||+ +.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112356778999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=303.81 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=208.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+++|+..+.||+|.|+.||++.+..+|+.+|+|.+... +..+.+++.+|+.+.+.|+||||+++..-+.+ ....|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEEE
Confidence 45677888999999999999999999999999988644 34467889999999999999999999997765 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DFGla~~ 517 (705)
+|+|.|++|..-+-+. ..+++..+-..+.||+++|.|+|. ++|||||+||+|++|-+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666543 368889999999999999999998 999999999999999643 3489999999998
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...+ ......+|||+|||||++...+|+..+|||+.||+||-|+.|..||.+.+. ..+.+.+.+|... -.
T Consensus 163 l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~yd----~~- 232 (355)
T KOG0033|consen 163 VNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGAYD----YP- 232 (355)
T ss_pred eCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccccC----CC-
Confidence 8732 233446899999999999999999999999999999999999999987442 2233444444321 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+..-....+....|+.+++..||.+|.|+.|.+++
T Consensus 233 ---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 ---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11122334667889999999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.03 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=207.1
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCCh
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL 449 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL 449 (705)
-+||+|.||+||-|++..+...+|||.+........+.+..||.+-++|+|+|||+++|.|.+ ++.+-|.||-++||||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence 479999999999999999999999999988888888889999999999999999999998765 7788899999999999
Q ss_pred hHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCeeeeeeccceecCCCCcceeee
Q 005257 450 DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 450 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
.++|+..=+...=.+..+--+.+||++||.|||+ +.|||||||-.|||++ -.|.+||+|||-++.... -.+.+..
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 9999764332122777888899999999999998 9999999999999997 568899999999876643 2334556
Q ss_pred eeccccCCCccccccC--CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 529 VVGTVGYLAPEVFSSG--RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~--~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
+.||..|||||++..+ .|..++|||||||.+.||.||++||.........+. .-|- .+.-+.++.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF----kVGm--------yKvHP~iPee 803 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF----KVGM--------YKVHPPIPEE 803 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh----hhcc--------eecCCCCcHH
Confidence 7899999999999775 489999999999999999999999976443211111 1111 1112456677
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.......+++.|..+||.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7788899999999999999999999886
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=309.10 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=203.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||++.+.. +..+|+|.+... ....+.+.+|++++++++|+||+++.+.+.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEE
Confidence 4578889999999999999998764 566999987643 3345678999999999999999999998765 57899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999976433 368899999999999999999998 899999999999999999999999999998665433
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........++..|+|||++....++.++|||||||++||+++ |+.||...... ........+.. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~-----------~ 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYR-----------M 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCC-----------C
Confidence 222222345678999999988889999999999999999999 89998754321 11111111110 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.........+.+++.+||+++|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.21 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=205.1
Q ss_pred CCCCcceEEeecCceEEEEEEEc-------CCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE-------GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
++|...+.||+|+||.||++... .....+|+|.++... .....++.+|++++.++ +||||++++++|.. +
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-E 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-C
Confidence 46778899999999999999763 234579999887543 33456789999999999 69999999998876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
+..++||||+++|+|.+++..... ...+++.++.+++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 678999999999999999976321 2358999999999999999999998 999999999999999
Q ss_pred ccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHH
Q 005257 502 DKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~ 579 (705)
+.++.+||+|||+++......... .....++..|||||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 999999999999998654322111 111233467999999988889999999999999999999 8889865332 12
Q ss_pred HHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 580 v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.......+.. ...+......+.+++.+||+.+|++||++.++++.|+....
T Consensus 245 ~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLREGHR-----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHcCCC-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 2222222111 11222334567899999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.38 Aligned_cols=268 Identities=23% Similarity=0.404 Sum_probs=205.6
Q ss_pred CCCcceEEeecCceEEEEEEEcC----CCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEG----GGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~ 438 (705)
.|...+.||+|+||.||++.+.. ++..+|||.++..... ..+.|.+|+++++.++||||+++++++... +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 46667899999999999999753 3788999999766443 567899999999999999999999988642 34689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999976443 58999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH---HhCchhHHH
Q 005257 519 GHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM---VQGKLLDAL 593 (705)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~---~~~~~~~~i 593 (705)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........+..... ....+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 11123456799999998888999999999999999999999998653221111000000 000001111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..... ...+..+...+.+++.+||+.+|++||++.|+++.|+..
T Consensus 240 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCc--CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 111223446789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.34 Aligned_cols=241 Identities=23% Similarity=0.400 Sum_probs=191.3
Q ss_pred eEEeecCceEEEEEEEcCCCe-------EEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 370 NVIGVGGNGKVYKGVLEGGGA-------EIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~-------~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+.||+|+||.||+|.....+. .+|+|.+........+.+.+|+.+++.++|||++++++++.. +...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence 369999999999999865443 488888765555556788999999999999999999999886 567899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC--------eeeeeecc
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN--------GRLGDFGL 514 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~--------~kL~DFGl 514 (705)
|+++|+|.+++..... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. ++++|||+
T Consensus 80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999976443 58999999999999999999998 99999999999999987765 58999998
Q ss_pred ceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCC-CCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGR-RPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~-~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....... .. . .
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~-~---------~ 217 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KL-Q---------F 217 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HH-H---------H
Confidence 8654322 22467889999999976 45799999999999999999985 5544322110 00 0 0
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
...+ ...+......+.+++..||+.||++|||++++++.|+
T Consensus 218 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 YEDR----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHcc----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111 1122233456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.94 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=206.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
.++|...+.||+|+||.||++.... ....+|+|.++... .....++.+|++++.++ +||||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3568889999999999999998643 23569999987543 34456788999999999 79999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
.+..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+ .+++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 6688999999999999999976432 1258999999999999999999998 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~ 578 (705)
++.++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... +
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~ 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---H
Confidence 9999999999999997654322111 111234568999999988889999999999999999998 8888865331 1
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+......+. . ...+......+.+++..||+.+|++||++.++++.|+...+
T Consensus 250 ~~~~~~~~~~---------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLLKEGH---------R--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHcCC---------C--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1112222111 1 11223345678889999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.61 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=210.3
Q ss_pred CCcceEEeecCceEEEEEEEcCCC----eEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
....++||+|+||+||||.+-..+ .+||+|++... ..+...++++|.-+|.+|+|||+++++|+|... .+.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHH
Confidence 455789999999999999985444 57999988655 344578899999999999999999999999863 37899
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
++||+.|+|.++++..+. .+.....+.|..|||+||.|||+ +.++||||.++|||+..-..+||.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999987544 68899999999999999999998 9999999999999999999999999999998876
Q ss_pred CCcceeee-eeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 521 GQVASTTR-VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 521 ~~~~~~~~-~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
+....... ..-.+.|||-|.+....++.++|||||||.+||++| |..|+++... +.+-+.+..|+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---~eI~dlle~geR--------- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---EEIPDLLEKGER--------- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---HHhhHHHhcccc---------
Confidence 55433221 223678999999999999999999999999999999 9999987542 222233333322
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
...++-+...+..++.+||..|+..||+++++...+.++.
T Consensus 919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2234556677889999999999999999999998887654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.13 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=200.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||+|+...++..||||+++... ....+.+.+|+.++++++||||+++++++.. ++.+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 4677889999999999999999889999999986542 2334678899999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ ++|.+++........+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 6898888765444478999999999999999999998 999999999999999999999999999997654332
Q ss_pred cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cch----------h
Q 005257 523 VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKL----------L 590 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~----------~ 590 (705)
. ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... +........ +.. .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhh
Confidence 1 11223568899999988654 5788999999999999999999999764321 111111110 000 0
Q ss_pred HHHHHhhhcCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDARLRAKGG-----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
............ ........+.+++..||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 001123566789999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.75 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=205.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..++..+|+|.+........+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence 3568888899999999999999988899999999977666667789999999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999876432 68999999999999999999998 999999999999999999999999999987654322
Q ss_pred cceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 523 VASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||...... .. ...+..+... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~-~~~~~~~~~~-----~- 227 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RV-LLKILKSEPP-----T- 227 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HH-HHHHhcCCCC-----C-
Confidence 2 223357899999999975 345678999999999999999999999764321 11 1111111100 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.+|.+||++.++++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 ---LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11122234567889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=308.70 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=201.3
Q ss_pred eEEeecCceEEEEEEEcC-CC--eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEG-GG--AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~-~~--~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|++|.||+|.+.. ++ ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999999864 33 3699999987655 567789999999999999999999998875 67899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+++|.+++.+... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999977543 368999999999999999999998 999999999999999999999999999998765432211
Q ss_pred --eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 526 --TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 526 --~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +........+. . ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-------~----~~ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGE-------R----LE 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCC-------c----CC
Confidence 112356789999999988889999999999999999998 99999654321 11111110000 0 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.+...+..+.+++..||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12233467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.44 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||.|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|||++++++++.. ....++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEe
Confidence 468889999999999999999988899999999976655566788999999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|..++... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999988542 58999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+. ..... +..... +. ...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~-~~~~~~-----~~----~~~ 237 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYL-IATNGT-----PE----LQN 237 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHhcCC-----cc----cCC
Confidence 1 22346889999999998888999999999999999999999999765431 11111 110000 00 111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++.+||..||++||++.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 22234567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.38 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=191.5
Q ss_pred eEEeecCceEEEEEEEcC--CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 370 NVIGVGGNGKVYKGVLEG--GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
+.||+|+||.||+|...+ ++..+|+|.++.... .....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence 358999999999998653 356799998875543 334578999999999999999999998876 6678999999999
Q ss_pred CChhHHHHhcCC--CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 447 GSLDKWIFQCDG--SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 447 gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
|+|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++++||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 2246778888999999999999998 99999999999999999999999999999754333221
Q ss_pred e-eeeeeccccCCCccccccC-------CCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 525 S-TTRVVGTVGYLAPEVFSSG-------RASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 525 ~-~~~~~gt~~y~APE~~~~~-------~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
. .....|+..|+|||++... .++.++|||||||++|||++ |+.||....... .......+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~----- 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVREQQL----- 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhhcccC-----
Confidence 1 1224567889999998642 35789999999999999996 999997643311 11111111000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+.. .........+.+.+++..|| .+|++|||+++|++.|+
T Consensus 229 ~~~-~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLP-KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCC-CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000 01111123345777889999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.47 Aligned_cols=198 Identities=26% Similarity=0.363 Sum_probs=162.5
Q ss_pred ceEEeecCceEEEEEEEcC--CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEEEeeCC
Q 005257 369 ENVIGVGGNGKVYKGVLEG--GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYDYME 445 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV~E~~~ 445 (705)
.++||+|+||.||+|.... +++.+|+|.+.... ....+.+|++++++++||||+++++++... +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 4679999999999999753 56889999986432 235678899999999999999999987542 446789999996
Q ss_pred CCChhHHHHhcC------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE----ccCCCeeeeeeccc
Q 005257 446 NGSLDKWIFQCD------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL----DKEMNGRLGDFGLA 515 (705)
Q Consensus 446 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl----d~~~~~kL~DFGla 515 (705)
++|..++.... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 48888775321 12258999999999999999999998 999999999999999 45678999999999
Q ss_pred eecCCCCcc--eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 516 RMHGHGQVA--STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 2234578999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.56 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=202.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++.+.. ++..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEec
Confidence 356677889999999999999998899999999876655556678899999999999999999998876 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999986543 68999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 524 ASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.. .+... ...... .+....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~-~~~~~~---~~~~~~- 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLM-TKSNFQ---PPKLKD- 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhh-hccCCC---CCcccc-
Confidence 1223357899999999974 4568899999999999999999999986543211 11111 111100 000000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+.+++..|++.+|++||++.+++++
T Consensus 234 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 ---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01123457889999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.66 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=206.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.+|+..+.||+|+||.||+|.++.++. .+|+|.+..... ....++.+|+.++++++||||++++++|.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence 456778999999999999999876554 689998865543 345678999999999999999999999875 5789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999976433 58999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCccee-eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVAST-TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
........ ....++..|+|||.+....++.++|||||||++||+++ |+.||...... .+...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~------- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKGER------- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCCCC-------
Confidence 53322111 11223568999999988889999999999999999998 99999764321 11122222111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+...+.+++..||..+|++||++.++++.|+....
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122233567889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.26 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=209.7
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
|.+.++||+|+||.|||+.++.+|..+|||++..+ .+.+++..|+.+|++.+.|++|+++|.+.. ...+++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcC
Confidence 66788999999999999999999999999998654 457899999999999999999999998876 568999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
.|+..+.++-++ ++|++.++..+++..++||+|||. ..-||||||+.||||+-+|.+||+|||.|-.+..... .
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 999999997644 379999999999999999999998 8899999999999999999999999999976654332 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
...++||+.|||||++..-.|..++||||||+...||.-|++||.+..+-- .+ -.+.........-++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AI------FMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AI------FMIPTKPPPTFKKPE 253 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------ee------EeccCCCCCCCCChH
Confidence 344799999999999999999999999999999999999999998755410 00 001111111112244
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+.++++.|+-+.|++|.|+-+++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 556789999999999999999999998874
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=312.17 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+++++.++|+|++++++.+.. ...+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence 35777889999999999999999899999999987553 3445678999999999999999999998876 578999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999998643 68999999999999999999998 999999999999999999999999999998775432
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+. ... ..+..+ .. ..
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~-~~~~~~---------~~--~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVL-FLIPKN---------NP--PS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHH-HHhhhc---------CC--CC
Confidence 2 223356888999999999888999999999999999999999999754321 111 111111 10 11
Q ss_pred CCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDED-EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... ....+.+++..||..+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 34568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.34 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=205.9
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|+||.+|++....+++.+|+|++... .....+++.+|+.++++++||||+++++++.. .+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence 478899999999999999999988999999998654 23345688999999999999999999998765 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++...... .+++.++.+++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999998754332 57899999999999999999998 999999999999999999999999999998664432
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.. .....|++.|+|||++.+...+.++|||||||+++||++|+.||..... .+.+... ..+.. ..
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~-~~~~~-----------~~ 220 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKI-IRGSY-----------PP 220 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHH-hcCCC-----------CC
Confidence 21 1234678899999999888899999999999999999999999976432 1111111 11111 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+......+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.03 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=198.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-----chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-----DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~ 437 (705)
.+|...+.||+|+||.||+|....++..||+|++.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999999889999999886432 22345688999999999999999999987643 3567
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999996543 58899999999999999999998 9999999999999999999999999999976
Q ss_pred cCCCCc--ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQV--ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~~------- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQPT------- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCCC-------
Confidence 532111 111224578999999999888899999999999999999999999975432 111111111000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
....+....+.+..++ .||..+|++||+++|+++
T Consensus 227 ----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0222223334455555 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.89 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=208.1
Q ss_pred cCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
+...++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666778899999999999999999999999889999999986432 2345678899999999 89999999998865
Q ss_pred cc----CceEEEEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 433 EK----GSLMLVYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 433 ~~----~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
.+ +..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 32 35899999999999999886421 22368999999999999999999998 999999999999999999999
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCccccccC-----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
||+|||+++........ .....|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..+..
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK 244 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH
Confidence 99999998765432221 1224688999999998643 3689999999999999999999999764321 11111
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+..+... .+ ..+......+.+++.+||+.+|++||++.+++++
T Consensus 245 -~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 -IPRNPPP-----TL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HhcCCCC-----CC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111000 00 1122334568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.31 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=203.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-----chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-----DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+|+..+.||+|++|.||+|....++..|++|.+.... .+..+.+.+|+.++++++|+||+++++++.. ...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence 4677889999999999999998888999999886543 2345678999999999999999999998876 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
++||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999997543 58899999999999999999998 999999999999999999999999999988654
Q ss_pred CCCcceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
... ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||..... .+..+........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~--------- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKEL--------- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccC---------
Confidence 433 223356889999999987766 89999999999999999999999976442 1121111110110
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 --PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 12222334667889999999999999999998863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.95 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=202.9
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.|+..+.||.|+||.||.+++..+.+.||||++....+ +..++++.|+..|.+++|||++.+.|++.. +...||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHH
Confidence 36667789999999999999999999999999976543 334678999999999999999999997776 66789999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|||- ||-.++|.-.+. ++.+.++..|+.+.+.||+|||+ .+.||||||+.||||.+.|.+||+|||.|.+..+.
T Consensus 106 EYCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9995 577777754433 68999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 522 QVASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..++|||.|||||++. .+.|+-++|||||||.+.||.-.++|+...+. ...++....+ +. +.+
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQN-es-----PtL- 245 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN-ES-----PTL- 245 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhc-CC-----CCC-
Confidence 3479999999999985 47899999999999999999999999876432 1111111111 10 111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+....+..++..|+++-|++|||..+++++
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 134566788999999999999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.65 Aligned_cols=251 Identities=30% Similarity=0.478 Sum_probs=200.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.+|+..+.||+|+||.||++.+.. +..+|+|.+.... ....++.+|++++++++|||++++++++.. ....++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEc
Confidence 356778899999999999998864 6689999886432 234678999999999999999999998775 5678999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999875433 58899999999999999999998 8999999999999999999999999999986543322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... . ..+....+ .+ ..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~-~~~~~~~~---------~~--~~ 221 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--E-VVETINAG---------FR--LY 221 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--H-HHHHHhCC---------CC--CC
Confidence 21222234678999999988889999999999999999998 99998754321 1 11111111 00 00
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.+......+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.45 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=198.3
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-----c
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----K 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~ 434 (705)
..++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567888999999999999999999889999999986542 22345678999999999999999999877532 2
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++++|++ +++|.+++.. ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999998 7799887742 258999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCc-hhH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGK-LLD 591 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~-~~~ 591 (705)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+..... .+. ..+
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCCHH
Confidence 9865432 223578999999999876 5689999999999999999999999975432 111111110 010 000
Q ss_pred HHH--------HhhhcCCCCCH--------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALD--------ARLRAKGGFDE--------DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id--------~~l~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ..+......+. .....+.+++..|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000111 012346789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=310.55 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=204.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|+..+.||+|+||.||+|+.+. ..+.|++|.+...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcc
Confidence 568889999999999999999753 3467999988654443 46789999999999999999999998876 5678
Q ss_pred EEEEeeCCCCChhHHHHhcCCC------CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGS------MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
++||||+++|+|.+++...... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765422 158999999999999999999998 8999999999999999999999999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
||+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||...... .+......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~~~~~~~ 237 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRLQAGKLE 237 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHHHcCCcC
Confidence 99987543322222233456788999999988888999999999999999998 78888643221 111111111110
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..........+.+++.+||+.+|++||++.++++.|.
T Consensus 238 ----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 ----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1112234467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.11 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=207.9
Q ss_pred ccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeee
Q 005257 353 RITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCK 431 (705)
Q Consensus 353 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~ 431 (705)
+.++.++..+...|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....++..|+.++.++ +||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3466677778889999999999999999999999889999999886543 3446788999999998 6999999999875
Q ss_pred e-----ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 432 R-----EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 432 ~-----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
. .....+++|||+++|+|.+++...... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence 3 245689999999999999999764432 58888999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW 581 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~ 581 (705)
++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+. ....
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~ 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RALF 236 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhhh
Confidence 99999999876532221 122356899999999985 346788999999999999999999999654321 1110
Q ss_pred HHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 582 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
. +..... ...........+.+++..||+.||.+||++.|+++
T Consensus 237 ~----------~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 L----------IPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h----------HhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000000 01111223457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.06 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~lV~ 441 (705)
+|+..+.||.|+||.||++....++..+|+|++... .....+.+.+|++++++++||||+++++++.. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999999988999999998654 33445678899999999999999999997754 245679999
Q ss_pred eeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGW--EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
||+++++|.+++.... ....+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999997632 2347899999999999999999999322 389999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.+..+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--------- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGKF--------- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHhcCCC---------
Confidence 544321 2234689999999999888899999999999999999999999976542 111122222211
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+|++.+|++||++.+|+++
T Consensus 228 --~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12333455678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=350.16 Aligned_cols=261 Identities=21% Similarity=0.331 Sum_probs=204.2
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-c
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-K 434 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~ 434 (705)
+.....++|.+.+.||+|+||+||++.+..++..+|+|.+... .......+..|+.++..|+||||+++++++... .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3344567899999999999999999999999999999998654 233456789999999999999999999987543 3
Q ss_pred CceEEEEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCC----CCCeeecCCCCCCeEEcc------
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGW----EKKVLHRDIKSSNVLLDK------ 503 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~----~~~iiHrDLkp~NILld~------ 503 (705)
..++|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997532 2236999999999999999999999732 145999999999999964
Q ss_pred -----------CCCeeeeeeccceecCCCCcceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCC
Q 005257 504 -----------EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIE 570 (705)
Q Consensus 504 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~ 570 (705)
...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23489999999986643322 233578999999999854 458899999999999999999999997
Q ss_pred CCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 571 EGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 571 ~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.... . ..+...+..+. .+ ........+.+|+..||+.+|.+||++.|+++
T Consensus 245 ~~~~-~-~qli~~lk~~p-------~l-----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANN-F-SQLISELKRGP-------DL-----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCc-H-HHHHHHHhcCC-------CC-----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5432 1 11111111111 00 01122456889999999999999999999984
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.82 Aligned_cols=263 Identities=24% Similarity=0.302 Sum_probs=201.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|++|.||+|.++.+++.||+|++.... ....+.+.+|++++++++|||++++++.+.. ....++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence 46788899999999999999999889999999886542 2234568899999999999999999998876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|..++.... .+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988888765322 58999999999999999999998 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH----HH-
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL----DA- 595 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i----d~- 595 (705)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................ +.....- +.
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL-GDLIPRHQQIFSTN 231 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChHHhhhcccc
Confidence 32 1223457889999999876 457899999999999999999999997644321111111110 1110000 00
Q ss_pred ----hhhcC---CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 ----RLRAK---GGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ----~l~~~---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+... ...+ ......+.+++..||+++|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0000 1123567899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.58 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=204.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||+|+||+||++....+++.||+|++.... ....+.+.+|+++++.++||||+++++.+.. .+.+++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEe
Confidence 45677889999999999999999889999999886553 3445788999999999999999999999886 578999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.+.+ .+++..+..++.+++.||.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999886532 68999999999999999999996 3589999999999999999999999999987543222
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc-CC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA-KG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~-~~ 601 (705)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .....+.+.+...... ..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ----DDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh----hhhhHHHHHHHHHhhccCC
Confidence 123578999999999988889999999999999999999999997543210000 0000001111111110 01
Q ss_pred CCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 602 GFD-EDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 602 ~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
... ......+.+++.+||+.||++||++.|++++.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 22446788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.43 Aligned_cols=247 Identities=30% Similarity=0.472 Sum_probs=199.6
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
++||+|+||.||++.+.. ++.||+|++...... ..+.+.+|++++++++||||+++++++.. ....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCc
Confidence 469999999999999987 899999998765443 56789999999999999999999998876 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee-e
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST-T 527 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~ 527 (705)
|.+++.+... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......... .
T Consensus 79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999976432 58899999999999999999998 9999999999999999999999999999986543221111 1
Q ss_pred eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
...++..|+|||.+.++.++.++|||||||++|||++ |..||...... ..... +..... ...+..
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~---------~~~~~~--~~~~~~ 219 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER---------IESGYR--MPAPQL 219 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH---------HhcCCC--CCCCcc
Confidence 1233567999999988889999999999999999999 88888654321 11111 111111 112233
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 607 EVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 607 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
....+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.45 Aligned_cols=239 Identities=25% Similarity=0.421 Sum_probs=191.7
Q ss_pred eEEeecCceEEEEEEEcCCC----------eEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 370 NVIGVGGNGKVYKGVLEGGG----------AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~----------~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||++++++|.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 46999999999999998766 45888877544333 6789999999999999999999998876 56789
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-------Ceeeeee
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-------NGRLGDF 512 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-------~~kL~DF 512 (705)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++ .+||+||
T Consensus 78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999976433 58999999999999999999998 9999999999999999887 7999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccC--CCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCch
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSG--RASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
|++..... .....++..|+|||++... .++.++|||||||++|||++ |..|+....... + ...+...
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~-~~~~~~~-- 222 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--K-ERFYQDQ-- 222 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--H-HHHHhcC--
Confidence 99986543 1123567789999999776 78999999999999999999 577776543211 1 0111100
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
...+......+.+++..||..+|.+||++.++++.|+
T Consensus 223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 -----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111267889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.96 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=207.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+.. ++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence 46888999999999999999998889999999986543 3356789999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
++++++|.+++........+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999765433368999999999999999999998 999999999999999999999999999987665433
Q ss_pred cc---eeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 523 VA---STTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 523 ~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ........... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~------~~~~ 228 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQNDP------PSLE 228 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCCC------CCcC
Confidence 22 12335689999999998776 7899999999999999999999999754321 11111111100 0010
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ..........+.+++..||+.||++||++.+++++
T Consensus 229 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 T-GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C-ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00011334678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.12 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=203.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||++....+++.+|+|++... .....+.+.+|++++++++|||++++++.+.. ++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence 477889999999999999999988999999998754 23456788999999999999999999998765 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla~~~~~~ 521 (705)
|+++++|.+++.+... ..+++..+.+++.|++.||.|||+ ++++|+||||+||+++++ +.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999976432 258999999999999999999998 999999999999999865 45799999999876543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+.... .+. . .
T Consensus 156 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~-~~~---------~--~ 219 (256)
T cd08220 156 SKA--YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIM-SGT---------F--A 219 (256)
T ss_pred ccc--cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHH-hcC---------C--C
Confidence 221 2246889999999998888999999999999999999999999764321 1111111 110 0 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++..||+++|++|||+.|+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1222344568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=315.59 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=205.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|||++++++.+.. ....++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecc
Confidence 578889999999999999999988899999999976655566778999999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.+. .+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998542 57899999999999999999998 9999999999999999999999999999976544332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||....+. .........+ ......
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--~~~~~~~~~~----------~~~~~~ 237 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNG----------TPELQN 237 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--hheeeeccCC----------CCCCCC
Confidence 2 22346889999999998888999999999999999999999999754321 0000000000 000111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++..||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22334567889999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.86 Aligned_cols=252 Identities=30% Similarity=0.513 Sum_probs=203.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCC----eEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
|+..+.||+|+||.||++.....+ ..||+|.+...... ..+.+..|+.++..++|+||+++++++.. .+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence 345788999999999999998765 88999999765443 56789999999999999999999998886 5788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++...... .+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999764321 28999999999999999999998 9999999999999999999999999999987655
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
..........++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ....+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---------- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYR---------- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC----------
Confidence 43222212236789999999988889999999999999999998 7888865332 111122222211
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
..........+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456788899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.14 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=201.7
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEcc
Confidence 455677999999999999998889999999987543 3445678999999999999999999998876 67899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998853 258999999999999999999998 9999999999999999999999999999976543322
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+....+.. .. .. +..... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-~~---------~~~~~~--~~~~ 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VL-FL---------IPKNSP--PTLE 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HH-hh---------hhcCCC--CCCC
Confidence 1122467889999999998889999999999999999999999987543211 10 00 111101 1122
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
......+.+++..||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3345668899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.54 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=189.9
Q ss_pred EEeecCceEEEEEEEcC--CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 371 VIGVGGNGKVYKGVLEG--GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.||+|+||.||+|.... ....+|+|.+.... ......+.+|+.+++.++||||+++++.|.. ....++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCCC
Confidence 58999999999997643 34578999876543 3345678999999999999999999998876 67899999999999
Q ss_pred ChhHHHHhcCC--CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 448 SLDKWIFQCDG--SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 448 sL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|.+++..... ....++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2245678889999999999999998 999999999999999999999999999987543322111
Q ss_pred -eeeeeccccCCCcccccc-------CCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 526 -TTRVVGTVGYLAPEVFSS-------GRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 526 -~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +........+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~~~-~----- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVREQDI-K----- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhhccCc-c-----
Confidence 122345678999998743 356889999999999999999 78888654321 111111111110 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+.. ...+......+.+++..|| .||++||++++|++.|.
T Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPK-PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC-CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 000 1112233456677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.81 Aligned_cols=250 Identities=29% Similarity=0.501 Sum_probs=198.3
Q ss_pred eEEeecCceEEEEEEEcCCC------eEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 370 NVIGVGGNGKVYKGVLEGGG------AEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~------~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+.||+|+||.||+|...+.. +.+|+|.+.... ......+.+|+.+++.++||||++++++|.. ....++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 36899999999999986433 689999886543 2456688999999999999999999998876 567899999
Q ss_pred eCCCCChhHHHHhcC----CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-----Ceeeeeec
Q 005257 443 YMENGSLDKWIFQCD----GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-----NGRLGDFG 513 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-----~~kL~DFG 513 (705)
|+++++|.+++.... ....+++.++..++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999997532 12358899999999999999999998 8999999999999999877 89999999
Q ss_pred cceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 514 LARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 514 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||...... +. ...+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~-~~~~~~~~--- 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV-LQHVTAGG--- 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HH-HHHHhcCC---
Confidence 99765432211 1112345678999999998899999999999999999998 99998754321 11 11111111
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
. ...+......+.+++.+||.++|++||++.++++.|+
T Consensus 231 ------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ------R--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------c--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 1122334567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.20 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=204.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|++|.||+|.+..+++.||+|+++.. .....+.+.+|++++++++|+||+++++++.. ++..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence 3688899999999999999999988999999988654 23345778999999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||++++.+..++.+. ..+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999987776655432 258999999999999999999998 99999999999999999999999999999876554
Q ss_pred CcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHHHHhhhc
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~id~~l~~ 599 (705)
.........++..|+|||++.+. .++.++||||||+++|||++|+.||..... .+..+.... .+.+..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHhhhccc
Confidence 43233345788999999999887 789999999999999999999999975432 222222111 01110000000000
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 ------------------KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...++......+.+++..||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00111123567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.20 Aligned_cols=250 Identities=27% Similarity=0.450 Sum_probs=202.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...+.||+|+||.||+|....+++.|++|.++.... ...+.+.+|+.++++++|+||+++++.+.. .+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 47788999999999999999988899999999876544 366789999999999999999999998765 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999987532 58899999999999999999998 999999999999999999999999999998765433
Q ss_pred cceee---eeeccccCCCccccccCC---CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 523 VASTT---RVVGTVGYLAPEVFSSGR---ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 523 ~~~~~---~~~gt~~y~APE~~~~~~---~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
..... ...++..|+|||++.+.. .+.++||||||+++|||++|+.||....... ...... ..+. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~-~~~~-----~-- 224 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHV-GAGH-----K-- 224 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHH-hcCC-----C--
Confidence 22211 246788999999998766 8899999999999999999999997543211 111110 0010 0
Q ss_pred hhcCCCCCH--HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 597 LRAKGGFDE--DEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 597 l~~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+. .....+.+++..||+.+|++||++.+++.
T Consensus 225 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 ----PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 12456788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.49 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=207.4
Q ss_pred CCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
....++||+|.||.|++|.+... ...||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ..+.+|+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHh
Confidence 34467899999999999998642 357999999876544 67899999999999999999999999875 4678999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|.++.|||.+.|++ ..+..|....+..++.|||.||.||.. +++|||||.++|+||-....+||+||||.|.+..+
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999988 334478888999999999999999998 99999999999999999999999999999987765
Q ss_pred Ccceee--eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 522 QVASTT--RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 522 ~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
...... ...-...|+|||.+...+++.++|||+|||.+|||++ |..||.+-... .+++.+|.+-+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------qIL~~iD~~er 333 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------QILKNIDAGER 333 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------HHHHhcccccc
Confidence 443311 1122567999999999999999999999999999999 89999764421 12344443322
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..-+..|.+.+++++..||..+|++||++..|.+
T Consensus 334 --LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 --LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 3345678899999999999999999999999973
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.61 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=203.0
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC------chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN------DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
+|+..+.||+|++|.||++....+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.. .+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence 4777899999999999999998889999999986542 1234678999999999999999999999876 67889
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-Ceeeeeecccee
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARM 517 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~ 517 (705)
+|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++..
T Consensus 80 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999997543 68899999999999999999998 9999999999999998776 599999999876
Q ss_pred cCCCCcc---eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH
Q 005257 518 HGHGQVA---STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 518 ~~~~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i 593 (705)
....... ......|+..|+|||.+.+..++.++||||+||+++||++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-------- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--------
Confidence 6433111 112346789999999998888999999999999999999999999653321 1111111000
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00112334445577889999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.55 Aligned_cols=194 Identities=22% Similarity=0.372 Sum_probs=166.7
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
...+|...+.||+|+||.||+|....++..||+|..... ....|+.++++++||||+++++++.. ....++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence 345799999999999999999999988899999975332 23569999999999999999999886 66789999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|++. ++|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 68888886543 268999999999999999999998 99999999999999999999999999999753322
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIE 570 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~ 570 (705)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12233578999999999998899999999999999999998665553
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.53 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=199.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|...+.||+|+||.||+|....+++.||+|.+.... ......+.+|+.++++++||||+++++++.. ++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence 46888999999999999999999889999999986543 2334567889999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ ++|..++..... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 589888865432 58899999999999999999998 999999999999999999999999999997654322
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCch-hHH----HHH
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKL-LDA----LDA 595 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~-~~~----id~ 595 (705)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +.+..... .+.. ... +..
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence 21 122356889999999865 45788999999999999999999999765421 11111100 0000 000 000
Q ss_pred -hhh--cCCCC--------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 -RLR--AKGGF--------DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 -~l~--~~~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ....+ .......+.+++.+|++.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 00000 01123457889999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.64 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=205.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|++++++++||||+++++.+.. ....++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEec
Confidence 4666788999999999999998889999999987543 3456778999999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998853 258899999999999999999998 9999999999999999999999999999977654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......++..|+|||++.+..++.++|||||||++|||++|+.||....+.. .. .....+ . ....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-~~~~~~---------~--~~~~ 221 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VL-FLIPKN---------N--PPTL 221 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hh-hhhhcC---------C--CCCC
Confidence 2223467889999999988889999999999999999999999997643210 00 011111 0 1223
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+.+++..||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 34556778999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.35 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=195.7
Q ss_pred cceEEeec--CceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 368 EENVIGVG--GNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 368 ~~~~LG~G--~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
..++||+| +|++||++..+.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence 35679999 78999999999999999999997553 2334567789999999999999999999876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC-CC
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH-GQ 522 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~-~~ 522 (705)
+++|+|.+++...... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++||+.+..... +.
T Consensus 81 ~~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999999654322 58999999999999999999998 9999999999999999999999999986543221 11
Q ss_pred cc-----eeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 523 VA-----STTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 523 ~~-----~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...... ..+.....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~-~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEK-LNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHH-hcCCccccccc
Confidence 00 0111356778999999876 45899999999999999999999999753221 111111 11111110000
Q ss_pred h------hh----------------------------cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 R------LR----------------------------AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~------l~----------------------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. +. ............+.+++..||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00 0000111234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.87 Aligned_cols=245 Identities=27% Similarity=0.343 Sum_probs=203.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|++|.||++.+..+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.. ++.+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence 46888999999999999999999889999999986532 2345678899999999999999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999997643 68999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. .....|++.|+|||.+.+...+.++||||||+++|||++|+.||..... .........+.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~------------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKILEGK------------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCC------------
Confidence 3 2234688999999999888889999999999999999999999976542 11112221111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
...+......+.+++..||..||.+|| +++++++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112223346778899999999999999 6666655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.55 Aligned_cols=247 Identities=31% Similarity=0.481 Sum_probs=199.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++.. +..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEEC
Confidence 3577889999999999999975 46789999986432 34678999999999999999999998864 347899999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 999999999976543 268999999999999999999998 9999999999999999999999999999976433211
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
....+..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........+ .+ ..
T Consensus 156 ----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~---------~~--~~ 217 (254)
T cd05083 156 ----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEKG---------YR--ME 217 (254)
T ss_pred ----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhCC---------CC--CC
Confidence 1233567999999988889999999999999999997 99998764421 111222111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
........+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122344678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=278.32 Aligned_cols=199 Identities=29% Similarity=0.449 Sum_probs=170.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...++||+|.||+||||+..++++.||+|+++... +.....-++||.+++.++|+|||+++++... +..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHH
Confidence 3555678999999999999999999999999987553 3345678999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
||.. +|.++....++ .+.......++.|+++||.++|+ +++.||||||.|.||+.+|++|++|||++|.++-.-
T Consensus 82 ~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9964 89888877655 58899999999999999999999 999999999999999999999999999999876544
Q ss_pred cceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhh-CCCCCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLS-GRRPIEE 571 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~Ellt-G~~Pf~~ 571 (705)
..... -+-|.+|++|.++.+.+ |++..|+||-||++.|+.. |++.|++
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 33222 35599999999998755 8999999999999999988 5544544
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.34 Aligned_cols=196 Identities=23% Similarity=0.294 Sum_probs=169.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
..+|...+.||+|+||.||++.+..+++.||||... ...+.+|+++|++|+|+||+++++++.. ++..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 457899999999999999999999999999999642 2345789999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
++. ++|..++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 689888865332 69999999999999999999998 999999999999999999999999999998764332
Q ss_pred cc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCC
Q 005257 523 VA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571 (705)
Q Consensus 523 ~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~ 571 (705)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 21 12235799999999999998999999999999999999998876543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.36 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=198.6
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++++|...+.||+|+||.||+|....++..||+|++..... .....+.+|+.+++.++|+||+++.+++.. +...++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence 45789999999999999999999988899999999865533 233467899999999999999999998875 6688999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
+||+. ++|.+++..... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++++||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 678777654332 57888999999999999999998 8999999999999999999999999999975433
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHHHHhhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDALDARLR 598 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~id~~l~ 598 (705)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...... .+...+.+.. +.......+.+.
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhh
Confidence 2211 1223578899999998754 5788999999999999999999999764431 1111111110 000000000000
Q ss_pred cC-------------CCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 599 AK-------------GGF-----DEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 599 ~~-------------~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.. ... .......+.+++.+|+..||.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 000 0011356778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.20 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=203.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence 4778899999999999999998889999999987654 3345679999999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+ +++|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999987544 368999999999999999999998 999999999999999999999999999998765443
Q ss_pred cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHHHHhh---
Q 005257 523 VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDALDARL--- 597 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~l--- 597 (705)
........|+..|+|||.+.+. .++.++||||+||+++||++|+.||...... ....+....... .....+..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP--NEETWPGLTSL 231 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCC--ChHHHhhccCc
Confidence 2223335789999999998654 4689999999999999999998777653321 111111111000 00000000
Q ss_pred --------hcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 --------RAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 --------~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... ....+....+.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0001223678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.54 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=201.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++.. ++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 467888999999999999999988899999998865422 235678899999999999999999999875 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|..+..... .+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999988765432 48999999999999999999998 89999999999999999999999999999876443
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHHHHh---
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDALDAR--- 596 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~id~~--- 596 (705)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....... .+.+.......
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhcc
Confidence 32 2233467899999999865 4578899999999999999999999875432 111111110 01110000000
Q ss_pred ------hhc--CC------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 ------LRA--KG------GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 ------l~~--~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... .. ...+.....+.+++..||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 00 0011234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.69 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=199.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-----chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-----DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~ 437 (705)
++|...+.||+|+||.||+|....++..||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999999999999999885431 22356788999999999999999999977543 3467
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+++|||+++++|.+++.+.. .+++..+.+++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 57889999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCc--ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQV--ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-------- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQP-------- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHHHhcCC--------
Confidence 532211 1122346889999999998888999999999999999999999999754211 1111111000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+......+..++..|+. +|++||++.+++++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0122233445567788888884 99999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.91 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=203.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+.. ++.+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence 36888999999999999999999999999999986543 2345678899999999999999999998875 6688999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999996543 68999999999999999999998 9999999999999999999999999999874211
Q ss_pred CCc--------------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 521 GQV--------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 521 ~~~--------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
... .......|+..|+|||.+....++.++|||||||++|||++|+.||.+.... .+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~ 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVIS 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 100 0111245788999999998888999999999999999999999999754321 11121111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
+.... ..........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIEW---------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccCC---------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11100 00111234567899999999999999998777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.63 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=199.9
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
...||+|+||.||++....++..||||++........+.+.+|+.+++.++||||+++++.+.. .+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCCCCc
Confidence 4569999999999999988899999999876555566778999999999999999999998876 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ....
T Consensus 106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 9998843 258899999999999999999998 8999999999999999999999999999876543322 2233
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ ..+.. .+...+. ......
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~-~~~~~-----~~~~~~~----~~~~~~ 245 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAM-RRIRD-----NLPPRVK----DSHKVS 245 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHh-----cCCCccc----cccccC
Confidence 57899999999998888999999999999999999999999764321 111 11100 0111111 111233
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+..++..||..||++|||+.++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 467788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.85 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...+.||+|+||.||+|.+..+|+.+|+|+++... ......+.+|++++++++||||+++++++.. ....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence 4777899999999999999999899999999986542 2234567889999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ ++|.+++..... .+++..+..++.||++||.|||+ ++++||||||+||+++.++++||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 997 588888765432 58999999999999999999998 999999999999999999999999999998654332
Q ss_pred cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cchh-H---HHHH-
Q 005257 523 VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLL-D---ALDA- 595 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~-~---~id~- 595 (705)
.. .....++..|+|||++.+. .++.++|||||||++|||++|+.|+..+... .+........ +... . .+..
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 1224578899999998764 4789999999999999999999987543321 1111111100 0000 0 0000
Q ss_pred -hhhcCCC---------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 -RLRAKGG---------FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 -~l~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....... ........+.+++..||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 011223567889999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.47 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=203.4
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeec-----c
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE-----K 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~-----~ 434 (705)
.++++|+..+.||+|++|.||+|..+.+++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999988889999999865443 446789999999999 699999999988642 2
Q ss_pred CceEEEEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
..+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 34799999999999999986532 22368999999999999999999998 999999999999999999999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
++........ ......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... ..... +..+
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~- 233 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK-IPRN- 233 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-hhcc-
Confidence 9876543222 2223568899999998753 34678999999999999999999999753321 11111 1111
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.......+....+.+.+++.+||..||++|||+.++++
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 --------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00001112224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.91 Aligned_cols=198 Identities=27% Similarity=0.374 Sum_probs=162.3
Q ss_pred ceEEeecCceEEEEEEEcC--CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceEEEEeeCC
Q 005257 369 ENVIGVGGNGKVYKGVLEG--GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLMLVYDYME 445 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~lV~E~~~ 445 (705)
..+||+|+||.||+|.... ++..||+|.+.... ....+.+|++++++++||||+++++++.. .+...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999764 45789999886442 23567889999999999999999998753 3457899999997
Q ss_pred CCChhHHHHhcC------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE----ccCCCeeeeeeccc
Q 005257 446 NGSLDKWIFQCD------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL----DKEMNGRLGDFGLA 515 (705)
Q Consensus 446 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl----d~~~~~kL~DFGla 515 (705)
+ +|.+++.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777775321 12358899999999999999999998 999999999999999 56678999999999
Q ss_pred eecCCCCcc--eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 516 RMHGHGQVA--STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 2234578999999999876 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.54 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=202.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|++|.||+|....+++.+|+|.+..... ...+.+.+|++++..++||||+++++.+.. ....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence 368888999999999999999998899999999876532 245678999999999999999999998875 6688999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+.+++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999999875432 368999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCcc----------------------------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 521 GQVA----------------------------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 521 ~~~~----------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111246889999999998888999999999999999999999999754
Q ss_pred CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 005257 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT----MRQVVK 634 (705)
Q Consensus 573 ~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 634 (705)
... ... .. ....... ..........+.+++.+||+.||++||+ +.|+++
T Consensus 236 ~~~--~~~-~~--------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD--ETF-SN--------ILKKEVT--FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH--HHH-HH--------HhcCCcc--CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 421 111 11 1111111 0011114577899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=306.62 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=197.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||+|++|.||+|..+.+++.||||.+..... .....+.+|++++++++||||+++++++.. +...++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence 568889999999999999999988899999999875432 223457789999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++ +|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 99998876443 68999999999999999999998 999999999999999999999999999987543221
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc--HHHHHHHHHHhCch--hHHHH---
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN--LVEMVWELMVQGKL--LDALD--- 594 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~--~~~~v~~~~~~~~~--~~~id--- 594 (705)
.. .....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..+..... ...+.
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11 122346889999999865 45889999999999999999999999654321 11111111111000 00000
Q ss_pred ------------HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 595 ------------ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 595 ------------~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..+.. ..........+.+++..|++++|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLIN-HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHH-hCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0000011256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.89 Aligned_cols=246 Identities=21% Similarity=0.392 Sum_probs=205.1
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccC----CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEEEe
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYD 442 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV~E 442 (705)
...+||+|+|-+||||.+..+|..||.-.++.. .....+.|..|+.+|+.|+||||++++....+. +..+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 356799999999999999999999997655432 334568899999999999999999999976543 345789999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla~~~~~~ 521 (705)
.|..|+|..|+++.+ .++.+.+.+|++||++||.|||+ ..++|||||||..||+|+.+ |.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998765 58899999999999999999997 46899999999999999875 88999999999887654
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.. ..++|||.|||||++. ..|++.+||||||++++||+|+..||..=.. ...++.++..|..+..+.+-
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV----- 268 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKV----- 268 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhcc-----
Confidence 33 3379999999999987 6899999999999999999999999975221 24456666677666654321
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.-..+.+++..|+.. ..+|||+.|+++
T Consensus 269 -----~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 -----KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 124578899999999 999999999987
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=306.34 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=204.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV~ 441 (705)
++|...+.||.|++|.||++.+..+++.+|+|.+..... .....+.+|++++++++||||++++++|... .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888999999999999999998899999999875433 4557799999999999999999999988643 34689999
Q ss_pred eeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876422 23368999999999999999999998 9999999999999999999999999999875543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc---cHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP---NLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~---~~~~~v~~~~~~~~~~~~id~~l 597 (705)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+. .......... .+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~-----~~ 228 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNP-----EL 228 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCch-----hh
Confidence 221 124578899999999888999999999999999999999999976522 11111 1111111110 01
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00011112234678999999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.44 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCCcceEEeecCceEEEEEEEcC-CCeEEEEEEeccC----------CchhHHHHHHHHHHhcc-CCCCCcceeeeeeee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHE----------NDGGTRAFLAEISSLGR-LKHKSLVGLRGWCKR 432 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~----------~~~~~~~~~~Ei~~l~~-l~Hpniv~l~g~~~~ 432 (705)
+|+..+.||+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999987 6788999987543 22234567889988875 799999999998876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
++..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 67899999999999999988542 223368999999999999999999995 36899999999999999999999999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .....+...
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~- 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLA-TKIVEAVYE- 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHH-HHHhhccCC-
Confidence 99998765433 223456889999999999888999999999999999999999999654321 111 111111110
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..........+.+++.+||+.||++||++.|+..++.
T Consensus 232 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ---------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0001123456889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.75 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHH-hccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISS-LGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||.||++.+..+++.||+|+++... .....++..|+.. ++.++||||+++++++.. ++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence 46888999999999999999999999999999987653 2334556667665 566789999999999876 66899999
Q ss_pred eeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 442 DYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 442 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||++ |+|.+++... .....+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 6898888653 223468999999999999999999998 5 89999999999999999999999999998654
Q ss_pred CCCcceeeeeeccccCCCcccccc----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSS----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
.... .+...|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... +....... +
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-~-------- 223 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE-E-------- 223 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh-c--------
Confidence 3221 122467899999998864 446889999999999999999999997533221 11111110 0
Q ss_pred hhhcCCCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFD-EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. ...+ ....+.+.+++..||..+|++||++.++++.
T Consensus 224 -~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 -PS--PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1111 1234568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.04 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=200.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc----------hhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND----------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~----------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
+|...+.||+|+||.||+|....+++.+|+|.++.... ...+.+.+|+.+++.++|||++++++++.. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence 46678899999999999999988899999998854211 113467889999999999999999998876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
+..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 78899999999999999997642 68999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCcc-eeeeeeccccCCCccccccCC--CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 515 ARMHGHGQVA-STTRVVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 515 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.||..... .....+..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~ 231 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HHHHHHhhccc-cCC
Confidence 9765432211 123346789999999987654 78999999999999999999999965332 11111111110 000
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+. ..........+.+++..||+++|++||++.+++++
T Consensus 232 ~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIP------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCC------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 11112334678889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.48 Aligned_cols=248 Identities=27% Similarity=0.328 Sum_probs=204.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.. ....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 4788899999999999999999889999999987542 2346789999999999999999999998765 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++... ..+++.++..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999754 268999999999999999999998 99999999999999999999999999998866443
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........+........ ...
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~ 219 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ADV 219 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------ccc
Confidence 2 22234678899999999888899999999999999999999999986553222222111110 112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTM--RQVV 633 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 633 (705)
..+......+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2333445778899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.93 Aligned_cols=253 Identities=24% Similarity=0.427 Sum_probs=209.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||+|++|.||++.+..+++.|+||++..... ...+.+.+|+..+.+++|+|++++++.+.. .+.+++|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence 367888999999999999999998899999999876644 456789999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++... ..+++..++.++.|+++||.|||+ ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999764 268999999999999999999995 2899999999999999999999999999998765433
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc-cHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.. ..+..... .
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~~~~~~~~-----------~ 221 (264)
T cd06623 155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM-QAICDGPP-----------P 221 (264)
T ss_pred Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH-HHHhcCCC-----------C
Confidence 222 235688999999999888899999999999999999999999976542 111111 11111100 1
Q ss_pred CCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDED-EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.. ....+.+++..||+++|++||++.+++++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12223 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.45 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=199.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
...||+|+||.||++....+++.||+|.+........+.+.+|+.++..++|||++++++.+.. ++..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCCC
Confidence 3469999999999999988899999999876555556778999999999999999999998876 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|..++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ....
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 9998743 258999999999999999999998 9999999999999999999999999999875543322 2233
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... +... .+..... .. ........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~-~~~~~~~-----~~----~~~~~~~~ 244 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK-RLRDSPP-----PK----LKNAHKIS 244 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-HHhccCC-----CC----ccccCCCC
Confidence 57899999999998888999999999999999999999999754321 1111 1111100 00 00111223
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+++..||+.+|++||++.+++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=303.09 Aligned_cols=257 Identities=25% Similarity=0.455 Sum_probs=200.2
Q ss_pred CCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-----
Q 005257 366 FSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG----- 435 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 435 (705)
|...+.||+|+||.||+|.+.. +++.||||++... .....+++.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567889999999999998753 4689999998654 23456678999999999999999999998764221
Q ss_pred ceEEEEeeCCCCChhHHHHhcC---CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCD---GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
..++++||+++|+|..++.... ....+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875422 12257899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 513 GLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 513 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||...... .....+..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~~- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIKGNR- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHcCCc-
Confidence 999865432211 1122345678999999988889999999999999999999 88888654321 11111111110
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
...+......+.+++.+||+.+|++||++.++++.|++.
T Consensus 234 ----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111223446789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.25 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=199.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||.|++|.||+|+...+++.||||++.... ......+.+|++++++++||||+++++++.. +...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 4788899999999999999999889999999886543 2234578899999999999999999998875 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+. ++|..++...... .+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 6899888764433 68999999999999999999998 999999999999999999999999999987654332
Q ss_pred cceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHHHH-----
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDALDA----- 595 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~id~----- 595 (705)
.. .....++..|+|||.+.+.. ++.++|||||||++|||+||+.||...... +...+.... +...+.+.+
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 21 22235688999999886644 688999999999999999999999764421 111111111 100000000
Q ss_pred -----hhhcCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 -----RLRAKGG-----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 -----~l~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....... ........+.+++.+||+.||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000 001122456789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.28 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=204.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+|+..+.||+|++|.||++.+..+++.+|+|++.... ....+++.+|++++++++||||+++++.+.. ++..++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEEe
Confidence 5677788999999999999999889999999987653 3445678999999999999999999998876 5789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999997643 368999999999999999999996 47999999999999999999999999999875533221
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc---cHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP---NLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~---~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.+ +....+..
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~----------- 221 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-QYIVNEPP----------- 221 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH-HHHhcCCC-----------
Confidence 1 15688999999999888999999999999999999999999975421 111111 11111100
Q ss_pred CCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDED-EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+.. ....+.+++..||..+|++||++.+++..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111122 45668899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.08 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=198.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc------hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||++++++|.. .+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEE
Confidence 4677889999999999999875 678899998864421 223568899999999999999999999886 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 79 IFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999996543 58899999999999999999998 89999999999999999999999999998754
Q ss_pred CCCC-----cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 519 GHGQ-----VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 519 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---- 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGL---- 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHhhhccCC----
Confidence 3211 11122346889999999998888999999999999999999999999754321 110000000000
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
....+......+..++.+||+++|++||++.++++
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01122234466789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.07 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=188.6
Q ss_pred EEeecCceEEEEEEEcCC--CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 371 VIGVGGNGKVYKGVLEGG--GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~--~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.||+|+||.||+|..... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.|.. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence 599999999999976433 2456777776543 3456789999999999999999999999876 66889999999999
Q ss_pred ChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC-cce
Q 005257 448 SLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ-VAS 525 (705)
Q Consensus 448 sL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~-~~~ 525 (705)
+|.+++.+... ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 2246777888999999999999998 999999999999999999999999999986432211 112
Q ss_pred eeeeeccccCCCcccccc-------CCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 526 TTRVVGTVGYLAPEVFSS-------GRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||..... .+....... +......++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~ 234 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIK-DQQVKLFKPQL 234 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh-hcccccCCCcc
Confidence 223467889999999743 245789999999999999997 5678765432 111111111 11111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.......+.+++..|| .+|++||+++++++.|.
T Consensus 235 ------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1123356777888999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.84 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=199.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-----hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-----GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+|...+.||+|++|.||+|....+++.||||++...... ....+..|++++++++|+||+++++++.. .+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 467788999999999999999888999999999765322 34567789999999999999999999886 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+ +|+|.+++.... ..+++.+++.++.||++||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 80 v~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred EEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 99999 899999996543 268999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHHHHhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ......... +......-+..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEAL--GTPTEENWPGV 230 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHc--CCCchhhhhhc
Confidence 43221 122356788999999855 45789999999999999999997777653321 111111100 00000000000
Q ss_pred ---------hcCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 ---------RAKGGF-----DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ---------~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...... .......+.+++..||+++|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 11224678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.43 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=206.6
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.+...||.|+||.|||+..+.++...|-|.+.....+..++|+-||++|...+||+||++++.+.. ++.+++..|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecC
Confidence 3446779999999999999998888889999988888889999999999999999999999997765 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
||-.+.++-..+. .|++.++.-+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+...... ...
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999998877554 69999999999999999999999 99999999999999999999999999997543221 122
Q ss_pred eeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 526 TTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
...++|||+|||||+.. ..+|++++||||||+.|.||..+.+|-..-.+. .|.-.+.....+..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSePPTL-------- 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTL-------- 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcCCCcc--------
Confidence 34479999999999863 468999999999999999999999997654431 11111111111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
--+......+.++...|+..||..||++.+++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1133455678889999999999999999999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=294.40 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=205.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC----c----hhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN----D----GGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~----~----~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
.-+.|...+.||+|..++|.++.++.++.+.|+|++.... . .-.++-.+|+.+|+++ -||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999999999999999999986431 1 1233457799999998 69999999998876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
..-+++|+|.|+.|.|.++|... ..+++++..+|++|+.+|++|||. +.|+||||||+|||+|++.++||+||
T Consensus 95 -~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 -DAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred -cchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 66789999999999999999653 379999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCcccccc------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSS------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|.++....+.. ....+|||+|+|||.+.- ..|+...|+|++||++|.|+.|-.||-....- .+...+.+
T Consensus 168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---lMLR~Ime 242 (411)
T KOG0599|consen 168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---LMLRMIME 242 (411)
T ss_pred ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---HHHHHHHh
Confidence 99998877653 345799999999999842 35889999999999999999999998643211 11222333
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
|+..- . ..--.+......+|+.+|++.||.+|-|++|++.+
T Consensus 243 GkyqF------~--speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 243 GKYQF------R--SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccccc------C--CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 33210 0 11112334567899999999999999999999874
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.53 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=202.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
.|...+.||+|++|.||++....+++.+++|++........+.+.+|+.+++.++|||++++++++.. .+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEecc
Confidence 34556799999999999999988899999999876555556778999999999999999999998775 67889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 99999999865 258999999999999999999998 9999999999999999999999999999875543322
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+. ... .....+.. +. ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~-~~~~~~~~-----~~----~~~~ 238 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAM-KRIRDNLP-----PK----LKNL 238 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHH-HHHHhcCC-----CC----Cccc
Confidence 222356899999999998888999999999999999999999999764321 111 11111100 00 0011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.93 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=205.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.++++++|||++++++.+.. .+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEec
Confidence 578889999999999999999888889999999876555556788999999999999999999998876 6688999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++.+. .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999998642 47899999999999999999998 9999999999999999999999999999876544322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
......|++.|+|||.+....++.++|||||||++||+++|+.||...... +.+......+. .....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~----------~~~~~ 237 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGT----------PELQN 237 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCC----------CCCCC
Confidence 122346889999999998888999999999999999999999999754321 11111100000 00111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+.+++..||..+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234568889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.58 Aligned_cols=252 Identities=24% Similarity=0.289 Sum_probs=204.4
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|+..+.||+|.-|+||++.+++++..+|+|++.+.. .........|-+||+.++||.+..|++.+.. +...|||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEEEe
Confidence 445678999999999999999999999999998763 3334556779999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC--
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH-- 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~-- 520 (705)
||+||+|..++++...+ .+++..++-++.+|+.||+|||- .|||.|||||+||||.++|++.|+||.|+....-
T Consensus 158 yCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999988776554 89999999999999999999998 9999999999999999999999999998742210
Q ss_pred -------------------------------CCc----------------------ceeeeeeccccCCCccccccCCCC
Q 005257 521 -------------------------------GQV----------------------ASTTRVVGTVGYLAPEVFSSGRAS 547 (705)
Q Consensus 521 -------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~s 547 (705)
... .....++||-.|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 012236899999999999999999
Q ss_pred ccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 005257 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP 627 (705)
Q Consensus 548 ~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 627 (705)
.++|.|+|||++|||+.|+.||.+..... .+...+-..+.- . -.+.....+.+|++..|.+||++|-
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------Tl~NIv~~~l~F-p-~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------TLRNIVGQPLKF-P-EEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchh-----------hHHHHhcCCCcC-C-CCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999998765321 111222222221 1 1124556789999999999999998
Q ss_pred C----HHHHHHH
Q 005257 628 T----MRQVVKV 635 (705)
Q Consensus 628 s----~~evl~~ 635 (705)
- +.||.++
T Consensus 381 g~~rGA~eIK~H 392 (459)
T KOG0610|consen 381 GSKRGAAEIKRH 392 (459)
T ss_pred ccccchHHhhcC
Confidence 7 7777663
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.84 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=202.1
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
|+..+.||+|+||.||+|....++..+|+|.+.... ....+.+.+|++++.+++||||+++++.+.. +...++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEeC
Confidence 667889999999999999998889999999886443 3345678899999999999999999998876 67889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999853 258999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
......|+..|+|||.+.+...+.++|||||||++|||++|..||...... ... ..+..+. . ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~-~~~~~~~---------~--~~~~ 222 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVL-FLIPKNN---------P--PTLE 222 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHH-HHHhcCC---------C--CCCC
Confidence 122346788999999998888899999999999999999999999754321 111 1111110 0 1122
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
......+.+++..||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3344668889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.45 Aligned_cols=243 Identities=26% Similarity=0.361 Sum_probs=198.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||.|++|.||+++...+++.+|+|++.... ....+.+.+|+++++.++||||+++++.+.. +...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 689999999999999889999999986542 2345678999999999999999999998875 678999999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999997543 58999999999999999999998 999999999999999999999999999998765432 2223
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..|+..|++||.+....++.++|+||||+++|||++|..||.....+..+.. ..+..+ .....++....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~ 220 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-NDILKG----------NGKLEFPNYID 220 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-HHHhcc----------CCCCCCCcccC
Confidence 4688999999999888899999999999999999999999976543222211 111100 01122333335
Q ss_pred HHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPT-----MRQVVK 634 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 634 (705)
..+.+++..||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 67899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.03 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=203.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...+.||+|+||.||+|..+.++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.. ....++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 4778899999999999999999989999999986542 2345678899999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-CeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~~ 521 (705)
|+++++|.+++...... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGV-LFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999764432 58999999999999999999998 9999999999999999885 4699999999766543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ..+.+.+.. .+.. .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~-~~~~-----------~ 220 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKIC-QGYF-----------A 220 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHh-cccC-----------C
Confidence 22 1223468899999999988889999999999999999999999997543 222222211 1110 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.........+.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.65 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=199.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+.|...+.||+|+||.||+|....+++.||+|++.... ....+++.+|+++++.++|||++++.++|.. ++..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEE
Confidence 356888899999999999999998889999999986442 2344678999999999999999999999886 667899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|+||++ |+|.+++..... .+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 577777754332 58999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.. ....|+..|+|||++. ...++.++||||||+++|||++|+.||...... ....... ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--~~~~~~~-~~~~------- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA-QNDS------- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--HHHHHHh-cCCC-------
Confidence 32 2246788999999874 356889999999999999999999998754321 1111110 0000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
. ..........+.+++..||+.+|++||++.+++.+.
T Consensus 232 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -P--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -C--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 111223456789999999999999999999998854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.95 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=206.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
.|...+.||+|++|.||++....+++.+++|++........+.+.+|++++++++|||++++++.+.. ....++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecC
Confidence 36778899999999999999988899999999977655567789999999999999999999998876 57889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999987643 368999999999999999999998 9999999999999999999999999999987655432
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~ 604 (705)
.....|+..|+|||.+....++.++||||||++++||++|+.||...... ..... .... ........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~---------~~~~~~~~ 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFK-IATN---------GPPGLRNP 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHH-HHhc---------CCCCcCcc
Confidence 23457889999999998888999999999999999999999999764321 11100 1000 00000011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 605 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
......+.+++..||+.||++|||+.+++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1114678899999999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.56 Aligned_cols=197 Identities=21% Similarity=0.341 Sum_probs=168.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcC--CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG--GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+|...+.||+|+||.||++...+ .+..||+|.+... +...+|++++++++||||+++++++.. ....++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEe
Confidence 468889999999999999998643 4578999987543 235689999999999999999998875 66889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|++. ++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 6888888432 269999999999999999999998 99999999999999999999999999999765443
Q ss_pred Cc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 522 QV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 522 ~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 22234679999999999998899999999999999999999999997643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=306.66 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=210.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
=|..++.||+|.|..|-++++--+|+.||||++.+.. .-....+.+|++.|+-++|||||+++.+... ...+|||.|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEEEE
Confidence 4677888999999999999999999999999997653 2344578899999999999999999998765 778999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~kL~DFGla~~~~~~ 521 (705)
.-.+|+|.+||.+... .+.+....+++.||+.|+.|+|. ..+|||||||+||.+- .-|-+||.|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999987655 59999999999999999999998 9999999999998764 5688999999999988776
Q ss_pred CcceeeeeeccccCCCccccccCCCC-ccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRAS-TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... +..+|+..|-|||++.+..|+ +++|||||||+||-|+||+.||+..... +.+-..+-.+
T Consensus 173 ~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDCK 235 (864)
T KOG4717|consen 173 KKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDCK 235 (864)
T ss_pred chh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhccc
Confidence 543 446999999999999998775 6899999999999999999999865432 1111112222
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+.....+..+|+..++..||.+|.+.++|...
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 44566677788999999999999999999999763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.52 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=199.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc----Cce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~ 437 (705)
+++|...+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++++++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999999989999999998643 2334567889999999999999999999875422 357
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++|+||+++ +|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 88777743 268999999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCcc--eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH
Q 005257 518 HGHGQVA--STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 518 ~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i 593 (705)
....... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+....... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHH
Confidence 5432211 1223568999999998754 46899999999999999999999999754321 011111111100 00100
Q ss_pred HH-----------hhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DA-----------RLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~-----------~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+. ........+ +.....+.+++..||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 1123568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=295.76 Aligned_cols=292 Identities=25% Similarity=0.359 Sum_probs=214.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCC----eEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.|+....||+|.||.||||.-.+++ +.+|||+++.+.+ .-...-.+|+.++++|+|||++.+..++...+..++
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 4777889999999999999765443 3789999976633 334567899999999999999999999887678899
Q ss_pred EEEeeCCCCChhHHHHhc--CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC----CCeeeeee
Q 005257 439 LVYDYMENGSLDKWIFQC--DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE----MNGRLGDF 512 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~----~~~kL~DF 512 (705)
+++||.+. +|...++.. .....++...+.+|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 888888643 223479999999999999999999998 889999999999999877 89999999
Q ss_pred ccceecCCCCcce--eeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 513 GLARMHGHGQVAS--TTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 513 Gla~~~~~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
|++|.+...-.+. ...++-|.+|+|||.+.+. .||.+.|||+.||++.||+|-++.|.+....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k-------------- 246 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK-------------- 246 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh--------------
Confidence 9999887654322 3346779999999999874 6899999999999999999998888764321
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHhccccCC------CCCcchhhHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMR------QVVKVLEGKIEAGI------ENETEDMDAYLLQ 657 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~------evl~~L~~~~~~~~------~~~~~~~~~~~~~ 657 (705)
+..+..+..+++.++.+++- .+.-++-|.++ ..++.++...-... ..-... +..-++
T Consensus 247 -------~~~~~Pfq~dQl~rIf~vLG---~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k-~~~a~~ 315 (438)
T KOG0666|consen 247 -------IKTKNPFQHDQLDRIFEVLG---TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK-DPSALD 315 (438)
T ss_pred -------cccCCCchHHHHHHHHHHcC---CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC-CchHHH
Confidence 11112344444444444432 23333333333 33333331111000 000001 111456
Q ss_pred HhhccccccccccccccCCCCCCCcccc
Q 005257 658 QVKSKDMWANYSRSFGYGYATHPTFHDI 685 (705)
Q Consensus 658 ~~~~~~~~~~~~r~~~~~~~~hp~f~~~ 685 (705)
++.++..++|-+|.++.+|+.||||.+-
T Consensus 316 LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhccHHHHhcccccccC
Confidence 6777778999999999999999999654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=288.91 Aligned_cols=270 Identities=22% Similarity=0.355 Sum_probs=208.5
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
...||.|..|.|++++.+.+|..+|||.+.+. +.+..+.++..+.++..-. .|+||+.+|++.. +...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICMELMST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHHHHHHH
Confidence 55699999999999999999999999999765 5667788889998877764 8999999999987 5677899999954
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
.++.+|+.... ++++.-+-++...+.+||.||.+ +++|||||+||+|||+|+.|++||||||++-.+-... ..
T Consensus 176 -C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 176 -CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred -HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 77787776544 58888888999999999999998 7999999999999999999999999999997654433 23
Q ss_pred eeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 527 TRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
+..+|-+.|||||.+.- .+|+.++||||||+.|+||+||+.||..-+.++. +...+.+.. .+.+....
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkvln~e-----PP~L~~~~-- 319 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKVLNEE-----PPLLPGHM-- 319 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHHHhcC-----CCCCCccc--
Confidence 44588999999999864 4688999999999999999999999987544321 122222211 12222111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhh
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVK 660 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~ 660 (705)
.....+.+++..|++.|+.+||...+++++== +. .-+....+...++.+.+.
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F--i~-~ye~a~~dVa~WF~dV~~ 371 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF--IK-RYETAEVDVASWFKDVMA 371 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc--ee-ecchhhccHHHHHHHHHh
Confidence 23456888999999999999999999887421 11 222333455555555544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.73 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=200.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCC---CCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLK---HKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~lV 440 (705)
.|+..+.||+|+||.||+|.+..+++.+|+|.+... ......++.+|+.++++++ |||++++++++.. +...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence 467788899999999999999888999999998654 3344567889999999997 9999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999988542 68999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... ......|+..|+|||.+.++ .++.++|||||||++|||++|+.||...... ... ....... .
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~-~~~~~~~-----~----- 219 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAM-MLIPKSK-----P----- 219 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhh-hccccCC-----C-----
Confidence 432 22334789999999998654 4689999999999999999999999754321 111 0000000 0
Q ss_pred CCCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDE-DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... .....+.+++..||+.||++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 -PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 134568899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.62 Aligned_cols=262 Identities=28% Similarity=0.404 Sum_probs=201.5
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV~E 442 (705)
|...+.||+|++|.||+|....+++.+|+|++.... ....+.+.+|++++++++|||++++++++... .+..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999999889999999997653 34456788999999999999999999998763 268999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++ +|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8988886543 268999999999999999999998 899999999999999999999999999998775544
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCch-----------
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKL----------- 589 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~----------- 589 (705)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ....+.........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 322333466889999998765 45789999999999999999999999764421 11111111000000
Q ss_pred ------hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 ------LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ------~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+. ..+...+...+.+++..||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLR--EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHH--HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00011125678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.16 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=208.0
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~lV~ 441 (705)
+|...+.||+|++|.||+|....++..|++|++..... ...+.+.+|+.++++++||||+++++.+.... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 46778999999999999999998899999999876543 45678999999999999999999999887621 6789999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997644 68999999999999999999998 99999999999999999999999999999877654
Q ss_pred Ccc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... ......++..|+|||.+.....+.++||||||++++||++|+.||..... .....+...... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-----------~~ 222 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSG-----------EP 222 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHhccccC-----------CC
Confidence 321 12234678899999999888899999999999999999999999976541 111111111100 01
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22333445778999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.79 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=207.1
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
..++.|+..+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|+++++.++|+|++++++.+.. ....++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEE
Confidence 356678888999999999999999988889999999876544 56778999999999999999999998876 5789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
+||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999997654 268999999999999999999998 9999999999999999999999999999865543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....+. ...... .......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~~--------- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLI-TTKGIPP--------- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhcCCCC---------
Confidence 221 122345788999999998888999999999999999999999999764321 111111 1110000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111234678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=332.35 Aligned_cols=266 Identities=28% Similarity=0.481 Sum_probs=216.0
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeee
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGW 429 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~ 429 (705)
++...++....+.||+|.||.|++|.... ....||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444555666799999999999998641 14679999987653 35677899999999999 69999999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcC------CC-------CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCD------GS-------MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~------~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp 496 (705)
|.. ++.+++|+||+..|+|.++|+.++ .. ..++..+++.++.|||.|++||++ .++|||||.+
T Consensus 371 ~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA 446 (609)
T ss_pred ecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence 987 788999999999999999998765 00 239999999999999999999998 9999999999
Q ss_pred CCeEEccCCCeeeeeeccceecCCCCcceeeeeec--cccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCC
Q 005257 497 SNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVG--TVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGK 573 (705)
Q Consensus 497 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~ 573 (705)
+|||+..+..+||+|||+|+...+........-.| ...|||||.+....++.++|||||||+||||++ |..||.+-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544433222222 446999999999999999999999999999999 889997622
Q ss_pred ccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 574 PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 574 ~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....+++.+.+|..++ .+..+...+..+|+.||+.+|++||++.++++.|+..+.
T Consensus 527 --~~~~l~~~l~~G~r~~-----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 --PTEELLEFLKEGNRME-----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --cHHHHHHHHhcCCCCC-----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1122344555554322 234456778899999999999999999999999987544
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.47 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=199.4
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|+..+.||.|++|.||+|.+..++..||+|++.... ....+.+.+|++++++++|||++++++++.. ++..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence 567789999999999999998889999999987543 2334678899999999999999999999876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
++ ++|.+++..... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||+++.......
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 689998865442 368999999999999999999998 8999999999999999999999999999976543322
Q ss_pred ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHH--------
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDAL-------- 593 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~i-------- 593 (705)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||..... .+........ +......
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223568899999988654 578899999999999999999999976432 1111111111 0000000
Q ss_pred --HHhhhcC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 --DARLRAK-----GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 --d~~l~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....... ..........+.+++.+|++++|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00011123567899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.72 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=198.8
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||.||++.+..+++.+++|.+..... ...+.+.+|++++++++||||+++++.+.. +...++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6899999999999998899999999865433 455678999999999999999999987765 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc-----
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV----- 523 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~----- 523 (705)
|.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999997643 68999999999999999999998 9999999999999999999999999999876543321
Q ss_pred --ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 524 --ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 524 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.......++..|+|||.......+.++||||||+++|||++|+.||...... +. ......+. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~-~~~~~~~~------------~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EI-FQNILNGK------------I 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HH-HHHHhcCC------------c
Confidence 1223356788999999998888999999999999999999999999765421 11 11111111 1
Q ss_pred CCCHHH--HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 602 GFDEDE--VERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 602 ~~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..+... ...+..++..||+.+|.+||++.++.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111222 567889999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.62 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=199.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~lV 440 (705)
++|+..+.||+|+||.||+|..+.+++.+|+|.++.... .....+.+|+.++.+++||||+++++++.... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 467788899999999999999998899999999975432 23345778999999999999999999887532 789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||++ ++|.+++..... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 499998865432 58999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHH-----------Hh-
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELM-----------VQ- 586 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~-----------~~- 586 (705)
... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ....+.... ..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 322 12234578899999998764 4689999999999999999999999754321 001000000 00
Q ss_pred -----CchhHHHHHhhhcCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 -----GKLLDALDARLRAKGGFDED-EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 -----~~~~~~id~~l~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+. ..++.. ..+.+.+++..||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhh--ccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000 111111 24567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.02 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=196.0
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|...+.||+|+||.||++.+..+++.+|+|++.... ......+.+|+.++.++. ||||+++++++.. ++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence 3445678999999999999999999999999987543 234567899999999996 9999999998876 667899999
Q ss_pred eCCCCChhHHHHh--cCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQ--CDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|+.. +|.++... ......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 66554321 1122368999999999999999999997 35899999999999999999999999999976543
Q ss_pred CCcceeeeeeccccCCCccccccC---CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG---RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+.+.+.. .+.. +.+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~-~~~~-----~~~ 231 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVV-KGDP-----PIL 231 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhc-CCCC-----CcC
Confidence 221 1223678999999998765 689999999999999999999999975431 111111111 1110 011
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ..........+.+++.+||+.+|++||++.++++.
T Consensus 232 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 S--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred C--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11112345678899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.91 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=200.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+|+..+.||+|++|.||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence 47888999999999999999998999999999876533 234667889999999999999999999876 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++ +|.+++........+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 898888765444468999999999999999999998 8999999999999999999999999999976543221
Q ss_pred ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCc--------hhHHH
Q 005257 524 ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGK--------LLDAL 593 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~--------~~~~i 593 (705)
......++..|++||++.+ ..++.++|||||||++|||++|+.||...... ......+...... .....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1122457889999999865 35788999999999999999999999764321 1111111100000 00000
Q ss_pred HHhhhc-----CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRA-----KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...... .....+.....+.+++..|++.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 00011123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.80 Aligned_cols=290 Identities=23% Similarity=0.315 Sum_probs=211.1
Q ss_pred CCCcceEEeecCceEEEEEEEcC--CCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEG--GGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~ 438 (705)
+|+..+.||+|+||.||+|.... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999987 78999999997643 34456788999999999999999999998763 16789
Q ss_pred EEEeeCCCCChhHHHHhcC--CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc----CCCeeeeee
Q 005257 439 LVYDYMENGSLDKWIFQCD--GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK----EMNGRLGDF 512 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~----~~~~kL~DF 512 (705)
+||||+++ +|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6776664322 12268999999999999999999998 99999999999999999 899999999
Q ss_pred ccceecCCCCc--ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 513 GLARMHGHGQV--ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 513 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
|+++....... .......++..|+|||++.+. .++.++|||||||+++||++|+.||........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------------ 224 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK------------ 224 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc------------
Confidence 99986543322 122335678999999988664 578999999999999999999999976433210
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh--ccc-c-CCCCCc-------chhhHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG--KIE-A-GIENET-------EDMDAYLLQQ 658 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~--~~~-~-~~~~~~-------~~~~~~~~~~ 658 (705)
. ..+.....+..+...+..+++..|+.+.+..+.... ... . ...... ......+.+.
T Consensus 225 -----------~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 225 -----------K-SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred -----------c-cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 0 000111223333333444444444433333222210 000 0 000000 0223346677
Q ss_pred hhccccccccccccccCCCCCCCc
Q 005257 659 VKSKDMWANYSRSFGYGYATHPTF 682 (705)
Q Consensus 659 ~~~~~~~~~~~r~~~~~~~~hp~f 682 (705)
+..+..++|..|.++.+++.||||
T Consensus 293 i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcCHHHHhcCCCC
Confidence 888888999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.22 Aligned_cols=265 Identities=27% Similarity=0.373 Sum_probs=201.1
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc----
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK---- 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~---- 434 (705)
.+.++|+..+.||+|+||.||+|.++.+++.||+|+++... ......+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45677899999999999999999999889999999987543 233456788999999999999999999886532
Q ss_pred -----CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 435 -----GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 435 -----~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
+.+++|+||+++ +|...+.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 378999999976 7777775432 268999999999999999999998 99999999999999999999999
Q ss_pred eeeccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhC
Q 005257 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQG 587 (705)
Q Consensus 510 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~ 587 (705)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+.+. ..+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~-~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL-CGS 236 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCC
Confidence 9999998765433222222356788999998865 35789999999999999999999999754321 11111111 111
Q ss_pred chhHHH------------H------HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 588 KLLDAL------------D------ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 588 ~~~~~i------------d------~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...... + .+... . .......+.+++..||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE--E-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhh--h-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000 0 00000 0 00124568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=303.37 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=198.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|...+.||+|+||.||+++...++..+|+|++.... ....+.+.+|++++++++|||+++++++|.. +...++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEe
Confidence 566788999999999999998889999999986442 2334578899999999999999999998876 667899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 58877775433 258999999999999999999998 99999999999999999999999999998754332
Q ss_pred cceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 523 VASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...... .... .+..+. ..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~-~~~~~~--------~~- 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY-HIAQNE--------SP- 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHH-HHHhcc--------CC-
Confidence 2246788999999974 456899999999999999999999998754321 1111 111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
..........+.+++.+||+.+|.+||++.++++.+...
T Consensus 243 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 243 -TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 111223445688999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=292.10 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=207.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|+||.||++.+..++..+|+|++..... ...+.+.+|+++++.++|||++++.+.+.. +...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence 47788999999999999999998899999999876533 556778999999999999999999998776 578999999
Q ss_pred eCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|+++++|.+++.... ....+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997642 12479999999999999999999998 89999999999999999999999999999876554
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.. ......|++.|+|||.+....++.++||||+|+++++|++|+.||...... +.. ........ .
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~-~~~~~~~~-----------~ 221 (258)
T cd08215 157 VD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELA-LKILKGQY-----------P 221 (258)
T ss_pred cc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHH-HHHhcCCC-----------C
Confidence 31 223357889999999998888999999999999999999999999765421 111 11111111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++.+||..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1222344678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.73 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=200.6
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----- 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----- 434 (705)
..++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999989999999998653 2334567788999999999999999999875322
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++||||+. ++|.+.+.. .++..++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 488887743 38889999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCch----
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKL---- 589 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~---- 589 (705)
++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+.. ..+ ..... .+..
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~-~~~~~~~~~~~~~~ 240 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQW-NKIIEQLGTPSDEF 240 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHH-HHHHHhcCCCCHHH
Confidence 987644322 22346789999999999989999999999999999999999999754321 111 01000 0000
Q ss_pred hHH--------HHHhhhcC-----------------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 LDA--------LDARLRAK-----------------GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ~~~--------id~~l~~~-----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+. .+.+.... ..........+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000 00011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=292.17 Aligned_cols=248 Identities=31% Similarity=0.478 Sum_probs=205.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||++....+++.+++|.+..... ...+.+.+|++++.+++|||++++++++.. ++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence 46778999999999999999998899999999976643 456789999999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998654 268999999999999999999998 999999999999999999999999999998765443
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.. .....++..|+|||...+..++.++||||+|+++|||++|+.||...... ...+.... .. ...
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~-----------~~~ 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIVQ-DD-----------HPP 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHhc-cC-----------CCC
Confidence 32 22346789999999998877899999999999999999999999754321 11111110 00 012
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.+......+..++.+||+.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22334567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.70 Aligned_cols=259 Identities=23% Similarity=0.249 Sum_probs=196.1
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCC-CCCcceeeeeeeec-cCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLK-HKSLVGLRGWCKRE-KGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~-~~~~~lV~E 442 (705)
|...+.||+|+||.||+|....++..+|+|+++... ........+|+.++.++. |||++++++++... .+.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999999889999999987542 222334567999999985 99999999988763 167899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888876533 268999999999999999999998 99999999999999999 999999999998664332
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH-HhCchhHHHHHhhhcC
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM-VQGKLLDALDARLRAK 600 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~-~~~~~~~~id~~l~~~ 600 (705)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .+.+.... ..+...+.+.......
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 21 22457899999998654 5578899999999999999999999976442 11111111 1111111111111100
Q ss_pred ----CCC-----------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 ----GGF-----------DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ----~~~-----------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+ .......+.+++..||+++|++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 11235788999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.74 Aligned_cols=261 Identities=15% Similarity=0.193 Sum_probs=188.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCCchhH-----------HHHHHHHHHhccCCCCCcceeee
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHENDGGT-----------RAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~~~~-----------~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
.++|...++||+|+||.||+|....+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46789999999999999999998876 56777776443322111 12234455667789999999999
Q ss_pred eeeeccC---ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC
Q 005257 429 WCKREKG---SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505 (705)
Q Consensus 429 ~~~~~~~---~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~ 505 (705)
.+..... ..++++|++.. ++.+.+.... ..++..+..++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 7654332 23677777643 6666664322 35788899999999999999998 9999999999999999999
Q ss_pred CeeeeeeccceecCCCCc------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHH
Q 005257 506 NGRLGDFGLARMHGHGQV------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~ 579 (705)
.++|+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HH
Confidence 999999999987643221 11122469999999999999999999999999999999999999997652211 11
Q ss_pred HHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 580 v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
+.... ......+..... ........+.+++..||+.+|++||++.++++.|+
T Consensus 243 ~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAK--CDFIKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhH--HHHHHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10000 001111111100 01123466889999999999999999999998763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.13 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=192.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||+||++....+++.+|+|.+.... ....+.+.+|+++++.++|||++++++.+.. .+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 689999999999999889999999986532 2234567889999999999999999998875 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++.+... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 9999976543 368999999999999999999998 9999999999999999999999999999876543221 222
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..++..|+|||++.+..++.++|||||||+++||++|+.||......... ..+.... .......+....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~ 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRT--------LEMAVEYPDKFS 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhcc--------ccccccCCccCC
Confidence 46788999999998888999999999999999999999999764321100 0011100 000112223345
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
..+.+++..||+.+|++||+.++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 67889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.56 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=198.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCC-CCCcceeeeeeeeccC----c
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKG----S 436 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~----~ 436 (705)
++|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++ ||||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999999998999999998765432 23467889999999995 6999999998865332 3
Q ss_pred eEEEEeeCCCCChhHHHHhcCC--CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeec
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG--SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFG 513 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFG 513 (705)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 89888865432 2468999999999999999999998 99999999999999998 8899999999
Q ss_pred cceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLD 591 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~ 591 (705)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||..... .......... +....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHhCCCCh
Confidence 99865432211 122356889999998865 4578999999999999999999999976432 1111111110 00000
Q ss_pred HHHHh---------hhcC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALDAR---------LRAK-----GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~---------l~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+. .... ....+.....+.+++..||++||.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000 00001234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.30 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=188.9
Q ss_pred EEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHH---hccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISS---LGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~---l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
.||+|+||.||++....+++.+|+|.+.... ......+.+|..+ +...+|||++.+.+.+.. .+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 4899999999999999889999999886542 1222334455443 334479999999998876 56889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||+++++.++|+|||++........
T Consensus 80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999999886543 69999999999999999999998 9999999999999999999999999999976543221
Q ss_pred eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................ .. ....
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~--~~~~ 218 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TV--NVEL 218 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cC--CcCC
Confidence 22468999999999864 458899999999999999999999997543221111111110 00 1222
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
+......+.+++..|++.||++|| ++++++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 334456788999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.64 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=206.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+|+..+.||+|++|.||++....+++.+|+|++... ......++.+|+++++.++|+||+++.+++.. ....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence 477889999999999999999988999999998754 23445678899999999999999999998876 578999999
Q ss_pred eCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 443 YMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|+++++|.+++.+.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999986632 12368999999999999999999998 99999999999999999999999999999876554
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. .....++..|++||.+.+..++.++|+||||+++|||++|+.||...... ........+.. .
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----------~ 219 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQRGKY-----------P 219 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCC-----------C
Confidence 2 12245788999999998888999999999999999999999999765421 11111111111 2
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++..|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.39 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=201.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-----CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~ 437 (705)
.+|+..+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999988999999987532 223456789999999999999999999987653 3467
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++++||+++++|.+++.... .+++..+.+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999986533 57899999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCc--ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQV--ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-------- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIFKIATQP-------- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHHHHHcCC--------
Confidence 532111 112235688999999999888899999999999999999999999975422 11111111000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+....+.+.+++..||+ +|..||+..+++.+
T Consensus 226 ---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0122344455678999999999 57999999987753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.08 Aligned_cols=265 Identities=26% Similarity=0.348 Sum_probs=199.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~l 439 (705)
.++|+..+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.++++++|+||+++++++.... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4578899999999999999999998999999999865432 22345678999999999999999999886533 46899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++ +|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 8888886543 368999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHHHH--
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDALDA-- 595 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~id~-- 595 (705)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +.+...... +.....+.+
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhh
Confidence 4321 1222345788999999865 45789999999999999999999999764421 111111110 000000000
Q ss_pred -------hhhcC-CCCC------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 596 -------RLRAK-GGFD------EDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 596 -------~l~~~-~~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
..... ..+. ....+.+.+++..|++.||++|||+.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000 0000 01235577899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=302.05 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=196.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-------
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK------- 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------- 434 (705)
++|+..+.||+|+||.||+|....+++.||||++.... ......+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999999899999999986543 223345678999999999999999999886532
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++||||+.+ +|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 346999999964 8888876533 258999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCcc---eeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 515 ARMHGHGQVA---STTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 515 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+. +...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCC
Confidence 9866432221 11234578899999988664 47889999999999999999999997654321111111110 1111
Q ss_pred HHHHHh---------hhcCCCC---------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDAR---------LRAKGGF---------DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~---------l~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+. +...... ...+...+.+++..||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000000 00012456789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.70 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=200.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc----Cc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~ 436 (705)
.++|...+.||+|+||.||+|....+++.||||.+... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999999989999999998653 2334556788999999999999999999876432 35
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68988886432 68999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHH----------
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELM---------- 584 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~---------- 584 (705)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 664432 12233467889999998865 46899999999999999999999999754321 000001000
Q ss_pred -HhCchhHHHHHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 585 -VQGKLLDALDARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 585 -~~~~~~~~id~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.....+.. +.... .........+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRS-LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHh-cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 00000 0011234667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.30 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=202.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeee---ccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKR---EKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---~~~~~ 437 (705)
..+|+..+.||+|++|.||+|....++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999999999999999987542 2345677889999999999999999997753 23468
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 68988885432 58999999999999999999998 9999999999999999999999999999976
Q ss_pred cCCCCcc---eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH---------
Q 005257 518 HGHGQVA---STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM--------- 584 (705)
Q Consensus 518 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~--------- 584 (705)
....... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........-......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5433221 1223578999999999865 46899999999999999999999999764321110000000
Q ss_pred ---HhCchhHHHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 585 ---VQGKLLDALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 585 ---~~~~~~~~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
....+...++ ........+ ......+.+++..||+.+|++||++.+++.+-
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000111111 111111111 12346789999999999999999999988853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=338.74 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=205.0
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+-+++....||.|.||.||-|...++|+-.|+|.+... .....+...+|++++..|+|||+|+.+|+-.. ....+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHH
Confidence 344677788999999999999999999999999987543 23345678899999999999999999997665 667899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
.||||++|+|.+.+.... ..++....-+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|....
T Consensus 1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999996532 35666667788999999999998 999999999999999999999999999998776
Q ss_pred CCCc---ceeeeeeccccCCCccccccC---CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH-HHHhCchhHH
Q 005257 520 HGQV---ASTTRVVGTVGYLAPEVFSSG---RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE-LMVQGKLLDA 592 (705)
Q Consensus 520 ~~~~---~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~-~~~~~~~~~~ 592 (705)
.... ......+||+-|||||++.+. ...-+.||||+|||++||+||++||...+.+ |... .+..|..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHK--- 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCC---
Confidence 5421 223457899999999999763 3567899999999999999999999875543 2211 1222222
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.++......-.+++..|+..||.+|.++.|++++
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 34455556667889999999999999998877765
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.62 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=207.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+.|+.-++||+||||.||-++.+.+|+.+|+|++.+. .+.+..--++|-.+|.+++.+.||.+--.+.. ++.++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEE
Confidence 45688899999999999999999999999999988654 23444556889999999999988887665554 889999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|+..|.||+|.-+|++.+.. .+++...+-++.+|+.||.+||+ ..||.|||||+|||||+.|+++|+|.|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999887653 79999999999999999999998 999999999999999999999999999999887
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.++.... .+||.+|||||++.++.|+...|.||+||+||||+.|+.||....+. + -.+.+|.+...
T Consensus 339 ~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------v----k~eEvdrr~~~ 404 (591)
T KOG0986|consen 339 EGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------V----KREEVDRRTLE 404 (591)
T ss_pred CCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------h----hHHHHHHHHhc
Confidence 7654332 38999999999999999999999999999999999999999754321 0 11233433322
Q ss_pred -CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 005257 600 -KGGFDEDEVERVLHLGLLCAYPDPRARPTMR 630 (705)
Q Consensus 600 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 630 (705)
...++....+....+....++.||.+|--.+
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2345666667788888888999999986433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.14 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=198.7
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
..+||+|+||.||++....+++.||||++..........+.+|+.+++.++|+|++++++.+.. .+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCc
Confidence 3569999999999999998999999999866555566778999999999999999999998876 678999999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 99987432 57899999999999999999998 8999999999999999999999999999876543221 2233
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..|++.|+|||.+.+..++.++||||+|+++|||++|..||...... +.+ . .+...+...........
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~-~---------~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM-K---------MIRDNLPPKLKNLHKVS 243 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-H---------HHHhhCCcccCCcccCC
Confidence 56889999999998888899999999999999999999999754321 111 1 11111110000111233
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+++.+||+.+|.+||++.+++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 457888999999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=294.84 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=193.0
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHH-hccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISS-LGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|....+++.||+|.+..... .....+..|..+ ....+|+|++++++.+.. ++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 468999999999999988899999999865422 223344555554 445589999999998875 678999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999997543 58999999999999999999998 9999999999999999999999999999876433
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||..... ..++..+..+.. ........
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--------~~~~~~~~ 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRI--------NWPEEVKE 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhccc--------CCCCcccc
Confidence 1224678899999999888889999999999999999999999976432 122222222111 00011112
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.....+.+++..||+.+|++||++.++.+.|.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 34567899999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.38 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=197.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|++|.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++.. +...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence 46888999999999999999999889999999986542 2334678899999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~~~~ 520 (705)
||++ ++|.+++..... ..+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 588887755432 246888899999999999999998 89999999999999985 56799999999976543
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHH-----
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDAL----- 593 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~i----- 593 (705)
... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... +........ +......
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccc
Confidence 221 11234678899999998664 5789999999999999999999999764321 111111110 0000000
Q ss_pred ---H--Hhhhc-CCC----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 ---D--ARLRA-KGG----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 ---d--~~l~~-~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+ ..... ... ..+.....+.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 000 011223557889999999999999999999873
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.84 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|...+.||+|++|.||+|+...+++.|+||++..... .......+|+..+.+++ |||++++++++.. ++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence 5667899999999999999988899999999865432 22334567999999999 9999999998876 7789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+ +|+|.+++..... ..+++.++..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred C-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 9 7899998876542 368999999999999999999998 9999999999999999999999999999986643322
Q ss_pred ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cc-h----------h
Q 005257 524 ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GK-L----------L 590 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~-~----------~ 590 (705)
.....++..|+|||++.. ..++.++||||||++++||++|+.||...... +.+...... +. . .
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 123467889999998754 45789999999999999999999998654321 111111100 00 0 0
Q ss_pred HHHHHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++..+.... .........+.+++..||+.+|++||+++|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0001113568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.74 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=204.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++.+++ ||||+++++++.. ++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence 4688899999999999999999988999999998653 2334567889999999998 9999999998875 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999997643 69999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-------------------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHH
Q 005257 520 HGQV-------------------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV 580 (705)
Q Consensus 520 ~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v 580 (705)
.... .......|+..|+|||......++.++||||||++++|+++|+.||...... . .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--L-T 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--H-H
Confidence 3321 1122346789999999998888999999999999999999999999765421 0 0
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM----RQVVK 634 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 634 (705)
..... .....++....+.+.+++..||+.+|++||++ .++++
T Consensus 231 ~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKIL------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01110 11122333345678999999999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.23 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=197.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|++|.||+|.+..+++.||||+++... .....++..|+.++.++. ||||++++++|.. +...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEe
Confidence 55778899999999999999999889999999997543 334556777888777775 9999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||++ ++|.+++..... .+++..+..++.|++.||+|||+ ..+++||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 478777755332 68999999999999999999996 258999999999999999999999999998765432
Q ss_pred CcceeeeeeccccCCCccccccCC----CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGR----ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+.... ...+. .
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~-~~~~~--------~ 236 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK-ILQEE--------P 236 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH-HhcCC--------C
Confidence 221 2235788999999987553 788999999999999999999999653221 111111 11111 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.. ..........+.+++.+||+.||++||++.+++++-
T Consensus 237 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 001112345688999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.67 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=200.7
Q ss_pred CCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC----chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 365 GFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN----DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
+|+..+.||+|++|.||++... .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+.. +..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence 3677889999999999999864 356889999986432 22345688999999999 59999999987765 667
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++||||+++|+|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 899999999999999986532 68999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCC--CCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i 593 (705)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... ........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK------- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------
Confidence 65544332233356889999999987654 788999999999999999999999643221 11111111110
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.....+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 227 -----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 -----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0011222334567889999999999999999999888774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.66 Aligned_cols=260 Identities=28% Similarity=0.371 Sum_probs=201.5
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|...+.||+|++|.||+|....+++.+++|++..... .....+.+|++++++++|+||+++++++.. +...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence 4567889999999999999988899999999876533 345678899999999999999999998876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++ +|..++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 975 8888886543 268999999999999999999998 999999999999999999999999999998775543
Q ss_pred ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHHH----HH--
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDAL----DA-- 595 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~i----d~-- 595 (705)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .+........ +...... ..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhh
Confidence 122234678899999998776 789999999999999999999999975432 1111111110 0000000 00
Q ss_pred -----hhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 -----RLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 -----~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...... .........+.+++..||++||.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 0112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=305.54 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=199.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccC-CCCCcceeeeeeeec-cCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE-KGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~-~~~~~ 438 (705)
.++|...+.||+|+||.||+|.+..+++.+|+|++... .......+.+|+.++.++ +||||++++++|... ....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45788889999999999999999888999999988543 233455678899999999 999999999988643 33689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||++ ++|..++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5998888542 58899999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCc----ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchh--
Q 005257 519 GHGQV----ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLL-- 590 (705)
Q Consensus 519 ~~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~-- 590 (705)
..... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~ 235 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV--IGPPSAE 235 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHH
Confidence 43322 12334578999999998755 45789999999999999999999999754321 11111010 01000
Q ss_pred -----------HHHHHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 -----------DALDARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 -----------~~id~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++ ...... .........+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000 0001124568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.49 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=190.7
Q ss_pred HHHhCCCCcceEE--eecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 360 EAATKGFSEENVI--GVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 360 ~~at~~f~~~~~L--G~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
....++|...+.+ |+|+||.||++..+.++..+|+|.+........ |+.....+ +|||++++++.+.. .+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-LKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-CCe
Confidence 3334556666655 999999999999999999999999865422211 22222212 69999999998876 568
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-Ceeeeeeccc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLA 515 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla 515 (705)
.++||||+++++|.+++.... .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999997543 68999999999999999999998 8999999999999999988 9999999998
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+...... ...|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..+. .
T Consensus 158 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~---------~ 221 (267)
T PHA03390 158 KIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLL---------K 221 (267)
T ss_pred eecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHH---------H
Confidence 7654322 2357899999999998889999999999999999999999997543221110 0000 0
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-MRQVVK 634 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 634 (705)
...............+.+++..||+++|.+||+ ++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 001001122234567889999999999999996 688875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.29 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=196.7
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccC---CCCCcceeeeeeeeccC----c
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRL---KHKSLVGLRGWCKREKG----S 436 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~~~~----~ 436 (705)
|+..+.||+|+||.||+|.++.++..+|+|++..... .....+.+|+.++.++ +|||++++++.+...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999988899999999975422 2234566787776665 69999999999876332 3
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.+++|||+.+ +|.+++...... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 899988764432 58999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH-----
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD----- 591 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~----- 591 (705)
........ ....++..|+|||++.+..++.++|||||||++|||++|+.||...... +........-....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcC
Confidence 76543221 2235788999999999888999999999999999999999998754321 11111111100000
Q ss_pred --------HHHHhhh-cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 --------ALDARLR-AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 --------~id~~l~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....... .......+....+.+++..||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 0000111234667899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.13 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=198.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----C
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----G 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~ 435 (705)
.++|...+.||+|+||.||+|....+++.||||++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368889999999999999999998889999999986542 223456889999999999999999999876422 2
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 7766541 258999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-C-chhHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-G-KLLDA 592 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~-~~~~~ 592 (705)
+...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...+.. + .....
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 7653321 23467889999999876 4688999999999999999999999976432 1111111110 0 00000
Q ss_pred ---HHH-----hhhcCCCCC--------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHhccc
Q 005257 593 ---LDA-----RLRAKGGFD--------EDEVERVLHLGLLCAYPDPRARPTMRQVVKV--LEGKIE 641 (705)
Q Consensus 593 ---id~-----~l~~~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 641 (705)
++. ........+ +.....+.+++..||+.||++||++.+++.+ +++..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 000000000 0123457899999999999999999999954 655433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.67 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=196.7
Q ss_pred CCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC----chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 365 GFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN----DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
+|+..+.||+|+||.||++... .+|..||+|++.... ....+.+.+|++++.++ +|+||+++++.+.. +..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence 4677899999999999999874 367899999986532 22346688899999999 59999999987765 668
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 899999999999999997543 58899999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccC--CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSG--RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i 593 (705)
..............|+..|+|||.+... .++.++||||||+++|||++|+.||...... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------- 223 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---------- 223 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH----------
Confidence 7654433333345689999999998753 4678999999999999999999999643211 11111111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
.......++......+.+++..||+.||++|| ++.+++.
T Consensus 224 --~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 --ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111222333446788999999999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.23 Aligned_cols=266 Identities=26% Similarity=0.320 Sum_probs=196.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeecc------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK------ 434 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 434 (705)
.++|+..+.||+|+||.||+|....+++.+|||++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4689999999999999999999998899999999865432 22346788999999999999999999775432
Q ss_pred -CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 435 -GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 435 -~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
..+++|+||+.+ +|...+.... ..+++.++..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 247999999965 6777765432 269999999999999999999998 999999999999999999999999999
Q ss_pred cceecCCCCcc----------eeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHH
Q 005257 514 LARMHGHGQVA----------STTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVW 581 (705)
Q Consensus 514 la~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~ 581 (705)
+++........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ....++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99765432211 11234678899999987653 5789999999999999999999999754321 111111
Q ss_pred HHHHhCch---------hHHHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 582 ELMVQGKL---------LDALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 582 ~~~~~~~~---------~~~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
........ ....+.......... ....+.+.+++.+|++.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11110000 000000000000000 011256789999999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.04 Aligned_cols=261 Identities=26% Similarity=0.327 Sum_probs=203.5
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc----CceE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GSLM 438 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~~ 438 (705)
+|...+.||+|++|.||+|+...+++.||||++.... ....+.+.+|+.+++.++||||+++.+++.... ..++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998889999999987653 345577899999999999999999999887643 3789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||++ ++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48888886433 69999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCc--ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cc------
Q 005257 519 GHGQV--ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GK------ 588 (705)
Q Consensus 519 ~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~------ 588 (705)
..... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... +.....+.. +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHh
Confidence 55431 122334678999999999887 7899999999999999999999999764421 111111110 00
Q ss_pred -------hhHHHHHhhhcCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 -------LLDALDARLRAKGG-----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 -------~~~~id~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+.. ...... ........+.+++..||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000 000000 011134568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=292.69 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=217.6
Q ss_pred HHHHHHHhCCCCcceEEeecCceEEEEEEEcCCC-----eEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeee
Q 005257 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGW 429 (705)
Q Consensus 356 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 429 (705)
.+++.....+++...++-+|.||.||.|.+++.. +.|-+|.++.. +.-+...++.|-..+..+.|||++++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566667778888899999999999999886432 45677777544 34456678999999999999999999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcC-----CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCD-----GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
|.++....+.+|.++.-|+|..+|..++ ..+.++..+...++.|++.|++|||+ ++|||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 9987788899999999999999998543 23468889999999999999999998 999999999999999999
Q ss_pred CCeeeeeeccceecCCCCcceee-eeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHH
Q 005257 505 MNGRLGDFGLARMHGHGQVASTT-RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~ 582 (705)
..+||+|=.++|..-+.+..-.. .--.+..||+||.+.+..|+.++|||||||++|||+| |+.|+.+-++. .+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em~~ 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EMEH 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HHHH
Confidence 99999999999866554332211 1123568999999999999999999999999999999 99999876653 2223
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.+.+|..+ ..+.+++.++..++.-||..+|++||+++|++.-|.+
T Consensus 510 ylkdGyRl-----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKDGYRL-----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhcccee-----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 33444322 1245677889999999999999999999999998874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=306.82 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=206.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
...|.+...||+|.|++|.+|++..++..||||.+.+.. ....+.+.+|+++|..|+|||||+++.+... ...+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEE
Confidence 456888999999999999999999999999999997653 3344668999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+.+|.+.++|.+.. ...+.....++.|+..|++|||+ +.|+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998765 46668899999999999999998 9999999999999999999999999999998875
Q ss_pred CCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
+.. ....+|++.|.|||++.+.+| .+++|+||+|++||-|++|..||++..-. ...+.. +..
T Consensus 208 ~~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rv------------l~g 270 (596)
T KOG0586|consen 208 GLM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRV------------LRG 270 (596)
T ss_pred ccc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchh------------eee
Confidence 443 345799999999999988765 68999999999999999999999864321 001111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+..++.-.....-+++++.+-++|.+|++++++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111222223445677788888999999999999774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=330.03 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=196.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeee--------
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-------- 432 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-------- 432 (705)
-..+|++.+.||+||||.|||++.+-+|+.+|||+|... .......+.+|++++++|+|||||+++....+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 446788899999999999999999999999999999765 34456678999999999999999987542110
Q ss_pred --------------------------------------------------------c-----------------------
Q 005257 433 --------------------------------------------------------E----------------------- 433 (705)
Q Consensus 433 --------------------------------------------------------~----------------------- 433 (705)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------c--------CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHh
Q 005257 434 -----------------------K--------GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482 (705)
Q Consensus 434 -----------------------~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH 482 (705)
+ ..+||-||||+...|++++.++.-. -.....++++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence 0 2368899999998888887654311 046788999999999999999
Q ss_pred cCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC----------------C-CCcceeeeeeccccCCCccccccC-
Q 005257 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG----------------H-GQVASTTRVVGTVGYLAPEVFSSG- 544 (705)
Q Consensus 483 ~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~----------------~-~~~~~~~~~~gt~~y~APE~~~~~- 544 (705)
+ +++|||||||.||+||++..+||+|||+|.... . ......+..+||.-|+|||++.+.
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 999999999999999999999999999997621 0 111234567999999999999764
Q ss_pred --CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCC
Q 005257 545 --RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPD 622 (705)
Q Consensus 545 --~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~d 622 (705)
+|+.|+|+||+|||++||+. ||...-+ ...+....+.|.+... ..+..+....-..++.++++.|
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~~LR~g~iP~~--------~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILTNLRKGSIPEP--------ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHHhcccCCCCCC--------cccccccchHHHHHHHHHhcCC
Confidence 59999999999999999985 5654321 1112222333333221 2233445556678999999999
Q ss_pred CCCCCCHHHHHH
Q 005257 623 PRARPTMRQVVK 634 (705)
Q Consensus 623 P~~RPs~~evl~ 634 (705)
|.+|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.02 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=193.3
Q ss_pred eEEeec--CceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVG--GNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G--~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
..||+| +||+||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 346666 99999999999899999999986542 2345678899999999999999999999876 668899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+++|.+++.+.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999998765332 58999999999999999999998 999999999999999999999999998654322111100
Q ss_pred ------eeeeeccccCCCccccccC--CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch--------
Q 005257 526 ------TTRVVGTVGYLAPEVFSSG--RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL-------- 589 (705)
Q Consensus 526 ------~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~-------- 589 (705)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence 0112345679999998763 4789999999999999999999999764321 111111100000
Q ss_pred ------------------h----------HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 ------------------L----------DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ------------------~----------~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ...+..+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00000000 11123355678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.87 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=202.9
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
+...+++|+..+.||+|+||.||++....+++.||||++... .....+.+.+|++++..++||||+++.+++......
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678899999999999999999999989999999988643 223456788999999999999999999988765667
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++|+||+ +++|..++.. ..+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999999 5689888753 257888899999999999999998 999999999999999999999999999987
Q ss_pred ecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH-----------
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM----------- 584 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~----------- 584 (705)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 543321 22356889999999766 56899999999999999999999999764431111111111
Q ss_pred -HhCchhHHHHHhhhcCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 585 -VQGKLLDALDARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 585 -~~~~~~~~id~~l~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+...+.+ ..+......+. .....+.+++..|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFV-QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHH-hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011111111 01111111111 123678899999999999999999998775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.88 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=188.0
Q ss_pred EEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHH---HHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEI---SSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei---~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
.||+|+||.||++....+++.||+|.+..... .....+..|. ..++...||||+++.+.+.. .+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 38999999999999988899999999865421 1222234443 34455679999999988775 66889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|..++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 80 ~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 80 NGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999999886432 69999999999999999999998 9999999999999999999999999999875533221
Q ss_pred eeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 525 STTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||................ ......
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~ 218 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------TMAVEL 218 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------------ccCCCC
Confidence 224689999999998754 68999999999999999999999997643211111111110 000122
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
+......+.+++..|+..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 223356788999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.97 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=204.2
Q ss_pred cccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeee
Q 005257 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGW 429 (705)
Q Consensus 352 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 429 (705)
++....++...+++|...+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 34445667778899999999999999999999998889999999987542 2234668889999999999999999998
Q ss_pred eeec-----cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 430 CKRE-----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 430 ~~~~-----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
+... ....+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence 7532 23468888887 7799887753 258999999999999999999998 999999999999999999
Q ss_pred CCeeeeeeccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHH
Q 005257 505 MNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWEL 583 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~ 583 (705)
+.+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~ 230 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLI 230 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999999998764332 223467899999999866 56889999999999999999999999654321 111111
Q ss_pred HH-hCchhHHH------------HHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 584 MV-QGKLLDAL------------DARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 584 ~~-~~~~~~~i------------d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. .+.....+ ...+....... ......+.+++..|++.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 01000000 00000000000 0123457899999999999999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.95 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=197.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.|+..+.||+|+||.||+|+...++..+|+|.+... .....+++.+|+++++.++|+|++++.+++.. ....++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEEE
Confidence 366677899999999999999988999999998643 22344678899999999999999999998876 66889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68888775433 258999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 522 QVASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
....|++.|+|||.+. ...++.++|||||||++|||++|+.||...... ..... ...+...
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~-~~~~~~~-------- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-IAQNESP-------- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHH-HhhcCCC--------
Confidence 2346788999999974 346788999999999999999999998654321 11111 1111100
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..........+.+++.+||+.+|++||++.++++...
T Consensus 233 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1112234466889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.45 Aligned_cols=202 Identities=28% Similarity=0.431 Sum_probs=175.4
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----CceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----GSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~~l 439 (705)
+...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++|+|||||+++++=.... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344678999999999999999999999999987653 344567889999999999999999998643321 24589
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc--CC--Ceeeeeeccc
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK--EM--NGRLGDFGLA 515 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~--~~--~~kL~DFGla 515 (705)
|||||++|||+..|.+-.....|++.+.+.++.+++.||.|||+ ++|+||||||.||++-. +| --||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999886666689999999999999999999998 99999999999999842 23 3699999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
+....+. ..+.++||+.|.+||++.. ..|+..+|.|||||++||++||..||.+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9887655 5667899999999999984 78999999999999999999999999754
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=322.53 Aligned_cols=290 Identities=19% Similarity=0.261 Sum_probs=196.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-eEEEEE------------------EeccCCchhHHHHHHHHHHhccCCCCCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-AEIAVK------------------RISHENDGGTRAFLAEISSLGRLKHKSL 423 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK------------------~i~~~~~~~~~~~~~Ei~~l~~l~Hpni 423 (705)
.++|...+.||+|+||+||++..+... ...++| .+. ........+.+|+.+|++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 467999999999999999998865322 112222 111 122234568899999999999999
Q ss_pred ceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCC--CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG--SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 424 v~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
+++++++.. .+..++|+|++. ++|..++..... .......++..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 226 v~l~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 999999876 667899999995 577777754321 1134466788899999999999998 999999999999999
Q ss_pred ccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC-CCCCCccHHHHH
Q 005257 502 DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLVEMV 580 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P-f~~~~~~~~~~v 580 (705)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987765443333446799999999999998999999999999999999998754 433222211111
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHhccccCCCCCcchhhHHHHHHh
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR-PTMRQVVKVLEGKIEAGIENETEDMDAYLLQQV 659 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~ 659 (705)
.+.+..-... + ..++. ....+.+.+..- ..... .+...+++.+ ..+..+.+++
T Consensus 381 ~~~~~~~~~~---~------~~~p~-~~~~~~~~i~~~---~~~~~~~~~~~~~~~~-------------~~~~~~~~li 434 (501)
T PHA03210 381 LKIIDSLSVC---D------EEFPD-PPCKLFDYIDSA---EIDHAGHSVPPLIRNL-------------GLPADFEYPL 434 (501)
T ss_pred HHHHHhcccC---h------hhcCC-cHHHHHHHhhhh---hcccCccchhhHHHhc-------------CCChHHHHHH
Confidence 1111100000 0 00100 011112211110 01111 1112222111 1223355667
Q ss_pred hccccccccccccccCCCCCCCccc
Q 005257 660 KSKDMWANYSRSFGYGYATHPTFHD 684 (705)
Q Consensus 660 ~~~~~~~~~~r~~~~~~~~hp~f~~ 684 (705)
.++..++|..|.++.+++.||||..
T Consensus 435 ~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 435 VKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHhccCcccCcCHHHHhhChhhhc
Confidence 7888999999999999999999965
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.84 Aligned_cols=255 Identities=25% Similarity=0.297 Sum_probs=196.3
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEeeC
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+....||.|+||+|+|-.++..|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+.. ++..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHH
Confidence 335679999999999999999999999999987754 5567888998875554 79999999999987 66789999999
Q ss_pred CCCChhHHHHhc--CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 445 ENGSLDKWIFQC--DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 445 ~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
. .||+.+.+.- .....+++.-+-+|......||.||.+ +..|||||+||+|||||..|.+||||||++-.....-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 5 4777654321 112368888888999999999999998 5899999999999999999999999999986554322
Q ss_pred cceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 523 VASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
..+.-+|-..|||||.+.. ..|+.++||||||+.|+|+.||+.|+..-.. ..+.+ ..+..|......-
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql-~~Vv~gdpp~l~~------ 292 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQL-CQVVIGDPPILLF------ 292 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHH-HHHHcCCCCeecC------
Confidence 2334578899999999964 3489999999999999999999999975321 11111 1122222211100
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..-..+....+...+..|+.+|-..||+..++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112345678889999999999999999998774
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.53 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=188.8
Q ss_pred CceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHH
Q 005257 376 GNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI 453 (705)
Q Consensus 376 ~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L 453 (705)
++|.||.+....+++.||||+++.. .....+.+.+|+++++.++||||+++++++.. +...+++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHHHHH
Confidence 4455555555567899999998754 34456789999999999999999999998775 67889999999999999999
Q ss_pred HhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc------ceee
Q 005257 454 FQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV------ASTT 527 (705)
Q Consensus 454 ~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~------~~~~ 527 (705)
...... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+........ ....
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 91 KTHFPE-GLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 764332 58899999999999999999998 9999999999999999999999999999875432211 1112
Q ss_pred eeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH-----------
Q 005257 528 RVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD----------- 594 (705)
Q Consensus 528 ~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id----------- 594 (705)
...++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+.. .+.....++
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKV-RGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-hccCccccccCchhhhcCCc
Confidence 2456788999999865 35889999999999999999999999764321 1111111 110000000
Q ss_pred ---------H--hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ---------A--RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ---------~--~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ...............+.+++..||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000011122334578889999999999999999999884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.43 Aligned_cols=280 Identities=21% Similarity=0.299 Sum_probs=210.7
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
+++|+...| .+.||+|+|+.|--++...++..+|||++.+.....+....+|++++... .|+||++++.|+.+
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 356776666 56799999999999999999999999999888777778899999999998 49999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeee
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLG 510 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~ 510 (705)
+...|||||-|.||+|..+|.+.. .+++.+..+++++|+.||.+||. ++|.||||||+|||-.+-.. +||+
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 778999999999999999997654 79999999999999999999998 99999999999999976543 7999
Q ss_pred eeccceecCC------CCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHH
Q 005257 511 DFGLARMHGH------GQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579 (705)
Q Consensus 511 DFGla~~~~~------~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~ 579 (705)
||.|..-... ...+.....+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+....-..|
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9998753321 1222334468999999999863 2358999999999999999999999998643211111
Q ss_pred HHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HhccccCCCCCcchhhHHHHHH
Q 005257 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL-EGKIEAGIENETEDMDAYLLQQ 658 (705)
Q Consensus 580 v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L-~~~~~~~~~~~~~~~~~~~~~~ 658 (705)
.+ ++....+-+.|. +.+ ++..+ .|+.+.......-.++
T Consensus 302 -----dr--------------Ge~Cr~CQ~~LF---------------------esIQEGkYe-FPdkdWahIS~eakdl 340 (463)
T KOG0607|consen 302 -----DR--------------GEVCRVCQNKLF---------------------ESIQEGKYE-FPDKDWAHISSEAKDL 340 (463)
T ss_pred -----cC--------------CCccHHHHHHHH---------------------HHHhccCCc-CChhhhHHhhHHHHHH
Confidence 11 111111111111 112 12223 4444444444444455
Q ss_pred hhccccccccccccccCCCCCCCcccccc
Q 005257 659 VKSKDMWANYSRSFGYGYATHPTFHDIRQ 687 (705)
Q Consensus 659 ~~~~~~~~~~~r~~~~~~~~hp~f~~~~~ 687 (705)
+.....-++..|..+...++|||+.-..+
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCccccccch
Confidence 55545556777888888899999975544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.45 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=195.2
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
|...+.||+|+||.||+|+...+++.|++|++..... ...+.+.+|+++++.++|||++++++++.. ....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence 5557789999999999999988899999999875422 334578899999999999999999998876 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 996 57877776533 258999999999999999999998 9999999999999999999999999999864322
Q ss_pred cceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 523 VASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.....|+..|+|||++. ...++.++|||||||++|||++|..||..... ...+..... ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~-~~~~--------- 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQ-NDSP--------- 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHh-cCCC---------
Confidence 12346889999999984 35688899999999999999999999876432 111111111 1000
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++.+||+.+|.+||++.+++.+
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111223467889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.20 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=197.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeecc---------
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK--------- 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--------- 434 (705)
.+|...+.||.|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++.+....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999999999999999997766666778999999999999999999998665322
Q ss_pred ----CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCeee
Q 005257 435 ----GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGRL 509 (705)
Q Consensus 435 ----~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~kL 509 (705)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588888753 258899999999999999999998 9999999999999997 4567899
Q ss_pred eeeccceecCCCCcc--eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 510 GDFGLARMHGHGQVA--STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 510 ~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
+|||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+. +........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL--EQMQLILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence 999999865432111 1122357889999998754 56788999999999999999999999754321 111111100
Q ss_pred C---------chhHHHHHhhh---cCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 G---------KLLDALDARLR---AKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 ~---------~~~~~id~~l~---~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. .....+..... .....+ ......+.+++..||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 00000000000 000000 1123567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.20 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=198.8
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc---
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK--- 434 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--- 434 (705)
....++|...+.||+|+||.||++....++..||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999999889999999986432 223456889999999999999999999876432
Q ss_pred --CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 435 --GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 435 --~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
...++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 2458999999 6799888753 258999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cchh
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLL 590 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~ 590 (705)
|+++...... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .......+.. +...
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 9998654322 23467889999999876 4588999999999999999999999976432 1111111110 0000
Q ss_pred HHHHHh------------hhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 591 DALDAR------------LRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 591 ~~id~~------------l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..+... +.... .........+.+++..|++.||++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000 000122345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=286.75 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=197.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-----CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+|...+.||+|+||.||++.+...+..+++|.++.. ......++..|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence 477889999999999999999876666666665432 22234457789999999999999999998876 567899
Q ss_pred EEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 440 VYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
||||+++++|.+++... .....+++.+++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999988653 223469999999999999999999998 99999999999999975 56999999999766
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .... .....+..
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~-~~~~~~~~--------- 222 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVV-LRIVEGPT--------- 222 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHH-HHHHcCCC---------
Confidence 43322 12234578899999999888889999999999999999999999965331 1111 11111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 --PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 12233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.28 Aligned_cols=301 Identities=19% Similarity=0.243 Sum_probs=215.4
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC--CCC----cceeeeeeeecc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK--HKS----LVGLRGWCKREK 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~--Hpn----iv~l~g~~~~~~ 434 (705)
..+++|.+...+|+|.||.|-++.+..++..||||+++... .-.+.-+-|+++|++|. -|+ ++++.+|+.- .
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-r 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-R 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-c
Confidence 34788999999999999999999999999999999986543 23445577999999993 232 6778887765 7
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-----------
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK----------- 503 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~----------- 503 (705)
++.|||+|.+ |.|+.++|..++.. +++...+..|+.|+++++++||+ .+++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCC
Confidence 8999999999 56999999876544 79999999999999999999999 99999999999999921
Q ss_pred ---------CCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc
Q 005257 504 ---------EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574 (705)
Q Consensus 504 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~ 574 (705)
+..+||+|||.|....... ...+.|..|+|||++.+-.++.++||||+||||.|+.+|...|+....
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458999999998754433 446889999999999999999999999999999999999999986542
Q ss_pred cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHhccccCCCCCcchhhH
Q 005257 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPD-PRARPTMRQVVKVLEGKIEAGIENETEDMDA 653 (705)
Q Consensus 575 ~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~d-P~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 653 (705)
.-........-|.++..+-.+.. .+....-+ |+..+ -..+-.++.+.+...-+.. ..........
T Consensus 315 -~EHLaMMerIlGp~P~~mi~r~~---------~~Kyf~~~--rldw~e~~~~~~~k~v~~~ckpl~~--~~~~~d~e~~ 380 (415)
T KOG0671|consen 315 -LEHLAMMERILGPIPSRMIKKTR---------KEKYFRRG--RLDWPEVSSKGKSKYVFEPCKPLKK--YMLQDDLEHV 380 (415)
T ss_pred -HHHHHHHHHhhCCCcHHHhhhhh---------hHhhhhcc--cccCccccccccchhhhcCCccHHH--HhccCcHHHh
Confidence 21221111111222222111110 11112111 33211 1111112222221110000 0011122344
Q ss_pred HHHHHhhccccccccccccccCCCCCCCccccc
Q 005257 654 YLLQQVKSKDMWANYSRSFGYGYATHPTFHDIR 686 (705)
Q Consensus 654 ~~~~~~~~~~~~~~~~r~~~~~~~~hp~f~~~~ 686 (705)
.+.++++.+..++|..|.+..+|+.||||.-++
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 588999999999999999999999999998665
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=283.75 Aligned_cols=237 Identities=26% Similarity=0.327 Sum_probs=194.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
||+|+||.||++....+++.+|+|.+..... .....+..|++++++++||||+++++.+.. +...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 6899999999999988899999999865432 245678999999999999999999998765 678899999999999
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 528 (705)
|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 999997543 58999999999999999999998 9999999999999999999999999999987644321 2233
Q ss_pred eeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 529 ~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||..... .........+ ...++....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~------------~~~~~~~~~ 217 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKD------------PLRFPEFLS 217 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcC------------CCCCCCCCC
Confidence 5678899999999888889999999999999999999999975432 1111111111 122233335
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
..+.+++..||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 67889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=282.83 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=201.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...++||+|.||+|.+++-+.+++.+|+|+++++ .+.....-+.|-++|+..+||.+..+.-.+.. .+++|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-CceEEE
Confidence 45788899999999999999999999999999999876 33445566889999999999999888766665 789999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||..||.|.-+|.+.+ .+++....-+-..|..||.|||+ ++||.||||.+|.|||.+|++||.||||++.--
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999886543 68888888899999999999999 999999999999999999999999999997532
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
. ....+..++|||.|+|||++....|...+|.|.+|||+|||+||+.||...+.. .+.+++..+ .+
T Consensus 320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~e--------d~-- 385 (516)
T KOG0690|consen 320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILME--------DL-- 385 (516)
T ss_pred c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHhh--------hc--
Confidence 2 223455689999999999999999999999999999999999999999875432 222222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
.++.....+...|..-.+..||.+|- .++||.+
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 12333334455566667888999994 4555544
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=297.42 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=196.5
Q ss_pred CCCCc-ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh--------------HHHHHHHHHHhccCCCCCcceeee
Q 005257 364 KGFSE-ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--------------TRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 364 ~~f~~-~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~--------------~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
++|.. .+.||+|+||.||+|.+..+++.||||+++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 567999999999999998889999999986542211 125788999999999999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
++.. ++..++||||++ |+|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 88 ~~~~-~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVE-GDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEec-CCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 8876 678899999997 6899888643 258999999999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCC-------------cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCc
Q 005257 509 LGDFGLARMHGHGQ-------------VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKP 574 (705)
Q Consensus 509 L~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~ 574 (705)
|+|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 1111223568899999998764 468999999999999999999999976543
Q ss_pred c-HHHHHHHHHHhCc---hhHHHHHh-hhc-CC-------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 575 N-LVEMVWELMVQGK---LLDALDAR-LRA-KG-------GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 575 ~-~~~~v~~~~~~~~---~~~~id~~-l~~-~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
. ....+........ ..+..+.. ... .. .........+.+++..||+.+|++||++.|++.+-
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1111111111100 00000000 000 00 00011235678999999999999999999998743
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.30 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=199.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|+..+.||+|++|.||+|+...+++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.. .+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence 456778999999999999999889999999987653 3345678899999999999999999998876 5789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
++ ++|.+++.+.. ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 97 59999997653 258999999999999999999998 9999999999999999999999999999987654332
Q ss_pred ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHH---------
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDA--------- 592 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~--------- 592 (705)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .+........ +...+.
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 1 2223457889999998776 789999999999999999999999976432 1111111100 000000
Q ss_pred -HHHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 -LDARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 -id~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+....... ...+.....+.+++..||..+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0001124568999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.99 Aligned_cols=197 Identities=29% Similarity=0.463 Sum_probs=170.7
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
.++||.|.||+||-|+++.+|+.||||++.+.. ..+...+.+|+.+|+.++||.||.+.-.|.. .++.+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc
Confidence 578999999999999999999999999998763 3445778999999999999999999887765 7789999999965
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeeeccceecCCCCc
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DFGla~~~~~~~~ 523 (705)
.-|.-.|...++ +|++..-.-++.||+.||.|||. ++|+|+||||+||||.+. -.+||||||.||.+++...
T Consensus 648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 444444444333 69998888999999999999998 999999999999999754 3689999999999876544
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
. ..++||+.|+|||++.+..|...-|+||.||++|--++|..||..+.
T Consensus 723 R--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 R--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred h--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 3 34799999999999999999999999999999999999999998653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.10 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=194.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV 440 (705)
..|++.++||+||.+.||++...+. ..+|+|++... +.+...-|..|+..|.+|+ |.+|+++++|-.. ++.+|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 4688899999999999999988654 55777766443 4456778999999999995 9999999998776 7899999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||=+ .+|..+|.+.... ...| .+..+..||+.|+.++|. .+|||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99974 5999999875543 2334 788999999999999998 99999999999999964 6899999999988766
Q ss_pred CCcce-eeeeeccccCCCccccccC-----------CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 521 GQVAS-TTRVVGTVGYLAPEVFSSG-----------RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 521 ~~~~~-~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
+.... ....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||..... +|. +
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a-----K 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA-----K 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH-----H
Confidence 54332 3346999999999998432 357899999999999999999999975321 111 1
Q ss_pred hhHHHHHhhhcCCCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDE-DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+....++... -+|+. .....+.+++..||+.||.+||+..+++++
T Consensus 582 l~aI~~P~~~--Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHE--IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCcc--ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2222333211 01111 111238999999999999999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=298.15 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=199.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----- 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----- 434 (705)
..++|...+.||+|++|.||+|.+..+++.||||++... .....+.+.+|+.+++.++|||++++.+++...+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999999988999999998653 2234466788999999999999999998765422
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++|+||+ +++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 2489999999 5699998854 268999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDA 592 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~ 592 (705)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+.+..... .+...+.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHH
Confidence 9865432 223467889999999865 3678999999999999999999999975432 111111110 0100111
Q ss_pred HHHhh------------hcC--CCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARL------------RAK--GGFD---EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l------------~~~--~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+..++ ... ..+. ......+.+++..|++++|++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 10000 000 0000 0124578899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=292.67 Aligned_cols=262 Identities=22% Similarity=0.250 Sum_probs=194.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCC--CeEEEEEEeccC--CchhHHHHHHHHHHhccC-CCCCcceeeeeeeec---cCc
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGG--GAEIAVKRISHE--NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE---KGS 436 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~---~~~ 436 (705)
+|...+.||+|+||.||++..... +..||+|++... .....+.+.+|+.++.++ +||||+++++.+... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477789999999999999999877 889999998653 222356788999999999 599999999865421 235
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++++||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899986 6899888643 268999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCcc---eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHH--------
Q 005257 517 MHGHGQVA---STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWEL-------- 583 (705)
Q Consensus 517 ~~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~-------- 583 (705)
........ ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1223578999999998765 46899999999999999999999999764321 11111000
Q ss_pred ---HHhCchhHHHHHhhhcCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 584 ---MVQGKLLDALDARLRAKGGF-----DEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 584 ---~~~~~~~~~id~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+........+. ........ .......+.+++.+|++.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIR-SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHH-hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 00000000 0112356889999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=317.28 Aligned_cols=210 Identities=27% Similarity=0.339 Sum_probs=187.5
Q ss_pred HHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeee
Q 005257 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR 432 (705)
Q Consensus 356 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 432 (705)
..+++...++|.+.++||+|+||.|..++++.+++.+|+|++++. .......|..|-.+|..-..+-|++++-.+.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456677778999999999999999999999999999999999773 34556778999999998888999999877766
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
..++|+|||||+||+|-.++.+.. +++++.++-++..|..||.-||+ .|+|||||||.|||||..|++||+||
T Consensus 147 -~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 -ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred -ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence 779999999999999999997655 69999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
|.|-.+..+..-.....+|||.|++||++.. +.|...+|.||+||++|||+.|..||..+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 9998777655555566799999999999853 57899999999999999999999999763
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=268.36 Aligned_cols=293 Identities=18% Similarity=0.277 Sum_probs=213.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeecc-CceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREK-GSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~-~~~~lV 440 (705)
.++|++.+++|+|.++.||.|....+++.++||.++.. ..+.+.+|+++|..|+ ||||+++++...+.. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788889999999999999998888999999999654 3477899999999997 999999999886432 356899
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla~~~~ 519 (705)
+||+.+.+...+.. .|+..++..++.++++||.|||+ +||+|||+||.|++||.. -.++|+|+|||..+.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999988876652 58888999999999999999999 999999999999999964 569999999999887
Q ss_pred CCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc--hhHHHHHh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK--LLDALDAR 596 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~--~~~~id~~ 596 (705)
++..... .+.+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||..+..+..+.|...-.-|. +..-+.+
T Consensus 185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K- 261 (338)
T KOG0668|consen 185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK- 261 (338)
T ss_pred CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH-
Confidence 6654332 356888999999865 568999999999999999999999998877665555433322221 1111110
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCC
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGY 676 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 676 (705)
.. -..++ ++-.++. |-+-+..-.++....+... ....++++.....++++.|.++++|
T Consensus 262 Y~--i~Ldp----~~~~i~~---------~~~rk~w~~Fi~~~n~hl~-------~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 262 YQ--IDLDP----QFEDILG---------RHSRKPWSRFINSENQHLV-------SPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred Hc--cCCCh----hHhhHhh---------ccccccHHHhCCccccccC-------ChHHHHHHHHHHhhccccccchHHH
Confidence 00 00111 1111111 1111111222222222111 1223445555556999999999999
Q ss_pred CCCCCccccccccccc
Q 005257 677 ATHPTFHDIRQSNSYS 692 (705)
Q Consensus 677 ~~hp~f~~~~~~~~~~ 692 (705)
+.||||.+++...+..
T Consensus 320 m~HpyF~~~~~~~~~~ 335 (338)
T KOG0668|consen 320 MAHPYFAPVREAESSR 335 (338)
T ss_pred hcCchHHHHHHHhhcc
Confidence 9999999998776654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=317.17 Aligned_cols=146 Identities=27% Similarity=0.394 Sum_probs=131.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|.+.++||+|+||.||+|.+..+++.||||+++... ......+.+|+.++..++||||+++++++.. ...+++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence 57888999999999999999999889999999986542 2334678899999999999999999987765 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
|||+++++|.+++.... .+++..++.++.||+.||.|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996543 58899999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=299.42 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=214.7
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeee-
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR- 432 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~- 432 (705)
.++.+...++.|.+.+.||.|.+|.||+++...+++.+|+|+.... ....+++..|.++++.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4445555677899999999999999999999999999999987554 33456788899999998 69999999998863
Q ss_pred ---ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 433 ---EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 433 ---~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
.++.+|||||||.+||..++++... ...+.|..+..|++.++.||.+||. ..++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEE
Confidence 2458999999999999999998776 4489999999999999999999998 99999999999999999999999
Q ss_pred eeeccceecCCCCcceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH
Q 005257 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 510 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~ 584 (705)
+|||++........ .....+||+.|||||++.- ..|+.++|+||||++..||.-|.+|+.+..+.. .+.
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-----aLF 238 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF 238 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----hhc
Confidence 99999987654332 2334689999999999854 357889999999999999999999997755410 000
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+.+..+.+..-+....+.+.+.+..|+.+|-++||++.+++++
T Consensus 239 -------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 -------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01111111122245667889999999999999999999998874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=279.79 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=203.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--ch-----hHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DG-----GTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~-----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
..++|-..++||+|||+.|||+.+....+.||||+-.... .. ..+...+|..+-+.|.||.||++++++.-+.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3446777889999999999999998888999999764331 11 1234678999999999999999999998778
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeee
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGD 511 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~D 511 (705)
..+|-|.|||+|.+|+-||++.+ .+++.++..|+.||+.||.||.+ ...+|||-||||.||||-. .|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeee
Confidence 88999999999999999998765 68999999999999999999986 5789999999999999954 47899999
Q ss_pred eccceecCCCCcc------eeeeeeccccCCCccccccC----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHH
Q 005257 512 FGLARMHGHGQVA------STTRVVGTVGYLAPEVFSSG----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW 581 (705)
Q Consensus 512 FGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~ 581 (705)
|||++.+..+... .+...+||.+|++||++.-+ +.+.|+||||.||++|.++.|+.||...... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----Q 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----Q 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----H
Confidence 9999988754432 23346899999999998533 5789999999999999999999999764321 1
Q ss_pred HHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 005257 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVV 633 (705)
Q Consensus 582 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 633 (705)
+.+....++.+-...+..+ +........+++.|++..-++|....++.
T Consensus 692 dILqeNTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHhhhchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 2233334443333333322 23335567889999999888887755543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=273.05 Aligned_cols=277 Identities=26% Similarity=0.387 Sum_probs=209.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeee-------ccCc
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-------EKGS 436 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-------~~~~ 436 (705)
|....+||+|.||.||+|..+.+++.||+|++-.++ ..-...-++|+++|..|+|+|++.++..|.. ....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 445667999999999999999999999999876543 2334567899999999999999999999863 2335
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+|+||++|+. +|.-+|.... .+++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||++|
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 8999999987 8888885432 369999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCc---ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 517 MHGHGQV---ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 517 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
.+..... ...+..+-|.+|++||.+.+ ..|+++.|||.-||++.||+||.+-+.+..+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq----------------- 235 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ----------------- 235 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-----------------
Confidence 7654322 22233456999999999877 46999999999999999999998887764321
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHhccccCCCCC---------cchhhHHHHHHhhc
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV--VKVLEGKIEAGIENE---------TEDMDAYLLQQVKS 661 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev--l~~L~~~~~~~~~~~---------~~~~~~~~~~~~~~ 661 (705)
+.+.-+-..|-+..|+--|.+..+ .+.++. +..++.. +.-.++.-++++.+
T Consensus 236 ----------------qql~~Is~LcGs~tkevWP~~d~lpL~~sie~--ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 236 ----------------QQLHLISQLCGSITKEVWPNVDNLPLYQSIEL--EPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred ----------------HHHHHHHHHhccCCcccCCCcccchHHHhccC--CCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 122223334555566666655432 222211 1011111 11113345667777
Q ss_pred cccccccccccccCCCCCCCcc
Q 005257 662 KDMWANYSRSFGYGYATHPTFH 683 (705)
Q Consensus 662 ~~~~~~~~r~~~~~~~~hp~f~ 683 (705)
...++|..|..+.+++.|-||-
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred HhccCcccCcchHhhhchhhhh
Confidence 7789999999999999999993
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=304.16 Aligned_cols=262 Identities=16% Similarity=0.185 Sum_probs=173.7
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCC----CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeee----e-ee
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGG----GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW----C-KR 432 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~----~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~----~-~~ 432 (705)
..++|...+.||+|+||.||+|++..+ +..||||++..... .+....| .+.+..+.++..+... . ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 89999998754322 1111111 1122222222222211 1 12
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCC-----------------CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGS-----------------MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLk 495 (705)
.+...++||||+++++|.+++...... .......+..++.|++.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 356789999999999999998653210 011234466899999999999998 999999999
Q ss_pred CCCeEEcc-CCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccC----------------------CCCccccE
Q 005257 496 SSNVLLDK-EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG----------------------RASTQTDV 552 (705)
Q Consensus 496 p~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksDV 552 (705)
|+|||++. ++.+||+|||+++..............|++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986654433334456889999999976322 23456799
Q ss_pred EEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH----------HHHHHHHHHHHcCCCC
Q 005257 553 FGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED----------EVERVLHLGLLCAYPD 622 (705)
Q Consensus 553 wS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~----------~~~~l~~l~~~Cl~~d 622 (705)
|||||+||||+++..|.... ...........+.-......... .....+ ......+|+..|++.|
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVE--PRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhc--cccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999977665432 11111111111111111111111 001111 1123457999999999
Q ss_pred CCCCCCHHHHHHH
Q 005257 623 PRARPTMRQVVKV 635 (705)
Q Consensus 623 P~~RPs~~evl~~ 635 (705)
|++|||+.|++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=272.32 Aligned_cols=292 Identities=20% Similarity=0.277 Sum_probs=219.9
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec----cCceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~~~l 439 (705)
.+..+.||.|+||.||..++..+|+.||+|++... +-...+.+.+|+++|..++|.|++..++..... -.++|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34577899999999999999999999999998654 233467889999999999999999988765421 125678
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
++|.|.. +|.+.+-. ...|+.+.+.-++.||++||.|||+ .+|.||||||.|.|+++|..+||||||++|..+
T Consensus 135 ~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence 8999954 88887754 2378999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
.++...++.-+-|..|+|||++.+ ..|+.+.||||.||++.||+..+..|....+- ++++-...
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi---------------qQL~lItd 272 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI---------------EQLQMIID 272 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH---------------HHHHHHHH
Confidence 777777766677999999999987 46999999999999999999999888765431 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCCCC
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYAT 678 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 678 (705)
..+....+.+...++=++.-+-.-|-+-|+..-+.. |. .+ .+....-+..+..+..+++..|....+++.
T Consensus 273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt-ls-----S~----~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK-IA-----SP----DDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee-ec-----CC----cccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 114445555554444444433345555666543322 11 11 111222333444566789999999999999
Q ss_pred CCCcccccccc
Q 005257 679 HPTFHDIRQSN 689 (705)
Q Consensus 679 hp~f~~~~~~~ 689 (705)
|||..+.|-..
T Consensus 343 ~~~~~e~R~r~ 353 (449)
T KOG0664|consen 343 HRYLEEGRLRF 353 (449)
T ss_pred cccccccceee
Confidence 99999888543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=275.04 Aligned_cols=220 Identities=19% Similarity=0.154 Sum_probs=177.1
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHHH
Q 005257 375 GGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF 454 (705)
Q Consensus 375 G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~ 454 (705)
|.+|.||++.+..+++.+|+|++.... .+.+|...+....||||+++++++.. ....++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986543 23345555556679999999998876 678899999999999999986
Q ss_pred hcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeecccc
Q 005257 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534 (705)
Q Consensus 455 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~ 534 (705)
+.. .+++.++..++.|++.||.|||+ ++++||||||+||+++.++.++++|||++....... ....++..
T Consensus 78 ~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 78 KFL---NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred Hhc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 543 58999999999999999999998 999999999999999999999999999886554321 12345778
Q ss_pred CCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHH
Q 005257 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHL 614 (705)
Q Consensus 535 y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l 614 (705)
|+|||.+.+..++.++||||+||++|||++|+.|+....... ... .. ...+......+.++
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------~~~-------~~----~~~~~~~~~~~~~l 208 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------NTH-------TT----LNIPEWVSEEARSL 208 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------ccc-------cc----cCCcccCCHHHHHH
Confidence 999999988889999999999999999999998875321100 000 00 01122234567889
Q ss_pred HHHcCCCCCCCCCCH
Q 005257 615 GLLCAYPDPRARPTM 629 (705)
Q Consensus 615 ~~~Cl~~dP~~RPs~ 629 (705)
+.+|++.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=276.83 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=197.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 438 (705)
..+|....+||+|+||.|.++..+++.+.+|||++++. .+.+.+--+.|-++|.-. +-|.++++...+.. -+++|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhhee
Confidence 34688899999999999999999999999999999765 233344456677888777 56677888875554 77999
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+.||+|-.++.+-+ .+.+..+.-++.+||-||-+||+ ++||.||||..|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988887654 58888999999999999999998 99999999999999999999999999999854
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
-.+. ..+...+||+.|+|||++...+|...+|.|||||+||||+.|+.||++.++. .+.+.+.+.+
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI~ehn---------- 566 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAIMEHN---------- 566 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHcc----------
Confidence 3322 2345589999999999999999999999999999999999999999987653 2222222211
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARP 627 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 627 (705)
..|+.....+...+....+...|.+|-
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 345555666677777778888888884
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=267.03 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=196.6
Q ss_pred hCCCCcc-eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeee---eccCce
Q 005257 363 TKGFSEE-NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCK---REKGSL 437 (705)
Q Consensus 363 t~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~---~~~~~~ 437 (705)
+++|++. ++||-|-.|.|-.+.++.+++.+|+|++... ..-.+|+++--.. .|||||.+++++. ....++
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4445443 5799999999999999999999999988532 3445677764333 6999999999874 335578
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeecc
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFGL 514 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFGl 514 (705)
.+|||+|+||.|...+.+.+. ..+++.++-.|++||+.|+.|||+ .+|.||||||+|+|... |..+||+|||.
T Consensus 135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 999999999999999977554 379999999999999999999999 99999999999999964 45689999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~i 593 (705)
|+...... .....+-|+.|.|||++...+|+..+|+||+||++|-|+||.+||...... +..-....+..|
T Consensus 211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g------ 282 (400)
T KOG0604|consen 211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG------ 282 (400)
T ss_pred ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc------
Confidence 98765422 233457799999999999999999999999999999999999999764321 111111111111
Q ss_pred HHhhhcCCCCCHHH----HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DARLRAKGGFDEDE----VERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~~l~~~~~~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+++.++ .+...++++..+..+|.+|-|+.+++.+
T Consensus 283 ------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 ------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 12344433 3567788888999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=265.67 Aligned_cols=239 Identities=29% Similarity=0.391 Sum_probs=194.7
Q ss_pred CceEEEEEEEcCCCeEEEEEEeccCCchh-HHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHHH
Q 005257 376 GNGKVYKGVLEGGGAEIAVKRISHENDGG-TRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF 454 (705)
Q Consensus 376 ~fg~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~ 454 (705)
+||.||+|...++++.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence 58999999999889999999997665444 6889999999999999999999999876 568899999999999999986
Q ss_pred hcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeecccc
Q 005257 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534 (705)
Q Consensus 455 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~ 534 (705)
... .+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 80 KRG---RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred hcc---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 543 38899999999999999999998 899999999999999999999999999998765442 2233567889
Q ss_pred CCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHH
Q 005257 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHL 614 (705)
Q Consensus 535 y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l 614 (705)
|++||.+.....+.++||||||++++||++|..||...... ....+....+... ...........+.++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 220 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPP---------FPPPEWKISPEAKDL 220 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCC---------CccccccCCHHHHHH
Confidence 99999998888899999999999999999999999762211 1111111111110 000000044678899
Q ss_pred HHHcCCCCCCCCCCHHHHHH
Q 005257 615 GLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 615 ~~~Cl~~dP~~RPs~~evl~ 634 (705)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=290.39 Aligned_cols=242 Identities=24% Similarity=0.269 Sum_probs=197.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.+..|.....+|.|+|+.|-++.+..+++..++|++.+... +-.+|+.++... +||||+++.+.+.+ +.+.++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecC-Cceeeee
Confidence 35677778889999999999999999999999999976522 223567666655 79999999999886 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE-ccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL-DKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl-d~~~~~kL~DFGla~~~~ 519 (705)
||.+.++-|.+.+.... ....++..|+.+|+.|+.|||+ ++||||||||+|||+ ++.++++|+|||.++...
T Consensus 395 ~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999998888776543 2337888899999999999998 999999999999999 588999999999998776
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. ....+-|..|.|||++....+++++|+||||++||||++|+.||...... ......+..
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~------------- 528 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQM------------- 528 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcC-------------
Confidence 55 12234588999999999999999999999999999999999999865432 111112221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.++........+|+.+|++.||.+||+|.++..+
T Consensus 529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 33344555678899999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=290.59 Aligned_cols=267 Identities=19% Similarity=0.254 Sum_probs=181.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEc----------------CCCeEEEEEEeccCCchhHHHH--------------HHH
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLE----------------GGGAEIAVKRISHENDGGTRAF--------------LAE 411 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~----------------~~~~~vavK~i~~~~~~~~~~~--------------~~E 411 (705)
..++|++.++||+|+||.||+|.+. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 2346799999876544333334 346
Q ss_pred HHHhccCCCCCc-----ceeeeeeee-------ccCceEEEEeeCCCCChhHHHHhcCC---------------------
Q 005257 412 ISSLGRLKHKSL-----VGLRGWCKR-------EKGSLMLVYDYMENGSLDKWIFQCDG--------------------- 458 (705)
Q Consensus 412 i~~l~~l~Hpni-----v~l~g~~~~-------~~~~~~lV~E~~~~gsL~~~L~~~~~--------------------- 458 (705)
+.++.+++|.++ ++++++|.. .++..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 13568999999999999999874211
Q ss_pred CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCc
Q 005257 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538 (705)
Q Consensus 459 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~AP 538 (705)
...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1135677889999999999999998 8999999999999999999999999999976544322222223457899999
Q ss_pred cccccCCC----------------------CccccEEEEehhHHHHhhCCC-CCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 539 EVFSSGRA----------------------STQTDVFGFGILILEVLSGRR-PIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 539 E~~~~~~~----------------------s~ksDVwS~Gvvl~ElltG~~-Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
|.+..... ..+.||||+||+++||++|.. |+..... ..... ............
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~-f~~~~---~~~~~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL-FNTEL---RQYDNDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh-hhhHH---hhccchHHHHHh
Confidence 99754321 234799999999999999875 6643211 00000 000000000000
Q ss_pred hhhcCCCCC--HHHHHHHHHHHHHcCCCCC---CCCCCHHHHHHH
Q 005257 596 RLRAKGGFD--EDEVERVLHLGLLCAYPDP---RARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~--~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 635 (705)
.......++ ........+++..++..+| .+|+|+.|++++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000001111 1233556777888887655 789999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=248.08 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=171.0
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
......||+|++|.|-+-++..+|...|+|++... +.+..++.++|+.+..+- ..|.+|.++|...+ .+..++.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeHHH
Confidence 33456799999999999999999999999999765 556677889999886665 79999999998776 6789999999
Q ss_pred CCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 444 MENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 444 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|.. ||+.+..+- +....+++.-+-+|+..+.+||.|||+ +..+||||+||+|||++.+|++|+||||.+-.+.+.-
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 964 888876542 334478999999999999999999999 6899999999999999999999999999997665432
Q ss_pred cceeeeeeccccCCCcccccc----CCCCccccEEEEehhHHHHhhCCCCCCCCCc
Q 005257 523 VASTTRVVGTVGYLAPEVFSS----GRASTQTDVFGFGILILEVLSGRRPIEEGKP 574 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~ 574 (705)
. .+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.||+....
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2 222467788999999854 3689999999999999999999999986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=268.83 Aligned_cols=300 Identities=21% Similarity=0.239 Sum_probs=207.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-----C---CCcceeeeeeee--
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-----H---KSLVGLRGWCKR-- 432 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-----H---pniv~l~g~~~~-- 432 (705)
..+|...++||.|.|++||++.+..+.+.||+|+.+.. ..-.+.-+.||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36788999999999999999999999999999988543 334566788999999984 3 359999998864
Q ss_pred -ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc--------
Q 005257 433 -EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-------- 503 (705)
Q Consensus 433 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-------- 503 (705)
.+.++|+|+|++ |-+|..+|.....+ .++...+.+|++||+.||.|||. +.+|||-||||+|||+..
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhh
Confidence 245899999999 66999999877655 69999999999999999999999 479999999999999900
Q ss_pred --------------------------------------------------------------------------------
Q 005257 504 -------------------------------------------------------------------------------- 503 (705)
Q Consensus 504 -------------------------------------------------------------------------------- 503 (705)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 005257 504 ------------------------------------------------------------------------------EM 505 (705)
Q Consensus 504 ------------------------------------------------------------------------------~~ 505 (705)
+.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 00
Q ss_pred CeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc-----cHHHHH
Q 005257 506 NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP-----NLVEMV 580 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-----~~~~~v 580 (705)
++||+|||-|+..... .+.-+.|..|+|||++.+..|++.+||||++|+++||+||...|++... +.....
T Consensus 392 ~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 1456666666543321 1223568889999999999999999999999999999999999975321 111111
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhh
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVK 660 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~ 660 (705)
...-.-|.++. .+...+.+..+...+--+ .| --.|-.+--+.+.|.+..+ .++.+ ...+.+++.
T Consensus 468 ~i~ELLG~iPr----~ia~~Gk~SRdFFnr~G~---Lr----hI~~LK~WpL~~VL~eKY~-~s~e~----A~~fsdFL~ 531 (590)
T KOG1290|consen 468 LIMELLGKIPR----KIALGGKYSRDFFNRRGE---LR----HIRRLKPWPLYEVLIEKYE-WSEED----AQQFSDFLS 531 (590)
T ss_pred HHHHHHhhccH----HHHhcCcchHhhhccccc---ee----cccccCCCcHHHHHHHHhC-CCHHH----HHHHHHHHH
Confidence 11111232222 222223344333211000 00 0111111123334443433 33322 334555666
Q ss_pred ccccccccccccccCCCCCCCcccccc
Q 005257 661 SKDMWANYSRSFGYGYATHPTFHDIRQ 687 (705)
Q Consensus 661 ~~~~~~~~~r~~~~~~~~hp~f~~~~~ 687 (705)
-|..+.|.+|.+|.+|+.|||+++.-.
T Consensus 532 PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 532 PMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccccHHHHhcCccccCCCC
Confidence 677799999999999999999986554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=274.60 Aligned_cols=203 Identities=25% Similarity=0.391 Sum_probs=175.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
-|...+.||-|+||+|.++...++...+|+|.+++.+ +.+....++|-.||..-..+-||+|+-.+.+ ++.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEE
Confidence 4778889999999999999999998999999987653 4455678899999999999999999987776 88999999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec---
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH--- 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~--- 518 (705)
||++||++-.+|.+.+ .+.+..++-++.++..|+++.|. .|+|||||||.|||||.+|++||.|||||.-+
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999998765 68888888999999999999998 99999999999999999999999999998432
Q ss_pred ------CCCCcc---------------------------e-----eeeeeccccCCCccccccCCCCccccEEEEehhHH
Q 005257 519 ------GHGQVA---------------------------S-----TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560 (705)
Q Consensus 519 ------~~~~~~---------------------------~-----~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ 560 (705)
..+.-. . ....+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 110000 0 01258999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCc
Q 005257 561 EVLSGRRPIEEGKP 574 (705)
Q Consensus 561 ElltG~~Pf~~~~~ 574 (705)
||+.|+.||....+
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999976544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=257.87 Aligned_cols=287 Identities=20% Similarity=0.224 Sum_probs=216.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-----cC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~ 435 (705)
..+|.....+|.|.- .|..+.+.-.+++||+|++... +....+.-.+|..++..+.|+|+++++.++... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346677778888888 7778888778899999988655 233445667899999999999999999988632 23
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..|+|||+|. .+|...+.- .+.-+.+..|..|++.|+.|||+ .+|+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 6799999995 589888862 46778888999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+ .+.+|-. ++.
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~k-----------i~~ 231 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNK-----------IIE 231 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHH-----------HHH
Confidence 875543 34566788999999999998889999999999999999999999998533 2333321 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc-----ccCCCCCcchhhHHHHHHhhcccccccccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI-----EAGIENETEDMDAYLLQQVKSKDMWANYSR 670 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 670 (705)
. .+..++.....+...+..-.. .||-... -.+...+ +...+.+ .......-+++.++..-.|..|
T Consensus 232 ~---lgtpd~~F~~qL~~~~r~yv~----~~~~y~~--~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 232 Q---LGTPDPSFMKQLQPTVRNYVE----NRPQYQA--ISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred H---hcCCCHHHHHHhhHHHHHHhh----cChHhhc--cchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhc
Confidence 1 255666777777777666554 2332221 1111111 1111222 1223445566778888999999
Q ss_pred ccccCCCCCCCcc
Q 005257 671 SFGYGYATHPTFH 683 (705)
Q Consensus 671 ~~~~~~~~hp~f~ 683 (705)
..+.++|.||||+
T Consensus 302 isv~daL~HPY~~ 314 (369)
T KOG0665|consen 302 ISVDDALRHPYIK 314 (369)
T ss_pred ccHHHHhcCCeee
Confidence 9999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=282.05 Aligned_cols=244 Identities=29% Similarity=0.434 Sum_probs=185.4
Q ss_pred CCcceEEeecCceE-EEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEee
Q 005257 366 FSEENVIGVGGNGK-VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 366 f~~~~~LG~G~fg~-Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
|...+++|.|+-|+ ||+|... ++.||||++-.+ ...-..+|+..|+.- +|||||++++.-.+ ...+||+.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehH
Confidence 56677899999875 8999996 689999988433 223446899999888 69999999975443 5678999999
Q ss_pred CCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---C--CCeeeeeecccee
Q 005257 444 MENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---E--MNGRLGDFGLARM 517 (705)
Q Consensus 444 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~--~~~kL~DFGla~~ 517 (705)
|. .+|.+++... .......-...+.++.|+++||++||+ .+||||||||.||||+. + .+++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 5999999873 111122225667889999999999999 99999999999999975 2 5689999999998
Q ss_pred cCCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhC-CCCCCCCCccHHHHHHHHHHhCch-hHHH
Q 005257 518 HGHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSG-RRPIEEGKPNLVEMVWELMVQGKL-LDAL 593 (705)
Q Consensus 518 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG-~~Pf~~~~~~~~~~v~~~~~~~~~-~~~i 593 (705)
...+.... .....||-+|+|||++....-+.++||||+|||+|..++| .+||.+...... .+..|.. +..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-----NIl~~~~~L~~- 734 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-----NILTGNYTLVH- 734 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-----hhhcCccceee-
Confidence 87654432 3446899999999999998888899999999999999994 999976422100 0111110 000
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
-....++ ...+|+..+++++|..||++.+|+.
T Consensus 735 -------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0011122 6788999999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=263.85 Aligned_cols=312 Identities=19% Similarity=0.197 Sum_probs=222.6
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC------CCCcceeeeeeeec
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK------HKSLVGLRGWCKRE 433 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~------Hpniv~l~g~~~~~ 433 (705)
+..-.+|......|+|-|++|.+|.+..-|..||||+|... .-..+.=+.|+++|++|. --|.++++-.|..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h- 505 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH- 505 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-
Confidence 34456788888899999999999999888899999999654 333445578999999995 3468888887765
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-Ceeeeee
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDF 512 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DF 512 (705)
.+++|||+|-+ ..+|.++|++.+....|....+..++.|+.-||..|.. .+|+|.||||.|||+++.. .+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccC
Confidence 78999999998 46999999988777789999999999999999999998 9999999999999999765 5799999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
|.|-....... +.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|++...+-.-.+ ..-..|++...
T Consensus 582 GSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl-~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL-FMELKGKFPNK 657 (752)
T ss_pred ccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH-HHHhcCCCcHH
Confidence 99976654432 233457789999999999999999999999999999999999988655321111 11234444433
Q ss_pred HHHh-hhcCCCCCHHHHH---HHHHHH-HHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccc
Q 005257 593 LDAR-LRAKGGFDEDEVE---RVLHLG-LLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWAN 667 (705)
Q Consensus 593 id~~-l~~~~~~~~~~~~---~l~~l~-~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (705)
+-.. .-....++.++-- +.-.+- ..-..+-+.-.|| +++...|.+. + ....+..+....+.+++.++.+.+|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt-kdl~s~l~~~-q-~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT-KDLGSELIAV-Q-RLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc-hhHHHHHhcc-C-CCCchhHHHHHHHHHHHHHHhccCh
Confidence 2111 1000111111000 000000 0000011223343 3344444322 1 1223334456667888999999999
Q ss_pred cccccccCCCCCCCccc
Q 005257 668 YSRSFGYGYATHPTFHD 684 (705)
Q Consensus 668 ~~r~~~~~~~~hp~f~~ 684 (705)
..|.+.-+||.||||..
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=251.72 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=195.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|...++||+|+|.+|..+.++.+.+.+|+|+++++. +++.+=...|-.+...- +||.+|.+..++.. +..++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEE
Confidence 457899999999999999999999999999999998762 33333345566666555 69999999986665 77899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|.||++||+|--++.+ ...|+++.+.-+...|+.||.|||+ ++||.||||..|+|||..|.+||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999665543 2379999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCC-----CCccHHHHHHHHHHhCchhHHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE-----GKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~-----~~~~~~~~v~~~~~~~~~~~~i 593 (705)
-... ..+..++|||.|+|||++.+..|....|.|++||+++||+.|+.||+- .+.+..+.+.+.+.+.
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------ 474 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------ 474 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------
Confidence 3322 234458999999999999999999999999999999999999999962 2233444444443322
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT 628 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 628 (705)
.++ ++.....+...+...-+++||.+|--
T Consensus 475 --qir----iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 --QIR----IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccc----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 121 22233344566777788999998853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=270.69 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=202.0
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
+.....||-||||.|=++..+.....+|+|++++. ...+.+....|-++|...+.|.||+++.-+.+ ...+|+.||
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmLmE 500 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYMLME 500 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhhHH
Confidence 33455699999999999998765555888887654 45566778999999999999999999998876 668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
-|-||.|...|++.+ .+......-++..+.+|+.|||. ++||.|||||+|.+||.+|-+||.|||.|+....+.
T Consensus 501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999997654 68888889999999999999998 999999999999999999999999999999887654
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.+-.++||+.|.|||++.+...+.++|.||||+++|||++|++||...++- .-...+..| +|. -.
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkG-----id~-----i~ 639 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKG-----IDK-----IE 639 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhh-----hhh-----hh
Confidence 345589999999999999999999999999999999999999999876541 112222222 221 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
++........++++..+..+|.+|-- ..+|.++
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 34444556778888888889999865 4555544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.94 Aligned_cols=304 Identities=25% Similarity=0.319 Sum_probs=222.2
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeecc
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREK 434 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~ 434 (705)
+....+.|...++||+|.|++||++++.. .++.||+|.+...+ ....+.+|+++|..+. +.||+++.+++.. +
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-n 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-N 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc-C
Confidence 44456678899999999999999999876 67899999986543 3456889999999995 8999999996654 7
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeec
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFG 513 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFG 513 (705)
+...+|+||++.....+++. .++..++..+++.+..||.++|. .|||||||||+|+|.+.. +.-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEech
Confidence 78999999999999999885 47788999999999999999998 999999999999999854 667999999
Q ss_pred cceecCCC--------------Cc-----------------------------ceeeeeeccccCCCcccccc-CCCCcc
Q 005257 514 LARMHGHG--------------QV-----------------------------ASTTRVVGTVGYLAPEVFSS-GRASTQ 549 (705)
Q Consensus 514 la~~~~~~--------------~~-----------------------------~~~~~~~gt~~y~APE~~~~-~~~s~k 549 (705)
||...... .. ......+||+||+|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99621100 00 00112479999999999865 567999
Q ss_pred ccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 550 TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 550 sDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
+||||.||+++.+++++.||.....+....+ +.+. .+...++.....+-..-+-..+..+|++
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~-ei~t----------------ifG~~~mrk~A~l~g~~~l~~ksn~~~~ 321 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALA-EIAT----------------IFGSAEMRKCAALPGRILLWQKSNIPTI 321 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHH-HHHH----------------HhChHHHHHHhhcCCceeeecccccccc
Confidence 9999999999999999999975433211111 1110 0111222222211111111233568888
Q ss_pred HHHHHHHHhc-cccCCC---------CCcchhhHHHHHHhhccccccccccccccCCCCCCCcccccccccc
Q 005257 630 RQVVKVLEGK-IEAGIE---------NETEDMDAYLLQQVKSKDMWANYSRSFGYGYATHPTFHDIRQSNSY 691 (705)
Q Consensus 630 ~evl~~L~~~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~hp~f~~~~~~~~~ 691 (705)
.++..-++.. .+..-. ...+-.+...++++.+....+|.+|.++++||.||||++.-.....
T Consensus 322 ~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~~ 393 (418)
T KOG1167|consen 322 PELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTERG 393 (418)
T ss_pred HHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhhh
Confidence 8888777665 232221 1112234567888888888999999999999999999876544443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.93 Aligned_cols=211 Identities=32% Similarity=0.546 Sum_probs=183.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChh
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~ 450 (705)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++.. ....++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence 68999999999999888899999998765432 35678999999999999999999998876 57889999999999999
Q ss_pred HHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeeccceecCCCCcceeeee
Q 005257 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARMHGHGQVASTTRV 529 (705)
Q Consensus 451 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~ 529 (705)
+++.... ..+++..+..++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 9987643 258999999999999999999998 89999999999999999 89999999999987654321 12234
Q ss_pred eccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHH
Q 005257 530 VGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608 (705)
Q Consensus 530 ~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~ 608 (705)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 788999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356788899999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=236.13 Aligned_cols=200 Identities=35% Similarity=0.519 Sum_probs=174.6
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
|...+.||+|++|.||++...++++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++.. ....++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence 45678899999999999999988899999999766554 67789999999999999999999998876 56889999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999976432 17899999999999999999998 89999999999999999999999999999877654311
Q ss_pred eeeeeeccccCCCcccc-ccCCCCccccEEEEehhHHHHhhCCCCCCC
Q 005257 525 STTRVVGTVGYLAPEVF-SSGRASTQTDVFGFGILILEVLSGRRPIEE 571 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~ 571 (705)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=258.58 Aligned_cols=198 Identities=28% Similarity=0.416 Sum_probs=171.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHH-----HHHHHHHHhccCC---CCCcceeeeeeee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTR-----AFLAEISSLGRLK---HKSLVGLRGWCKR 432 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~-----~~~~Ei~~l~~l~---Hpniv~l~g~~~~ 432 (705)
..|...+.||.|+||.|+.|+++.+...|+||.+.+++ +.+.+ ..-.||.+|.+|+ |+||++++.++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999999999999999987652 12222 3567999999997 9999999998876
Q ss_pred ccCceEEEEeeC-CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 433 EKGSLMLVYDYM-ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 433 ~~~~~~lV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
++.+||+||-. ++.+|.+++.... .+++.+..-|++||+.|+++||+ ++|||||||-+||.++.+|-+||+|
T Consensus 641 -dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 -DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred -CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 77889999987 5678999996543 68999999999999999999999 9999999999999999999999999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCC
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEE 571 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~ 571 (705)
||.|.....+.. ..++||.+|.|||++.+.+| ...-|||++|++||.++....||.+
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999987655433 34789999999999999876 5678999999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=264.20 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=206.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|.....+|.|.||.|||+++..+++..|+|.++.+......-..+|+-+++..+||||+.++|-+.. ...++++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEE
Confidence 3567788999999999999999999999999999998877777778899999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
||.+|+|.+.-+- ..++++.++..+++...+||+|||+ ++-+|||||-.|||+++.|.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999987653 3379999999999999999999998 999999999999999999999999999987664332
Q ss_pred cceeeeeeccccCCCcccc---ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 523 VASTTRVVGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~---~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.....++||+.|||||+. ..+.|..++|||++|+...|+.--..|..+..+.- +..++.+.... .+.++.
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---~l~LmTkS~~q---pp~lkD 239 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---ALFLMTKSGFQ---PPTLKD 239 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH---HHHHhhccCCC---CCcccC
Confidence 233457999999999986 45679999999999999999988777766544311 11112111110 011221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+ ....+.+-++++.|+..+|.+||++..+++
T Consensus 240 k----~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 K----TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C----ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 223466888999999999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=224.68 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=191.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+.|.+.+.||+|.||.+-++.++.+...+++|-+.... ...++|.+|..---.| .|.||+.-+.+..+..+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456888999999999999999999999999999986553 3467899998876666 59999998887776677888999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc--cCCCeeeeeeccceecC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD--KEMNGRLGDFGLARMHG 519 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld--~~~~~kL~DFGla~~~~ 519 (705)
||++.|+|..-+... .+.+....+++.|+++||.|+|+ .++||||||.+||||- +..++||||||+.+..+
T Consensus 102 E~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998877432 47888899999999999999999 9999999999999993 33579999999987543
Q ss_pred CCCcceeeeeeccccCCCccccccC-----CCCccccEEEEehhHHHHhhCCCCCCCCCc-cHHHHHHHHHHhCchhHHH
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSG-----RASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-~~~~~v~~~~~~~~~~~~i 593 (705)
..- ...--+..|.+||..... ...+.+|||.||++++.++||..||+.... +..-|-|..+.+++... +
T Consensus 175 ~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~-~ 249 (378)
T KOG1345|consen 175 TTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA-L 249 (378)
T ss_pred cee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc-C
Confidence 211 111235679999987542 357789999999999999999999984321 22234455565555431 1
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.... . ...+.++.+..+-+.++|++|=...++.+
T Consensus 250 P~~F---~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 250 PKKF---N----PFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred chhh---c----ccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1111 1 12355677778889999999944444444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=272.95 Aligned_cols=198 Identities=17% Similarity=0.254 Sum_probs=141.5
Q ss_pred ccCCC-CCcceeeeeeee------ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005257 416 GRLKH-KSLVGLRGWCKR------EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488 (705)
Q Consensus 416 ~~l~H-pniv~l~g~~~~------~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 488 (705)
+.++| +||++++++|.. ....+++++||+ +++|.++|.... ..+++.+++.++.||++||.|||+ ++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 34556 688888887721 124577889988 569999996432 359999999999999999999998 99
Q ss_pred eeecCCCCCCeEEcc-------------------CCCeeeeeeccceecCCCC---------------cceeeeeecccc
Q 005257 489 VLHRDIKSSNVLLDK-------------------EMNGRLGDFGLARMHGHGQ---------------VASTTRVVGTVG 534 (705)
Q Consensus 489 iiHrDLkp~NILld~-------------------~~~~kL~DFGla~~~~~~~---------------~~~~~~~~gt~~ 534 (705)
|+||||||+||||+. ++.+||+|||+++...... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4556777777775422100 000112468999
Q ss_pred CCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHH
Q 005257 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHL 614 (705)
Q Consensus 535 y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l 614 (705)
|||||++.+..++.++|||||||+||||++|..|+...... ...+.... +.+ ...........+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~~~~----~~~-------~~~~~~~~~~~~ 244 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLRHRV----LPP-------QILLNWPKEASF 244 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHHHhh----cCh-------hhhhcCHHHHHH
Confidence 99999999999999999999999999999988886532111 01111000 000 001122345678
Q ss_pred HHHcCCCCCCCCCCHHHHHHH
Q 005257 615 GLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 615 ~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.+||+++|.+||++.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=209.25 Aligned_cols=168 Identities=21% Similarity=0.183 Sum_probs=126.1
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
|+|.+++...+. .+++.+++.++.|++.||.|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999975432 69999999999999999999998 44 999999999999999 99998764422
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHH
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDED 606 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~ 606 (705)
..||+.|||||++.+..++.++|||||||++|||++|+.||..... ........... ..............
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~ 134 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNG------MPADDPRDRSNLES 134 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHH------hccCCccccccHHH
Confidence 2589999999999999999999999999999999999999965332 11111111100 00000000001112
Q ss_pred HHH--HHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 607 EVE--RVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 607 ~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
... .+.+++..||+.+|.+||++.|+++++....
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222 5899999999999999999999999887543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=224.12 Aligned_cols=179 Identities=20% Similarity=0.202 Sum_probs=137.9
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcC-CCeEEEEEEeccC-----CchhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHE-----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
.......+|...+.||+|+||+||+|++.. +++.||||++... .....+.|.+|+++|++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 344567789999999999999999999875 6777899987533 12235568999999999999999864432
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeEEccCCCeeee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI-KSSNVLLDKEMNGRLG 510 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDL-kp~NILld~~~~~kL~ 510 (705)
.+..+|||||+++++|... . . .. ...++.|++++|.|||+ ++|+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEE
Confidence 2357999999999999632 1 1 11 14678999999999998 99999999 9999999999999999
Q ss_pred eeccceecCCCCcce-------eeeeeccccCCCccccccCC------CCccccEE
Q 005257 511 DFGLARMHGHGQVAS-------TTRVVGTVGYLAPEVFSSGR------ASTQTDVF 553 (705)
Q Consensus 511 DFGla~~~~~~~~~~-------~~~~~gt~~y~APE~~~~~~------~s~ksDVw 553 (705)
|||+|+.+....... .+...+++.|+|||.+.... .+..+|-|
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999998765432111 13467888999999986532 23446666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=205.32 Aligned_cols=245 Identities=21% Similarity=0.385 Sum_probs=187.2
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.+|.+...|..|+|+++++ .+++|++... .....++|..|.-.|+-+.||||++++|.|.. ...+.++..||+.|
T Consensus 196 tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp~g 272 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMPFG 272 (448)
T ss_pred hhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeeccch
Confidence 4578889999999999854 4666766433 33445789999999999999999999999987 57889999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeee--eeccceecCCCCcce
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG--DFGLARMHGHGQVAS 525 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~--DFGla~~~~~~~~~~ 525 (705)
+|..+|+...+ ......+..+++.++|+|++|||+ .++-|.---|.+..+++|++.+++|+ |--.+-.
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq-------- 342 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------- 342 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee--------
Confidence 99999987543 367888999999999999999997 33445556799999999999998875 2111110
Q ss_pred eeeeeccccCCCccccccCCC---CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 526 TTRVVGTVGYLAPEVFSSGRA---STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~---s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....-.+.||+||.++..+. -.++|+|||.+++|||.|...||.+-.+-.... .. .-+.++ ..
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--ki---------aleglr--v~ 409 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--KI---------ALEGLR--VH 409 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--hh---------hhcccc--cc
Confidence 111123678999999977543 457999999999999999999998754421111 01 111222 33
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
+++.....+.+|+.-|++.||.+||.+..++-+|+++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 45566677889999999999999999999999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=210.76 Aligned_cols=261 Identities=21% Similarity=0.208 Sum_probs=192.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCC-eEEEEEEeccCCchhHHHHHHHHHHhccCCC----CCcceeeeeeeeccCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGG-AEIAVKRISHENDGGTRAFLAEISSLGRLKH----KSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H----pniv~l~g~~~~~~~~~~l 439 (705)
+|...+.||+|+||.||++.....+ ..+|+|............+..|+.++..+.. +++..++......+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7899999999999999999987664 6799998766544333367888888888863 4677777765333556799
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-----CCeeeeeecc
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-----MNGRLGDFGL 514 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-----~~~kL~DFGl 514 (705)
||+.+ |.+|.++..... ...++....++|+.|++.+|.+||+ .+++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 779999876655 3479999999999999999999998 999999999999999865 4589999999
Q ss_pred ce--ecCCCCc-----c-e-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHH
Q 005257 515 AR--MHGHGQV-----A-S-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELM 584 (705)
Q Consensus 515 a~--~~~~~~~-----~-~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~ 584 (705)
++ .+..... . . .....||..|.++.+..+.+.+.+.|+||++.++.|+..|..||...... ....+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 3322111 1 1 12356999999999999999999999999999999999999999654321 111110000
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..... .......+..+.++...+-..+..++|....+...|.+...
T Consensus 254 ---------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 254 ---------RKLLT--DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred ---------hhhcc--ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00000 00111122344455555555799999999999999876655
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=194.31 Aligned_cols=195 Identities=19% Similarity=0.276 Sum_probs=136.7
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++..++.|+++|+.|+++ ++|+|+|+|+|.+.. ..+||||||+++|...
T Consensus 20 ~~w~~~G~a~~~~~~i~LT~~~~~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~--- 87 (218)
T cd07308 20 GNWTVGGSTVITKNYIRLTPDVPSQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPG--- 87 (218)
T ss_pred CCeEEcCCeEEeCCEEEeCCCCCCCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCC---
Confidence 6899999999999999999999999999999999998 479999999998763 4589999999999643
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCc-ccccccccccCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLT-SVSAHAAGYWPDNQTDSSGSNSNSGTGD 194 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~-S~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (705)
..|+.+|- ....+.+||||||+.|. +-...+|.+-+|.-+ +..... +.+.....+|
T Consensus 88 -~~g~~~G~-------~~~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~-------d~~~~~~~~c----- 144 (218)
T cd07308 88 -SDGPLFGG-------PDKFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYET-------DGEKLELASC----- 144 (218)
T ss_pred -CCCccccc-------CCCCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccC-------CCccccccce-----
Confidence 24555555 23467899999999985 223344544333221 110000 0000011122
Q ss_pred CccccceeecCC-CcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeee
Q 005257 195 DEKSFKELKLNN-GKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWS 273 (705)
Q Consensus 195 ~~~~~~~~~l~~-g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~ws 273 (705)
.+...+ +.+++++|.|....+.|.+.... +.....-..++.. .+|+..|+||||+||...+.|.|++|.
T Consensus 145 ------~~~~~~~~~~~~~~I~y~~~~l~v~i~~~~---~~~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~ 214 (218)
T cd07308 145 ------SLKFRNSNAPTTLRISYLNNTLKVDITYSE---GNNWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVH 214 (218)
T ss_pred ------eEecccCCCCeEEEEEEECCEEEEEEeCCC---CCCccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEE
Confidence 222222 67899999999888888887432 2222233333322 467899999999999999999999997
Q ss_pred ec
Q 005257 274 FS 275 (705)
Q Consensus 274 f~ 275 (705)
+.
T Consensus 215 ~~ 216 (218)
T cd07308 215 TY 216 (218)
T ss_pred ee
Confidence 64
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.67 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=201.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCC-CcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHK-SLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~~lV~ 441 (705)
...|...++||.|+||.+|.|....+|+.||||.-+.. ....++.-|.++...|++- .|..+..+ ..++..-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y-~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHY-GTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhh-ccccccceeee
Confidence 45788999999999999999999999999999976433 2335677899999999764 44444444 44477778999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DFGla~~~ 518 (705)
|.+ |.||.++..-+.. .++...++-++-|++.-++|+|. +++|||||||+|+|..-+ ..+.++|||||+.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 7799998877665 59999999999999999999998 999999999999999643 45889999999876
Q ss_pred CCCCc------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 519 GHGQV------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 519 ~~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
..... .......||.+|.+--...+.+.+.+.|+-|+|.+|..+-.|..||++-....-..-.+.+.+.++...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54322 223457899999998888888889999999999999999999999998665443333444444332221
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+..-. ..+ +.++.-.+..|-..--++.|...-+.+.+.-+..
T Consensus 245 ie~LC---~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 245 IEVLC---KGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHh---CCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11111 122 2345666777888889999999888887776655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=198.75 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=202.0
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.|...++||+|.||..+.|+.--++++||||.-... ....++..|.+..+.| ..++|...+-+-. ++.+-.||+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGq-eG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-EGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeecc-ccchhhhhhhh
Confidence 588899999999999999999889999999975543 3345677788777777 4677777765443 35566899999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-----CCeeeeeeccceec
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-----MNGRLGDFGLARMH 518 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-----~~~kL~DFGla~~~ 518 (705)
+ |-||+++..-++. .++.+.+..+++|++.-++|+|+ +.+|.|||||+|+||..- ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9 7799998877765 69999999999999999999998 999999999999999643 34789999999988
Q ss_pred CCCCcce------eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 519 GHGQVAS------TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 519 ~~~~~~~------~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
....... .....||.+||+-....+.+.+.+.|+-|+|-++...+.|..||++-...-...-.+.+.+.+-...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 6554322 3446899999999999999999999999999999999999999998665444444455544333222
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
++.-. ..+ ++++...+..++ ..+-.+-|...-+...+.+.++..
T Consensus 260 i~~Lc---~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 260 IEVLC---EGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHHH---hcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhc
Confidence 22211 112 234444555544 457888899998888887766533
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=198.18 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=196.4
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch---hHHHHHHHHHHhccCCCC-CcceeeeeeeeccCceEEEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---GTRAFLAEISSLGRLKHK-SLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~~lV~ 441 (705)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++...+.. ....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence 566788999999999999997 67999998765332 467899999999999988 79999998844 55579999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-CeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~ 520 (705)
+++.++++.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||+++....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999999999776543211258899999999999999999998 8899999999999999988 699999999986554
Q ss_pred CCcc-----eeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhH
Q 005257 521 GQVA-----STTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLD 591 (705)
Q Consensus 521 ~~~~-----~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~ 591 (705)
.... ......|+..|+|||.+.. .......|+||+|++++++++|..|+...... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 4322 2345689999999999987 57899999999999999999999997654421 111222222111110
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....... ..........+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccC--ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001122567888888999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-21 Score=217.09 Aligned_cols=254 Identities=20% Similarity=0.233 Sum_probs=185.2
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEecc-----CCchh-HHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISH-----ENDGG-TRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~-----~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
...+++|.|.+|.|+........+..+.|.... ..... ...+..|+.+-..++|||++..+..+.+.. ...-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-GILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-cchhh
Confidence 456789999999888887765555555554431 11111 122667888888999999988877766533 33444
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++ +|..++... ..++..++..+++|+..|+.|||+ .+|.|||||++|++++.++.+||+|||.+..+..
T Consensus 400 mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999999 999988654 268899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc---ceeeeeeccccCCCccccccCCCCc-cccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 521 GQV---ASTTRVVGTVGYLAPEVFSSGRAST-QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 521 ~~~---~~~~~~~gt~~y~APE~~~~~~~s~-ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
+.. ......+|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||.......... .+....+.. .... .
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~~~~~-~~~~-~ 549 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNYSDQR-NIFE-G 549 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhcccccc-cccc-C
Confidence 433 3345578999999999999988865 5899999999999999999996533211000 000000000 0000 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
. .......+..-..++..++++||.+|-++.+|++
T Consensus 550 ~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 P---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred h---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0111233456677888899999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.8e-20 Score=180.21 Aligned_cols=141 Identities=19% Similarity=0.179 Sum_probs=108.7
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch--h-------HHH-----------------HHHHHHHhccCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG--G-------TRA-----------------FLAEISSLGRLKHKS 422 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~Hpn 422 (705)
.+.||+|+||.||+|.+. +|+.||||+++..... . ... ...|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 7899999998654211 1 111 234999999998887
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeEE
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL-HEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiHrDLkp~NILl 501 (705)
+.....+.. . ..+|||||++++++...+... ..++..+..+++.|++.+|.+| |+ .+|+||||||+|||+
T Consensus 81 v~~p~~~~~--~-~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--K-SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--c-CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 643332211 2 238999999988776543222 2688999999999999999999 66 899999999999999
Q ss_pred ccCCCeeeeeeccceecCC
Q 005257 502 DKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~ 520 (705)
+ ++.++|+|||+|....+
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 47899999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=181.98 Aligned_cols=180 Identities=16% Similarity=0.167 Sum_probs=136.1
Q ss_pred cCHHHHH--HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHH---H------HHHHHHHhccCCCCC
Q 005257 354 ITYQEIE--AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR---A------FLAEISSLGRLKHKS 422 (705)
Q Consensus 354 ~~~~el~--~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~---~------~~~Ei~~l~~l~Hpn 422 (705)
..|.++. ...++|...++||.|+||.||.... ++..+|||.+........+ . +.+|++.+.+++||+
T Consensus 19 ~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 19 NKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred ccHHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 3455543 3678999999999999999999655 3567999999755322222 2 679999999999999
Q ss_pred cceeeeeeeec-------cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005257 423 LVGLRGWCKRE-------KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495 (705)
Q Consensus 423 iv~l~g~~~~~-------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLk 495 (705)
|..+..+.... .+..+|||||++|.+|.++. .++. ....+++.+|..||+ .+++|||+|
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dik 162 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ---HGMVSGDPH 162 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH---cCCccCCCC
Confidence 99988875432 23578999999999998874 2332 245699999999998 999999999
Q ss_pred CCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHh
Q 005257 496 SSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL 563 (705)
Q Consensus 496 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ell 563 (705)
|+||+++.++ ++|+|||............ .+.....+..++|+||||+.+.-+.
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999888 9999999887553221111 1233445667999999999986543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=171.71 Aligned_cols=141 Identities=20% Similarity=0.185 Sum_probs=111.0
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh--------------------------HHHHHHHHHHhccCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--------------------------TRAFLAEISSLGRLKHKS 422 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~--------------------------~~~~~~Ei~~l~~l~Hpn 422 (705)
.+.||+|++|.||+|.+. +|+.||||+++...... ...+..|.+.+.+++|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 78999999987542110 112357899999999998
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHH-HHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKW-IFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
+.....+... ..+|||||++++++... +.. ..++..+..+++.|++.+|.+||+ ..+|+||||||+|||+
T Consensus 81 i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK---KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec---CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEE
Confidence 7544433322 23899999998865443 322 257888999999999999999996 4799999999999999
Q ss_pred ccCCCeeeeeeccceecCC
Q 005257 502 DKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~ 520 (705)
+ ++.++|+|||++....+
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=194.68 Aligned_cols=217 Identities=22% Similarity=0.335 Sum_probs=160.8
Q ss_pred hccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 005257 415 LGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494 (705)
Q Consensus 415 l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDL 494 (705)
|+.+.|.|+.+++|.|.. +...++|.+|++.|+|.+.+.... ..+++.....++++++.||.|||+. .--.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 467899999999999998 578899999999999999997633 3689999999999999999999982 33399999
Q ss_pred CCCCeEEccCCCeeeeeeccceecCCC-CcceeeeeeccccCCCccccccC-------CCCccccEEEEehhHHHHhhCC
Q 005257 495 KSSNVLLDKEMNGRLGDFGLARMHGHG-QVASTTRVVGTVGYLAPEVFSSG-------RASTQTDVFGFGILILEVLSGR 566 (705)
Q Consensus 495 kp~NILld~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwS~Gvvl~ElltG~ 566 (705)
+++|+++|..+.+||+|||+....... .........-...|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766421 11111111234579999999763 1467899999999999999999
Q ss_pred CCCCCCCccHH-HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 567 RPIEEGKPNLV-EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 567 ~Pf~~~~~~~~-~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.||........ +.+...+..+. ...+.+.+.. ..+..+.+..++..||..+|.+||+++++...++....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~-~~~~rP~i~~----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGG-SNPFRPSIEL----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHHHHhcC-CCCcCcchhh----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99986432211 11111122200 0111111110 11333468999999999999999999999998886655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-20 Score=199.84 Aligned_cols=233 Identities=25% Similarity=0.296 Sum_probs=179.9
Q ss_pred EeecCceEEEEEEE---cCCCeEEEEEEeccCCch--hHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEeeCC
Q 005257 372 IGVGGNGKVYKGVL---EGGGAEIAVKRISHENDG--GTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 372 LG~G~fg~Vy~~~~---~~~~~~vavK~i~~~~~~--~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+|+|.||.|+++.- .+.+.-+|+|.+++.... .......|..++...+ ||.++++...+.. +..++++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhcc
Confidence 78999999987543 345677899887665321 1124566888888887 9999998876654 788999999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|.|...+.+.. .+...........++-+++++|+ .+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988886533 57777888888999999999998 99999999999999999999999999999865443322
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
+||..|||||++. .....+|.||||++.+||+||..||.. +.+...++.+...+.
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~~~~~~p~ 208 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILKAELEMPR 208 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhhhccCCch
Confidence 8999999999997 578899999999999999999999975 111112222244555
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTM--RQVVKVLE 637 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~ 637 (705)
+.......+.......+|..|--. ..+.++++
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 666666777777777788888544 44445444
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-17 Score=165.94 Aligned_cols=201 Identities=19% Similarity=0.232 Sum_probs=133.8
Q ss_pred CCCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCC
Q 005257 35 SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIK 114 (705)
Q Consensus 35 ~~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~ 114 (705)
..+|.+.|+|.+.++.|+||++.+.+.|++||+.|+++ .+|+|+|+|+|.+.+...+||||||+++....
T Consensus 19 i~~w~~~G~a~v~~~~IrLTp~~~~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~-- 88 (248)
T cd06901 19 MPLWDFLGSTMVTSQYIRLTPDHQSKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM-- 88 (248)
T ss_pred CCCEEEcceEEEcCCeEEECCCCCCCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC--
Confidence 47899999999998899999999989999999999999 57999999999987666789999999998632
Q ss_pred CCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCC-CCCCCeeEEecCCCcccccccccccC-CCCCCCCCCCCCCCC
Q 005257 115 GATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFN-DIDENHVGIDVNSLTSVSAHAAGYWP-DNQTDSSGSNSNSGT 192 (705)
Q Consensus 115 ~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgidvns~~S~~~~~~~~~~-~~~~~~~~~~~~~~~ 192 (705)
..|..+|- .....-+||-|||+.|..-. ....+=|.+=+|.= +.. |+ +.+.+.....+|...
T Consensus 89 --~~G~~fG~-------~~~f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDG-t~~------yd~~~Dg~~~~~~~C~~~ 152 (248)
T cd06901 89 --QPGPVFGS-------KDNFHGLAIFFDTYSNQNGEHEHVHPYISAMVNNG-SLS------YDHDRDGTHTELAGCSAP 152 (248)
T ss_pred --ccCccccc-------CCCCceEEEEEECCCCCCCcccCCCceEEEEEcCC-Cee------ecccCCCchhhcCceeee
Confidence 33444454 23446799999999986310 01111122222211 111 11 111112233444322
Q ss_pred CCCccccceeecCCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCcc-ccccceecccccccccccccceeee
Q 005257 193 GDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSG-VLEDEMYVGFTAATGQLVESHKILA 271 (705)
Q Consensus 193 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~-~l~~~~~vGfsastg~~~~~h~i~~ 271 (705)
++ ..+.+.+++|.|....+.|.+...+. .. .... .+... .||...|+||||+||...+.|.|++
T Consensus 153 ~r----------n~~~~t~~rI~Y~~~~l~v~vd~~~~--~~--w~~C-f~~~~v~LP~~~yfGiSA~Tg~~sd~hdIls 217 (248)
T cd06901 153 FR----------NKDHDTFVAIRYSKGRLTVMTDIDGK--NE--WKEC-FDVTGVRLPTGYYFGASAATGDLSDNHDIIS 217 (248)
T ss_pred cc----------CCCCCeEEEEEEECCeEEEEEecCCC--Cc--eeee-EEeCCeecCCCCEEEEEecCCCCCCcEEEEE
Confidence 22 23456789999977778888865432 11 1111 22222 2677799999999999999999999
Q ss_pred eeecc
Q 005257 272 WSFSN 276 (705)
Q Consensus 272 wsf~~ 276 (705)
-.+..
T Consensus 218 v~~~~ 222 (248)
T cd06901 218 MKLYE 222 (248)
T ss_pred EEEec
Confidence 66544
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=169.25 Aligned_cols=138 Identities=20% Similarity=0.344 Sum_probs=109.3
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-----CCCCcceeeeeeeecc--Cc-e
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-----KHKSLVGLRGWCKREK--GS-L 437 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-----~Hpniv~l~g~~~~~~--~~-~ 437 (705)
....+.||+|+||.||. ++.++.. +||++........+.+.+|++++..+ .||||++++|++..+. +. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 6666555 69988766555667899999999999 5799999999988753 23 3
Q ss_pred EEEEee--CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeEEcc----CCCeeee
Q 005257 438 MLVYDY--MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGV-LYLHEGWEKKVLHRDIKSSNVLLDK----EMNGRLG 510 (705)
Q Consensus 438 ~lV~E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~iiHrDLkp~NILld~----~~~~kL~ 510 (705)
.+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +..++|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 378999 5589999999542 35544 35678888888 89998 99999999999999974 3479999
Q ss_pred eeccc
Q 005257 511 DFGLA 515 (705)
Q Consensus 511 DFGla 515 (705)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=179.15 Aligned_cols=234 Identities=22% Similarity=0.228 Sum_probs=153.6
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCC----------CCcceeeeeee-
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKH----------KSLVGLRGWCK- 431 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~H----------pniv~l~g~~~- 431 (705)
+...+.||.|+++.||.+++..+++++|||...... ....+++.+|.-.+..+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345778999999999999999999999999876543 2345677777766666433 11221111111
Q ss_pred --------ecc--C-----ceEEEEeeCCCCChhHHHHh---cCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 005257 432 --------REK--G-----SLMLVYDYMENGSLDKWIFQ---CDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHR 492 (705)
Q Consensus 432 --------~~~--~-----~~~lV~E~~~~gsL~~~L~~---~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHr 492 (705)
... . ..+++|+-+. ++|.+++.- ... ...+....+..+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 100 1 2467888884 588887643 221 1245566777888999999999999 999999
Q ss_pred CCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCcccccc--------CCCCccccEEEEehhHHHHhh
Q 005257 493 DIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS--------GRASTQTDVFGFGILILEVLS 564 (705)
Q Consensus 493 DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwS~Gvvl~Ellt 564 (705)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|+|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999987765432211 133577999997643 247889999999999999999
Q ss_pred CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 005257 565 GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR 626 (705)
Q Consensus 565 G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 626 (705)
|+.||........ .+..+ ..+. +.++.+..|+...++.+|++|
T Consensus 246 ~~lPf~~~~~~~~---------------~~~~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEAD---------------PEWDF---SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGST---------------SGGGG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccc---------------ccccc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999975432100 00011 3344 777889999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=198.85 Aligned_cols=249 Identities=20% Similarity=0.206 Sum_probs=177.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHH--hccCCCCCcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISS--LGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~--l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++...+.||.+.|=+|.+|++++ |. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-.. +...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-DKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-hHHHHHHH
Confidence 46667889999999999999975 44 9999886554 3344555444433 444589999999887554 45678899
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee--cC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--HG 519 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~--~~ 519 (705)
+|..+ +|.|.|.. +..+...+..=|+.|++.||.-+|. .+|+|+|||.+||||+.=.=+.|+||..-+- ..
T Consensus 101 qyvkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 99866 89888853 3367888888899999999999998 9999999999999999866689999986542 22
Q ss_pred CCCcceeeeeec----cccCCCccccccC----------C-CCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHH
Q 005257 520 HGQVASTTRVVG----TVGYLAPEVFSSG----------R-ASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWEL 583 (705)
Q Consensus 520 ~~~~~~~~~~~g----t~~y~APE~~~~~----------~-~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~ 583 (705)
++.....+-+-. -..|+|||.+... . .+++.||||+||++.||++ |++||.- .+.. .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~--a 246 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLL--A 246 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHH--h
Confidence 222222111111 2469999987431 1 5788999999999999988 7777742 1111 1
Q ss_pred HHhC--chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 584 MVQG--KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 584 ~~~~--~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
++.| ...+.+-+.+. -..+..+++.+++.||++|-++++.++.-.+.
T Consensus 247 Yr~~~~~~~e~~Le~Ie---------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIE---------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HhccCccCHHHHHHhCc---------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1222 11222222221 12578899999999999999999999875543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.9e-18 Score=165.45 Aligned_cols=186 Identities=15% Similarity=0.082 Sum_probs=137.7
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch----hHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG----GTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~----~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.....|++|+||+||.+.. .+.+++.+.+.....- ..+.+.+|+++|++|. |+++.+++++ +..+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEE
Confidence 4567899999999997765 4677887777544321 1125789999999995 5788888885 2358999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeEEccCCCeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI-KSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDL-kp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||+.|.+|...+.. ....++.|++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||+|.....
T Consensus 78 eyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 78 SYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99999988654311 123578899999999998 99999999 79999999999999999999986554
Q ss_pred CCcc----e--------eeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 521 GQVA----S--------TTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 521 ~~~~----~--------~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
.... . ..-...++.|++|+...- .+.-...+.++-|+-+|.++|++.+.-.+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 3310 0 000124677778875432 22225678889999999999999887543
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.8e-16 Score=154.30 Aligned_cols=200 Identities=19% Similarity=0.204 Sum_probs=136.6
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
++|.+.|+|.+.++.|+||++.+++.|.+|.+.|++. -+|+.+|+|+|.... ..+||||||+++....
T Consensus 22 ~~W~~~G~t~~~~~~IrLTp~~~~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~--- 89 (225)
T cd06902 22 PFWSHGGDAIASLEQVRLTPSLRSKKGSVWTKNPFSF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTKERG--- 89 (225)
T ss_pred CceEecccEEecCCEEEECCCCCCCEEEEeeCCCcCC--------CCEEEEEEEEEecCC-CCCCCEEEEEEECCCC---
Confidence 7899999999999999999999999999999999984 359999999998764 2468999999997632
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCC-cccccccccccCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSL-TSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~-~S~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (705)
..|+.+|- .....-+||.|||+.|.+ ..+...|-+=+|.= +.... +.+.......+|...|+
T Consensus 90 -~~G~~~G~-------~~~f~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~-------~~D~~~~~~~~C~~~~r 152 (225)
T cd06902 90 -EEGPVFGS-------SDKWNGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDH-------QNDGLTQALGSCLRDFR 152 (225)
T ss_pred -CCCCccCC-------CCcccEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccc-------cCCCcccccceEEEecc
Confidence 24555655 234567899999998863 23344564443331 11110 11111222344432222
Q ss_pred CccccceeecCCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCcc-ccccceecccccccccccccceeeeee
Q 005257 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSG-VLEDEMYVGFTAATGQLVESHKILAWS 273 (705)
Q Consensus 195 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~-~l~~~~~vGfsastg~~~~~h~i~~ws 273 (705)
+...+.++.|+|....+.|.+.... .+.......-+++.. .||+..|+||||+||...+.|.|++|+
T Consensus 153 ----------n~~~p~~~rI~Y~~~~l~V~~d~~~--~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~ 220 (225)
T cd06902 153 ----------NKPYPVRAKITYYQNVLTVSINNGF--TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFL 220 (225)
T ss_pred ----------CCCCCeEEEEEEECCeEEEEEeCCc--CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEE
Confidence 1235789999997777888776322 222111222233333 377889999999999999999999998
Q ss_pred ecc
Q 005257 274 FSN 276 (705)
Q Consensus 274 f~~ 276 (705)
+.+
T Consensus 221 ~~s 223 (225)
T cd06902 221 TFS 223 (225)
T ss_pred Eec
Confidence 864
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=164.21 Aligned_cols=142 Identities=19% Similarity=0.219 Sum_probs=110.4
Q ss_pred CCcceEEeecCceEEEEEE-EcCCCeEEEEEEeccCCch------------------------hHHHHHHHHHHhccCCC
Q 005257 366 FSEENVIGVGGNGKVYKGV-LEGGGAEIAVKRISHENDG------------------------GTRAFLAEISSLGRLKH 420 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~-~~~~~~~vavK~i~~~~~~------------------------~~~~~~~Ei~~l~~l~H 420 (705)
|+..+.||+|++|.||+|. +..+|+.||||+++..... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6778899999999999998 6667899999998754210 01235689999999976
Q ss_pred CC--cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCC
Q 005257 421 KS--LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK-VLHRDIKSS 497 (705)
Q Consensus 421 pn--iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-iiHrDLkp~ 497 (705)
.. +.+++++ ...++||||+++++|...+... ..+...+...++.|++.+|.+||+ .+ ++||||||+
T Consensus 110 ~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe-----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence 33 3334432 2348999999998887654222 135566778999999999999998 88 999999999
Q ss_pred CeEEccCCCeeeeeeccceecC
Q 005257 498 NVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~~~ 519 (705)
||+++ +++++|+|||++....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-17 Score=168.10 Aligned_cols=198 Identities=21% Similarity=0.289 Sum_probs=142.1
Q ss_pred CCCCcceeeeeeee--------------------------ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHH
Q 005257 419 KHKSLVGLRGWCKR--------------------------EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK 472 (705)
Q Consensus 419 ~Hpniv~l~g~~~~--------------------------~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 472 (705)
+|||||++.+.+.+ +...+|+||..++. +|..++... ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 59999998876642 23468999999865 999999643 466777888999
Q ss_pred HHHHHHHHHhcCCCCCeeecCCCCCCeEEc--cCC--CeeeeeeccceecCCCC-----cceeeeeeccccCCCcccccc
Q 005257 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLD--KEM--NGRLGDFGLARMHGHGQ-----VASTTRVVGTVGYLAPEVFSS 543 (705)
Q Consensus 473 qia~gL~yLH~~~~~~iiHrDLkp~NILld--~~~--~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~APE~~~~ 543 (705)
|+++|+.|||. ++|.|||+|+.|||+. ++. .+.|+|||++-...... .......-|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999998 9999999999999983 443 36899999985433211 111122356778999999854
Q ss_pred C--C----CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHH
Q 005257 544 G--R----ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL 617 (705)
Q Consensus 544 ~--~----~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~ 617 (705)
. + .-.|+|.|+.|.+.||+++...||....+-..+.. .+++.. + +..+..++..+.+++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--~Yqe~q--------L---Palp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--TYQESQ--------L---PALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--hhhhhh--------C---CCCcccCChHHHHHHHH
Confidence 2 2 24689999999999999999999986433211110 011111 1 22344455667888899
Q ss_pred cCCCCCCCCCCHHHHHHHHH
Q 005257 618 CAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 618 Cl~~dP~~RPs~~evl~~L~ 637 (705)
.++.||++||+..-....|+
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999876666554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.4e-18 Score=181.74 Aligned_cols=173 Identities=24% Similarity=0.416 Sum_probs=132.3
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
+++|.|++|...+|.+||.........++.....++.|++.|+.| ++.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 588999999999999999876666678899999999999999999 68899999999999999999999999998
Q ss_pred eecCCCC-----cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCch
Q 005257 516 RMHGHGQ-----VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 516 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
....... ....+..+||..||+||.+.+..|+.|+||||||++|+||+. =..++... .....++.|.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~d~r~g~i 477 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLTDIRDGII 477 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------HhhhhhhcCCC
Confidence 7665544 334566789999999999999999999999999999999987 22222210 01112223322
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
.... . .++ ..-..+..+.+++.|.+||++.+
T Consensus 478 p~~~----~--~d~-----p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 478 PPEF----L--QDY-----PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ChHH----h--hcC-----cHHHHHHHHhcCCCcccCchHHH
Confidence 2111 0 111 12246778899999999995443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.6e-17 Score=187.63 Aligned_cols=254 Identities=22% Similarity=0.214 Sum_probs=179.3
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC---CCCcceeeeeeeec
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK---HKSLVGLRGWCKRE 433 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~ 433 (705)
.+.+.-.+.|.+.+.||+|+||+||+|...+ ++.||+|.-+..+. .+|.--.+++.||+ -+-|..+.....-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~- 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF- 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc-
Confidence 3444555678999999999999999999987 89999997654432 33433445555665 1223333332222
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-------cCCC
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-------KEMN 506 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-------~~~~ 506 (705)
.+.-+||+||.+.|+|.+++. ..+.++|.....++.|++.-+..||. .+|||+||||.|.||. ++..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccc
Confidence 345679999999999999996 33378999999999999999999998 9999999999999994 2345
Q ss_pred eeeeeeccceecCC-CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGH-GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
++|+|||.+-.+.- .........++|-.+-.+|+..+.++++++|.|.++.+++-|+.|+.-- ..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~ 905 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VK 905 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hc
Confidence 89999999854321 1223455678899999999999999999999999999999999986431 11
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.|.. ..++..++ ..+..+.+..+..+++ ++|...=|...++...|++.+.
T Consensus 906 ~g~~-~~~~~~~~--Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSS-WMVKTNFP--RYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcc-eeccccch--hhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHHHHH
Confidence 1111 11111111 1122344444555444 3555556888888888876654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=157.22 Aligned_cols=134 Identities=21% Similarity=0.299 Sum_probs=111.0
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--h------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--G------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+.||+|++|.||+|.. .+..+++|+...... . ....+.+|+.++..++|+++.....++.. ....+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEE
Confidence 5799999999999988 467799997654321 1 12457889999999999998776666654 45678999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
||++|++|.+++... .+ ++..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998532 22 888999999999999998 9999999999999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=177.86 Aligned_cols=141 Identities=20% Similarity=0.266 Sum_probs=112.2
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEec-cC-Cc------hhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HE-ND------GGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~-~~-~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
......|...+.||+|+||+||+|.+... .+++|+.. .. .. ...+.+.+|++++..++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 33445567789999999999999988643 34444321 11 11 12356889999999999999988777666
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
. ....++||||+++++|.+++. ....++.+++.+|.+||+ .+++||||||+|||+ +++.++|+|
T Consensus 407 ~-~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 407 D-PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred e-CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEe
Confidence 5 456789999999999998874 356789999999999998 999999999999999 678999999
Q ss_pred eccceec
Q 005257 512 FGLARMH 518 (705)
Q Consensus 512 FGla~~~ 518 (705)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=154.32 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=108.4
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch----------------------hHHHHHHHHHHhccCCCCC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG----------------------GTRAFLAEISSLGRLKHKS 422 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~----------------------~~~~~~~Ei~~l~~l~Hpn 422 (705)
.|...+.||+|+||.||++... +|+.||||++...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4777889999999999999885 6899999987543210 1123567899999998874
Q ss_pred --cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 423 --LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 423 --iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
+...++ ....++||||+++++|..... ......++.+++.++.++|+ .+++||||||+||+
T Consensus 95 i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID-----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee-----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence 344443 234589999999999876542 13456788999999999998 99999999999999
Q ss_pred EccCCCeeeeeeccceecCC
Q 005257 501 LDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~ 520 (705)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.9e-17 Score=184.80 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=143.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
..+|...+.|..|+||.||..+++.+.+++|+| +++.+. ++ +||..+-+ ..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----il-----------Rnilt~a~-------npfvv-- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----IL-----------RNILTFAG-------NPFVV-- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hh-----------hccccccC-------Cccee--
Confidence 457888999999999999999999888999994 432211 11 11222221 11222
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+-...++..+ .++. +++.+++|||+ .+|+|||+||.|.+|+.-|.+|+.|||+.+......
T Consensus 136 ----gDc~tllk~~g---~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG---PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccCC---CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33333343222 3333 23889999998 999999999999999999999999999986432111
Q ss_pred --------------cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhC
Q 005257 523 --------------VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQG 587 (705)
Q Consensus 523 --------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~ 587 (705)
......++||+.|+|||++....|...+|.|++|+++||.+-|..||.++.+. +...+ +.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---is-- 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---IS-- 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hh--
Confidence 11123469999999999999999999999999999999999999999987542 11111 10
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP 627 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 627 (705)
......+-+.....+..+++...++.+|.+|-
T Consensus 273 --------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 --------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00000111223335567777888888999993
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=152.75 Aligned_cols=130 Identities=21% Similarity=0.283 Sum_probs=104.2
Q ss_pred EEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.||+|++|.||+|.+. +..|++|+...... .....+.+|++++..++|+++.....++.. ....++|||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEE
Confidence 3899999999999864 67899998643321 113557789999999998876544444443 456689999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|+++++|.+++.... . .++.+++.+|.+||+ .+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998874321 1 789999999999998 9999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-14 Score=134.01 Aligned_cols=136 Identities=18% Similarity=0.161 Sum_probs=112.8
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCC--CCcceeeeeeeeccCceEEEEeeCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH--KSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++.+... ++..++++||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecC
Confidence 45789999999999999864 6799998865433 5678899999999976 488888887654 467899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
++.+..+ +......++.+++.+|.+||.....+++|+|++|+||+++..+.+++.|||.++..
T Consensus 77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8777543 55677788999999999999844457999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.8e-14 Score=140.21 Aligned_cols=138 Identities=20% Similarity=0.241 Sum_probs=97.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch--hHHHH----------------------HHHHHHhccCCCCC--
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG--GTRAF----------------------LAEISSLGRLKHKS-- 422 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~----------------------~~Ei~~l~~l~Hpn-- 422 (705)
.+.||+|+||.||+|.+. +++.||||++...... ....+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 6889999988654221 11111 34555555554432
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHH-HHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKW-IFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
+.+.++. ...++||||++++.+... +.... .. .+...++.+++.++.++|. .++|+|+||||+||++
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 3333331 235899999998654321 21110 11 6678899999999999996 3899999999999999
Q ss_pred ccCCCeeeeeeccceecCC
Q 005257 502 DKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~ 520 (705)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-14 Score=143.29 Aligned_cols=136 Identities=20% Similarity=0.232 Sum_probs=106.2
Q ss_pred ceEEe-ecCceEEEEEEEcCCCeEEEEEEeccCC-------------chhHHHHHHHHHHhccCCCCCc--ceeeeeeee
Q 005257 369 ENVIG-VGGNGKVYKGVLEGGGAEIAVKRISHEN-------------DGGTRAFLAEISSLGRLKHKSL--VGLRGWCKR 432 (705)
Q Consensus 369 ~~~LG-~G~fg~Vy~~~~~~~~~~vavK~i~~~~-------------~~~~~~~~~Ei~~l~~l~Hpni--v~l~g~~~~ 432 (705)
...|| .||.|+||++... +..++||++.... ......+.+|++++.+|+|+++ +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999999885 6779999875321 1223567889999999998885 566666543
Q ss_pred ccCc---eEEEEeeCCC-CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 433 EKGS---LMLVYDYMEN-GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 433 ~~~~---~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
+... .++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 3332 3599999997 6898887532 34443 36789999999998 9999999999999999988999
Q ss_pred eeeecccee
Q 005257 509 LGDFGLARM 517 (705)
Q Consensus 509 L~DFGla~~ 517 (705)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.4e-13 Score=134.90 Aligned_cols=202 Identities=19% Similarity=0.255 Sum_probs=125.9
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++.+++.|.++.+.|++. .+|+.+|+|+|........||||||+++....
T Consensus 22 ~~W~~~G~t~i~~~~IrLTp~~~~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~--- 90 (229)
T PF03388_consen 22 PNWDIGGSTVITDNFIRLTPDRQSQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDPG--- 90 (229)
T ss_dssp TTEEEEET-EEESSEEEEE-SSTTEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSSS---
T ss_pred CCEEECCeEEecCCEEEECCCcccCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCcc---
Confidence 5899999999999999999999999999999999988 25999999999988556689999999997543
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCC-CCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFN-DIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (705)
..|..+|- .....-+||=||||.|.+-. ......|.+-+|.- +.....-. +.....-++|+..|+
T Consensus 91 -~~G~~fG~-------~~~f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDG----t~~~~~~~--dg~~~~~~~C~~~~r 156 (229)
T PF03388_consen 91 -SDGPVFGG-------PDKFDGLGIFIDTYDNDEGGHKRGFPYISAMLNDG----TKSYDHDN--DGKDQSLGSCSADYR 156 (229)
T ss_dssp -SSCSBTTB--------SS-EEEEEEEEES-TTCTTCTSTSSEEEEEEEES----SS---GGG--TTTTT-SEEEE---B
T ss_pred -ccccccCC-------CcccceEEEEEEcccCCCcccccccceEEEEecCC----Cccccccc--cCcccccccceeccC
Confidence 25666665 23456789999999986321 12334455444431 11110010 101122233433222
Q ss_pred CccccceeecCCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeee
Q 005257 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWS 273 (705)
Q Consensus 195 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~ws 273 (705)
+.+.+.++.|.|....+.|.+...-.........=..++ .-.||+..|+||||+||...+.|.|++-.
T Consensus 157 ----------n~~~p~~~ri~Y~~~~l~v~id~~~~~~~~~~~~Cf~~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s~~ 224 (229)
T PF03388_consen 157 ----------NSDVPTRIRISYSKNTLTVSIDSNYLKNQDDWELCFTTD-GVDLPEGYYFGVSAATGELSDNHDILSVK 224 (229)
T ss_dssp ----------TESSEEEEEEEEETTEEEEEEETSCCSECCTTEEEEEES-TEEGGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred ----------cCCCCEEEEEEEECCeEEEEEecccccCCcCCcEEEEcC-CeecCCCCEEEEEecCCCCCCcEEEEEEE
Confidence 124467899999888888888632111111111111111 11367888999999999999999998853
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-12 Score=128.90 Aligned_cols=186 Identities=18% Similarity=0.148 Sum_probs=124.6
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++ +++.|.+|-+.|+++-+ +|+.+|+|+|+.... .+||||||+++......
T Consensus 21 ~~W~~~G~t~v~~~~IrLTp~-~s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~~-~~gdGla~W~t~~~~~~- 90 (215)
T cd06903 21 PNWQTSGNPKLESGRIILTPP-GNQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPEG-RSGGGLNFWLVKDGNAD- 90 (215)
T ss_pred CCeEEcCcEEeeCCeEEECCC-CCceEeEeeCCcCCCCC-------CEEEEEEEEecccCC-cCCCEEEEEEECCCccc-
Confidence 689999999999999999999 99999999999998842 599999999987643 68999999999764311
Q ss_pred CCCC-CcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecC-CCcccccccccccCCCCCCCCCCCCCCCCC
Q 005257 116 ATEA-QHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVN-SLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193 (705)
Q Consensus 116 ~~~g-~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvn-s~~S~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (705)
.| +.+|- .....-+||.|||+.|. .| .|-+-+| +-+... ...+ +....++|...|
T Consensus 91 --~g~~~fG~-------~~~f~Gl~I~~Dt~~n~---~p---~i~~~~NDGt~~yd-------~~~d-~~~~~g~C~~~~ 147 (215)
T cd06903 91 --VGTSSIYG-------PSKFDGLQLLIDNNGGS---GG---SLRGFLNDGSKDYK-------NEDV-DSLAFGSCLFAY 147 (215)
T ss_pred --CCccccCC-------CCCCcEEEEEEECCCCC---Cc---eEEEEECCCCeecc-------ccCC-cccccceeeEec
Confidence 11 23333 23445689999999873 12 2333222 211111 1111 234445554333
Q ss_pred CCccccceeecCCCcceEEEEEecC--ceEEEEEEEccCCCCCCCceeeeecCccccc-cceecccccccccccccceee
Q 005257 194 DDEKSFKELKLNNGKNYQVWIDYAD--SFINITMVEAGMKRPKRPLLSVPLNLSGVLE-DEMYVGFTAATGQLVESHKIL 270 (705)
Q Consensus 194 ~~~~~~~~~~l~~g~~~~~~I~Y~~--~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~-~~~~vGfsastg~~~~~h~i~ 270 (705)
+ +.+.+.++.|.|.. ..+.|.+. + ...+-...|. || ...|+||||+||...+.|.|+
T Consensus 148 r----------n~~~p~~iri~Y~~~~~~l~v~vd--~----~~Cf~~~~v~----lP~~~y~fGiSAaTg~~~d~hdIl 207 (215)
T cd06903 148 Q----------DSGVPSTIRLSYDALNSLFKVQVD--N----RLCFQTDKVQ----LPQGGYRFGITAANADNPESFEIL 207 (215)
T ss_pred c----------CCCCCEEEEEEEECCCCEEEEEEC--C----CEEEecCCee----cCCCCCEEEEEEcCCCCCCcEEEE
Confidence 2 34558999999955 77777763 2 1111111233 55 457799999999999999999
Q ss_pred eeee
Q 005257 271 AWSF 274 (705)
Q Consensus 271 ~wsf 274 (705)
+-.+
T Consensus 208 ~~~~ 211 (215)
T cd06903 208 KLKV 211 (215)
T ss_pred EEEE
Confidence 8654
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.7e-15 Score=167.75 Aligned_cols=257 Identities=25% Similarity=0.263 Sum_probs=185.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-CCeEEEEEEeccCC--chhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHEN--DGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~ 438 (705)
...|...+.||+|.|+.|-...... ....+|+|.+.... .........|..+-..+. |+|++.+++.... ....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Ccccc
Confidence 3456777789999999998887743 34567777776553 222334455777777776 9999999996655 66788
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeEEccCC-Ceeeeeeccce
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH-EGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLAR 516 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~ 516 (705)
++.+|..++++..-+.... ....+....-.++.|+..++.|+| + .++.||||||+|.+++..+ +.+++|||+|.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988873211 114566677889999999999999 6 9999999999999999999 99999999998
Q ss_pred ecCC--CCcceeeeeec-cccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 517 MHGH--GQVASTTRVVG-TVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 517 ~~~~--~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
.+.. +........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+....... +.....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~----------~~~~~~ 243 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD----------GRYSSW 243 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc----------ccceee
Confidence 7766 33334445678 9999999998874 45788999999999999999999987533211 000011
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.....................+...++..+|..|.+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111000000011122344566777788899999999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-12 Score=143.07 Aligned_cols=143 Identities=16% Similarity=0.164 Sum_probs=100.7
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhH----------------------------------------HHH
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT----------------------------------------RAF 408 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~----------------------------------------~~~ 408 (705)
.+.||.|++|.||+|+++ +|+.||||+.+....... -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 468999999999999987 578999998754321100 024
Q ss_pred HHHHHHhccCC----CCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHH-HHHHHhc
Q 005257 409 LAEISSLGRLK----HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA-GVLYLHE 483 (705)
Q Consensus 409 ~~Ei~~l~~l~----Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 483 (705)
.+|...+.+++ |.+-+.+-.++.+.....+|||||++|++|.++...... .. .+.+++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh
Confidence 44555555542 333344444443334456899999999999987653211 12 24456666666 4677887
Q ss_pred CCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 484 ~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
.+++|+|++|.||+++.++.+++.|||++.....
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=132.32 Aligned_cols=205 Identities=17% Similarity=0.293 Sum_probs=142.5
Q ss_pred HHHhccCCCCCcceeeeeeeec----cCceEEEEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCC
Q 005257 412 ISSLGRLKHKSLVGLRGWCKRE----KGSLMLVYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWE 486 (705)
Q Consensus 412 i~~l~~l~Hpniv~l~g~~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~ 486 (705)
..-|-.+-|-|||+++.|..+. +.+..++.|||..|+|..+|++.+. ...+......+++-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445566799999999987542 3467899999999999999987432 3468888999999999999999997 78
Q ss_pred CCeeecCCCCCCeEEccCCCeeeeeeccceec---CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHh
Q 005257 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH---GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL 563 (705)
Q Consensus 487 ~~iiHrDLkp~NILld~~~~~kL~DFGla~~~---~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ell 563 (705)
++|+|+++..+-|++..++-+|++----.... ............+-++|.|||.=.....+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998887532111000 000111122245678999999877777788999999999999998
Q ss_pred hCCCCCCCC-CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 564 SGRRPIEEG-KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 564 tG~~Pf~~~-~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
-+..--... ....++. .+...+ +.... ..-...+..|++..|+.||+|++++.+
T Consensus 277 ilEiq~tnseS~~~~ee--------~ia~~i---~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEE--------NIANVI---IGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhh--------hhhhhe---eeccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 876542221 1111100 000000 00000 011346678999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.5e-12 Score=139.04 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=181.8
Q ss_pred CCCcceEEee--cCceEEEEEEE--cCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCce
Q 005257 365 GFSEENVIGV--GGNGKVYKGVL--EGGGAEIAVKRISHEND--GGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 365 ~f~~~~~LG~--G~fg~Vy~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 437 (705)
.|...+.+|. |.+|.||.+.. ...+..+|+|+-+.... .....=.+|+..-.++ .|+|.++....... .+.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcc
Confidence 4566778999 99999999998 78889999998443322 3333345677777777 49999996665544 7788
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA----GVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDF 512 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DF 512 (705)
++-+|++. .+|..+.+.... .++...++....+... ||.++|. ..++|-|+||.||++..+ ..++++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 99999985 688777754322 4778888888888888 9999998 999999999999999999 88999999
Q ss_pred ccceecCCCCcce----eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 513 GLARMHGHGQVAS----TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 513 Gla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
|+...+..+.... ..+..|...|++||.+.+ -++...|+|++|.+++|..++..+...+... .|....++.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----~W~~~r~~~ 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS----SWSQLRQGY 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC----Ccccccccc
Confidence 9998877654222 222357778999998754 6788999999999999999987776544211 123333322
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+... +...-...+.....++++.+|..|++.+.+..
T Consensus 343 ip~e----------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 IPLE----------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Cchh----------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 2221 11111233444777889999999999887765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=136.63 Aligned_cols=147 Identities=13% Similarity=0.126 Sum_probs=96.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch----------------------------------hHH--
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG----------------------------------GTR-- 406 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~----------------------------------~~~-- 406 (705)
-..|+. +.||.|++|+||+|+++++|+.||||+.+..... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 7899999999999999987999999998643110 011
Q ss_pred ----HHHHHHHHhccCC----CCCcceeeeeeeeccCceEEEEeeCCCCChhHHH--HhcCC-CCcccHHHHHHHHHHHH
Q 005257 407 ----AFLAEISSLGRLK----HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI--FQCDG-SMMLSCEERIRVLKDVA 475 (705)
Q Consensus 407 ----~~~~Ei~~l~~l~----Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L--~~~~~-~~~l~~~~~~~i~~qia 475 (705)
+|.+|...+.+++ +.+.+.+-.++.+-....+|||||++|+.+.++- ...+. ...+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1344444444442 3333443333333334568999999999998753 22110 01233333333344432
Q ss_pred HHHHHHhcCCCCCeeecCCCCCCeEEccCC----CeeeeeeccceecCC
Q 005257 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDFGLARMHGH 520 (705)
Q Consensus 476 ~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DFGla~~~~~ 520 (705)
. .+++|+|+||.||+++.++ .+++.|||++.....
T Consensus 278 -------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 8999999999999999888 999999999976644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=128.54 Aligned_cols=171 Identities=19% Similarity=0.297 Sum_probs=130.9
Q ss_pred EEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCc
Q 005257 382 KGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM 461 (705)
Q Consensus 382 ~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~ 461 (705)
.|..+.++.+|.|...+..+........+-++.|+.||||||++++..... ++.+|||+|-+. -|..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH------
Confidence 566777888999998877766556667888999999999999999996554 779999999984 67777754
Q ss_pred ccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCcccc
Q 005257 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541 (705)
Q Consensus 462 l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~ 541 (705)
+......-.+.||+.||.+||+ +.+++|++|.-.-|+++..|..||++|.++........ ......--..|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 3455566678999999999997 58999999999999999999999999998864432221 00001112246667655
Q ss_pred ccCCCCccccEEEEehhHHHHhhCC
Q 005257 542 SSGRASTQTDVFGFGILILEVLSGR 566 (705)
Q Consensus 542 ~~~~~s~ksDVwS~Gvvl~ElltG~ 566 (705)
.... -..|.|-|||+++|++.|.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCcc
Confidence 3322 4579999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.9e-11 Score=114.39 Aligned_cols=132 Identities=17% Similarity=0.078 Sum_probs=96.0
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGS 448 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gs 448 (705)
.+.|+.|.++.||++... +..+++|....... ....+..|++++..+.+.++++.+-++. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999875 67899998754432 2234678999999987666554333232 223479999999988
Q ss_pred hhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 449 LDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW--EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 449 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+.... .....++.+++++|..||... ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 78 l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 111345678999999999821 12369999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.9e-10 Score=113.58 Aligned_cols=195 Identities=19% Similarity=0.249 Sum_probs=134.2
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|...+...-|+||.+.+++.|.++=..||... +|.-.+.|.|..+.....|||||+.++-...
T Consensus 72 ~~W~~~Gstvv~~~~irLT~d~qsk~GAv~n~~Pv~s~--------~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~--- 140 (351)
T KOG3839|consen 72 PNWNLSGSTVVTSNYIRLTPDEQSKSGAVWNRQPVFSR--------DWEVLVHFKVHGQSKNLFGDGMAIWYTKERA--- 140 (351)
T ss_pred cCccccccEEEEeeeeeccccccccccccccCCCcccc--------ceeEEEEEEEecCCCcccccceEEEeecccc---
Confidence 68999999999988999999999999999999999753 5999999999999888899999999987643
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCe--eEEecCCCcccccccccccCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENH--VGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~H--vgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (705)
..|..+|-+. ..+.+||=.|||.|.+ +-+..-| |.+.+|.. +.+|.-+.+.-.+-..+|
T Consensus 141 -q~GPvFG~~d-------kF~GL~vfidtY~n~~-g~~~~v~P~isvmv~~g------s~sYD~~~Dg~~tel~gc---- 201 (351)
T KOG3839|consen 141 -QPGPVFGSKD-------KFTGLAVFIDTYGNHN-GPHEHVFPYISVMVNIG------SLSYDHSKDGTHTELAGC---- 201 (351)
T ss_pred -cCCCCCCCcc-------cceeEEEEEeccCCcC-CCcccceeeEEEEeccC------CcccccCCCCCccccccc----
Confidence 2566677643 3467899999998853 1122111 22222211 222222211111111112
Q ss_pred CCccccceeecCCCc-ceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCccc-cccceecccccccccccccceeee
Q 005257 194 DDEKSFKELKLNNGK-NYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGV-LEDEMYVGFTAATGQLVESHKILA 271 (705)
Q Consensus 194 ~~~~~~~~~~l~~g~-~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~-l~~~~~vGfsastg~~~~~h~i~~ 271 (705)
...+++.. --.+-|.|..+++++.....+ |. ....-.++..+ ||.--|+|+||+||...+.|.|.+
T Consensus 202 -------~a~~rn~~~dt~~~iry~~~~l~~~~dl~~---~~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS 269 (351)
T KOG3839|consen 202 -------TANFRNLPHDTLVVIRYEKKTLSISIDLEG---PN--EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVS 269 (351)
T ss_pred -------eeeeccCCCcceeEEEecCCceEEEEecCC---Cc--eeeeeeeecceecccceEEeeeeccCccchhhHHHH
Confidence 11222221 134668898888888877654 22 24555777776 788899999999999999999988
Q ss_pred e
Q 005257 272 W 272 (705)
Q Consensus 272 w 272 (705)
-
T Consensus 270 ~ 270 (351)
T KOG3839|consen 270 L 270 (351)
T ss_pred h
Confidence 6
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=9e-10 Score=108.20 Aligned_cols=140 Identities=16% Similarity=0.128 Sum_probs=99.7
Q ss_pred ceEEeecCceEEEEEEEcC------CCeEEEEEEeccCC----------------------chhHHHHH----HHHHHhc
Q 005257 369 ENVIGVGGNGKVYKGVLEG------GGAEIAVKRISHEN----------------------DGGTRAFL----AEISSLG 416 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~------~~~~vavK~i~~~~----------------------~~~~~~~~----~Ei~~l~ 416 (705)
...||.|--+.||.|...+ .+..+|||+.+... ....+.+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 35789999764321 01122333 7999999
Q ss_pred cCCC--CCcceeeeeeeeccCceEEEEeeCCCCChhH-HHHhcCCCCcccHHHHHHHHHHHHHHHHHH-hcCCCCCeeec
Q 005257 417 RLKH--KSLVGLRGWCKREKGSLMLVYDYMENGSLDK-WIFQCDGSMMLSCEERIRVLKDVAAGVLYL-HEGWEKKVLHR 492 (705)
Q Consensus 417 ~l~H--pniv~l~g~~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiHr 492 (705)
++.. -++.+.+.+ ..-+|||||+.+..+.. .+.+ ..++..+...+..+++.+|..| |. .++||+
T Consensus 82 rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 9854 344555543 23479999997654422 2221 1345566778889999999999 76 899999
Q ss_pred CCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 493 DIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 493 DLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||++.|||++ ++.+.|+|||.+-...+.
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999999997 468999999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-10 Score=127.32 Aligned_cols=248 Identities=20% Similarity=0.220 Sum_probs=170.4
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEc-CCCeEEEEEEeccCCchhHHH--HHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLE-GGGAEIAVKRISHENDGGTRA--FLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~i~~~~~~~~~~--~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
.-+.+|.....||.|.|+.|++...+ .++..+++|.+.........+ -+.|+.+...+ .|.++++....... ...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-ccc
Confidence 34567889999999999999998876 667889999876553332222 24566555555 47777765443332 345
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLA 515 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla 515 (705)
.++--||++++++...+. ....+.+..++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence 568899999999877662 12267888899999999999999998 999999999999999876 88899999998
Q ss_pred eecCCCCcceeeeeeccccCC--CccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYL--APEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
..+.-. .....+.-+++ +++......+..+.|++|||.-+.|.+++...-..... |..+..+....
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~~~i~~~~~p~-- 482 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------SLTIRSGDTPN-- 482 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------ceeeecccccC--
Confidence 642111 11112233444 44445556788999999999999999998654333221 11222222111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.......+..+......+++..||.+.++..+.+
T Consensus 483 ----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 ----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----------CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1112245566666778899999999887766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.2e-09 Score=106.71 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=109.4
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCC--Ccceeeeeeeecc--CceEEEEee
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHK--SLVGLRGWCKREK--GSLMLVYDY 443 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hp--niv~l~g~~~~~~--~~~~lV~E~ 443 (705)
.+.|+.|..+.||++...+ |+.+++|....... .....+..|.++++.+++. ++.+++.++.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3568999999999998854 57899998754322 1355788999999999764 3566777654321 356899999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG--------------------------------------- 484 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 484 (705)
+++.++...+.. ..++..++..++.+++++|..||+.
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888775521 1467778888888999999888842
Q ss_pred --------------CCCCeeecCCCCCCeEEcc--CCCeeeeeecccee
Q 005257 485 --------------WEKKVLHRDIKSSNVLLDK--EMNGRLGDFGLARM 517 (705)
Q Consensus 485 --------------~~~~iiHrDLkp~NILld~--~~~~kL~DFGla~~ 517 (705)
....++|+|+.|.||+++. ++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2e-08 Score=103.43 Aligned_cols=193 Identities=20% Similarity=0.287 Sum_probs=128.8
Q ss_pred CeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCCC
Q 005257 37 NLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGA 116 (705)
Q Consensus 37 ~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~~ 116 (705)
-|...|||-.....|+|+++-.++.|.+|-+..+++ --|...-+|+|+..+ -.++|||||..+....
T Consensus 55 FW~~~GdAIas~eqvRlaPSmrsrkGavWtka~~~f--------e~weVev~~rVtGrG-RiGAdGlaiWYt~~~G---- 121 (497)
T KOG3838|consen 55 FWSHHGDAIASSEQVRLAPSMRSRKGAVWTKASVPF--------ENWEVEVQFRVTGRG-RIGADGLAIWYTRGRG---- 121 (497)
T ss_pred eeeecCcccccccceeeccccccccCceeecccCCc--------ccceEEEEEEecccc-cccCCceEEEEecCCC----
Confidence 488999999888899999999999999977666655 348999999999874 4579999999986532
Q ss_pred CCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCC-CCCCCCCCCCCCCCC
Q 005257 117 TEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQ-TDSSGSNSNSGTGDD 195 (705)
Q Consensus 117 ~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 195 (705)
--|..+|-.+ .=.-+++=||.|-|+ +.-|..-|.+-.|.-. .+ |+..+ .-+-+-.+|
T Consensus 122 ~~GpVfGg~d-------~WnGigiffDSfdnD--~qknnP~Is~~lndGt----~~---ydh~~DGasQ~LssC------ 179 (497)
T KOG3838|consen 122 HVGPVFGGLD-------SWNGIGIFFDSFDND--GQKNNPAISVLLNDGT----IP---YDHPGDGASQGLSSC------ 179 (497)
T ss_pred cccccccccc-------cccceEEEeeccccc--CCcCCccEEEEecCCc----cc---ccCCCccHHHHHHHh------
Confidence 2344444322 223479999999986 4445666666554421 11 11111 001111222
Q ss_pred ccccceeecCCC-cceEEEEEecCceEEEEEEEccCCCCCCC-ceeeeecCcc-ccccceecccccccccccccceeeee
Q 005257 196 EKSFKELKLNNG-KNYQVWIDYADSFINITMVEAGMKRPKRP-LLSVPLNLSG-VLEDEMYVGFTAATGQLVESHKILAW 272 (705)
Q Consensus 196 ~~~~~~~~l~~g-~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~-~ls~~vdl~~-~l~~~~~vGfsastg~~~~~h~i~~w 272 (705)
..++.|. -++.|.|+|-...|.|.+...- .|..+ -+- ++... .||..-|+|.|||||....-|+|++.
T Consensus 180 -----qrDFRNkPyPvRarItY~~nvLtv~innGm--tp~d~yE~C--~rve~~~lp~nGyFGvSAATGgLADDHDVl~F 250 (497)
T KOG3838|consen 180 -----QRDFRNKPYPVRARITYYGNVLTVMINNGM--TPSDDYEFC--VRVENLLLPPNGYFGVSAATGGLADDHDVLSF 250 (497)
T ss_pred -----hHHhccCCCCceEEEEEeccEEEEEEcCCC--CCCCCccee--EeccceeccCCCeeeeeecccccccccceeee
Confidence 2344444 3789999998888888775432 33322 122 33333 47899999999999999999999987
Q ss_pred e
Q 005257 273 S 273 (705)
Q Consensus 273 s 273 (705)
.
T Consensus 251 l 251 (497)
T KOG3838|consen 251 L 251 (497)
T ss_pred E
Confidence 3
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-08 Score=95.53 Aligned_cols=142 Identities=17% Similarity=0.251 Sum_probs=102.4
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccC--C------chhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceE
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--N------DGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLM 438 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~------~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~ 438 (705)
....|-+|+-+.|+++.+. |+.+.||.-... . .-..+..++|.+.|.+++--.|. +.+-+|. ...-.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCe
Confidence 5678999999999999986 677788753221 1 11235678899999998755553 2232333 23346
Q ss_pred EEEeeCCC-CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeeeecc
Q 005257 439 LVYDYMEN-GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGDFGL 514 (705)
Q Consensus 439 lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~DFGl 514 (705)
|+|||+++ .++.+++...... .........++.+|-+.+.-||. ..+||+||..+||+|..+++ +.+.|||+
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecc
Confidence 89999976 4788888664332 22333337889999999999998 99999999999999976553 58999999
Q ss_pred cee
Q 005257 515 ARM 517 (705)
Q Consensus 515 a~~ 517 (705)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=97.01 Aligned_cols=130 Identities=21% Similarity=0.254 Sum_probs=95.0
Q ss_pred EEeecCceEEEEEEEcCCCeEEEEEEeccC--Cch------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDG------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.+++|+-+.+|.+.+. |.++++|.-... ... ....-.+|.++|.+++--.|.--.-+..+ .+...|+||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEEE
Confidence 5789999999999775 455777743222 111 12346789999999875544322222222 445679999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|++|-.|.+.+... ...++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888543 25677788888889998 9999999999999998764 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.9e-10 Score=129.05 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=164.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
..+.|.+.+-+-+|.++.++.+.-...+...++|..... .....+....+-.++-..++|-++...--+. .....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcc
Confidence 344566667778899999988877666644444443222 2222333334444444445565554443322 245789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
|+++|..+++|...|+... ..+..-....+..+..+++|||. ..+.|||++|.|++...++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999887644 34555556677788899999998 66999999999999999999999999843211
Q ss_pred C---------------------CCC----c-----ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC
Q 005257 519 G---------------------HGQ----V-----ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568 (705)
Q Consensus 519 ~---------------------~~~----~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P 568 (705)
. ... . .......||+.|.+||.+.+......+|.|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 000 0 112235789999999999999999999999999999999999999
Q ss_pred CCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 005257 569 IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMR 630 (705)
Q Consensus 569 f~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 630 (705)
|....+. .+.+.+..+.+ ....-+.........++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq---~~f~ni~~~~~---------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ---QIFENILNRDI---------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchh---hhhhccccCCC---------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9875432 12222222211 11222233334455566666667787776554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.6e-08 Score=105.56 Aligned_cols=171 Identities=20% Similarity=0.305 Sum_probs=132.6
Q ss_pred ceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee---ccCceEEEEeeCCC-CChhHH
Q 005257 377 NGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR---EKGSLMLVYDYMEN-GSLDKW 452 (705)
Q Consensus 377 fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---~~~~~~lV~E~~~~-gsL~~~ 452 (705)
-.+.||+...-+|..+++|+++....+.......-++.++++.|+|+|++..++.. .+..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 46899999999999999999965554444444566889999999999999987752 24578999999985 467665
Q ss_pred HHhcC------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 453 IFQCD------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 453 L~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
-+... .....++..+|.++.|+..||.++|+ .|+.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 11257889999999999999999999 8999999999999999999999999888776544
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P 568 (705)
+.. |-+. --.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 330 1111 12356777899999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-07 Score=96.88 Aligned_cols=142 Identities=16% Similarity=0.112 Sum_probs=100.5
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hH----------HHHHHHHHHhccCCCCCc--ceeeeeeeec---
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GT----------RAFLAEISSLGRLKHKSL--VGLRGWCKRE--- 433 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~----------~~~~~Ei~~l~~l~Hpni--v~l~g~~~~~--- 433 (705)
+.+-.-....|+++... |+.+.||+....... .. ..+.+|...+.+|...+| .+.+++....
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44554444557777663 678999976433211 11 137789999888854443 3344443321
Q ss_pred -cCceEEEEeeCCCC-ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-------C
Q 005257 434 -KGSLMLVYDYMENG-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-------E 504 (705)
Q Consensus 434 -~~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-------~ 504 (705)
...-+||+|++++- +|.+++..... ...+...+..++.+++..+.-||. .+|+|+|++++|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 22468999999876 89998854322 245667788999999999999998 99999999999999975 4
Q ss_pred CCeeeeeecccee
Q 005257 505 MNGRLGDFGLARM 517 (705)
Q Consensus 505 ~~~kL~DFGla~~ 517 (705)
..+.|+||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.5e-07 Score=89.55 Aligned_cols=127 Identities=24% Similarity=0.332 Sum_probs=81.5
Q ss_pred EEEEEEEcCCCeEEEEEEeccCC--------------c--------h----hHHHHHHHHHHhccCCCCC--cceeeeee
Q 005257 379 KVYKGVLEGGGAEIAVKRISHEN--------------D--------G----GTRAFLAEISSLGRLKHKS--LVGLRGWC 430 (705)
Q Consensus 379 ~Vy~~~~~~~~~~vavK~i~~~~--------------~--------~----~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~ 430 (705)
.||.|... ++..+|||..+... . . ......+|.+.|.++...+ +.+.+.+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 48999885 47799999864320 0 0 0123567999999997664 4455543
Q ss_pred eeccCceEEEEeeCC--CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 431 KREKGSLMLVYDYME--NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY-LHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 431 ~~~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
. .-+|||||++ +..+..+. .. .++..+...++.+++..+.. +|. .+++|+||.+.|||++++ .+
T Consensus 79 -~---~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 -N---RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp -E---TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred -e---CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 1 2379999998 54554433 21 12245566778888886666 466 999999999999999988 99
Q ss_pred eeeeeccceecCC
Q 005257 508 RLGDFGLARMHGH 520 (705)
Q Consensus 508 kL~DFGla~~~~~ 520 (705)
.|+|||.+....+
T Consensus 146 ~iIDf~qav~~~~ 158 (188)
T PF01163_consen 146 YIIDFGQAVDSSH 158 (188)
T ss_dssp EE--GTTEEETTS
T ss_pred EEEecCcceecCC
Confidence 9999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.5e-06 Score=90.15 Aligned_cols=260 Identities=18% Similarity=0.196 Sum_probs=161.4
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeee------eeccCceEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWC------KREKGSLML 439 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~------~~~~~~~~l 439 (705)
...+.||+|+-+.+|-.--- ...+-|+..........+.. ..|... .||-+-.-+.|= -++.....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34677999999999964322 12455777655443333322 233333 566443322221 122223677
Q ss_pred EEeeCCCCCh-hHHHH---hcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 440 VYDYMENGSL-DKWIF---QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 440 V~E~~~~gsL-~~~L~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.|..+++..= ..++. +........|.-.++.++.+|.+.+-||+ .|.+-+|+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 8888766422 22221 11222357899999999999999999998 99999999999999999999999885544
Q ss_pred eecCCCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhC-CCCCCCC-----CccHHHHHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSG-RRPIEEG-----KPNLVEMVWELM 584 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG-~~Pf~~~-----~~~~~~~v~~~~ 584 (705)
....++.. ....+|...|.+||.-. +...+...|-|.+|+++++++.| ++||.+. .++..+ ..+
T Consensus 165 qi~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~I 239 (637)
T COG4248 165 QINANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDI 239 (637)
T ss_pred eeccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhh
Confidence 44333322 22347889999999754 34567889999999999999885 9999752 111111 123
Q ss_pred HhCchhHHHHHhhhc---CCCCCHH-HHHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHhcc
Q 005257 585 VQGKLLDALDARLRA---KGGFDED-EVERVLHLGLLCAYP--DPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 585 ~~~~~~~~id~~l~~---~~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~~~ 640 (705)
..|.....-+.+... ...++-. ....+..+..+|... ++.-|||++..+..|..+.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 334443333322211 1122222 124566677778753 4778999999988876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-07 Score=106.63 Aligned_cols=151 Identities=22% Similarity=0.351 Sum_probs=102.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce----e----eeeeccccCCCccccc
Q 005257 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS----T----TRVVGTVGYLAPEVFS 542 (705)
Q Consensus 471 ~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~----~----~~~~gt~~y~APE~~~ 542 (705)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+.......... . .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998 5899999999999999999999999999875443311100 0 0012345799999999
Q ss_pred cCCCCccccEEEEehhHHHHhhCCCC-CCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCC
Q 005257 543 SGRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYP 621 (705)
Q Consensus 543 ~~~~s~ksDVwS~Gvvl~ElltG~~P-f~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~ 621 (705)
....+.++|+||+||++|-+..|..+ +......+ ..- ..+.. .+... ..++...+.++.+-+.+.+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~----~~~~~---~~~~~---~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYS----FSRNL---LNAGA---FGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc-hhh----hhhcc---ccccc---ccccccCcHHHHHHHHHHhcC
Confidence 88899999999999999999854444 43322111 000 00000 00011 223344556677777788899
Q ss_pred CCCCCCCHHHHHH
Q 005257 622 DPRARPTMRQVVK 634 (705)
Q Consensus 622 dP~~RPs~~evl~ 634 (705)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877654
|
|
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-05 Score=79.57 Aligned_cols=95 Identities=14% Similarity=0.132 Sum_probs=71.2
Q ss_pred ecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCC-CCCCCCCCccccc
Q 005257 47 ESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHG-IKGATEAQHLGLF 125 (705)
Q Consensus 47 ~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~-~~~~~~g~~lGl~ 125 (705)
.++.||||+...++.|-+.|.+++|--+. -...+|.+..-.. ...++||+||||+--.. ...+..||.||+-
T Consensus 30 ~~g~LRLT~~~~nqata~~~~~~FPs~~n------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa 102 (255)
T cd06900 30 VNNRLRLTDASGNQATAVTLQRLFPSAGN------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYA 102 (255)
T ss_pred ccCeEEeccCccCcceeEEEeeeeccCCC------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccc
Confidence 48999999999999999999999987432 2777888877654 45589999999984322 2245678899997
Q ss_pred ccC-CCCCCCCcEEEEEeecccCC
Q 005257 126 NRT-NDGNSSNHVFGVEFDVFKNQ 148 (705)
Q Consensus 126 ~~~-~~~~~~~~~vaVEFDt~~n~ 148 (705)
.++ .........++|-||-|-|.
T Consensus 103 ~~~~~~~GfaGGwLGiGlDEyGNF 126 (255)
T cd06900 103 QRNDGVPGFAGGWLGIGLDEYGNF 126 (255)
T ss_pred cccCCCCccccceEEEEEeccccc
Confidence 664 23335667889999987773
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=88.27 Aligned_cols=137 Identities=23% Similarity=0.269 Sum_probs=95.2
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc----------------------hhHHHHHHHHHHhccCCCC--C
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND----------------------GGTRAFLAEISSLGRLKHK--S 422 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~----------------------~~~~~~~~Ei~~l~~l~Hp--n 422 (705)
.+...||-|--+.||.|..+ .|.++|||.-+.... -....-.+|.+.|.+|.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999997 478899995432110 0112346799999999655 6
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
+.+.++| +...+||||+++-.|...- +.....-.++..|+.-+.-+-. .|+||+|+.+-||+++
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 6666664 3457999999886664431 1233333344444444443334 8999999999999999
Q ss_pred cCCCeeeeeeccceecCC
Q 005257 503 KEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 503 ~~~~~kL~DFGla~~~~~ 520 (705)
++|.+.++||--+....+
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999987754433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.7e-06 Score=83.04 Aligned_cols=139 Identities=22% Similarity=0.210 Sum_probs=104.0
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccC-----C-chhHHHHHHHHHHhccCCCCC--cceeeeeeeecc----CceEE
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE-----N-DGGTRAFLAEISSLGRLKHKS--LVGLRGWCKREK----GSLML 439 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-----~-~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~~----~~~~l 439 (705)
-|+||-+.|++..+. |..+-+|+-... . ..+...|.+|+..|.+|..-+ +.+.. ++...+ ...+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467999999998775 446889976421 1 335678999999999996433 33333 332111 23689
Q ss_pred EEeeCCC-CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC--eeeeeeccce
Q 005257 440 VYDYMEN-GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN--GRLGDFGLAR 516 (705)
Q Consensus 440 V~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~--~kL~DFGla~ 516 (705)
|+|-+++ -+|.+++.+.... +.+..++..++.+++..+.-||+ .++.|+|+-+.|||++.++. ++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9997753 5888888553322 56788889999999999999998 99999999999999986667 8999998765
Q ss_pred e
Q 005257 517 M 517 (705)
Q Consensus 517 ~ 517 (705)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.3e-06 Score=84.38 Aligned_cols=108 Identities=22% Similarity=0.275 Sum_probs=83.9
Q ss_pred HHHHHHHHHHhccCCCCC--cceeeeeeeecc---CceEEEEeeCCCC-ChhHHHHhcCCCCcccHHHHHHHHHHHHHHH
Q 005257 405 TRAFLAEISSLGRLKHKS--LVGLRGWCKREK---GSLMLVYDYMENG-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGV 478 (705)
Q Consensus 405 ~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~~---~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL 478 (705)
.....+|...+.+|+... ..+.+++..... ...+||+|++++. +|.+++.... .++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 345778888888886443 345555554322 2358999999874 7999886533 256677889999999999
Q ss_pred HHHhcCCCCCeeecCCCCCCeEEccCC---Ceeeeeeccceec
Q 005257 479 LYLHEGWEKKVLHRDIKSSNVLLDKEM---NGRLGDFGLARMH 518 (705)
Q Consensus 479 ~yLH~~~~~~iiHrDLkp~NILld~~~---~~kL~DFGla~~~ 518 (705)
.-||+ .+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 9999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.2e-05 Score=78.44 Aligned_cols=139 Identities=16% Similarity=0.190 Sum_probs=81.9
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc--ceeeeeeeeccCceEEEEeeCCCC
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL--VGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..-.+ .+.++++.. .+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCc
Confidence 568999999999842 3457788765432 33456889999999864444 455665543 55678899999886
Q ss_pred C-hhHHH---------------------HhcCCCCcccHHHHH-HHHH----------HHHH-HHHHHhc-CCCCCeeec
Q 005257 448 S-LDKWI---------------------FQCDGSMMLSCEERI-RVLK----------DVAA-GVLYLHE-GWEKKVLHR 492 (705)
Q Consensus 448 s-L~~~L---------------------~~~~~~~~l~~~~~~-~i~~----------qia~-gL~yLH~-~~~~~iiHr 492 (705)
. +...+ +..... ........ .+.. .+.. ...+|.. .....++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 21111 111000 01111000 0000 0011 1122221 113567999
Q ss_pred CCCCCCeEEccCCCeeeeeecccee
Q 005257 493 DIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 493 DLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|+.|.||++++++ +.|.||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.8e-05 Score=88.94 Aligned_cols=143 Identities=17% Similarity=0.152 Sum_probs=91.7
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh------------------------------HH----------HHH
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG------------------------------TR----------AFL 409 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~------------------------------~~----------~~~ 409 (705)
+.|+.++-|.||+|+++. |+.||||+.+..-... .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999985 8999999865421100 01 133
Q ss_pred HHHHHhccCC----CCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC
Q 005257 410 AEISSLGRLK----HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485 (705)
Q Consensus 410 ~Ei~~l~~l~----Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 485 (705)
+|..-+.+++ +..-+.+-.++.+-.+.-.|+|||++|-.+.+...-... .++.+.+.....++.- .-+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f~--~q~~--- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAFL--RQLL--- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHHH--HHHH---
Confidence 4544444442 222333334444334556899999999999888532221 2443333322222211 1111
Q ss_pred CCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
..+++|.|..|.||+++.++.+.+.|||+.....+
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 26899999999999999999999999999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.8e-05 Score=74.43 Aligned_cols=145 Identities=16% Similarity=0.169 Sum_probs=85.1
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeeeeeec--cCceEEEEeeC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGWCKRE--KGSLMLVYDYM 444 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~--~~~~~lV~E~~ 444 (705)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++.++... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4679999999999999875 47999986543 45567788999988885433 44556544321 23468999999
Q ss_pred CCCChhH----------------HHH---hcC-CCCcccHHH---------HHHH------------HHHHHH-HHHHHh
Q 005257 445 ENGSLDK----------------WIF---QCD-GSMMLSCEE---------RIRV------------LKDVAA-GVLYLH 482 (705)
Q Consensus 445 ~~gsL~~----------------~L~---~~~-~~~~l~~~~---------~~~i------------~~qia~-gL~yLH 482 (705)
++..+.. .+. ... ....+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 111 110 000111100 0000 111222 233333
Q ss_pred c----CCCCCeeecCCCCCCeEEc-cCCCeeeeeecccee
Q 005257 483 E----GWEKKVLHRDIKSSNVLLD-KEMNGRLGDFGLARM 517 (705)
Q Consensus 483 ~----~~~~~iiHrDLkp~NILld-~~~~~kL~DFGla~~ 517 (705)
+ .....++|+|+.|.|||++ +++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 2357899999999999999 666667999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.9e-06 Score=95.51 Aligned_cols=183 Identities=17% Similarity=0.118 Sum_probs=130.7
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC-cceeeeeeeeccCceEEEEeeCCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS-LVGLRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~~lV~E~~~~ 446 (705)
..+-+++|++++++|.+...+.. ...+.+... ....-++++|.+++||| .+..++-+.. +...+++++++.+
T Consensus 246 ~fh~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhhhhcC
Confidence 34457899999999987754433 335555332 34456889999999999 6666665543 5678899999987
Q ss_pred C-ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 447 G-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 447 g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+ +-..-. ......+...+...+.+.-+++|++||+ ..-+|+| ||+..+ ...|.+||+.+..+.... .
T Consensus 319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred CccccccC--ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 7 221111 1111134445556677778899999998 4458888 777765 678999999988766544 2
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCC
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf 569 (705)
.....+|+.|+|||+.....+..+.|+|+.|+--.++.-|-.|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 33467899999999999999999999999999777777776664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00019 Score=71.35 Aligned_cols=140 Identities=16% Similarity=0.200 Sum_probs=91.5
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHH---------HHHHHHHhccCCCC---Ccceeee
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA---------FLAEISSLGRLKHK---SLVGLRG 428 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~---------~~~Ei~~l~~l~Hp---niv~l~g 428 (705)
...++|...+++-......|.+-... +..+++|..+.......+. ..+++..+.+++.. ....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 35567888888887777777666554 6889999876543322222 23444444444322 2222222
Q ss_pred eeeec----cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 429 WCKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 429 ~~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
++... ....+++|||++|..|.++. .++. .+...+++++.-||. .|+.|+|..|.|++++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 22211 12456899999998887654 1222 244567788999998 999999999999999865
Q ss_pred CCeeeeeecccee
Q 005257 505 MNGRLGDFGLARM 517 (705)
Q Consensus 505 ~~~kL~DFGla~~ 517 (705)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00022 Score=71.64 Aligned_cols=156 Identities=19% Similarity=0.219 Sum_probs=100.4
Q ss_pred ccCHHHHHHHhCCCCcceEEe---ecCceEEEEEEEcCCCeEEEEEEeccCCch-------------------hHHH---
Q 005257 353 RITYQEIEAATKGFSEENVIG---VGGNGKVYKGVLEGGGAEIAVKRISHENDG-------------------GTRA--- 407 (705)
Q Consensus 353 ~~~~~el~~at~~f~~~~~LG---~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-------------------~~~~--- 407 (705)
..+.+.+....++..+....| .|--+.||+|... ++..+|||+....... ..++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 456667777777766666555 5666789998763 4788999988643211 1111
Q ss_pred --HHHHHHHhccCCCC--CcceeeeeeeeccCceEEEEeeCCCCCh-hHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHh
Q 005257 408 --FLAEISSLGRLKHK--SLVGLRGWCKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482 (705)
Q Consensus 408 --~~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~~~lV~E~~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH 482 (705)
..+|+.-|.++... .+.+-+++. .-.|||||+....+ .-.|.. ..+...+...+..++++.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR-----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec-----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHH
Confidence 13566666666422 333334322 22699999965311 111111 12334466777778888887776
Q ss_pred cCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 483 ~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
. ..++||+||..=|||+. ++.+.|+|+|-|....++
T Consensus 184 ~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 184 K--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred H--hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 5 48999999999999999 889999999998765543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.80 E-value=6.3e-05 Score=73.90 Aligned_cols=103 Identities=19% Similarity=0.151 Sum_probs=81.2
Q ss_pred HHHHHhccCCC-CCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005257 410 AEISSLGRLKH-KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488 (705)
Q Consensus 410 ~Ei~~l~~l~H-pniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 488 (705)
.|.-+++.+++ +++.+++|.|-. ++|.||.+.+++...-.....-...+|..|.+|+.++++.+.+|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47778888866 589999999943 578999987766421000000014689999999999999999999876666
Q ss_pred eeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 489 iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+.-.|++++|+-+++++++|+.|...+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00014 Score=81.72 Aligned_cols=144 Identities=19% Similarity=0.191 Sum_probs=92.0
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-------------------------------hHH------HHHHH
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-------------------------------GTR------AFLAE 411 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-------------------------------~~~------~~~~E 411 (705)
.+.||.-+.|.||+|++++ |+.||||+-+..-.. ..+ +|.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4679999999999999987 899999975432100 001 24445
Q ss_pred HHHhccC----CCCC---cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC
Q 005257 412 ISSLGRL----KHKS---LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484 (705)
Q Consensus 412 i~~l~~l----~Hpn---iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 484 (705)
.+-..+. +|-+ -|.+-.++.+-.....|+||||+|..+.+.-.-.+. .++...+..-+.+...-+-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qI----- 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQI----- 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHH-----
Confidence 4433333 3555 122333333333466899999999988776533222 3555554444444322222
Q ss_pred CCCCeeecCCCCCCeEEcc----CCCeeeeeeccceecCC
Q 005257 485 WEKKVLHRDIKSSNVLLDK----EMNGRLGDFGLARMHGH 520 (705)
Q Consensus 485 ~~~~iiHrDLkp~NILld~----~~~~kL~DFGla~~~~~ 520 (705)
...|++|+|-.|.||+++. ++.+.+-|||+.....+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2368999999999999983 67899999999876554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00036 Score=84.23 Aligned_cols=81 Identities=16% Similarity=0.288 Sum_probs=57.6
Q ss_pred ceEEeecCceEEEEEEEcCCC--eEEEEEEeccCC-chhHHHHHHHHHHhccCC-CCCc--ceeeeeeeecc--CceEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGG--AEIAVKRISHEN-DGGTRAFLAEISSLGRLK-HKSL--VGLRGWCKREK--GSLMLV 440 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~--~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~-Hpni--v~l~g~~~~~~--~~~~lV 440 (705)
.+.++.|.+..+|+.....++ ..+++|+..... ......+.+|.++|+.+. |+++ .+++.+|.+.. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998775433 467888764432 123457889999999995 6665 67777775421 467899
Q ss_pred EeeCCCCCh
Q 005257 441 YDYMENGSL 449 (705)
Q Consensus 441 ~E~~~~gsL 449 (705)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00041 Score=71.12 Aligned_cols=139 Identities=14% Similarity=0.082 Sum_probs=81.7
Q ss_pred EeecCc-eEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEeeCCCCCh
Q 005257 372 IGVGGN-GKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYMENGSL 449 (705)
Q Consensus 372 LG~G~f-g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL 449 (705)
|-.|.. ..||+.... +..+.||+..... ..+..+|++++..+. +--+.+++++... .+..++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccH
Confidence 444555 789999764 3578888765432 345678888888884 3334456665544 3567899999999877
Q ss_pred hHHH-------------------HhcCC-CCccc--HHHHHHHHH--------------------HHHHHHHHHhc----
Q 005257 450 DKWI-------------------FQCDG-SMMLS--CEERIRVLK--------------------DVAAGVLYLHE---- 483 (705)
Q Consensus 450 ~~~L-------------------~~~~~-~~~l~--~~~~~~i~~--------------------qia~gL~yLH~---- 483 (705)
.... +.... ...+. ......... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11100 00111 000000000 01111222211
Q ss_pred CCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 484 ~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.....++|+|+.|.|||++++....|.||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123569999999999999987778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0033 Score=66.56 Aligned_cols=79 Identities=14% Similarity=0.043 Sum_probs=55.9
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCC---CCcceeeeeeeec--cCceEEEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH---KSLVGLRGWCKRE--KGSLMLVY 441 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H---pniv~l~g~~~~~--~~~~~lV~ 441 (705)
...+.||.|..+.||+....+ + .+.+|..+. ......+.+|...|+.|.- -.+.+++++|..+ .+..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 345679999999999987643 3 466776432 1123578899999988853 3567788877532 35689999
Q ss_pred eeCCCCCh
Q 005257 442 DYMENGSL 449 (705)
Q Consensus 442 E~~~~gsL 449 (705)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.002 Score=63.77 Aligned_cols=133 Identities=20% Similarity=0.308 Sum_probs=89.2
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC----------------chhHHHHHHHHHHhccCC------CCCcc
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN----------------DGGTRAFLAEISSLGRLK------HKSLV 424 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~----------------~~~~~~~~~Ei~~l~~l~------Hpniv 424 (705)
+....||+|+.-.||.--. +....||+..... ....+++.+|+.-...+. +.+|.
T Consensus 4 ~~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CCCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 3456799999999986533 3447888876654 223466777776666665 78899
Q ss_pred eeeeeeeeccCceEEEEeeCCC------CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 005257 425 GLRGWCKREKGSLMLVYDYMEN------GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSN 498 (705)
Q Consensus 425 ~l~g~~~~~~~~~~lV~E~~~~------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~N 498 (705)
+++|+... +.-+.+|+|.+.+ -+|.+++.+. .++. +..+.+.+ -..||-+ ..|+.+|++|+|
T Consensus 81 r~~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L~~---f~~~l~~---~~Iv~~dl~~~N 148 (199)
T PF10707_consen 81 RFYGFVET-NLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQALDE---FKRYLLD---HHIVIRDLNPHN 148 (199)
T ss_pred cEeEEEec-CCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHHHH---HHHHHHH---cCCeecCCCccc
Confidence 99999887 4456888888743 2577777432 3444 44444443 3445655 889999999999
Q ss_pred eEEccCC----Ceeeee-ecc
Q 005257 499 VLLDKEM----NGRLGD-FGL 514 (705)
Q Consensus 499 ILld~~~----~~kL~D-FGl 514 (705)
|++..+. .+.|+| ||-
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEEEecCCCceEEEEEeCCCC
Confidence 9996432 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0016 Score=66.49 Aligned_cols=74 Identities=18% Similarity=0.178 Sum_probs=44.4
Q ss_pred eEEeecCce-EEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCC---Ccceeeeeeeecc--CceEEEEee
Q 005257 370 NVIGVGGNG-KVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHK---SLVGLRGWCKREK--GSLMLVYDY 443 (705)
Q Consensus 370 ~~LG~G~fg-~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~g~~~~~~--~~~~lV~E~ 443 (705)
+.|+.||.. .||+.. ..+++|..+. ......+.+|.+++..|... .+.+.++.+...+ ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777776 588751 2467776433 22345788899999887532 2333343332211 234789999
Q ss_pred CCCCChh
Q 005257 444 MENGSLD 450 (705)
Q Consensus 444 ~~~gsL~ 450 (705)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0023 Score=62.97 Aligned_cols=126 Identities=24% Similarity=0.364 Sum_probs=90.3
Q ss_pred CCCCcceEEeecCc-eEEEEEEEcCCCeEEEEEEeccC---C--------c----------hhHHHHHHHHHHhccCC--
Q 005257 364 KGFSEENVIGVGGN-GKVYKGVLEGGGAEIAVKRISHE---N--------D----------GGTRAFLAEISSLGRLK-- 419 (705)
Q Consensus 364 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~~vavK~i~~~---~--------~----------~~~~~~~~Ei~~l~~l~-- 419 (705)
..++..+.||.|.- |.|||+... |..+|+|.+..- . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56777899999999 999999996 679999983221 0 0 11235888999888885
Q ss_pred -CCCc--ceeeeeeeecc-----------------CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHH
Q 005257 420 -HKSL--VGLRGWCKREK-----------------GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479 (705)
Q Consensus 420 -Hpni--v~l~g~~~~~~-----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~ 479 (705)
+.++ ++++||..-.. ....||.||.+... .+...+ +.+|.+-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 4456 89999884321 12467888876532 123333 445666677
Q ss_pred HHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 480 yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8998 99999999999986 3589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0015 Score=62.36 Aligned_cols=128 Identities=20% Similarity=0.221 Sum_probs=86.7
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
..+.|++|++|.||+|.+. |..+|+|+-+.+ .....+..|.++|..+.-.++.+-+-.+. .-.+.|||+.|-
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4567999999999999997 568999976543 34577889999999998877765333222 224569999988
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC--CCeEEccCCCeeeeeecccee
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS--SNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp--~NILld~~~~~kL~DFGla~~ 517 (705)
.|.+.-.. .+...+ ..+++.---|.. .+|-|..|.- .||++.+ ..+.|+||.-|..
T Consensus 98 ~L~~~~~~------~~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 88765431 122222 333444333443 7788888763 4555554 4899999998873
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0015 Score=67.54 Aligned_cols=138 Identities=14% Similarity=0.024 Sum_probs=77.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcce-eeeeeeeccCceEEEEeeCCCCChh
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG-LRGWCKREKGSLMLVYDYMENGSLD 450 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~-l~g~~~~~~~~~~lV~E~~~~gsL~ 450 (705)
+..|-...+|+... ++..+++|..........-...+|.++++.+....+.+ ++..+ . -++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E--HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C--CEEEEEeccCcccc
Confidence 45677789998874 46678888754332221113567888888886544433 33322 1 26899999987654
Q ss_pred HH-----------------HHhcCC-CCcccHHHH-HHHHHH---------HHHHHHHHhc-----CCCCCeeecCCCCC
Q 005257 451 KW-----------------IFQCDG-SMMLSCEER-IRVLKD---------VAAGVLYLHE-----GWEKKVLHRDIKSS 497 (705)
Q Consensus 451 ~~-----------------L~~~~~-~~~l~~~~~-~~i~~q---------ia~gL~yLH~-----~~~~~iiHrDLkp~ 497 (705)
.. |+.... ...+..... .....+ +...+..+-. .....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 111111 111222211 111111 1111221211 11356999999999
Q ss_pred CeEEccCCCeeeeeecccee
Q 005257 498 NVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 498 NILld~~~~~kL~DFGla~~ 517 (705)
||++++++ +.|.||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0027 Score=64.51 Aligned_cols=142 Identities=13% Similarity=0.101 Sum_probs=80.6
Q ss_pred ceEEeecCceEEEEEEEcC-CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcce-eeeeeeeccCceEEEEeeCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG-LRGWCKREKGSLMLVYDYMEN 446 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~-l~g~~~~~~~~~~lV~E~~~~ 446 (705)
.+.|..|-...+|+....+ .+..+++|+....... .-+..+|+.++..+...++++ +++.+ . . .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q-N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C-C---cEEEEeeCC
Confidence 3567778888999997653 2467888976533221 122347888888886544443 33322 1 2 379999998
Q ss_pred CChhHH--------------H---HhcCCCC--------cc-cHHHHHHHHH----------------------HHH---
Q 005257 447 GSLDKW--------------I---FQCDGSM--------ML-SCEERIRVLK----------------------DVA--- 475 (705)
Q Consensus 447 gsL~~~--------------L---~~~~~~~--------~l-~~~~~~~i~~----------------------qia--- 475 (705)
.++... | +...... .. .+..+..+.. .+.
T Consensus 77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 156 (235)
T cd05157 77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI 156 (235)
T ss_pred CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence 765321 1 1111100 11 1122112111 111
Q ss_pred HHHH-HHhc-CCCCCeeecCCCCCCeEEcc-CCCeeeeeeccce
Q 005257 476 AGVL-YLHE-GWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLAR 516 (705)
Q Consensus 476 ~gL~-yLH~-~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~ 516 (705)
..|. .+.. .....++|+|+.+.|||+++ ++.+.|.||..|.
T Consensus 157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1111 1111 12357999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.01 Score=65.00 Aligned_cols=77 Identities=14% Similarity=0.076 Sum_probs=52.5
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccC------C-chhHHHHHHHHHHhccCC---CCCcceeeeeeeeccCceE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE------N-DGGTRAFLAEISSLGRLK---HKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~------~-~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~ 438 (705)
.+.||.|.+..||++...++++.++||.-... . ....+.+..|.+.|..+. -.++.+++.+. ....+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D---~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD---EELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---CCCCE
Confidence 45799999999999999754468999974311 0 123456677888887763 23455666642 34568
Q ss_pred EEEeeCCCCC
Q 005257 439 LVYDYMENGS 448 (705)
Q Consensus 439 lV~E~~~~gs 448 (705)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0089 Score=63.32 Aligned_cols=142 Identities=20% Similarity=0.175 Sum_probs=83.0
Q ss_pred eEEeecCceEEEEEEEcC------CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEEEe
Q 005257 370 NVIGVGGNGKVYKGVLEG------GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~------~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV~E 442 (705)
+.|..|-...+|+..... .++.+++|+..... .......+|.+++..+....+. ++++.+ . + .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-P-N---GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cchhh
Confidence 456667777999988653 25778899865432 2233456788888888544444 344433 2 2 35899
Q ss_pred eCCCCChhHH-----------------HHhcCCCC------cc--cHHHHHH--------------------------HH
Q 005257 443 YMENGSLDKW-----------------IFQCDGSM------ML--SCEERIR--------------------------VL 471 (705)
Q Consensus 443 ~~~~gsL~~~-----------------L~~~~~~~------~l--~~~~~~~--------------------------i~ 471 (705)
|++|..+... +++..... .. -+..+.. +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988766431 11111100 00 0111111 11
Q ss_pred HHHHHHHHHHhc------CCCCCeeecCCCCCCeEEccC----CCeeeeeecccee
Q 005257 472 KDVAAGVLYLHE------GWEKKVLHRDIKSSNVLLDKE----MNGRLGDFGLARM 517 (705)
Q Consensus 472 ~qia~gL~yLH~------~~~~~iiHrDLkp~NILld~~----~~~kL~DFGla~~ 517 (705)
..+..-+..|.. .....++|+|+.+.|||++++ +.++++||..|..
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 122223334431 235789999999999999985 7899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0017 Score=77.43 Aligned_cols=198 Identities=18% Similarity=0.162 Sum_probs=131.1
Q ss_pred HHHHHHHHhccCCCCCcceeeeeeeeccC---ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhc
Q 005257 407 AFLAEISSLGRLKHKSLVGLRGWCKREKG---SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483 (705)
Q Consensus 407 ~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 483 (705)
...-|++.+.++.|+|++.++.|-.+... .+.+..|++..-++...+.... .++....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHH
Confidence 34567788889999999999998765322 1233457777777777775433 67888899999999999999998
Q ss_pred CCCCCeeecCCCCC---CeEEccCCCeeee--eeccceecCCCCcceeeeeeccccCCCccccccCCCC--ccccEEEEe
Q 005257 484 GWEKKVLHRDIKSS---NVLLDKEMNGRLG--DFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS--TQTDVFGFG 556 (705)
Q Consensus 484 ~~~~~iiHrDLkp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s--~ksDVwS~G 556 (705)
....|.-+..+ +...+.++...++ ||+..+.......... ..-+..|-+||......+. ...|+|.+|
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHH
Confidence 55555555444 4444556666666 8887765543322211 1234567788887665444 447999999
Q ss_pred hhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 557 ILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 557 vvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
..+..+..|..+-..... ... -+ +......+......|...++++|++..+++...
T Consensus 380 ll~~~~~~~~~i~~~~~~---------------~~~---~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV---------------PVS---LL------DVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHhhhhhcCcccccccc---------------hhh---hh------ccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999987655322110 000 00 001111456677789999999999999988764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.035 Score=59.24 Aligned_cols=142 Identities=15% Similarity=0.154 Sum_probs=75.3
Q ss_pred eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeee-----eeeccCceEEEEe
Q 005257 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGW-----CKREKGSLMLVYD 442 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~-----~~~~~~~~~lV~E 442 (705)
+.|+.|....+|+....+ | .+++|+..... .+....|+.++..|...+ +.+.+.. +....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCC-C-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456677778999987643 3 58889875212 233344555555553222 2222211 1112456789999
Q ss_pred eCCCCChhH-----------HH---HhcCCC--------CcccH-HHHHH------------HHHH-HHHHHHHHhc---
Q 005257 443 YMENGSLDK-----------WI---FQCDGS--------MMLSC-EERIR------------VLKD-VAAGVLYLHE--- 483 (705)
Q Consensus 443 ~~~~gsL~~-----------~L---~~~~~~--------~~l~~-~~~~~------------i~~q-ia~gL~yLH~--- 483 (705)
|++|..+.. .| +..... ..+.| .+... .+.+ +...+..+..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 111000 01111 11111 1111 1112233321
Q ss_pred -CCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 484 -GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 484 -~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
....++||+|+.|.||+++.+...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999966555799999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.018 Score=60.70 Aligned_cols=143 Identities=14% Similarity=0.099 Sum_probs=84.1
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeee-----eeeccCceEEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGW-----CKREKGSLMLVY 441 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~-----~~~~~~~~~lV~ 441 (705)
.+.|..|....+|+.... +..+++|+... ........|+.++..|.+.+ +.+.+.. .....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456777878899998664 34688898754 22345667888888775433 3333331 112234568999
Q ss_pred eeCCCCChhH----HH----------HhcCCC--------CcccHHHHH----------HHHHHHHHHHHHHhc----CC
Q 005257 442 DYMENGSLDK----WI----------FQCDGS--------MMLSCEERI----------RVLKDVAAGVLYLHE----GW 485 (705)
Q Consensus 442 E~~~~gsL~~----~L----------~~~~~~--------~~l~~~~~~----------~i~~qia~gL~yLH~----~~ 485 (705)
+|++|..+.. .. +..... ....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 11 110000 011221111 011123334444442 22
Q ss_pred CCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4679999999999999987767899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.063 Score=57.06 Aligned_cols=144 Identities=13% Similarity=0.109 Sum_probs=81.1
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeeee-----eeccCceEEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGWC-----KREKGSLMLVY 441 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~-----~~~~~~~~lV~ 441 (705)
.+.++.|....+|+.... ++ .+++|+..... ...+...|++++..|.... +.+.+... ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 345677777899988653 33 57788765422 1334556677777764322 23333311 11235678999
Q ss_pred eeCCCCChhH-----------H---HHhcCCC------C---cccHHHHHH------------HHHHHHHHHHHHhc---
Q 005257 442 DYMENGSLDK-----------W---IFQCDGS------M---MLSCEERIR------------VLKDVAAGVLYLHE--- 483 (705)
Q Consensus 442 E~~~~gsL~~-----------~---L~~~~~~------~---~l~~~~~~~------------i~~qia~gL~yLH~--- 483 (705)
||++|..+.. . ++..... . .-.|..... ....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998865421 1 1111000 0 011111110 01123344555532
Q ss_pred -CCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 484 -GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 484 -~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
....+++|+|+.+.||+++.++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.035 Score=60.04 Aligned_cols=142 Identities=16% Similarity=0.149 Sum_probs=81.9
Q ss_pred eEEeecCceEEEEEEEcC----CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEEEeeC
Q 005257 370 NVIGVGGNGKVYKGVLEG----GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~----~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV~E~~ 444 (705)
..|-.|-...+|+..... .++.+++|+......... .-.+|..++..+...++. ++++.+ . .+ .|.||+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~-~-~g---~v~efi 115 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRF-P-NG---RVEEFI 115 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEE-C-Cc---eEEEee
Confidence 345557778899987543 236788997755432222 226788888888665554 344433 2 22 589999
Q ss_pred CCCChhHH-----------------HHhcC--CC-CcccHHHHHHHHHHH-----------------HHHHHHH----hc
Q 005257 445 ENGSLDKW-----------------IFQCD--GS-MMLSCEERIRVLKDV-----------------AAGVLYL----HE 483 (705)
Q Consensus 445 ~~gsL~~~-----------------L~~~~--~~-~~l~~~~~~~i~~qi-----------------a~gL~yL----H~ 483 (705)
++.+|... +++.+ .. ....+.++.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87666421 11111 01 012233333332211 1112222 21
Q ss_pred -CCCCCeeecCCCCCCeEEcc-CCCeeeeeecccee
Q 005257 484 -GWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARM 517 (705)
Q Consensus 484 -~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~ 517 (705)
.....++|+|+++.|||+++ ++.+++.||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22457999999999999986 46799999998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.064 Score=56.12 Aligned_cols=31 Identities=23% Similarity=0.471 Sum_probs=26.0
Q ss_pred CCeeecCCCCCCeEEccCCC-eeeeeecccee
Q 005257 487 KKVLHRDIKSSNVLLDKEMN-GRLGDFGLARM 517 (705)
Q Consensus 487 ~~iiHrDLkp~NILld~~~~-~kL~DFGla~~ 517 (705)
..++|+|+.|.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 56999999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.0005 Score=83.25 Aligned_cols=163 Identities=14% Similarity=0.016 Sum_probs=113.3
Q ss_pred HHHHHHHHHhccCCCCCcceeeeeee-eccCceEEEEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhc
Q 005257 406 RAFLAEISSLGRLKHKSLVGLRGWCK-REKGSLMLVYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHE 483 (705)
Q Consensus 406 ~~~~~Ei~~l~~l~Hpniv~l~g~~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~ 483 (705)
+..+.|...+++..|+++.....-.. .+....+..++|+.+|.+.+.|-+.-. ...+...-+.....+......-+|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33455666666678998766544322 234456889999999999998876422 2223332233333333555555553
Q ss_pred C--CCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHH
Q 005257 484 G--WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILE 561 (705)
Q Consensus 484 ~--~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~E 561 (705)
. ...-.+|++||+-|.+|..+.++|++++|+.+...+.... ....++++.|++|+....-+++.++|+|..|+-+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2 2345899999999999999999999999999844333222 223467888999999888888989999999999999
Q ss_pred HhhCCCCC
Q 005257 562 VLSGRRPI 569 (705)
Q Consensus 562 lltG~~Pf 569 (705)
..-|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887665
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.01 Score=65.23 Aligned_cols=51 Identities=16% Similarity=0.253 Sum_probs=40.2
Q ss_pred HHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhc
Q 005257 405 TRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC 456 (705)
Q Consensus 405 ~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~ 456 (705)
..+++-...+++.+.|+|+.+.+.+.........+|+|++ +.||++.+...
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 3556777888999999999999987665445678999999 56999988653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.014 Score=60.94 Aligned_cols=149 Identities=17% Similarity=0.174 Sum_probs=95.5
Q ss_pred cCHHHHHHHhC---CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC----------------chhH------HHH
Q 005257 354 ITYQEIEAATK---GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN----------------DGGT------RAF 408 (705)
Q Consensus 354 ~~~~el~~at~---~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~----------------~~~~------~~~ 408 (705)
+.|-.|....+ -++..+.||-|--+.||.+.+.. |.+.++|.-+... .+.. -..
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 34444544443 35678999999999999999864 6778888432110 0000 123
Q ss_pred HHHHHHhccCCC-C-CcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCC
Q 005257 409 LAEISSLGRLKH-K-SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486 (705)
Q Consensus 409 ~~Ei~~l~~l~H-p-niv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 486 (705)
.+|...|+.|.- . -+.+.+++ +..++|||++.+-.|...-+ ......++.-+.++ +.-|..
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~---Iv~la~--- 220 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH-----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGL---IVRLAN--- 220 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc-----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHH---HHHHHH---
Confidence 457777777742 2 23334442 35589999998877765432 22333333333332 334444
Q ss_pred CCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 487 ~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
+|+||+|..-=||++++++.++++||--+-...+
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechHhhccCC
Confidence 9999999999999999999999999986654443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.12 Score=54.94 Aligned_cols=138 Identities=12% Similarity=0.136 Sum_probs=76.8
Q ss_pred EEEEEEEcCCCeEEEEEEecc--CCchhHHHHHHHHHHhccCC--CCCcceeeeeeeecc-CceEEEEeeCCCCChhHHH
Q 005257 379 KVYKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLK--HKSLVGLRGWCKREK-GSLMLVYDYMENGSLDKWI 453 (705)
Q Consensus 379 ~Vy~~~~~~~~~~vavK~i~~--~~~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~-~~~~lV~E~~~~gsL~~~L 453 (705)
.+|..... ++.+++. ... .......+..+|..+|+.+. ---....++.|.++. +..+.||+|++|..+.+.+
T Consensus 40 ~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 40 DTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred ceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 44444433 5667777 331 12233455667777777763 233455677787655 5779999999884332222
Q ss_pred HhcCC-----------------------------------CCcccHHHHHHHH--------HHHHHHHHHHhcC-----C
Q 005257 454 FQCDG-----------------------------------SMMLSCEERIRVL--------KDVAAGVLYLHEG-----W 485 (705)
Q Consensus 454 ~~~~~-----------------------------------~~~l~~~~~~~i~--------~qia~gL~yLH~~-----~ 485 (705)
..... ++.-.|...+..+ -....-..+|+.. .
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 11000 0000111111100 0112223333321 1
Q ss_pred CCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
...++|+|+.+.||+++.+.-+=|.||+++..-+
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3579999999999999988888999999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.14 Score=55.15 Aligned_cols=74 Identities=18% Similarity=0.038 Sum_probs=46.1
Q ss_pred EEeecCceEEEEEEEcCCCeEEEEEEeccC-------CchhHHHHHHHHHHhccCC--CCCcce-eeeeeeeccCceEEE
Q 005257 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE-------NDGGTRAFLAEISSLGRLK--HKSLVG-LRGWCKREKGSLMLV 440 (705)
Q Consensus 371 ~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-------~~~~~~~~~~Ei~~l~~l~--Hpniv~-l~g~~~~~~~~~~lV 440 (705)
.||.|....||++...++++.|+||.-... ..-..+...-|.+.|.... -|..++ ++. +. .....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D--~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FD--TEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-Ec--cccceeh
Confidence 479999999999998654468999963211 1222334455666776652 354444 444 32 3455799
Q ss_pred EeeCCCC
Q 005257 441 YDYMENG 447 (705)
Q Consensus 441 ~E~~~~g 447 (705)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.21 Score=52.52 Aligned_cols=75 Identities=20% Similarity=0.312 Sum_probs=45.5
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC---CCCcceeeeeeeeccCceEEEEee
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK---HKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
...+.|+-|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+.+.+++... ++..+||+||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEEe
Confidence 345678989999999987 457789999765 333456778888888773 3345667776654 4456899999
Q ss_pred CCCC
Q 005257 444 MENG 447 (705)
Q Consensus 444 ~~~g 447 (705)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.18 Score=54.31 Aligned_cols=142 Identities=17% Similarity=0.192 Sum_probs=79.3
Q ss_pred eEEeecCceEEEEEEEcCC---CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEGG---GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.|..|=...+|+....+. +..|++|+....... .-.-.+|..+++.+..-++. ++++++ . .+ +|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeehhhc
Confidence 4455577778998876532 237888876543322 22235788888888766664 345443 2 22 5899997
Q ss_pred CCChhH-------HH----------HhcC--CCC-cccHHHHHHHHHHH----------------------HHHHHHHhc
Q 005257 446 NGSLDK-------WI----------FQCD--GSM-MLSCEERIRVLKDV----------------------AAGVLYLHE 483 (705)
Q Consensus 446 ~gsL~~-------~L----------~~~~--~~~-~l~~~~~~~i~~qi----------------------a~gL~yLH~ 483 (705)
+-.|.. .+ +..+ ... .-.|..+.++..++ ..-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765531 11 1111 000 11233332222221 111221111
Q ss_pred -----CCCCCeeecCCCCCCeEEcc-CCCeeeeeecccee
Q 005257 484 -----GWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARM 517 (705)
Q Consensus 484 -----~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~ 517 (705)
......+|.|+.+.|||+++ ++.++++||..|..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11245899999999999975 57899999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.11 Score=55.19 Aligned_cols=75 Identities=24% Similarity=0.248 Sum_probs=59.4
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
+....|++|++- |++|... ..-.+.+...++.+.+.-+.-+.. +-+.=|||+.-.||||+ +|++-|+||
T Consensus 297 e~~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence 344567777776 4454321 135688999999999888888876 57889999999999999 999999999
Q ss_pred ccceec
Q 005257 513 GLARMH 518 (705)
Q Consensus 513 Gla~~~ 518 (705)
-++|.-
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999954
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.19 Score=53.67 Aligned_cols=144 Identities=19% Similarity=0.216 Sum_probs=94.4
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---------------------chhHHH-----HHHHHHHhccCCC
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---------------------DGGTRA-----FLAEISSLGRLKH 420 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---------------------~~~~~~-----~~~Ei~~l~~l~H 420 (705)
.+..+|..|--+.||.+.-. +|..+|||+.+..- ....+. -..|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999876 46779999865320 011111 1346777777765
Q ss_pred CCcceeeeeeeeccCceEEEEeeCCCCChh-HHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLD-KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 421 pniv~l~g~~~~~~~~~~lV~E~~~~gsL~-~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
..|.- -.-..- + ...|||+|+.....- -.|+ ...++...+..+-.|++.-|.-|.. ..++||.||.-=|+
T Consensus 226 aGIP~-PePIlL-k-~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPC-PEPILL-K-NHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNL 296 (520)
T ss_pred cCCCC-CCceee-e-cceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhhh
Confidence 55321 111111 2 236999999532221 1111 1247777788888888888888877 47899999999999
Q ss_pred EEccCCCeeeeeeccceecCCC
Q 005257 500 LLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~ 521 (705)
|+. +|.+.|+|-+-+....++
T Consensus 297 Lyh-dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred eEE-CCEEEEEEccccccCCCh
Confidence 995 468999998887655544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.062 Score=53.65 Aligned_cols=31 Identities=29% Similarity=0.435 Sum_probs=22.3
Q ss_pred CCeeecCCCCCCeEE-ccCCCeeeeeecccee
Q 005257 487 KKVLHRDIKSSNVLL-DKEMNGRLGDFGLARM 517 (705)
Q Consensus 487 ~~iiHrDLkp~NILl-d~~~~~kL~DFGla~~ 517 (705)
..++|.|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 579999999999999 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 705 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 4e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 8e-16 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 9e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 5e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-14 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-14 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 2e-11 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 2b7y_A | 182 | Fava Bean Lectin-Glucose Complex Length = 182 | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 1n3o_A | 252 | Pterocarcpus Angolensis Lectin In Complex With Alph | 3e-11 | ||
| 1q8o_A | 252 | Pterocartpus Angolensis Lectin Pal In Complex With | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 5e-11 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 5e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 9e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 3e-08 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 8e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 1e-07 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-06 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 6e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252 | Back alignment and structure |
|
| >pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 705 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-115 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-104 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-101 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-70 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 2e-58 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 7e-58 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 4e-57 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-57 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-57 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 2e-56 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 2e-56 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 4e-56 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 5e-56 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 8e-56 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-55 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 1e-54 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 1e-54 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 1e-54 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 2e-54 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 3e-54 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 9e-54 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 1e-53 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-53 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 2e-52 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-52 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-52 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 1e-51 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 2e-51 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-50 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 1e-49 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-49 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 9e-49 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 4e-48 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-48 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-48 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 1e-47 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-46 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-46 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-45 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-45 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 3e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-38 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-36 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-34 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-34 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-34 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-33 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-32 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-32 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 7e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-32 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-31 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-31 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-31 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 6e-31 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-31 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-31 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-30 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-30 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-30 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 5e-30 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-30 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-30 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-30 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 9e-30 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-29 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-29 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-29 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-29 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-29 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 4e-29 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 3e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-29 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-28 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-27 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-27 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-27 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-27 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-27 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-27 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-27 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-26 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-26 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-26 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-25 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-25 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-25 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 9e-25 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-25 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-24 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-24 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-24 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-24 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-24 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-24 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-24 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-24 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-24 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-24 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-24 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-24 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-23 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-23 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-23 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-23 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-23 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-23 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-23 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-23 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-23 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-23 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-22 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-22 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-22 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-22 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-22 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-22 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-22 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-22 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-22 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 1e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-21 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-21 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-21 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-20 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-20 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-20 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-20 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-20 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-20 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-18 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-18 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-18 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-18 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-16 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-16 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-16 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-15 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-15 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-15 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-15 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 9e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-14 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-06 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 8e-14 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 9e-14 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-13 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-13 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-12 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 3e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 7e-12 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-11 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-11 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-11 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 8e-11 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 8e-11 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-115
Identities = 114/319 (35%), Positives = 187/319 (58%), Gaps = 13/319 (4%)
Query: 343 EDWELEY-WPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN 401
ED E+ R + +E++ A+ FS +N++G GG GKVYKG L G +AVKR+ E
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEER 66
Query: 402 D-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF-QCDGS 459
GG F E+ + H++L+ LRG+C +LVY YM NGS+ + + +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 460 MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519
L +R R+ A G+ YLH+ + K++HRD+K++N+LLD+E +GDFGLA++
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP----- 574
+ TT V GT+G++APE S+G++S +TDVFG+G+++LE+++G+R + +
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 575 -NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVV 633
L++ V L+ + KL +D L +G + ++EVE+++ + LLC P RP M +VV
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 634 KVLEGKIEAGIENETEDMD 652
++LEG A E + +
Sbjct: 304 RMLEGDGLAERWEEWQKEE 322
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-104
Identities = 91/302 (30%), Positives = 157/302 (51%), Gaps = 24/302 (7%)
Query: 351 PHRITYQEIEAATKGFSEE------NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG- 403
H ++ E++ T F E N +G GG G VYKG + +AVK+++ D
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDIT 69
Query: 404 ---GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM 460
+ F EI + + +H++LV L G+ + L LVY YM NGSL + DG+
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 461 MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520
LS R ++ + A G+ +LHE +HRDIKS+N+LLD+ ++ DFGLAR
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 521 GQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP--NLV 577
T+R+VGT Y+APE G + ++D++ FG+++LE+++G ++E + L+
Sbjct: 186 FAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 578 EMVWELMVQGKLLDAL-DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
++ E+ + K ++ D ++ D VE + + C + RP +++V ++L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 637 EG 638
+
Sbjct: 302 QE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-101
Identities = 100/307 (32%), Positives = 162/307 (52%), Gaps = 17/307 (5%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND 402
+ + + +R+ ++E AT F + +IG G GKVYKGVL G A++A+KR + E+
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESS 76
Query: 403 GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG-SMM 461
G F EI +L +H LV L G+C E+ ++L+Y YMENG+L + ++ D +M
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM---H 518
+S E+R+ + A G+ YLH ++HRD+KS N+LLD+ ++ DFG+++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP---- 574
+ +T V GT+GY+ PE F GR + ++DV+ FG+++ EVL R I + P
Sbjct: 193 DQTHL--STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
NL E E G+L +D L + + + + C RP+M V+
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 635 VLEGKIE 641
LE +
Sbjct: 309 KLEYALR 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-70
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 31/308 (10%)
Query: 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEIS 413
+ + + + V G G V+K L +AVK ++ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQ-NEYEVY 70
Query: 414 SLGRLKHKSLVGLRGWCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV 470
SL +KH++++ G KR L L+ + E GSL ++ ++S E +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHI 126
Query: 471 LKDVAAGVLYLHE-------GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ- 522
+ +A G+ YLHE G + + HRDIKS NVLL + + DFGLA G+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 523 VASTTRVVGTVGYLAPEVFSSG-----RASTQTDVFGFGILILEVLSGRRPI----EEGK 573
T VGT Y+APEV A + D++ G+++ E+ S +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 574 PNLVEMVWELMVQGKLLDALD---ARLRAKGGFDEDEVERVL-HLGLLCAYPDPRARPTM 629
E + + + + + R + + + +L C D AR +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 630 RQVVKVLE 637
V + +
Sbjct: 307 GCVGERIT 314
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 2e-58
Identities = 71/266 (26%), Positives = 107/266 (40%), Gaps = 43/266 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLTNST------TFTIGRALYPSKIPTKR 74
FVF+ F NL L G A V +L LTN ++GRA Y + I
Sbjct: 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWD 61
Query: 75 PNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+ V F+TSF F + GL F P + LGLF+ G++
Sbjct: 62 SATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSG-GGFLGLFDSAVSGST- 119
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
VEFD ++N F D H+G DVNS++S+
Sbjct: 120 YQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTV----------------------- 156
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
+ L NG+ +V I Y + + +L+ ++LS VL + + V
Sbjct: 157 ------KWSLANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRV 210
Query: 255 GFTAATGQ---LVESHKILAWSFSNT 277
GF+AATG +E+H + +WSF++
Sbjct: 211 GFSAATGASGGKIETHDVFSWSFASK 236
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-58
Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 42/283 (14%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESRILTLTNS------TTFTIGRALYPSKIPTKRPNS 77
F F FNSS+ L G ATV S L LT T ++GRA Y S I ++
Sbjct: 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKST 61
Query: 78 SYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHV 137
V ++TSF + + G+ F VP G + + + LG+F+ NS
Sbjct: 62 GAVASWATSFTANIFAPNKSSSADGIAFALVP-VGSEPKSNSGFLGVFDSDVYDNS-AQT 119
Query: 138 FGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEK 197
VEFD F N ++ D H+GIDVNS+ S+ +
Sbjct: 120 VAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASW------------------------ 154
Query: 198 SFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFT 257
L NG+N ++ I Y + + R ++S ++++ L + + +GF+
Sbjct: 155 -----GLANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFS 209
Query: 258 AATG---QLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
A TG E+H +L+WSF+ +K + S+++
Sbjct: 210 ATTGLSEGYTETHDVLSWSFA-SKLPDDSTTEPLDIASYLVRN 251
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-57
Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 45/284 (15%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESR-ILTLTNST------TFTIGRALYPSKIPTKRPN 76
+ + F F FN +NL L A+V S L LTN ++GRA Y + I
Sbjct: 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT 61
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
+ V F+TSF F + GL F VP G+ G + NS+ H
Sbjct: 62 TGTVASFATSFTFNIQVPNNAGPADGLAFALVPV----GSQPKDKGGFLGLFDGSNSNFH 117
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VEFD N+++ D E H+GIDVNS+ S+ +
Sbjct: 118 TVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV-------------------- 156
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
NG+N +V I Y S + + ++S ++L VL + + VGF
Sbjct: 157 ---------NGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGF 207
Query: 257 TAATG---QLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
+A TG VE++ +L+WSF+ +K S L + VL K
Sbjct: 208 SATTGINKGNVETNDVLSWSFA-SKLSDETTSEGLNLANLVLNK 250
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-57
Identities = 71/310 (22%), Positives = 142/310 (45%), Gaps = 34/310 (10%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGG 389
+ + + +D + I + ++ + IG G G V++ G
Sbjct: 17 TTENLYFQGAMDGDDMD-------IPWCDLN-------IKEKIGAGSFGTVHRAEWHG-- 60
Query: 390 AEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447
+++AVK + + FL E++ + RL+H ++V G + +L +V +Y+ G
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRG 119
Query: 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507
SL + + + L R+ + DVA G+ YLH ++HR++KS N+L+DK+
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRR 567
++ DFGL+R+ + S+ GT ++APEV ++ ++DV+ FG+++ E+ + ++
Sbjct: 179 KVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 568 PIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP 627
P P ++V + + K RL + V + C +P RP
Sbjct: 238 PWGNLNP--AQVVAAVGFKCK-------RLEIPRNLNPQ----VAAIIEGCWTNEPWKRP 284
Query: 628 TMRQVVKVLE 637
+ ++ +L
Sbjct: 285 SFATIMDLLR 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 70/333 (21%), Positives = 120/333 (36%), Gaps = 47/333 (14%)
Query: 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAE-- 411
E +IG G G VYKG L +AVK S N + F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKN 57
Query: 412 ISSLGRLKHKSLVGLRGWCKREKGS----LMLVYDYMENGSLDKWIFQCDGSMMLSCEER 467
I + ++H ++ +R +LV +Y NGSL K++
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSS 113
Query: 468 IRVLKDVAAGVLYLHE------GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521
R+ V G+ YLH ++ + HRD+ S NVL+ + + DFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 522 QVA-------STTRVVGTVGYLAPEVFSS-------GRASTQTDVFGFGILILEVLSGRR 567
++ + VGT+ Y+APEV A Q D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 568 PIEEGKP-NLVEMVWELMVQG--------KLLDALDARLRAKGGFDEDEVERVLHLGLL- 617
+ G+ +M ++ V L+ R + + E+ + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 618 -CAYPDPRARPTMRQVVKVLEGKIEAGIENETE 649
C D AR T + + + ++ E
Sbjct: 294 DCWDQDAEARLTAQXAEERMA-ELMMIWERNKS 325
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-56
Identities = 67/259 (25%), Positives = 101/259 (38%), Gaps = 37/259 (14%)
Query: 24 SAVDFVFNGFNSSN--LSLYGTATVESR-ILTLTN-STTFTIGRALYPSKIPTKRPNSSY 79
V F FN F+ N ++ G TV S + LTN + ++GR LY + +
Sbjct: 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGN 61
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V F TSF F M K G++F P + + G +D + H G
Sbjct: 62 VASFLTSFSFEMKDIKDYDPADGIIFFIAP-EDTQIPAGSIGGGTLG-VSDTKGAGHFVG 119
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
VEFD + N E+ND +HVGIDVNS+ SV
Sbjct: 120 VEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTV---------------------------- 151
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
+G +V + Y DS V ++ ++L L + + GF+A+
Sbjct: 152 -PWNSVSGAVVKVTVIY-DSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSAS 209
Query: 260 TGQL-VESHKILAWSFSNT 277
+ H I +WSF++T
Sbjct: 210 GSLGGRQIHLIRSWSFTST 228
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 2e-56
Identities = 75/263 (28%), Positives = 117/263 (44%), Gaps = 40/263 (15%)
Query: 24 SAVDFVFNGFNSS--NLSLYGTATVES-RILTLT------NSTTFTIGRALYPSKIPTKR 74
++V F F F S +L G A+V S + L LT N ++GRALY + I +
Sbjct: 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQ 61
Query: 75 PNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+S V F T+F F+++ A F+ P I + + LGLF +N+ S
Sbjct: 62 SSSL-VASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSD 120
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
N V VEFD + N + D + H+GIDVNS+ S +A +
Sbjct: 121 NGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDW------------------- 161
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
NGK I Y + ++ V + ++S + L+ V B + V
Sbjct: 162 ----------QNGKTATAHISYNSASKRLS-VVSSYPNSSPVVVSFDVELNNVBPBWVRV 210
Query: 255 GFTAATGQLVESHKILAWSFSNT 277
GF+A TGQ +++ ILAWSF ++
Sbjct: 211 GFSATTGQYTQTNNILAWSFRSS 233
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 4e-56
Identities = 68/285 (23%), Positives = 108/285 (37%), Gaps = 44/285 (15%)
Query: 24 SAVDFVFNGFNSS---NLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKR 74
+V F F F S ++ G A + L L + ++ GRALY +
Sbjct: 3 DSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD 62
Query: 75 PNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+ V F T F F + G GL F P ++LGLFN++ S
Sbjct: 63 NKTESVASFYTEFTFFLKIT-GNGPADGLAFFLAP-PDSDVKDAGEYLGLFNKSTATQPS 120
Query: 135 -NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
N V VEFD + N F + H+GI+VNS+ SV+
Sbjct: 121 KNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATK---------------------- 158
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
+++ + +GK I Y D I V +LS +++ L + +
Sbjct: 159 ----RWEDSDIFSGKIATARISY-DGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVR 213
Query: 254 VGFTAATGQL-VESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
VG +A+TG + IL+W FS+ S + + P + +
Sbjct: 214 VGISASTGNNQFLTVYILSWRFSSN--LQSTSVKAAMEPE--ITR 254
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 5e-56
Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 45/278 (16%)
Query: 12 LLLSIFLSFESISAVDFVFNGFN--SSNLSLYGTATV-ESRILTLTNSTT------FTIG 62
+LL+ S +S+S F F F+ NL G A + IL LT + + T+G
Sbjct: 1 MLLNRANSTDSLS---FSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVG 57
Query: 63 RALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHL 122
R L+ +++ +++ V T F F ++ A F+ P I + L
Sbjct: 58 RILHSAQVRLWEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLL 117
Query: 123 GLFNRTNDGN-SSNHVFGVEFDVFKNQ--EFNDIDENHVGIDVNSLTSVSAHAAGYWPDN 179
GLFN N S+N V VEFD F Q D + H+GIDVNS+ S W
Sbjct: 118 GLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRS---SKVVRWE-- 172
Query: 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLS 239
GK V + Y + V A +R LS
Sbjct: 173 ------------------------RREGKTLNVLVTY-NPSTRTIDVVATYPDGQRYQLS 207
Query: 240 VPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNT 277
++L+ +L + + VGF+AA+G+ ++H + +WSF++T
Sbjct: 208 HVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFTST 245
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-56
Identities = 64/258 (24%), Positives = 99/258 (38%), Gaps = 38/258 (14%)
Query: 26 VDFVFNGF-NSSNLSLYGTATVESR-ILTLTN--STTFTIGRALYPSKIPTKRPNSSYVY 81
V F + F + +L G A + + L + T ALY + +P + V
Sbjct: 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVA 60
Query: 82 PFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVE 141
F TSF F ++ + G+VF P+ G T+ NS N VE
Sbjct: 61 SFITSFSFIVSNVQRYPPTDGVVFFLAPWG--TEIPPNSQGGYLGITDSSNSQNQFVAVE 118
Query: 142 FDVFKN-QEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFK 200
FD N + + +H+GIDVNS+ S+ A
Sbjct: 119 FDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN---------------------------- 150
Query: 201 ELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260
+G + I Y DS I V + + +S ++L VL +++ VGF+A T
Sbjct: 151 -WNRVSGSLEKATIIY-DSDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATT 208
Query: 261 -GQLVESHKILAWSFSNT 277
E H I +WSF++T
Sbjct: 209 WNPERERHDIYSWSFTST 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-55
Identities = 81/313 (25%), Positives = 134/313 (42%), Gaps = 32/313 (10%)
Query: 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEIS 413
I Y+EIE E V+G G G V K ++A+K+I E++ +AF+ E+
Sbjct: 5 IDYKEIE-------VEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESE--RKAFIVELR 53
Query: 414 SLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD 473
L R+ H ++V L G C + LV +Y E GSL + + + +
Sbjct: 54 QLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN-GRLGDFGLARMHGHGQVASTTRVVGT 532
+ GV YLH K ++HRD+K N+LL ++ DFG A T G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGS 166
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592
++APEVF S + DVF +GI++ EV++ R+P +E ++W V
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGT--- 221
Query: 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMD 652
R ++ + + L C DP RP+M ++VK++ + E +
Sbjct: 222 ---RPP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT-HLMRYFPGADEPLQ 273
Query: 653 AYLLQQVKSKDMW 665
+ +
Sbjct: 274 YPCQHSLPPGEDG 286
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 68/267 (25%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 24 SAVDFVFNGF------NSSNLSLYGTATVESRILTLT------NSTTFTIGRALYPSKIP 71
+ V+F + F N + ++ G AT L LT N + G+A Y +
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 72 TKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDG 131
+ F TSF F + Y G GL F P LGLF
Sbjct: 62 LWDS-TGKAASFYTSFTFLLKNY-GAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAA 118
Query: 132 NSS-NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNS 190
+ S N V VEFD + N+++ND H+GIDVNS+ SV+
Sbjct: 119 DPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT------------------- 159
Query: 191 GTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED 250
++ I Y D+ I V + + +LS ++L+ VL
Sbjct: 160 -------RWENDDAYGSSIATAHITY-DARSKILTVLLSYEHGRDYILSHVVDLAKVLPQ 211
Query: 251 EMYVGFTAATGQLVESHKILAWSFSNT 277
++ +GF+A G E IL+W F +T
Sbjct: 212 KVRIGFSAGVG-YDEVTYILSWHFFST 237
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-54
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 43/267 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLTN-----STTFTIGRALYPSKIPTKRP 75
+ F N F N ++L G A+V S +L LT +++GRALY + +
Sbjct: 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGN 61
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFH-GIKGATEAQHLGLFNRTNDGNSS 134
+ V FSTSF F + + GL F P I + +++LGLFN +N +SS
Sbjct: 62 TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSS 120
Query: 135 NHVFGVEFDVFKNQEFNDIDE--NHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGT 192
N + VEFD + ++ D H+GIDVN + S+ + +G +
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI-------NGGVAF--- 170
Query: 193 GDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252
L K + Y ++ ++L +L + +
Sbjct: 171 ------ATITYLAPNKTLIASLVYPS-------------NQTTFSVAASVDLKEILPEWV 211
Query: 253 YVGFTAATGQ--LVESHKILAWSFSNT 277
VGF+AATG VE+H +L+WSF++T
Sbjct: 212 RVGFSAATGYPTEVETHDVLSWSFTST 238
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 1e-54
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 43/265 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVESR-ILTLTN-----STTFTIGRALYPSKIPTKRP 75
++ F F F N L G A V S +L LTN ++ ++GRALY +
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ V F TSF F + GL F P + LG+F N SN
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAP-VDTQPLDLGGMLGIFKDGY-FNKSN 119
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
+ VEFD F N ++ D H+GI+VNS+ S+ +
Sbjct: 120 QIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNW-------------------- 158
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255
NG+ V+I Y S ++T ++ +++ VL + + G
Sbjct: 159 ---------TNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFG 209
Query: 256 FTAATG---QLVESHKILAWSFSNT 277
F+A TG V+++ +L+WSF +
Sbjct: 210 FSATTGIDKGYVQTNDVLSWSFESN 234
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 2e-54
Identities = 63/264 (23%), Positives = 98/264 (37%), Gaps = 39/264 (14%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLT----NSTTFTIGRALYPSKIPTKRPN 76
+ F F F N +LS G A+V +L L N T G A Y + I N
Sbjct: 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN 61
Query: 77 SSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ + F TSF F M A GL F P + GLFN T +SS
Sbjct: 62 TGELASFITSFSFFMETSANPKAATDGLTFFLAP-PDSPLRRAGGYFGLFNDTK-CDSSY 119
Query: 136 HVFGVEFDVFKNQ-EFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
VEFD + F D H+GIDVN + S++A +
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGL--------------N 165
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
+ + + + + K + Y ++ ++L +L + + V
Sbjct: 166 NVANVEIIYEASSKTLTASLTYPSD-------------QTSISVTSIVDLKEILPEWVSV 212
Query: 255 GFTAATGQ-LVESHKILAWSFSNT 277
GF+ +T +H++L W F++T
Sbjct: 213 GFSGSTYIGRQATHEVLNWYFTST 236
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 3e-54
Identities = 68/260 (26%), Positives = 105/260 (40%), Gaps = 39/260 (15%)
Query: 26 VDFVFNGF--NSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPF 83
F+ F + NL G LTLT + T+GRALY S I + V F
Sbjct: 4 TSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANF 63
Query: 84 STSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFD 143
TSF F + G F P K T +LG+FN + + VEFD
Sbjct: 64 VTSFTFVINAPNSYNVADGFTFFIAP-VDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFD 121
Query: 144 VFKNQEFNDIDE-NHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKEL 202
F N ++ + H+GIDVNS+ SV+ +
Sbjct: 122 TFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----------------------------W 152
Query: 203 KLNNGKNYQVWIDY--ADSFINITMVEAG---MKRPKRPLLSVPLNLSGVLEDEMYVGFT 257
KL NG+ V I + A + + +++ + LS ++L V+ + + +GF+
Sbjct: 153 KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFS 212
Query: 258 AATGQLVESHKILAWSFSNT 277
A TG +H++L+WSF +
Sbjct: 213 ATTGAEYAAHEVLSWSFHSE 232
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-54
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 45/261 (17%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESR-ILTLTNST---TFTIGRALYPSKIPTKRPNSSY 79
+ F FN +NL L G ATV S L LTN ++GRA Y + I
Sbjct: 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDN 61
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
+ FST+F F + + +GL F VP G + + ++LGLFN TN + H
Sbjct: 62 LASFSTNFTFRINAKNIENSAYGLAFALVP-VGSRPKLKGRYLGLFNTTN-YDRDAHTVA 119
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
V FD N + IDVNS+ ++ + +
Sbjct: 120 VVFDTVSN---------RIEIDVNSIRPIATESCNFG----------------------- 147
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
NNG+ +V I Y ++ + ++ +S + L +ED + VGF+A
Sbjct: 148 ----HNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSAT 203
Query: 260 TG---QLVESHKILAWSFSNT 277
+G + E+H +L+WSFS+
Sbjct: 204 SGSKKETTETHNVLSWSFSSN 224
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 1e-53
Identities = 76/285 (26%), Positives = 107/285 (37%), Gaps = 46/285 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLTNST------TFTIGRALYPSKIPTKR 74
V F +N F N+ L G A V S L L ++GRALY + I
Sbjct: 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWD 61
Query: 75 PNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+ V F+ SF F GL F P H G N+ S
Sbjct: 62 KETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPI----DTKPQTHAGYLGLFNENESG 117
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
+ V VEFD F+N D H+GI+VNS+ S+
Sbjct: 118 DQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTT----------------------- 152
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
L N K +V I Y S + + +LS ++L L + + +
Sbjct: 153 ------SWDLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRI 206
Query: 255 GFTAATGQLV--ESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
GF+AATG + ESH +L+WSF++ S + L SFVL +
Sbjct: 207 GFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPLDLTSFVLHE 251
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-53
Identities = 67/314 (21%), Positives = 127/314 (40%), Gaps = 49/314 (15%)
Query: 338 EREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI 397
E + + EIE E IG GG G V+KG L + +A+K +
Sbjct: 7 EFPKSRLPT-------LADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSL 52
Query: 398 SHENDGGT-------RAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+ G + F E+ + L H ++V L G +V +++ G L
Sbjct: 53 ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLY 109
Query: 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-----EM 505
+ + ++R++ D+A G+ Y+ ++HRD++S N+ L +
Sbjct: 110 HRLLDKAHP--IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPV 166
Query: 506 NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS--SGRASTQTDVFGFGILILEVL 563
++ DFGL++ H S + ++G ++APE + + D + F +++ +L
Sbjct: 167 CAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 564 SGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDP 623
+G P +E ++ + + +G ED R+ ++ LC DP
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPT-----------IPEDCPPRLRNVIELCWSGDP 271
Query: 624 RARPTMRQVVKVLE 637
+ RP +VK L
Sbjct: 272 KKRPHFSYIVKELS 285
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-52
Identities = 69/268 (25%), Positives = 106/268 (39%), Gaps = 45/268 (16%)
Query: 23 ISAVDFVFNGFN--SSNLSLYGTATV-ESRILTLTNST------TFTIGRALYPSKIPTK 73
+ + F F+ F + NL+L G A + +S +L LT + GR LY +
Sbjct: 1 VETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW 60
Query: 74 RPNSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN 132
+ V F T F F++ PY L GLVF P +LG+FN + N
Sbjct: 61 DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQG-YGYLGVFNNSKQDN 119
Query: 133 SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGT 192
S VEFD F N ++ H+GIDVNS+ S+
Sbjct: 120 S-YQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQ--------------------- 156
Query: 193 GDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252
+L+NG+ V I Y + +V ++ +++ VL D +
Sbjct: 157 --------PFQLDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWV 208
Query: 253 YVGFTAATG---QLVESHKILAWSFSNT 277
VG + ATG E+H + +WSF +
Sbjct: 209 DVGLSGATGAQRDAAETHDVYSWSFQAS 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 69/316 (21%), Positives = 123/316 (38%), Gaps = 35/316 (11%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
V+G G G+ K G + +K + ++ R FL E+ + L+H +++ G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
++ L + +Y++ G+L I D +R+ KD+A+G+ YLH
Sbjct: 75 VLYKD-KRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARM-------------HGHGQVASTTRVVGTVGY 535
++HRD+ S N L+ + N + DFGLAR+ VVG +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595
+APE+ + + DVF FGI++ E++ + P ++ L V+G L
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNVRGFL------ 240
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYL 655
+ + C DP RP+ ++ LE + +
Sbjct: 241 DRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLE-TLRMHLAGHLPLGPQ-- 293
Query: 656 LQQVKSKDMWANYSRS 671
+ + W Y R
Sbjct: 294 -LEQLDRGFWETYRRG 308
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 74/271 (27%), Positives = 104/271 (38%), Gaps = 52/271 (19%)
Query: 23 ISAVDFVFNGF--NSSNLSLYGTATVES-RILTLTN-----STTFTIGRALYPSKIPTKR 74
+ + F FN F N L L A + S +L LT T + GRALY +
Sbjct: 1 MKTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD 60
Query: 75 PNSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNS 133
+ V F T F F++ P+ GLVF P + G + G++N S
Sbjct: 61 STTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEG-GGYFGIYN----PLS 115
Query: 134 SNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
VEFD F+N D H+GIDVNS+ S
Sbjct: 116 PYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTV---------------------- 151
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
L+NG V I Y S + +V ++ ++L VL + +
Sbjct: 152 -------PFTLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVN 204
Query: 254 VGFTAATGQ-------LVESHKILAWSFSNT 277
VGF+AATG E+H IL+WSFS +
Sbjct: 205 VGFSAATGDPSGKQRNATETHDILSWSFSAS 235
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-51
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 40/266 (15%)
Query: 22 SISAVDFVFNGF--NSSNLSLYGTATVES-RILTLTN---STTFTIGRALYPSKIPTKRP 75
+ F F+ F N N+ G A+V + +L +T TT +IGRALY + I
Sbjct: 2 LSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDS 61
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ V F+TSF F + K GL F P + + + + ++D SSN
Sbjct: 62 ITGKVASFATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSN 120
Query: 136 HVFGVEFDVFKNQEFN--DIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
+ VEFD + + +N D D H+GIDVNS+ S+ +
Sbjct: 121 QIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDW------------------ 162
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
NG+ V I Y ++T+ + +++ ++L +L + +
Sbjct: 163 -----------RNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVS 211
Query: 254 VGFTAATGQLV--ESHKILAWSFSNT 277
VGF+ G E+H +L+W F++
Sbjct: 212 VGFSGGVGNAAEFETHDVLSWYFTSN 237
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-50
Identities = 75/317 (23%), Positives = 138/317 (43%), Gaps = 41/317 (12%)
Query: 329 IKRKQRRARE--REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLE 386
+K+ R+ +DWE I +I IG G G VYKG
Sbjct: 1 MKKGHHHHHHGSRDAADDWE-------IPDGQIT-------VGQRIGSGSFGTVYKGKWH 46
Query: 387 GGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444
G ++AVK + + +AF E+ L + +H +++ G+ + L +V +
Sbjct: 47 G---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ--LAIVTQWC 101
Query: 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504
E SL + + ++ I + + A G+ YLH K ++HRD+KS+N+ L ++
Sbjct: 102 EGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHED 156
Query: 505 MNGRLGDFGLARMHGHGQVAST-TRVVGTVGYLAPEVF---SSGRASTQTDVFGFGILIL 560
++GDFGLA + ++ G++ ++APEV S S Q+DV+ FGI++
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 561 EVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAY 620
E+++G+ P N +++ + D R + +R+ L C
Sbjct: 217 ELMTGQLPY-SNINNRDQIIEMVGRGSLSPDLSKVR--------SNCPKRMKRLMAECLK 267
Query: 621 PDPRARPTMRQVVKVLE 637
RP+ +++ +E
Sbjct: 268 KKRDERPSFPRILAEIE 284
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 67/264 (25%), Positives = 101/264 (38%), Gaps = 46/264 (17%)
Query: 25 AVDFVFNGF--NSSNLSLYGTATVESR-ILTLTNST-----TFTIGRALYPSKIPTKRPN 76
+ F F F N +NL L A V S L LT ++GRALY + I +
Sbjct: 3 STSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH--D 60
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
++ + F+TSF F MA GL F P + LGLF ++S
Sbjct: 61 NTTLASFTTSFSFVMAAPAAAAVADGLAFFLAP-PDTQPQARGGFLGLFADRA-HDASYQ 118
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VEFD + N D + H+GID N + S
Sbjct: 119 TVAVEFDTYSN--AWDPNYTHIGIDTNGIESKKTT------------------------- 151
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
+ G+ + I Y S + +S ++L +L + + VGF
Sbjct: 152 ----PFDMVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGF 207
Query: 257 TAATG---QLVESHKILAWSFSNT 277
+A TG +VE+H I++WSF+ +
Sbjct: 208 SATTGLNAGVVETHDIVSWSFAVS 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 54/304 (17%), Positives = 116/304 (38%), Gaps = 49/304 (16%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND 402
+ I ++++ + +G+++KG +G +I VK + +
Sbjct: 3 KHSG-------IDFKQLN-------FLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDW 46
Query: 403 GG--TRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYDYMENGSLDKWIFQCDGS 459
+R F E L H +++ + G C+ L+ +M GSL + +
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTN 105
Query: 460 MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519
++ + ++ D+A G+ +LH E + + S +V++D++M R+ +
Sbjct: 106 FVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF--- 161
Query: 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQT---DVFGFGILILEVLSGRRPIEEGKPNL 576
+ + ++APE T D++ F +L+ E+++ P +
Sbjct: 162 ---SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-- 216
Query: 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL---CAYPDPRARPTMRQVV 633
+E+ ++ ++G R G H+ L C DP RP +V
Sbjct: 217 MEIGMKVALEGL-------RPTIPPGISP-------HVSKLMKICMNEDPAKRPKFDMIV 262
Query: 634 KVLE 637
+LE
Sbjct: 263 PILE 266
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-49
Identities = 64/278 (23%), Positives = 107/278 (38%), Gaps = 62/278 (22%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYP 82
+ F+ + FN +NL L G ATV S L L+ ++ ++ RA Y + I + + V
Sbjct: 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVAS 61
Query: 83 FSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEF 142
F T+F + ++ + GL F+ VP S VEF
Sbjct: 62 FDTNFTMNIRTHRQANSAVGLDFVLVP-------------------VQPESKGDTVTVEF 102
Query: 143 DVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKEL 202
D F + + IDVN+ S ++
Sbjct: 103 DTFLS---------RISIDVNNNDIKSVPW----------------------------DV 125
Query: 203 KLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQ 262
+G+N +V I Y S ++ + K +S + L + D + VGF+A +G
Sbjct: 126 HDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGA 185
Query: 263 L---VESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
E+H +L+WSFS+ +L ++ S + VL K
Sbjct: 186 YQWSYETHDVLSWSFSSKFINLKDQ--KSERSNIVLNK 221
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 64/265 (24%), Positives = 107/265 (40%), Gaps = 51/265 (19%)
Query: 24 SAVDFVFNGFNS-SNLSLYGTATVESR-ILTLTNSTT------FTIGRALYPSKIPTKRP 75
+ F F F++ L L G AT+ S+ L LT + ++GRA Y I K
Sbjct: 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK-- 59
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+S+ V F+T+F F + ++ +GL F VP + + LG+FN TN+ +
Sbjct: 60 DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKK-QEFLGIFN-TNNPEPNA 117
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
V F+ FKN+ D D+N + VN
Sbjct: 118 RTVAVVFNTFKNRI--DFDKNFIKPYVNENCDFH-------------------------- 149
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255
NG+ V I Y S ++ + + +S ++L +++ + VG
Sbjct: 150 --------KYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVG 201
Query: 256 FTAATG---QLVESHKILAWSFSNT 277
F+ +G E+H +L+WSFS+
Sbjct: 202 FSPTSGLTEDTTETHDVLSWSFSSK 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 74/302 (24%), Positives = 126/302 (41%), Gaps = 42/302 (13%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAE--ISSLGRLKHKSLVGL 426
+G G G+V++G G +AVK S ++ +++ E + + L+H++++G
Sbjct: 13 LECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGF 67
Query: 427 RGWCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ S L L+ Y E GSL ++ L +R++ +A+G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 484 -----GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV---ASTTRVVGTVGY 535
+ + HRD+KS N+L+ K + D GLA MH VGT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 536 LAPEVF------SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV--QG 587
+APEV + + D++ FG+++ EV RR + G + + +V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 588 KLLDALDA------RLRAKGGFDEDEVERVLHLGLL--CAYPDPRARPTMRQVVKVLEGK 639
D R + D L L+ C Y +P AR T ++ K L K
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLT-K 299
Query: 640 IE 641
I+
Sbjct: 300 ID 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 7e-48
Identities = 76/305 (24%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 345 WELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG 404
E I + E+ E +IG+GG GKVY+ G E+AVK H+ D
Sbjct: 2 LE-------IDFAELT-------LEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDED 45
Query: 405 T----RAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM 460
E LKH +++ LRG C +E +L LV ++ G L++ +
Sbjct: 46 ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLCLVMEFARGGPLNRVL----SGK 100
Query: 461 MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--------LGDF 512
+ + + +A G+ YLH+ ++HRD+KSSN+L+ +++ + DF
Sbjct: 101 RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160
Query: 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG 572
GLAR + G ++APEV + S +DV+ +G+L+ E+L+G P
Sbjct: 161 GLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
Query: 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
+ + + + + L E L C PDP +RP+ +
Sbjct: 218 DG--LAVAYGVAMNKL-------ALPIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNI 264
Query: 633 VKVLE 637
+ L
Sbjct: 265 LDQLT 269
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 1e-47
Identities = 73/267 (27%), Positives = 105/267 (39%), Gaps = 51/267 (19%)
Query: 26 VDFVFNGF--NSSNLSLYGTATVES-RILTLTNST------TFTIGRALYPSKIPTKRPN 76
F F+ F NS L+L A+++S +L LT T + GRALY I
Sbjct: 3 QSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDST 62
Query: 77 SSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ V F T F F + PY GL F VP + +LG+F +
Sbjct: 63 TGNVASFETRFSFNITQPYAYPEPADGLTFFMVP-PNSPQGEDGGNLGVFK----PPEGD 117
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
+ F VEFD F+N D H+GIDVNS+ S
Sbjct: 118 NAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLH----------------------- 152
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVL--EDEMY 253
+L NG V I Y + +V A LS ++L + +
Sbjct: 153 ------FQLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVN 206
Query: 254 VGFTAATG---QLVESHKILAWSFSNT 277
VG +A TG VE+H+I++WSF+++
Sbjct: 207 VGLSATTGYQKNAVETHEIISWSFTSS 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 66/320 (20%), Positives = 135/320 (42%), Gaps = 52/320 (16%)
Query: 333 QRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEI 392
++ ++ +++W+ I ++++E +IG G G+VY G G E+
Sbjct: 16 RKASQTSIFLQEWD-------IPFEQLE-------IGELIGKGRFGQVYHGRWHG---EV 58
Query: 393 AVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
A++ I +N+ +AF E+ + + +H+++V G C L ++ + +L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLCKGRTLY 117
Query: 451 KWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510
+ D ++L + ++ +++ G+ YLH K +LH+D+KS NV D +
Sbjct: 118 SVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVIT 171
Query: 511 DFGLARMHGHGQVAS----TTRVVGTVGYLAPEVFSSGRA---------STQTDVFGFGI 557
DFGL + G Q G + +LAPE+ S +DVF G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 558 LILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL 617
+ E+ + P + ++W + + ++ G ++ + + L
Sbjct: 232 IWYELHAREWPFKTQPA--EAIIW--QMGTGMK-----PNLSQIGMGKE----ISDILLF 278
Query: 618 CAYPDPRARPTMRQVVKVLE 637
C + RPT +++ +LE
Sbjct: 279 CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 73/316 (23%), Positives = 128/316 (40%), Gaps = 48/316 (15%)
Query: 351 PHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFL- 409
R ++I+ IG G G+V+ G G ++AVK + ++
Sbjct: 31 VQRTIAKQIQ-------MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFR 78
Query: 410 -AEISSLGRLKHKSLVGLRGWCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCE 465
EI ++H++++G + GS L L+ DY ENGSL ++ S L +
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAK 134
Query: 466 ERIRVLKDVAAGVLYLHE-----GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-- 518
+++ +G+ +LH + + HRD+KS N+L+ K + D GLA
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 519 -GHGQVASTTRVVGTVGYLAPEV------FSSGRASTQTDVFGFGILILEVLSGRRPIEE 571
+ VGT Y+ PEV + ++ D++ FG+++ EV RR +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSG 252
Query: 572 GKPNLVEMVWELMV--QGKLLDALDA------RLRAKGGFDEDEVERVLHLGLL--CAYP 621
G ++ + +V D + R + DE R + L+ C
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAH 311
Query: 622 DPRARPTMRQVVKVLE 637
+P +R T +V K L
Sbjct: 312 NPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 37/296 (12%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAE--ISSLGRLKHKSLVGL 426
+ IG G G+V++G G E+AVK S + R++ E I L+H++++G
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGF 101
Query: 427 RGWCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
++ G+ L LV DY E+GSL ++ ++ E I++ A+G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 484 GWEK-----KVLHRDIKSSNVLLDKEMNGRLGDFGLARMH----GHGQVASTTRVVGTVG 534
+ HRD+KS N+L+ K + D GLA H +A R VGT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKR 216
Query: 535 YLAPEV------FSSGRASTQTDVFGFGILILEVLSGRRP---IEEGKPNLVEMVWELMV 585
Y+APEV + + D++ G++ E+ E+ + ++V
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 586 QGKLLDAL---DARLRAKGGFDEDEVERVL-HLGLLCAYPDPRARPTMRQVVKVLE 637
++ + R + E RV+ + C Y + AR T ++ K L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 54/206 (26%), Positives = 78/206 (37%), Gaps = 36/206 (17%)
Query: 26 VDFVFNGF--NSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPF 83
F+ F + NL G LTLT + T+GRALY S I + V F
Sbjct: 4 TSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANF 63
Query: 84 STSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFD 143
TSF F + G F P K T +LG+FN + + VEFD
Sbjct: 64 VTSFTFVINAPNSYNVADGFTFFIAP-VDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFD 121
Query: 144 VFKNQEFNDIDE-NHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKEL 202
F N ++ + H+GIDVNS+ SV+ +
Sbjct: 122 TFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----------------------------W 152
Query: 203 KLNNGKNYQVWIDY--ADSFINITMV 226
KL NG+ V I + A + + +++
Sbjct: 153 KLQNGEEANVVIAFNAATNVLTVSLT 178
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 44/284 (15%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F E +IG GG G+V+K G +KR+ + N+ E+ +L +L H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVH 68
Query: 426 LRG---------------WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV 470
G + + L + ++ + G+L++WI + G L + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALEL 127
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
+ + GV Y+H KK+++RD+K SN+ L ++GDFGL + + +
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--K 182
Query: 531 GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590
GT+ Y++PE SS + D++ G+++ E+L E + + G +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTDLRDGIIS 237
Query: 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
D D + + L LL P RP ++++
Sbjct: 238 DIFDKKEKT------------LLQKLLS--KKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 73/274 (26%), Positives = 109/274 (39%), Gaps = 33/274 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT--RAFLAEISSLGRL-KHKS 422
F + +G G G+V+K + G AVKR G LAE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 423 LVGLRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLY 480
V L W E G L L + SL + S+ E ++ L+D + +
Sbjct: 119 CVRLEQAW--EEGGILYLQTELCG-PSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
LH + ++H D+K +N+ L +LGDFGL G G Y+APE+
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPEL 227
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
T DVF G+ ILEV G+ W+ + QG L A L
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQGYLPPEFTAGL--- 277
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
E+ VL ++ PDP+ R T ++
Sbjct: 278 ----SSELRSVL---VMMLEPDPKLRATAEALLA 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G GK G + +K I+ E++ L +KH ++V R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLHEGWEK 487
+ E GSL +V DY E G L K I G + E++I + + ++H+ +
Sbjct: 91 SFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLF--QEDQILDWFVQICLALKHVHD---R 144
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
K+LHRDIKS N+ L K+ +LGDFG+AR ++ ++A +GT YL+PE+ +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPY 202
Query: 547 STQTDVFGFGILILEVLSGRRP 568
+ ++D++ G ++ E+ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA---FLAEISSLGRLKHKS 422
F E IG G +VY+ G +A+K++ + +A + EI L +L H +
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYL 481
++ E L +V + + G L + I L E + + + + + ++
Sbjct: 94 VIKYYASFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEV 540
H ++V+HRDIK +NV + +LGD GL R A + +VGT Y++PE
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK----LLDALDAR 596
+ ++D++ G L+ E+ + + P K NL + + + Q D
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEQCDYPPLPSDHYSEE 266
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635
LR L +C PDP RP + V V
Sbjct: 267 LR--------------QLVNMCINPDPEKRPDVTYVYDV 291
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 63/292 (21%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G G+V+ G L +AVK FL E L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
G C +++ + +V + ++ G ++ L + ++++ D AAG+ YL K
Sbjct: 179 GVCTQKQ-PIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLES---K 232
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT----VGYLAPEVFSS 543
+HRD+ + N L+ ++ ++ DFG++R G G V + APE +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNY 289
Query: 544 GRASTQTDVFGFGILILEVLS-GRRP------------IEEG----KPNLV-EMVWELMV 585
GR S+++DV+ FGIL+ E S G P +E+G P L + V+ LM
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349
Query: 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
Q C +P RP+ + + L+
Sbjct: 350 Q-------------------------------CWAYEPGQRPSFSTIYQELQ 370
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 59/292 (20%), Positives = 100/292 (34%), Gaps = 42/292 (14%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLV 424
F +G GG G V++ + A+KRI N R + E+ +L +L+H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 425 GLRGWC-----------KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD 473
K L + +L W+ + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV---- 529
+A V +LH K ++HRD+K SN+ + ++GDFGL + T
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 530 -------VGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582
VGT Y++PE S + D+F G+++ E+L P
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQ--MERVRTLT 238
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ K + E V+ +L P P RP +++
Sbjct: 239 DVRNLKFPPLFTQKYPC---------EYVMVQDMLS--PSPMERPEAINIIE 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 76/321 (23%), Positives = 133/321 (41%), Gaps = 47/321 (14%)
Query: 339 REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVK 395
+ ++ + + + E VIG G G VY G L + AVK
Sbjct: 12 VQAVQHVVIGPSSLIVHFNE------------VIGRGHFGCVYHGTLLDNDGKKIHCAVK 59
Query: 396 RISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF 454
++ D G + FL E + H +++ L G C R +GS ++V YM++G L +I
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
Query: 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514
+ + ++ I VA G+ YL KK +HRD+ + N +LD++ ++ DFGL
Sbjct: 120 NETHN--PTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 515 AR-MHGHGQVASTTRVVGTVGYL------APEVFSSGRASTQTDVFGFGILILEVLS-GR 566
AR M+ V G A E + + +T++DV+ FG+L+ E+++ G
Sbjct: 175 ARDMYDK----EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 567 RPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR 626
P + ++QG+ L E + + + L C +P R
Sbjct: 231 PPY-PDVNT--FDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMR 276
Query: 627 PTMRQVVKVLEGKIEAGIENE 647
P+ ++V + I
Sbjct: 277 PSFSELVSRISAIFSTFIGEH 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 75/323 (23%), Positives = 139/323 (43%), Gaps = 39/323 (12%)
Query: 339 REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVK 395
+ ++ + + + E VIG G G VY G L + AVK
Sbjct: 76 VQAVQHVVIGPSSLIVHFNE------------VIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 396 RISHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIF 454
++ D G + FL E + H +++ L G C R +GS ++V YM++G L +I
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514
+ + ++ I VA G+ +L KK +HRD+ + N +LD++ ++ DFGL
Sbjct: 184 NETHN--PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 515 AR-MHGHGQVASTTRVVGT--VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIE 570
AR M+ + + V ++A E + + +T++DV+ FG+L+ E+++ G P
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY- 297
Query: 571 EGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMR 630
+ ++QG+ L E + + + L C +P RP+
Sbjct: 298 PDVNT--FDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFS 344
Query: 631 QVVKVLEGKIEAGIENETEDMDA 653
++V + I ++A
Sbjct: 345 ELVSRISAIFSTFIGEHYVHVNA 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 71/309 (22%), Positives = 136/309 (44%), Gaps = 35/309 (11%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGG 389
+ K + WE+E IT + +G G G+VY+GV +
Sbjct: 200 RNKPTIYGVSPNYDKWEME--RTDITMKHK------------LGGGQYGEVYEGVWKKYS 245
Query: 390 AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL 449
+AVK + E+ FL E + + +KH +LV L G C RE ++ ++M G+L
Sbjct: 246 LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNL 303
Query: 450 DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
++ +C+ +S + + +++ + YL + K +HR++ + N L+ + ++
Sbjct: 304 LDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKV 359
Query: 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
DFGL+R+ + + + APE + + S ++DV+ FG+L+ E+ + G P
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 569 IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT 628
G V+EL+ + ++ E E+V L C +P RP+
Sbjct: 420 Y-PGIDL--SQVYELLEKDYRMERP-----------EGCPEKVYELMRACWQWNPSDRPS 465
Query: 629 MRQVVKVLE 637
++ + E
Sbjct: 466 FAEIHQAFE 474
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 71/318 (22%), Positives = 120/318 (37%), Gaps = 74/318 (23%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEI--AVKRISHE 400
+ L+ + +IE +G G G V +GV +I A+K +
Sbjct: 2 KKLFLK--RDNLLIADIE-----------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 48
Query: 401 NDGGTR-AFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGS 459
+ + E + +L + +V L G C+ E +LMLV + G L K++
Sbjct: 49 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREE 106
Query: 460 MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519
+ +L V+ G+ YL E K +HRD+ + NVLL ++ DFGL++ G
Sbjct: 107 --IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161
Query: 520 HGQVASTTRVVGT--VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP-------- 568
T R G + + APE + + S+++DV+ +G+ + E LS G++P
Sbjct: 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
Query: 569 ----IEEGK-----PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
IE+GK P ++ LM C
Sbjct: 222 VMAFIEQGKRMECPPECPPELYALMSD-------------------------------CW 250
Query: 620 YPDPRARPTMRQVVKVLE 637
RP V + +
Sbjct: 251 IYKWEDRPDFLTVEQRMR 268
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 7/204 (3%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G+ K + G + K + + + + ++E++ L LKH ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 429 -WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLHE--G 484
R +L +V +Y E G L I + EE + RV+ + + H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
VLHRD+K +NV LD + N +LGDFGLAR+ H + T VGT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ ++D++ G L+ E+ + P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
V+G G G VY G IA+K I + ++ EI+ LKHK++V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEKKV 489
E G + + + + GSL + G + + E+ I K + G+ YLH + ++
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYLH---DNQI 143
Query: 490 LHRDIKSSNVLLDKEMNGR--LGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGR- 545
+HRDIK NVL++ +G + DFG + R+ G T GT+ Y+APE+ G
Sbjct: 144 VHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 546 -ASTQTDVFGFGILILEVLSGRRP 568
D++ G I+E+ +G+ P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 71/298 (23%), Positives = 134/298 (44%), Gaps = 35/298 (11%)
Query: 341 EMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE 400
+ WE+E IT + +G G G+VY+GV + +AVK + E
Sbjct: 4 NYDKWEME--RTDITMKHK------------LGGGQYGEVYEGVWKKYSLTVAVKTL-KE 48
Query: 401 NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM 460
+ FL E + + +KH +LV L G C RE ++ ++M G+L ++ +C+
Sbjct: 49 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE 107
Query: 461 MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520
+S + + +++ + YL + K +HRD+ + N L+ + ++ DFGL+R+
Sbjct: 108 -VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163
Query: 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579
+ + + APE + + S ++DV+ FG+L+ E+ + G P G
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDL--SQ 220
Query: 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
V+EL+ + ++ E E+V L C +P RP+ ++ + E
Sbjct: 221 VYELLEKDYRMERP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 65/294 (22%), Positives = 105/294 (35%), Gaps = 52/294 (17%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT--RAFLAEISSLGRL-KHKS 422
F E IG G G V+K V G A+KR G + L E+ + L +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 423 LVGLRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLY 480
+V W E +++ +Y GSL I + M E ++ L V G+ Y
Sbjct: 73 VVRYFSAW--AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNG-------------------RLGDFGLARMHGHG 521
+H ++H DIK SN+ + + ++GD G
Sbjct: 131 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-----T 182
Query: 522 QVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV 580
+++S G +LA EV + D+F + ++ G
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------ 236
Query: 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
W + QG+ L + L E +L + +PDP RP+ +VK
Sbjct: 237 WHEIRQGR-LPRIPQVL-------SQEFTELLK---VMIHPDPERRPSAMALVK 279
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 58/295 (19%), Positives = 116/295 (39%), Gaps = 66/295 (22%)
Query: 369 ENVIGVGGNGKVYKGVL--EGGGAEI--AVKRISHENDGGTR-AFLAEISSLGRLKHKSL 423
V+G G G VYKG+ EG +I A+K + L E + + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
L G C ++ L+ M G L ++ + + + + + +A G+ YL +
Sbjct: 80 CRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLED 135
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEV 540
++++HRD+ + NVL+ + ++ DFGLA++ G + G + ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWE 582
+ Q+DV+ +G+ + E+++ G +P +E+G+ P V+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+M + C D +RP R+++
Sbjct: 251 IMRK-------------------------------CWMIDADSRPKFRELIIEFS 274
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 71/315 (22%), Positives = 131/315 (41%), Gaps = 37/315 (11%)
Query: 324 CSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKG 383
L + + + + WE+ + + +G G G+V+ G
Sbjct: 241 HRLTTVCPTSKPQTQGLAKDAWEIP--RESLRLEV------------KLGQGCFGEVWMG 286
Query: 384 VLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443
G +A+K + AFL E + +L+H+ LV L E + +V +Y
Sbjct: 287 TWNGTT-RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEY 342
Query: 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK 503
M GSL ++ G L + + + +A+G+ Y+ +HRD++++N+L+ +
Sbjct: 343 MSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGE 398
Query: 504 EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL 563
+ ++ DFGLAR+ + + + + APE GR + ++DV+ FGIL+ E+
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 564 S-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPD 622
+ GR P G N V + + +G + + E + L C +
Sbjct: 459 TKGRVPY-PGMVN--REVLDQVERGYRMPC-----------PPECPESLHDLMCQCWRKE 504
Query: 623 PRARPTMRQVVKVLE 637
P RPT + LE
Sbjct: 505 PEERPTFEYLQAFLE 519
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 84/273 (30%), Positives = 129/273 (47%), Gaps = 33/273 (12%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKHKSLVGLR 427
IG G G V G G ++AVK I + T +AFLAE S + +L+H +LV L
Sbjct: 26 LQTIGKGEFGDVMLGDYRG--NKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
G EKG L +V +YM GSL ++ S +L + ++ DV + YL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GN 136
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSSGR 545
+HRD+ + NVL+ ++ ++ DFGL + AS+T+ G V + APE +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 546 ASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604
ST++DV+ FGIL+ E+ S GR P P + V + +G +DA
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPY-PRIPL--KDVVPRVEKGYKMDA-----------P 236
Query: 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ V + C + D RP+ Q+ + LE
Sbjct: 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
E +G G G+V+ G G +A+K + AFL E + +L+H+ LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
E + +V +YM GSL ++ G L + + + +A+G+ Y+
Sbjct: 247 VVSEE--PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER---MN 300
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD++++N+L+ + + ++ DFGLAR+ + + + + APE GR +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 549 QTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607
++DV+ FGIL+ E+ + GR P G N V + + +G + +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYP-GMVN--REVLDQVERGYRMPCP-----------PEC 406
Query: 608 VERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
E + L C +P RPT + LE
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 63/311 (20%), Positives = 131/311 (42%), Gaps = 36/311 (11%)
Query: 340 EEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGG----GAEIAVK 395
E+ + + E + + + +G G G V + G +AVK
Sbjct: 31 EDRDPTQFE--ERHLKFLQ------------QLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 396 RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG-SLMLVYDYMENGSLDKWIF 454
++ H + R F EI L L+H ++V +G C +L L+ +Y+ GSL ++
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514
+ + + ++ + G+ YL K+ +HRD+ + N+L++ E ++GDFGL
Sbjct: 137 KHKER--IDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 515 ARMHGHGQVASTTRVVGT--VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEG 572
++ + + G + + APE + + S +DV+ FG+++ E+ + +
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251
Query: 573 KPNLVEMV----WELMVQGKLLDALDA--RLRAKGGFDEDEVERVLHLGLLCAYPDPRAR 626
+ M+ M+ L++ L RL G ++ + + C + R
Sbjct: 252 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQR 307
Query: 627 PTMRQVVKVLE 637
P+ R + ++
Sbjct: 308 PSFRDLALRVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 61/282 (21%), Positives = 124/282 (43%), Gaps = 22/282 (7%)
Query: 369 ENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV 424
+G G G V + G +AVK++ H + R F EI L L+H ++V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 425 GLRGWC-KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+G C + +L L+ +Y+ GSL ++ + + + ++ + G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG- 131
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVF 541
K+ +HRD+ + N+L++ E ++GDFGL ++ + + G + + APE
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV----WELMVQGKLLDALDA-- 595
+ + S +DV+ FG+++ E+ + + + M+ M+ L++ L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL G ++ + + C + RP+ R + ++
Sbjct: 250 RLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 61/292 (20%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEI--AVKRISHENDGGTR-AFLAEISSLGRLKHKSLVG 425
+ +G G G V +GV +I A+K + + + E + +L + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C+ E +LMLV + G L K++ + +L V+ G+ YL E
Sbjct: 401 LIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE-- 454
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFSS 543
K +HR++ + NVLL ++ DFGL++ G T R G + + APE +
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 544 GRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWELMV 585
+ S+++DV+ +G+ + E LS G++P IE+GK P ++ LM
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 573
Query: 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
C RP V + +
Sbjct: 574 D-------------------------------CWIYKWEDRPDFLTVEQRMR 594
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 47/312 (15%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGG 389
A++ W L + + IG G G V G G
Sbjct: 173 MEGTVAAQDEFYRSGWALN--MKELKLLQ------------TIGKGEFGDVMLGDYRG-- 216
Query: 390 AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL 449
++AVK I ND +AFLAE S + +L+H +LV L G EKG L +V +YM GSL
Sbjct: 217 NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 450 DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
++ S +L + ++ DV + YL +HRD+ + NVL+ ++ ++
Sbjct: 275 VDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKV 330
Query: 510 GDFGLARMHGHGQVASTTRVVGT---VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-G 565
DFGL + +++ V + APE + ST++DV+ FGIL+ E+ S G
Sbjct: 331 SDFGLTKE-------ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383
Query: 566 RRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRA 625
R P P + V + +G +DA + V + C + D
Sbjct: 384 RVPY-PRIPL--KDVVPRVEKGYKMDA-----------PDGCPPAVYDVMKNCWHLDAAT 429
Query: 626 RPTMRQVVKVLE 637
RPT Q+ + LE
Sbjct: 430 RPTFLQLREQLE 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 61/293 (20%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLV 424
E +IG G +G+V G L G +A+K + R FL+E S +G+ H +++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G R + M+V +YMENGSLD ++ DG + + + +L+ V AG+ YL +
Sbjct: 114 RLEGVVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSD- 169
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFS 542
+HRD+ + NVL+D + ++ DFGL+R+ A+ T G + + APE +
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 543 SGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWELM 584
S+ +DV+ FG+++ EVL+ G RP +EEG + +LM
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM 287
Query: 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ C + D RP Q+V VL+
Sbjct: 288 LD-------------------------------CWHKDRAQRPRFSQIVSVLD 309
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 63/294 (21%)
Query: 368 EENVIGVGGNGKVYKGVLEGGGAEI--AVKRISHENDGGTR--AFLAEISSLGRLKHKSL 423
E+ +G G G V KG + AVK + +E + LAE + + +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V + G C+ E S MLV + E G L+K++ Q + + I ++ V+ G+ YL E
Sbjct: 81 VRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL-E 134
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVF 541
E +HRD+ + NVLL + ++ DFGL++ + + G V + APE
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWEL 583
+ + S+++DV+ FG+L+ E S G++P +E+G+ +++L
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252
Query: 584 MVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
M C D RP V L
Sbjct: 253 MNL-------------------------------CWTYDVENRPGFAAVELRLR 275
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 6e-31
Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 30/143 (20%)
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
++V VEFD + N ++ D + H+GIDVNS+ S +
Sbjct: 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQ------------------ 42
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
NGK I Y +S V + K LS + L VL + + V
Sbjct: 43 -----------NGKIATAHISY-NSVSKRLSVTSYYAGSKPATLSYDIELHTVLPEWVRV 90
Query: 255 GFTAATGQLVESHKILAWSFSNT 277
G +A+TGQ E + + +WSF+++
Sbjct: 91 GLSASTGQDKERNTVHSWSFTSS 113
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 29/280 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G V+ G ++A+K I E F+ E + +L H LV L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
C + + LV ++ME+G L ++ G + E + + DV G+ YL E
Sbjct: 71 VCLEQA-PICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEE---AC 124
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEVFSSGR 545
V+HRD+ + N L+ + ++ DFG+ R Q T GT V + +PEVFS R
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181
Query: 546 ASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604
S+++DV+ FG+L+ EV S G+ P E + N V E + G L
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPY-ENRSN--SEVVEDISTGFRLYK-----------P 227
Query: 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGI 644
V + C P RP ++++ L E+G+
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 21/298 (7%)
Query: 369 ENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV 424
+ +G G G V + G A +AVK++ H R F EI L L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 425 GLRGWCKREKG-SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
RG SL LV +Y+ +G L ++ + L + + G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLG- 144
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVF 541
++ +HRD+ + N+L++ E + ++ DFGLA++ + R G + + APE
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRP--IEEGKPNLVEMVWELMVQGKLLDALDA--R 596
S S Q+DV+ FG+++ E+ + + ++ ++ +LL+ L+ R
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAY 654
L A + V L LC P P+ RP+ + L+ ET A+
Sbjct: 263 LPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAH 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 30/269 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G VYKG+ E+A + + F E L L+H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 429 -W--CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEG 484
W + K ++LV + M +G+L ++ + M + +R + + G+ +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMK---IKVLRSWCRQILKGLQFLHTR 148
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
++HRD+K N+ + G +GD GLA + + V+GT ++APE++
Sbjct: 149 -TPPIIHRDLKCDNIFIT-GPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYE 203
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
DV+ FG+ +LE+ + P E + ++ + G + D
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVA----- 255
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
EV+ ++ C + R +++
Sbjct: 256 --IPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 28/277 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHENDGGTRA-FLAEISSLGRLKHKSL 423
+ VIG G G+VYKG+L+ + +A+K + R FL E +G+ H ++
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ L G + K +M++ +YMENG+LDK++ + DG S + + +L+ +AAG+ YL
Sbjct: 109 IRLEGVISKYK-PMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLAN 165
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVF 541
+HRD+ + N+L++ + ++ DFGL+R+ A+ T G + + APE
Sbjct: 166 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 542 SSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
S + ++ +DV+ FGI++ EV++ G RP N V + + G L
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPY-WELSN--HEVMKAINDGFRLPTP------- 272
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
D + L + C + RP +V +L+
Sbjct: 273 ----MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 76/323 (23%), Positives = 130/323 (40%), Gaps = 43/323 (13%)
Query: 339 REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVK 395
E++D + + + IG G G VY G A+K
Sbjct: 8 LAEVKDVLIPHERVVTHSDRV------------IGKGHFGVVYHGEYIDQAQNRIQCAIK 55
Query: 396 ---RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKW 452
RI+ AFL E + L H +++ L G +G ++ YM +G L ++
Sbjct: 56 SLSRITEMQQ--VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 453 IFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512
I + + ++ I VA G+ YL E+K +HRD+ + N +LD+ ++ DF
Sbjct: 114 IRSPQRN--PTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 513 GLARMHGHGQVASTTRVVGT---VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP 568
GLAR + S + V + A E + R +T++DV+ FG+L+ E+L+ G P
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 569 IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT 628
+ + QG+ L E + + + C DP RPT
Sbjct: 229 Y-RHIDP--FDLTHFLAQGRRLPQP-----------EYCPDSLYQVMQQCWEADPAVRPT 274
Query: 629 MRQVVKVLEGKIEAGIENETEDM 651
R +V +E + A + + +
Sbjct: 275 FRVLVGEVEQIVSALLGDHYVQL 297
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 74/276 (26%), Positives = 135/276 (48%), Gaps = 27/276 (9%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRISHENDGGTRA-FLAEISSLGRLKHKSLV 424
+ V+G G G+V G L+ + +A+K + R FL E S +G+ H +++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G + K +M+V +YMENGSLD ++ + D + + + +L+ +A+G+ YL +
Sbjct: 110 RLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSD- 165
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEVFS 542
+HRD+ + N+L++ + ++ DFGL R+ A+ T G + + +PE +
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 543 SGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ ++ +DV+ +GI++ EV+S G RP N + V + + +G L
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPY-WEMSN--QDVIKAVDEGYRLPPP-------- 272
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
D + L L C D RP Q+V +L+
Sbjct: 273 ---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 60/282 (21%), Positives = 120/282 (42%), Gaps = 22/282 (7%)
Query: 369 ENVIGVGGNGKVYKGVL----EGGGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSL 423
+G G GKV + G ++AVK + EI L L H+++
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 424 VGLRGWCKREKG-SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
V +G C + G + L+ +++ +GSL +++ + ++ +++++ + G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLG 143
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEV 540
++ +HRD+ + NVL++ E ++GDFGL + + T + V + APE
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVW--ELMVQGKLLDALDA-- 595
+ +DV+ FG+ + E+L+ L + M +L++ L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL ++ V L C P R + + +++ E
Sbjct: 261 RLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 3e-30
Identities = 37/298 (12%), Positives = 73/298 (24%), Gaps = 48/298 (16%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI---SHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
+ VG V+ + A+K + + + RL +S R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 428 GWCK-------------------------REKGSLMLVYDYMENGSLDKWIFQCD----G 458
+ + +L+ L+ D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518
+ + L K ++H N+ + + LGD
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRA--STQTDVFGFGILILEVLSGRRPIEEGKPNL 576
G V Y E ++ A + + + G+ I V P P +
Sbjct: 245 G----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
++ D+L D V+ ++ L D R R + ++
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLP---DFVKTLI-GRFLN--FDRRRRLLPLEAME 352
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLR-- 427
+G GG G V + + + G ++A+K+ E R EI + +L H ++V R
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 428 ---GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+L +Y E G L K++ Q + L +L D+++ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGR---LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
+++HRD+K N++L + D G A+ G++ + VGT+ YLAPE+
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELL 195
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588
+ + D + FG L E ++G RP PN + W V+ K
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFL---PNWQPVQWHGKVREK 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F E V+G G G+V K A+K+I H + L+E+ L L H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 426 LRG-WCKRE-----------KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD 473
W +R K +L + +Y ENG+L I ++ +E R+ +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQ 124
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST------- 526
+ + Y+H + ++HRD+K N+ +D+ N ++GDFGLA+
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 527 ------TRVVGTVGYLAPEVFS-SGRASTQTDVFGFGILILEVLSG 565
T +GT Y+A EV +G + + D++ GI+ E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 30/296 (10%)
Query: 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLG 416
+ K + +G GG V G A+KRI E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 417 RLKHKSLVGLRGWCKREKGS---LMLVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLK 472
H +++ L +C RE+G+ L+ + + G+L I + D L+ ++ + +L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV--- 529
+ G+ +H K HRD+K +N+LL E L D G S +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 530 -----VGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW 581
T+ Y APE+F S +TDV+ G ++ ++ G P +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM--VFQKGDSV 256
Query: 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
L VQ +L R + ++L+ ++ DP RP + ++ LE
Sbjct: 257 ALAVQNQLSIPQSPRH-------SSALWQLLN-SMMT--VDPHQRPHIPLLLSQLE 302
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 67/317 (21%), Positives = 116/317 (36%), Gaps = 74/317 (23%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVKRISH 399
D+E++ RI IG G G V++G+ +A+K +
Sbjct: 8 RDYEIQ--RERIELGRC------------IGEGQFGDVHQGIYMSPENPALAVAIKTCKN 53
Query: 400 E-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDG 458
+D FL E ++ + H +V L G + ++ + G L ++
Sbjct: 54 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRKY 111
Query: 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518
S L I ++ + YL K+ +HRDI + NVL+ +LGDFGL+R
Sbjct: 112 S--LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP--------- 568
++ + ++APE + R ++ +DV+ FG+ + E+L G +P
Sbjct: 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
Query: 569 ---IEEGK-----PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAY 620
IE G+ PN ++ LM + C
Sbjct: 227 IGRIENGERLPMPPNCPPTLYSLMTK-------------------------------CWA 255
Query: 621 PDPRARPTMRQVVKVLE 637
DP RP ++ L
Sbjct: 256 YDPSRRPRFTELKAQLS 272
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 63/290 (21%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G G+V+ G G ++AVK + + AFLAE + + +L+H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+E + ++ +YMENGSL ++ G L+ + + + +A G+ ++ E +
Sbjct: 76 VVTQE--PIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEVFSSGR 545
+HRD++++N+L+ ++ ++ DFGLAR+ + T G + + APE + G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 546 ASTQTDVFGFGILILEVLS-GRRP------------IEEG----KPNLV-EMVWELMVQG 587
+ ++DV+ FGIL+ E+++ GR P +E G +P+ E +++LM
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM--- 243
Query: 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
LC P RPT + VLE
Sbjct: 244 ----------------------------RLCWKERPEDRPTFDYLRSVLE 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 59/295 (20%), Positives = 118/295 (40%), Gaps = 66/295 (22%)
Query: 369 ENVIGVGGNGKVYKGVL--EGGGAEI--AVKRISHEN-DGGTRAFLAEISSLGRLKHKSL 423
V+G G G VYKG+ EG +I A+K + + L E + + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
L G C ++ L+ M G L ++ + + + + + +A G+ YL +
Sbjct: 80 CRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLED 135
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEV 540
++++HRD+ + NVL+ + ++ DFGLA++ G + G + ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWE 582
+ Q+DV+ +G+ + E+++ G +P +E+G+ P V+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+MV+ C D +RP R+++
Sbjct: 251 IMVK-------------------------------CWMIDADSRPKFRELIIEFS 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 33/250 (13%)
Query: 333 QRRAREREEMEDWELEYWPHRITYQEIE--AATKGFSEENVIGVGGNGKVYKGVLEGGGA 390
+ R E ED E ++ + E + + +G G G+V++ + G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 391 EIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLD 450
+ AVK++ E + E+ + L +V L G RE + + + +E GSL
Sbjct: 85 QCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSL- 137
Query: 451 KWIFQCDGSMMLSC----EERIRV-LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505
G ++ E+R L G+ YLH +++LH D+K+ NVLL
Sbjct: 138 -------GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSS-- 185
Query: 506 NGR---LGDFGLA-RMHGHGQVASTTR---VVGTVGYLAPEVFSSGRASTQTDVFGFGIL 558
+G L DFG A + G S + GT ++APEV + D++ +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 559 ILEVLSGRRP 568
+L +L+G P
Sbjct: 246 MLHMLNGCHP 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 72/316 (22%), Positives = 131/316 (41%), Gaps = 77/316 (24%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND 402
WE++ P +T+ + +G G G V G G ++A+K I E
Sbjct: 17 GSWEID--PKDLTFLK------------ELGTGQFGVVKYGKWRGQ-YDVAIKMI-KEGS 60
Query: 403 GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMML 462
F+ E + L H+ LV L G C +++ + ++ +YM NG L ++ +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHR--F 117
Query: 463 SCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522
++ + + KDV + YL K+ LHRD+ + N L++ + ++ DFGL+R +
Sbjct: 118 QTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 523 VASTTRVVGT---VGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRP---------- 568
T VG+ V + PEV + S+++D++ FG+L+ E+ S G+ P
Sbjct: 175 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231
Query: 569 --IEEG----KPNLV-EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYP 621
I +G +P+L E V+ +M C +
Sbjct: 232 EHIAQGLRLYRPHLASEKVYTIMYS-------------------------------CWHE 260
Query: 622 DPRARPTMRQVVKVLE 637
RPT + ++ +
Sbjct: 261 KADERPTFKILLSNIL 276
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 57/287 (19%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
E +G G G+V+ ++AVK + AFLAE + + L+H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+E + ++ ++M GSL ++ +GS + I +A G+ ++ + +
Sbjct: 251 VVTKE--PIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ---RN 304
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
+HRD++++N+L+ + ++ DFGLAR+ + + + + APE + G +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 549 QTDVFGFGILILEVLS-GRRP------------IEEG----KPNLV-EMVWELMVQGKLL 590
++DV+ FGIL++E+++ GR P +E G +P E ++ +M++
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR---- 420
Query: 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
C P RPT + VL+
Sbjct: 421 ---------------------------CWKNRPEERPTFEYIQSVLD 440
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 66/296 (22%), Positives = 113/296 (38%), Gaps = 70/296 (23%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRISHENDGGTR-AFLAEISSLGRLKHKSLV 424
++G G G+VY+GV E +AVK + + F++E + L H +V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G + E ++ + G L ++ + S L + + + YL
Sbjct: 77 KLIGIIEEE--PTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLES- 131
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL-----APE 539
+HRDI N+L+ +LGDFGL+R + +V L +PE
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRY-----IEDEDYYKASVTRLPIKWMSPE 184
Query: 540 VFSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEG----KPNLV-EMVW 581
+ R +T +DV+ F + + E+LS G++P +E+G KP+L +++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY 244
Query: 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
LM + C DP RP ++V L
Sbjct: 245 TLMTR-------------------------------CWDYDPSDRPRFTELVCSLS 269
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 67/340 (19%), Positives = 128/340 (37%), Gaps = 62/340 (18%)
Query: 339 REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVK 395
+E++ED + + T ++G G G V + L+ +AVK
Sbjct: 12 KEKLEDVLIP--EQQFTLGR------------MLGKGEFGSVREAQLKQEDGSFVKVAVK 57
Query: 396 --RISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KGSLMLVYDYMENGS 448
+ FL E + + H + L G R M++ +M++G
Sbjct: 58 MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 449 LDKWIFQC---DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505
L ++ + L + +R + D+A G+ YL + +HRD+ + N +L ++M
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM 174
Query: 506 NGRLGDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFG 556
+ DFGL+R ++ V +LA E + + +DV+ FG
Sbjct: 175 TVCVADFGLSRKIYSGDYYRQGCASKLP--------VKWLALESLADNLYTVHSDVWAFG 226
Query: 557 ILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLG 615
+ + E+++ G+ P G N ++ ++ G L +EV ++
Sbjct: 227 VTMWEIMTRGQTPY-AGIEN--AEIYNYLIGGNRLKQPP--------ECMEEVYDLM--- 272
Query: 616 LLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYL 655
C DP+ RP+ + LE + T Y+
Sbjct: 273 YQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI 312
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 63/290 (21%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G G V G +G ++AVK I E F E ++ +L H LV G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
C +E + +V +Y+ NG L ++ L + + + DV G+ +L +
Sbjct: 71 VCSKEY-PIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLES---HQ 124
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEVFSSGR 545
+HRD+ + N L+D+++ ++ DFG+ R Q VGT V + APEVF +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFK 181
Query: 546 ASTQTDVFGFGILILEVLS-GRRP------------IEEG----KPNLV-EMVWELMVQG 587
S+++DV+ FGIL+ EV S G+ P + +G +P+L + ++++M
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS- 240
Query: 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
C + P RPT +Q++ +E
Sbjct: 241 ------------------------------CWHELPEKRPTFQQLLSSIE 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 35/281 (12%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE---IAVKRISHEN---DGGTRAFLAEISSLGRLKHKS 422
+G G G V +G + + +AVK + + F+ E++++ L H++
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
L+ L G + +V + GSL + + G R VA G+ YL
Sbjct: 83 LIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLE 138
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEV 540
K+ +HRD+ + N+LL ++GDFGL R + + APE
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA---R 596
+ S +D + FG+ + E+ + G+ P W + ++L +D R
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP------------WIGLNGSQILHKIDKEGER 243
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
L +D + ++ + C P RPT + L
Sbjct: 244 LPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 66/295 (22%)
Query: 369 ENVIGVGGNGKVYKGVL--EGGGAEI--AVKRI-SHENDGGTRAFLAEISSLGRLKHKSL 423
V+G G G V+KGV EG +I +K I +A + ++G L H +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L G C SL LV Y+ GSL + Q G+ L + + +A G+ YL E
Sbjct: 78 VRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLEE 133
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT---VGYLAPEV 540
++HR++ + NVLL ++ DFG+A + + ++A E
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRP------------IEEGK-----PNLVEMVWE 582
G+ + Q+DV+ +G+ + E+++ G P +E+G+ V+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+MV+ C D RPT +++
Sbjct: 249 VMVK-------------------------------CWMIDENIRPTFKELANEFT 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 39/295 (13%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLRG- 428
++G G V++G + G A+K ++ + E L +L HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ +L+ ++ GSL + + + L E + VL+DV G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 489 VLHRDIKSSNVLL----DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HR+IK N++ D + +L DFG AR + + + GT YL P+++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERA 190
Query: 545 RASTQT--------DVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDA 595
D++ G+ +G P P + V ++ GK A+
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 596 RLRAKGGFDE----------------DEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+A+ G + + VL +L A D Q
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL-ANILEA--DQEKCWGFDQFFA 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 71/337 (21%), Positives = 139/337 (41%), Gaps = 53/337 (15%)
Query: 329 IKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGG 388
++ + ++R+ +E + + + E F + + +G G G V+K +
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQ------KVGELKDDDFEKISELGAGNGGVVFKVSHKPS 57
Query: 389 GAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447
G +A K I E R + E+ L +VG G + G + + ++M+ G
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGG 116
Query: 448 SLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505
SLD+ + + G + E+I +V V G+ YL E + K++HRD+K SN+L++
Sbjct: 117 SLDQ-VLKKAGRI----PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRG 169
Query: 506 NGRLGDFGLARMHGHGQVASTTR--VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVL 563
+L DFG++ GQ+ + VGT Y++PE S Q+D++ G+ ++E+
Sbjct: 170 EIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 564 SGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL------ 617
GR PI +E+++ V+G + ++ ++ + +
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 618 -----------------------CAYPDPRARPTMRQ 631
C +P R ++Q
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 39/298 (13%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSLGRLKHKSLVGLRG- 428
++G G V++G + G A+K ++ + + E L +L HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ +L+ ++ GSL + + + L E + VL+DV G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 489 VLHRDIKSSNVLL----DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HR+IK N++ D + +L DFG AR + + + GT YL P+++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERA 190
Query: 545 RASTQT--------DVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDA 595
D++ G+ +G P P + V ++ GK A+
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 596 RLRAKGGFDE----------------DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+A+ G + + VL +L A D Q
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA-NILEA--DQEKCWGFDQFFAETS 305
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 30/146 (20%)
Query: 134 SNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
++ + VE D + N + D H+GID+ S+ S
Sbjct: 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTA---------------------- 38
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
+ + NGK I Y +S +S ++L VL + +
Sbjct: 39 -------KWNMQNGKVGTAHIIY-NSVDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVR 90
Query: 254 VGFTAATGQLVESHKILAWSFSNTKF 279
VG +A+TG E++ IL+WSF++
Sbjct: 91 VGLSASTGLYKETNTILSWSFTSKLK 116
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 3e-12
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 28 FVFNGFNSSNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVY 81
F+ + T L LT + ++GRAL+ + + +S+ V
Sbjct: 131 NQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHI-WESSAVVA 189
Query: 82 PFSTSFIFAMAPYKGVLAGHGLVFLFVPFH-GIKGATEAQHLGLFNRTN 129
F +F F + G+ F I + + LGLF N
Sbjct: 190 SFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 65/326 (19%), Positives = 133/326 (40%), Gaps = 61/326 (18%)
Query: 339 REEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE---IAVK 395
+ ++ED ++ + + + ++G G G V +G L+ +AVK
Sbjct: 23 QNKLEDVVID--RNLLILGK------------ILGEGEFGSVMEGNLKQEDGTSLKVAVK 68
Query: 396 RISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGSLMLVYDYMENGSL 449
+ +N FL+E + + H +++ L G C M++ +M+ G L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 450 DKWIFQC---DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506
++ G + + ++ + D+A G+ YL + LHRD+ + N +L +M
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT 185
Query: 507 GRLGDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGI 557
+ DFGL++ ++ V ++A E + ++++DV+ FG+
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMP--------VKWIAIESLADRVYTSKSDVWAFGV 237
Query: 558 LILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGL 616
+ E+ + G P G N +++ ++ G L ED ++ + +
Sbjct: 238 TMWEIATRGMTPY-PGVQN--HEMYDYLLHGHRLKQ-----------PEDCLDELYEIMY 283
Query: 617 LCAYPDPRARPTMRQVVKVLEGKIEA 642
C DP RPT + LE +E+
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 59/308 (19%), Positives = 113/308 (36%), Gaps = 88/308 (28%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGA-------EIAVKRISHENDGGTRAFLAEISSLGRLKHK 421
+G G K++KGV G E+ +K + + + +F S + +L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL 481
LV G C +LV ++++ GSLD ++ + ++ ++ V K +AA + +L
Sbjct: 73 HLVLNYGVCVCGD-ENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAAMHFL 129
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGR--------LGDFGLARMHGHGQVASTTRVVGTV 533
E ++H ++ + N+LL +E + + L D G++ V+
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKD 175
Query: 534 GY------LAPEVFSSGRA-STQTDVFGFGILILEVLS-GRRP------------IEEG- 572
+ PE + + + TD + FG + E+ S G +P E+
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 573 ---KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629
P E + L+ C +P RP+
Sbjct: 236 QLPAPKAAE-LANLINN-------------------------------CMDYEPDHRPSF 263
Query: 630 RQVVKVLE 637
R +++ L
Sbjct: 264 RAIIRDLN 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 70/318 (22%), Positives = 119/318 (37%), Gaps = 31/318 (9%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENV-----IGVGGNGKVYKGV 384
K+ R D E TY E + IG G G V++G+
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGI 410
Query: 385 L---EGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440
E +A+K + +D FL E ++ + H +V L G + ++
Sbjct: 411 YMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--PVWII 468
Query: 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
+ G L ++ S L I ++ + YL K+ +HRDI + NVL
Sbjct: 469 MELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVL 523
Query: 501 LDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560
+ +LGDFGL+R ++ + ++APE + R ++ +DV+ FG+ +
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 561 EVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
E+L G +P +G N V + G+ L + + L C
Sbjct: 584 EILMHGVKPF-QGVKN--NDVIGRIENGERLPMP-----------PNCPPTLYSLMTKCW 629
Query: 620 YPDPRARPTMRQVVKVLE 637
DP RP ++ L
Sbjct: 630 AYDPSRRPRFTELKAQLS 647
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 72/321 (22%), Positives = 124/321 (38%), Gaps = 69/321 (21%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
+ E+ IT +G G G+VY+G + G + +AVK +
Sbjct: 23 DLKEVP--RKNITLIR------------GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 398 SHENDGGTRA----FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI 453
+ + FL E + + H+++V G + ++ + M G L ++
Sbjct: 69 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKSFL 124
Query: 454 FQCDGSMM----LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
+ L+ + + V +D+A G YL E +HRDI + N LL GR+
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 181
Query: 510 ---GDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGI 557
GDFG+AR G + V ++ PE F G +++TD + FG+
Sbjct: 182 AKIGDFGMARDIYRASYYRKGGCAMLP--------VKWMPPEAFMEGIFTSKTDTWSFGV 233
Query: 558 LILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGL 616
L+ E+ S G P K N + V E + G +D ++ V +
Sbjct: 234 LLWEIFSLGYMPY-PSKSN--QEVLEFVTSGGRMDPP-----------KNCPGPVYRIMT 279
Query: 617 LCAYPDPRARPTMRQVVKVLE 637
C P RP +++ +E
Sbjct: 280 QCWQHQPEDRPNFAIILERIE 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRA-FLAEISSLGRLKHKSLVG 425
++G GG G VY+ +A+K + +D R E + GRL+ +V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 426 L--RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ G G L + + L + + G L+ + +++ + + + H
Sbjct: 99 IHDFG---EIDGQLYVDMRLINGVDLAAMLRR-QGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
HRD+K N+L+ + L DFG+A ++ VGT+ Y+APE FS
Sbjct: 153 ---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
A+ + D++ ++ E L+G P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/283 (23%), Positives = 123/283 (43%), Gaps = 39/283 (13%)
Query: 366 FSEENVIGVGGNGK-VYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSL 423
F ++V+G G G VY+G+ + ++AVKRI E E+ L +H ++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNR--DVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ K + + + +L +++ Q D + E I +L+ +G+ +LH
Sbjct: 81 IRYFCTEKDRQ-FQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS 136
Query: 484 GWEKKVLHRDIKSSNVLL-----DKEMNGRLGDFGLARMHGHGQVASTTR--VVGTVGYL 536
++HRD+K N+L+ ++ + DFGL + G+ + + R V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 537 APEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKP--NLVEMVWELMVQGKLLD 591
APE+ S + D+F G + V+S P ++ +++ LD
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLGACSLD 248
Query: 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
L ED + R L ++ DP+ RP+ + V+K
Sbjct: 249 CLHPEK------HEDVIARELIEKMIA--MDPQKRPSAKHVLK 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 77/324 (23%), Positives = 135/324 (41%), Gaps = 68/324 (20%)
Query: 345 WELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEI--AVKRISHEND 402
L+ + I +Q+ VIG G G+V K ++ G + A+KR+ +
Sbjct: 20 PVLD--WNDIKFQD------------VIGEGNFGQVLKARIKKDGLRMDAAIKRM---KE 62
Query: 403 GGT----RAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKW----- 452
+ R F E+ L +L H +++ L G C+ G L L +Y +G+L +
Sbjct: 63 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSR 121
Query: 453 --------IFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504
+ LS ++ + DVA G+ YL + K+ +HRD+ + N+L+ +
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN 178
Query: 505 MNGRLGDFGLARMHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTDVFGFGILI 559
++ DFGL+R V T+G L A E + +T +DV+ +G+L+
Sbjct: 179 YVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 560 LEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLC 618
E++S G P G ++E + QG L+ + + V L C
Sbjct: 232 WEIVSLGGTPY-CGMTC--AELYEKLPQGYRLEK-----------PLNCDDEVYDLMRQC 277
Query: 619 AYPDPRARPTMRQVVKVLEGKIEA 642
P RP+ Q++ L +E
Sbjct: 278 WREKPYERPSFAQILVSLNRMLEE 301
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 24/282 (8%)
Query: 369 ENVIGVGGNGKVYKGVL----EGGGAEIAVKRI-SHENDGGTRAFLAEISSLGRLKHKSL 423
+G G GKV +G G +AVK + + + EI L L H+ +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 424 VGLRGWCKREKG-SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+ +G C+ SL LV +Y+ GSL ++ + + + + + + G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH 151
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT--VGYLAPEV 540
+ +HRD+ + NVLLD + ++GDFGLA+ G R G V + APE
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 541 FSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMV--WELMVQGKLLDALDA-- 595
+ +DV+ FG+ + E+L+ L + M +L + L+
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
RL + V HL C + RPT ++ +L+
Sbjct: 269 RLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 72/321 (22%), Positives = 124/321 (38%), Gaps = 69/321 (21%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
+ E+ IT +G G G+VY+G + G + +AVK +
Sbjct: 64 DLKEVP--RKNITLIR------------GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 109
Query: 398 SHENDGGT----RAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI 453
+ + FL E + + H+++V G + ++ + M G L ++
Sbjct: 110 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILLELMAGGDLKSFL 165
Query: 454 FQCDGSMM----LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
+ L+ + + V +D+A G YL E +HRDI + N LL GR+
Sbjct: 166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 222
Query: 510 ---GDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGI 557
GDFG+AR G + V ++ PE F G +++TD + FG+
Sbjct: 223 AKIGDFGMARDIYRAGYYRKGGCAMLP--------VKWMPPEAFMEGIFTSKTDTWSFGV 274
Query: 558 LILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGL 616
L+ E+ S G P K N + V E + G +D ++ V +
Sbjct: 275 LLWEIFSLGYMPY-PSKSN--QEVLEFVTSGGRMDPP-----------KNCPGPVYRIMT 320
Query: 617 LCAYPDPRARPTMRQVVKVLE 637
C P RP +++ +E
Sbjct: 321 QCWQHQPEDRPNFAIILERIE 341
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 72/345 (20%), Positives = 144/345 (41%), Gaps = 75/345 (21%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
++WE+ +IT +G G G VY+GV +G + +A+K +
Sbjct: 18 DEWEVA--REKITMSR------------ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 398 SHENDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC 456
+ R FL E S + +V L G + +++ + M G L ++
Sbjct: 64 NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSL 122
Query: 457 -------DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
S + I++ ++A G+ YL+ K +HRD+ + N ++ ++ ++
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 179
Query: 510 GDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILIL 560
GDFG+ R G G + V +++PE G +T +DV+ FG+++
Sbjct: 180 GDFGMTRDIYETDYYRKGGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLW 231
Query: 561 EVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCA 619
E+ + +P + G N E V +++G LLD ++ + + L +C
Sbjct: 232 EIATLAEQPYQ-GLSN--EQVLRFVMEGGLLDKP-----------DNCPDMLFELMRMCW 277
Query: 620 YPDPRARPTMRQVVKVLEGKIEAGIEN------------ETEDMD 652
+P+ RP+ +++ ++ ++E G E E++D
Sbjct: 278 QYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEELD 322
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 65/317 (20%), Positives = 127/317 (40%), Gaps = 61/317 (19%)
Query: 345 WELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEG---GGAEI--AVKRISH 399
++ I + +G G GKV+ ++ AVK +
Sbjct: 36 HHIK--RRDIVLKW------------ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 81
Query: 400 ENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGS 459
++ + F E L L+H+ +V G C L++V++YM +G L++++
Sbjct: 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 460 MM------------LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507
L + + V VAAG++YL +HRD+ + N L+ + +
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197
Query: 508 RLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTDVFGFGILILE 561
++GDFG++R ++ R VG L PE + +T++DV+ FG+++ E
Sbjct: 198 KIGDFGMSRDIYS----TDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252
Query: 562 VLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAY 620
+ + G++P N + + QG+ L+ V + C
Sbjct: 253 IFTYGKQPW-YQLSN--TEAIDCITQGRELER-----------PRACPPEVYAIMRGCWQ 298
Query: 621 PDPRARPTMRQVVKVLE 637
+P+ R +++ V L+
Sbjct: 299 REPQQRHSIKDVHARLQ 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 39/302 (12%), Positives = 75/302 (24%), Gaps = 61/302 (20%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA---FLAEISSLGRLKHKSLVGLR 427
V+G + + G V + A E+ L L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 428 GWCKR--------EKGSLMLVYDYMENGSLDKWI---------FQCDGSMM--------- 461
R + + + D W+ Q +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDER-DMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 462 ----LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517
L R+++ V + LH ++H ++ +++LD+ L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQ-----TDVFGFGILILEVLSGRRPIEEG 572
G V+ R A + G+ D + G+ I + P +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
L + R+ + V +L G L R Q
Sbjct: 321 AA---------------LGGSEWIFRSCKNIPQ-PVRALLE-GFLR--YPKEDRLLPLQA 361
Query: 633 VK 634
++
Sbjct: 362 ME 363
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 34/212 (16%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRA-FLAEISSLGRLKHKSLVGLRG 428
+G GG VY ++A+K I T F E+ + +L H+++V
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75
Query: 429 WCKREKGSLMLVYDY----------ME--NGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
+ D ME G + G LS + I +
Sbjct: 76 -----------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILD 122
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYL 536
G+ + H+ +++HRDIK N+L+D ++ DFG+A+ + T V+GTV Y
Sbjct: 123 GIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+PE TD++ GI++ E+L G P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ + IG G G V+K +A+KR+ +++G + L EI L LKHK++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLH 482
V L L LV+++ + L K+ C+G + ++ L + G+ + H
Sbjct: 64 VRLHD-VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE---IVKSFLFQLLKGLGFCH 118
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-F 541
VLHRD+K N+L+++ +L +FGLAR G + VV T+ Y P+V F
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPI 569
+ ST D++ G + E+ + RP+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 49/295 (16%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAE-----IAVKRISHE-NDGGTRAFLAEISSLGRLKHKS 422
+G GKVYKG L G +A+K + + F E RL+H +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKW-------------IFQCDGSMMLSCEERIR 469
+V L G ++ L +++ Y +G L ++ L + +
Sbjct: 74 VVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 470 VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTR 528
++ +AAG+ YL V+H+D+ + NVL+ ++N ++ D GL R ++ A +
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA----ADYYK 185
Query: 529 VVGTVGYL-----APEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582
+ L APE G+ S +D++ +G+++ EV S G +P G N + V E
Sbjct: 186 L-LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSN--QDVVE 241
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
++ ++L +D V L + C P RP + + L
Sbjct: 242 MIRNRQVLPCP-----------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ +G G GKVYK + GA A K I +++ ++ EI L H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEG 484
L G G L ++ ++ G++D + + D + E +I+ V + + + +LH
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS- 135
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYLAPEV 540
K+++HRD+K+ NVL+ E + RL DFG++ + T + +GT ++APEV
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 541 FSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKPNLVEM 579
D++ GI ++E+ + +P E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMA-------QIEPPHHEL 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
F +G G G VYK + + G +A+K++ E+D + + EIS + + +V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEG 484
G + L +V +Y GS+ I + ++ E+ I +L+ G+ YLH
Sbjct: 89 YYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT---EDEIATILQSTLKGLEYLHF- 143
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYLAPEV 540
+ +HRDIK+ N+LL+ E + +L DFG+A GQ+ T V+GT ++APEV
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ D++ GI +E+ EGKP ++
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMA-------EGKPPYADI 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 25/241 (10%)
Query: 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSL 415
Q + + + IG G G V K V + G +AVKRI D + L ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 416 GRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLK 472
R +V G RE G + + M + S DK+ + E I ++
Sbjct: 75 MRSSDCPYIVQFYGALFRE-GDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRV 529
+ +L E K++HRDIK SN+LLD+ N +L DFG++ GQ+ + TR
Sbjct: 133 ATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRD 185
Query: 530 VGTVGYLAPEVFSSGRA----STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585
G Y+APE + ++DV+ GI + E+ +GR P + V++ +
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS-----VFDQLT 240
Query: 586 Q 586
Q
Sbjct: 241 Q 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/319 (20%), Positives = 132/319 (41%), Gaps = 60/319 (18%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
++ I + +G G GKV+ +AVK +
Sbjct: 8 HVQHIK--RRDIVLKR------------ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL 53
Query: 398 SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC- 456
+ F E L L+H+ +V G C L++V++YM++G L+K++
Sbjct: 54 KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHG 112
Query: 457 ------------DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504
L + + + +A+G++YL + +HRD+ + N L+
Sbjct: 113 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 169
Query: 505 MNGRLGDFGLAR-MHGHGQVASTTRVVGT----VGYLAPEVFSSGRASTQTDVFGFGILI 559
+ ++GDFG++R ++ RV G + ++ PE + +T++DV+ FG+++
Sbjct: 170 LLVKIGDFGMSRDVYS----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
Query: 560 LEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLC 618
E+ + G++P N V E + QG++L+ + V + L C
Sbjct: 226 WEIFTYGKQPW-FQLSN--TEVIECITQGRVLERP-----------RVCPKEVYDVMLGC 271
Query: 619 AYPDPRARPTMRQVVKVLE 637
+P+ R ++++ K+L
Sbjct: 272 WQREPQQRLNIKEIYKILH 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 74/309 (23%)
Query: 366 FSEENVIGVGGNGKV-YKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSL 423
E ++G G +G V ++G +G +AVKR+ + L EI L H ++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQG--RPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 424 VGLRGWCKREKGSLMLVYDYME--NGSLDKWI----FQCDGSMMLSCEERIRVLKDVAAG 477
+ ++ +Y +E N +L + + + I +L+ +A+G
Sbjct: 72 IRYYCSETTDRF----LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR-------------LGDFGLARMHGHGQVA 524
V +LH K++HRD+K N+L+ + DFGL + GQ +
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 525 STTR---VVGTVGYLAPEVFSSG-------RASTQTDVFGFGILILEVLS-GRRP----- 568
T GT G+ APE+ R + D+F G + +LS G+ P
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 569 -----IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDP 623
I G +L EM L A D + +++ DP
Sbjct: 245 SRESNIIRGIFSLDEMKC--------LHDRSLIAEAT-----DLISQMID-------HDP 284
Query: 624 RARPTMRQV 632
RPT +V
Sbjct: 285 LKRPTAMKV 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 36/287 (12%)
Query: 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEISSL 415
Q +A +G G G+V+K G IAVK++ + L ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 416 GRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLK 472
+ +V G + + + M +K + G + ERI ++
Sbjct: 78 LKSHDCPYIVQCFGTFITN-TDVFIAMELM-GTCAEKLKKRMQGPI----PERILGKMTV 131
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRV 529
+ + YL E + V+HRD+K SN+LLD+ +L DFG++ G++ R
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRS 184
Query: 530 VGTVGYLAPEVFSSGRA-----STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584
G Y+APE + DV+ GI ++E+ +G+ P + K +E++
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVL 239
Query: 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
+ +L L GF D V C D R RP +
Sbjct: 240 TK--VLQEEPPLLPGHMGFSGDFQSFV----KDCLTKDHRKRPKYNK 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-RAFLAEISSLGRLKHKSLV 424
+ + + +G G VYKG + +A+K I E++ G + E+S L LKH ++V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHE 483
L + SL LV++Y++ L +++ C + + +++ L + G+ Y H
Sbjct: 64 TLHDII-HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHR 118
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FS 542
VLHRD+K N+L+++ +L DFGLAR VV T+ Y P++
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174
Query: 543 SGRASTQTDVFGFGILILEVLSGR 566
S STQ D++G G + E+ +GR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 25/236 (10%)
Query: 337 REREEMEDWELEYWPHRI--TYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAV 394
D E + Y+ + ++G G G V K + G +A+
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLG----------LVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 395 KRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKW 452
K+ S ++ + + EI L +L+H++LV L C ++K LV++++++ ++
Sbjct: 56 KKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-KKKKRWYLVFEFVDH-TILDD 113
Query: 453 IFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511
+ + + ++ L + G+ + H ++HRDIK N+L+ + +L D
Sbjct: 114 LELFPNGLD---YQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 512 FGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGR 566
FG AR V T Y APE+ + DV+ G L+ E+ G
Sbjct: 168 FGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
++ IG G +G VY + G E+A+++++ + + EI + K+ ++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLHEG 484
L +V +Y+ GSL + + E +I V ++ + +LH
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS- 134
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYLAPEV 540
+V+HRDIKS N+LL + + +L DFG Q+ +VGT ++APEV
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEV 187
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRP 568
+ + D++ GI+ +E++ G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 60/281 (21%), Positives = 107/281 (38%), Gaps = 52/281 (18%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
+G G G V+ G E +K I+ + AEI L L H +++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 430 CKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + ++ +V + E G L ++ + LS ++K + + Y H +
Sbjct: 89 FE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QH 144
Query: 489 VLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
V+H+D+K N+L ++ DFGLA + + ++ GT Y+APEVF
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVF-KRD 201
Query: 546 ASTQTDVFGFG-IL-ILEVLSGRRP------------IEEGKPNLVEMVWELMVQGKLLD 591
+ + D++ G ++ L L+G P +PN L Q
Sbjct: 202 VTFKCDIWSAGVVMYFL--LTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV--- 256
Query: 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
D ++++L DP RP+ QV
Sbjct: 257 --------------DLLKQMLT-------KDPERRPSAAQV 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 42/216 (19%), Positives = 75/216 (34%), Gaps = 30/216 (13%)
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
K L + +L W+ + + + +A V +LH K +
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGL 185
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST-----------TRVVGTVGYLAP 538
+HRD+K SN+ + ++GDFGL + T T VGT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598
E S + D+F G+++ E+L E + + K
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFT---- 296
Query: 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ E ++ +L P P RP +++
Sbjct: 297 -----QKYPQEHMMVQDMLS--PSPTERPEATDIIE 325
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRA-FLAEISSLGRLKHKSLVGLRG 428
+G GG K ++ A K + R EIS L H+ +VG G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + +V + SL + + L+ E L+ + G YLH +
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHR---NR 161
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
V+HRD+K N+ L++++ ++GDFGLA ++ G+ GT Y+APEV S S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ DV+ G ++ +L G+ P E L E
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFET--SCLKET 249
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRA-FLAEISSLGRLKHKSLVGLRG 428
+G GG K ++ A K + R EIS L H+ +VG G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + +V + SL + + L+ E L+ + G YLH +
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHR---NR 135
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
V+HRD+K N+ L++++ ++GDFGLA ++ G+ GT Y+APEV S S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 193
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ DV+ G ++ +L G+ P E L E
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFET--SCLKET 223
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 76/334 (22%), Positives = 135/334 (40%), Gaps = 62/334 (18%)
Query: 341 EMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVK 395
+ WE R+ + +G G G+V + G +AVK
Sbjct: 18 DASKWEFP--RDRLKLGK------------PLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 396 RI-SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL---- 449
+ RA ++E+ L + H ++V L G C + G LM++ ++ + G+L
Sbjct: 64 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 450 ---------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
K + L+ E I VA G+ +L +K +HRD+ + N+L
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 180
Query: 501 LDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTDVFG 554
L ++ ++ DFGLAR ++ V L APE + Q+DV+
Sbjct: 181 LSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 555 FGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLH 613
FG+L+ E+ S G P K + E + +G + A D + E+ + +
Sbjct: 236 FGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPD--------YTTPEMYQTM- 284
Query: 614 LGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENE 647
L C + +P RPT ++V+ L ++A + +
Sbjct: 285 --LDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK--RISHENDGGTRA-FLAEISSLGRLKHKSLVGLRG 428
+G GG +V+ ++AVK R D F E + L H ++V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 429 WCKREKGSLMLVYDYME--NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
+ E + L Y ME +G + I +G ++ + I V+ D + + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ--- 134
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVASTTRVVGTVGYLAPEVFSSG 544
++HRD+K +N+++ ++ DFG+AR V T V+GT YL+PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
++DV+ G ++ EVL+G P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
IG G G V + G ++AVK + E+ + +H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI-RVLKDVAAGVLYLHEG 484
+ L ++ ++++ G+L + Q + EE+I V + V + YLH
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLN-----EEQIATVCEAVLQALAYLHA- 159
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYLAPEV 540
+ V+HRDIKS ++LL + +L DFG Q++ +VGT ++APEV
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEV 212
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRP 568
S +T+ D++ GI+++E++ G P
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 65/274 (23%), Positives = 102/274 (37%), Gaps = 42/274 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
IG G G+V V +G A K+I F EI + L H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ + + LV + G L + + + + R++KDV + V Y H + V
Sbjct: 76 E-DNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVA 128
Query: 491 HRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
HRD+K N L + +L DFGLA G++ T VGT Y++P+V G
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVL-EGLYG 185
Query: 548 TQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604
+ D + G ++ +L L G P ++ + F
Sbjct: 186 PECDEWSAGVMMYVL--LCGYPPFSAPTDSEVMLKI----------------REGTFTFP 227
Query: 605 EDEVERV------LHLGLLCAYPDPRARPTMRQV 632
E + V L LL P+ R T Q
Sbjct: 228 EKDWLNVSPQAESLIRRLLT--KSPKQRITSLQA 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 14/243 (5%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGG 389
K + + ++ + + + + + + + +G G G V++ V + G
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 390 AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL 449
K I+ EIS + +L H L+ L + +K ++L+ +++ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLSGGEL 135
Query: 450 DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509
I +S E I ++ G+ ++H E ++H DIK N++ + + +
Sbjct: 136 FDRI--AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV 190
Query: 510 --GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGIL--ILEVLSG 565
DFGLA ++ T + APE+ TD++ G+L +L LSG
Sbjct: 191 KIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL--LSG 246
Query: 566 RRP 568
P
Sbjct: 247 LSP 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/231 (22%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSL--VG 425
IG GG+ KV++ + E A+K ++ E + ++ EI+ L +L+ S +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 426 LRGWCKREKGSLMLVYDYME--NGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLH 482
L + + +V ME N L+ W+ + S+ + K++ V +H
Sbjct: 93 LYDYEI-TDQYIYMV---MECGNIDLNSWLKK-KKSI---DPWERKSYWKNMLEAVHTIH 144
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR-MHGHGQVASTTRVVGTVGYLAPE 539
+ ++H D+K +N L+ +G L DFG+A M VGTV Y+ PE
Sbjct: 145 Q---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 540 VF-----------SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
S + S ++DV+ G ++ + G+ P ++ + ++
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G G V+K G +A+K+ S ++ + L EI L +LKH +LV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLHEGWE 486
R K L LV++Y ++ ++ + + + E ++ + V + H+
Sbjct: 69 EVF-RRKRRLHLVFEYCDH-TVLHELDRYQRGVP---EHLVKSITWQTLQAVNFCHKHN- 122
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGR 545
+HRD+K N+L+ K +L DFG AR+ V T Y +PE+ +
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 546 ASTQTDVFGFGILILEVLSGR 566
DV+ G + E+LSG
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 25/206 (12%)
Query: 371 VIGVGGNGKVYKG---VLEGGGAEIAVKRISHENDGGTRA-FLAEISSLGRLKHKSLVGL 426
I GG G +Y + G + +K + H D +A +AE L + H S+V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNG--RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 427 R--GWCKREKGSLM--LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
G + +V +Y+ SL + Q L E I L ++ + YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH 199
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+++ D+K N++L +E +L D G ++ S + GT G+ APE+
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEI-V 249
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP 568
+ TD++ G + +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHK 421
+ +S IG GG+ KV++ + E A+K ++ E + ++ EI+ L +L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 422 SL--VGLRGWCKREKGSLMLVYDYME--NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
S + L + + +V ME N L+ W+ + S + ER K++
Sbjct: 115 SDKIIRLYDYEI-TDQYIYMV---MECGNIDLNSWLKK-KKS--IDPWERKSYWKNMLEA 167
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR-MHGHGQVASTTRVVGTVG 534
V +H+ ++H D+K +N L+ +G L DFG+A M VG V
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 535 YLAPEVFSS-----------GRASTQTDVFGFGILILEVLSGRRP 568
Y+ PE + S ++DV+ G ++ + G+ P
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 18/247 (7%)
Query: 330 KRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSE----ENVIGVGGNGKVYKGVL 385
+ R D + + Q +E + +G G G V++
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178
Query: 386 EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445
G A K + ++ EI ++ L+H +LV L + + ++++Y++M
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMS 237
Query: 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505
G L + + +S +E + ++ V G+ ++H E +H D+K N++ +
Sbjct: 238 GGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR 292
Query: 506 NGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGIL--ILE 561
+ L DFGL Q GT + APEV TD++ G+L IL
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL- 349
Query: 562 VLSGRRP 568
LSG P
Sbjct: 350 -LSGLSP 355
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 74/332 (22%), Positives = 132/332 (39%), Gaps = 75/332 (22%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRI 397
+ LEY + I Y IG G G+V++ G +AVK +
Sbjct: 38 KLLSLEYPRNNIEYVR------------DIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 85
Query: 398 -SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL------- 449
+ F E + + + ++V L G C + L+++YM G L
Sbjct: 86 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSM 144
Query: 450 --------------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495
+ G LSC E++ + + VAAG+ YL E +K +HRD+
Sbjct: 145 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201
Query: 496 SSNVLLDKEMNGRLGDFGLAR---------MHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+ N L+ + M ++ DFGL+R G+ + + ++ PE R
Sbjct: 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP--------IRWMPPESIFYNRY 253
Query: 547 STQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
+T++DV+ +G+++ E+ S G +P G + E V + G +L E
Sbjct: 254 TTESDVWAYGVVLWEIFSYGLQPY-YGMAH--EEVIYYVRDGNILACP-----------E 299
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ + +L LC P RP+ + ++L+
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G G+V+K G ++A+K++ +E +G L EI L LKH+++V L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 428 G-------WCKREKGSLMLVYDYMEN---GSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
R KGS+ LV+D+ E+ G L + + + E RV++ + G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNG 136
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS----TTRVVGTV 533
+ Y+H +LHRD+K++NVL+ ++ +L DFGLAR + + T RVV T+
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192
Query: 534 GYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
Y PE+ D++G G ++ E+ + R PI +G
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/234 (22%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHK 421
+ +S IG GG+ KV++ + E A+K ++ E + ++ EI+ L +L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 422 SL--VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
S + L + + +V + N L+ W+ + S + ER K++ V
Sbjct: 68 SDKIIRLYDYEI-TDQYIYMVMEC-GNIDLNSWLKK-KKS--IDPWERKSYWKNMLEAVH 122
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR-MHGHGQVASTTRVVGTVGYL 536
+H+ ++H D+K +N L+ +G L DFG+A M VGTV Y+
Sbjct: 123 TIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 537 APEVFSSGRA-----------STQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
PE + S ++DV+ G ++ + G+ P ++ + ++
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 69/279 (24%), Positives = 108/279 (38%), Gaps = 42/279 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS-----HENDGGTRAFLAEISSLGRLKHKSLVG 425
VIG G V + + G + AVK + T E S LKH +V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 426 LRGWCKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G L +V+++M+ L + + + D + S ++ + + Y H+
Sbjct: 91 LLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 485 WEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
++HRD+K VLL + +LG FG+A G + + RV GT ++APEV
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205
Query: 542 SSGRASTQTDVFGFG-IL-ILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
DV+G G IL IL LSG P K L E + ++
Sbjct: 206 KREPYGKPVDVWGCGVILFIL--LSGCLPFYGTKERLFEGI----------------IKG 247
Query: 600 KGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
K + + + L +L DP R T+ +
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLM--LDPAERITVYEA 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 46/226 (20%), Positives = 90/226 (39%), Gaps = 24/226 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLR 427
V+ GG VY+ G G E A+KR+ + RA + E+ + +L H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 428 GWC-------KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
+ +L+ + + ++ + + + LSC+ +++ V +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEF-LKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR-----------V 529
+H + ++HRD+K N+LL + +L DFG A H S +
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 530 VGTVGYLAPEVFSSGR---ASTQTDVFGFGILILEVLSGRRPIEEG 572
T Y PE+ + D++ G ++ + + P E+G
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G VY+ G E+A+K I + G + E+ +LKH S++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + + LV + NG +++++ S E + + G+LYLH
Sbjct: 79 YFEDSN-YVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHS---HG 132
Query: 489 VLHRDIKSSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
+LHRD+ SN+LL + MN ++ DFGLA ++ + T GT Y++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHG 190
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
++DV+ G + +L GR P + +
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDT--DTVKNT 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ + +G G G VYK + G +A+KRI E++G + EIS L L H ++
Sbjct: 23 YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLH 482
V L + L LV+++ME L K + + + S +I+ L + GV + H
Sbjct: 82 VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQLLRGVAHCH 136
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-F 541
+ +LHRD+K N+L++ + +L DFGLAR G + T VV T+ Y AP+V
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 542 SSGRASTQTDVFGFGILILEVLSGR 566
S + ST D++ G + E+++G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLV 424
F ++G G G+VYKG G A+K + D EI+ L + H+++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84
Query: 425 G-----LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGV 478
++ L LV ++ GS+ I G+ + EE I + +++ G+
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--KEEWIAYICREILRGL 142
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVG 534
+LH+ KV+HRDIK NVLL + +L DFG++ Q+ T +GT
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPY 194
Query: 535 YLAPEVFSSGRASTQT-----DVFGFGILILEVLSGRRPIEEGKPNLVEM 579
++APEV + T D++ GI +E + EG P L +M
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIE-------MAEGAPPLCDM 237
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 38/230 (16%), Positives = 73/230 (31%), Gaps = 23/230 (10%)
Query: 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHENDGGTRAFLAEI 412
E + +K +++G G +VY+ + +K N +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 413 SSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI--FQCDGSMMLSCEERIRV 470
L + + +LV + G+L I ++ ++ I
Sbjct: 119 ERLKPSMQHMFMKFYS-AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL-----------DKEMNGRLGDFGLAR-MH 518
+ + +H+ +++H DIK N +L D L D G + M
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ T T G+ E+ S+ + Q D FG + +L G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 38/307 (12%), Positives = 82/307 (26%), Gaps = 70/307 (22%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA----------------------- 407
V+G + + G V + A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 408 -----FLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLVYDYME--NGSLDKWIFQ-CDG 458
F+ + + K ++ +R + S +Y M+ + + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 459 SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518
L R+++ V + LH ++H ++ +++LD+ L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSS-----------GRASTQTDVFGFGILILEVLSGRR 567
G + G+ PE+ + + D + G++I +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 568 PIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP 627
PI + L + R+ + V +L G L R
Sbjct: 312 PITKDAA---------------LGGSEWIFRSCKNIPQ-PVRALLE-GFLR--YPKEDRL 352
Query: 628 TMRQVVK 634
Q ++
Sbjct: 353 LPLQAME 359
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 27/220 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR-AFLAEIS-SLGRLKHKSL 423
+G G G V K G +AVKRI + + L ++ S+ +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLD---KWIFQCDGSMMLSCEERI--RVLKDVAAGV 478
V G RE G + + + M + SLD K + ++ E I ++ + +
Sbjct: 69 VTFYGALFRE-GDVWICMELM-DTSLDKFYKQVIDKGQTI----PEDILGKIAVSIVKAL 122
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---TRVVGTVGY 535
+LH + V+HRD+K SNVL++ ++ DFG++ G + G Y
Sbjct: 123 EHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGCKPY 175
Query: 536 LAPEVFSSGRA----STQTDVFGFGILILEVLSGRRPIEE 571
+APE + S ++D++ GI ++E+ R P +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLV 424
F++ IG G G+V+KG+ +A+K I E + EI+ L + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC---EERIR-VLKDVAAGVLY 480
G + L ++ +Y+ GS ++ E +I +L+++ G+ Y
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSAL--------DLLEPGPLDETQIATILREILKGLDY 134
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGYL 536
LH +K +HRDIK++NVLL + +L DFG+A GQ+ T VGT ++
Sbjct: 135 LHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWM 186
Query: 537 APEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
APEV ++ D++ GI +E+ G P
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT-----RAFLAEISSLGRLKH 420
F + +G G VYKG+ + G +A+K + +++ GT R EIS + LKH
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKH 62
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMEN---GSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
+++V L + L LV+++M+N +D + + + G
Sbjct: 63 ENIVRLYDVI-HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQLLQG 120
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
+ + HE +LHRD+K N+L++K +LGDFGLAR G ++ VV T+ Y A
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 538 PEV-FSSGRASTQTDVFGFGILILEVLSGR 566
P+V S ST D++ G ++ E+++G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 18/214 (8%)
Query: 366 FSEENVIGVGGNGKVYKGV-LEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLK--- 419
+ IG G GKV+K L+ GG +A+KR+ +G + + E++ L L+
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 420 HKSLVGLR----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA 475
H ++V L + L LV+++++ L ++ + + E ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-PEPGVPTETIKDMMFQLL 130
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGY 535
G+ +LH V+HRD+K N+L+ +L DFGLAR++ Q+A T+ VV T+ Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVV-TLWY 185
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPI 569
APEV +T D++ G + E+ R+P+
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/300 (22%), Positives = 118/300 (39%), Gaps = 58/300 (19%)
Query: 362 ATKGFSEE----NVIGVGGNGKVYKGVLEGGGAEIAVKRIS---------HENDGGTRAF 408
+T GF E ++G G + V + + + E AVK I E A
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 409 LAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER 467
L E+ L ++ H +++ L+ + LV+D M+ G L ++ + + LS +E
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKET 126
Query: 468 IRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
++++ + + LH+ ++HRD+K N+LLD +MN +L DFG + G+
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182
Query: 528 RVVGTVGYLAPEVFSSGRASTQT------DVFGFG-IL-ILEVLSGRRP-IEEGKPNLVE 578
V GT YLAPE+ D++ G I+ L L+G P + ++
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAGSPPFWHRKQMLMLR 239
Query: 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
M+ + F E + L L P+ R T +
Sbjct: 240 MI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLV--VQPQKRYTAEEA 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ IG G G VYK G A+K+I E++G + EIS L LKH ++
Sbjct: 4 YHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYLH 482
V L K L+LV+++++ L K + C+G + + L + G+ Y H
Sbjct: 63 VKLYDVI-HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH 117
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-F 541
+ VLHRD+K N+L+++E ++ DFGLAR G T +V T+ Y AP+V
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 542 SSGRASTQTDVFGFGILILEVLSGR 566
S + ST D++ G + E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 67/306 (21%), Positives = 125/306 (40%), Gaps = 40/306 (13%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTR--AFLAEISSLGRLKHKSLVGL 426
+G G G+V + E A+K I + + L E++ L L H +++ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
+ + +K + LV + + G L I + + ++K V +GV YLH+
Sbjct: 102 YDFFE-DKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHK--- 154
Query: 487 KKVLHRDIKSSNVLL-DKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
++HRD+K N+LL KE + + DFGL+ + + + +GT Y+APEV
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLR- 211
Query: 544 GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603
+ + DV+ G+++ +L+G P G E+ L + K F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPF--GGQTDQEI-------------LRKVEKGKYTF 256
Query: 604 DEDEVERV------LHLGLLCAYPDPRARPTMRQVVKV--LEGKIEAGIENETEDMDAYL 655
D E + V L +L D + R + +Q ++ ++ A
Sbjct: 257 DSPEWKNVSEGAKDLIKQMLQ--FDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314
Query: 656 LQQVKS 661
++ ++
Sbjct: 315 IENMRK 320
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAF----LAEISSLGRLK- 419
+ IGVG G VYK G +A+K + N GG + E++ L RL+
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 420 --HKSLVGLR----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD 473
H ++V L + + LV+++++ L ++ + L E +++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMRQ 128
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTV 533
G+ +LH ++HRD+K N+L+ +L DFGLAR++ + Q+A T VV T+
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALTPVVV-TL 183
Query: 534 GYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
Y APEV +T D++ G + E+ R+P+ G
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLV 424
+ + VIG G V ++A+KRI+ E + L EI ++ + H ++V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLD---KWIFQCDGSMMLSCEERI--RVLKDVAAGVL 479
K L LV + GS+ K I +E +L++V G+
Sbjct: 77 SYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR----VVGTVGY 535
YLH+ +HRD+K+ N+LL ++ + ++ DFG++ G + + VGT +
Sbjct: 136 YLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 536 LAPEVFSSGRA-STQTDVFGFGILILEVLSGRRP 568
+APEV R + D++ FGI +E+ +G P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHKS 422
FS+ IG G G VY +A+K++S +++ + + E+ L +L+H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVLYL 481
+ RG C + + LV +Y + D + + E I V G+ YL
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDL-LEVHKKPLQ---EVEIAAVTHGALQGLAYL 170
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H ++HRD+K+ N+LL + +LGDFG A +A VGT ++APEV
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVI 222
Query: 542 SSGRAST---QTDVFGFGILILEVLSGRRP 568
+ + DV+ GI +E+ + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 73/340 (21%), Positives = 140/340 (41%), Gaps = 64/340 (18%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-------IAVK 395
ED + E+ ++T + +G G G+V G + +AVK
Sbjct: 26 EDPKWEFPRDKLTLGK------------PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 396 RI-SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL---- 449
+ + ++E+ + + KHK+++ L G C ++ G L ++ +Y G+L
Sbjct: 74 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYL 132
Query: 450 ---------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
+ ++ ++ + +A G+ YL +K +HRD+ + NVL
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189
Query: 501 LDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTDVFG 554
+ + ++ DFGLAR ++ T G L APE + Q+DV+
Sbjct: 190 VTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 555 FGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLH 613
FG+L+ E+ + G P G P E +++L+ +G +D +E+ ++
Sbjct: 245 FGVLMWEIFTLGGSPY-PGIPV--EELFKLLKEGHRMDKPA--------NCTNELYMMM- 292
Query: 614 LGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDA 653
C + P RPT +Q+V+ L+ + E D+
Sbjct: 293 --RDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQ 330
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ +G G G+VYK + +A+KRI HE +G + E+S L L+H+++
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ L+ L L+++Y EN L K++ D + +S L + GV + H
Sbjct: 96 IELKSVI-HHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGR-----LGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
LHRD+K N+LL +GDFGLAR G T ++ T+ Y P
Sbjct: 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPP 206
Query: 539 EV-FSSGRASTQTDVFGFGILILEVLSGR 566
E+ S ST D++ + E+L
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 51/287 (17%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-------------HENDGGTRAFLAEISSL 415
+G G G+V + G +E A+K I + EIS L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 416 GRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA 475
L H +++ L + +K LV ++ E G L + I + ++K +
Sbjct: 101 KSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQIL 156
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLL-DKEMNGRL--GDFGLARMHGHGQVASTTRVVGT 532
+G+ YLH+ ++HRDIK N+LL +K + DFGL+ +GT
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGT 211
Query: 533 VGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLD 591
Y+APEV + + + DV+ G+++ +L G P + ++++ V
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----------- 259
Query: 592 ALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ K FD ++ + + L +L D R T +
Sbjct: 260 -----EKGKYYFDFNDWKNISDEAKELIKLMLT--YDYNKRCTAEEA 299
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 80/354 (22%), Positives = 142/354 (40%), Gaps = 75/354 (21%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-------IAVK 395
WEL R+ + +G G G+V G + +AVK
Sbjct: 62 PRWELP--RDRLVLGK------------PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK 107
Query: 396 RISHENDGGT----RAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL- 449
+ T ++E+ + + KHK+++ L G C ++ G L ++ +Y G+L
Sbjct: 108 ML---KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLR 163
Query: 450 ------------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSS 497
+ + LS ++ + VA G+ YL KK +HRD+ +
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR 220
Query: 498 NVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTD 551
NVL+ ++ ++ DFGLAR +H T G L APE + Q+D
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 552 VFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVER 610
V+ FG+L+ E+ + G P G P E +++L+ +G +D +E+
Sbjct: 276 VWSFGVLLWEIFTLGGSPY-PGVPV--EELFKLLKEGHRMDKPS--------NCTNELYM 324
Query: 611 VLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDM 664
++ C + P RPT +Q+V+ L+ + ++M Y D+
Sbjct: 325 MM---RDCWHAVPSQRPTFKQLVEDLDRIVA---LTSNQEMGYYHHHHHHDYDI 372
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 66/273 (24%), Positives = 107/273 (39%), Gaps = 40/273 (14%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+G G VY+ +G A+K + D + EI L RL H +++ L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ + LV + + G L I + G S + +K + V YLHE ++
Sbjct: 118 E-TPTEISLVLELVTGGELFDRIVE-KGY--YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 491 HRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
HRD+K N+L + ++ DFGL+++ H + T V GT GY APE+
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCAYG 228
Query: 548 TQTDVFGFG-IL-ILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
+ D++ G I IL L G P ++ + + L + F
Sbjct: 229 PEVDMWSVGIITYIL--LCGFEP-----------FYDERGDQFMFRRI---LNCEYYFIS 272
Query: 606 DEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ V L L+ DP+ R T Q
Sbjct: 273 PWWDEVSLNAKDLVRKLIV--LDPKKRLTTFQA 303
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 15/213 (7%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGL 426
+G G G VY + +A+K + G E+ L+H +++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
G+ + L+ +Y G++ + + + + + ++A + Y H
Sbjct: 75 YGYFHDAT-RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS--- 127
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
K+V+HRDIK N+LL ++ DFG + +H + GT+ YL PE+
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 547 STQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ D++ G+L E L G+ P E E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEA--NTYQET 215
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 72/324 (22%), Positives = 137/324 (42%), Gaps = 64/324 (19%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-------IAVK 395
ED + E+ ++T + +G G G+V G + +AVK
Sbjct: 72 EDPKWEFPRDKLTLGK------------PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 119
Query: 396 RI-SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL---- 449
+ + ++E+ + + KHK+++ L G C ++ G L ++ +Y G+L
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYL 178
Query: 450 ---------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
+ ++ ++ + +A G+ YL +K +HRD+ + NVL
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235
Query: 501 LDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSGRASTQTDVFG 554
+ + ++ DFGLAR ++ T G L APE + Q+DV+
Sbjct: 236 VTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 555 FGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLH 613
FG+L+ E+ + G P G P E +++L+ +G +D K +E+ ++
Sbjct: 291 FGVLMWEIFTLGGSPY-PGIPV--EELFKLLKEGHRMD--------KPANCTNELYMMM- 338
Query: 614 LGLLCAYPDPRARPTMRQVVKVLE 637
C + P RPT +Q+V+ L+
Sbjct: 339 --RDCWHAVPSQRPTFKQLVEDLD 360
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHKSLVG 425
+ V+G G G+V + G E AVK IS + + L E+ L +L H +++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L + + +KG LV + G L I S + R+++ V +G+ Y+H+
Sbjct: 91 LYEFFE-DKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHK-- 144
Query: 486 EKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
K++HRD+K N+LL K+ N R+ DFGL+ + +GT Y+APEV
Sbjct: 145 -NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVLH 201
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
G + DV+ G+++ +LSG P + ++++ V + K
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------------EKGKY 244
Query: 602 GFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
F+ + ++V L +L P R + R
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLT--YVPSMRISARDA 279
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 73/327 (22%), Positives = 130/327 (39%), Gaps = 65/327 (19%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
E WE + + + +G G GKV + G G E +AVK +
Sbjct: 39 EKWEFP--RNNLQF------------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 398 ---SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL---- 449
+H ++ A ++E+ + L +H+++V L G C G ++++ +Y G L
Sbjct: 85 KSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLLNFL 141
Query: 450 -------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502
+ + S + + VA G+ +L K +HRD+ + NVLL
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198
Query: 503 KEMNGRLGDFGLARMHGHGQVASTTR-VVGTVGYL-----APEVFSSGRASTQTDVFGFG 556
++GDFGLAR + + + +V L APE + Q+DV+ +G
Sbjct: 199 NGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 557 ILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLG 615
IL+ E+ S G P N ++L+ G + F + ++
Sbjct: 254 ILLWEIFSLGLNPYPGILVN--SKFYKLVKDGYQMAQPA--------FAPKNIYSIM--- 300
Query: 616 LLCAYPDPRARPTMRQVVKVLEGKIEA 642
C +P RPT +Q+ L+ + +
Sbjct: 301 QACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 72/286 (25%), Positives = 112/286 (39%), Gaps = 53/286 (18%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS--------HENDGGTRAFLAEISSLGRLK-HK 421
VIG G + V + V G E AVK + + + A E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL 481
++ L + + LV+D M G L ++ + + LS +E +++ + V +L
Sbjct: 161 HIITLIDSYE-SSSFMFLVFDLMRKGELFDYLTE-KVA--LSEKETRSIMRSLLEAVSFL 216
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H ++HRD+K N+LLD M RL DFG + G+ + GT GYLAPE+
Sbjct: 217 HA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPEIL 271
Query: 542 SSGRASTQT------DVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDA 592
T D++ G IL L L+G P + ++ M+
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTL--LAGSPPFWHRRQILMLRMI------------ 317
Query: 593 LDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ + F E + L LL DP AR T Q
Sbjct: 318 ----MEGQYQFSSPEWDDRSSTVKDLISRLLQ--VDPEARLTAEQA 357
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 29/231 (12%)
Query: 371 VIGVGGNGKVY---------------KGVLEGGGAEIAVKRISHENDGGTRAFLAEISSL 415
+ G K+ K +LE F E+ +
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 416 GRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWI-----FQCDGSMMLSCEERIRV 470
+K++ + G + ++Y+YMEN S+ K+ + + + + +
Sbjct: 98 TDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
+K V Y+H EK + HRD+K SN+L+DK +L DFG + ++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 531 GTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
GT ++ PE FS+ + D++ GI + + P K +LVE+
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVEL 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 73/343 (21%), Positives = 135/343 (39%), Gaps = 68/343 (19%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE-----IAVKRI 397
D + E+ + + + V+G G GKV G +AVK +
Sbjct: 36 YDLKWEFPRENLEFGK------------VLGSGAFGKVMNATAYGISKTGVSIQVAVKML 83
Query: 398 -SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL------ 449
+ A ++E+ + +L H+++V L G C G + L+++Y G L
Sbjct: 84 KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRS 142
Query: 450 --------------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495
K + + + +L+ E+ + VA G+ +L K +HRD+
Sbjct: 143 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199
Query: 496 SSNVLLDKEMNGRLGDFGLARMHGHGQVAST-TRVVGTVGYL-----APEVFSSGRASTQ 549
+ NVL+ ++ DFGLAR + S VV L APE G + +
Sbjct: 200 ARNVLVTHGKVVKICDFGLAR-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 550 TDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608
+DV+ +GIL+ E+ S G P + ++L+ G +D + + +E+
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVD--ANFYKLIQNGFKMD--------QPFYATEEI 304
Query: 609 ERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDM 651
++ C D R RP+ + L ++ E +++
Sbjct: 305 YIIM---QSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 372 IGVGGNGKVYKGV--LEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
+G G G VYK + A+K+I E G + + EI+ L LKH +++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 430 C-KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI------RVLKDVAAGVLYLH 482
+ L++DY E+ L I S ++ +L + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGR----LGDFGLARMHG--HGQVASTTRVVGTVGYL 536
W VLHRD+K +N+L+ E R + D G AR+ +A VV T Y
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 537 APEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
APE+ + + D++ G + E+L+ PI +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 9/207 (4%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F + V+G GG G+V+ ++ G A K+++ + G + + E L ++ +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYL 481
+V L + K L LV M G + I+ D E R + +G+ +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H+ + +++RD+K NVLLD + N R+ D GLA GQ + GT G++APE+
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPELL 361
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRP 568
D F G+ + E+++ R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 69/324 (21%), Positives = 128/324 (39%), Gaps = 55/324 (16%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRI 397
WE +R+++ + +G G GKV + G +AVK +
Sbjct: 16 HKWEFP--RNRLSFGK------------TLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 398 -SHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDYMENGSL------ 449
+ A ++E+ L L H ++V L G C G +++ +Y G L
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRR 120
Query: 450 ---------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500
D + L E+ + VA G+ +L K +HRD+ + N+L
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177
Query: 501 LDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILI 559
L ++ DFGLAR + V ++APE + + ++DV+ +GI +
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 560 LEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLC 618
E+ S G P + ++++ +G + + + E+ ++ C
Sbjct: 238 WELFSLGSSPYPGMPVD--SKFYKMIKEGFRMLSPE--------HAPAEMYDIM---KTC 284
Query: 619 AYPDPRARPTMRQVVKVLEGKIEA 642
DP RPT +Q+V+++E +I
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQISE 308
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 67/288 (23%), Positives = 108/288 (37%), Gaps = 47/288 (16%)
Query: 363 TKGFSEE----NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--TRAFLAEISSLG 416
+ FS+ +G G V + V + G E A K I+ + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 417 RLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
+L+H ++V L +E+ LV+D + G L + I S + ++ +
Sbjct: 61 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILE 116
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG---RLGDFGLARMHGHGQVASTTRVVGTV 533
+ Y H ++HR++K N+LL + G +L DFGLA + GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTP 171
Query: 534 GYLAPEVFSSGRASTQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLL 590
GYL+PEV S D++ G IL IL L G P +E + L +
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYIL--LVGYPPFWDEDQHRLYAQI---------- 219
Query: 591 DALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ E + V L +L +P+ R T Q
Sbjct: 220 ------KAGAYDYPSPEWDTVTPEAKSLIDSMLT--VNPKKRITADQA 259
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 70/276 (25%), Positives = 109/276 (39%), Gaps = 42/276 (15%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
V+G G +V+ G A+K I + EI+ L ++KH+++V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ LV + G L I + G + ++ V++ V + V YLH E
Sbjct: 74 IYE-STTHYYLVMQLVSGGELFDRILE-RGV--YTEKDASLVIQQVLSAVKYLH---ENG 126
Query: 489 VLHRDIKSSNVLL-DKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
++HRD+K N+L E N ++ DFGL++M +G + GT GY+APEV +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKP 183
Query: 546 ASTQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
S D + G I IL L G P EE + L E +
Sbjct: 184 YSKAVDCWSIGVITYIL--LCGYPPFYEETESKLFEKI----------------KEGYYE 225
Query: 603 FDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
F+ + + LL DP R T +
Sbjct: 226 FESPFWDDISESAKDFICHLLE--KDPNERYTCEKA 259
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 55/318 (17%), Positives = 100/318 (31%), Gaps = 78/318 (24%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS-----HENDGGTRAFLAEISSLGRLKHKSLVG 425
IG G G V + A A+K ++ N E+ + +L H ++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 426 LRGWCKREKGSLMLVYDYMENGSL------------------------------------ 449
L + ++ + LV + G L
Sbjct: 93 LYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 450 -DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508
F+ + + +++ + + + YLH + + HRDIK N L +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208
Query: 509 L--GDFGLARMHGH---GQVASTTRVVGTVGYLAPEVFSSGRAS--TQTDVFGFGILILE 561
+ DFGL++ G+ T GT ++APEV ++ S + D + G+L+
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 562 VLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV------LHL 614
+L G P + + V L K F+ + L
Sbjct: 269 LLMGAVPFPGVNDADTISQV----------------LNKKLCFENPNYNVLSPLARDLLS 312
Query: 615 GLLCAYPDPRARPTMRQV 632
LL + R +
Sbjct: 313 NLLN--RNVDERFDAMRA 328
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 44/276 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--TRAFLAEISSLGRLKHKSLVGLRG 428
++G G G+V K E AVK I+ + T L E+ L +L H +++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ + S +V + G L I + S + R++K V +G+ Y+H+
Sbjct: 89 ILE-DSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 489 VLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
++HRD+K N+LL +K+ + ++ DFGL+ +GT Y+APEV G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR-GT 198
Query: 546 ASTQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ DV+ G IL IL LSG P + + ++++ V K
Sbjct: 199 YDEKCDVWSAGVILYIL--LSGTPPFYGKNEYDILKRV----------------ETGKYA 240
Query: 603 FDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
FD + + L +L P R T Q
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQC 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 75/334 (22%), Positives = 138/334 (41%), Gaps = 69/334 (20%)
Query: 338 EREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEI 392
+ +ED + E+ + + +G G GKV K G +
Sbjct: 9 AFKILEDPKWEFPRKNLVLGK------------TLGEGEFGKVVKATAFHLKGRAGYTTV 56
Query: 393 AVKRI-SHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSL-- 449
AVK + + + R L+E + L ++ H ++ L G C ++ G L+L+ +Y + GSL
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRG 115
Query: 450 -------------------DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ L+ + I ++ G+ YL E K++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYL-----APEVFSSG 544
HRD+ + N+L+ + ++ DFGL+R ++ + V + G + A E
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDH 227
Query: 545 RASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603
+TQ+DV+ FG+L+ E+++ G P G P E ++ L+ G ++ D
Sbjct: 228 IYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPP--ERLFNLLKTGHRMERPD--------N 276
Query: 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+E+ R++ L C +P RP + K LE
Sbjct: 277 CSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-22
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKS 422
F + V+G GG G+V + G A K++ + G L E L ++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYL 481
+V L + K +L LV M G L I+ G E R ++ G+ L
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFP-EARAVFYAAEICCGLEDL 302
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
H +++++RD+K N+LLD + R+ D GLA GQ VGTVGY+APEV
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVV 357
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRP 568
+ R + D + G L+ E+++G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKH 420
+ + + +G G VYK + +A+K+I S DG R L EI L L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-VLKDVAAGVL 479
+++GL K ++ LV+D+ME L+ I + S I+ + G+
Sbjct: 72 PNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS---HIKAYMLMTLQGLE 126
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
YLH+ W +LHRD+K +N+LLD+ +L DFGLA+ G A T +VV T Y APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPE 182
Query: 540 V-FSSGRASTQTDVFGFGILILEVLSGRRPI 569
+ F + D++ G ++ E+L R P
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
S+ ++G G G+V+K G ++A K I EIS + +L H +L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L + K ++LV +Y++ G L I D S L+ + I +K + G+ ++H
Sbjct: 151 LYDAFE-SKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMH--- 204
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
+ +LH D+K N+L ++ DFGLAR + + GT +LAPEV +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNY 262
Query: 544 GRASTQTDVFGFGIL--ILEVLSGRRP 568
S TD++ G++ +L LSG P
Sbjct: 263 DFVSFPTDMWSVGVIAYML--LSGLSP 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-22
Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 54/305 (17%)
Query: 354 ITYQEIEAATKGFSEE----NVIGVGGNGKVYKGVLEGGGAEIAVKRIS--------HEN 401
+T + K +E +G G G+V ++A++ IS
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 402 DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM 461
EI L +L H ++ ++ + + +V + ME G L + +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVG---NKR 235
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMH 518
L + V YLHE ++HRD+K NVLL +++ ++ DFG +++
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 519 GHGQVASTTRVVGTVGYLAPEVFSSGRA---STQTDVFGFGILILEVLSGRRP--IEEGK 573
G + T + GT YLAPEV S + D + G+++ LSG P +
Sbjct: 293 GETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350
Query: 574 PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV----LHL--GLLCAYPDPRARP 627
+L + + K F + V L L LL DP+AR
Sbjct: 351 VSLKDQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLV--VDPKARF 392
Query: 628 TMRQV 632
T +
Sbjct: 393 TTEEA 397
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-21
Identities = 27/114 (23%), Positives = 43/114 (37%), Gaps = 10/114 (8%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVESRILTLTN------STTFTIGRALYPSKIPTKRP 75
++ F F F N +L G AT + +L +T + + GR LY + +
Sbjct: 2 QSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRL-WE 60
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTN 129
+S+ + F T F ++ GL F P + LGLF N
Sbjct: 61 DSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYH-GGFLGLFPNAN 113
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 40/276 (14%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGL 426
++G G G+V K E AVK I + + T L E+ L +L H +++ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
+ + S +V + G L I + S + R++K V +G+ Y+H+
Sbjct: 87 FEILE-DSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK--- 139
Query: 487 KKVLHRDIKSSNVLL-DKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
++HRD+K N+LL KE + + DFGL+ +GT Y+APEV
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR- 196
Query: 544 GRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
G + DV+ G+++ +LSG P + + ++++ V K
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV----------------ETGKYA 240
Query: 603 FDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
FD + + L +L P R T Q
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQC 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 64/302 (21%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLR 427
E+V+G G + +V + E AVK I + E+ L + + H++++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI------------RVLKDVA 475
+ + E+ LV++ M GS+ I V++DVA
Sbjct: 78 EFFE-EEDRFYLVFEKMRGGSI----L-----------SHIHKRRHFNELEASVVVQDVA 121
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTR---- 528
+ + +LH K + HRD+K N+L ++ ++ DF L S
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 529 --VVGTVGYLAPEVFSSGRASTQT-----DVFGFG-IL-ILEVLSGRRP---IEEGKPNL 576
G+ Y+APEV + D++ G IL IL LSG P
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPFVGRCGSDCGW 236
Query: 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMR 630
Q L +++ K F + + + L LL D + R +
Sbjct: 237 DRGEACPACQNMLFESI---QEGKYEFPDKDWAHISCAAKDLISKLLV--RDAKQRLSAA 291
Query: 631 QV 632
QV
Sbjct: 292 QV 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 21/217 (9%)
Query: 366 FSEENVIGVGGN--GKVYKGVLEGGGAEIAVKRIS--HENDGGTRAFLAEISSLGRLKHK 421
+ VIG G V + G + V+RI+ ++ E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIR-VLKDVAAGVL 479
++V R L +V +M GS D M E I +L+ V +
Sbjct: 87 NIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALD 142
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG-LARMHGHGQVAST-----TRVVGTV 533
Y+H +HR +K+S++L+ + L M HGQ V +
Sbjct: 143 YIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 534 GYLAPEVFSSGRA--STQTDVFGFGILILEVLSGRRP 568
+L+PEV ++D++ GI E+ +G P
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 64/307 (20%), Positives = 112/307 (36%), Gaps = 51/307 (16%)
Query: 350 WPHRITYQEIEAATKGFSE-----ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG 404
+ +Q E ++ + V+G+G NGKV + G + A+K +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR 69
Query: 405 TRAFLAEISSLGRL-KHKSLVGLRGWC---KREKGSLMLVYDYMENGSL-DKWIFQCDGS 459
E+ + +V + K L+++ + ME G L + + G
Sbjct: 70 Q-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GD 122
Query: 460 MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL-DKEMNG--RLGDFGLAR 516
+ E +++D+ + +LH + HRD+K N+L KE + +L DFG A+
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGIL--ILEVLSGRRP-IEEGK 573
+ + T Y+APEV + D++ G++ IL L G P
Sbjct: 180 ETTQNALQT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGFPPFYSNTG 234
Query: 574 PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARP 627
+ + + G+ GF E V L LL DP R
Sbjct: 235 QAISPGMKRRIRLGQY------------GFPNPEWSEVSEDAKQLIRLLLK--TDPTERL 280
Query: 628 TMRQVVK 634
T+ Q +
Sbjct: 281 TITQFMN 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 71/286 (24%), Positives = 109/286 (38%), Gaps = 54/286 (18%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS--------HENDGGTRAFLAEISSLGRLKHKS 422
+G G G+V ++A+K IS EI L +L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI--RVLKDVAAGVLY 480
++ ++ + + +V + ME G L + + + +E + V Y
Sbjct: 77 IIKIKNFF--DAEDYYIVLELMEGGELFDKVVG-NKRL----KEATCKLYFYQMLLAVQY 129
Query: 481 LHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
LHE ++HRD+K NVLL +++ ++ DFG +++ G + T + GT YLA
Sbjct: 130 LHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLA 184
Query: 538 PEVFSSGRA---STQTDVFGFG-IL-ILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592
PEV S + D + G IL I LSG P E Q L D
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPPF-----------SEHRTQVSLKDQ 231
Query: 593 LDARLRAKGGFDEDEVERV----LHL--GLLCAYPDPRARPTMRQV 632
+ K F + V L L LL DP+AR T +
Sbjct: 232 I---TSGKYNFIPEVWAEVSEKALDLVKKLLV--VDPKARFTTEEA 272
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 63/292 (21%), Positives = 108/292 (36%), Gaps = 63/292 (21%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLR 427
+ +G G K V + AVK IS + T+ EI++L + H ++V L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI------------RVLKDVA 475
++ LV + + G L F ERI +++ +
Sbjct: 73 EVFH-DQLHTFLVMELLNGGEL----F-----------ERIKKKKHFSETEASYIMRKLV 116
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLAR-MHGHGQVASTTRVVG 531
+ V ++H+ V+HRD+K N+L + + ++ DFG AR Q T
Sbjct: 117 SAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCF 171
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGIL--ILEVLSGRRP-IEEGKPNLVEMVWELMVQGK 588
T+ Y APE+ + D++ G++ + LSG+ P + E+M
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVPFQSHDRSLTCTSAVEIM---- 225
Query: 589 LLDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQVVK 634
+ F+ + + V L GLL DP R M +
Sbjct: 226 -----KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT--VDPNKRLKMSGLRY 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS------HENDGGTRAFLAEISSLGRLKHKSLV 424
+G G V K + G E A K I E+S L ++ H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L + + ++L+ + + G L ++ Q S LS EE +K + GV YLH
Sbjct: 79 TLHDVYE-NRTDVVLILELVSGGELFDFLAQ-KES--LSEEEATSFIKQILDGVNYLHT- 133
Query: 485 WEKKVLHRDIKSSNVLL-DKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
KK+ H D+K N++L DK + +L DFGLA G + GT ++APE+
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 541 FSSGRASTQTDVFGFGIL--ILEVLSGRRP 568
+ + D++ G++ IL LSG P
Sbjct: 190 VNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 65/276 (23%), Positives = 104/276 (37%), Gaps = 43/276 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG--TRAFLAEISSLGRLKHKSLVGLRG 428
+G G V + V + G E A K I+ + + E +L+H ++V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ E+ LV+D + G L + I S + ++ + + Y H
Sbjct: 96 SIQ-EESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NG 148
Query: 489 VLHRDIKSSNVLLDKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
++HR++K N+LL + G +L DFGLA + GT GYL+PEV
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKKDP 206
Query: 546 ASTQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
S D++ G IL IL L G P +E + L +
Sbjct: 207 YSKPVDIWACGVILYIL--LVGYPPFWDEDQHRLYAQI----------------KAGAYD 248
Query: 603 FDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ E + V L +L +P+ R T Q
Sbjct: 249 YPSPEWDTVTPEAKSLIDSMLT--VNPKKRITADQA 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 19/204 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+G G G V++ V K + + EIS L +H++++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER--IRVLKDVAAGVLYLHEGWEKK 488
+ L+++++++ + + I + ER + + V + +LH
Sbjct: 71 E-SMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHS---HN 122
Query: 489 VLHRDIKSSNVLLDKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+ H DI+ N++ + + +FG AR G + Y APEV
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVV 180
Query: 547 STQTDVFGFGIL--ILEVLSGRRP 568
ST TD++ G L +L LSG P
Sbjct: 181 STATDMWSLGTLVYVL--LSGINP 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLR 427
+G G G VY + +A+K + +G EI L+H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWE 486
+ K + L+ ++ G L K + Q G E+R ++++A + Y HE
Sbjct: 81 NYFHDRK-RIYLMLEFAPRGELYKEL-QKHGRF---DEQRSATFMEELADALHYCHE--- 132
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+KV+HRDIK N+L+ + ++ DFG + +H T GT+ YL PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM--CGTLDYLPPEMIEGKTH 189
Query: 547 STQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ D++ G+L E L G P + P+ E
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDS--PSHTET 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 59/284 (20%), Positives = 99/284 (34%), Gaps = 47/284 (16%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLR 427
V+G+G NGKV + + + A+K + E+ R + +V +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 121
Query: 428 GWC---KREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ L++V + ++ G L + + G + E ++K + + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH- 178
Query: 484 GWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
+ HRD+K N+L +L DFG A+ +T T Y+APEV
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 234
Query: 541 FSSGRASTQTDVFGFG-IL-ILEVLSGRRP--IEEGKPNLVEMVWELMVQGKLLDALDAR 596
+ D++ G I+ IL L G P G M
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYIL--LCGYPPFYSNHGLAISPGM-------------KTRI 279
Query: 597 LRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQVVK 634
+ F E V L LL +P R T+ + +
Sbjct: 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLK--TEPTQRMTITEFMN 321
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 8e-21
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 19/232 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAE---ISSLGRLK 419
FS +IG GG G+VY G A+K + + G L E +S +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGV 478
+V + + L + D M G L + G E +R ++ G+
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFS---EADMRFYAAEIILGL 305
Query: 479 LYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
++H + V++RD+K +N+LLD+ + R+ D GLA + VGT GY+AP
Sbjct: 306 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAP 359
Query: 539 EVFSSGRASTQT-DVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
EV G A + D F G ++ ++L G P + K + + + +
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI------SHENDGGTRAFLAEISSLGRLKHKSLV 424
+G G V K +G G E A K I S E++ L ++H +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L + K ++L+ + + G L ++ + S L+ +E + LK + GV YLH
Sbjct: 72 TLHDIFE-NKTDVVLILELVSGGELFDFLAE-KES--LTEDEATQFLKQILDGVHYLHS- 126
Query: 485 WEKKVLHRDIKSSNVLL-DKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
K++ H D+K N++L DK + +L DFG+A G + GT ++APE+
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEI 182
Query: 541 FSSGRASTQTDVFGFGIL--ILEVLSGRRP 568
+ + D++ G++ IL LSG P
Sbjct: 183 VNYEPLGLEADMWSIGVITYIL--LSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS------HENDGGTRAFLAEISSLGRLKHKSLV 424
+G G V K + G E A K I E+S L ++ H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L + + ++L+ + + G L ++ Q S LS EE +K + GV YLH
Sbjct: 79 TLHDVYE-NRTDVVLILELVSGGELFDFLAQ-KES--LSEEEATSFIKQILDGVNYLHT- 133
Query: 485 WEKKVLHRDIKSSNVLL-DKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
KK+ H D+K N++L DK + +L DFGLA G + GT ++APE+
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 541 FSSGRASTQTDVFGFGIL--ILEVLSGRRP 568
+ + D++ G++ IL LSG P
Sbjct: 190 VNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 66/291 (22%), Positives = 104/291 (35%), Gaps = 67/291 (23%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRG 428
IGVG + + + E AVK I T EI L R +H +++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKD 83
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI------------RVLKDVAA 476
+ + +V + M+ G L ++I VL +
Sbjct: 84 VYD-DGKYVYVVTELMKGGEL----L-----------DKILRQKFFSEREASAVLFTITK 127
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLL-DKEMNG---RLGDFGLAR-MHGHGQVASTTRVVG 531
V YLH + V+HRD+K SN+L D+ N R+ DFG A+ + + T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCY 182
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGIL--ILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
T ++APEV D++ G+L + L+G P G + E + + GK
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTM--LTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 590 LDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMRQVVK 634
V L +L DP R T V++
Sbjct: 241 ------------SLSGGYWNSVSDTAKDLVSKMLH--VDPHQRLTAALVLR 277
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 37/229 (16%)
Query: 350 WPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFL 409
I Y + VIG G G V++ L E+A+K++ + R
Sbjct: 36 EQREIAYTNCK----------VIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR--- 81
Query: 410 AEISSLGRLKHKSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC 464
E+ + +KH ++V L+ K+++ L LV +Y+ ++ +
Sbjct: 82 -ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139
Query: 465 EERIRV-----LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMH 518
I++ L+ + Y+H + HRDIK N+LLD +L DFG A++
Sbjct: 140 MLLIKLYMYQLLR----SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
Query: 519 GHGQVASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGR 566
G+ + + + + Y APE+ F + +T D++ G ++ E++ G+
Sbjct: 193 IAGE-PNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 69/279 (24%), Positives = 104/279 (37%), Gaps = 44/279 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G V + V G E A I + + E LKH ++V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
E+G L++D + G L + I S + ++ + VL+ H+
Sbjct: 78 SIS-EEGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MG 130
Query: 489 VLHRDIKSSNVLL---DKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSG 544
V+HR++K N+LL K +L DFGLA + G Q GT GYL+PEV
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKD 188
Query: 545 RASTQTDVFGFG-IL-ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
D++ G IL IL L G P +E + L + +
Sbjct: 189 PYGKPVDLWACGVILYIL--LVGYPPFWDEDQHRLYQQI----------------KAGAY 230
Query: 602 GFDEDEVERV------LHLGLLCAYPDPRARPTMRQVVK 634
F E + V L +L +P R T + +K
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLT--INPSKRITAAEALK 267
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+++ VIG G G VY+ L G +A+K++ + R E+ + +L H ++V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 426 LR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----VLKDVA 475
LR K+++ L LV DY+ ++ + + ++ + +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR--- 167
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVG 534
+ Y+H + HRDIK N+LLD + +L DFG A+ G+ + + + +
Sbjct: 168 -SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYIC-SRY 221
Query: 535 YLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPI 569
Y APE+ F + ++ DV+ G ++ E+L G +PI
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRI------SHENDGGTRAFLAEISSLGRLKHKS 422
+G G V K + G + A K I S E+S L ++H +
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
++ L + K ++L+ + + G L ++ + + L+ EE LK + GV YLH
Sbjct: 76 VITLHEVYE-NKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH 131
Query: 483 EGWEKKVLHRDIKSSNVLL-DKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
++ H D+K N++L D+ + ++ DFGLA G + GT ++AP
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAP 186
Query: 539 EVFSSGRASTQTDVFGFGIL--ILEVLSGRRP 568
E+ + + D++ G++ IL LSG P
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYIL--LSGASP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 44/278 (15%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKH-KSLVGLR 427
+G G V + + + G E A K + L EI+ L K ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 428 GWCKREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWE 486
+ ++L+ +Y G + + + +S + IR++K + GV YLH+
Sbjct: 96 EVYE-NTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQ--- 149
Query: 487 KKVLHRDIKSSNVLL-DKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
++H D+K N+LL G + DFG++R GH ++GT YLAPE+ +
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNY 207
Query: 544 GRASTQTDVFGFGIL--ILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
+T TD++ GI+ +L L+ P + E + +
Sbjct: 208 DPITTATDMWNIGIIAYML--LTHTSPFVGEDNQETYLNI----------------SQVN 249
Query: 601 GGFDEDEVERV------LHLGLLCAYPDPRARPTMRQV 632
+ E+ V LL +P RPT
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLV--KNPEKRPTAEIC 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G V E A+K I EN E + RL H V
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK--VPYVTRERDVMSRLDHPFFVK 94
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEG 484
L + ++ L Y +NG L K+I + GS E R ++ + + YLH
Sbjct: 95 LYFTFQDDE-KLYFGLSYAKNGELLKYI-RKIGSFD---ETCTRFYTAEIVSALEYLHG- 148
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR-VVGTVGYLAPEVFSS 543
K ++HRD+K N+LL+++M+ ++ DFG A++ + VGT Y++PE+ +
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
A +D++ G +I ++++G P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 58/243 (23%), Positives = 99/243 (40%), Gaps = 50/243 (20%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS---------HENDGGTRAFLA------------ 410
IG G G V E A+K +S R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 411 -----EISSLGRLKHKSLVGLRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC 464
EI+ L +L H ++V L + L +V++ + G + + LS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136
Query: 465 EERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQV 523
++ +D+ G+ YLH +K++HRDIK SN+L+ ++ + ++ DFG++ G +
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 524 ASTTRVVGTVGYLAPEVFS------SGRASTQTDVFGFGILILEVL-SGRRPIEEGKPNL 576
S T VGT ++APE S SG+A DV+ G+ L G+ P + +
Sbjct: 194 LSNT--VGTPAFMAPESLSETRKIFSGKAL---DVWAMGV-TLYCFVFGQCPFMD--ERI 245
Query: 577 VEM 579
+ +
Sbjct: 246 MCL 248
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 17/226 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G GKV A+K ++ + R E+ + L+H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWE 486
+++ + +V D + G L ++ Q + EE +++ + ++ + YL
Sbjct: 82 Y-SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFK---EETVKLFICELVMALDYLQN--- 133
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
++++HRD+K N+LLD+ + + DF +A M +T + GT Y+APE+FSS +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 547 ---STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
S D + G+ E+L GRRP + + +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 64/287 (22%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-------DGGTRAFLAEISSLGRL----K 419
++G GG G V+ G ++A+K I L E++ L ++
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 420 HKSLVGLRGWCKREKGSLML---------VYDY-MENGSLDKWIFQCDGSMMLSCEERIR 469
H ++ L W + ++G +++ ++DY E G L +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-------------GPSRC 143
Query: 470 VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTR 528
V A + + H + V+HRDIK N+L+D +L DFG + H + +
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF- 198
Query: 529 VVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587
GT Y PE S + + V+ GIL+ +++ G P E +
Sbjct: 199 -DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------- 243
Query: 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ L+A L + ++ L P P +RP++ +++
Sbjct: 244 ---EILEAELHFPAHVSP-DCCALIR-RCLA--PKPSSRPSLEEILL 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 41/219 (18%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS-------HENDGGTRAFLAEISSLGRLKHKS- 422
++G GG G VY G+ +A+K + E GTR + E+ L ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108
Query: 423 -LVGLRGWCKREKGSLML---------VYDYM-ENGSLDKWIFQCDGSMMLSCEERIRVL 471
++ L W +R +++ ++D++ E G+L + E
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-------------ELARSFF 155
Query: 472 KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVASTTRVV 530
V V + H VLHRDIK N+L+D +L DFG + V +
Sbjct: 156 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF--D 209
Query: 531 GTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRP 568
GT Y PE R V+ GIL+ +++ G P
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
IG G KV G E+A+K I N + E+ + L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-- 80
Query: 430 CKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
E + +L L+ +Y G + ++ + +E + + + V Y H+
Sbjct: 81 ---EVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQ-- 132
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
K+++HRD+K+ N+LLD +MN ++ DFG + G G Y APE+F G+
Sbjct: 133 -KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELF-QGK 188
Query: 546 --ASTQTDVFGFGILILEVLSGRRPIE-EGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ DV+ G+++ ++SG P + + L E V L + R
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------------LRGKYRIPFY 236
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
D E +L L +P R T+ Q++K
Sbjct: 237 MSTD-CENLLK-RFLV--LNPIKRGTLEQIMK 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 57/293 (19%), Positives = 103/293 (35%), Gaps = 80/293 (27%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRIS---------HENDGGTRAFLAEISSLGRLKHKS 422
+G G G V+ V + E+ VK I E+ + L EI+ L R++H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIF-----QCDGSMM---------LSCEERI 468
++ + D EN + G + L
Sbjct: 91 IIKV--------------LDIFEN---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528
+ + + + V YL K ++HRDIK N+++ ++ +L DFG A G++ T
Sbjct: 134 YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF- 189
Query: 529 VVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586
GT+ Y APEV G + +++ G+ + ++ P
Sbjct: 190 -CGTIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC---------------- 231
Query: 587 GKLLDALDARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ + E+ ++ GLL P P R T+ ++V
Sbjct: 232 -------ELEETVEAAIHPPYLVSKELMSLVS-GLLQ--PVPERRTTLEKLVT 274
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 27/257 (10%)
Query: 324 CSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKG 383
+ + + A + E + R+ + F VIG G +V
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDD-------FEILKVIGRGAFSEVAVV 80
Query: 384 VLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440
++ G A+K ++ + G F E L + + L + +++ L LV
Sbjct: 81 KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLV 139
Query: 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
+Y G L + + + E R L ++ + +H +HRDIK N+
Sbjct: 140 MEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNI 193
Query: 500 LLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFG---- 554
LLD+ + RL DFG ++ G V S VGT YL+PE+ + T +G
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 555 ---FGILILEVLSGRRP 568
G+ E+ G+ P
Sbjct: 253 WWALGVFAYEMFYGQTP 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 46/218 (21%), Positives = 88/218 (40%), Gaps = 17/218 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G GKV + + AVK ++ +G EI L RL+HK+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQ 70
Query: 426 LRG-WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L EK + +V +Y G + + + + G+ YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS- 127
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV-GTVGYLAPEVFSS 543
+ ++H+DIK N+LL ++ G+A T R G+ + PE+ +
Sbjct: 128 --QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 544 GR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
+ + D++ G+ + + +G P E N+ ++
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKL 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS 422
F E + G G G V G + G +A+K++ + R L + L L H +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 423 LVGLR------GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-----L 471
+V L+ G R L +V +Y+ + +L + + I+V +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 472 KDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL--GDFGLARMHGHGQVASTTRV 529
+ + LH V HRDIK NVL+++ +G L DFG A+ + + +
Sbjct: 140 R----SIGCLHLP-SVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSE-PNVAYI 192
Query: 530 VGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ Y APE+ F + +T D++ G + E++ G PI G
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGD 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLR 427
VIG G G+V L+ A+K ++ T F E L K + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGWE 486
+ ++ +L LV DY G L + + + + EE R L ++ + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIAIDSVHQ--- 193
Query: 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA 546
+HRDIK N+L+D + RL DFG ++ VGT Y++PE+ +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 547 STQT-----DVFGFGILILEVLSGRRP 568
D + G+ + E+L G P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGG--TRAFLAEISSLGRLKHKSLV 424
+GVG GKV G + G ++AVK +I + G R EI +L +H ++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHII 74
Query: 425 GLRGWCKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
L + +V +Y+ G L +I + + E R+ + + + V Y
Sbjct: 75 KLY-----QVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDY 126
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
H V+HRD+K NVLLD MN ++ DFGL+ M G+ T+ G+ Y APEV
Sbjct: 127 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 181
Query: 541 FSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
SGR A + D++ G+++ +L G P ++ ++ +
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVPTL 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 51/238 (21%), Positives = 95/238 (39%), Gaps = 29/238 (12%)
Query: 348 EYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA 407
EYW + E + +G G +V++ + ++ VK + +
Sbjct: 21 EYWDYESHVVEWGNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKI 77
Query: 408 FLAEISSLGRLK-HKSLVGLRGWCK-REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCE 465
EI L L+ +++ L K + LV++++ N + ++Q L+ +
Sbjct: 78 -KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQ-----TLT-D 129
Query: 466 ERIR-----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHG 519
IR +LK + Y H ++HRD+K NV++D E RL D+GLA +
Sbjct: 130 YDIRFYMYEILK----ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 520 HGQVASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576
GQ RV + + PE+ D++ G ++ ++ + P G N
Sbjct: 183 PGQ-EYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEIS 413
K + +G G G V + + G ++A+K++S R F E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 414 SLGRLKHKSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
L ++H++++GL R LV +M+ L K + S EE+I
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL-----KFS-EEKI 128
Query: 469 R-----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523
+ +LK G+ Y+H V+HRD+K N+ ++++ ++ DFGLAR
Sbjct: 129 QYLVYQMLK----GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR----HAD 177
Query: 524 ASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
A T V T Y APEV S + D++ G ++ E+L + + +GK
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGK 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEISSLG 416
+ IG G G V +A+K++S R F E+ +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMK 79
Query: 417 RLKHKSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-- 469
+ HK+++GL E + +V + M+ +L + I M L ER+
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELD-HERMSYL 132
Query: 470 ---VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526
+L G+ +LH ++HRD+K SN+++ + ++ DFGLAR G +
Sbjct: 133 LYQMLC----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--M 183
Query: 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T V T Y APEV D++ G ++ E++ + G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGT 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 67/276 (24%), Positives = 107/276 (38%), Gaps = 42/276 (15%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLRGWC 430
+G G G+V V +AVK + + + EI L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+RE L +Y G L I G + + R + AGV+YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS---TTRVVGTVGYLAPEVFSSGR-- 545
HRDIK N+LLD+ N ++ DFGLA + + GT+ Y+APE+ R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELL-KRREF 184
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
+ DV+ GI++ +L+G P ++ + E +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----------------SDWKEKKTYL 228
Query: 606 -------DEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+LH +L +P AR T+ + K
Sbjct: 229 NPWKKIDSAPLALLH-KILV--ENPSARITIPDIKK 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G GKV + G A+K I +++ L E L +H L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTA 212
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEG 484
L+ + + L V +Y G L F + S E+R R ++ + + YLH
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLHS- 266
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFSS 543
EK V++RD+K N++LDK+ + ++ DFGL + G T GT YLAPEV
Sbjct: 267 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 323
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
D +G G+++ E++ GR P
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHKS 422
++ + IG G G V +A+K+IS H+ R L EI L R +H++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRT-LREIKILLRFRHEN 86
Query: 423 LVGL----RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----VLKD 473
++G+ R + + +V D ME L K + + LS + I +L+
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK----TQHLS-NDHICYFLYQILR- 139
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--HGHGQVASTTRVVG 531
G+ Y+H VLHRD+K SN+LL+ + ++ DFGLAR+ H T V
Sbjct: 140 ---GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 532 TVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T Y APE+ +S + D++ G ++ E+L RPI GK
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGK 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 43/230 (18%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEIS 413
K + IG G G V +A+K++S R F E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 414 SLGRLKHKSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
+ + HK+++ L E + LV + M+ +L + I L ER+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELD-HERM 166
Query: 469 R-----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523
+L G+ +LH ++HRD+K SN+++ + ++ DFGLAR G +
Sbjct: 167 SYLLYQMLC----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T V T Y APEV D++ G ++ E++ + + G+
Sbjct: 220 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGR 266
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ + +G GGNG V+ V +A+K+I + + L EI + RL H ++V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 426 LR-------------GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR--- 469
+ E S+ +V +YME L + L EE R
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQGPLL-EEHARLFM 126
Query: 470 --VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVAST 526
+L+ G+ Y+H VLHRD+K +N+ ++ E + ++GDFGLAR+
Sbjct: 127 YQLLR----GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 527 --TRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
+ + T Y +P + S + D++ G + E+L + + G
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFAGA 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGR-LKHKSLVGL 426
V+G G GKV +G AVK + + D + E L K L L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLK-DVAAGVLYLHEGW 485
C + L V +Y+ G L ++ E ++A G+ +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYAAEIAIGLFFLQS-- 460
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFSSG 544
K +++RD+K NV+LD E + ++ DFG+ + + G T GT Y+APE+ +
Sbjct: 461 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQ 517
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
D + FG+L+ E+L+G+ P
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 57/258 (22%), Positives = 98/258 (37%), Gaps = 34/258 (13%)
Query: 324 CSLFLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKG 383
+++ + +D + R+ ++ + VIG G G+V
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFGEVQLV 88
Query: 384 VLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440
+ A+K +S + F E + +V L + ++ L +V
Sbjct: 89 RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMV 147
Query: 441 YDYMENGSLDKWIFQCDGSMMLSC----EERIRV-LKDVAAGVLYLHEGWEKKVLHRDIK 495
+YM G L ++S E+ R +V + +H +HRD+K
Sbjct: 148 MEYMPGGDL----VN-----LMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVK 195
Query: 496 SSNVLLDKEMNGRLGDFGLA-RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQ----T 550
N+LLDK + +L DFG +M+ G V T VGT Y++PEV S
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGREC 254
Query: 551 DVFGFGILILEVLSGRRP 568
D + G+ + E+L G P
Sbjct: 255 DWWSVGVFLYEMLVGDTP 272
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLKH 420
+ + + +G G G V G +AVK++S ++ + E+ L +KH
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 421 KSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----V 470
++++GL E + LV M L+ + L+ ++ ++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLT-DDHVQFLIYQI 141
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
L+ G+ Y+H ++HRD+K SN+ ++++ ++ DFGLAR T V
Sbjct: 142 LR----GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYV 190
Query: 531 GTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T Y APE+ + + D++ G ++ E+L R + G
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGT 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGG--TRAFLAEISSLGRLKHKSLV 424
+GVG GKV G E G ++AVK +I + G R EI +L +H ++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHII 79
Query: 425 GLRGWCKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
L + + +V +Y+ G L +I + L +E R+ + + +GV Y
Sbjct: 80 KLY-----QVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDY 131
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV 540
H V+HRD+K NVLLD MN ++ DFGL+ M G+ T+ G+ Y APEV
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 186
Query: 541 FSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
SGR A + D++ G+++ +L G P ++ ++ +
Sbjct: 187 I-SGRLYAGPEVDIWSSGVILYALLCGTLPFDD--DHVPTL 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 44/277 (15%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA-EISSLGRLKHKSLVGLRGWC 430
+G G G+V V +AVK + + + EI L H+++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+RE L +Y G L I G + + R + AGV+YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS---TTRVVGTVGYLAPEVFSSGR-- 545
HRDIK N+LLD+ N ++ DFGLA + + GT+ Y+APE+ R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELL-KRREF 184
Query: 546 ASTQTDVFGFGILILEVL-SGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604
+ DV+ GI +L + +G P ++ + E +
Sbjct: 185 HAEPVDVWSCGI-VLTAMLAGELPWDQPSDSCQEY----------------SDWKEKKTY 227
Query: 605 E-------DEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+LH +L +P AR T+ + K
Sbjct: 228 LNPWKKIDSAPLALLH-KILV--ENPSARITIPDIKK 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAF---------LAE 411
++ + I G G V GV + G +A+KR+ + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 412 ISSLGRLKHKSLVGL----RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER 467
I L H +++GL + + L LV + M L + I +++S +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD--QRIVIS-PQH 135
Query: 468 IR-----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522
I+ +L G+ LHE V+HRD+ N+LL + + DF LAR
Sbjct: 136 IQYFMYHILL----GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 523 VASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
A+ T V Y APE+ + D++ G ++ E+ R+ + G
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGS 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 38/260 (14%), Positives = 75/260 (28%), Gaps = 48/260 (18%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLR 427
G + ++ + ++A+ + + D + L+ L R+ + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
+ ++V +++ GSL + D S IR ++ +AA H
Sbjct: 98 DVV-HTRAGGLVVAEWIRGGSLQEVA---DTSPSP--VGAIRAMQSLAAAADAAHR---A 148
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
V S V + + G V V+ + A+
Sbjct: 149 GVALSIDHPSRVRVSID----------------GDV-----VLAYPATMPD-------AN 180
Query: 548 TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDE 607
Q D+ G G + +L R P+ E E G+ ++ D
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA-V 239
Query: 608 VERVLHLGLLCAYPDPRARP 627
R + D R
Sbjct: 240 AARSVQ-------GDGGIRS 252
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLKHKSLVG 425
++G G GKV + G A+K I +++ + E L +H L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 69
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEG 484
L+ + + L V +Y G L F + + EER R ++ + + YLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS- 123
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFSS 543
+ V++RDIK N++LDK+ + ++ DFGL + G T GT YLAPEV
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLED 179
Query: 544 GRASTQTDVFGFGILILEVLSGRRP 568
D +G G+++ E++ GR P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEISSLGRLKH 420
+G G G V V GA++A+K++ R F E+ L ++H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRH 83
Query: 421 KSLVGLR-----GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----V 470
++++GL + LV +M L K + L E+RI+ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLG-EDRIQFLVYQM 137
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
LK G+ Y+H ++HRD+K N+ ++++ ++ DFGLAR + T V
Sbjct: 138 LK----GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYV 186
Query: 531 GTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
T Y APEV + R + D++ G ++ E++ + + +G
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGS 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 43/254 (16%), Positives = 85/254 (33%), Gaps = 51/254 (20%)
Query: 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI-----------------SHEN- 401
E ++K +S +G G G V + G A+K++ H N
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 402 ---------------DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMEN 446
+ + L ++ +Y+ +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 447 GSLDKWIFQCDGSMMLSCEERIR-----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501
+L K + S I + + V ++H + HRDIK N+L+
Sbjct: 123 -TLHKVLKSFIRSGRSIPMNLISIYIYQLFR----AVGFIHSL---GICHRDIKPQNLLV 174
Query: 502 DKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILI 559
+ + N +L DFG A+ + S + + Y APE+ + + D++ G +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSE-PSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 560 LEVLSGRRPIEEGK 573
E++ +P+ G+
Sbjct: 233 GELI-LGKPLFSGE 245
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGG--TRAFLAEISSLGRLKHKSLV 424
+G G GKV ++A+K + + R EIS L L+H ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHII 72
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQ----CDGSMM--------LSCEERIRVLK 472
L YD + I G + ++ +E R +
Sbjct: 73 KL--------------YDVITT---PTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ 115
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGT 532
+ + Y H K++HRD+K N+LLD +N ++ DFGL+ + G T+ G+
Sbjct: 116 QIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGS 170
Query: 533 VGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
Y APEV +G+ A + DV+ GI++ +L GR P ++ + +
Sbjct: 171 PNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD--EFIPNL 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 371 VIGVGGNGKVY---KGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGRLKHKS 422
V+G G GKV+ K A+K + + T E L + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT---KMERDILVEVNHPF 87
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYL 481
+V L + + +G L L+ D++ G L + +M + EE ++ L ++A + +L
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFT-EEDVKFYLAELALALDHL 142
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEV 540
H +++RD+K N+LLD+E + +L DFGL++ H + A + GTV Y+APEV
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 541 FSSGRASTQTDVFGFGILILEVLSGRRP 568
+ + D + FG+L+ E+L+G P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 371 VIGVGGNGKVY---KGVLEGGGAEIAVKR------ISHENDGGTRAFLAEISSLGRLKHK 421
V+G GG GKV+ K G A+K + + D T AE + L +KH
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNILEEVKHP 81
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLY 480
+V L + + G L L+ +Y+ G L Q + + E+ L +++ + +
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFM-EDTACFYLAEISMALGH 136
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPE 539
LH+ K +++RD+K N++L+ + + +L DFGL + G V T GT+ Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPE 191
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ + D + G L+ ++L+G P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 455 QCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514
+ L+ E I VA G+ +L +K +HRD+ + N+LL ++ ++ DFGL
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 515 ARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEG 572
AR + ++APE + Q+DV+ FG+L+ E+ S G P
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQV 632
K + E + +G + A D + E+ + + L C + +P RPT ++
Sbjct: 300 KID--EEFCRRLKEGTRMRAPD--------YTTPEMYQTM---LDCWHGEPSQRPTFSEL 346
Query: 633 VKVLEGKIEAGIE 645
V+ L ++A +
Sbjct: 347 VEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 22/92 (23%), Positives = 42/92 (45%), Gaps = 7/92 (7%)
Query: 369 ENVIGVGGNGKVYKGVLEG-----GGAEIAVKRI-SHENDGGTRAFLAEISSLGRL-KHK 421
+G G G+V + G +AVK + RA ++E+ L + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWI 453
++V L G C + G LM++ ++ + G+L ++
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDG----GTRAFLAEISSLGRLKHK 421
VIG G KV L+ A+K ++ + D + + S H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHP 70
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLY 480
LVGL C + + L V +Y+ G L +F L EE R +++ + Y
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNY 125
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPE 539
LHE + +++RD+K NVLLD E + +L D+G+ + G ST GT Y+APE
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPE 180
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ D + G+L+ E+++GR P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 38/233 (16%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLK 419
+ F ++++G G G V + G +A+K+I R L EI L K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRT-LREIKILKHFK 67
Query: 420 HKSLVGL----RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----V 470
H++++ + R + ++ + M+ L + I + MLS ++ I+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLS-DDHIQYFIYQT 121
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST---- 526
L+ V LH V+HRD+K SN+L++ + ++ DFGLAR+ ++
Sbjct: 122 LR----AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 527 -----TRVVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573
V T Y APEV +S + S DV+ G ++ E+ RRPI G+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGR 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 56/217 (25%), Positives = 83/217 (38%), Gaps = 27/217 (12%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431
IG G G + +AVK I EI + L+H ++V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFK---- 82
Query: 432 RE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
E L ++ +Y G L + I S +E + + +GV Y H
Sbjct: 83 -EVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---M 135
Query: 488 KVLHRDIKSSNVLLDKEMNGRL--GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
++ HRD+K N LLD RL DFG ++ +T VGT Y+APEV +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL-LRQ 192
Query: 546 --ASTQTDVFGFGILILEVL-SGRRPIEEGKPNLVEM 579
DV+ G+ L V+ G P E+ P
Sbjct: 193 EYDGKIADVWSCGV-TLYVMLVGAYPFED--PEEPRD 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 21/234 (8%)
Query: 346 ELEYWPHRITYQEIEAATKGFSEEN-----VIGVGGNGKVYKGVLEGGGAEIAVKRISHE 400
+E + +E A+ ++ VIG G KV L+ A++ + E
Sbjct: 29 GIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE 88
Query: 401 N---DGGTRAFLAEISSLGR-LKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC 456
D E + H LVGL C + + L V +Y+ G L +F
Sbjct: 89 LVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHM 144
Query: 457 DGSMMLSCEERIRV-LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515
L EE R +++ + YLHE + +++RD+K NVLLD E + +L D+G+
Sbjct: 145 QRQRKLP-EEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
Query: 516 RMH-GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ G ST GT Y+APE+ D + G+L+ E+++GR P
Sbjct: 201 KEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGR-LKHKSLVGL 426
++G G GKV+ + A+K + + D + E L +H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGW 485
+ K +L V +Y+ G L I C R ++ G+ +LH
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFD-LSRATFYAAEIILGLQFLHS-- 136
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFSSG 544
K +++RD+K N+LLDK+ + ++ DFG+ + + +T GT Y+APE+
Sbjct: 137 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQ 193
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
+ + D + FG+L+ E+L G+ P
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGR-LKHKSLV 424
V+G G GKV +G AVK + ++D + E L K L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLT 84
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHE 483
L C + L V +Y+ G L ++ E ++A G+ +L
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYAAEIAIGLFFLQS 139
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFS 542
K +++RD+K NV+LD E + ++ DFG+ + + G T GT Y+APE+ +
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIA 194
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP 568
D + FG+L+ E+L+G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 371 VIGVGGNGKVY---KGVLEGGGAEIAVKRIS----HENDGGTRAFLAEISSLGRLKHKS- 422
V+G G GKV+ K G A+K + + T E L ++
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYL 481
LV L + + + L L+ DY+ G L + E +++ + ++ + +L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFT-EHEVQIYVGEIVLALEHL 175
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR--MHGHGQVASTTRVVGTVGYLAPE 539
H+ +++RDIK N+LLD + L DFGL++ + + A GT+ Y+AP+
Sbjct: 176 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPD 230
Query: 540 VFSSGRASTQTDV--FGFGILILEVLSGRRP--IEEGKPNLVEM 579
+ G + V + G+L+ E+L+G P ++ K + E+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 18/153 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGW 429
V+G+G NGKV + + + A+K + E+ R + +V +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDV 79
Query: 430 C---KREKGSLMLVYDYMENGSL-DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
+ L++V + ++ G L + + G + E ++K + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH--- 134
Query: 486 EKKVLHRDIKSSNVLL-DKEMNG--RLGDFGLA 515
+ HRD+K N+L K N +L DFG A
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGR-LKHKSLVGL 426
V+G G GKV ++ G AVK + + D + E L H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHEGW 485
C + L V +++ G L I + E R R ++ + +++LH+
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFD-EARARFYAAEIISALMFLHD-- 142
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFSSG 544
K +++RD+K NVLLD E + +L DFG+ + +G +T GT Y+APE+
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEM 199
Query: 545 RASTQTDVFGFGILILEVLSGRRP 568
D + G+L+ E+L G P
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVK-----RISHENDGGTRAFLAEISSLGR-LKHKSLV 424
VIG G GKV + AVK I + + + ++E + L + +KH LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLV 102
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV-LKDVAAGVLYLHE 483
GL + + L V DY+ G L + E R R ++A+ + YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGEL---FYHLQRERCFL-EPRARFYAAEIASALGYLHS 157
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH-GHGQVASTTRVVGTVGYLAPEVFS 542
+++RD+K N+LLD + + L DFGL + + H ST GT YLAPEV
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLH 212
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP 568
D + G ++ E+L G P
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 24/211 (11%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---LAEISSLGRLKHKS 422
F +G G G+V + G A+K + + + L E L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSL-----DKWIFQCDGSMMLSCEERIRVLKDVAAG 477
LV L K +L +V +Y+ G + F + + + +
Sbjct: 103 LVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ--------IVLT 153
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
YLH +++RD+K N+L+D++ ++ DFG A+ T + GT LA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALA 206
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
PE+ S + D + G+LI E+ +G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 3e-12
Identities = 38/261 (14%), Positives = 75/261 (28%), Gaps = 40/261 (15%)
Query: 17 FLSFE-SISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRP 75
++ S V + + G A + + + S G +K +
Sbjct: 29 RFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLKSQRGSVWTKTKAAFEN- 87
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ F + +G + GL + G+ G +F + N
Sbjct: 88 -------WEVEVTFRVTG-RGRIGADGLAIWYTENQGLDG-------PVFGSADMWNG-- 130
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
G+ FD F N + V + + D+Q D + S D
Sbjct: 131 --VGIFFDSFDNDGKKNNPAIVVVGNNGQINY----------DHQNDGATQALASCQRD- 177
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255
N + I Y + + + + + V+ + + G
Sbjct: 178 -------FRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFG 229
Query: 256 FTAATGQLVESHKILAWSFSN 276
+AATG L + H +L++
Sbjct: 230 ISAATGGLADDHDVLSFLTFQ 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 49/246 (19%), Positives = 91/246 (36%), Gaps = 54/246 (21%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISH--ENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+IG G G V + + +A+K+I E+ + L EI+ L RL H +V +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 429 WCKREKGSLM----LVYDYMENGSLDKWIFQCDGSMMLSCEERIR-----VLKDVAAGVL 479
+ +V + ++ K + L+ E I+ +L GV
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLT-ELHIKTLLYNLLV----GVK 170
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG----- 534
Y+H +LHRD+K +N L++++ + ++ DFGLAR + + ++ +
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 535 ---------------------YLAPEV-FSSGRASTQTDVFG----FGILILEVLSGRRP 568
Y APE+ + DV+ F L+ +
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 569 IEEGKP 574
+ P
Sbjct: 288 HADRGP 293
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 55/282 (19%), Positives = 100/282 (35%), Gaps = 69/282 (24%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEIS 413
+ +++IG G G VY + +A+K++ R F L EI+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77
Query: 414 SLGRLKHKSLVGLRGWCK----REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR 469
L RLK ++ L + L +V + ++ L K + L+ EE I+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKT---PIFLT-EEHIK 132
Query: 470 -----VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524
+L G ++HE ++HRD+K +N LL+++ + ++ DFGLAR +
Sbjct: 133 TILYNLLL----GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 525 STTRVVGTVG---------------------YLAPEV-FSSGRASTQTDVFGFGILILEV 562
+ + Y APE+ + D++ G + E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 563 LSG----------RRPIEEGKPNLVEMVWELMVQGKLLDALD 594
L+ R P+ G + D
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 62/245 (25%), Positives = 101/245 (41%), Gaps = 58/245 (23%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF---------LAEISSLG 416
+ +G G G V+K + G +AVK+I AF EI L
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILT 63
Query: 417 RLK-HKSLVGLRGWCKREKGS-LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR----- 469
L H+++V L + + + LV+DYME L I + +L +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILE-PVHKQYVVYQ 117
Query: 470 VLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV 529
++K + YLH G +LHRD+K SN+LL+ E + ++ DFGL+R + + +
Sbjct: 118 LIK----VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 530 --------------------VGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRP 568
V T Y APE+ S + + D++ G ++ E+L +P
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKP 229
Query: 569 IEEGK 573
I G
Sbjct: 230 IFPGS 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
E L + H ++ + G + + + ++ DY+E G L S
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGEL---FSLLRKSQRFP-NPVA 108
Query: 469 RV-LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTT 527
+ +V + YLH K +++RD+K N+LLDK + ++ DFG A+ T
Sbjct: 109 KFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTY 161
Query: 528 RVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ GT Y+APEV S+ + D + FGILI E+L+G P
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 8e-11
Identities = 38/289 (13%), Positives = 83/289 (28%), Gaps = 42/289 (14%)
Query: 17 FLSFE-SISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRP 75
L E S+ + G+ + S+ + LT G K
Sbjct: 5 HLKREHSLIKPYQGVGSSSMPLWDFQGSTILTSQYVRLTPDERSKEGSIWNHQPCFLKD- 63
Query: 76 NSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+ F + K L G G+ + + G +F ++ +
Sbjct: 64 -------WEMHVHFKVHGTGKKNLHGDGIALWYTRDRLVPG-------PVFGSKDNFHG- 108
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
+ D + N E + ++ + VN+ + H+ D + +
Sbjct: 109 ---LAIFLDTYPNDETTERVFPYISVMVNNGSLSYDHS----KDGRWTELAGCTAD---- 157
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
N + + + Y+ + + K + + L Y
Sbjct: 158 --------FRNRDHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDITGVRLP----TGYYF 205
Query: 255 GFTAATGQLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPKDSIFKS 303
G +A TG L ++H I++ + + + + + P + KS
Sbjct: 206 GASAGTGDLSDNHDIISMKLFQLMVEHTPD-EENIDWTKIEPSVNFLKS 253
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-11
Identities = 14/40 (35%), Positives = 26/40 (65%)
Query: 238 LSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNT 277
LS ++L V+ + + +GF+A TG +H++L+WSF +
Sbjct: 6 LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 45
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 42/248 (16%), Positives = 73/248 (29%), Gaps = 61/248 (24%)
Query: 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT--------RAFLAEIS 413
T+ IG G G+V++ + + +A+K I+ E L EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 414 SLGRL---------KHKSLVGLRGWC-----------------KREKGSLMLVYDYMENG 447
L + + +GL KGS D+ ++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 448 SLDKWIFQCDGSMML--------SCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499
L + G + L S +L + A + + HRD+ NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 500 LLDKEMNGRLGDFGLARMHGHG----------QVASTTRVVGTVGY----LAPEVFSSGR 545
LL K +L + S G V + + ++F +G
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF-TGD 252
Query: 546 ASTQTDVF 553
Q D++
Sbjct: 253 GDYQFDIY 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/164 (18%), Positives = 57/164 (34%), Gaps = 41/164 (25%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG--- 428
IG G G++ G +A+K ++ +K L G
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGSGDGIPQ 69
Query: 429 --WCKREKGSLMLVYDYMENG-SLDKWIFQCDGSM------MLSCE--ERIRVLKDVAAG 477
+ +V + + G SL+ CD + M++ + R+
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME-------- 119
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR-----LGDFGLAR 516
Y+H K +++RD+K N L+ + N + DF LA+
Sbjct: 120 --YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 35/248 (14%), Positives = 69/248 (27%), Gaps = 88/248 (35%)
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL--------------------------- 501
++++ V G+ YLH + +++H DIK N+LL
Sbjct: 150 KIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 502 ----------------------DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+++ ++ D G A T + T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLE 263
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN--------LVEMV----------- 580
V +T D++ + E+ +G E + ++
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 581 --WELMVQ-----GKLLDA-------LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR 626
+ + G L L L K + ++E L P R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 627 PTMRQVVK 634
T + ++
Sbjct: 384 ATAAECLR 391
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 34/170 (20%), Positives = 62/170 (36%), Gaps = 38/170 (22%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAF--------LAEISSLGRLKHKSL 423
IG GG G +Y + A + E F +A+ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 424 VGLRG-----WC----KREKGSLMLVYDYMENG-SLDKWIFQCDGSMMLSC-----EERI 468
+ G + + +V + + G L K I +G+ S +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRML 161
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR 516
VL+ Y+HE + +H DIK++N+LL + + L D+GL+
Sbjct: 162 DVLE-------YIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-06
Identities = 52/409 (12%), Positives = 108/409 (26%), Gaps = 120/409 (29%)
Query: 327 FLIKRKQRRAREREEMEDWELEYWPHRITYQEIEAATKGF------------------SE 368
FL+ + R+ M +E Y + + K
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQ--RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA 150
Query: 369 ENVI--GVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEIS--SLGRLKHKSLV 424
+NV+ GV G+G K + A + +I +L V
Sbjct: 151 KNVLIDGVLGSG---KTWV----ALDVCL-----SYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 425 --GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIR---VLKDVAAGVL 479
L+ + + D+ N L Q + +L + VL +V
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV----- 253
Query: 480 YLHEGWEKKVLHR-DIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP 538
K + ++ +LL TTR +L+
Sbjct: 254 -----QNAKAWNAFNLSCK-ILL------------------------TTRFKQVTDFLSA 283
Query: 539 ----EVFSSGRASTQTDVFGFGIL--ILEVLSGRRPIE--EGKPNLVEMVWELMVQG--- 587
+ + T T +L L+ P E P + ++ E + G
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 588 ----------KLLDALDARLRAKGGFDEDEVERVLH-LGLLCAYPDPRARPTMRQVVKVL 636
KL +++ L + E ++ L + P PT ++ ++
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNV---LEPAEYRKMFDRLSVF---PPSAHIPT--ILLSLI 395
Query: 637 EGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATHPTFHDI 685
+ +++ + + ++ + + I
Sbjct: 396 WFDVI---KSDVMVV----VNKLHKYSLVEKQPKESTISI------PSI 431
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 50/315 (15%), Positives = 89/315 (28%), Gaps = 111/315 (35%)
Query: 429 WCKREKGSLMLVYDYMENGSLDK---WIF--------QCDGSMMLSCEERIRVLKDVAAG 477
W K +V ++E L ++ Q + E+R R+ D
Sbjct: 69 WTLLSKQE-EMVQKFVE-EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126
Query: 478 VLY----LHEGWE-KKVLHRDIKSSNVLLDKEMNGRLGDFG---LARMHGHGQVASTTRV 529
Y L + ++ L + NVL+D G LG G +A V + +V
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLID----GVLG-SGKTWVA-----LDVCLSYKV 176
Query: 530 VGTVGYLAPEVF--SSGRASTQTDVFGFGILILEVL----------------SGRRPIEE 571
+ + ++F + ++ V + +L+ L + + I
Sbjct: 177 QCKMDF---KIFWLNLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 572 GKPNLVEM---------------VWELMV------QGKLL---------DALDARLR--- 598
+ L + V K+L D L A
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 599 ----AKGGFDEDEVERVLHLGLLCAYPD-PRARPTMRQVVKVLEGKIEAGIENETEDMDA 653
DEV+ +L L C D P R+V+ ++ + I D
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP------REVLTTNPRRL-SIIAESIRDG-- 340
Query: 654 YLLQQVKSKDMWANY 668
W N+
Sbjct: 341 --------LATWDNW 347
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 34/165 (20%), Positives = 62/165 (37%), Gaps = 41/165 (24%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG--- 428
IG G G +++G ++A+K +D +K L G G
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-------YKLLAGCTGIPN 70
Query: 429 --WCKREKGSLMLVYDYMENG-SLDKWIFQCDGSM------MLSCE--ERIRVLKDVAAG 477
+ +E +LV D + G SL+ + C M + + R++
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ-------- 120
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR-----LGDFGLARM 517
+HE K +++RDIK N L+ + + + DFG+ +
Sbjct: 121 --SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 43/179 (24%), Positives = 66/179 (36%), Gaps = 29/179 (16%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG--- 428
IG G G +Y G G E+A+K + E K + G G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIY-----KMMQGGVGIPT 69
Query: 429 --WCKREKGSLMLVYDYMENG-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
WC E ++V + + G SL+ C S + + + + + + Y+H
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHS-- 123
Query: 486 EKKVLHRDIKSSNVLLDKEMNG---RLGDFGLARM------HGHGQVASTTRVVGTVGY 535
K +HRD+K N L+ G + DFGLA+ H H + GT Y
Sbjct: 124 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 12/104 (11%)
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD------KEMNGRLGDFGLARMHGHGQ 522
++ K + G+ Y+H ++H DIK NVL++ + ++ D G A
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH 191
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR 566
T + T Y +PEV D++ LI E+++G
Sbjct: 192 Y---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/154 (25%), Positives = 59/154 (38%), Gaps = 23/154 (14%)
Query: 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG--- 428
IG G G++Y G E+A+K + + L E + L G G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIY-----RILQGGTGIPN 67
Query: 429 --WCKREKGSLMLVYDYMENG-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
W E +LV D + G SL+ C + L + + + V ++H
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHS-- 121
Query: 486 EKKVLHRDIKSSNVLLDKEMNGR---LGDFGLAR 516
K LHRDIK N L+ + DFGLA+
Sbjct: 122 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 34/175 (19%), Positives = 55/175 (31%), Gaps = 45/175 (25%)
Query: 372 IGVGGNGKVYKGVLEGG-----GAEIAVKRISHENDGGTRAF-----LAEISSLGRLKHK 421
IG GG G +Y + A VK +N A+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 422 SLVGLRG-----WCKREKGSL----MLVYDYMENG-SLDKWIFQCDGSM------MLSCE 465
+ G + ++ D G L K LS
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 466 --ERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR 516
+ + Y+HE + +H DIK+SN+LL+ + + L D+GLA
Sbjct: 161 ILDILE----------YIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 26/175 (14%), Positives = 58/175 (33%), Gaps = 45/175 (25%)
Query: 372 IGVGGNGKVYKGV--------LEGGGAEIAVK------RISHENDGGTRAFLA-EISSLG 416
G +Y+ + ++K R+ +E + RA +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 417 RLKHKSLVG---LRGWCKREKGSLMLVYDYMENG-SLDKWIFQCDGS-------MMLSCE 465
+L L+ G+ + LV + G SL + + ++C
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 466 --ERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLAR 516
+ + +LHE + +H ++ + N+ +D E + L +G A
Sbjct: 168 LLDALE----------FLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 705 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.97 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.48 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.14 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.96 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.61 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 81.12 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.11 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=499.85 Aligned_cols=225 Identities=34% Similarity=0.551 Sum_probs=201.9
Q ss_pred hccCceeeEEeCCCCCCCeEEEcceEeecCcEEecCCCCC------eEEEEEcCCCccccCCCCCcccceEEEEEEEEec
Q 005257 20 FESISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTF------TIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAP 93 (705)
Q Consensus 20 ~~~~~~~~f~f~~f~~~~~~~~g~a~~~~~~l~lt~~~~~------~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 93 (705)
+.++..++|+|++|+..||+|+|||++.+|.||||+...+ ++|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 21 ~~sa~~~sF~f~~F~~~nL~l~GdA~i~~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFsF~I~~ 100 (281)
T 3ujo_A 21 AASANLISFTFKKFNETNLILQRDATVSSGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQA 100 (281)
T ss_dssp ---CEEEEEEESSCCSTTEEECSSCCCBTTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEEEECCC
T ss_pred cCcCCcceEEcCCCCccCEEEecceEEeCCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEEEEEec
Confidence 4456789999999999999999999999999999998765 9999999999999999999999999999999998
Q ss_pred CCCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 94 YKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 94 ~~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
++...+||||||||+|....|. +.||||||||.+++ ++++|+|||||||++|++| ||++|||||||||++|+++++
T Consensus 101 ~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~S~~t~~- 176 (281)
T 3ujo_A 101 PNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSIKTTS- 176 (281)
T ss_dssp SSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSCCSCEEE-
T ss_pred CCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEeccccccC-CCCCCeEEEEcCCCCcccccc-
Confidence 8777899999999999876654 68999999998776 7889999999999999987 999999999999999988743
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~ 251 (705)
+.+.+|+.++|||+| ..++|+|++++.+. |+.|+|++.|||+++|||+
T Consensus 177 ----------------------------~~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~ 226 (281)
T 3ujo_A 177 ----------------------------WDFANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEW 226 (281)
T ss_dssp ----------------------------CCCCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSE
T ss_pred ----------------------------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCc
Confidence 356799999999999 56788998887553 5678999999999999999
Q ss_pred eeccccccccc---ccccceeeeeeecccc
Q 005257 252 MYVGFTAATGQ---LVESHKILAWSFSNTK 278 (705)
Q Consensus 252 ~~vGfsastg~---~~~~h~i~~wsf~~~~ 278 (705)
||||||||||. ..|.|+|++|+|++..
T Consensus 227 v~VGFSAsTG~~~~~~e~H~IlsWSFss~l 256 (281)
T 3ujo_A 227 VSVGFSATTGLSKGYVETNEVLSWSFASKL 256 (281)
T ss_dssp EEEEEEEEECSSTTSCCCCEEEEEEEEEEE
T ss_pred EEEEEEeecCCCCcccceeEEEEEEEEEEc
Confidence 99999999996 5899999999999875
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=485.50 Aligned_cols=222 Identities=33% Similarity=0.532 Sum_probs=201.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCCCC------eEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNSTTF------TIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~~~------~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|+ ..||+|+|||++. +|.||||+...+ ++|||+|++||+|||+.+|++|||+|+|+|.|.++
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 46899999998 6899999999994 899999998765 99999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
+...+||||||||+|....|. ..||||||||.+++ +.++|+|||||||++|.+|+||++|||||||||++|+++++
T Consensus 82 ~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~-- 157 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK-- 157 (251)
T ss_dssp STTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE--
T ss_pred CCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce--
Confidence 777899999999999876655 57999999998766 77899999999999999988999999999999999988743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
+.+.+|+.++|||+| ..+.|+|+|+..+. |..|+|++.|||+++|||+|
T Consensus 158 ---------------------------~~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v 208 (251)
T 3ipv_A 158 ---------------------------WSLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWV 208 (251)
T ss_dssp ---------------------------CCCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEE
T ss_pred ---------------------------eEecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcE
Confidence 357899999999999 56799999986543 66789999999999999999
Q ss_pred ecccccccccc---cccceeeeeeecccc
Q 005257 253 YVGFTAATGQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsastg~~---~~~h~i~~wsf~~~~ 278 (705)
|||||||||.. .|.|+|++|+|++..
T Consensus 209 ~VGFSAsTG~~~~~~e~h~IlsWsF~s~l 237 (251)
T 3ipv_A 209 RVGFSAATGASGGKIETHDVFSWSFASKL 237 (251)
T ss_dssp EEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEEecCCCccccceeEEEEEEEEEEC
Confidence 99999999988 899999999999875
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=482.16 Aligned_cols=225 Identities=30% Similarity=0.488 Sum_probs=201.6
Q ss_pred hccCceeeEEeCCCC--CCCeEEEcceEe-ecCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEE
Q 005257 20 FESISAVDFVFNGFN--SSNLSLYGTATV-ESRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFA 90 (705)
Q Consensus 20 ~~~~~~~~f~f~~f~--~~~~~~~g~a~~-~~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~ 90 (705)
+.++..++|+|++|+ ..||+|+|||++ .+|.|+||+... +++|||+|++||+|||+.+|++|||+|+|+|.
T Consensus 6 ~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~ 85 (261)
T 3zyr_A 6 ANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFF 85 (261)
T ss_dssp --CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEE
T ss_pred cCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEE
Confidence 456778999999998 689999999999 489999999875 79999999999999999999999999999999
Q ss_pred EecCCCCCCCCceEEEEeeCCC-CCCCCCCCcccccccCCCCC-CCCcEEEEEeecc---cCCCCCCCCCCeeEEecCCC
Q 005257 91 MAPYKGVLAGHGLVFLFVPFHG-IKGATEAQHLGLFNRTNDGN-SSNHVFGVEFDVF---KNQEFNDIDENHVGIDVNSL 165 (705)
Q Consensus 91 i~~~~~~~~g~G~aF~~~~~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~~Hvgidvns~ 165 (705)
|.++ ...+||||||||+|.+. +|.+++||||||||.+++++ +.||+|||||||+ +|.+| ||++|||||||||+
T Consensus 86 I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNsi 163 (261)
T 3zyr_A 86 LSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNSI 163 (261)
T ss_dssp EECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESSS
T ss_pred EecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCCC
Confidence 9887 66789999999999865 58889999999999887644 5789999999999 99887 99999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeec
Q 005257 166 TSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLN 243 (705)
Q Consensus 166 ~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vd 243 (705)
.|+++++ +.+.+|+.++|||+| ..++|+|++++.+. ..|+|++.||
T Consensus 164 ~S~~s~~-----------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vd 211 (261)
T 3zyr_A 164 RSSKVVR-----------------------------WERREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVD 211 (261)
T ss_dssp SCSEEEE-----------------------------CCCCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECC
T ss_pred Ccccccc-----------------------------ccccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEec
Confidence 9988743 356799999999999 56899999987552 3789999999
Q ss_pred Cccccccceecccccccccccccceeeeeeecccc
Q 005257 244 LSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 244 l~~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
|+++|||+||||||||||...|.|+|++|+|++..
T Consensus 212 L~~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~l 246 (261)
T 3zyr_A 212 LTTILPEWVRVGFSAASGEQFQTHNLESWSFTSTL 246 (261)
T ss_dssp GGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred hHHhCcCcEEEEEEecCCCccceEEEEEEEEEEEc
Confidence 99999999999999999999999999999999875
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=470.87 Aligned_cols=221 Identities=32% Similarity=0.523 Sum_probs=199.9
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 46899999998 5899999999996 7999999876 68999999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEeeCCC-CCCCCCCCcccccccCCCCCCCCcEEEEEeecccC---CCCCCCCCCeeEEecCCCcccccc
Q 005257 96 GVLAGHGLVFLFVPFHG-IKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKN---QEFNDIDENHVGIDVNSLTSVSAH 171 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgidvns~~S~~~~ 171 (705)
...+||||||||+|... +|.++.||||||+|.++ ++..+|+|||||||++| .+ +||++|||||||||++|++++
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~~~ 159 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIKTV 159 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccceE
Confidence 77789999999999865 68889999999999764 47799999999999999 88 599999999999999998874
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccc
Q 005257 172 AAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLE 249 (705)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~ 249 (705)
+ ++|.+|+.++|||+| ..++|+|+|++.+. |..|+|+..|||+++||
T Consensus 160 ~-----------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~ 208 (239)
T 1dbn_A 160 Q-----------------------------WDWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILP 208 (239)
T ss_dssp E-----------------------------CCCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSC
T ss_pred c-----------------------------ccccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCC
Confidence 3 358899999999999 55789999987643 56789999999999999
Q ss_pred cceecccccccccc--cccceeeeeeeccc
Q 005257 250 DEMYVGFTAATGQL--VESHKILAWSFSNT 277 (705)
Q Consensus 250 ~~~~vGfsastg~~--~~~h~i~~wsf~~~ 277 (705)
|+||||||||||.. .|.|+|++|+|+++
T Consensus 209 e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 209 EWVRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp SEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred ccEEEEEEeccCCCccceeeEEEEEEeEec
Confidence 99999999999998 99999999999864
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=467.95 Aligned_cols=219 Identities=29% Similarity=0.475 Sum_probs=196.1
Q ss_pred eeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCC
Q 005257 25 AVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKG 96 (705)
Q Consensus 25 ~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 96 (705)
.++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~~ 82 (237)
T 1fny_A 3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPNP 82 (237)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSST
T ss_pred ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCCC
Confidence 5799999998 5899999999996 7999999876 689999999999999999999999999999999998877
Q ss_pred CCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccccc
Q 005257 97 VLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYW 176 (705)
Q Consensus 97 ~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~ 176 (705)
..+||||||||+|....| ++.||||||||.++ ++..+|+|||||||++|.+ +||++|||||||||+.|+++++
T Consensus 83 ~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~---- 155 (237)
T 1fny_A 83 ATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVP---- 155 (237)
T ss_dssp TSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEE----
T ss_pred CCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccCcc-cCCCCCceEEecCCcccccccc----
Confidence 778999999999986655 48899999999764 4789999999999999998 5999999999999999988743
Q ss_pred CCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceec
Q 005257 177 PDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254 (705)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~v 254 (705)
++|.+|+.++|||+| ..+.|+|+|++.+ .|..|+|+..|||+++|||+|||
T Consensus 156 -------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~V 208 (237)
T 1fny_A 156 -------------------------WNWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRF 208 (237)
T ss_dssp -------------------------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEE
T ss_pred -------------------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCCcceEEEEechHHhCCCcEEE
Confidence 358899999999999 5568999998754 36678999999999999999999
Q ss_pred ccccccccc---cccceeeeeeeccc
Q 005257 255 GFTAATGQL---VESHKILAWSFSNT 277 (705)
Q Consensus 255 Gfsastg~~---~~~h~i~~wsf~~~ 277 (705)
|||||||.. .|.|+|++|+|+++
T Consensus 209 GFSAsTG~~~~~~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 209 GFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEEeeCCCCcccceeEEEEEEEEEe
Confidence 999999998 99999999999875
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=463.55 Aligned_cols=218 Identities=29% Similarity=0.488 Sum_probs=198.6
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCC-CCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNS-TTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLA 99 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 99 (705)
..++|+|++|+ ..||+|+|||++. +|.|+||++ ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~~ 81 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP 81 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 46799999998 5899999999996 799999998 8899999999999999999999999999999999998877778
Q ss_pred CCceEEEEeeCC-CCCCCC-CCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccC
Q 005257 100 GHGLVFLFVPFH-GIKGAT-EAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWP 177 (705)
Q Consensus 100 g~G~aF~~~~~~-~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~ 177 (705)
||||||||+|.. .+|.++ .||||||+|. ++.+|+|||||||++|.+++||++||||||||+++|+++++
T Consensus 82 gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~----- 152 (232)
T 1v6i_A 82 ADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP----- 152 (232)
T ss_dssp CCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE-----
T ss_pred CCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCcccccccc-----
Confidence 999999999986 468778 8999999986 56789999999999999999999999999999999988743
Q ss_pred CCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecc
Q 005257 178 DNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255 (705)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vG 255 (705)
++|.+|+.++|||+| ..++|+|+|++ + +|..|+|+..|||+++|||+||||
T Consensus 153 ------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VG 205 (232)
T 1v6i_A 153 ------------------------WNSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFG 205 (232)
T ss_dssp ------------------------CCCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEE
T ss_pred ------------------------ccccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEE
Confidence 358899999999999 55789999987 3 477899999999999999999999
Q ss_pred ccccccc--ccccceeeeeeecccc
Q 005257 256 FTAATGQ--LVESHKILAWSFSNTK 278 (705)
Q Consensus 256 fsastg~--~~~~h~i~~wsf~~~~ 278 (705)
|| |||. ..|.|+|++|+|++..
T Consensus 206 FS-sTG~~~~~~~h~IlsWsF~s~l 229 (232)
T 1v6i_A 206 FS-ASGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp EE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred EE-ecCCCccccEEEEEEEEEEeec
Confidence 99 9998 6999999999998764
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=463.91 Aligned_cols=221 Identities=28% Similarity=0.397 Sum_probs=198.9
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC---CCeEEE-EEcCCCccccCCCCCcccceEEEEEEEEecC-C
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST---TFTIGR-ALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY-K 95 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~---~~~~Gr-~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 95 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|| |+|++||+|||+.+|+++||+|+|+|.|.++ +
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 46899999998 5899999999996 7999999986 689999 9999999999999999999999999999887 5
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCC-CCCCCCeeEEecCCCccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEF-NDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
...+||||||||+|....| ++.||||||||.++ ++..+|+|||||||++|.++ |||++||||||||+++|+++++
T Consensus 82 ~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~-- 157 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER-- 157 (242)
T ss_dssp GGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE--
T ss_pred CCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceec--
Confidence 6678999999999986655 47899999999765 57899999999999999997 8999999999999999988743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCC--cceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccc
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNG--KNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED 250 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g--~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~ 250 (705)
++|.+| +.++|||+| ..++|+|+|++.+. |..|+|+..|||+++|||
T Consensus 158 ---------------------------~~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e 208 (242)
T 1fx5_A 158 ---------------------------WNKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPE 208 (242)
T ss_dssp ---------------------------CCCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCS
T ss_pred ---------------------------ccccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCc
Confidence 357899 999999999 55689999987643 567899999999999999
Q ss_pred ceeccccccc--ccccccceeeeeeecccc
Q 005257 251 EMYVGFTAAT--GQLVESHKILAWSFSNTK 278 (705)
Q Consensus 251 ~~~vGfsast--g~~~~~h~i~~wsf~~~~ 278 (705)
+||||||||| |.. |.|+|++|+|++..
T Consensus 209 ~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l 237 (242)
T 1fx5_A 209 WVSVGFSGSTYIGRQ-ATHEVLNWYFTSTF 237 (242)
T ss_dssp EEEEEEEEEEETTSC-EEEEEEEEEEEEES
T ss_pred cEEEEEEecccCCCc-ceeEEEEEEeEeec
Confidence 9999999999 988 99999999999864
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=462.72 Aligned_cols=220 Identities=30% Similarity=0.517 Sum_probs=196.6
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|+ ..||+|+|||++. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 81 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 35799999998 5899999999996 7999999876 5799999999999999999999999999999999887
Q ss_pred C-CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 95 K-GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 95 ~-~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
+ ...+||||||||+|....| ++.||||||||.++ ++..+|+|||||||++|. |.||++|||||||||+.|+++++
T Consensus 82 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~- 157 (239)
T 1gzc_A 82 YTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP- 157 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEE-
T ss_pred CCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCcccccccc-
Confidence 6 6678999999999986655 48899999999764 577899999999999998 77799999999999999988743
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~ 251 (705)
++|.+|+.++|||+| ..+.|+|++++.+ .|..|+|+..|||+.+|||+
T Consensus 158 ----------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~ 207 (239)
T 1gzc_A 158 ----------------------------FQLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDW 207 (239)
T ss_dssp ----------------------------CCCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSE
T ss_pred ----------------------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCccceEEEEechHHhCCCc
Confidence 358899999999999 5568999998654 36678999999999999999
Q ss_pred eeccccccccc---ccccceeeeeeeccc
Q 005257 252 MYVGFTAATGQ---LVESHKILAWSFSNT 277 (705)
Q Consensus 252 ~~vGfsastg~---~~~~h~i~~wsf~~~ 277 (705)
||||||||||. ..|.|+|++|+|+++
T Consensus 208 v~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 208 VDVGLSGATGAQRDAAETHDVYSWSFQAS 236 (239)
T ss_dssp EEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred eEEEEEeccCCCccccceEEEEEEEeEEe
Confidence 99999999997 489999999999875
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=456.72 Aligned_cols=215 Identities=29% Similarity=0.462 Sum_probs=196.4
Q ss_pred eeEEeCCCC-CCCeEEEcceEee-cCcEEecCC--CCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCC
Q 005257 26 VDFVFNGFN-SSNLSLYGTATVE-SRILTLTNS--TTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGH 101 (705)
Q Consensus 26 ~~f~f~~f~-~~~~~~~g~a~~~-~~~l~lt~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~ 101 (705)
++|+|++|. ..||+|+|||++. +|.|+||++ ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+||
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~gd 80 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPTD 80 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCCC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCC
Confidence 479999998 7899999999996 799999998 778999999999999999999999999999999999887777899
Q ss_pred ceEEEEeeCC-CCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCC---CeeEEecCCCcccccccccccC
Q 005257 102 GLVFLFVPFH-GIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDE---NHVGIDVNSLTSVSAHAAGYWP 177 (705)
Q Consensus 102 G~aF~~~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgidvns~~S~~~~~~~~~~ 177 (705)
||||||+|.. .+|.++.|+||||+|.+ ++.+|+|||||||++|. +||++ |||||||||+.|.++++
T Consensus 81 GlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~----- 150 (234)
T 2eig_A 81 GVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVN----- 150 (234)
T ss_dssp EEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEE-----
T ss_pred cEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceec-----
Confidence 9999999986 47888899999999975 67899999999999998 59999 99999999999987743
Q ss_pred CCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecc
Q 005257 178 DNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255 (705)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vG 255 (705)
++|.+|+.++|||+| ..+.|+|+|++ + +|..|+|+..|||+++|||+||||
T Consensus 151 ------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VG 203 (234)
T 2eig_A 151 ------------------------WNRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVG 203 (234)
T ss_dssp ------------------------CCCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEE
T ss_pred ------------------------ccccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEE
Confidence 357899999999999 55689999998 4 477899999999999999999999
Q ss_pred ccccc--ccccccceeeeeeecccc
Q 005257 256 FTAAT--GQLVESHKILAWSFSNTK 278 (705)
Q Consensus 256 fsast--g~~~~~h~i~~wsf~~~~ 278 (705)
||||| |.. +.|+|++|+|++..
T Consensus 204 FSAsT~~G~~-~~h~IlsWsF~s~l 227 (234)
T 2eig_A 204 FSATTWNPER-ERHDIYSWSFTSTL 227 (234)
T ss_dssp EEEEECSSCC-EEEEEEEEEEEEEC
T ss_pred EEeeecCCCc-ceeEEEEEEEEecC
Confidence 99999 988 99999999999864
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=463.83 Aligned_cols=221 Identities=32% Similarity=0.524 Sum_probs=199.6
Q ss_pred ceeeEEeCCCCCCCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGV 97 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 97 (705)
..++|+|++|+..||+|+|||.+.+|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.+++..
T Consensus 2 ~~~~F~f~~F~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~ 81 (253)
T 1g7y_A 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cceEEEcCCCCcCCEEEecceEEeCCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCC
Confidence 4689999999989999999999999999999976 5799999999999999999999999999999999987667
Q ss_pred CCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccC
Q 005257 98 LAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWP 177 (705)
Q Consensus 98 ~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~ 177 (705)
.+||||||||+|....| ++.|+||||||.++ ++..+|+|||||||++|.+ +||++|||||||||+.|.++++
T Consensus 82 ~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~----- 153 (253)
T 1g7y_A 82 SSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTAS----- 153 (253)
T ss_dssp GCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE-----
T ss_pred CCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceeccC-cCCCCCcEeeccCCccccceec-----
Confidence 78999999999987655 48899999999764 4779999999999999998 6999999999999999987743
Q ss_pred CCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecc
Q 005257 178 DNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255 (705)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vG 255 (705)
++|.+|+.++|||+| ..++|+|++.+.+ .|..|+|+..|||+.+||++||||
T Consensus 154 ------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~~~VG 207 (253)
T 1g7y_A 154 ------------------------WGLANGQNAEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIG 207 (253)
T ss_dssp ------------------------CCCCTTSEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEE
T ss_pred ------------------------cccCCCCeEEEEEEEeCCCCEEEEEEecCC--CCCcceEEEEechHHhCCCceEEE
Confidence 357899999999999 4578999998754 356789999999999999999999
Q ss_pred cccccccc---cccceeeeeeecccc
Q 005257 256 FTAATGQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 256 fsastg~~---~~~h~i~~wsf~~~~ 278 (705)
||||||.. .+.|+|++|+|++..
T Consensus 208 FSAsTG~~~~~~~~H~IlsWsF~s~l 233 (253)
T 1g7y_A 208 FSATTGLSEGYTETHDVLSWSFASKL 233 (253)
T ss_dssp EEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred EEeCcCCCCcccceeEEEEEEEEeeC
Confidence 99999998 999999999999864
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=464.91 Aligned_cols=223 Identities=29% Similarity=0.484 Sum_probs=198.6
Q ss_pred ceeeEEeCCCC---CCCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN---SSNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~---~~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|. ..||+|+|||.+.+|.||||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~~ 82 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 82 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEecC
Confidence 45799999998 57999999999999999999976 5799999999999999999999999999999999887
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCC-CCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTN-DGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
...+||||||||+|....| ++.|+||||+|.++ +++..+|+|||||||++|.+|+||++||||||||++.|+++++
T Consensus 83 -~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~- 159 (257)
T 1hql_A 83 -GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR- 159 (257)
T ss_dssp -SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE-
T ss_pred -CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceec-
Confidence 6678999999999986654 48899999999765 3678899999999999999999999999999999999988754
Q ss_pred cccCCCCCCCCCCCCCCCCCCCcccccee-ecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKEL-KLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED 250 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~ 250 (705)
| ++ .|.+|+.++|||+| ..++|+|++...+. ..|+|+..|||+.+||+
T Consensus 160 --~------------------------~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e 210 (257)
T 1hql_A 160 --W------------------------EDSDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPE 210 (257)
T ss_dssp --C------------------------CHHHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCS
T ss_pred --c------------------------CcccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCC
Confidence 3 11 25579999999999 45799999987644 45899999999999999
Q ss_pred ceecccccccc-cccccceeeeeeecccc
Q 005257 251 EMYVGFTAATG-QLVESHKILAWSFSNTK 278 (705)
Q Consensus 251 ~~~vGfsastg-~~~~~h~i~~wsf~~~~ 278 (705)
+|||||||||| ...+.|+|++|+|++..
T Consensus 211 ~~~vGFSAsTG~~~~~~H~IlsWsF~s~~ 239 (257)
T 1hql_A 211 SVRVGISASTGNNQFLTVYILSWRFSSNL 239 (257)
T ss_dssp EEEEEEEEECCSCCCEEEEEEEEEEEEEC
T ss_pred ceEEEEEeccCCCccceeEEEEEEeEecC
Confidence 99999999999 89999999999999876
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=458.47 Aligned_cols=222 Identities=30% Similarity=0.514 Sum_probs=199.5
Q ss_pred cCceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC---CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 22 SISAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST---TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 22 ~~~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
++..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 s~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~- 80 (242)
T 1qnw_A 2 LSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD- 80 (242)
T ss_dssp -CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-
T ss_pred CccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-
Confidence 3457899999998 5899999999996 7999999987 7899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEeeCCC-CCCCCCCCcccccccCCCCCCCCcEEEEEeecc----cCCCCCCCCCCeeEEecCCCccccc
Q 005257 96 GVLAGHGLVFLFVPFHG-IKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVF----KNQEFNDIDENHVGIDVNSLTSVSA 170 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgidvns~~S~~~ 170 (705)
...+||||||||+|... +|.++.||||||+|.++ ++..+|+|||||||+ +|. +||++||||||||++.|+++
T Consensus 81 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~ 157 (242)
T 1qnw_A 81 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKT 157 (242)
T ss_dssp SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCccccce
Confidence 66789999999999864 78889999999999764 577899999999999 998 69999999999999999887
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccc
Q 005257 171 HAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVL 248 (705)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l 248 (705)
++ ++|.+|+.++|||+| ..+.|+|+|.+.+ .|..|+|+..|||+.+|
T Consensus 158 ~~-----------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l 206 (242)
T 1qnw_A 158 VK-----------------------------WDWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAIL 206 (242)
T ss_dssp EE-----------------------------CCCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHS
T ss_pred ec-----------------------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeEEEeechHHhc
Confidence 43 357899999999999 5568999997654 36678999999999999
Q ss_pred ccceecccccccccc--cccceeeeeeecccc
Q 005257 249 EDEMYVGFTAATGQL--VESHKILAWSFSNTK 278 (705)
Q Consensus 249 ~~~~~vGfsastg~~--~~~h~i~~wsf~~~~ 278 (705)
||+||||||||||.. .|.|+|++|+|++..
T Consensus 207 ~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~l 238 (242)
T 1qnw_A 207 PEWVSVGFSGGVGNAAEFETHDVLSWYFTSNL 238 (242)
T ss_dssp CSEEEEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred CCceEEEEEeccCCCccceEEEEEEEEeEeec
Confidence 999999999999998 999999999999764
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=457.02 Aligned_cols=222 Identities=31% Similarity=0.492 Sum_probs=200.2
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGH 101 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~ 101 (705)
..++|+|++|+ ..||+|+|||...+|.|+||++..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+||
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~gd 81 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVAD 81 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCEEETBEEEEECSCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCCC
T ss_pred cceEEEcCCCCCCCCCEEEeeceecCCCEEEeCCCCCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCCCC
Confidence 46799999998 5899999999966899999999999999999999999999999999999999999999887777899
Q ss_pred ceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCC--CCeeEEecCCCcccccccccccCCC
Q 005257 102 GLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDID--ENHVGIDVNSLTSVSAHAAGYWPDN 179 (705)
Q Consensus 102 G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgidvns~~S~~~~~~~~~~~~ 179 (705)
||||+|+|....|. +.|+||||||.++ ++..+|+|||||||++|.+ +||+ +||||||||++.|+++.+
T Consensus 82 GlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~------- 151 (234)
T 2bqp_A 82 GFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKS------- 151 (234)
T ss_dssp EEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEE-------
T ss_pred cEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEe-------
Confidence 99999999876666 8899999999774 5788999999999999998 5999 999999999999987743
Q ss_pred CCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCC---CCCCCceeeeecCccccccceec
Q 005257 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMK---RPKRPLLSVPLNLSGVLEDEMYV 254 (705)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~---~~~~~~ls~~vdl~~~l~~~~~v 254 (705)
+++.+|+.++|||+| ..++|+|++...+.. +|..|+|+..|||+.+||++|||
T Consensus 152 ----------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yv 209 (234)
T 2bqp_A 152 ----------------------WKLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRI 209 (234)
T ss_dssp ----------------------CCCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEE
T ss_pred ----------------------eEEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEE
Confidence 357799999999999 447999999887655 67789999999999999999999
Q ss_pred ccccccccccccceeeeeeeccc
Q 005257 255 GFTAATGQLVESHKILAWSFSNT 277 (705)
Q Consensus 255 Gfsastg~~~~~h~i~~wsf~~~ 277 (705)
|||||||...+.|+|++|+|+++
T Consensus 210 GFSAsTG~~~~~H~IlsWsF~s~ 232 (234)
T 2bqp_A 210 GFSATTGAEYAAHEVLSWSFHSE 232 (234)
T ss_dssp EEEEECSSSCCEEEEEEEEEEEE
T ss_pred EEEeccCCCcccEEEEEEEEEee
Confidence 99999999999999999999875
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=456.20 Aligned_cols=221 Identities=32% Similarity=0.511 Sum_probs=197.0
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++.. +++|||+|++||+|||+ +|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~~ 80 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQG 80 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCBS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEecC
Confidence 46899999998 5899999999996 78999999876 79999999999999999 999999999999999987
Q ss_pred CCCCCCCceEEEEeeCCCCCCC-CCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGA-TEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
...+||||||+|+|....|.+ +.|+||||+|.+++++..+|+|||||||++|.+++||++||||||||++.|+++.+
T Consensus 81 -~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~- 158 (240)
T 2fmd_A 81 -SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASK- 158 (240)
T ss_dssp -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-
T ss_pred -CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeE-
Confidence 667899999999998766665 88999999998777778999999999999999988999999999999999987743
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~ 251 (705)
+++.+|+.++|||+| ..++|+|++.+.+. ..|+|+..|||+.+||++
T Consensus 159 ----------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~ 207 (240)
T 2fmd_A 159 ----------------------------WDWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBW 207 (240)
T ss_dssp ----------------------------CCCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSE
T ss_pred ----------------------------EEeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCc
Confidence 357799999999999 45789999987554 468999999999999999
Q ss_pred eecccccccccccccceeeeeeecccc
Q 005257 252 MYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 252 ~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
||||||||||...+.|+|++|+|++..
T Consensus 208 ~yvGFSAsTG~~~~~H~IlsWsF~s~~ 234 (240)
T 2fmd_A 208 VRVGFSATTGQYTQTNNILAWSFRSSL 234 (240)
T ss_dssp EEEEEEEECCSSCBCCEEEEEEEEEEE
T ss_pred eEEEEEeccCCccccEEEEEEEeEecC
Confidence 999999999999999999999999864
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=458.76 Aligned_cols=218 Identities=34% Similarity=0.519 Sum_probs=196.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 81 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence 46799999998 5899999999996 7999999976 5799999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
+...+||||||||+|....| ++.||||||||.+ ++.+|+|||||||++|. +||++||||||||++.|.++++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~-- 153 (253)
T 1sbf_A 82 DTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS-- 153 (253)
T ss_dssp STTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE--
T ss_pred CCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceec--
Confidence 77778999999999987655 4889999999975 67899999999999998 6999999999999999988743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
++|.+|+.++|||+| ..++|+|++++.+. |..|+|+..|||+.+|||+|
T Consensus 154 ---------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~ 204 (253)
T 1sbf_A 154 ---------------------------WDLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWV 204 (253)
T ss_dssp ---------------------------CCCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEE
T ss_pred ---------------------------ccccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCce
Confidence 358899999999999 45789999987643 56789999999999999999
Q ss_pred ecccccccccc--cccceeeeeeecccc
Q 005257 253 YVGFTAATGQL--VESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsastg~~--~~~h~i~~wsf~~~~ 278 (705)
|||||||||.. .+.|+|++|+|++..
T Consensus 205 ~VGFSAsTG~~~~~~~H~IlsWsF~s~l 232 (253)
T 1sbf_A 205 RIGFSAATGLDIPGESHDVLSWSFASNL 232 (253)
T ss_dssp EEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred EEEEEeccCCCccceeeEEEEEEeEeec
Confidence 99999999998 999999999999864
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=459.94 Aligned_cols=219 Identities=34% Similarity=0.528 Sum_probs=197.7
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKG 96 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 96 (705)
..++|+|++|+..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 81 (252)
T 1fat_A 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (252)
T ss_dssp CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCSS
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCCC
Confidence 467999999998899999999996 7999999976 579999999999999999999999999999999998766
Q ss_pred CCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccccc
Q 005257 97 VLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYW 176 (705)
Q Consensus 97 ~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~ 176 (705)
..+||||||||+|....| ++.|+||||||.+ ++.+|+|||||||++|.+ +||++||||||||++.|.++++
T Consensus 82 ~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~---- 152 (252)
T 1fat_A 82 AGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTR---- 152 (252)
T ss_dssp CBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE----
T ss_pred CCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceec----
Confidence 778999999999987655 4889999999975 678999999999999998 6999999999999999987743
Q ss_pred CCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceec
Q 005257 177 PDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254 (705)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~v 254 (705)
++|.+|+.++|||+| ..++|+|++...+. |..|+|+..|||+.+||++|||
T Consensus 153 -------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~V 205 (252)
T 1fat_A 153 -------------------------WDFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSV 205 (252)
T ss_dssp -------------------------CCCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEE
T ss_pred -------------------------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEE
Confidence 357899999999999 45789999987643 5678999999999999999999
Q ss_pred ccccccccc---cccceeeeeeecccc
Q 005257 255 GFTAATGQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 255 Gfsastg~~---~~~h~i~~wsf~~~~ 278 (705)
|||||||.. .+.|+|++|+|++..
T Consensus 206 GFSAsTG~~~~~~~~H~IlsWsF~s~l 232 (252)
T 1fat_A 206 GFSATTGINKGNVETNDVLSWSFASKL 232 (252)
T ss_dssp EEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred EEEeccCCCCcccceEEEEEEEEEeeC
Confidence 999999998 999999999999864
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=455.74 Aligned_cols=219 Identities=29% Similarity=0.473 Sum_probs=196.2
Q ss_pred ceeeEEeCCC----C--CCCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEE
Q 005257 24 SAVDFVFNGF----N--SSNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAM 91 (705)
Q Consensus 24 ~~~~f~f~~f----~--~~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 91 (705)
..++|+|++| . ..||+|+|||.+.+|.|+||++. .+++|||+|++||+||+ .+|+++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~I 80 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEEE
Confidence 3579999999 6 47999999999999999999976 57999999999999999 9999999999999999
Q ss_pred ecCCCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCC-CCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccc
Q 005257 92 APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTND-GNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSA 170 (705)
Q Consensus 92 ~~~~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~ 170 (705)
.++ ...+||||||||+|....| ++.|+||||||.+++ ++..+|+|||||||++|.+|+||++||||||||++.|+++
T Consensus 81 ~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~ 158 (243)
T 1gsl_A 81 KNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT 158 (243)
T ss_dssp EES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred ecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccccce
Confidence 987 6678999999999986654 488999999998753 6788999999999999999999999999999999999877
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCccccceeecCC---CcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCc
Q 005257 171 HAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNN---GKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLS 245 (705)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~ 245 (705)
.+ ++|.+ |+.++|||+| ..++|+|+|.+.+. ..|+|+..|||+
T Consensus 159 ~~-----------------------------~~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~ 206 (243)
T 1gsl_A 159 TR-----------------------------WENDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLA 206 (243)
T ss_dssp EE-----------------------------CCHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHH
T ss_pred ee-----------------------------eEEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechH
Confidence 43 24666 9999999999 45799999987654 468999999999
Q ss_pred cccccceecccccccccccccceeeeeeecccc
Q 005257 246 GVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 246 ~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
.+||++|||||||||| ..+.|+|++|+|++..
T Consensus 207 ~~l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~l 238 (243)
T 1gsl_A 207 KVLPQKVRIGFSAGVG-YDEVTYILSWHFFSTL 238 (243)
T ss_dssp HHSCSEEEEEEEEEEC-BSEEEEEEEEEEEEEC
T ss_pred HhCCCceEEEEEeccC-CcceeEEEEEEEEeec
Confidence 9999999999999999 9999999999999864
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=450.24 Aligned_cols=217 Identities=30% Similarity=0.492 Sum_probs=194.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+ ++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~~ 79 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCCC
Confidence 46899999998 5899999999996 7999999987 47999999999999999877 9999999999999887
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGY 175 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~ 175 (705)
...+||||||||+|....|. +.|+||||||.++ ++..+|+|||||||++|. +||++||||||+||+.|.++++
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~--- 152 (233)
T 1n47_A 80 AAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP--- 152 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE---
T ss_pred CCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEeccccCC--CCCCCCcEEEccCCcccccccc---
Confidence 67789999999999876665 8899999999764 578899999999999998 6999999999999999987743
Q ss_pred cCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccccee
Q 005257 176 WPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253 (705)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~ 253 (705)
++|.+|+.++|||+| ..++|+|++...+. +..|+|+..|||+.+|||+||
T Consensus 153 --------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~ 204 (233)
T 1n47_A 153 --------------------------FDMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVR 204 (233)
T ss_dssp --------------------------CCCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEE
T ss_pred --------------------------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceE
Confidence 357799999999999 45789999987543 356899999999999999999
Q ss_pred cccccccccc---cccceeeeeeeccc
Q 005257 254 VGFTAATGQL---VESHKILAWSFSNT 277 (705)
Q Consensus 254 vGfsastg~~---~~~h~i~~wsf~~~ 277 (705)
||||||||.. .+.|+|++|+|+++
T Consensus 205 vGFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 205 VGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp EEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred EEEEeccCCCccccceeEEEEEEEEee
Confidence 9999999998 99999999999875
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=450.91 Aligned_cols=217 Identities=31% Similarity=0.500 Sum_probs=194.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC-
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY- 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 94 (705)
..++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 81 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCC
Confidence 36799999998 5899999999996 7999999876 6899999999999999999999999999999999887
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
+...+||||||||+|....| ++.|+||||+|.+ +.+|+|||||||++|. +||++||||||||++.|.++.+
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~-- 152 (242)
T 1wbf_A 82 PRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-- 152 (242)
T ss_dssp CSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE--
T ss_pred CCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceee--
Confidence 56678999999999986654 4789999999864 6789999999999998 6999999999999999987743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
++|.+|+.++|||+| ..++|+|+++..+. |..|+|+..|||+.+|||+|
T Consensus 153 ---------------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v 203 (242)
T 1wbf_A 153 ---------------------------FTLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESV 203 (242)
T ss_dssp ---------------------------CCCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEE
T ss_pred ---------------------------eEecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCce
Confidence 358899999999999 55789999987643 55789999999999999999
Q ss_pred eccccccc----ccc---cccceeeeeeecccc
Q 005257 253 YVGFTAAT----GQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsast----g~~---~~~h~i~~wsf~~~~ 278 (705)
|||||||| |.. .|.|+|++|+|++..
T Consensus 204 ~VGFSAsTg~~~G~~~~~~~~h~IlsWsF~s~l 236 (242)
T 1wbf_A 204 NVGFSAATGDPSGKQRNATETHDILSWSFSASL 236 (242)
T ss_dssp EEEEEEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred EEEEEEeecCcCCccccccceEEEEEEEeEecC
Confidence 99999999 888 899999999999864
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=448.66 Aligned_cols=216 Identities=31% Similarity=0.493 Sum_probs=194.2
Q ss_pred eeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC-
Q 005257 25 AVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY- 94 (705)
Q Consensus 25 ~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 94 (705)
.++|+|++|+ ..||+|+|||.+. +|.|+||++. .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 5799999998 5899999999996 7999999976 5799999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
+...+||||||||+|....| ++.|+||||+|.+ +. +|+|||||||++|. +||++||||||||++.|.++.+
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~-- 152 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH-- 152 (238)
T ss_dssp SSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE--
T ss_pred CCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEe--
Confidence 66778999999999986655 4889999999975 45 99999999999998 6999999999999999987743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccc--
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED-- 250 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~-- 250 (705)
++|.+|+.++|||+| ..++|+|++...+ .|..|+|+..|||+.+||+
T Consensus 153 ---------------------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~~ 203 (238)
T 1f9k_A 153 ---------------------------FQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSE 203 (238)
T ss_dssp ---------------------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCS
T ss_pred ---------------------------ecccCCCEEEEEEEEeCCCCEEEEEEecCC--CCCceeEEEEechHHhCCCCc
Confidence 358899999999999 4568999998764 3567899999999999999
Q ss_pred ceecccccccccc---cccceeeeeeecccc
Q 005257 251 EMYVGFTAATGQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 251 ~~~vGfsastg~~---~~~h~i~~wsf~~~~ 278 (705)
+||||||||||.. .+.|+|++|+|++..
T Consensus 204 ~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~~ 234 (238)
T 1f9k_A 204 WVNVGLSATTGYQKNAVETHEIISWSFTSSL 234 (238)
T ss_dssp EEEEEEEEEECSSTTCCCEEEEEEEEEEEEC
T ss_pred eEEEEEEeCcCCCCcccceEEEEEeEeEeec
Confidence 9999999999998 999999999999764
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=443.71 Aligned_cols=214 Identities=31% Similarity=0.495 Sum_probs=192.5
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCC---CCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNS---TTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLA 99 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 99 (705)
..++|+|++|+..||+|+|||.+. +|.|+||++ ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 81 (226)
T 1avb_A 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCCC
Confidence 467999999998999999999996 899999998 7789999999999999999999999999999999998877778
Q ss_pred CCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCC
Q 005257 100 GHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDN 179 (705)
Q Consensus 100 g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~ 179 (705)
||||||||+|....|. +.|+||||+|.+ +++..+|+|||||||+ +||||||||+++|+++++ |
T Consensus 82 gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~---~--- 144 (226)
T 1avb_A 82 AYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATES---C--- 144 (226)
T ss_dssp CEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEE---C---
T ss_pred CCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc---------CCccceeecCcccCcccc---C---
Confidence 9999999999876666 889999999976 4577899999999998 689999999999988754 3
Q ss_pred CCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccc
Q 005257 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFT 257 (705)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfs 257 (705)
++.|.+|+.++|||+| ..++|+|++++.+. ++.|+|+..|||+++|||+||||||
T Consensus 145 ---------------------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFS 201 (226)
T 1avb_A 145 ---------------------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS--EEKCHVSATVPLEKEVEDWVSVGFS 201 (226)
T ss_dssp ---------------------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred ---------------------CccccCCCeEEEEEEEeCCCcEEEEEEeecCC--CccceEEEEechHHhCCCceEEEEE
Confidence 2357799999999999 55689999987643 3478999999999999999999999
Q ss_pred cccccc---cccceeeeeeeccc
Q 005257 258 AATGQL---VESHKILAWSFSNT 277 (705)
Q Consensus 258 astg~~---~~~h~i~~wsf~~~ 277 (705)
||||.. .|.|+|++|+|+++
T Consensus 202 AsTG~~~~~~~~h~IlsWsF~s~ 224 (226)
T 1avb_A 202 ATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp EEECSSGGGCEEEEEEEEEEEEE
T ss_pred eccCCCCcccceeEEEEEEEEee
Confidence 999998 99999999999875
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=436.82 Aligned_cols=213 Identities=26% Similarity=0.467 Sum_probs=190.4
Q ss_pred ceeeEEeCCCCCCC-eEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFNSSN-LSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~~~~-~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
..++|+|++|...| |+|+|||.+. +|.||||++.. +++|||+|++||+|||+. +++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~~~~ 79 (240)
T 1ioa_A 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIRAKN 79 (240)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECCBSC
T ss_pred cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEeCCC
Confidence 35799999999889 9999999996 89999998876 799999999999999986 89999999999999887
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGY 175 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~ 175 (705)
...+||||||||+|....|. +.||||||||.+ +++..+|+|||||||+ +||||||||+++|+++++
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~--- 145 (240)
T 1ioa_A 80 QSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNEN--- 145 (240)
T ss_dssp TTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEE---
T ss_pred CCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc---------CCceeeeeCCcccccccc---
Confidence 77789999999999877666 889999999975 4577899999999998 689999999999988754
Q ss_pred cCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccccee
Q 005257 176 WPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253 (705)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~ 253 (705)
| ++.|.+|+.++|||+| ..+.|+|++++.+. ++.|+|+..|||+++|||+||
T Consensus 146 ~------------------------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~ 199 (240)
T 1ioa_A 146 C------------------------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVS 199 (240)
T ss_dssp C------------------------CHHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEE
T ss_pred C------------------------CccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceE
Confidence 3 2356799999999999 55789999987643 457899999999999999999
Q ss_pred cccccccccc---cccceeeeeeecccc
Q 005257 254 VGFTAATGQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 254 vGfsastg~~---~~~h~i~~wsf~~~~ 278 (705)
||||||||.. .|.|+|++|+|++..
T Consensus 200 VGFSAsTG~~~~~~~~H~IlsWsF~s~~ 227 (240)
T 1ioa_A 200 VGFSPTSGLTEDTTETHDVLSWSFSSKF 227 (240)
T ss_dssp EEEEEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred EEEEeccCCCCcccceeEEEEEEEEeeC
Confidence 9999999998 999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=453.56 Aligned_cols=262 Identities=23% Similarity=0.432 Sum_probs=217.7
Q ss_pred CCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...+.||+|+||+||+|.+. .++..||||+++.......++|.+|+++|++|+|||||+++|+|.+ ++.++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEE
Confidence 45677899999999999999975 3578899999987777778899999999999999999999999986 67899
Q ss_pred EEEeeCCCCChhHHHHhcC----------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 439 LVYDYMENGSLDKWIFQCD----------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
||||||++|+|.++|++.. ....++|.++++|+.|||.||.|||+ ++||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 23469999999999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+...+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~ 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQ 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 99999998765433222 233579999999999999999999999999999999998 8999987543 222333333
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
+.. ...+..+++.+.+++..||+.||++||||.||.+.|+...+..
T Consensus 246 ~~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 246 GRV-----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp TCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCC-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 322 2233445567899999999999999999999999998766533
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=454.21 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=211.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...++||+|+||+||+|.++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+ .+.++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 346678899999999999999753 578999999987777778899999999999999999999999986 67899
Q ss_pred EEEeeCCCCChhHHHHhcCC------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 439 LVYDYMENGSLDKWIFQCDG------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
||||||++|+|.++|++... ..+++|.++++|+.|||.||.|||+ ++||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence 99999999999999976432 2369999999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i 273 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI 273 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 99999999987654332 23344689999999999999999999999999999999999 8999986543 2222333
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+.. ...+..+++.+.+|+..||+.||++||||.||++.|+.+.+
T Consensus 274 ~~g~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 TQGRE-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHTCC-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCC-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 33321 22334455678999999999999999999999999998776
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=450.98 Aligned_cols=274 Identities=20% Similarity=0.247 Sum_probs=219.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+.|...++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++++|+|||||++++++.+ ++.+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEec
Confidence 457778899999999999999999999999999975432 2469999999999999999999876 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-CeeeeeeccceecCCCC
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~~~ 522 (705)
|++|+|.++|.+.+ .+++.++..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+......
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999997654 69999999999999999999998 9999999999999999987 59999999999775433
Q ss_pred cce----eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 523 VAS----TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 523 ~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
... ....+||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+..+... .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~~------~- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIASEPPP------I- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHHSCCG------G-
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHcCCCC------c-
Confidence 211 223579999999999999999999999999999999999999997654321 01111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCCCC
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYAT 678 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 678 (705)
...+......+.+++..||+.||++|||+.|+++.|...++ ...++.
T Consensus 276 --~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~-------------------------------~~~~l~ 322 (336)
T 4g3f_A 276 --REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ-------------------------------EVGGLK 322 (336)
T ss_dssp --GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH-------------------------------HTTSSC
T ss_pred --hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh-------------------------------hhhhcc
Confidence 11233345678899999999999999999999998874433 123589
Q ss_pred CCCccccccccccc
Q 005257 679 HPTFHDIRQSNSYS 692 (705)
Q Consensus 679 hp~f~~~~~~~~~~ 692 (705)
|||+.+.+...++|
T Consensus 323 hPw~~~~~~Pr~ns 336 (336)
T 4g3f_A 323 SPWKGEYKEPRGNS 336 (336)
T ss_dssp SCSSSSCCCCCC--
T ss_pred CCCcCCCCCCCCCC
Confidence 99998877655543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=446.94 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=211.0
Q ss_pred CCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++..++||+|+||+||+|.+. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.. ++.++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~l 106 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLSM 106 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEEE
Confidence 455788999999999999974 356889999997553 3446789999999999999999999999986 678899
Q ss_pred EEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
|||||++|+|.++|..... ...++|.++++|+.|||.||+|||+ ++||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 9999999999999975321 1358999999999999999999999 99999999999999999999
Q ss_pred eeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+|+....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||.+... ..+...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 99999999987644322 22344689999999999999999999999999999999998 8999987543 2223333
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
..+.. ...+.+++..+.+|+..||+.||++||||.||++.|+.
T Consensus 261 ~~~~~-----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 261 RNRQV-----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HcCCC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 33322 22344556778999999999999999999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=442.87 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.+++...++||+|+||+||+|++++ .||||+++.. ..+..+.|.+|+++|++++|||||+++|+|.+ +.++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEE
Confidence 3567788999999999999998753 5999998654 34456789999999999999999999998864 568999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||++|+|.++|+..+. .+++.++++|+.|||.||+|||+ ++||||||||+||||++++++||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999976543 69999999999999999999998 9999999999999999999999999999987654
Q ss_pred CC-cceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 521 GQ-VASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 521 ~~-~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.. .......+||+.|||||++.+ ++++.++|||||||+||||+||+.||...... ..+...+..+... +.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~----p~ 258 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYAS----PD 258 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCC----CC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCC----CC
Confidence 32 223445689999999999864 46899999999999999999999999764431 2222222222111 00
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+ ...+.+++..+.+++..||+.||++||||.||++.|+.+..
T Consensus 259 ~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 L---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp S---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 12233455778999999999999999999999999875533
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=442.45 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=211.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|+++.+++.||||++.+. .....+.+.+|+++|++|+|||||++++++.+ ++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 4588899999999999999999999999999999753 23446779999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.++|.+.+ .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999997654 69999999999999999999999 9999999999999999999999999999998754
Q ss_pred CC-cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQ-VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ..+...+..+.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~----------- 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKLE----------- 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-----------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-----------
Confidence 33 2334557999999999999999999999999999999999999999986543 12222222222
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..++......+.+++..||+.||++|||+.|++.
T Consensus 251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 2233334456889999999999999999887543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=447.03 Aligned_cols=270 Identities=25% Similarity=0.370 Sum_probs=223.1
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCCc-hhHHHHHHHHHHhccCCC-CCcceeeee
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHEND-GGTRAFLAEISSLGRLKH-KSLVGLRGW 429 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~H-pniv~l~g~ 429 (705)
++++...++|+..+.||+|+||+||+|.+... ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 44556677899999999999999999998653 36899999976543 446789999999999965 899999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKS 496 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp 496 (705)
|.+.++.++||||||++|+|.++|+.... ...+++.+++.++.|||.||+|||+ ++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence 98766778999999999999999976321 2358999999999999999999999 9999999999
Q ss_pred CCeEEccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCc
Q 005257 497 SNVLLDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKP 574 (705)
Q Consensus 497 ~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~ 574 (705)
+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997654433 23445789999999999999999999999999999999998 9999986543
Q ss_pred cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 575 ~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
. +.+...+..+.. ...+..+...+.+++..||+.||++|||+.|++++|+.+++.
T Consensus 294 ~--~~~~~~i~~g~~-----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 D--EEFCRRLKEGTR-----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp S--HHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--HHHHHHHHcCCC-----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2 222333333321 222334456788999999999999999999999999987763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=443.78 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=206.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+++|++|+|||||++++++.+ ++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 5799999999999999999999999999999999765 33456789999999999999999999999876 77899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|||++|+|.++|...+.. .+++.+++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~-~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999765433 68999999999999999999999 99999999999999999999999999999876432
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. ...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+ +...+..+.. .
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~-~~~~i~~~~~-----------~ 243 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KN-LVLKIISGSF-----------P 243 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-HHHHHHHTCC-----------C
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HH-HHHHHHcCCC-----------C
Confidence 2 122346899999999999999999999999999999999999999986542 12 2222222221 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++..||+.||++|||+.|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223344568899999999999999999999873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=441.49 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=212.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+.|+..++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++.. ++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeC
Confidence 458889999999999999999999999999999977665666778999999999999999999999886 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
|++|+|.+++.+. .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 153 ~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999999652 58999999999999999999999 9999999999999999999999999999997754432
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... + +...+..+ .......
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~-~~~~i~~~---------~~~~~~~ 292 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--K-AMKMIRDN---------LPPRLKN 292 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-HHHHHHHS---------SCCCCSC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--H-HHHHHHcC---------CCCCCCc
Confidence 234578999999999999999999999999999999999999999865431 1 12222211 1101111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+.+++..||+.||++|||+.|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22334568899999999999999999999874
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=403.67 Aligned_cols=197 Identities=28% Similarity=0.506 Sum_probs=171.0
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCc
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHG 102 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G 102 (705)
..++|+|++|+..||+|+|||.+. +|.|+||++..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+|||
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~gdG 81 (223)
T 1dhk_B 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAVG 81 (223)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCSE
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCCc
Confidence 357999999998999999999996 8999999999999999999999999999999999999999999998877778999
Q ss_pred eEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCC
Q 005257 103 LVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTD 182 (705)
Q Consensus 103 ~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~ 182 (705)
|||||+|....|. +++|||||||+ +||||||||++ |+++++ |
T Consensus 82 lAF~l~p~~~~p~-------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~---~------ 123 (223)
T 1dhk_B 82 LDFVLVPVQPESK-------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVP---W------ 123 (223)
T ss_dssp EEEEEEEC-------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEE---C------
T ss_pred eEEEEecCCCCCC-------------------ccEEEEEecCC---------CCcccccCCcc-cccccc---C------
Confidence 9999999754322 35899999998 68999999999 987754 3
Q ss_pred CCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceeccccccc
Q 005257 183 SSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260 (705)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsast 260 (705)
++.|.+|+.++|||+| ..+.|+|++++.+ .++.|+|+..|||+++||++|||||||||
T Consensus 124 ------------------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~e~~~VGFSAsT 183 (223)
T 1dhk_B 124 ------------------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATS 183 (223)
T ss_dssp ------------------CGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEE
T ss_pred ------------------CccccCCCEEEEEEEEeCCCCEEEEEEecCC--CCccceEEEEechHHhCCCceEEEEEecc
Confidence 2467799999999999 5568999998654 34578999999999999999999999999
Q ss_pred ccc---cccceeeeeeecccc
Q 005257 261 GQL---VESHKILAWSFSNTK 278 (705)
Q Consensus 261 g~~---~~~h~i~~wsf~~~~ 278 (705)
|.. .+.|+|++|+|++..
T Consensus 184 G~~~~~~~~H~IlsWsF~s~~ 204 (223)
T 1dhk_B 184 GAYQWSYETHDVLSWSFSSKF 204 (223)
T ss_dssp CSGGGSCCEEEEEEEEEEEEC
T ss_pred CCCccccceEEEEEEEEEecc
Confidence 998 999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=423.40 Aligned_cols=247 Identities=21% Similarity=0.404 Sum_probs=202.1
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec---cCceEEEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE---KGSLMLVY 441 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~---~~~~~lV~ 441 (705)
...++||+|+||+||+|.+..++..||+|++... .....+.|.+|+++|++|+|||||++++++... +..++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999999999999999999654 344567799999999999999999999988542 34689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEcc-CCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLDK-EMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld~-~~~~kL~DFGla~~~ 518 (705)
|||++|+|.++|.+.. .+++..+..++.||+.||+|||+ ++ ||||||||+||||+. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999997654 69999999999999999999998 66 999999999999985 789999999999864
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
... .....+||+.|||||++.+ +++.++|||||||++|||+||+.||.+... ...+...+..+.....+
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~----- 251 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASF----- 251 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGG-----
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCCCCC-----
Confidence 332 2345689999999999864 699999999999999999999999976432 12233333333221111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++..||+.||++|||+.|++++
T Consensus 252 -----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122457889999999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=443.09 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=213.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.+.|+..++||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.. ++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEe
Confidence 3568899999999999999999999999999999987766667789999999999999999999999887 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
||++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 229 y~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 229 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999999653 58999999999999999999999 999999999999999999999999999999775443
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... + +...+..+.. +.+ .
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~-~~~~i~~~~~-----~~~----~ 368 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--K-AMKMIRDNLP-----PRL----K 368 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-HHHHHHHSCC-----CCC----S
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--H-HHHHHHcCCC-----CCC----c
Confidence 2 234578999999999999999999999999999999999999999765431 1 1122221110 011 1
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+++..||+.||++|||+.|++++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112234567899999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=426.32 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=201.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC---ceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG---SLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~~~lV 440 (705)
++|...++||+|+||+||+|++. |+.||||+++... .....+.+|+..+.+++|||||+++++|..+.. .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 34667889999999999999984 7899999986432 222234557777888999999999999986443 57999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW-----EKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
||||++|+|.++|+.. .++|.++.+++.|++.||+|||+.+ .++||||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999753 5899999999999999999999731 349999999999999999999999999999
Q ss_pred eecCCCCcc---eeeeeeccccCCCccccccC------CCCccccEEEEehhHHHHhhCCCCCCCCCc------------
Q 005257 516 RMHGHGQVA---STTRVVGTVGYLAPEVFSSG------RASTQTDVFGFGILILEVLSGRRPIEEGKP------------ 574 (705)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~------------ 574 (705)
+........ .....+||+.|||||++.+. .++.++|||||||+||||+||+.|+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 877554332 22346899999999999754 367899999999999999999877642211
Q ss_pred cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 575 ~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+.+...+..+.+ ++.+.. ...+.+..+.+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccC----CCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111222222221111 011100 01123566788999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=415.32 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=195.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|+++|++++||||+++++++.. ++.+|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence 57999999999999999999999999999999997542 2345679999999999999999999998876 7789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+ +|+|.+++.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 689999997643 69999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ..+.+.+..+.
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~~~----------- 228 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISNGV----------- 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-----------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCC-----------
Confidence 33 2334689999999999988776 5799999999999999999999976432 12222222222
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++....+.+.+++..||+.||++|||+.|++++
T Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12223334567899999999999999999999883
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=423.02 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=196.1
Q ss_pred CCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|+..+.||+|+||+||+|+.. .+++.||||+++... ......+.+|+++|++++|||||++++++.+ ++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence 46899999999999999999874 457899999997542 2234468899999999999999999999876 77899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
||||||++|+|.++|.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999997654 69999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..... .....+||+.|||||++.+..++.++||||+||++|||+||+.||...... .+...+.++.
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~---------- 242 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMILKAK---------- 242 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC----------
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHHcCC----------
Confidence 43322 233468999999999999999999999999999999999999999865431 1222222221
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
..++......+.+++..||+.||++|||+
T Consensus 243 --~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 --LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 22333345668899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=409.99 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=192.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccC--------
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKG-------- 435 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~-------- 435 (705)
+|+..+.||+|+||+||+|+++.+++.||||+++....+ ..+.+.+|+++|++|+|||||++++++...+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 478899999999999999999999999999999765443 45679999999999999999999998865332
Q ss_pred ---ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 436 ---SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 436 ---~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
.+|+|||||++|+|.+++..........+..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 379999999999999999865443345677789999999999999999 99999999999999999999999999
Q ss_pred ccceecCCCCcc-----------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHH
Q 005257 513 GLARMHGHGQVA-----------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW 581 (705)
Q Consensus 513 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~ 581 (705)
|+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||...... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHHH
Confidence 999876543221 1234689999999999999999999999999999999996 77542110 0111
Q ss_pred HHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 582 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
........... .......+.+++..||++||++|||+.|+++
T Consensus 238 ~~~~~~~~p~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNLKFPPL-----------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTTCCCHH-----------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCCCC-----------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222222111 1122345678999999999999999999987
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=365.18 Aligned_cols=172 Identities=31% Similarity=0.501 Sum_probs=155.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGH 101 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~ 101 (705)
..++|+|++|+ ..||+|+|||+..+|.|+||+...+++|||+|++||+||++.+|+++||+|+|+|.|.+.+...+||
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~gd 81 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVAD 81 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECSSSEEEECSCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCCC
T ss_pred cceEEEcCCCCCCCCCEEEeccccCCCCCeEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCCCC
Confidence 46899999998 6899999999955799999999999999999999999999999999999999999999877777899
Q ss_pred ceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCC--CCeeEEecCCCcccccccccccCCC
Q 005257 102 GLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDID--ENHVGIDVNSLTSVSAHAAGYWPDN 179 (705)
Q Consensus 102 G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgidvns~~S~~~~~~~~~~~~ 179 (705)
||||||+|....|. +.||||||+|.+ +++..+|+|||||||++|.+ |||+ +|||||||||+.|+++++
T Consensus 82 GlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~------- 151 (181)
T 2ltn_A 82 GFTFFIAPVDTKPQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKS------- 151 (181)
T ss_dssp EEEEEEEETTCCCC-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEE-------
T ss_pred ceEEEEecCCCCCC-CCCccccccccC-CCCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceec-------
Confidence 99999999876666 889999999976 45788999999999999998 6999 999999999999988753
Q ss_pred CCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEE
Q 005257 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVE 227 (705)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~ 227 (705)
++|.+|+.++|||+| ..++|+|+|+.
T Consensus 152 ----------------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~ 179 (181)
T 2ltn_A 152 ----------------------WKLQNGEEANVVIAFNAATNVLTVSLTY 179 (181)
T ss_dssp ----------------------CCCCTTCCEEEEEEEETTTTEEEEEEEE
T ss_pred ----------------------cccCCCCEEEEEEEEECCCCEEEEEEec
Confidence 347799999999999 66789999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=409.15 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=204.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeee-----ccCc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-----EKGS 436 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-----~~~~ 436 (705)
++|...+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|+.|+|||||++++++.. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57899999999999999999999999999999997553 3345678999999999999999999998753 2357
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+|||||||+ |+|.+++.+.. .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 68999986533 79999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCC---cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCch--
Q 005257 517 MHGHGQ---VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKL-- 589 (705)
Q Consensus 517 ~~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~-- 589 (705)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.... ....+.........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764322 1223456899999999998775 5699999999999999999999999875431 11111111110000
Q ss_pred --------hHHHHHhhhcCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 --------LDALDARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 --------~~~id~~l~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+......+. .....+.+|+..||..||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001110011111 112467889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=400.08 Aligned_cols=305 Identities=20% Similarity=0.289 Sum_probs=209.7
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 436 (705)
...++|+..++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|..+ +||||+++++++.. ++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCE
Confidence 34678999999999999999999875 357899999986543 345688999999998 69999999998876 778
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLA 515 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla 515 (705)
+++||||+++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999983 48999999999999999999999 999999999999999877 79999999999
Q ss_pred eecCCCCc---------------------------ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCC
Q 005257 516 RMHGHGQV---------------------------ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRR 567 (705)
Q Consensus 516 ~~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~ 567 (705)
+....... ...+..+||+.|||||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543221 112335799999999999775 58999999999999999999999
Q ss_pred CCCCCCccHHHHHHHHHHhCchhHHHHHh-----hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 568 PIEEGKPNLVEMVWELMVQGKLLDALDAR-----LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 568 Pf~~~~~~~~~~v~~~~~~~~~~~~id~~-----l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
||..+..+...........|......... .......+......+.+.....-...|...........
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-------- 317 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT-------- 317 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc--------
Confidence 99776543221111111111110000000 00000111111111111111111111111000000000
Q ss_pred CCCCCcchhhHHHHHHhhccccccccccccccCCCCCCCccccc
Q 005257 643 GIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYATHPTFHDIR 686 (705)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~hp~f~~~~ 686 (705)
.............+++.++..++|..|.++.++++||||.++.
T Consensus 318 -~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 318 -NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred -cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0011123344567888889999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=413.80 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=212.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|.+.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+++|+.|+||||+++++++.. ++.++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence 3579999999999999999999999999999999987766667789999999999999999999998876 778999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC--CCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE--MNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~--~~~kL~DFGla~~~~~ 520 (705)
||++|+|.++|.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 235 ~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 235 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred ecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999986433 269999999999999999999999 999999999999999854 8999999999998765
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+..+... +.
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~~------~~-- 376 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWN------MD-- 376 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCCC------CC--
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCCC------CC--
Confidence 43 334568999999999999999999999999999999999999999865431 112222222110 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+.+|+..||+.||.+|||+.|++++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001123567889999999999999999999884
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.64 Aligned_cols=286 Identities=38% Similarity=0.700 Sum_probs=237.9
Q ss_pred CcccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeee
Q 005257 351 PHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGW 429 (705)
Q Consensus 351 ~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 429 (705)
.++++++++..+.++|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 467899999999999999999999999999999865 578899999876532 233468999999999999999999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
|.. ....++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 96 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECC-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred Eec-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 876 6678999999999999999986532 33599999999999999999999993333999999999999999999999
Q ss_pred eeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCC------CCccHHHHHHH
Q 005257 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE------GKPNLVEMVWE 582 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~------~~~~~~~~v~~ 582 (705)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||.. ......+++..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999998765555555556799999999999888899999999999999999999999952 22234444444
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
...........+..+. ..+...+...+.+++..||+.||.+|||+.|++++|++..
T Consensus 255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 4444444444444443 5567888999999999999999999999999999998653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.38 Aligned_cols=283 Identities=35% Similarity=0.622 Sum_probs=236.0
Q ss_pred cccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 352 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
.++++.++..++++|...+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||++++++|.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34556677778899999999999999999999975 57899999988777677788999999999999999999999987
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~ 510 (705)
. .+..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 106 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 106 E-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp C-TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred C-CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence 6 6788999999999999999965432 2358999999999999999999999 999999999999999999999999
Q ss_pred eeccceecCCCC-cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc----cHHHHHHHHHH
Q 005257 511 DFGLARMHGHGQ-VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP----NLVEMVWELMV 585 (705)
Q Consensus 511 DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~----~~~~~v~~~~~ 585 (705)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ....+......
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 999998754322 2223345789999999999888999999999999999999999999975432 34444444444
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+.+...+++.+. .....+....+.+++..||+.||++|||+.|+++.|+...+
T Consensus 262 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4544444444433 44567888999999999999999999999999999997765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=409.79 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=203.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHH---HHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRA---FLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~---~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|...++||+|+||+||+|+++.+|+.||||++++.. ...... ...++.+++.++|||||++++++.+ .+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEE
Confidence 56899999999999999999999999999999996431 122222 3345677888999999999998876 7789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|||||||+||+|.++|.+.. .+++..+..++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997654 69999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
..... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..........+....
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i------------ 406 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------ 406 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH------------
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh------------
Confidence 75433 234689999999999965 57999999999999999999999999754321111111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVK 634 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 634 (705)
+.....++......+.+|+..||+.||.+|++ +.||++
T Consensus 407 ~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112333344567889999999999999998 677765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=371.81 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=214.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.. ++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEE
Confidence 3567889999999999999999999999999999977677778889999999999999999999999986 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999987443 69999999999999999999999 999999999999999999999999999998765433
Q ss_pred cce-------------eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 523 VAS-------------TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 523 ~~~-------------~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
... .....||+.|+|||++.+..++.++|||||||++|||++|..|+.......... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~ 236 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNV 236 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhh
Confidence 211 113579999999999999999999999999999999999999987533210000 0001
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....+.. .+......+.+++..||+.||++|||+.++++.|+....
T Consensus 237 ~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 RGFLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 122233568889999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.14 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=212.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEE
Confidence 4679999999999999999999998999999999977666667789999999999999999999999886 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999753 48999999999999999999999 999999999999999999999999999998765443
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........+. ....
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~----------~~~~ 237 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT----------PELQ 237 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS----------CCCS
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC----------CCCC
Confidence 32 33457999999999999999999999999999999999999999765431 11111111111 0011
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+......+.+++..||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223344668899999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=371.80 Aligned_cols=271 Identities=25% Similarity=0.444 Sum_probs=207.7
Q ss_pred CcccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeee
Q 005257 351 PHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 351 ~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
+..+...++....++|+..+.||+|+||+||+|.+. +..||||++.... ....+.+.+|++++++++||||+++++
T Consensus 24 ~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 24 QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp --------CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344455555566678999999999999999999874 7889999987653 334567999999999999999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEccCCC
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld~~~~ 506 (705)
++.. ....++||||+++|+|.+++........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 102 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 102 AVTQ-PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp EECS-TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCC
T ss_pred EEEE-CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCc
Confidence 9876 66789999999999999999765433359999999999999999999998 78 999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........
T Consensus 178 ~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~ 254 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFK 254 (309)
T ss_dssp EEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHS
T ss_pred EEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc
Confidence 9999999998654332 2233467999999999999999999999999999999999999999865431 111111001
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. .....+......+.+++..||+.||++|||+.++++.|+..++
T Consensus 255 ~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 C-----------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C-----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0122333445678899999999999999999999999998766
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=366.73 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=217.8
Q ss_pred CcccCHHHHHHHhCC----------CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCC
Q 005257 351 PHRITYQEIEAATKG----------FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH 420 (705)
Q Consensus 351 ~~~~~~~el~~at~~----------f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H 420 (705)
+..+++++++.+++. |...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888887764 6667899999999999999998899999999987766677889999999999999
Q ss_pred CCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 421 pniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
|||+++++++.. .+..++||||+++++|.+++.+ ..+++.++..++.|++.||.|||+ .+|+||||||+|||
T Consensus 102 ~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLV-GEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred CCcceEEEEEEE-CCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence 999999999886 6789999999999999999853 258999999999999999999999 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV 580 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v 580 (705)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... + .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~-~ 249 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q-A 249 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-H
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-H
Confidence 99999999999999987654332 223467999999999999989999999999999999999999999765431 1 1
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
...+...... . ..........+.+++..||+.||++|||+.|++++-
T Consensus 250 ~~~~~~~~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 250 MKRLRDSPPP-----K----LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHHHSSCC-----C----CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHhcCCCC-----C----cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111111100 0 011112345688899999999999999999998853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=361.14 Aligned_cols=280 Identities=32% Similarity=0.566 Sum_probs=228.2
Q ss_pred CcccCHHHHHHHhCCCCcc------eEEeecCceEEEEEEEcCCCeEEEEEEeccC----CchhHHHHHHHHHHhccCCC
Q 005257 351 PHRITYQEIEAATKGFSEE------NVIGVGGNGKVYKGVLEGGGAEIAVKRISHE----NDGGTRAFLAEISSLGRLKH 420 (705)
Q Consensus 351 ~~~~~~~el~~at~~f~~~------~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~----~~~~~~~~~~Ei~~l~~l~H 420 (705)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 3678999999999999988 9999999999999987 4788999998653 23346779999999999999
Q ss_pred CCcceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 421 pniv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
|||+++++++.. .+..++||||+++|+|.+++........+++..++.++.|++.||.|||+ .+|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEec-CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999876 66889999999999999999765444579999999999999999999998 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~ 578 (705)
++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... ...
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999999999999876543322 2233578999999998865 5889999999999999999999999764321 111
Q ss_pred HHHHHHHh-C-chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 579 MVWELMVQ-G-KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 579 ~v~~~~~~-~-~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.+...... . .+.+.+++.+ ...+......+.+++..||+.||.+|||+.++++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC---SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccc---cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11122211 1 1222222222 3456777889999999999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=369.69 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=209.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++++.++||||+++++++.. .+.+++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence 45789999999999999999999989999999999654 33456778999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997654 58999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCC-ccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRAS-TQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... ....+||+.|+|||++.+..+. .++|||||||++|||++|+.||..... ......+..+.
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~----------- 230 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLRGK----------- 230 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-----------
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-----------
Confidence 432 2335799999999999887765 799999999999999999999986542 11222222221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.||.+|||+.|++++
T Consensus 231 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12222334567889999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=373.89 Aligned_cols=271 Identities=24% Similarity=0.367 Sum_probs=220.0
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEE-----cCCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceee
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVL-----EGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLR 427 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~ 427 (705)
...+++...++|...+.||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4455666778899999999999999999994 4556899999997653 34456799999999999 799999999
Q ss_pred eeeeeccCceEEEEeeCCCCChhHHHHhcCC-------------------------------------------------
Q 005257 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDG------------------------------------------------- 458 (705)
Q Consensus 428 g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------- 458 (705)
++|......+++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998766668999999999999999976432
Q ss_pred --------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc-
Q 005257 459 --------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV- 523 (705)
Q Consensus 459 --------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~- 523 (705)
...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1128999999999999999999999 9999999999999999999999999999986644322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.+...+..+.. ..
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~-----------~~ 316 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR-----------MR 316 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHHHTCC-----------CC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHHcCCC-----------CC
Confidence 23344678999999999999999999999999999999998 99999765432 122222222111 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+......+.+++..||+.||++|||+.|++++|+..++
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 223344568899999999999999999999999997765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=359.61 Aligned_cols=262 Identities=22% Similarity=0.370 Sum_probs=209.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. .+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence 457889999999999999999999999999999986542 3345678999999999999999999998875 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999997654 68999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
...........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........ ..... ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~-~~~~~-~~~--- 235 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQD-SVPNV-TTD--- 235 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSS-CCCCH-HHH---
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhc-cCCCc-chh---
Confidence 54444444567999999999999989999999999999999999999999865431 111122211 11111 011
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHhccc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-TMRQVVKVLEGKIE 641 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 641 (705)
.....+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 236 ---~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 236 ---VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ---SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ---cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1122345688999999999999998 99999999987655
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=368.23 Aligned_cols=258 Identities=32% Similarity=0.490 Sum_probs=210.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCC---eEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGG---AEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.+..++ ..||||+++.. .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEE
Confidence 45777899999999999999997544 46999999765 33456789999999999999999999999876 667899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999975433 69999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 520 HGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~--------- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVEEG--------- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHTT---------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcC---------
Confidence 433222 223456788999999998899999999999999999999 99999765431 111222211
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||++|||+.++++.|+....
T Consensus 271 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 YR--LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 22233445678899999999999999999999999998776
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=367.12 Aligned_cols=270 Identities=26% Similarity=0.326 Sum_probs=207.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC---ceE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG---SLM 438 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~~~ 438 (705)
..++|+..++||+|+||+||+|.+. ++.||||++.... .....+.+|+.++.+++||||+++++++..... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467889999999999999999886 7899999986442 334556779999999999999999999876432 379
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC----------CeeecCCCCCCeEEccCCCee
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK----------KVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~----------~iiHrDLkp~NILld~~~~~k 508 (705)
+||||+++|+|.+++... .+++.+++.++.|++.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 999999999999999653 48999999999999999999998 6 999999999999999999999
Q ss_pred eeeeccceecCCCCcc-eeeeeeccccCCCccccccC-----CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 509 LGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSG-----RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 509 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
|+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876544322 22335799999999999763 45678899999999999999999997532210000000
Q ss_pred HHHhCchhHHHHHhh-hc--CCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 583 LMVQGKLLDALDARL-RA--KGGF-----DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 583 ~~~~~~~~~~id~~l-~~--~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..........+.... .. .... .......+.+++..||+.||++|||+.|+++.|+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111111111111 00 0111 12456679999999999999999999999999987644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=366.41 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=208.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||+||+|....+++.||||+++.. .....+.+.+|+.+++.++||||+++++++.. .+.+++|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEE
Confidence 5688899999999999999999999999999999654 23345678999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|..++.+.. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997643 68999999999999999999998 9999999999999999999999999999986433
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~------------ 221 (337)
T 1o6l_A 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEE------------ 221 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC------------
T ss_pred CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHHcCC------------
Confidence 222 233468999999999999989999999999999999999999999765421 1122222111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
..++......+.+++..||+.||++|| ++.|++++
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 222333446688999999999999999 89998774
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.72 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=213.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEc-------CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE-------GGGAEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
.++|...+.||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+++++ +||||++++++|..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 357888999999999999999874 2456899999976533 3457899999999999 89999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
.+.+++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 6789999999999999999986532 1358999999999999999999999 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~ 578 (705)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999987654322 12223456889999999999899999999999999999999 999997654321
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+...+..+. . ...+......+.+++..||+.||++||++.|+++.|+.++.
T Consensus 314 -~~~~~~~~~---------~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 -LFKLLKEGH---------R--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -HHHHHHTTC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHhcCC---------C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111222221 1 22233445678899999999999999999999999997765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=375.83 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=212.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
..++|...+.||+|+||.||+|.+..+++.||||+++.... ...++|.+|++++++++||||++++++|.. ++..++|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEE
Confidence 34567889999999999999999998899999999875432 334578999999999999999999999876 6688999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999976432 58999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCccee-eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 521 GQVAST-TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 521 ~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
...... ....+++.|+|||++.++.++.++|||||||++|||++ |+.||...... .+.+.+..+. +
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~---------~ 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEKGG---------R 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHTTC---------C
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC---------C
Confidence 321111 11245788999999998889999999999999999998 99999765432 1222222221 1
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..++..+.+++..||+.||++|||+.++++.|+....
T Consensus 334 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 --LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 12233345678899999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=360.52 Aligned_cols=268 Identities=21% Similarity=0.383 Sum_probs=210.9
Q ss_pred hCCCCcceEEeecCceEEEEEE----EcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGV----LEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~ 437 (705)
.++|+..+.||+|+||+||+|. ...+++.||||++........+.+.+|++++++++||||++++++|... ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3568889999999999999998 4567899999999877767778899999999999999999999988643 3568
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999976532 58999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcc--eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc-------
Q 005257 518 HGHGQVA--STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK------- 588 (705)
Q Consensus 518 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~------- 588 (705)
....... ......++..|+|||++.+..++.++|||||||++|||++|..|+...... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHH
Confidence 6543221 122235678899999999999999999999999999999999998642211 111111111
Q ss_pred -hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 589 -LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 589 -~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+.+..... ...+......+.+++..||+.||++|||+.|+++.|+...+
T Consensus 240 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 240 HLIELLKNNGR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccCc--CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111111111 22334455778999999999999999999999999987655
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=374.07 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=201.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|...+.||+|+||.||+|.+. .++..||||+++... ....+.|.+|+.++++++||||++++++|.. .+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceE
Confidence 357899999999999999999986 456789999997653 3456789999999999999999999999876 67889
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++.+... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999976432 68999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 519 GHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+... +..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~---------i~~ 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKA---------VDE 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHH---------HHT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---------HHc
Confidence 5432221 122345778999999999999999999999999999998 99999765421 11111 222
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
... ...+......+.+++..||+.||++||++.++++.|+..+.
T Consensus 266 ~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 266 GYR--LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp TEE--CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC--CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 211 22233455678999999999999999999999999998765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=383.17 Aligned_cols=266 Identities=23% Similarity=0.269 Sum_probs=215.0
Q ss_pred cCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeee
Q 005257 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWC 430 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~ 430 (705)
..++++...+++|+..++||+|+||+||+|.++.+++.||||+++... ....+.+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677778899999999999999999999999999999999986531 22234488999999999999999999988
Q ss_pred eeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeee
Q 005257 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510 (705)
Q Consensus 431 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~ 510 (705)
.+ .+.+++||||+++|+|.+++.+... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 144 ~~-~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QD-DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EC-SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred ee-CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 76 6789999999999999999976432 69999999999999999999998 999999999999999999999999
Q ss_pred eeccceecCCCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 511 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...... +.. ..+.
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~-~~i~ 294 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY-GKIM 294 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH-HHHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHH-Hhhh
Confidence 99999877655544444568999999999986 456899999999999999999999999865421 111 1111
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKV 635 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 635 (705)
.. ..++.. ..........+.+++..|+..+|++ ||++.|++++
T Consensus 295 ~~------~~~~~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NH------KERFQF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp TH------HHHCCC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hc------cccccC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 10 001110 1111123456788899999888888 9999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=388.24 Aligned_cols=259 Identities=24% Similarity=0.447 Sum_probs=216.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..++..||||+++... ...++|.+|+.+|++++||||++++++|.. ...+++|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEE
Confidence 456778899999999999999999889999999996543 346789999999999999999999999976 668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++...... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999875433 68999999999999999999999 999999999999999999999999999998765443
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........+++.|+|||++....++.++|||||||++|||++ |+.||....... +.+.+ ....+ .
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~---------~~~~~--~ 438 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL---------EKDYR--M 438 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH---------HTTCC--C
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---------HcCCC--C
Confidence 322233456789999999998899999999999999999999 999997654321 11112 11111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..+...+.+++..||+.||++|||+.++++.|+...+
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 2233445678899999999999999999999999997754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=357.24 Aligned_cols=271 Identities=20% Similarity=0.288 Sum_probs=216.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~lV~ 441 (705)
++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999999999999999997543 234577889999999999999999999887533 3679999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE----ccCCCeeeeeecccee
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL----DKEMNGRLGDFGLARM 517 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl----d~~~~~kL~DFGla~~ 517 (705)
||+++++|.+++........+++.+++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999999875544459999999999999999999999 999999999999999 7888899999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccc--------cCCCCccccEEEEehhHHHHhhCCCCCCCCCc--cHHHHHHHHHHhC
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFS--------SGRASTQTDVFGFGILILEVLSGRRPIEEGKP--NLVEMVWELMVQG 587 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~--~~~~~v~~~~~~~ 587 (705)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ...+.+.. +..+
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~ 242 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-IITG 242 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH-HHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH-HhcC
Confidence 755432 23357999999999986 46789999999999999999999999974322 11122222 2111
Q ss_pred chhHHH-------------HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 588 KLLDAL-------------DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 588 ~~~~~i-------------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.....+ ...+.............+.+++..||+.||++|||++|+++...+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 110000 00111112445677888999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=362.55 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=208.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|+.++..++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCE
Confidence 46788999999999999999999999999999999765322 35779999999999999999999999876 678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC----Ceeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDF 512 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DF 512 (705)
+++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999643 269999999999999999999999 9999999999999998876 7999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~~~~---- 234 (361)
T 2yab_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANITAVS---- 234 (361)
T ss_dssp SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTC----
T ss_pred CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC----
Confidence 99987655332 23457999999999999889999999999999999999999999765421 1122222221
Q ss_pred HHHhhhcCCCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKGGFDED----EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++.. ....+.+++..||..||++|||+.|++++
T Consensus 235 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 --------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112211 23567899999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.08 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=198.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..++||+|+||+||+|.+..+++.||||++..... .....+..|+..+.++ +||||++++++|.. ++.+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEE
Confidence 578999999999999999999998999999999865432 3344566677666665 89999999999876 7789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+ +++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6799999876543 69999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+..+..+.....+.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~~~~~~~~~------ 274 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQGYLPPEFT------ 274 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTTTCCCHHHH------
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhccCCCcccc------
Confidence 32 2233569999999999875 79999999999999999999987765421 123333333222111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. .....+.+++..||+.||++|||+.|++++
T Consensus 275 ~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 A----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 123568899999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=353.94 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=211.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|.+.. ++.||+|++.... ...+++.+|++++++++||||+++++++.. .+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEe
Confidence 567888999999999999999874 6789999997543 345679999999999999999999999876 6689999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999975433 68999999999999999999998 9999999999999999999999999999986654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..+ .. ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~~~---------~~--~~ 227 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG---------FR--LY 227 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT---------CC--CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhcC---------cc--CC
Confidence 23333456788999999998899999999999999999999 99999765431 111112111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+......+.+++..||+.||++||++.++++.|+...+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 222334668899999999999999999999999997765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=357.64 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=209.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.++||||+++++++.. .+.+++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEE
Confidence 46788999999999999999999999999999998644 3445678899999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc--CCCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK--EMNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~--~~~~kL~DFGla~~~~~ 520 (705)
|+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999996533 268999999999999999999999 99999999999999987 78999999999988755
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~----------- 220 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEY----------- 220 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCC-----------
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCC-----------
Confidence 43 234468999999999999888899999999999999999999999765421 12222222211
Q ss_pred CCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.++. .....+.+++..||+.||.+|||+.|++++
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 123568899999999999999999999984
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.04 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=215.3
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
...++|...+.||+|+||.||+|.+.. +++.||||+++.... ...+.+.+|+.++++++||||++++++|.. .
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-G 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-C
Confidence 345788999999999999999999973 458999999976543 345679999999999999999999999876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC---------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG---------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRD 493 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrD 493 (705)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ ++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 788999999999999999986431 1368999999999999999999999 9999999
Q ss_pred CCCCCeEEccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCC
Q 005257 494 IKSSNVLLDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEE 571 (705)
Q Consensus 494 Lkp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~ 571 (705)
|||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976543221 22233567899999999998899999999999999999999 9999976
Q ss_pred CCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 572 GKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 572 ~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
... ..+...+..+.. ...+......+.+++..||+.||++||++.++++.|+...+
T Consensus 280 ~~~---~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAH---EEVIYYVRDGNI-----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCH---HHHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCh---HHHHHHHhCCCc-----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 542 122222222221 11223344678899999999999999999999999997765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=358.70 Aligned_cols=262 Identities=24% Similarity=0.442 Sum_probs=220.0
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
+...++|...+.||+|+||.||+|.+..++..||+|++... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEE
Confidence 34466788899999999999999999998999999998653 3456789999999999999999999999876 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++...... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTT-TSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcccC-CccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999875433 69999999999999999999998 999999999999999999999999999998776
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
...........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ . +.+.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~---------~~~~~~~~ 230 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y---------ELLEKDYR 230 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H---------HHHHTTCC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---------HHHhccCC
Confidence 554444444677889999999998899999999999999999999 9999976543211 1 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||.+|||+.++++.|+...+
T Consensus 231 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 231 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 22233345678899999999999999999999999987765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=348.48 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=212.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+. ++..||+|++.... ...+++.+|++++.+++||||+++++++.. .+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEE
Confidence 457888999999999999999887 46789999996543 345679999999999999999999999875 678899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999976432 58999999999999999999999 999999999999999999999999999998776554
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+.. .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~-----------~ 224 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQGHR-----------L 224 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCC-----------C
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHcCCC-----------C
Confidence 444344456778999999988889999999999999999999 99999765431 11111111110 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+......+.+++..||+.||++|||+.++++.|+...+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1122234568899999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.51 Aligned_cols=257 Identities=21% Similarity=0.382 Sum_probs=204.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeE----EEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|+..+.||+|+||+||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.. +..+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeE
Confidence 4688899999999999999998766654 588887544 33456789999999999999999999999975 3578
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+|+||+++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++++||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999987543 69999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~--------- 235 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKG--------- 235 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT---------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHHHHcC---------
Confidence 544322 2233466889999999999999999999999999999999 9999986543211 1111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||++||++.++++.|+....
T Consensus 236 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC--CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC--CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 12233445678899999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=375.84 Aligned_cols=253 Identities=31% Similarity=0.429 Sum_probs=209.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|++++||||++++++|...++.+++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 356778899999999999999986 6799999997543 567899999999999999999999998875668999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++...... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999875432 57999999999999999999999 999999999999999999999999999998643321
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+..+ .+ .
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~---------~~--~ 405 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG---------YK--M 405 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHTT---------CC--C
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---------CC--C
Confidence 12357889999999999999999999999999999998 999997644321 11222222 11 2
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..+...+.+++..||+.||++|||+.++++.|+....
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2333455678899999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=368.63 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=203.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 437 (705)
..++|...+.||+|+||+||+|.++.+++.||||+++.. .....+.+.+|..++..+ +||||+++++++.. .+.+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEE
Confidence 346899999999999999999999999999999999754 233456788999999988 69999999998876 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++|+|..++.+.. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999997653 69999999999999999999999 9999999999999999999999999999985
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+..+.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~--------- 240 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDE--------- 240 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC---------
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHHcCC---------
Confidence 43322 2234468999999999998888999999999999999999999999865431 1222222221
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTM------RQVVK 634 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 634 (705)
..++......+.+++..||+.||++||++ .|+++
T Consensus 241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22333344568899999999999999998 66665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=353.32 Aligned_cols=263 Identities=19% Similarity=0.216 Sum_probs=212.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|...+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++..+ +|+|++++++++.. ....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEE
Confidence 457889999999999999999998899999999986443 334678899999999 79999999998875 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC-----eeeeeeccce
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN-----GRLGDFGLAR 516 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~-----~kL~DFGla~ 516 (705)
||+ +++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999976533 59999999999999999999998 99999999999999987776 9999999998
Q ss_pred ecCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 517 MHGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 517 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 77654321 223467999999999999989999999999999999999999999875432222222222111110
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.... .+ .....+.+.+++..||+.||++||++.++++.|+...+
T Consensus 240 ~~~~-~~------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 TPLR-EL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp SCHH-HH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHH-HH------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 00 01223578899999999999999999999999998766
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=360.35 Aligned_cols=262 Identities=17% Similarity=0.202 Sum_probs=211.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+++++++ +||||+++++++.. ....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEE
Confidence 3578899999999999999999998999999999875432 34688999999999 99999999998876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC-----eeeeeeccce
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN-----GRLGDFGLAR 516 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~-----~kL~DFGla~ 516 (705)
||+ +++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 9999999986532 69999999999999999999999 99999999999999998887 9999999998
Q ss_pred ecCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 517 MHGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 517 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76543321 123468999999999999999999999999999999999999999875433222222222111110
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.... .+. . ..+ .+.+++..||+.||.+||++.++.+.|+....
T Consensus 239 ~~~~-~~~--~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 239 TPIE-VLC--E----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp SCHH-HHT--T----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCHH-HHh--c----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 000 0 112 78899999999999999999999999987765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=381.42 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=212.7
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
...++|...+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++. ...+++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEE
Confidence 345678889999999999999999874 6789999997543 45678999999999999999999999885 4578999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999975422 258899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
..........+|+.|+|||++....++.++|||||||++|||++ |+.||...... .+...+..+ .+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~---------~~- 403 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERG---------YR- 403 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHHT---------CC-
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---------CC-
Confidence 32222223356789999999998899999999999999999999 99999765421 111222221 11
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+...+.+++..||+.||++|||+.++++.|+....
T Consensus 404 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11233445678999999999999999999999999997765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.76 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=200.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|...+.||+|+||.||+|.+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccE
Confidence 45788899999999999999998643 4679999987643 344567999999999999999999999874 45789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999976432 58999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~~~~~-------- 235 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGER-------- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC--------
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHHcCCC--------
Confidence 5544333344567889999999998899999999999999999996 999997654321 1111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++|||+.++++.|+...+
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12233445678899999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=349.41 Aligned_cols=253 Identities=25% Similarity=0.475 Sum_probs=206.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh-------HHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG-------TRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~-------~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||+|.+..+++.||||++....... .+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 467888999999999999999999899999999986543221 1678999999999999999999998854
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEccCCC-----ee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLDKEMN-----GR 508 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld~~~~-----~k 508 (705)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++. +|
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 PPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp TTEEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred CCeEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 2379999999999999887543 269999999999999999999998 78 999999999999988776 99
Q ss_pred eeeeccceecCCCCcceeeeeeccccCCCccccc--cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS--SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.................
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 999999985433 233457899999999984 45578999999999999999999999986554322222111111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
+ . ....+......+.+++..||+.||++|||+.++++.|+.
T Consensus 246 ~---------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 G---------L--RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp C---------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred C---------C--CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 1 122334445678999999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.14 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=201.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc--CCCCCcceeeeeeeec---cCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR--LKHKSLVGLRGWCKRE---KGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~---~~~~ 437 (705)
.++|...+.||+|+||+||+|.+ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999988 4789999998543 34555666666655 7999999999987642 3458
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW-----EKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
++||||+++|+|.+++.. ..+++..+++++.|++.||.|||... .++|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999943 26999999999999999999999211 299999999999999999999999999
Q ss_pred ccceecCCCCcce---eeeeeccccCCCccccccC------CCCccccEEEEehhHHHHhhC----------CCCCCCCC
Q 005257 513 GLARMHGHGQVAS---TTRVVGTVGYLAPEVFSSG------RASTQTDVFGFGILILEVLSG----------RRPIEEGK 573 (705)
Q Consensus 513 Gla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~Gvvl~ElltG----------~~Pf~~~~ 573 (705)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765443322 2234799999999999876 445799999999999999999 88886532
Q ss_pred c--cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 574 P--NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 574 ~--~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
. ................. .+. ....+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRP----NIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCC----CCC-GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCC----CCC-hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 11111111111111000 000 0011234678899999999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.32 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=207.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.. ...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence 34688899999999999999999999999999998765321 35779999999999999999999998876 678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC----Ceeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDF 512 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DF 512 (705)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999643 269999999999999999999998 9999999999999999887 7999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ....+....
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~-~~~~~~~~~---- 233 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--E-TLANVSAVN---- 233 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--H-HHHHHHHTC----
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--H-HHHHHHhcC----
Confidence 99987754332 23357999999999999889999999999999999999999999765421 1 111111111
Q ss_pred HHHhhhcCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKGGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++. .....+.+++..||+.||++|||+.|++++
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 123567889999999999999999999884
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.27 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=202.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-------
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG------- 435 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~------- 435 (705)
++|+..+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999999899999999997543 3456789999999999999999999998865321
Q ss_pred -------------------------------------------------ceEEEEeeCCCCChhHHHHhcCCCCcccHHH
Q 005257 436 -------------------------------------------------SLMLVYDYMENGSLDKWIFQCDGSMMLSCEE 466 (705)
Q Consensus 436 -------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~ 466 (705)
.+++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998765555677788
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc-----------ceeeeeeccccC
Q 005257 467 RIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV-----------ASTTRVVGTVGY 535 (705)
Q Consensus 467 ~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~y 535 (705)
++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999998 9999999999999999999999999999987765421 112335799999
Q ss_pred CCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHH
Q 005257 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLG 615 (705)
Q Consensus 536 ~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~ 615 (705)
+|||++.+..++.++|||||||++|||++|..|+... .........+..... .......+.+++
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~~~~~-----------~~~~~~~~~~li 306 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLKFPLL-----------FTQKYPQEHMMV 306 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTCCCHH-----------HHHHCHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccCCCcc-----------cccCChhHHHHH
Confidence 9999999989999999999999999999987664211 111111222211111 122345678899
Q ss_pred HHcCCCCCCCCCCHHHHHHH
Q 005257 616 LLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 616 ~~Cl~~dP~~RPs~~evl~~ 635 (705)
..||+.||++|||+.|++++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=366.69 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=202.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|...++||+|+||+||+|+++.+++.||||+++... ....+.+.+|..++.++ +||||+++++++.. +..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence 457889999999999999999999999999999997642 23345688899999887 89999999998876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|..++.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999997643 69999999999999999999999 99999999999999999999999999999863
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc------cHHHHHHHHHHhCchhHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP------NLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~------~~~~~v~~~~~~~~~~~~ 592 (705)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.+.+.+..
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~------ 276 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------ 276 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH------
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc------
Confidence 3222 223446899999999999999999999999999999999999999964321 111112222211
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
....++......+.+++..||+.||++||++
T Consensus 277 ------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 ------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1123333445678899999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=356.36 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=206.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||++....+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEE
Confidence 56888999999999999999999999999999986542 2345678899999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997643 68999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ....+..+.
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~-~~~~i~~~~------------ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--K-TYEKILNAE------------ 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H-HHHHHHHCC------------
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--H-HHHHHHhCC------------
Confidence 2 23357999999999999989999999999999999999999999765421 1 112222111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
..++......+.+++..|++.||++|| ++.+++++
T Consensus 220 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 122333345688999999999999999 88888763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=355.66 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=214.6
Q ss_pred HhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
..++|...+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CC
Confidence 3567888999999999999999983 445889999997653 3456789999999999999999999998876 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC---------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG---------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDL 494 (705)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCccccc
Confidence 88999999999999999986532 1248999999999999999999998 99999999
Q ss_pred CCCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCC
Q 005257 495 KSSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEG 572 (705)
Q Consensus 495 kp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~ 572 (705)
||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 2223467889999999988889999999999999999999 99999765
Q ss_pred CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 573 ~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.... +...+..+.. ...+......+.+++..||+.||++||++.++++.|+..+.
T Consensus 257 ~~~~---~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 PPER---LFNLLKTGHR-----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CGGG---HHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHHhhcCCc-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4321 1122222211 12233345678899999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=365.20 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=215.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
.++|...+.||+|+||.||+|.+.. .+..||||++.... ....+.+.+|+++++++ +||||++++++|..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence 4678889999999999999999753 23689999997653 34457899999999999 99999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
++..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 6788999999999999999986542 1359999999999999999999999 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~ 578 (705)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~ 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 99999999999999987654332 22233467899999999999999999999999999999999 9999976542 2
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
.+...+..+.. ...+......+.+++..||+.||++|||+.|+++.|+......
T Consensus 301 ~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 ELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHTTCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 22222222211 1222334467889999999999999999999999999877633
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=353.55 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=203.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEc
Confidence 46778899999999999999985 688999998643 45678999999999999999999999875 347999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC-eeeeeeccceecCCCC
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN-GRLGDFGLARMHGHGQ 522 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~-~kL~DFGla~~~~~~~ 522 (705)
+++|+|.+++........+++..++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999986544335789999999999999999999854478999999999999998887 799999999765432
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+.. ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-----------~~ 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR-----------PP 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCC-----------CC
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCC-----------CC
Confidence 22346899999999999989999999999999999999999999865433222222211 1111 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
........+.+++..||+.||++|||+.++++.|+...+..
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 22233456889999999999999999999999999876533
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.16 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=208.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++.. ...+++|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEE
Confidence 57888999999999999999999999999999986542 2345678999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999997654 58999999999999999999998 9999999999999999999999999999987643
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~------------ 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGK------------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC------------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHcCC------------
Confidence 3 2335799999999999998999999999999999999999999986542 12222222222
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
..++......+.+++..||+.||.+||+ +.+++++
T Consensus 255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1223334466889999999999999998 7877763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.55 Aligned_cols=265 Identities=23% Similarity=0.411 Sum_probs=199.5
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCe---EEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGA---EIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
....++|...+.||+|+||.||+|.+..++. .||||+++.. .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999876654 8999998765 3455678999999999999999999999987532
Q ss_pred C-----ceEEEEeeCCCCChhHHHHhcCC---CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 435 G-----SLMLVYDYMENGSLDKWIFQCDG---SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 435 ~-----~~~lV~E~~~~gsL~~~L~~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
. ..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 2 23899999999999999965321 2258999999999999999999999 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELM 584 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~ 584 (705)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~ 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYL 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHHH
Confidence 999999999876543322 2223456889999999999999999999999999999999 999997654321 11111
Q ss_pred HhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 585 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+.. ...+......+.+++..||+.||++|||+.++++.|++.+.
T Consensus 253 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 253 IGGNR-----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HTTCC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC-----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11110 12233445678999999999999999999999999998776
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.54 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=209.5
Q ss_pred hCCCCcceEEeecCceEEEEEEE-----cCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVL-----EGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||.||+|.+ ..+++.||||+++.. .......+.+|+.++++++||||+++++++.. ...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCC
Confidence 35678899999999999999995 346788999999655 34455678999999999999999999999876 667
Q ss_pred eEEEEeeCCCCChhHHHHhcCC----CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---Ceee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDG----SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM---NGRL 509 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~---~~kL 509 (705)
.++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 8999999999999999986532 2358999999999999999999999 9999999999999999554 5999
Q ss_pred eeeccceecCCCC-cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhC
Q 005257 510 GDFGLARMHGHGQ-VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 510 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i~~~ 302 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTSG 302 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHTT
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC
Confidence 9999997543211 122223467899999999999999999999999999999998 99999765431 122222222
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||++||++.++++.|+...+
T Consensus 303 ~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 303 GR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11 12233344668899999999999999999999999986544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.07 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=207.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeE----EEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...+.||+|+||+||+|.+..+++. ||+|.+.... ....+.+.+|+.++++++||||++++++|. ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccE
Confidence 5688899999999999999999877654 7888775442 334456788999999999999999999885 45789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999997642 268999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... ......||..|+|||++.+..++.++|||||||++|||++ |+.||....... +...+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~------- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKGER------- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTTCB-------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCC-------
Confidence 544322 2344567889999999998999999999999999999999 999998654321 1122222111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++||++.++++.|+....
T Consensus 236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11222234467889999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=364.41 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=207.6
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
....++|...+.||+|+||.||+|.++.+++.||||+++... ....+.+..|..++..+ +||||+++++++.. ..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence 345678999999999999999999999999999999997542 33456788899999877 99999999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 8999999999999999997643 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~------- 234 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDN------- 234 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC-------
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhCC-------
Confidence 86433222 234468999999999999989999999999999999999999999865431 1222222211
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMR-QVVK 634 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 634 (705)
..++......+.+++..||+.||++||++. ++++
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 222333445688999999999999999997 6653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=358.34 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=213.0
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
+...++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345578889999999999999999973 35678999999754 234457899999999999 89999999999876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCC--------------------CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGS--------------------MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHR 492 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~--------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHr 492 (705)
.+..++||||+++|+|.+++...... ..+++.+++.++.||+.||.|||+ .+|+||
T Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~ 196 (344)
T 1rjb_A 121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 196 (344)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 67899999999999999999764321 248999999999999999999999 999999
Q ss_pred CCCCCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCC
Q 005257 493 DIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIE 570 (705)
Q Consensus 493 DLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~ 570 (705)
||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866543322 2333567899999999988899999999999999999998 999997
Q ss_pred CCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 571 EGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 571 ~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..... ..+...+..+ .. ...+......+.+++..||+.||.+|||+.++++.|+....
T Consensus 277 ~~~~~--~~~~~~~~~~---------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 277 GIPVD--ANFYKLIQNG---------FK--MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TCCCS--HHHHHHHHTT---------CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCcH--HHHHHHHhcC---------CC--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 65432 1112222221 11 12223345678899999999999999999999999998766
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=372.10 Aligned_cols=255 Identities=23% Similarity=0.273 Sum_probs=208.3
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
..++|...+.||+|+||.||+|.+..+++.+|+|++..... ...+.+.+|+++++.++||||+++++++.. ++..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEE
Confidence 34578899999999999999999999999999999976532 345678999999999999999999998876 778999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc---cCCCeeeeeeccce
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD---KEMNGRLGDFGLAR 516 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld---~~~~~kL~DFGla~ 516 (705)
||||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999997643 69999999999999999999999 9999999999999998 45789999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..+....
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~----- 232 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGAYDF----- 232 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCC-----
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCCC-----
Confidence 7654332 22346799999999999998999999999999999999999999976542 12222232222110
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..||+.||++|||+.|++++
T Consensus 233 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 ---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000111234568899999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=364.82 Aligned_cols=269 Identities=19% Similarity=0.207 Sum_probs=209.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCC-----CeEEEEEEeccCCchhH-----------HHHHHHHHHhccCCCCCcce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHENDGGT-----------RAFLAEISSLGRLKHKSLVG 425 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~i~~~~~~~~-----------~~~~~Ei~~l~~l~Hpniv~ 425 (705)
..++|...+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998764 47899999876542211 23455677788889999999
Q ss_pred eeeeeeecc---CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 426 LRGWCKREK---GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 426 l~g~~~~~~---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
+++++.... ...++||||+ +++|.+++..... .+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 999987532 3579999999 9999999976432 69999999999999999999999 9999999999999999
Q ss_pred --cCCCeeeeeeccceecCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCc
Q 005257 503 --KEMNGRLGDFGLARMHGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKP 574 (705)
Q Consensus 503 --~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~ 574 (705)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876533211 11334699999999999998999999999999999999999999985332
Q ss_pred c--HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 575 N--LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 575 ~--~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
. ....... .....+.+.++..+.. . ..+..+.+++..||+.||++||++.++++.|+..+..
T Consensus 267 ~~~~~~~~~~-~~~~~~~~~~~~~~~~-~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKI-RYRENIASLMDKCFPA-A----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHH-HHHHCHHHHHHHHSCT-T----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHH-HhhhhHHHHHHHhccc-c----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 2 1111111 1122333344433321 1 2235688899999999999999999999999987663
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=355.90 Aligned_cols=271 Identities=24% Similarity=0.362 Sum_probs=219.8
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceee
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLR 427 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~ 427 (705)
...+.....++|...+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34455566788999999999999999999853 4568999999976543 3456789999999999 799999999
Q ss_pred eeeeeccCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 005257 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDI 494 (705)
Q Consensus 428 g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDL 494 (705)
+++...+...++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9988766678999999999999999976542 1238999999999999999999999 99999999
Q ss_pred CCCCeEEccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCC
Q 005257 495 KSSNVLLDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEG 572 (705)
Q Consensus 495 kp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~ 572 (705)
||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654332 22334578999999999999899999999999999999998 99999765
Q ss_pred CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 573 ~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
... +.+...+..+.. ...+......+.+++..||+.||.+|||+.++++.|+..++
T Consensus 255 ~~~--~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 255 KID--EEFCRRLKEGTR-----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCS--HHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chh--HHHHHHhccCcc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 432 112222222211 11222334568899999999999999999999999997765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=360.80 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=206.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-----CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.. ++.++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence 4688899999999999999999999999999998643 12245779999999999999999999998876 67899
Q ss_pred EEEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeeeecc
Q 005257 439 LVYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGDFGL 514 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~DFGl 514 (705)
+||||+++|+|.+++.+.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 23358999999999999999999998 99999999999999987655 99999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+..+.... .
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~~~~~~--~ 252 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKGKYKM--N 252 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHHTCCCC--C
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHcCCCCC--C
Confidence 987755332 22345799999999999998999999999999999999999999976422 2222222222110 0
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+... . .....+.+++..||+.||++|||+.|++++
T Consensus 253 ~~~~--~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 253 PRQW--S----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHH--T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccc--c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 1 123568899999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=351.23 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=199.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------------------------hhHHHHHHHHHHhc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------------------------GGTRAFLAEISSLG 416 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------------------------~~~~~~~~Ei~~l~ 416 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3578899999999999999999999999999999865421 12356889999999
Q ss_pred cCCCCCcceeeeeeeec-cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005257 417 RLKHKSLVGLRGWCKRE-KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495 (705)
Q Consensus 417 ~l~Hpniv~l~g~~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLk 495 (705)
+++||||+++++++... ...+++||||+++++|.+++. ...+++.++..++.|++.||.|||+ .+|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence 99999999999998752 457899999999999988653 2369999999999999999999999 999999999
Q ss_pred CCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCC---CCccccEEEEehhHHHHhhCCCCCCCC
Q 005257 496 SSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR---ASTQTDVFGFGILILEVLSGRRPIEEG 572 (705)
Q Consensus 496 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~Gvvl~ElltG~~Pf~~~ 572 (705)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654332 223457999999999997755 378899999999999999999999764
Q ss_pred CccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 573 KPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 573 ~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... .....+..... . ..........+.+++..||+.||++|||+.|++++
T Consensus 244 ~~~---~~~~~~~~~~~--------~--~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIM---CLHSKIKSQAL--------E--FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHH---HHHHHHHHCCC--------C--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHH---HHHHHHhcccC--------C--CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 321 11111111111 0 00111234568899999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=364.04 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=207.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEE
Confidence 5688899999999999999999999999999998653 23345778999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997533 69999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..............+..
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------- 234 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------- 234 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----------
Confidence 33 2344689999999999864 4589999999999999999999999975433222222121111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPT-MRQVVK 634 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 634 (705)
....++......+.+++..||+.||.+||+ +.++.+
T Consensus 235 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 -TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112233344567889999999999999998 666654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.13 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=203.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence 46888999999999999999999999999999997553 3345778999999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++ +|.+++..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99975 66666655332 69999999999999999999999 99999999999999999999999999999876533
Q ss_pred CcceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHHHHhhhc
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~id~~l~~ 599 (705)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+...... .+....... .+.......+....
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhhhcc
Confidence 22 223357899999999997765 899999999999999999998886554321 111111111 01000000000000
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 ---------------KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ---------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000111234567899999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.07 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=211.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.++..++|+++++.+.++.......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4678999999999999999999988999999999865432 34688999999999999988888888776788899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceecC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~~ 519 (705)
|+ +++|.+++..... .+++.+++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999999975433 69999999999999999999999 999999999999999 588999999999998766
Q ss_pred CCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 520 HGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 54321 123457999999999999999999999999999999999999999763321000001111110000000
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.+. .. ....+.+++..||+.||++||++.++++.|+....
T Consensus 240 -~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 240 -EVLC--KG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -HHHT--TT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHH--hh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0000 11 23568899999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.64 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=206.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-------eEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-------AEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++++++||||+++++++.. ++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CC
Confidence 356788999999999999999988766 5799999977666677889999999999999999999999876 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC--------e
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN--------G 507 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~--------~ 507 (705)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 78999999999999999976432 48999999999999999999999 99999999999999998887 9
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... .. .....
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~-~~~~~- 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RK-LQFYE- 232 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH-HHHHH-
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HH-HHHhh-
Confidence 99999998754322 22457899999999987 678999999999999999999655544332211 10 01111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||++|||+.++++.|+....
T Consensus 233 --------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 --------DR----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --------TT----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --------cc----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 01 11222224567889999999999999999999999997765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.40 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=208.7
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+. ++..||||++.... ...+++.+|++++.+++||||+++++++.. .+..++||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 98 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIIT 98 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEE
Confidence 3557888999999999999999887 46789999997543 335779999999999999999999999876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999976332 59999999999999999999998 99999999999999999999999999999866543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+ ..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~---------~~-- 239 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQG---------LR-- 239 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTT---------CC--
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhcc---------cC--
Confidence 3222233456788999999998899999999999999999998 99999765431 111112211 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+....+.+.+++..||+.||++|||+.++++.|+...+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11222234578899999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=376.05 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=206.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|++++||||+++++++.. +..++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEe
Confidence 34567888999999999999999975 5679999997543 345789999999999999999999998864 5789999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999965322 258999999999999999999999 99999999999999999999999999999876544
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+ .+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~---------~~-- 399 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERG---------YR-- 399 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT---------CC--
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---------CC--
Confidence 3333334467889999999998899999999999999999999 99999765421 122222222 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+.+.+.+++..||+.||++|||+.++++.|+....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 12233455678899999999999999999999999997765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=363.24 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=208.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 457889999999999999999999999999999997553 3345678999999999999999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---Ceeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM---NGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~---~~kL~DFGla~~ 517 (705)
|||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999998653 268999999999999999999999 9999999999999998654 599999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+....
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~------ 249 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDY------ 249 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCC------
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCC------
Confidence 654322 2335799999999999998999999999999999999999999976543 12222222222110
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..||+.||++||++.|++++
T Consensus 250 --~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001234568899999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=373.20 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=212.5
Q ss_pred HHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeee
Q 005257 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR 432 (705)
Q Consensus 356 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 432 (705)
+.++....++|...++||+|+||+||+|.++.+++.||+|+++.. .....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 445666778999999999999999999999999999999998653 12233457899999999999999999998876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
...+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 141 -~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 -DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp -SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 67899999999999999999653 48999999999999999999999 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCC----CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR----ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... +. ...+..+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~-~~~i~~~~ 289 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GT-YSKIMNHK 289 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-HHHHHTHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hH-HHHHHhcc
Confidence 999877655444444578999999999997654 789999999999999999999999865431 11 11111110
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRA--RPTMRQVVKVL 636 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 636 (705)
..+. ..........+.+++..||+.+|.+ ||++.|++++-
T Consensus 290 ------~~~~--~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 290 ------NSLT--FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp ------HHCC--CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ------cccc--CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0011 0111123456788999999999988 99999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=360.37 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=207.6
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 437 (705)
..++|...+.||+|+||.||+|....+++.||||+++.. .....+.+.+|..++..+ +||||+++++++.. .+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEE
Confidence 346789999999999999999999988999999998754 223456788999999988 89999999998876 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++|+|.+++.+.. .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999997643 58999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+..+.
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~--------- 237 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHN--------- 237 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC---------
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHHHhCC---------
Confidence 433222 233468999999999999999999999999999999999999999765421 1222222211
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
..++......+.+++..||+.||++||+ +++++++
T Consensus 238 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2233344567889999999999999995 5777653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.67 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=210.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence 4679999999999999999999999999999999987665566789999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc--CCCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK--EMNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~--~~~~kL~DFGla~~~~~ 520 (705)
|+++|+|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999986533 258999999999999999999998 99999999999999974 47799999999987755
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. ...+..... ...
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~-~~~i~~~~~--------~~~ 270 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ET-LQNVKRCDW--------EFD 270 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH-HHHHHHCCC--------CCC
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HH-HHHHHhCCC--------CCC
Confidence 432 23457999999999999989999999999999999999999999865421 11 111111110 000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|++++
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112234568899999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=349.78 Aligned_cols=265 Identities=18% Similarity=0.271 Sum_probs=208.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|++++..++|++++..+.++.......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35789999999999999999999988999999998754432 2457889999999999999998888877778889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~ 518 (705)
||+ +++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999975433 59999999999999999999999 999999999999999 78899999999999876
Q ss_pred CCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 519 GHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 554321 22345789999999999999999999999999999999999999976432110000011100000000
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ..+. .. ....+.+++..||+.||++||++.++++.|+...+
T Consensus 239 ~-~~~~--~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 I-EVLC--KG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H-HHHT--TT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h-hhhh--cc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 0000 11 23568899999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.37 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=203.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|+..+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence 3578899999999999999999999999999999865432 234668899999999999999999998876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999998543 269999999999999999999998 99999999999999999999999999999866433
Q ss_pred Cc-ceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 522 QV-ASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~-~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ..+......
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~--------- 227 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTY--------- 227 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HHHHTTCTT---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHhccccc---------
Confidence 22 22234679999999999987665 789999999999999999999997644321111 111111000
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00112234567889999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.87 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=202.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.++.+++.||||++... .....+.+.+|..++.++ +||||+++++++.. ...+++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEE
Confidence 4688899999999999999999999999999999754 233456688999999988 89999999998876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999997643 68999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc------HHHHHHHHHHhCchhHHH
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN------LVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~------~~~~v~~~~~~~~~~~~i 593 (705)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+.+..+
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------ 234 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 234 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------
Confidence 2221 233468999999999999989999999999999999999999999642210 111111111111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
...++......+.+++..||+.||++||++
T Consensus 235 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 122333445678899999999999999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=361.32 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=204.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 57889999999999999999999999999999986431 2234578999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+ +|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+++++++||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887643 69999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... ...+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... +...+. ..
T Consensus 161 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------~~~~i~---~~ 223 (336)
T 3h4j_B 161 GNFL--KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------LFKKVN---SC 223 (336)
T ss_dssp SBTT--CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------CBCCCC---SS
T ss_pred Cccc--ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------HHHHHH---cC
Confidence 4322 33579999999999988765 789999999999999999999997643210 000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+......+.+++..||+.||.+|||+.|++++
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011222334567899999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.53 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=199.5
Q ss_pred CCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.|...+.||+|+||+||+|.+..+ ...||||.++.. .....+.+.+|+.++++++||||++++++|...++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 356678999999999999997543 246899998654 3355678999999999999999999999987656788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999975432 58999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcc---eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 521 GQVA---STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 521 ~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ...+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~~~~~------- 314 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRR------- 314 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHHTTCC-------
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHHcCCC-------
Confidence 3221 1233467889999999999999999999999999999999 6777765432111 111122211
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
...+......+.+++..||+.||++||++.|+++.|+.....
T Consensus 315 ----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111223445788999999999999999999999999977663
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.89 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=200.1
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
..+.||+|+||.||+|....+++.||+|+++.......+.+.+|++++++++||||+++++++.. .+.+++||||+++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCC
Confidence 35789999999999999999999999999987666677889999999999999999999999876 67899999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE--ccCCCeeeeeeccceecCCCCcce
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL--DKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl--d~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|.+++.... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9999987543 268999999999999999999998 999999999999999 5678899999999987754432
Q ss_pred eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCH
Q 005257 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605 (705)
Q Consensus 526 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~ 605 (705)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. ..+..... ........
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~-~~i~~~~~--------~~~~~~~~ 313 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETL-NNILACRW--------DLEDEEFQ 313 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH-HHHHHTCC--------CSCSGGGT
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHhccC--------CCChhhhc
Confidence 22347999999999999888999999999999999999999999865421 111 11111110 00000001
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 606 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+.+++..||+.||++|||+.|++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 223568899999999999999999999983
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=352.90 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=215.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEE-----cCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVL-----EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
..++|...+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~ 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-G 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-C
Confidence 446788899999999999999985 34678999999976543 3457799999999999 99999999999876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCC---------------CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGS---------------MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
+..++||||+++|+|.+++...... ..+++.+++.++.|++.||.|||+ .+|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceE
Confidence 6889999999999999999765421 248999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~ 577 (705)
|++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence 99999999999999998765543322 223467889999999998899999999999999999999 99999765432
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
........ .... ...+......+.+++..||+.||.+|||+.|+++.|+..+.
T Consensus 255 ~~~~~~~~---------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 SKFYKMIK---------EGFR--MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHHH---------HTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHhc---------cCCC--CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11111111 1111 11223344678899999999999999999999999998766
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.23 Aligned_cols=272 Identities=19% Similarity=0.207 Sum_probs=212.9
Q ss_pred cccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-----CCCccee
Q 005257 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-----HKSLVGL 426 (705)
Q Consensus 352 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv~l 426 (705)
..+++++.....++|...++||+|+||+||+|.+..+++.||||++.. .....+.+..|+.+++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 456667777778999999999999999999999998999999999864 3344567788999999886 9999999
Q ss_pred eeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---
Q 005257 427 RGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK--- 503 (705)
Q Consensus 427 ~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~--- 503 (705)
++++.. .+..++||||+ +++|.+++...... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 102 ~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMY-YDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEE-TTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cceeeE-CCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 998876 67899999999 89999999875433 58999999999999999999998 99999999999999975
Q ss_pred ----------------------CCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHH
Q 005257 504 ----------------------EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILE 561 (705)
Q Consensus 504 ----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~E 561 (705)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7889999999998754322 23578999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCccHHHHHHHHHHhCchhHHH-HHhhhc---------------C-------------CCCC---HHHHH
Q 005257 562 VLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL-DARLRA---------------K-------------GGFD---EDEVE 609 (705)
Q Consensus 562 lltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i-d~~l~~---------------~-------------~~~~---~~~~~ 609 (705)
|++|+.||........-...... .+...... ...... . ...+ ....+
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESI-IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHH-TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHh-cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999765432111101111 11111111 000000 0 0000 00115
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 610 RVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 610 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+.+++..||+.||++|||+.|++++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 67799999999999999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=373.24 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=198.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|+..+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEE
Confidence 35688899999999999999999999999999998753 33445678899999999999999999999886 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999997643 68999999999999999999995 2789999999999999999999999999998643
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+
T Consensus 301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~------------ 364 (446)
T 4ejn_A 301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILME------------ 364 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHC------------
T ss_pred CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHHhC------------
Confidence 3222 233468999999999999999999999999999999999999999765431 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
...++......+.+++..||+.||.+|| ++.|++++
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1222333446788999999999999999 99998874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.31 Aligned_cols=260 Identities=19% Similarity=0.261 Sum_probs=202.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
-++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.. ++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEE
Confidence 467899999999999999999999899999999987542 2234778999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999997643 58999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~-~-------- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIP-R-------- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCC-C--------
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCC-C--------
Confidence 54433344567899999999999889999999999999999999999999764321 11111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHhccc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARP-TMRQVVKVLEGKIE 641 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 641 (705)
...........+.+++..||+.||++|| ++.++++.|+..+.
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0111222345688899999999999999 99999999997765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.38 Aligned_cols=255 Identities=20% Similarity=0.340 Sum_probs=198.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccC---c
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG---S 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|++++.+++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4678999999999999999999998999999999976532 334678999999999999999999998875332 3
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999997643 68999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCc--ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 517 MHGHGQV--ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 517 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~- 241 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIPPSA- 241 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCCCHHH-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCCCccc-
Confidence 7654322 2233457899999999999989999999999999999999999999765432 2222222222111100
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
. .. .....+.+++..||+.||++||+..+++.
T Consensus 242 ---~-~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 242 ---R-HE----GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ---H-ST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ---c-cC----CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 01 12356789999999999999997776654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=342.18 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=208.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEe
Confidence 4568889999999999999999999999999999987666667889999999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceecC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~~ 519 (705)
|+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999987643 58999999999999999999998 999999999999999 788999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...... .....+..+..
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~---------- 224 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGTF---------- 224 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC----------
T ss_pred Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCC----------
Confidence 4432 233578999999999865 4899999999999999999999999765431 12222222211
Q ss_pred CCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 KGGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..+. .....+.+++..||+.||++||++.++++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1121 12356889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=357.41 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=214.6
Q ss_pred CCCCcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~ 438 (705)
++|+..+.||+|+||.||+|.+ ..+++.||||++........+.+.+|++++++++||||+++++++.. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999994 56789999999987776677889999999999999999999998864 345689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 58999999999999999999998 99999999999999999999999999999877
Q ss_pred CCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC----chhHH
Q 005257 519 GHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG----KLLDA 592 (705)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~----~~~~~ 592 (705)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...... .+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHH
Confidence 5443221 2234678889999999888899999999999999999999999865321110000 000000 01111
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+..... ...+......+.+++..||+.||++|||+.|+++.|+....
T Consensus 257 ~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQR--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 22334455778999999999999999999999999997765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.80 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=207.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
..++|...+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCC
Confidence 34678889999999999999999753 33569999987653 3456789999999999999999999998754 456
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 899999999999999976543 58999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...+..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~~~-------- 231 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGD-------- 231 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHHTC--------
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhcCC--------
Confidence 65543333334567889999999988899999999999999999998 9999976443211 11111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ...+....+.+.+++..||+.||++||++.|+++.|+...+
T Consensus 232 -~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 -R--LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C--CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1 11222334668899999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.05 Aligned_cols=261 Identities=26% Similarity=0.464 Sum_probs=199.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
..++|...+.||+|+||+||+|.+.. .||||+++... ....+.+.+|++++++++||||+++++++. ....++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEE
Confidence 35678999999999999999998753 49999987553 345578999999999999999999999764 456899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999996543 369999999999999999999999 999999999999999999999999999998654
Q ss_pred CCC-cceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 520 HGQ-VASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 520 ~~~-~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
... ........||+.|+|||++. +..++.++|||||||++|||++|+.||...... +.+......+.....+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-- 247 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDL-- 247 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCT--
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcch--
Confidence 322 22233457899999999986 567889999999999999999999999764431 2222333332221100
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..........+.+++..||+.||++|||+.++++.|+...+
T Consensus 248 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 -----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11223345678999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.56 Aligned_cols=268 Identities=21% Similarity=0.352 Sum_probs=208.7
Q ss_pred CCCCcceEEeecCceEEEEEE----EcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-Cce
Q 005257 364 KGFSEENVIGVGGNGKVYKGV----LEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~ 437 (705)
+.|+..+.||+|+||.||+|. ...+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457888999999999999999 45678999999997543 344578999999999999999999999987632 568
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999966543 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc--eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC---chhHH
Q 005257 518 HGHGQVA--STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG---KLLDA 592 (705)
Q Consensus 518 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~---~~~~~ 592 (705)
....... ......||..|+|||++.+..++.++|||||||++|||++|+.|+.... .......... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGGHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCcccccCHHH
Confidence 7654322 1223467888999999998889999999999999999999999864321 1111110000 00011
Q ss_pred HHHhhhc--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 593 LDARLRA--KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 593 id~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
+...+.. ....+......+.+++..||+.||.+|||+.++++.|+.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111110 12233445567899999999999999999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.53 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=196.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC----chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN----DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||++... .+++.||+|+++... ......+.+|+.+++.++||||+++++++.. .+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CC
Confidence 356888999999999999999985 578999999997642 2334567899999999999999999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 8999999999999999997643 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~-------- 236 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKC-------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT--------
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhC--------
Confidence 75433221 223357899999999999889999999999999999999999999865421 111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
...++......+.+++..||+.||++|| ++.|++++
T Consensus 237 ----~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 ----KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ----CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1222333446788999999999999999 67777764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=345.16 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=210.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|...+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.. ++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeC
Confidence 56788999999999999999987 568899999975533 34679999999999999999999999876 6688999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++++|.+++..... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999976432 58999999999999999999998 9999999999999999999999999999986643322
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+. . ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~~~~---------~--~~ 225 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTGF---------R--LY 225 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTC---------C--CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHhcCC---------c--CC
Confidence 22223456788999999988899999999999999999999 89999765421 1112222211 0 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+......+.+++..||+.||++||++.++++.|+...+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122334568899999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.43 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=212.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEc-------CCCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLE-------GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
..++|...+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|+++++++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3567888999999999999999975 356789999997653 34467799999999999 89999999999876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||||+||
T Consensus 113 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 113 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred -CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 6688999999999999999976432 1248999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~ 577 (705)
|++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 9999999999999999876544322 2233467889999999988889999999999999999999 9999976542
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+...+..+.. ...+......+.+++..||+.||.+||++.|+++.|+....
T Consensus 266 ~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 EELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112222222211 11223344678899999999999999999999999998766
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.80 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=205.1
Q ss_pred hCCCCcceEEeec--CceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVG--GNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G--~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|+..++||+| +||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ++.++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEE
Confidence 4578899999999 99999999999999999999997553 3445678889999999999999999999886 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++...... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999765333 69999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc------ceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 519 GHGQV------ASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 519 ~~~~~------~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .... ..+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~-~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK-LNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-hcCCCC
Confidence 32211 11122478999999999987 5789999999999999999999999976433110 0000 001000
Q ss_pred HHHHHh-----------------------hh-----------cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDAR-----------------------LR-----------AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~-----------------------l~-----------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++.. +. ....+.......+.+++..||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 00 0001122234568899999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.60 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=192.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+..+++.||||+++... ..+.+.+|++++.+++||||+++++++.. ....++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEE
Confidence 4567899999999999999999999889999999997543 34668899999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFGla~~~ 518 (705)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999996532 68999999999999999999998 99999999999999975 889999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.....+..+...
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~-------- 269 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYY-------- 269 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCC--------
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCc--------
Confidence 4432 223457999999999999989999999999999999999999999765432 1122222222110
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
............+.+++..||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112334568899999999999999999999884
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=340.96 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=205.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.++++++||||+++++++... .+..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 56888999999999999999985 7889999987653 34456799999999999999999999998763 2678999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
|||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+ ++||||||+|||++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999976433 268999999999999999999998 77 999999999999999999999999887643
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCc---cccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRAST---QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~---ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
... ...||+.|+|||++.+..++. ++|||||||++|||++|+.||...... +........+.
T Consensus 164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~------- 228 (271)
T 3kmu_A 164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGMKVALEGL------- 228 (271)
T ss_dssp SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHHHHHHHSCC-------
T ss_pred ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHHHHHHhcCC-------
Confidence 222 246899999999998755444 799999999999999999999765431 11111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
. ...+......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 229 --~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 --R--PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 2223344567889999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=369.71 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=213.3
Q ss_pred ccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeee
Q 005257 353 RITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGW 429 (705)
Q Consensus 353 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 429 (705)
.+.++++....++|...+.||+|+||+||++..+.+++.||||++++.. ....+.+.+|..++..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3455666777889999999999999999999999999999999996532 2233458899999999999999999998
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
+.. .+.+++||||+++|+|.+++.+.+. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||
T Consensus 130 ~~~-~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 130 FQD-ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EEC-SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred Eee-CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEE
Confidence 876 6789999999999999999976532 58999999999999999999998 99999999999999999999999
Q ss_pred eeeccceecCCCCcceeeeeeccccCCCccccc-------cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS-------SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 510 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
+|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...... +. ..
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~-~~ 280 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ET-YG 280 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-HH
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HH-HH
Confidence 999999877655443344468999999999987 356899999999999999999999999865431 11 11
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR---PTMRQVVKV 635 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 635 (705)
.+... ...+.. ..........+.+++..||. +|.+| |++.|++++
T Consensus 281 ~i~~~------~~~~~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHY------KEHLSL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTH------HHHCCC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhc------ccCcCC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11110 001100 11112234568899999999 99998 689998774
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=358.56 Aligned_cols=263 Identities=18% Similarity=0.218 Sum_probs=205.2
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-----CchhHHHHHHHHHHhccCCCCCcceeeeeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-----NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR 432 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 432 (705)
++....++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456677899999999999999999999999999999998643 33456789999999999999999999999876
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcC-------------------------------------CCCcccHHHHHHHHHHHH
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCD-------------------------------------GSMMLSCEERIRVLKDVA 475 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia 475 (705)
.+..++||||+++|+|.+++.... ....+++..++.++.|++
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 678999999999999999985210 012356788899999999
Q ss_pred HHHHHHhcCCCCCeeecCCCCCCeEEccCC--CeeeeeeccceecCCCC---cceeeeeeccccCCCcccccc--CCCCc
Q 005257 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEM--NGRLGDFGLARMHGHGQ---VASTTRVVGTVGYLAPEVFSS--GRAST 548 (705)
Q Consensus 476 ~gL~yLH~~~~~~iiHrDLkp~NILld~~~--~~kL~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~--~~~s~ 548 (705)
.||.|||+ .+|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 8999999999999998776 89999999998764322 112344679999999999865 67899
Q ss_pred cccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 005257 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT 628 (705)
Q Consensus 549 ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 628 (705)
++|||||||++|||++|+.||...... +............. ..........+.+++..||+.||.+||+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFE---------NPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCTT---------SGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcccccC---------CcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999999765431 22212111111000 0000112356889999999999999999
Q ss_pred HHHHHHH
Q 005257 629 MRQVVKV 635 (705)
Q Consensus 629 ~~evl~~ 635 (705)
+.+++++
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.15 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=204.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.+..++..||||++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEE
Confidence 457888999999999999999999999999999986432 2234678999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997653 58999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~------------ 222 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRV------------ 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHT------------
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHHhC------------
Confidence 322 23457899999999999989999999999999999999999999864421 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...++......+.+++..||+.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 122333344668899999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=355.98 Aligned_cols=269 Identities=22% Similarity=0.410 Sum_probs=217.0
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeee
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
..++++...++|...+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455667788999999999999999999876 3468899999975533 34567899999999999999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcC-------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCD-------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL 501 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl 501 (705)
++.. .+..++||||+++|+|.+++.... ....+++.+++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 96 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 96 VVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 9876 668899999999999999997532 11357999999999999999999999 999999999999999
Q ss_pred ccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHH
Q 005257 502 DKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEM 579 (705)
Q Consensus 502 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~ 579 (705)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HH
Confidence 9999999999999986543321 11223467889999999998899999999999999999999 8899876442 11
Q ss_pred HHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 580 v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....+..+.. ...+......+.+++..||+.||++|||+.|+++.|+....
T Consensus 249 ~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VLRFVMEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2222222221 11223344668899999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.92 Aligned_cols=258 Identities=21% Similarity=0.375 Sum_probs=204.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeE----EEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
.++|+..+.||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STV 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCc
Confidence 35788999999999999999999777654 577777544 34456789999999999999999999999875 357
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++|+||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999987543 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 518 HGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 518 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~~~-------- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKG-------- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT--------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcC--------
Confidence 6543222 2233456889999999999999999999999999999999 9999987543221 1111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||.+||++.|+++.|+....
T Consensus 236 -~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 -ER--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -CC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -CC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 12233345568899999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.85 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=206.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.+|...+.||+|+||+||+|.+..+ ...||+|.+..... ...+.+.+|+.++++++||||++++++|...++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577889999999999999997543 34699999876533 4457799999999999999999999998776778899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999997533 258999999999999999999998 999999999999999999999999999998665
Q ss_pred CCCc---ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 520 HGQV---ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 520 ~~~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||........ ......+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~~~------- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGR------- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHTTC-------
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhcCC-------
Confidence 4322 12233567889999999998899999999999999999999 5555554332110 11111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ...+......+.+++..||+.||++|||+.++++.|+....
T Consensus 250 --~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 --R--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 11122234568899999999999999999999999998766
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.53 Aligned_cols=261 Identities=28% Similarity=0.361 Sum_probs=207.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCC---eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGG---AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.|...++||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.++++++||||+++++++...+...++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3556789999999999999975544 3799999976543 45678999999999999999999999998755566999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997633 368999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCc---ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQV---ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
... .......+|+.|+|||.+.+..++.++|||||||++|||++|..|+....... .....+..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~--------- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQGR--------- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHHTTC---------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhhcCC---------
Confidence 221 12223467899999999999999999999999999999999666654332210 0111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
. ...+......+.+++..||+.||.+|||+.++++.|+......
T Consensus 246 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 R--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C--CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 1122333467889999999999999999999999999877643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.85 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=196.0
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeee-------e
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCK-------R 432 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~-------~ 432 (705)
....+|...++||+|+||.||+|.+..+++.||||++........+.+.+|+.++.+++ ||||+++++++. .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457889999999999999999999899999999997776667788999999999996 999999999884 2
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEccCCCeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLDKEMNGRLG 510 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld~~~~~kL~ 510 (705)
....+++||||+. |+|.+++........+++.+++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence 2345899999996 7999998764444479999999999999999999998 77 9999999999999999999999
Q ss_pred eeccceecCCCCcc-----------eeeeeeccccCCCcccc---ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH
Q 005257 511 DFGLARMHGHGQVA-----------STTRVVGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576 (705)
Q Consensus 511 DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~---~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~ 576 (705)
|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 99999876543221 11134689999999998 5667899999999999999999999999754321
Q ss_pred HHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
..+..... ..........+.+++..||+.||++||++.|+++.|+......
T Consensus 260 --------------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 --------------RIVNGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------------HhhcCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 01111111 0111122245788999999999999999999999999776633
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.20 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=195.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc----hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND----GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~----~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|+..+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+++++.++||||+++++++.. .+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceE
Confidence 357888999999999999999985 78899999865432 235678999999999999999999999876 66789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCCeEEcc--------CCCe
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK---VLHRDIKSSNVLLDK--------EMNG 507 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~---iiHrDLkp~NILld~--------~~~~ 507 (705)
+||||+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+ |+||||||+|||++. ++.+
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 99999999999999842 268999999999999999999999 66 999999999999986 6789
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
||+|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ...
T Consensus 156 kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~-~~~ 229 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVAYGV-AMN 229 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHH-HTS
T ss_pred EEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHhh-hcC
Confidence 9999999986544322 2357899999999999889999999999999999999999999865431 111111 111
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
. .. ...+......+.+++..||+.||++|||+.|+++.|+.
T Consensus 230 ~--------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 K--------LA--LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C--------CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C--------CC--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 00 12233445678899999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.94 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=202.3
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-----chhHHHHHHHHHHhccCC---CCCcceeeeeeeec
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-----DGGTRAFLAEISSLGRLK---HKSLVGLRGWCKRE 433 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~ 433 (705)
..++|+..+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999999899999999986432 122356777888877775 99999999998764
Q ss_pred cC----ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 434 KG----SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 434 ~~----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
.. ..++||||+. |+|.+++...... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence 33 5799999997 5999999765433 59999999999999999999999 99999999999999999999999
Q ss_pred eeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH-HHHHHHHHHhCc
Q 005257 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL-VEMVWELMVQGK 588 (705)
Q Consensus 510 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~-~~~v~~~~~~~~ 588 (705)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+........
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999986643322 233578999999999999899999999999999999999999997654321 111111110000
Q ss_pred hhH------HHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 LLD------ALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 ~~~------~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ............. .+..+.+.+++..||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 0000000000000 1123567899999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.30 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=210.8
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEE
Confidence 3467888999999999999999986 46789999986543 34678999999999999999999999876 44689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999964321 258999999999999999999998 99999999999999999999999999999877654
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..+. .
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~---------~-- 228 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERGY---------R-- 228 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTC---------C--
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhccc---------C--
Confidence 3333333456889999999988889999999999999999999 99999765421 1112222111 1
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++|||+.++++.|+....
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11222344678899999999999999999999999997765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.71 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=185.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEE
Confidence 46888999999999999999998889999999986432 2234678999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997543 368999999999999999999998 9999999999999999999999999999987653
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+.......
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~ 228 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---------------TLNKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---------------HHHHHhhcc
Confidence 3222 223578999999999998889999999999999999999999997643210 000000000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11222234567899999999999999999998873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.84 Aligned_cols=257 Identities=28% Similarity=0.394 Sum_probs=208.5
Q ss_pred hCCCCcce-EEeecCceEEEEEEE--cCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 363 TKGFSEEN-VIGVGGNGKVYKGVL--EGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 363 t~~f~~~~-~LG~G~fg~Vy~~~~--~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
.++|...+ .||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|+++++.++||||+++++++. .+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence 45677777 999999999999955 4567899999997553 334678999999999999999999999983 5678
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999997643 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 518 HGHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 518 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~----- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKGER----- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCC-----
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCC-----
Confidence 75543322 122346789999999988889999999999999999999 99999865431 12222222211
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++||++.++++.|+....
T Consensus 239 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22233445678999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.85 Aligned_cols=267 Identities=25% Similarity=0.413 Sum_probs=215.3
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCC-----eEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWC 430 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~ 430 (705)
+++...++|...+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.++.++ +||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556678999999999999999999987655 3799999976543 3456799999999999 899999999998
Q ss_pred eeccCceEEEEeeCCCCChhHHHHhcCC-----------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 431 KREKGSLMLVYDYMENGSLDKWIFQCDG-----------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 431 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
.. .+..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||||+||
T Consensus 120 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 TH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNV 195 (333)
T ss_dssp CS-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGC
T ss_pred ec-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceE
Confidence 76 6688999999999999999975321 2358999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~ 577 (705)
|++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 273 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-- 273 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--
Confidence 9999999999999999866443322 2233567889999999998899999999999999999998 99999765432
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.........+ .. ...+......+.+++..||+.||.+|||+.++++.|+....
T Consensus 274 ~~~~~~~~~~---------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 SKFYKLVKDG---------YQ--MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHHT---------CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcC---------CC--CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1111221111 11 11122234678899999999999999999999999986654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=353.12 Aligned_cols=258 Identities=29% Similarity=0.510 Sum_probs=203.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCC----eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++|...+.||+|+||.||+|.+..++ ..||||++..... .....+.+|+.++++++||||+++++++.. .+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcE
Confidence 45667899999999999999986543 4699999976533 345678999999999999999999999876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999976433 68999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 519 GHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~~------- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDGF------- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTC-------
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCCC-------
Confidence 5432211 222356789999999998899999999999999999998 99999764421 1222222221
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ...+......+.+++..||+.||++||++.++++.|+....
T Consensus 268 --~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 268 --R--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp --C--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --c--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11223345678899999999999999999999999987765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.44 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=195.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||+||++.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEE
Confidence 467999999999999999999999999999999996543 334678899999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC--eeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN--GRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~--~kL~DFGla~~~~~ 520 (705)
|+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999997643 59999999999999999999998 99999999999999987765 99999999975432
Q ss_pred CCcceeeeeeccccCCCccccccCCCCcc-ccEEEEehhHHHHhhCCCCCCCCCc--cHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQ-TDVFGFGILILEVLSGRRPIEEGKP--NLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k-sDVwS~Gvvl~ElltG~~Pf~~~~~--~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..... .....+ ..+.... .
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~-~~~~~~~--------~ 239 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI-QRILSVK--------Y 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH-HHHHTTC--------C
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH-HHHhcCC--------C
Confidence 22 2233579999999999988777655 8999999999999999999976432 111111 1111110 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ..........+.+++..||+.||++|||+.|++++
T Consensus 240 ~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 S--IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C--CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C--CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00011223567899999999999999999999885
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.68 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=204.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
+|....+||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.. .+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeC
Confidence 45566799999999999999998999999999987766667889999999999999999999999876 67899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-CCCeeeeeeccceecCCCCc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-EMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-~~~~kL~DFGla~~~~~~~~ 523 (705)
++++|.+++........+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999999876544467899999999999999999998 99999999999999987 89999999999987654322
Q ss_pred ceeeeeeccccCCCccccccCC--CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........... ... ......
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-----------~~~~~~ 245 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVG-----------MFKVHP 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHH-----------HHCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhc-----------cccccc
Confidence 223357899999999987643 88999999999999999999999975332211110 000 001112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++..||+.||++||++.++++.
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2333445678899999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=341.46 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=207.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|+..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEE
Confidence 46789999999999999999999999999999998654 33445778899999999999999999999876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~DFGla~~ 517 (705)
|||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887643 68999999999999999999999 99999999999999987655 99999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+....
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~------ 226 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDY------ 226 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCC------
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhccccC------
Confidence 654332 23357899999999999989999999999999999999999999765431 1112222211100
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..||+.||++|||+.|++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000011234568899999999999999999999884
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=366.36 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=199.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----C
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----G 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~ 435 (705)
.++|+..+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999999999999999999754 3345677899999999999999999999886432 4
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++ +|.+.+.. .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 57999999976 56666632 48999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCch-----
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKL----- 589 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~----- 589 (705)
+...... ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.....+. .|..
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHH
Confidence 8765432 23446899999999999999999999999999999999999999986542 111111111 1110
Q ss_pred ---hHHHHHhhhcC---CCC-----------------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 ---LDALDARLRAK---GGF-----------------DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ---~~~id~~l~~~---~~~-----------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+... ... .......+.+++..||+.||++|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 000 01124678999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.94 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=194.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHH-hccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISS-LGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|..+ ++.++||||+++++++.. .+.+++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~l 116 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYF 116 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEE
Confidence 46888999999999999999999999999999997642 2334566778777 577899999999998876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997643 58999999999999999999998 999999999999999999999999999998643
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~----------- 255 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKP----------- 255 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHHSC-----------
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcc-----------
Confidence 3221 23346899999999999999999999999999999999999999976442 11122222111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
..++......+.+++..||+.||.+||++.+
T Consensus 256 -~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1222333456889999999999999999853
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.14 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=201.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|....+++.||||++... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 110 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV 110 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEE
Confidence 4688899999999999999999888999999999753 23455678999999999999999999999886 6789999
Q ss_pred EeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|||+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999996521 22368999999999999999999998 999999999999999999999999999998664
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||........... ..+..+...
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~--------- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEQCDYP--------- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH-HHHHTTCSC---------
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH-HHhhcccCC---------
Confidence 4322 22335789999999999998999999999999999999999999976543322221 112221111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..........+.+++..||+.||++|||+.++++.|+.+..
T Consensus 257 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 -PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 01112234568899999999999999999999999987755
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.09 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=199.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|+||+||+|.+ .+++.||+|++..... ...+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEE
Confidence 4688899999999999999998 5688999999865532 234778999999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++ +|.+++..... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99975 99999876433 58999999999999999999999 99999999999999999999999999999866432
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhH--------
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLD-------- 591 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~-------- 591 (705)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +........ +....
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhc
Confidence 22 2233578999999999876 45899999999999999999999999765421 111111110 00000
Q ss_pred --HHHHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 --ALDARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 --~id~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++...... .........+.+++..||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 0011233567899999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.32 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=207.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++..++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCE
Confidence 45688899999999999999999999999999998764321 35779999999999999999999999876 678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC----Ceeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDF 512 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DF 512 (705)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999997532 68999999999999999999999 9999999999999999887 7999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ....+..+.
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-~~~~i~~~~---- 234 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--E-TLANITSVS---- 234 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--H-HHHHHHTTC----
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--H-HHHHHHhcc----
Confidence 99987654332 23357899999999999889999999999999999999999999765421 1 111222111
Q ss_pred HHHhhhcCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKGGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++. .....+.+++..||+.||++|||+.|++++
T Consensus 235 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 --------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111 123567899999999999999999999884
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.03 Aligned_cols=273 Identities=25% Similarity=0.361 Sum_probs=203.6
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc--CCCCCcceeeeeeee
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR--LKHKSLVGLRGWCKR 432 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~ 432 (705)
+...-....++|...+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 33334445678999999999999999999986 789999998543 23344555555544 499999999999876
Q ss_pred cc---CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEEccC
Q 005257 433 EK---GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW-----EKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 433 ~~---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDLkp~NILld~~ 504 (705)
.. ...++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.+ ..+|+||||||+|||++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 32 5789999999999999999653 5899999999999999999999810 1299999999999999999
Q ss_pred CCeeeeeeccceecCCCCcce---eeeeeccccCCCccccccCCCCcc------ccEEEEehhHHHHhhC----------
Q 005257 505 MNGRLGDFGLARMHGHGQVAS---TTRVVGTVGYLAPEVFSSGRASTQ------TDVFGFGILILEVLSG---------- 565 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k------sDVwS~Gvvl~ElltG---------- 565 (705)
+.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998765433221 123479999999999987766655 9999999999999999
Q ss_pred CCCCCCCCc--cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 566 RRPIEEGKP--NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 566 ~~Pf~~~~~--~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.||..... ..................+.... ....+...+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW-----SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-----GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccCccccccc-----hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 666654221 11111111111111100000000 012667889999999999999999999999999998766
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=367.61 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=206.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence 56888999999999999999999899999999986542 2235678999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+. ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999643 269999999999999999999998 9999999999999999999999999999987755
Q ss_pred CCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....+..+.
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~----------- 232 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGI----------- 232 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTC-----------
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCC-----------
Confidence 432 233579999999999988765 78999999999999999999999865431 1122222221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+......+.+++..||+.||++|||+.|+++
T Consensus 233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1112223356788999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.49 Aligned_cols=263 Identities=24% Similarity=0.280 Sum_probs=200.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEE
Confidence 578889999999999999999999999999999865533 235678899999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999886433 58999999999999999999998 99999999999999999999999999999876533
Q ss_pred CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh--
Q 005257 522 QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR-- 598 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~-- 598 (705)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .+...........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT-LGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCHHHHHHHHTC
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hcccccccccccccc
Confidence 22 2234578999999999876 56899999999999999999999999875432111111111 1111110000000
Q ss_pred ---------cCCCC-C-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 ---------AKGGF-D-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ---------~~~~~-~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... . ......+.+++..||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0 1223457899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.05 Aligned_cols=282 Identities=25% Similarity=0.350 Sum_probs=212.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|+..+.||+|+||+||+|.+.. ++.||+|++.... ....+.+.+|++++++++||||+++++++.. +..+++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEE
Confidence 4678899999999999999999864 8899999987543 2335678999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++ +|.+++..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 88888865432 58999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------------- 227 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----------------------- 227 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----------------------
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----------------------
Confidence 322 2233578999999999876 568999999999999999999999997643210
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCC----cchhhHHHHHHhhccccccccccccccC
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENE----TEDMDAYLLQQVKSKDMWANYSRSFGYG 675 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 675 (705)
.+..+...+..+.|...|...++....+...+...... .......+.+++..+..++|..|.++.+
T Consensus 228 ----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 228 ----------QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp ----------HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred ----------HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 01112222223334333333332222221111000000 0112345667888888899999999999
Q ss_pred CCCCCCccccc
Q 005257 676 YATHPTFHDIR 686 (705)
Q Consensus 676 ~~~hp~f~~~~ 686 (705)
++.||||.++.
T Consensus 298 ll~hp~f~~~~ 308 (311)
T 3niz_A 298 AMNHPYFKDLD 308 (311)
T ss_dssp HHTSGGGTTSC
T ss_pred HhcCcccccCC
Confidence 99999998765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=349.32 Aligned_cols=265 Identities=23% Similarity=0.256 Sum_probs=209.1
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec---cCceE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE---KGSLM 438 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~---~~~~~ 438 (705)
..++|...+.||+|+||.||++....+++.||||++........+.+.+|+++++.++||||+++++++... ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346789999999999999999999889999999999776666778899999999999999999999998732 34789
Q ss_pred EEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 439 LVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+||||+++|+|.+++... .....+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999763 223369999999999999999999999 8999999999999999999999999999876
Q ss_pred cCCCCcc--------eeeeeeccccCCCccccccCC---CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 518 HGHGQVA--------STTRVVGTVGYLAPEVFSSGR---ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 518 ~~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||..... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~ 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ----------KG 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH----------TT
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc----------cc
Confidence 5321110 011235799999999987654 68999999999999999999999853100 00
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
......+..... ..........+.+++..||+.||.+||++.++++.|+...+
T Consensus 254 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 DSVALAVQNQLS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp SCHHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred chhhHHhhccCC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 001111111111 11122334578899999999999999999999999997755
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.81 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=200.5
Q ss_pred CCCCc-ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSE-ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~-~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+.|.. .+.||+|+||.||+|.+..+++.||||++........+.+.+|++++.++ +||||+++++++.. ++.+++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEE
Confidence 45666 37899999999999999988999999999876666678899999999885 79999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~DFGla~~~ 518 (705)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999997653 68999999999999999999999 99999999999999998776 999999999765
Q ss_pred CCCCc------ceeeeeeccccCCCcccccc-----CCCCccccEEEEehhHHHHhhCCCCCCCCCccH-----------
Q 005257 519 GHGQV------ASTTRVVGTVGYLAPEVFSS-----GRASTQTDVFGFGILILEVLSGRRPIEEGKPNL----------- 576 (705)
Q Consensus 519 ~~~~~------~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~----------- 576 (705)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223569999999999865 457899999999999999999999997643211
Q ss_pred -HHHHHHHHHhCchhHHHHHhhhcCCCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 577 -VEMVWELMVQGKLLDALDARLRAKGGFDED----EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 577 -~~~v~~~~~~~~~~~~id~~l~~~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+.+.+..+. ..++.. ....+.+++..||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGK------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCC------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccC------------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111112222221 112221 23568899999999999999999999884
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.89 Aligned_cols=270 Identities=23% Similarity=0.415 Sum_probs=206.0
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
+++....++|...+.||+|+||.||+|.+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444556788999999999999999998864 45689999987553 344577999999999999999999999987
Q ss_pred eccC----ceEEEEeeCCCCChhHHHHhc---CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC
Q 005257 432 REKG----SLMLVYDYMENGSLDKWIFQC---DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE 504 (705)
Q Consensus 432 ~~~~----~~~lV~E~~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~ 504 (705)
.... ..++||||+++|+|.+++... .....+++.+++.++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCC
Confidence 5332 459999999999999999643 223469999999999999999999998 999999999999999999
Q ss_pred CCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHH
Q 005257 505 MNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 505 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~ 582 (705)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence 9999999999986644322 12233467889999999999899999999999999999999 888987654321 111
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccC
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 643 (705)
.+..+.. ...+......+.+++..||+.||.+||++.++++.|+...+..
T Consensus 261 ~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 YLLHGHR-----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHTTCC-----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCC-----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111110 1222334467889999999999999999999999999877643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=342.25 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=209.5
Q ss_pred CCCCcce-EEeecCceEEEEEEEc--CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEEN-VIGVGGNGKVYKGVLE--GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~-~LG~G~fg~Vy~~~~~--~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEE
Confidence 3455555 8999999999999864 457889999997653 345678999999999999999999999984 457899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999996533 369999999999999999999998 999999999999999999999999999998775
Q ss_pred CCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 520 HGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~~~~------- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKR------- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCC-------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhcCCc-------
Confidence 443222 122356889999999988889999999999999999998 99999765432 11122222211
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++||++.++++.|+....
T Consensus 232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22333445678999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=377.32 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=205.0
Q ss_pred CCcce-EEeecCceEEEEEEEc--CCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 366 FSEEN-VIGVGGNGKVYKGVLE--GGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 366 f~~~~-~LG~G~fg~Vy~~~~~--~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
+...+ .||+|+||.||+|.+. .++..||||+++... ....+++.+|+++|++++||||++++++|.. +.+++||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~ 414 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVM 414 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEE
Confidence 33344 7999999999999875 346789999997653 3456889999999999999999999999864 4689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999996543 369999999999999999999999 99999999999999999999999999999876543
Q ss_pred Cccee--eeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 522 QVAST--TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 522 ~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~--------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKR--------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCC---------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCC---------
Confidence 32221 22345689999999998999999999999999999998 99999875432 12222322221
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+...+.+++..||+.||++||++.++++.|+....
T Consensus 558 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 558 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 22334455778999999999999999999999999987644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.29 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=204.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|...+.||+|+||.||+|.++.+++.||||++..... ...+|++++.++ +||||+++++++.. ...+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEE
Confidence 4568889999999999999999999999999999976533 234688888888 79999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC----CCeeeeeecccee
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE----MNGRLGDFGLARM 517 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~----~~~kL~DFGla~~ 517 (705)
||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997543 69999999999999999999999 999999999999998543 3499999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+...+..+...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~------- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS------- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC-------
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc-------
Confidence 654432 223357899999999998878899999999999999999999999864332233333333333221
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+.......+.+++..||+.||++||++.+++++
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011112334668899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=379.33 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=212.9
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
++...++|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|++++||||++++++|.. +.++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 337 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIY 337 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccce
Confidence 34455678889999999999999999975 5679999997543 345789999999999999999999998864 5789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
|||||+++|+|.++|..... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999965322 258999999999999999999998 99999999999999999999999999999866
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
............++..|+|||++....++.++|||||||++|||++ |+.||..... ..+...+..+.
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~--------- 481 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGY--------- 481 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTC---------
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC---------
Confidence 4322222222356788999999998899999999999999999999 9999976542 11222222221
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+ ...+..+...+.+++..||+.||++|||+.++++.|+....
T Consensus 482 ~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred C--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1 12233445678899999999999999999999999997765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=352.05 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=203.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+.|...+.||+|+||+||+|....+++.||||++..... ...+.+.+|++++++++||||+++++++.. ++..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEE
Confidence 347888999999999999999988999999999975432 234678999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||++ |+|.+++..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 688888865432 68999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.......... .
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~-~------- 271 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNES-P------- 271 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCC-C-------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCC-C-------
Confidence 2 2357999999999984 56789999999999999999999999976542 122222211110 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..........+.+++..||+.||++|||+.+++++..
T Consensus 272 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 272 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0111223456788999999999999999999988643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=362.92 Aligned_cols=273 Identities=20% Similarity=0.267 Sum_probs=216.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~lV~ 441 (705)
++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999999999999999997543 234567889999999999999999999887533 3679999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE----ccCCCeeeeeecccee
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL----DKEMNGRLGDFGLARM 517 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl----d~~~~~kL~DFGla~~ 517 (705)
||+++|+|.+++........+++.+++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999999765444359999999999999999999999 999999999999999 7778899999999987
Q ss_pred cCCCCcceeeeeeccccCCCcccccc--------CCCCccccEEEEehhHHHHhhCCCCCCCCCc-cHHHHHHHHHHhCc
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSS--------GRASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWELMVQGK 588 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-~~~~~v~~~~~~~~ 588 (705)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+...+..+.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 654332 233579999999999864 4678899999999999999999999964321 11112222222222
Q ss_pred hhHHH-------------HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 589 LLDAL-------------DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 589 ~~~~i-------------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....+ ...+.............+.+++..||+.||++||++.|+++.++..+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11100 001111123456778889999999999999999999999999887654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.44 Aligned_cols=267 Identities=21% Similarity=0.378 Sum_probs=212.5
Q ss_pred CCCCcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-CceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-GSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~ 438 (705)
++|...+.||+|+||.||+|.+ ..+++.||||++........+.+.+|++++++++||||+++++++.... ..++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4578889999999999999984 5578999999998777777788999999999999999999999886532 4689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999976543 58999999999999999999998 99999999999999999999999999999877
Q ss_pred CCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc--------
Q 005257 519 GHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK-------- 588 (705)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~-------- 588 (705)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+..... ...+......
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhHHH
Confidence 5443221 1224567889999999888899999999999999999999999764211 1111111111
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.+.+..... ...+......+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 272 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 272 LIELLKNNGR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcCCC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 12233445678999999999999999999999999986643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.81 Aligned_cols=265 Identities=18% Similarity=0.189 Sum_probs=201.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccCCch-----------hHHHHHHHHHHhccCCCCCcceeee
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHENDG-----------GTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~~~-----------~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
.++|...+.||+|+||.||+|.+.. ++..+|||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3578899999999999999999986 6788999998765332 1234678889999999999999999
Q ss_pred eeeec---cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC
Q 005257 429 WCKRE---KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM 505 (705)
Q Consensus 429 ~~~~~---~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~ 505 (705)
++... ....++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 88763 45789999999 999999997543 69999999999999999999998 9999999999999999887
Q ss_pred --CeeeeeeccceecCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH
Q 005257 506 --NGRLGDFGLARMHGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV 577 (705)
Q Consensus 506 --~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~ 577 (705)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 11335789999999999998999999999999999999999999965322211
Q ss_pred --HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 578 --EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 578 --~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
........ ..+...+..... .......+.+++..||+.||++||++.++++.|+...
T Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 AVQTAKTNLL-DELPQSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHH-HTTTHHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHhhc-ccccHHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111 111111111111 0123356889999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=348.60 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=181.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.++..++ ||||+++++++.. +...++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence 47899999999999999999999999998643 4467789999999997 9999999999876 67899999999999
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---CeeeeeeccceecCCCCcc
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM---NGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~---~~kL~DFGla~~~~~~~~~ 524 (705)
+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 9999997643 69999999999999999999998 9999999999999998665 799999999987654332
Q ss_pred eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc----HHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN----LVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 525 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~----~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+..+.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------------ 232 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------------ 232 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------------
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------------
Confidence 223457899999999999999999999999999999999999999764321 1111122222221
Q ss_pred CCCC----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFD----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+. ......+.+++..||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111 1234678899999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.64 Aligned_cols=253 Identities=30% Similarity=0.423 Sum_probs=201.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||+|.+. ++.||||+++.. ...+.+.+|++++++++||||+++++++....+..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 457888999999999999999885 789999998644 3457899999999999999999999998765668899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999976432 148899999999999999999998 999999999999999999999999999997654322
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+..+ .. .
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~---------~~--~ 233 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG---------YK--M 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT---------CC--C
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcC---------CC--C
Confidence 22357889999999998899999999999999999998 999997644211 11111111 11 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+......+.+++..||+.||++||++.++++.|+....
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2233345678899999999999999999999999987644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=364.01 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=211.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...++||+|+||.||+|.+..+++.||||++..... .+++.+|++++..|+|++.+..+.++.......+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4678999999999999999999998999999998765433 24578999999999887666666666555778899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceecC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~~ 519 (705)
|+ +++|.+++..... .+++.+++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999976443 69999999999999999999999 999999999999999 688999999999998776
Q ss_pred CCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 520 HGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 54321 122468999999999999999999999999999999999999999875432222222222221111111
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.... ..+ ...+.+++..||+.||++||++.+|++.|+.+..
T Consensus 238 ~~l~---~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 238 EALC---RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHH---TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHh---cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111 112 3568899999999999999999999999998765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.95 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=208.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~l 439 (705)
.++|+..+.||+|+||.||++....+++.||+|++.... ....+.+.+|++++++++||||+++++++.. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999999899999999997543 3456679999999999999999999998764 3567899
Q ss_pred EEeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeEEccCCCeeeeeec
Q 005257 440 VYDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKK-----VLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
||||+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997642 22359999999999999999999998 67 9999999999999999999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+...+..+..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~---- 233 (279)
T 2w5a_A 162 LARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKF---- 233 (279)
T ss_dssp HHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC----
T ss_pred hheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhccc----
Confidence 99876543221 1234689999999999988999999999999999999999999986542 112222222221
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
...+......+.+++..||+.||++||++.|+++.+..
T Consensus 234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11222344678899999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.27 Aligned_cols=298 Identities=26% Similarity=0.382 Sum_probs=201.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|+..+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence 4678899999999999999999998999999999976533 345778999999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcC---CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCD---GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
||++ |+|.+++.... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999987532 12358999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +...... ..+
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~----------~~~ 225 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIF----------DIM 225 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH----------HHH
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH----------HHh
Confidence 53322 1223578999999999876 46899999999999999999999999765421 1110000 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCCCCCcchhhHHHHHHhhccccccccccccccCCC
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYA 677 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 677 (705)
+..+......+..+. -..++...++. .++.+.+.... .......+.+++..+...+|..|.++.+++
T Consensus 226 ---~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 226 ---GTPNESLWPSVTKLP--KYNPNIQQRPP-RDLRQVLQPHT-------KEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp ---CSCCTTTCGGGGGCT--TCCTTCCCCCC-CCSHHHHGGGC-------SSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ---CCCChhHhhhhhhhh--hcccccccccc-hhHHHhhcccc-------cccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000000000000000 00001111110 11111221111 112344577788888889999999999999
Q ss_pred CCCCcccccccccc
Q 005257 678 THPTFHDIRQSNSY 691 (705)
Q Consensus 678 ~hp~f~~~~~~~~~ 691 (705)
.||||.+.......
T Consensus 293 ~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 293 HHPWFAEYYHHASM 306 (317)
T ss_dssp TSGGGGGGCC----
T ss_pred CChhhhcccchhhc
Confidence 99999987755443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=351.96 Aligned_cols=204 Identities=28% Similarity=0.430 Sum_probs=167.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCC-CCCcceeeeeeeecc-Cce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREK-GSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~-~~~ 437 (705)
..++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++.+++ ||||+++++++..++ ..+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456899999999999999999999999999999998654 3345667889999999997 999999999987533 468
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++|||||+ ++|..++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 5999998652 58999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCC--------------------CcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 518 HGHG--------------------QVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 518 ~~~~--------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
.... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5431 1112344689999999999976 678999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.11 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=208.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence 35688899999999999999999999999999998654 23445678999999999999999999999876 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999987643 68999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +. ...+..+.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~-~~~~~~~~----------- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ET-YLRIKKNE----------- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-HHHHHTTC-----------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH-HHHHhhcc-----------
Confidence 3322 223357899999999999888999999999999999999999999764421 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.||++|||+.|+++.
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11222334568889999999999999999998874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=342.99 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=199.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|...+.||+|+||.||++....++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEE
Confidence 56888999999999999999999999999999987653 3346789999999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceec
Q 005257 443 YMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMH 518 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~ 518 (705)
|+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986531 12369999999999999999999998 999999999999999 45678999999999866
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
.... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...... ........... ..
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~------~~- 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKATYKEP------NY- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC------CC-
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhccCCc------cc-
Confidence 5432 223457899999999986 57899999999999999999999999865421 11111111100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|+++.
T Consensus 245 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 --AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000123567889999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=349.94 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=207.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEE--EEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEI--AVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~v--avK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.+..++..+ |+|++... .....+.+.+|++++.++ +||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEE
Confidence 57888999999999999999998888755 99988754 334456789999999999 89999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
||||+++|+|.+++.... ....+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997643 12368999999999999999999998 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~ 255 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 255 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGG
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHHhh
Confidence 999999999743221 11223456889999999988889999999999999999998 99999765421 1111111
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+ .. ...+......+.+++..||+.||.+|||+.++++.|+...+
T Consensus 256 ~~---------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 256 QG---------YR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GT---------CC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC---------CC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11 11 12223344678899999999999999999999999987765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.16 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCcceEEeecCceEEEEEEE----cCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEE
Q 005257 366 FSEENVIGVGGNGKVYKGVL----EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLML 439 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~l 439 (705)
|...+.||+|+||+||++.+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999988865 34688999999976543 4467799999999999999999999998764 356899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999653 48999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcc--eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHH---HHHHHhCchhHHHH
Q 005257 520 HGQVA--STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMV---WELMVQGKLLDALD 594 (705)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v---~~~~~~~~~~~~id 594 (705)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||........... ........+.+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 54322 12334678899999999988899999999999999999999999865321110000 00000011112222
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.... ...+......+.+++..||+.||++|||+.|+++.|+...+
T Consensus 266 ~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 2111 22334455778999999999999999999999999987655
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=371.94 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=210.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
..++|...+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|..++||||+++++++.. ++.++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEE
Confidence 346788999999999999999999999999999998653 22345678899999999999999999998876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999976542 259999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+...
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------- 404 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------- 404 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----------
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----------
Confidence 54432 23358999999999999888999999999999999999999999864321 111111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
...++......+.+++..||+.||.+|| ++.|++++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1223334456788999999999999999 78888764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=353.28 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=204.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------hhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~ 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-Q 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-S
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-C
Confidence 4578999999999999999999999999999999976531 133467889999999999999999999876 6
Q ss_pred CceEEEEeeCCCC-ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 435 GSLMLVYDYMENG-SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 435 ~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 7899999999777 9999997543 69999999999999999999999 999999999999999999999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~ 592 (705)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~ 236 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------T 236 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------G
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------H
Confidence 9987755432 234679999999999988776 8899999999999999999999965221 0
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...... .+......+.+++..||++||++|||+.++++.
T Consensus 237 ~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111233568899999999999999999999885
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.10 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=206.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEE
Confidence 56888999999999999999999999999999986432 2234678999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997653 58999999999999999999998 9999999999999999999999999999976543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... + ....+....
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-~~~~~~~~~------------ 228 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--E-THRRIVNVD------------ 228 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H-HHHHHHTTC------------
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--H-HHHHHhccc------------
Confidence 22 22357899999999999988999999999999999999999999764421 1 111111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++......+.+++..||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 12223334568899999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.37 Aligned_cols=196 Identities=26% Similarity=0.346 Sum_probs=156.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec----cCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~ 436 (705)
.++|...+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+++|++++||||+++++++... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36789999999999999999999999999999999654 234557799999999999999999999988532 256
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 469999986532 69999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCc--------------------------ceeeeeeccccCCCcccc-ccCCCCccccEEEEehhHHHHhhC
Q 005257 517 MHGHGQV--------------------------ASTTRVVGTVGYLAPEVF-SSGRASTQTDVFGFGILILEVLSG 565 (705)
Q Consensus 517 ~~~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~Gvvl~ElltG 565 (705)
....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 123446889999999986 456799999999999999999993
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=377.71 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=203.0
Q ss_pred eEEeecCceEEEEEEEc--CCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLE--GGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~--~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
+.||+|+||.||+|.+. .+++.||||+++... ....+++.+|+++|.+++||||++++++|. .+..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEEEccC
Confidence 47999999999999664 456899999997642 334678999999999999999999999985 346899999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc--
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV-- 523 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~-- 523 (705)
+|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999997543 68999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..+.. ..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~-----------~~ 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKGER-----------MG 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCC-----------CC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCC-----------CC
Confidence 22233456889999999999999999999999999999998 99999875432 22222322221 22
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+..+...+.+++..||+.||++||++.++++.|+....
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 333455678999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=337.74 Aligned_cols=249 Identities=21% Similarity=0.396 Sum_probs=202.3
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec---cCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE---KGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~---~~~~~l 439 (705)
.|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++... +..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467788999999999999999999999999998754 344567799999999999999999999987642 345899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEc-cCCCeeeeeeccce
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLD-KEMNGRLGDFGLAR 516 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld-~~~~~kL~DFGla~ 516 (705)
||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999997643 58999999999999999999998 77 99999999999998 78999999999997
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... .....||+.|+|||++. +.++.++|||||||++|||++|+.||...... .........+......
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~--- 251 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKPASF--- 251 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCCGGG---
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhccCCcccc---
Confidence 654332 23457899999999886 46899999999999999999999999764321 1222222222111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++..||+.||.+|||+.+++++
T Consensus 252 -------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 -------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122468899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.17 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=208.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence 35688899999999999999999999999999998654 23456778999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987643 68999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... + .+..+..+.
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-~~~~~~~~~----------- 257 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--E-TYLRIKKNE----------- 257 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H-HHHHHHHTC-----------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--H-HHHHHhcCC-----------
Confidence 3322 223357899999999999888999999999999999999999999764321 1 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.||++||++.|+++.
T Consensus 258 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222334567889999999999999999998873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.32 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=208.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEE
Confidence 357888999999999999999999999999999997653 3445778999999999999999999998886 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||+++++|.+++.... .+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999997654 58999999999999999999998 5 899999999999999999999999999875432
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh--------------
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-------------- 586 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-------------- 586 (705)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 22335789999999999999999999999999999999999999986543222211110000
Q ss_pred -------------CchhHHHHHhhhcC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 -------------GKLLDALDARLRAK--GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 -------------~~~~~~id~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+.++...... ..........+.+++..||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01111112111110 00111234568899999999999999999999884
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.58 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=198.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCC--CCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKH--KSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~ 438 (705)
.++|+..+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++.+++| |||+++++++.. +..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEE
Confidence 456889999999999999999985 57889999987543 3445778999999999986 999999999876 67899
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||| +.+++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 55789999997643 68999999999999999999999 9999999999999997 578999999999876
Q ss_pred CCCCcc-eeeeeeccccCCCcccccc-----------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh
Q 005257 519 GHGQVA-STTRVVGTVGYLAPEVFSS-----------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~----- 231 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLH----- 231 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHH-----
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHH-----
Confidence 543322 2334679999999999864 678999999999999999999999997643321 1111
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
..++.... ..++......+.+++..||+.||.+|||+.|++++..
T Consensus 232 ----~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 232 ----AIIDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ----HHHCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----HHhcCCcc--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11111111 2222233456789999999999999999999998644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=334.94 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=203.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc------hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|...+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeE
Confidence 468889999999999999999998899999999875422 136789999999999999999999999876 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC----Ceeeeeec
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDFG 513 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DFG 513 (705)
++||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 68999999999999999999998 9999999999999998877 79999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+...... .
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~--~ 230 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISAVNYD--F 230 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCC--C
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHhcccC--C
Confidence 9987654322 23357899999999999889999999999999999999999999765421 111122111110 0
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..... . .....+.+++..||+.||++||++.++++
T Consensus 231 ~~~~~--~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 231 DEEYF--S----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CHHHH--T----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cchhc--c----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000 1 12356889999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.86 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||.||++.+..+++.||+|++........+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEE
Confidence 4568889999999999999999998999999999986655556678999999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccceecC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~~~~ 519 (705)
|+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987643 58999999999999999999998 999999999999999 788999999999997654
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~--------~ 226 (304)
T 2jam_A 161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGYYE--------F 226 (304)
T ss_dssp CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCCCC--------C
T ss_pred CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCC--------C
Confidence 322 1234689999999999998999999999999999999999999976542 1122222222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...........+.+++..||+.||++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112334678899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=356.34 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=204.8
Q ss_pred CCCCcceEEeecCceEEEEEEEc---CCCeEEEEEEeccCC----chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHEN----DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
++|...+.||+|+||.||+|... .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.. ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~ 132 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 132 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-Cc
Confidence 57888999999999999999984 478999999986532 22345677899999999 69999999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 8999999999999999997643 58999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDA 592 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~ 592 (705)
+..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+..
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 8765443333444679999999999985 34789999999999999999999999754321 1111111
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKVL 636 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 636 (705)
........++......+.+++..||+.||++|| ++.|++++.
T Consensus 277 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 --RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --HHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111111233444456788999999999999999 899888754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=345.40 Aligned_cols=274 Identities=26% Similarity=0.394 Sum_probs=211.3
Q ss_pred cCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc--CCCCCcceeeeeee
Q 005257 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR--LKHKSLVGLRGWCK 431 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~ 431 (705)
.+..--....++|...+.||+|+||.||+|.+. ++.||||++.. ...+.+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 334344455678999999999999999999984 78999999853 344677888888877 79999999999987
Q ss_pred ecc---CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEEcc
Q 005257 432 REK---GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW-----EKKVLHRDIKSSNVLLDK 503 (705)
Q Consensus 432 ~~~---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDLkp~NILld~ 503 (705)
... ..+++||||+++|+|.+++.+. .+++.+++.++.|++.||.|||... ..+|+||||||+|||++.
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 643 2789999999999999999653 5899999999999999999999210 189999999999999999
Q ss_pred CCCeeeeeeccceecCCCCcc---eeeeeeccccCCCccccccCC------CCccccEEEEehhHHHHhhC---------
Q 005257 504 EMNGRLGDFGLARMHGHGQVA---STTRVVGTVGYLAPEVFSSGR------ASTQTDVFGFGILILEVLSG--------- 565 (705)
Q Consensus 504 ~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~s~ksDVwS~Gvvl~ElltG--------- 565 (705)
++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876554322 123357899999999997652 33689999999999999999
Q ss_pred -CCCCCCCCc--cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 566 -RRPIEEGKP--NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 566 -~~Pf~~~~~--~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.||..... ...+.....+........+..+ ....+....+.+++..||+.||++|||+.++++.|+...+
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhCCCCccc-----ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 778865321 1112222222221111000000 0123567789999999999999999999999999997765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.61 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=193.5
Q ss_pred CCCCcc-eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhcc-CCCCCcceeeeeeee---ccCceE
Q 005257 364 KGFSEE-NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGR-LKHKSLVGLRGWCKR---EKGSLM 438 (705)
Q Consensus 364 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~-l~Hpniv~l~g~~~~---~~~~~~ 438 (705)
++|... ++||+|+||+||+|.+..+++.||||+++. ...+.+|+.++.+ .+||||+++++++.. +...++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 689999999999999999999999999853 2456788888744 589999999998753 245689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeeccc
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFGLA 515 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFGla 515 (705)
+||||+++|+|.+++..... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999976432 369999999999999999999998 99999999999999997 788999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH-HHHHHHHHHhCchhHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL-VEMVWELMVQGKLLDALD 594 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~-~~~v~~~~~~~~~~~~id 594 (705)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..+...
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~---- 285 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 285 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC----
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc----
Confidence 8764332 2234688999999999999999999999999999999999999997643210 00011111111110
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
............+.+++..||+.||++|||+.|++++-
T Consensus 286 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000112345688999999999999999999999853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.96 Aligned_cols=262 Identities=15% Similarity=0.184 Sum_probs=205.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC--------CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcce---------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG--------GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG--------- 425 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~--------- 425 (705)
.++|...+.||+|+||.||+|.+.. .++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999986 3789999998644 45789999999999999988
Q ss_pred ------eeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 426 ------LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 426 ------l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
+++++...+...++||||+ +++|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 5666666567889999999 9999999986522 369999999999999999999999 9999999999999
Q ss_pred EEccCC--CeeeeeeccceecCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCC
Q 005257 500 LLDKEM--NGRLGDFGLARMHGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEE 571 (705)
Q Consensus 500 Lld~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~ 571 (705)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999866432211 11234789999999999998999999999999999999999999986
Q ss_pred CCccHHHHHHHHHHhCchhHHHHHhhhc-CCC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 572 GKPNLVEMVWELMVQGKLLDALDARLRA-KGG--FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 572 ~~~~~~~~v~~~~~~~~~~~~id~~l~~-~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
....... +..... .+...... ... ........+.+++..||+.||++||++.++++.|+...+
T Consensus 271 ~~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTED-IMKQKQ------KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHH-HHHHHH------HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHH-HHHHHH------hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 5322111 111100 00000000 000 000123568899999999999999999999999998765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.64 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=206.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.++.+++.||||++.... ....+.+.+|++++++++||||+++++++.. ...+++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEE
Confidence 357888999999999999999999999999999996542 2345678999999999999999999998876 678999
Q ss_pred EEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 440 VYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999976432 3369999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+..+
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---------- 408 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---------- 408 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----------
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----------
Confidence 54432 223358999999999999989999999999999999999999999764321 111111211111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTM 629 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 629 (705)
...++......+.+++..||+.||++||++
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 122333445678899999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=340.43 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=206.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee----------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR---------- 432 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---------- 432 (705)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999999889999999997543 356789999999999999999998753
Q ss_pred -----ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 433 -----EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 433 -----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
....+++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 13457999999999999999976432 268999999999999999999998 999999999999999999999
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..|+... .........+
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRDG 234 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHTT
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhcc
Confidence 9999999987655432 22346899999999999889999999999999999999999886421 1111111111
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. .+......+.+++..||+.||++|||+.|+++.|+....
T Consensus 235 ~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 I--------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp C--------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred c--------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 1 122223457889999999999999999999999986654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.27 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=199.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----C
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----G 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~ 435 (705)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999999999999999986542 334567899999999999999999999887532 3
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 78999998752 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDAL 593 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~i 593 (705)
+..... .+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+..... .|......
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 876432 233578999999999877 6799999999999999999999999986542 122111111 12111111
Q ss_pred HHh------------hhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DAR------------LRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~~------------l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... +.... .........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 110 00000 0111224568899999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.35 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=202.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .......+.+|+..+..+ +||||+++++++.. .+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEE
Confidence 45688899999999999999999988999999998764 334567789999999999 99999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCC-CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC--------------
Q 005257 440 VYDYMENGSLDKWIFQCDG-SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-------------- 504 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-------------- 504 (705)
||||+++++|.+++..... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 1368999999999999999999999 999999999999999844
Q ss_pred -----CCeeeeeeccceecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHH
Q 005257 505 -----MNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVE 578 (705)
Q Consensus 505 -----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~ 578 (705)
..+||+|||++........ ..||+.|+|||++.+. .++.++|||||||++|||++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4799999999987654322 3589999999999765 56789999999999999999988765431
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+..+..+.. ...+......+.+++..||+.||++|||+.|++++
T Consensus 236 -~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -QWHEIRQGRL-----------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHHTTCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHHcCCC-----------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1222222221 12222334568899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.44 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=194.5
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--------chhHHHHHHHHHHhccCCCCCcceeeeeeeec
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--------DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE 433 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 433 (705)
..++|...+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4568899999999999999999999999999999986532 112235789999999999999999999875
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---Ceeee
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM---NGRLG 510 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~---~~kL~ 510 (705)
....++||||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 446899999999999999886432 69999999999999999999998 9999999999999997544 59999
Q ss_pred eeccceecCCCCcceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC
Q 005257 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 511 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+..+
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~~ 360 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSG 360 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHTT
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhcC
Confidence 999998765432 2334689999999999853 568899999999999999999999997643210 011112222
Q ss_pred chhHHHHHhhhcCCCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 588 KLLDALDARLRAKGGFDED----EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. .+.+. ....+.+++..||+.||++||++.|++++
T Consensus 361 ~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KY------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 11111 23568899999999999999999999884
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.54 Aligned_cols=244 Identities=15% Similarity=0.142 Sum_probs=192.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHH---HHhccCCCCCcceee-------ee
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEI---SSLGRLKHKSLVGLR-------GW 429 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei---~~l~~l~Hpniv~l~-------g~ 429 (705)
.++|...+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999999743 334567899999 566666899999998 54
Q ss_pred eeeccC----------------ceEEEEeeCCCCChhHHHHhcC----CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005257 430 CKREKG----------------SLMLVYDYMENGSLDKWIFQCD----GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489 (705)
Q Consensus 430 ~~~~~~----------------~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 489 (705)
+...+. ..++||||+ +|+|.+++.... ....+++..++.++.||+.||.|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 443211 378999999 689999997632 11245678999999999999999999 999
Q ss_pred eecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccC-----------CCCccccEEEEehh
Q 005257 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-----------RASTQTDVFGFGIL 558 (705)
Q Consensus 490 iHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwS~Gvv 558 (705)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344577 999999999877 89999999999999
Q ss_pred HHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 559 ILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 559 l~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+|||++|+.||...... ..... .......+ ...+.+++..||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~------------~~~~~---~~~~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL------------GGSEW---IFRSCKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------------------CCSGG---GGSSCCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccc------------cchhh---hhhhccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999753310 00111 11111222 356788999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.27 Aligned_cols=265 Identities=23% Similarity=0.343 Sum_probs=209.6
Q ss_pred ccCHHHHHHHhCCCCcc-eEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCC-CCCcceeee
Q 005257 353 RITYQEIEAATKGFSEE-NVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLK-HKSLVGLRG 428 (705)
Q Consensus 353 ~~~~~el~~at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~-Hpniv~l~g 428 (705)
.+.++..+...++|... +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++ ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455566666777777 88999999999999999999999999987542 334678999999999994 699999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CC
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EM 505 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~ 505 (705)
++.. .+..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. ++
T Consensus 97 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 97 VYEN-TSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEC-SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBC
T ss_pred EEEe-CCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCC
Confidence 9876 6789999999999999999865322 369999999999999999999998 99999999999999997 78
Q ss_pred CeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 506 NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. ...+.
T Consensus 172 ~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~-~~~i~ 246 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ET-YLNIS 246 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH-HHHHH
T ss_pred cEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HH-HHHHH
Confidence 999999999987654322 23457999999999999999999999999999999999999999765431 11 11111
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ..............+.+++..||+.||++|||+.+++++
T Consensus 247 ~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVN--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcc--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111 000011112334568899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.13 Aligned_cols=263 Identities=16% Similarity=0.131 Sum_probs=207.3
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEE-----EcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC---CCCcceeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGV-----LEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK---HKSLVGLRGW 429 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~ 429 (705)
++....++|...+.||+|+||+||+|. ...+++.||||+++... ..++..|++++.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 444556789999999999999999994 55678899999996543 456677777777775 9999999999
Q ss_pred eeeccCceEEEEeeCCCCChhHHHHhcC--CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc----
Q 005257 430 CKREKGSLMLVYDYMENGSLDKWIFQCD--GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---- 503 (705)
Q Consensus 430 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---- 503 (705)
+.. .+..++||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 136 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 136 HLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEC-SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred eec-CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence 876 678899999999999999997532 23369999999999999999999998 99999999999999998
Q ss_pred -------CCCeeeeeeccceecCCC-CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc
Q 005257 504 -------EMNGRLGDFGLARMHGHG-QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN 575 (705)
Q Consensus 504 -------~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~ 575 (705)
++.+||+|||+++..... ........+||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 899999999999865422 223334568999999999999989999999999999999999999998643210
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHhccccCCCC
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRAR-PTMRQVVKVLEGKIEAGIEN 646 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~~~~ 646 (705)
.. .+...+. ... ..+.+.+++..|++.+|.+| |+++++.+.|+..++.....
T Consensus 292 ------------~~--~~~~~~~--~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~ 344 (365)
T 3e7e_A 292 ------------EC--KPEGLFR--RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344 (365)
T ss_dssp ------------EE--EECSCCT--TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ------------ce--eechhcc--ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhh
Confidence 00 0000111 111 23456678888999999999 78999999998887744443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.79 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=209.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+.|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEE
Confidence 346888999999999999999999899999999997653 3456789999999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999853 268999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+. . .
T Consensus 173 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~~~~~~~~~---------~--~ 237 (303)
T 3a7i_A 173 QIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--K-VLFLIPKNN---------P--P 237 (303)
T ss_dssp BCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-HHHHHHHSC---------C--C
T ss_pred ccc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--H-HHHHhhcCC---------C--C
Confidence 322 23357899999999999989999999999999999999999999765421 1 111111111 0 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.........+.+++..||+.||++|||+.+++++.
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 12223345688999999999999999999998854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.39 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=195.7
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
..++|...+.||+|+||+||+|.+..+++.||||+++.... ...+.+.+|++++++++||||+++++++.. +..+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEEE
Confidence 44679999999999999999999999999999999975532 234567899999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-----cCCCeeeeeecc
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-----KEMNGRLGDFGL 514 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-----~~~~~kL~DFGl 514 (705)
||||++ |+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999997654 58999999999999999999999 9999999999999994 455699999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDA 592 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~ 592 (705)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +........ +.....
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchh
Confidence 987653322 22345789999999999774 4899999999999999999999999765431 222111111 000000
Q ss_pred HHHhhhcCC----------CCC------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 LDARLRAKG----------GFD------EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 id~~l~~~~----------~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.-+...... ... ......+.+++..||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000000 000 0023567899999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=335.36 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=198.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEE
Confidence 357888999999999999999999889999999986532 2345678999999999999999999998876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999997653 58999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ......+..+.
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~---------- 227 (276)
T 2h6d_A 163 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRGGV---------- 227 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC----------
T ss_pred CCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCc----------
Confidence 4322 233578999999999987665 6899999999999999999999976432 11122222111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.||++|||+.+++++
T Consensus 228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11222234568899999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=349.32 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=197.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHH--HHHHhccCCCCCcceeeeeeee----ccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA--EISSLGRLKHKSLVGLRGWCKR----EKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~--Ei~~l~~l~Hpniv~l~g~~~~----~~~~ 436 (705)
.++|...+.||+|+||.||+|.. +++.||||++.... .+.+.. |+..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999987 47899999986432 333444 4445666899999999975532 2335
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC---------CeeecCCCCCCeEEccCCCe
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK---------KVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~---------~iiHrDLkp~NILld~~~~~ 507 (705)
+++||||+++|+|.+++... ..++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcE
Confidence 78999999999999999653 35899999999999999999998 6 99999999999999999999
Q ss_pred eeeeeccceecCCCCc-------ceeeeeeccccCCCcccccc-------CCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 508 RLGDFGLARMHGHGQV-------ASTTRVVGTVGYLAPEVFSS-------GRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 508 kL~DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|+....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987654321 11223468999999999976 356678999999999999999987765432
Q ss_pred cc--HHHHHHHHHHhCchhHHHHHhh---hcCCC------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 574 PN--LVEMVWELMVQGKLLDALDARL---RAKGG------FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 574 ~~--~~~~v~~~~~~~~~~~~id~~l---~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
.. ...............+.+.... ..... ........+.+++..||+.||++|||+.|+++.|+.++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 0000000000000111111000 00011 1224566799999999999999999999999999988763
Q ss_pred C
Q 005257 643 G 643 (705)
Q Consensus 643 ~ 643 (705)
.
T Consensus 320 ~ 320 (336)
T 3g2f_A 320 W 320 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=337.28 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=204.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC----chhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN----DGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~ 437 (705)
.++|...+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999899999999986542 3345789999999999999999999998853 34578
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||++++ |.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 7777766443 369999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCC-cceeeeeeccccCCCccccccCC--CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 518 HGHGQ-VASTTRVVGTVGYLAPEVFSSGR--ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 518 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~------ 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGKGS------ 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCC------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHhcCC------
Confidence 65322 22233457899999999987644 37899999999999999999999986432 11122222221
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 230 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12223344568899999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.11 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=205.8
Q ss_pred HhCCCCcceEEeecCceEEEEEE-----EcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGV-----LEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
..++|...+.||+|+||.||+|. ...++..||||++... .......+.+|+.++++++||||+++++++.. ..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CC
Confidence 34678999999999999999999 4456788999999754 33456679999999999999999999999876 66
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCC----CcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCee
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGS----MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGR 508 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~k 508 (705)
..++||||+++|+|.+++...... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 789999999999999999875321 358999999999999999999998 99999999999999984 44699
Q ss_pred eeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHh
Q 005257 509 LGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQ 586 (705)
Q Consensus 509 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~ 586 (705)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~ 260 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTS 260 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHhc
Confidence 999999975543221 12223467889999999988899999999999999999998 99999765421 12222222
Q ss_pred CchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 587 ~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.. ...+......+.+++..||+.||.+||++.++++.|+....
T Consensus 261 ~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 GGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 211 11223344678899999999999999999999999986544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.40 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=205.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEE
Confidence 356888999999999999999999889999999986543 3445788999999999999999999998876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999998543 268999999999999999999998 99999999999999999999999999999865432
Q ss_pred Cc-ceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 522 QV-ASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~-~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~--------- 227 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTY--------- 227 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHHTTCTT---------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhhcccc---------
Confidence 21 12234578999999999987664 78999999999999999999999765432111 1111111100
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00011233567889999999999999999998873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=356.17 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=169.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc----Cc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++|++++||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46789999999999999999999999999999999754 2344578899999999999999999999887533 57
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+++||||++ |+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 5999999653 269999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCcc---------------------eeeeeeccccCCCcccc-ccCCCCccccEEEEehhHHHHhhCCCCC
Q 005257 517 MHGHGQVA---------------------STTRVVGTVGYLAPEVF-SSGRASTQTDVFGFGILILEVLSGRRPI 569 (705)
Q Consensus 517 ~~~~~~~~---------------------~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~Gvvl~ElltG~~Pf 569 (705)
........ ..+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 23456899999999986 5567999999999999999999854444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.64 Aligned_cols=251 Identities=21% Similarity=0.354 Sum_probs=197.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCC--CCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLK--HKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.++.+++ ||||+++++++.. .+.+++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEE
Confidence 458899999999999999999875 8899999987543 345678999999999996 5999999998876 667999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 56889999997643 68999999999999999999998 9999999999999995 5789999999998765
Q ss_pred CCCcc-eeeeeeccccCCCcccccc-----------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC
Q 005257 520 HGQVA-STTRVVGTVGYLAPEVFSS-----------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 520 ~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~----- 279 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHA----- 279 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHH-----
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHH-----
Confidence 43322 2234579999999999865 368999999999999999999999997643321 11111
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.++.... ..++......+.+++..||+.||++||++.|++++-
T Consensus 280 ----~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 280 ----IIDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ----HHCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----HhCcccc--CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1111111 112222245678999999999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.76 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=207.4
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------hhHHHHHHHHHHhccC-CCCCcceeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------GGTRAFLAEISSLGRL-KHKSLVGLRG 428 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~Ei~~l~~l-~Hpniv~l~g 428 (705)
......++|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 344455679999999999999999999998899999999865431 1245678999999999 7999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
++.. ....++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 168 ~~~~-~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYES-SSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEB-SSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEee-CCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 8876 678999999999999999997643 68999999999999999999998 9999999999999999999999
Q ss_pred eeeeccceecCCCCcceeeeeeccccCCCcccccc------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR 315 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH
Confidence 999999987654432 234579999999999863 35788999999999999999999999764321 1112
Q ss_pred HHHhCchhHHHHHhhhcCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+..+.. .+.. .....+.+++..||+.||++|||+.+++++
T Consensus 316 ~i~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 MIMEGQY------------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHTCC------------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhCCC------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2222211 1111 123458899999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.83 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=202.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++..++||||+++++++.. .+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEE
Confidence 4678899999999999999999998899999999987766677889999999999999999999999876 668999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++++|.+++..... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999876433 58999999999999999999998 999999999999999999999999999975432111
Q ss_pred cceeeeeeccccCCCcccc-----ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 523 VASTTRVVGTVGYLAPEVF-----SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~-----~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
.......||+.|+|||++ ....++.++|||||||++|||++|+.||...... +.... ...+....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~~~------ 241 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK-IAKSDPPT------ 241 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH-HHHSCCCC------
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH-HhccCCcc------
Confidence 112235789999999998 3567899999999999999999999999765431 11111 11111000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+......+.+++..||+.||++|||+.+++++
T Consensus 242 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 ---LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01122234568899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=348.80 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=206.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC--------CCCcceeeeeeee--
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK--------HKSLVGLRGWCKR-- 432 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~--------Hpniv~l~g~~~~-- 432 (705)
.++|...++||+|+||+||+|.+..+++.||||++... ....+.+.+|+++++.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999998643 345677899999999996 7889999998863
Q ss_pred -ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCC-----
Q 005257 433 -EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEM----- 505 (705)
Q Consensus 433 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~----- 505 (705)
....+++||||+ +++|.+++..... ..+++.+++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 245789999999 5677776665432 269999999999999999999998 7 999999999999999775
Q ss_pred --------------------------------------------CeeeeeeccceecCCCCcceeeeeeccccCCCcccc
Q 005257 506 --------------------------------------------NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541 (705)
Q Consensus 506 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~ 541 (705)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876533 2334789999999999
Q ss_pred ccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc----HHHHHHHHH-HhCchhHHHH----------------------
Q 005257 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN----LVEMVWELM-VQGKLLDALD---------------------- 594 (705)
Q Consensus 542 ~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~----~~~~v~~~~-~~~~~~~~id---------------------- 594 (705)
.+..++.++|||||||++|||++|+.||...... ..+...... ..+.....+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9989999999999999999999999999754321 111111111 1111111100
Q ss_pred ------HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ------ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ------~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+......+.+++..||+.||++|||+.|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01111123466778889999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.30 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=204.9
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-------------hhHHHHHHHHHHhccCCCCCcceeee
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-------------GGTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
..++|...++||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45679999999999999999999999999999999875421 23567899999999999999999999
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC---
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM--- 505 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~--- 505 (705)
++.. ...+++||||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFED-KKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEC-SSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEc-CCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9876 678999999999999999997643 69999999999999999999999 9999999999999998775
Q ss_pred CeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 506 NGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 506 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||++|+.||..... ..+...+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~ 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE 260 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 699999999987755432 23357999999999987 4689999999999999999999999986543 12223333
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+........ . . .....+.+++..||+.||.+|||+.|++++
T Consensus 261 ~~~~~~~~~~-~---~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 KGKYYFDFND-W---K----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HCCCCCCHHH-H---T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCCCccc-c---C----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3321100000 0 1 123568899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.99 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=203.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeec-cCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKRE-KGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~-~~~~~lV~ 441 (705)
++|+..+.||+|+||+||+|.+..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++... ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999999989999999998643 3567899999999997 99999999988753 45689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-CeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~ 520 (705)
||+++++|.+++. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999884 48899999999999999999998 9999999999999999776 899999999987654
Q ss_pred CCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHH--HHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW--ELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~--~~~~~~~~~~~id~~l 597 (705)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .........+.++...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 432 223478999999999877 67899999999999999999999999765432211111 1111111111111100
Q ss_pred h-----------c----------CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 R-----------A----------KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~-----------~----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. . ...........+.+++..||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0 000011134678999999999999999999999884
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.71 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=195.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----C
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----G 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~ 435 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999999999999999999754 2344567899999999999999999999886533 2
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999974 78888742 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cc------
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GK------ 588 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~------ 588 (705)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.....+.. +.
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHH
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 8654322 223457899999999999989999999999999999999999999865421 111111111 00
Q ss_pred --hhHHHHHhhhcCCC---C-----------------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 --LLDALDARLRAKGG---F-----------------DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 --~~~~id~~l~~~~~---~-----------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+...+......... . .......+.+++..||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000000 0 11235678999999999999999999999884
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=342.28 Aligned_cols=285 Identities=23% Similarity=0.338 Sum_probs=206.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|...+.||+|+||+||+|.+..+++.||||++...... ....+.+|++++++++||||+++++++.. .+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEec
Confidence 4688899999999999999999989999999998654322 22245679999999999999999999876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|++ |+|.+++..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 997 599999876543 68999999999999999999998 999999999999999999999999999998654332
Q ss_pred cceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~---------------------- 209 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQ---------------------- 209 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH----------------------
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH----------------------
Confidence 2 2233578999999999876 56899999999999999999999999764421 00
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccccCC----CCCcchhhHHHHHHhhccccccccccccccCCC
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGI----ENETEDMDAYLLQQVKSKDMWANYSRSFGYGYA 677 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 677 (705)
+..+...+-.+.+...|........-.-..+... ..........+.+++..+..++|..|.++.+++
T Consensus 210 ---------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 210 ---------LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp ---------HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ---------HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 1111111222222222222111110000000000 000112344567788888889999999999999
Q ss_pred CCCCcccccccc
Q 005257 678 THPTFHDIRQSN 689 (705)
Q Consensus 678 ~hp~f~~~~~~~ 689 (705)
+||||.+.....
T Consensus 281 ~hp~f~~~~~~~ 292 (324)
T 3mtl_A 281 KHPFFLSLGERI 292 (324)
T ss_dssp TSGGGGGGCSTT
T ss_pred cChhhhhccccc
Confidence 999998876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.96 Aligned_cols=267 Identities=25% Similarity=0.330 Sum_probs=199.1
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-----hHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-----GTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
....++|...+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|++++++++||||+++++++.. .
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 84 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-K 84 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-T
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-C
Confidence 34457899999999999999999999988999999998654221 23468899999999999999999998876 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
...++||||+++ +|..++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 788999999986 8988886533 368999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-CchhHH
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKLLDA 592 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~~~~ 592 (705)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... +........ +.....
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEE 235 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTT
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChh
Confidence 987643322 22335789999999998764 5899999999999999999999998765421 111111110 100000
Q ss_pred HHHhhh---------cCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 593 LDARLR---------AKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 593 id~~l~---------~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.-+... .....+ ......+.+++..||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000000 000001 12236789999999999999999999999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.09 Aligned_cols=264 Identities=17% Similarity=0.224 Sum_probs=199.3
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec------
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE------ 433 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------ 433 (705)
+...++|...+.||+|+||.||+|.+..+++.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45677899999999999999999999999999999998654322 23699999999999999999988542
Q ss_pred -------------------------------cCceEEEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHH
Q 005257 434 -------------------------------KGSLMLVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYL 481 (705)
Q Consensus 434 -------------------------------~~~~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yL 481 (705)
...+++||||++ |+|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234889999998 5888877642 1223699999999999999999999
Q ss_pred hcCCCCCeeecCCCCCCeEEc-cCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhH
Q 005257 482 HEGWEKKVLHRDIKSSNVLLD-KEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILI 559 (705)
Q Consensus 482 H~~~~~~iiHrDLkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl 559 (705)
|+ .+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 98 9999999999999998 688999999999987654432 2335789999999998764 489999999999999
Q ss_pred HHHhhCCCCCCCCCccHHHHHHHHHH-hCc-hhHHHHHh---hhc-----C------CCCCHHHHHHHHHHHHHcCCCCC
Q 005257 560 LEVLSGRRPIEEGKPNLVEMVWELMV-QGK-LLDALDAR---LRA-----K------GGFDEDEVERVLHLGLLCAYPDP 623 (705)
Q Consensus 560 ~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~-~~~~id~~---l~~-----~------~~~~~~~~~~l~~l~~~Cl~~dP 623 (705)
|||++|+.||...... +.....+. .|. ..+.+... ... . ..++......+.+++..||+.||
T Consensus 233 ~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999865431 22211111 111 11111100 000 0 00111234568899999999999
Q ss_pred CCCCCHHHHHHH
Q 005257 624 RARPTMRQVVKV 635 (705)
Q Consensus 624 ~~RPs~~evl~~ 635 (705)
++|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=375.94 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=209.1
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCce
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 437 (705)
..++|...+.||+|+||.||+|.+..+++.||||+++.. .....+.+..|..++..+ +||||+++++++.. .+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence 456799999999999999999999999999999998753 234456788999999988 79999999998765 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+|||||+++|+|..++.... .+++.+++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999998654 69999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+..+
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~---------- 557 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEH---------- 557 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHSS----------
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHHhC----------
Confidence 443322 23446899999999999999999999999999999999999999987543 1122222222
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTM-----RQVVK 634 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 634 (705)
...++......+.+++..||+.||++||++ +||++
T Consensus 558 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 123344445678899999999999999997 66665
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=363.49 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=201.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||+||+|.+..++..||||++.... ....+.+.+|+.+++.++||||++++++|.. ....++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 446888999999999999999999999999999987653 3346788999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DFGla~~ 517 (705)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887643 68999999999999999999998 999999999999999764 4599999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... ....+||+.|+|||++. +.++.++||||+||++|||++|+.||..... ..+...+..+.....
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~----- 257 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKYTFD----- 257 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC-----
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----
Confidence 764432 23457999999999986 4699999999999999999999999986543 122222222221100
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||.+|||+.|++++
T Consensus 258 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 ---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00001223567899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=355.31 Aligned_cols=200 Identities=20% Similarity=0.262 Sum_probs=173.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC------CCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL------KHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l------~Hpniv~l~g~~~~~~~~ 436 (705)
..+|...+.||+|+||+||+|.+..+++.||||++... ....+.+.+|++++..+ +|+||+++++++.. .+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCe
Confidence 45688899999999999999999999999999999643 33446677888887777 57799999998876 678
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC--eeeeeecc
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN--GRLGDFGL 514 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~--~kL~DFGl 514 (705)
+++||||+. ++|.+++...... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6999999775433 58999999999999999999998 89999999999999999887 99999999
Q ss_pred ceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCC
Q 005257 515 ARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGK 573 (705)
Q Consensus 515 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~ 573 (705)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9765432 223578999999999999899999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.45 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=205.2
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc----Cc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK----GS 436 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~ 436 (705)
..++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++.+++||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3467999999999999999999999999999999997543 334577899999999999999999999886432 46
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++||||++ |+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 5999988652 58999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCcce--eeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchhHH
Q 005257 517 MHGHGQVAS--TTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLLDA 592 (705)
Q Consensus 517 ~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~~~ 592 (705)
......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+....... ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~ 255 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQED 255 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC-CHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC-CHHH
Confidence 765332211 234589999999998754 45899999999999999999999999765432 111111111110 0000
Q ss_pred H-----------HHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 L-----------DARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 i-----------d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+ ...+......+ ......+.+++..||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000001111 1123568899999999999999999999884
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=362.96 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=207.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEE
Confidence 456888999999999999999999999999999986542 3456789999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE---ccCCCeeeeeeccce
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL---DKEMNGRLGDFGLAR 516 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl---d~~~~~kL~DFGla~ 516 (705)
||||+.+|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999987543 69999999999999999999999 999999999999999 467899999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+...+..+.....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~---- 247 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVEKGKYTFE---- 247 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 7654432 233579999999999865 6999999999999999999999999865431 12222322221100
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|++++
T Consensus 248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00001234568899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=338.97 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=203.1
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
..++|...+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++.+++||||+++++++.. .+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEe
Confidence 4567899999999999999999999889999999997543 45778999999999999999999999876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999974332 68999999999999999999998 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ... .....
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~---------~~~~~ 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMI-PTN---------PPPTF 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH-HHS---------CCCCC
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH-hcC---------CCccc
Confidence 22 223357899999999999888999999999999999999999999765421 111111 111 00001
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+......+.+++..||+.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234568899999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.38 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEE
Confidence 568889999999999999999999999999999865432 334568899999999999999999999876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988765433 58999999999999999999999 99999999999999999999999999999865443
Q ss_pred CcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHH-HHhCchhHHHHHhhhc
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWEL-MVQGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~-~~~~~~~~~id~~l~~ 599 (705)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +..... ...+............
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHhhh
Confidence 22 22335789999999999775 7899999999999999999999999875432 111111 1112111110000000
Q ss_pred ----C--------CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 ----K--------GGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ----~--------~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ...+ ....+.+.+++..||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000 1224678899999999999999999998874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=346.06 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=202.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-------c
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-------K 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-------~ 434 (705)
++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|+++++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999999899999999986553 23356788999999999999999999998753 3
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
+.+++||||+++ +|.+.+..... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 78777765432 59999999999999999999999 9999999999999999999999999999
Q ss_pred ceecCCCCc---ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 515 ARMHGHGQV---ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 515 a~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .+...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL-CGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Confidence 987653221 22234578999999999876 45899999999999999999999999875432111111111 11111
Q ss_pred HHHHHhhh-----cC------CCCC-HH------HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDARLR-----AK------GGFD-ED------EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~l~-----~~------~~~~-~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...-+... .. .... .+ ....+.+++..||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 00 0000 00 12457899999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.78 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=205.9
Q ss_pred hCCCCcceEEeecCceEEEEEEE-cCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC------cceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVL-EGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS------LVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|++++..++|++ ++++++++.. .+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CC
Confidence 46789999999999999999998 557899999998643 344567889999999987665 8999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc------------
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK------------ 503 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~------------ 503 (705)
..++||||+ +++|.+++..... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 899999999 8899999976543 268999999999999999999998 99999999999999987
Q ss_pred -------CCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH
Q 005257 504 -------EMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576 (705)
Q Consensus 504 -------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~ 576 (705)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998754322 23578999999999999899999999999999999999999998654321
Q ss_pred HHHHHHHHHhCchhHHHHH------------------------------hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 005257 577 VEMVWELMVQGKLLDALDA------------------------------RLRAKGGFDEDEVERVLHLGLLCAYPDPRAR 626 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~------------------------------~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 626 (705)
......... +.....+.. .+...........+.+.+++..||+.||++|
T Consensus 242 ~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 111111111 111111100 0000111233556789999999999999999
Q ss_pred CCHHHHHHH
Q 005257 627 PTMRQVVKV 635 (705)
Q Consensus 627 Ps~~evl~~ 635 (705)
||+.|++++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.79 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=203.9
Q ss_pred cCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeee
Q 005257 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR 432 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 432 (705)
+.+.++....++|...+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444455567788999999999999999999998889999999986543 3457889999999999 89999999999875
Q ss_pred c-----cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 433 E-----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 433 ~-----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
. ...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 3 3578999999999999999976432 268999999999999999999999 999999999999999999999
Q ss_pred eeeeeccceecCCCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHH
Q 005257 508 RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~ 582 (705)
||+|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... .....
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~ 245 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFL 245 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHH
Confidence 9999999986543221 223357899999999986 467899999999999999999999999765421 11111
Q ss_pred HHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 583 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ...... ..........+.+++..||..||.+||++.+++++
T Consensus 246 ~-~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 I-PRNPAP----------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-HHSCCC----------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred h-hcCccc----------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 111000 01112233568899999999999999999999884
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=335.35 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=189.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hh-HHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GG-TRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|+..+.||+|+||+||+|.+..+++.||||++..... .. .+.+.++...++.++||||+++++++.. ++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEE
Confidence 4678889999999999999999998999999999976532 22 2334555566888999999999999886 6789999
Q ss_pred EeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 441 YDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
|||++ |+|.+++... .....+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5888887642 223379999999999999999999998 7 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeeccccCCCcccc----ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVF----SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ...........
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~------ 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQVVEEPS------ 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHHHHSCC------
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHHhccCC------
Confidence 54322 2234789999999996 45678999999999999999999999997643321 11111111111
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
. ..........+.+++..||+.||++|||+.|+++
T Consensus 232 ---~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ---P--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---C--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 1111223456889999999999999999999988
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.58 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=204.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||+||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.. ...+++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEE
Confidence 45688999999999999999999989999999998643 23346788999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc---cCCCeeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD---KEMNGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld---~~~~~kL~DFGla~~ 517 (705)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887653 68999999999999999999999 9999999999999995 456799999999986
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
..... .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+...+..+.....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~----- 242 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFD----- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSC-----
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 65432 2233579999999999875 5999999999999999999999999765431 12222222221100
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+++..||+.||++|||+.|++++
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001223567899999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.35 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=187.0
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
...++|...+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++.+++||||+++++++.. .+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEE
Confidence 34578999999999999999999998889999999986543 3345678999999999999999999998876 668899
Q ss_pred EEeeCCCCChhHHHHhc-----CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 440 VYDYMENGSLDKWIFQC-----DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999742 122368999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCc----ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch
Q 005257 515 ARMHGHGQV----ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 515 a~~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~~ 244 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTL-QNDP 244 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHH-TSSC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHh-ccCC
Confidence 976543221 11233578999999999865 568999999999999999999999998654321 111111 1110
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. ....... ..........+.+++..||+.||.+||++.+++++
T Consensus 245 ~~-~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PS-LETGVQD-KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CC-TTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Cc-ccccccc-chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0000000 00111223567889999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.49 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=206.4
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---------chhHHHHHHHHHHhccCC-CCCcceeeeeee
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---------DGGTRAFLAEISSLGRLK-HKSLVGLRGWCK 431 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---------~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~ 431 (705)
..++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568899999999999999999999999999999997543 122456889999999996 999999999887
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGD 511 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~D 511 (705)
. +...++||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 95 ~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 T-NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp C-SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred c-CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 5 678999999999999999997643 68999999999999999999998 9999999999999999999999999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccc------cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFS------SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
||++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+.
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~ 242 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMIM 242 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHHHh
Confidence 999987654332 23357899999999985 456889999999999999999999999764421 1112222
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.+... ............+.+++..||+.||++|||+.|+++
T Consensus 243 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22110 000011233467889999999999999999999886
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.84 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=196.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----CceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----GSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~~ 438 (705)
.+|...+.||+|+||.||+|.+..+++.||||++..... ...+|+++|++++||||+++++++.... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 357888999999999999999998899999999865432 2346999999999999999999885422 2367
Q ss_pred EEEeeCCCCChhHHHHhc-CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeeeccce
Q 005257 439 LVYDYMENGSLDKWIFQC-DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLAR 516 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DFGla~ 516 (705)
+||||+++ +|.+.+... .....+++..+..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 666665431 223369999999999999999999998 999999999999999965 568999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cc-hhHHH
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GK-LLDAL 593 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~-~~~~i 593 (705)
....... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+.+.+.. |. ..+.+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 7654332 2335789999999998764 789999999999999999999999987542 1222222111 11 11111
Q ss_pred HHhhhcCC--------C------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DARLRAKG--------G------FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~~l~~~~--------~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........ . +.......+.+|+.+||+.||.+||++.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11000000 0 111224678899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.55 Aligned_cols=272 Identities=22% Similarity=0.283 Sum_probs=201.2
Q ss_pred CHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-----------hHHHHHHHHHHhccCCCCCc
Q 005257 355 TYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-----------GTRAFLAEISSLGRLKHKSL 423 (705)
Q Consensus 355 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-----------~~~~~~~Ei~~l~~l~Hpni 423 (705)
..+++....++|...+.||+|+||.||+|.+.. ++.||||++...... ..+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356778889999999999999999999999865 889999998653221 23789999999999999999
Q ss_pred ceeeeeeeec----cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 424 VGLRGWCKRE----KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 424 v~l~g~~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
+++++++... ...+++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 9999988542 236899999997 68888887533 369999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCcc-HH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPN-LV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~ 577 (705)
|++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999997544332 2234578999999999876 67899999999999999999999999865421 11
Q ss_pred HHHHHHHHhCchhHHH-----------HHhhhcCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 578 EMVWELMVQGKLLDAL-----------DARLRAKGGF-----DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~i-----------d~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+..........+.. ...+...... .......+.+++..||+.||++|||+.|++++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111111111100 0000000000 01123568899999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.59 Aligned_cols=270 Identities=19% Similarity=0.234 Sum_probs=194.4
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG- 435 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~- 435 (705)
.+.....++|...+.||+|+||.||+|.+..+++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566788999999999999999999999899999999986542 334456788888999999999999999865222
Q ss_pred -----ceEEEEeeCCCCChhHHHHh-cCCCCcccHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeEEcc-CCC
Q 005257 436 -----SLMLVYDYMENGSLDKWIFQ-CDGSMMLSCEERIRVLKDVAAGVLYLH--EGWEKKVLHRDIKSSNVLLDK-EMN 506 (705)
Q Consensus 436 -----~~~lV~E~~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~iiHrDLkp~NILld~-~~~ 506 (705)
.+++||||+++ +|...+.. ......+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 27899999986 55544432 233346899999999999999999999 7 99999999999999996 899
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHH
Confidence 99999999987654332 2234789999999998664 4899999999999999999999999875431 11111111
Q ss_pred -hCchhHHHHHhhhc---------C---------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 586 -QGKLLDALDARLRA---------K---------GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 586 -~~~~~~~id~~l~~---------~---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+.........+.. . ..........+.+++..||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01111111000000 0 11111245678999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.95 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=199.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-CC--eEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-GG--AEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||+||+|.+.. ++ ..||||+++.. .....+.+.+|++++++++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PP 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--CC
Confidence 3568889999999999999998743 22 36999998754 33456789999999999999999999998875 34
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.++|+||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 889999999999999997643 258999999999999999999999 999999999999999999999999999998
Q ss_pred ecCCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 517 MHGHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 517 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
......... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||...... +.. ..+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~-~~~~~~~~---- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL-HKIDKEGE---- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH-HHHHTSCC----
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHH-HHHHccCC----
Confidence 775443221 223467889999999988889999999999999999999 99999765421 111 11111100
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
. ...+......+.+++..||+.||++||++.++++.|++..+
T Consensus 243 ----~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 ----R--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----C--CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 11222344678899999999999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.34 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=198.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------hhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------GGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 4568889999999999999999999999999999865421 223458899999999999999999998864
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeee
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGD 511 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~D 511 (705)
...++||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 3489999999999999988643 268999999999999999999998 99999999999999987664 99999
Q ss_pred eccceecCCCCcceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 512 FGLARMHGHGQVASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 512 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
||+++....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...+..+.
T Consensus 161 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 236 (322)
T 2ycf_A 161 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGK 236 (322)
T ss_dssp CTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHTC
T ss_pred Cccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhCc
Confidence 999987654321 22346899999999974 4678999999999999999999999997643210 0111122221
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... .+... . .....+.+++..||+.||++||++.+++++
T Consensus 237 ~~~--~~~~~--~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNF--IPEVW--A----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCC--CHHHH--T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc--Cchhh--h----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 100 00000 1 123568899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=347.00 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=187.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-----cC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~ 435 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46889999999999999999999999999999998654 233456789999999999999999999988642 25
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899998854 269999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHH-
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDA- 592 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~- 592 (705)
+..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... .+.+..... .|.....
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 865432 334678999999999877 6789999999999999999999999986543 111111111 1111000
Q ss_pred -----------HHHhhhcCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 593 -----------LDARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 593 -----------id~~l~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+........ .....+.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0011110011111 113567899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=332.76 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=197.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec---------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE--------- 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--------- 433 (705)
.++|+..+.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4568889999999999999999998899999999854 334567789999999999999999999987642
Q ss_pred ---cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeee
Q 005257 434 ---KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510 (705)
Q Consensus 434 ---~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~ 510 (705)
....++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 346899999999999999997643 368889999999999999999999 999999999999999999999999
Q ss_pred eeccceecCCCC-------------cceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccH
Q 005257 511 DFGLARMHGHGQ-------------VASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576 (705)
Q Consensus 511 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~ 576 (705)
|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 999998654321 1122345789999999999764 68999999999999999998 5543211
Q ss_pred HHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+.... ......++......+.+++..||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRSVS--------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHSTT--------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhccccc--------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111110 111122334455678899999999999999999999884
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=369.33 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=209.2
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcC---CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEG---GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
....++|...+.||+|+||.||+|.+.. .+..||||++.... ....+.+.+|+.++++++||||+++++++. ++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~ 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--EN 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cC
Confidence 3445678889999999999999999864 34679999987543 334577999999999999999999999884 45
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 68999999999999999976432 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
+..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+..+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~~~~~----- 610 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGER----- 610 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHHTCC-----
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCC-----
Confidence 8775544333344567889999999998899999999999999999997 99999765431 11122222111
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+......+.+++..||+.||++|||+.++++.|+...+
T Consensus 611 ------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12233445678899999999999999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.32 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=197.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee----------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR---------- 432 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---------- 432 (705)
.++|...+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999999999999999999987766677889999999999999999999998742
Q ss_pred ---ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCee
Q 005257 433 ---EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGR 508 (705)
Q Consensus 433 ---~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~k 508 (705)
.....++||||++ |+|.+++.+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEE
Confidence 2457899999997 699999853 258999999999999999999998 9999999999999997 567999
Q ss_pred eeeeccceecCCCCc--ceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 509 LGDFGLARMHGHGQV--ASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 509 L~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
|+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +.......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 999999987643221 11223457899999998865 67899999999999999999999999865431 11111111
Q ss_pred hCch-------------hHHHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 586 QGKL-------------LDALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 586 ~~~~-------------~~~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... ...+...... ...+ ......+.+++..||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTE-PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTS-CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccC-CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1100 0011111110 0001 1124568899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.97 Aligned_cols=268 Identities=19% Similarity=0.226 Sum_probs=206.7
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CC-----Ccceeeeee
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HK-----SLVGLRGWC 430 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hp-----niv~l~g~~ 430 (705)
+......++|...+.||+|+||+||+|.+..+++.||||+++.. ....+++..|+.++..++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 33445568899999999999999999999999999999999643 334566788888888885 44 489999988
Q ss_pred eeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc--cCCCee
Q 005257 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD--KEMNGR 508 (705)
Q Consensus 431 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld--~~~~~k 508 (705)
.. .+..++||||++ |+|.+++...... .+++..+..++.|++.||.|||. .+.+|+||||||+|||++ .++.+|
T Consensus 126 ~~-~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MF-RNHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EE-TTEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred cc-CCceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEE
Confidence 76 678999999996 5999999775433 58999999999999999999994 137999999999999995 577899
Q ss_pred eeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hC
Q 005257 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QG 587 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~ 587 (705)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..... .+
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~~~i~~~~~ 275 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV--DQMNKIVEVLG 275 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 9999999876533 22357899999999999999999999999999999999999999865431 11111111 11
Q ss_pred chhHHHHHh---------------------------------------h-----------hcCCCCCHHHHHHHHHHHHH
Q 005257 588 KLLDALDAR---------------------------------------L-----------RAKGGFDEDEVERVLHLGLL 617 (705)
Q Consensus 588 ~~~~~id~~---------------------------------------l-----------~~~~~~~~~~~~~l~~l~~~ 617 (705)
.....+... + .........+...+.+++..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 111100000 0 00011223445678999999
Q ss_pred cCCCCCCCCCCHHHHHHH
Q 005257 618 CAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 618 Cl~~dP~~RPs~~evl~~ 635 (705)
||+.||++|||+.|++++
T Consensus 356 mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred hcCCChhhCCCHHHHhcC
Confidence 999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.85 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=205.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchh-----------------HHHHHHHHHHhccCCCCCcce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGG-----------------TRAFLAEISSLGRLKHKSLVG 425 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~-----------------~~~~~~Ei~~l~~l~Hpniv~ 425 (705)
.++|...+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.++.+++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 68999999986542111 178999999999999999999
Q ss_pred eeeeeeeccCceEEEEeeCCCCChhHH------HHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 426 LRGWCKREKGSLMLVYDYMENGSLDKW------IFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 426 l~g~~~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
+++++.. .+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ ..+++||||||+||
T Consensus 108 ~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp CSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred EEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 9999876 6789999999999999998 54321 3479999999999999999999996 38999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccC-CCCc-cccEEEEehhHHHHhhCCCCCCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG-RAST-QTDVFGFGILILEVLSGRRPIEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~ 577 (705)
+++.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876543 23345789999999999877 5666 999999999999999999999865431
Q ss_pred HHHHHHHHhCchhHHHHH-----hhhc--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 578 EMVWELMVQGKLLDALDA-----RLRA--KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~-----~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
......+..+......+. .... ...........+.+++..||+.||++|||+.|++++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112222322221100000 0000 000002234678899999999999999999999884
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.07 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=194.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-----ceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG-----SLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~-----~~~ 438 (705)
.+|...+.||+|+||.||+|.+..+++ ||+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999987655 899988644322 2369999999999999999999865332 278
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCeeeeeecccee
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGRLGDFGLARM 517 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~kL~DFGla~~ 517 (705)
+||||++++.+............+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875444433322223479999999999999999999999 9999999999999999 799999999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCc-hhHHHH
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGK-LLDALD 594 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~-~~~~id 594 (705)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.....+. .|. ..+.+.
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 654432 2235789999999998764 5899999999999999999999999875431 22211111 011 111111
Q ss_pred ---Hhhhc-----CCC------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ---ARLRA-----KGG------FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ---~~l~~-----~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.... ... +.......+.+++..||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 10000 000 111133578899999999999999999999885
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=340.99 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=198.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-----
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG----- 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 435 (705)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999999999999999997643 3345778999999999999999999999875332
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||+. ++|.+++.. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 2399999997 688887732 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhH--
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLD-- 591 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~-- 591 (705)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....... .+....
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCcHHH
Confidence 865432 233578999999999877 6789999999999999999999999986542 122211111 011000
Q ss_pred ----------HHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ----------ALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ----------~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+....... ......+.+++..||+.||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0001111000000 1124578899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=338.43 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=205.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-----------CCCcceeeeeee
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-----------HKSLVGLRGWCK 431 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~g~~~ 431 (705)
.++|...+.||+|+||+||+|.+..+++.||||++... ....+.+.+|++++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35789999999999999999999989999999998643 334567889999999886 899999999887
Q ss_pred ecc---CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEc-----
Q 005257 432 REK---GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLD----- 502 (705)
Q Consensus 432 ~~~---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld----- 502 (705)
... ..+++||||+ +++|.+++...... .+++..+..++.||+.||.|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 532 2689999999 88999999775433 58999999999999999999998 7 999999999999995
Q ss_pred -cCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc----HH
Q 005257 503 -KEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN----LV 577 (705)
Q Consensus 503 -~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~----~~ 577 (705)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3447999999999876532 22347899999999999989999999999999999999999999754321 11
Q ss_pred HHHHHHH-HhCchhHHH----------------------------HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 005257 578 EMVWELM-VQGKLLDAL----------------------------DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT 628 (705)
Q Consensus 578 ~~v~~~~-~~~~~~~~i----------------------------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 628 (705)
+.+.... ..+.....+ ...+.....++......+.+++..||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111 011111110 11112223456778889999999999999999999
Q ss_pred HHHHHHH
Q 005257 629 MRQVVKV 635 (705)
Q Consensus 629 ~~evl~~ 635 (705)
+.|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=338.39 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=202.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeec----cCce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGSL 437 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~~ 437 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5688999999999999999999998999999999965433 3456788999999999999999999987643 2678
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||++ |+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 6999988652 58999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcc---------eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccH-HHHHHHHHHh
Q 005257 518 HGHGQVA---------STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNL-VEMVWELMVQ 586 (705)
Q Consensus 518 ~~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~-~~~v~~~~~~ 586 (705)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6533211 1223578999999998754 678999999999999999999999998654211 1111111100
Q ss_pred Cc---------h--hHHHHHhhhcCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 587 GK---------L--LDALDARLRAKGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 587 ~~---------~--~~~id~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.. . .......+....... ......+.+++..||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0 000000000000000 1223567899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.16 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=203.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-eEEEEEEeccCCchhHHHHHHHHHHhccCCCCC------cceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-AEIAVKRISHENDGGTRAFLAEISSLGRLKHKS------LVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~ 435 (705)
.++|...+.||+|+||.||+|.+..++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++.. .+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CC
Confidence 468999999999999999999997666 78999998643 344567889999999998766 8888887776 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE--------------
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL-------------- 501 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl-------------- 501 (705)
..++||||+ +++|.+++...... .+++.+++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence 899999999 66777777664432 69999999999999999999998 999999999999999
Q ss_pred -----ccCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH
Q 005257 502 -----DKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL 576 (705)
Q Consensus 502 -----d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~ 576 (705)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 667899999999998754322 23578999999999999999999999999999999999999998654321
Q ss_pred HHHHHHHHHhCchhHHHHHhh------------------------------hcCCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 005257 577 VEMVWELMVQGKLLDALDARL------------------------------RAKGGFDEDEVERVLHLGLLCAYPDPRAR 626 (705)
Q Consensus 577 ~~~v~~~~~~~~~~~~id~~l------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 626 (705)
........ .+.....+.... .........+...+.+++..||+.||++|
T Consensus 247 ~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEKI-LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHH-HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHH-cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 11111111 111111111000 00011223445678999999999999999
Q ss_pred CCHHHHHHH
Q 005257 627 PTMRQVVKV 635 (705)
Q Consensus 627 Ps~~evl~~ 635 (705)
||+.|++++
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.88 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=205.1
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
..++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEE
Confidence 346789999999999999999999988999999998654 23456789999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC---CCeeeeeeccce
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE---MNGRLGDFGLAR 516 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~---~~~kL~DFGla~ 516 (705)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999887643 58999999999999999999998 999999999999999764 469999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .+...+..+.....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---- 242 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFD---- 242 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 6654332 223468999999999875 5899999999999999999999999765421 12222222221100
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... .......+.+++..||+.||++|||+.|+++.
T Consensus 243 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 LPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 01223568899999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.53 Aligned_cols=256 Identities=14% Similarity=0.053 Sum_probs=183.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccC--CCCCcceee-------eee
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRL--KHKSLVGLR-------GWC 430 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l--~Hpniv~l~-------g~~ 430 (705)
..+|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458889999999999999999998999999999987543 3345677785444444 699988744 333
Q ss_pred eecc----------------CceEEEEeeCCCCChhHHHHhcCCCCcccHHHH------HHHHHHHHHHHHHHhcCCCCC
Q 005257 431 KREK----------------GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER------IRVLKDVAAGVLYLHEGWEKK 488 (705)
Q Consensus 431 ~~~~----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ 488 (705)
...+ ..+++||||++ |+|.+++...+. .+.+..+ ..++.||+.||+|||+ ++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 3211 33799999998 899999986432 3455555 7888999999999998 99
Q ss_pred eeecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCC
Q 005257 489 VLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGR 566 (705)
Q Consensus 489 iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~ 566 (705)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876432 113467799999999987 67999999999999999999999
Q ss_pred CCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 567 RPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 567 ~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.||......... .+.............. ..........+.+++..||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKG----SWKRPSLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTT----CCCBCCTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCccccc----chhhhhhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999765321000 0000000000000000 0111233467889999999999999999999876
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.21 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEc-CCCeEEEEEEeccCC--chhHHHHHHHHHHhccC---CCCCcceeeeeeee--
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLE-GGGAEIAVKRISHEN--DGGTRAFLAEISSLGRL---KHKSLVGLRGWCKR-- 432 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~-- 432 (705)
.+.++|...+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999995 678999999986432 22234566777777666 89999999998862
Q ss_pred --ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeee
Q 005257 433 --EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLG 510 (705)
Q Consensus 433 --~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~ 510 (705)
.....++||||++ |+|.+++...... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 3457899999998 6999999775433 58999999999999999999999 999999999999999999999999
Q ss_pred eeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHh-Cch
Q 005257 511 DFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ-GKL 589 (705)
Q Consensus 511 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~-~~~ 589 (705)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ +..
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~ 238 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLP 238 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCC
Confidence 999998654322 223357899999999999889999999999999999999999999865431 111111110 000
Q ss_pred h-HHH-------HHhhhc-----CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 L-DAL-------DARLRA-----KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ~-~~i-------d~~l~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ... ...... ...+.......+.+++..||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000 000000 000112234567899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.41 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=202.2
Q ss_pred HHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeecc
Q 005257 357 QEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK 434 (705)
Q Consensus 357 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 434 (705)
++.....++|...+.||+|+||.||+|.+.. .+|+|+++... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-P 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-S
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-C
Confidence 3344456788999999999999999999864 39999987542 2334567889999999999999999999886 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCC
Confidence 67999999999999999996543 268999999999999999999999 9999999999999998 67999999999
Q ss_pred ceecCCCC----cceeeeeeccccCCCcccccc---------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHH
Q 005257 515 ARMHGHGQ----VASTTRVVGTVGYLAPEVFSS---------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVW 581 (705)
Q Consensus 515 a~~~~~~~----~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~ 581 (705)
++...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 87653211 112223468999999999864 35789999999999999999999999765432 111
Q ss_pred HHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 582 ELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 582 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+..+... ..........+.+++..||+.||++|||+.++++.|+...+
T Consensus 253 ~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 253 WQMGTGMKP----------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHTTCCC----------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHhccCCCC----------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 122222110 00111223467899999999999999999999999997655
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.94 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=199.1
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC-----
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG----- 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 435 (705)
.++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 457888999999999999999999999999999997543 2345678999999999999999999998875332
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
..++||||++ ++|.+++.. .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 3599999997 588887732 58999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDAL 593 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~i 593 (705)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....... .+......
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCCHHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 865432 233578999999999877 6789999999999999999999999986542 121111111 11110000
Q ss_pred ------------HHhhhcC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 ------------DARLRAK-----GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 ------------d~~l~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+... ..........+.+++..||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 01112335678899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=335.15 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=176.4
Q ss_pred HhCCCCcc-eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHH-HHhccCCCCCcceeeeeeeec---cCc
Q 005257 362 ATKGFSEE-NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEI-SSLGRLKHKSLVGLRGWCKRE---KGS 436 (705)
Q Consensus 362 at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei-~~l~~l~Hpniv~l~g~~~~~---~~~ 436 (705)
..++|... ++||+|+||.||+|.+..+++.||||++.... ...+|+ ..+..++||||+++++++... +..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35678874 46999999999999999999999999986431 122233 345667999999999988642 345
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeec
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFG 513 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFG 513 (705)
+++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 8999999999999999986543 369999999999999999999999 99999999999999986 4559999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHH
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDA 592 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~ 592 (705)
+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..+
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 248 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG----- 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-----
Confidence 998664322 2335789999999999888899999999999999999999999975432111 0000000000
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHhc
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK--VLEGK 639 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 639 (705)
...............+.+++..||+.||++|||+.|+++ ++.+.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000001111233456889999999999999999999998 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.01 Aligned_cols=263 Identities=21% Similarity=0.353 Sum_probs=200.6
Q ss_pred cccCHHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCC--CCCcceee
Q 005257 352 HRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLK--HKSLVGLR 427 (705)
Q Consensus 352 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~--Hpniv~l~ 427 (705)
+.+.++.+....++|...+.||+|+||.||++.+.. ++.||||++... .....+.+.+|+.++.+++ ||||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 344455555666789999999999999999999864 788999998754 3345678899999999997 59999999
Q ss_pred eeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCe
Q 005257 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNG 507 (705)
Q Consensus 428 g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~ 507 (705)
+++.. ....++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+|||+++ +.+
T Consensus 95 ~~~~~-~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 95 DYEIT-DQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp EEEEC-SSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEE
T ss_pred EEeec-CCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeE
Confidence 98876 668999999 56889999997643 68999999999999999999999 99999999999999964 899
Q ss_pred eeeeeccceecCCCCcc-eeeeeeccccCCCcccccc-----------CCCCccccEEEEehhHHHHhhCCCCCCCCCcc
Q 005257 508 RLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSS-----------GRASTQTDVFGFGILILEVLSGRRPIEEGKPN 575 (705)
Q Consensus 508 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~ 575 (705)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 99999999876543221 1234578999999999865 46888999999999999999999999765432
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
. ..... .++.... ..++......+.+++..||+.||++||++.|+++.-
T Consensus 246 ~-~~~~~---------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 246 I-SKLHA---------IIDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp H-HHHHH---------HHCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred H-HHHHH---------HHhcccc--cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1 11111 1111111 112222245688999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=332.40 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=194.7
Q ss_pred HHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch------hHHHHHHHHHHhccC----CCCCcceeee
Q 005257 359 IEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG------GTRAFLAEISSLGRL----KHKSLVGLRG 428 (705)
Q Consensus 359 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~Ei~~l~~l----~Hpniv~l~g 428 (705)
.+...++|...+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999999888999999998654321 223456788888888 8999999999
Q ss_pred eeeeccCceEEEEee-CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCC
Q 005257 429 WCKREKGSLMLVYDY-MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMN 506 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~ 506 (705)
++.. .+..++|+|+ +.+++|.+++.... .+++.+++.++.|++.||.|||+ .+|+||||||+||+++ .++.
T Consensus 106 ~~~~-~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFET-QEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC------CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTE
T ss_pred EEec-CCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCe
Confidence 8876 5678999999 78999999997643 58999999999999999999998 8999999999999999 8899
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 9999999998765432 233568999999999877665 4589999999999999999999964210
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... ..++......+.+++..||+.||++|||+.|++++
T Consensus 245 ------~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ------ILEAE----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHHTC----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------Hhhhc----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 11223334567899999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=345.06 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=182.2
Q ss_pred ceEEeecCceEEEEEEEc--CCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeee-ccCceEEEEeeCC
Q 005257 369 ENVIGVGGNGKVYKGVLE--GGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-EKGSLMLVYDYME 445 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~lV~E~~~ 445 (705)
.++||+|+||+||+|.++ .+++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....+++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999976 457889999986442 34578899999999999999999999864 3567899999997
Q ss_pred CCChhHHHHhcC------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEE----ccCCCeeeeeeccc
Q 005257 446 NGSLDKWIFQCD------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLL----DKEMNGRLGDFGLA 515 (705)
Q Consensus 446 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILl----d~~~~~kL~DFGla 515 (705)
|+|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 58888775321 12249999999999999999999999 999999999999999 67889999999999
Q ss_pred eecCCCCc--ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc----------HHHHHHH
Q 005257 516 RMHGHGQV--ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN----------LVEMVWE 582 (705)
Q Consensus 516 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~----------~~~~v~~ 582 (705)
+....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654322 223446899999999999874 5899999999999999999999999754321 1111111
Q ss_pred HHHhCc---------hh--HHHHHhhhc--CCCCCH---------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 005257 583 LMVQGK---------LL--DALDARLRA--KGGFDE---------DEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636 (705)
Q Consensus 583 ~~~~~~---------~~--~~id~~l~~--~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 636 (705)
.+.... +. ..+...+.. ...... .....+.+|+..||+.||.+|||+.|++++-
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 110000 00 000000000 000000 0134678899999999999999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.47 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=181.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHH-HhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEIS-SLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... ...+++..|+. +++.++||||+++++++.. .+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEE
Confidence 4678889999999999999999998999999999976533 34455666666 7888899999999999876 6788999
Q ss_pred EeeCCCCChhHHHHhc--CCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQC--DGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 888877531 123368999999999999999999998 7 999999999999999999999999999986
Q ss_pred cCCCCcceeeeeeccccCCCcccc----ccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHH
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVF----SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~i 593 (705)
...... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....... +.. .....+..
T Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~---- 247 (327)
T 3aln_A 176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQL-TQVVKGDP---- 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCC----
T ss_pred cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHH-HHHhcCCC----
Confidence 644322 2234789999999998 45678999999999999999999999997643210 000 00000000
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+.+. ..........+.+++..||+.||++||++.++++.
T Consensus 248 -~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 -PQLS--NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCC--CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CCCC--CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000 10111234578899999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.74 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=201.3
Q ss_pred HHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch------hHHHHHHHHHHhccCC--CCCcceeeeeee
Q 005257 360 EAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG------GTRAFLAEISSLGRLK--HKSLVGLRGWCK 431 (705)
Q Consensus 360 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~ 431 (705)
....++|...+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34467789999999999999999999999999999998754221 2245678999999996 599999999987
Q ss_pred eccCceEEEEeeCCC-CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc-cCCCeee
Q 005257 432 REKGSLMLVYDYMEN-GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD-KEMNGRL 509 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld-~~~~~kL 509 (705)
. .+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++ +++.+||
T Consensus 119 ~-~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 R-PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp C-SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred c-CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 6 6788999999976 89999997643 68999999999999999999998 9999999999999999 7889999
Q ss_pred eeeccceecCCCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCc
Q 005257 510 GDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588 (705)
Q Consensus 510 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~ 588 (705)
+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...+.
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~~~~ 259 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQ 259 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHCC
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hhccc
Confidence 9999998765432 223578999999999977665 6889999999999999999999965210 11111
Q ss_pred hhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 589 ~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++......+.+++..||+.||++|||+.|+++.
T Consensus 260 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122233567899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.58 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=181.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-hH-HHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-GT-RAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-~~-~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||.||+|.+..+++.||||++...... .. +.+.++..+++.++||||+++++++.. .+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEE
Confidence 35678889999999999999999988999999999765332 22 334445567888899999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK-KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|||+ ++.+..++.... ..+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||+++...
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 455655554332 268999999999999999999997 5 99999999999999999999999999997654
Q ss_pred CCCcceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... +. ......+...
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~-~~~~~~~~~~---- 248 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EV-LTKVLQEEPP---- 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HH-HHHHHHSCCC----
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HH-HHHHhccCCC----
Confidence 4322 23357899999999984 4568899999999999999999999997643321 11 1111111100
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+. ........+.+++..||+.||.+||++.+++++
T Consensus 249 -~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 -LLP----GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CCC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCC----ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 011233568889999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=339.77 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=185.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEEEee
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.|...+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.. +..+++||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEec
Confidence 455578899999999987544 46899999998643 345678999999886 89999999998875 6789999999
Q ss_pred CCCCChhHHHHhcCCCC----cccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-------------CC
Q 005257 444 MENGSLDKWIFQCDGSM----MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-------------MN 506 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-------------~~ 506 (705)
+. |+|.+++....... ..++..++.++.||+.||.|||+ .+|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 69999997643211 12344567899999999999998 999999999999999754 48
Q ss_pred eeeeeeccceecCCCCcc---eeeeeeccccCCCcccccc-------CCCCccccEEEEehhHHHHhh-CCCCCCCCCcc
Q 005257 507 GRLGDFGLARMHGHGQVA---STTRVVGTVGYLAPEVFSS-------GRASTQTDVFGFGILILEVLS-GRRPIEEGKPN 575 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~ 575 (705)
+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999887654322 1234579999999999865 568999999999999999999 99999764322
Q ss_pred HHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 576 ~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.. .+..+.... +.. ...........+.+++..||+.||.+|||+.++++
T Consensus 247 ~~-----~i~~~~~~~---~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ES-----NIIRGIFSL---DEM--KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-----HHHHTCCCC---CCC--TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HHhcCCCCc---ccc--cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111111000 000 01123456678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.15 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=185.7
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV 440 (705)
...+|...++||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++.. ....++|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv 96 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIA 96 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEE
Confidence 345688899999999999654333 3578999999865432 2356799999999 89999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-----CCCeeeeeeccc
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-----EMNGRLGDFGLA 515 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-----~~~~kL~DFGla 515 (705)
|||++ |+|.+++..... .+.+.+++.++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99996 599999976543 35556678999999999999999 99999999999999953 335789999999
Q ss_pred eecCCCCc--ceeeeeeccccCCCccccc---cCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCch
Q 005257 516 RMHGHGQV--ASTTRVVGTVGYLAPEVFS---SGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKL 589 (705)
Q Consensus 516 ~~~~~~~~--~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~ 589 (705)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||......... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~~~~~~~ 246 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----ILLGACS 246 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----HHTTCCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----HHhccCC
Confidence 87654322 2234467999999999997 4567889999999999999999 99998654322111 1111000
Q ss_pred hHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 590 ~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
.. ...........+.+++..||+.||++|||+.++++
T Consensus 247 ~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD--------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT--------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 01112234456789999999999999999999985
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.41 Aligned_cols=202 Identities=13% Similarity=0.158 Sum_probs=151.7
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCC-CCCCCceEEEEeeCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKG-VLAGHGLVFLFVPFHGIK 114 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~G~aF~~~~~~~~~ 114 (705)
.+|.++|+|.+.++.|+||++..++.|||||+.|+++ +||+|+|+|.|.+++. ..+||||||+|+|...
T Consensus 25 ~~~~l~G~a~i~~g~l~LT~~~~~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~-- 94 (253)
T 2dur_A 25 PLWDFQGSTILTSQYVRLTPDERSKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL-- 94 (253)
T ss_dssp CSEEEEETCEECSSCEEEECSSSSEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS--
T ss_pred CCEEEccceEEECCEEEECCCCCCCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC--
Confidence 6899999999999999999999999999999999997 6899999999998765 5689999999999743
Q ss_pred CCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCC-CCCCCCCCCCCCCCC
Q 005257 115 GATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPD-NQTDSSGSNSNSGTG 193 (705)
Q Consensus 115 ~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~-~~~~~~~~~~~~~~~ 193 (705)
..|++||+.+ .++.|||||||++|.++.| |+++||+++.|..++ +|+. .+..+....+|
T Consensus 95 --~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~---~~d~~~dg~~~~~~~c---- 154 (253)
T 2dur_A 95 --VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSL---SYDHSKDGRWTELAGC---- 154 (253)
T ss_dssp --CEETBTEECS-------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCC---CCCGGGTTGGGCCEEE----
T ss_pred --CCCcccCcCC-------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCce---eeeccCCCcccccccc----
Confidence 3589999733 3688999999999985433 555555555554443 2321 00000011111
Q ss_pred CCccccceeec-CCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeee
Q 005257 194 DDEKSFKELKL-NNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAW 272 (705)
Q Consensus 194 ~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~w 272 (705)
.+.+ +.|.+++|||+|+...|+|++.+.+.. +..+. ..++ ...||+++||||||+||...+.|+|++|
T Consensus 155 -------~~~~~n~g~~~~v~I~Y~~~~L~V~l~~~~~~-~~~~~--~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilsw 223 (253)
T 2dur_A 155 -------TADFRNRDHDTFLAVRYSRGRLTVMTDLEDKN-EWKNC--IDIT-GVRLPTGYYFGASAGTGDLSDNHDIISM 223 (253)
T ss_dssp -------ECCCBTCSSCEEEEEEEETTEEEEEEECSSSS-CCEEE--EEEC-CEECCSSBEEEEEEEESSSCCEEEEEEE
T ss_pred -------cHhhccCCCCeEEEEEEECCEEEEEEeCCCCC-CceEE--EEeC-CcccCCCcEEEEEeccCCCcceEEEEEE
Confidence 2233 348899999999777999999865432 33333 3445 4459999999999999999999999999
Q ss_pred eecccc
Q 005257 273 SFSNTK 278 (705)
Q Consensus 273 sf~~~~ 278 (705)
+|.+-.
T Consensus 224 sf~sl~ 229 (253)
T 2dur_A 224 KLFQLM 229 (253)
T ss_dssp EEEECC
T ss_pred EEEecc
Confidence 998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=352.84 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=202.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeee-----ccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKR-----EKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-----~~~~ 436 (705)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.. ..+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999999988999999998765 33456779999999999999999999998643 2557
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC---eeeeeec
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN---GRLGDFG 513 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~---~kL~DFG 513 (705)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 79999999999999999876554569999999999999999999999 99999999999999997765 8999999
Q ss_pred cceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC----ch
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG----KL 589 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~----~~ 589 (705)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..|.......+ ..
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------CCS
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchhhhh
Confidence 9987654432 23457899999999999999999999999999999999999999764321 11100000000 00
Q ss_pred hHH------HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 005257 590 LDA------LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631 (705)
Q Consensus 590 ~~~------id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 631 (705)
.+. ....+.............+.+++..||..||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000 000111112234456788999999999999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=349.06 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=193.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc----
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS---- 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~---- 436 (705)
.++|...+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3679999999999999999999975 68999999986543 34456789999999999999999999998864332
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987743 68999999999999999999998 999999999999999986 89999999998
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
..... ....||+.|+|||++.++. +.++|||||||++|||++|..|+...... .+..
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~~~----- 286 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------GLPE----- 286 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------SCCT-----
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------cccc-----
Confidence 76543 3357999999999987654 89999999999999999999887642110 0000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHhc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-MRQVVKVLEGK 639 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~~ 639 (705)
..........+.+++..||+.||++||+ ++++.+.|.+.
T Consensus 287 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 ----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0001122356889999999999999995 56666666543
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=299.59 Aligned_cols=205 Identities=14% Similarity=0.172 Sum_probs=156.1
Q ss_pred eeeEEeCCCCC-----CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCC
Q 005257 25 AVDFVFNGFNS-----SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLA 99 (705)
Q Consensus 25 ~~~f~f~~f~~-----~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 99 (705)
..||..+.+.. .+|.++|+|.+.++.|+||++..++.||+||+.|+++ +||+|+|+|+|.+++ ..+
T Consensus 33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i~~~~IrLT~~~~~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~~-~~~ 103 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIG 103 (260)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEECSSCEEEECSSTTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCC
T ss_pred ceeEcCccccCCCCccCCeEEcccEEeeCCEEEeCCCCCCCEEEEEECCCccc--------cCEEEEEEEEEecCC-CCC
Confidence 34665444431 6899999999988999999999999999999999954 799999999998864 368
Q ss_pred CCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCC-CC------CCCeeEEecCC-Ccccccc
Q 005257 100 GHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFN-DI------DENHVGIDVNS-LTSVSAH 171 (705)
Q Consensus 100 g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgidvns-~~S~~~~ 171 (705)
||||||+|+|... ..|++||+. ..++.|||||||+.|.++. +| +++|+|||+|+ +.|.+..
T Consensus 104 gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~~ 172 (260)
T 1gv9_A 104 ADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALA 172 (260)
T ss_dssp CCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCSE
T ss_pred CCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccceee
Confidence 9999999999743 368889983 3468899999999997531 23 45677777765 5554332
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCccccceeec-CCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCcccccc
Q 005257 172 AAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKL-NNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED 250 (705)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~ 250 (705)
. + .+.+ ++|.+++|||+|+...|+|++.....+......++..+| ...||+
T Consensus 173 ~---c------------------------~~~~~n~g~~~~~~I~Y~~~~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~ 224 (260)
T 1gv9_A 173 S---C------------------------QRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPT 224 (260)
T ss_dssp E---E------------------------CCCCBSCSSCEEEEEEEETTEEEEEEECSSCCCTTCCEEEEEET-TCCCCS
T ss_pred c---c------------------------ChhhccCCCcEEEEEEEECCEEEEEEeeccCCCCCcceEEEEEc-ccccCC
Confidence 1 1 1123 258899999999777899999764222222346888899 677999
Q ss_pred ceecccccccccccccceeeeeeeccc
Q 005257 251 EMYVGFTAATGQLVESHKILAWSFSNT 277 (705)
Q Consensus 251 ~~~vGfsastg~~~~~h~i~~wsf~~~ 277 (705)
++||||||+||...+.|+|++|+|..-
T Consensus 225 ~~~vGfSAaTG~~~e~hdIlsw~~~~l 251 (260)
T 1gv9_A 225 QGHFGISAATGGLADDHDVLSFLTFQL 251 (260)
T ss_dssp SBEEEEEEECCSSCCEEEEEEEEEEEE
T ss_pred CcEEEEEEeCCCCcceEEEEEEEEEEe
Confidence 999999999999999999999999763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=328.75 Aligned_cols=244 Identities=15% Similarity=0.132 Sum_probs=186.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCC-CCcceeeee---------
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKH-KSLVGLRGW--------- 429 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~H-pniv~l~g~--------- 429 (705)
+.+|...++||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..++| +|......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457778899999999999999999999999999874432 236789999999999987 322211111
Q ss_pred ------------eeec----cCceEEEEeeCCCCChhHHHHhc----CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005257 430 ------------CKRE----KGSLMLVYDYMENGSLDKWIFQC----DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489 (705)
Q Consensus 430 ------------~~~~----~~~~~lV~E~~~~gsL~~~L~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 489 (705)
+... ....+++|+++ +++|.+++... .....+++..++.++.||+.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1110 12456777766 67999988532 223368899999999999999999998 999
Q ss_pred eecCCCCCCeEEccCCCeeeeeeccceecCCCCcceeeeeeccccCCCcccc----------ccCCCCccccEEEEehhH
Q 005257 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF----------SSGRASTQTDVFGFGILI 559 (705)
Q Consensus 490 iHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDVwS~Gvvl 559 (705)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 334577 999999999 555688999999999999
Q ss_pred HHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 560 LEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 560 ~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
|||++|+.||...... +.....+.....++ +.+.+++..||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~---------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL---------------GGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGG---------------SCSGGGGSSCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchh---------------hhHHHHHhhcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999764321 01111121112233 56889999999999999999988865
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.50 Aligned_cols=232 Identities=15% Similarity=0.144 Sum_probs=184.2
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
.++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++.+++||||+++++++.. ++..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEE
Confidence 3578999999999999999999998899999999976532 335789999999999999999999999876 678999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++++|.+++.. .....++.+++.|++.||.|||+ ++|+||||||+|||++.++.+||+++
T Consensus 109 v~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~------- 173 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP------- 173 (286)
T ss_dssp EEECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred EEEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec-------
Confidence 9999999999999843 23556789999999999999999 99999999999999999999999743
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH-HHHHHHHHHhCchhHHHHHhhh
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL-VEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~-~~~v~~~~~~~~~~~~id~~l~ 598 (705)
+|++| ++.++|||||||++|||++|+.||....... .... .....+..... ..+
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~~~~--~~~- 228 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ERDTAGQPIEP--ADI- 228 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-CBCTTSCBCCH--HHH-
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-HHHhccCCCCh--hhc-
Confidence 34443 7889999999999999999999998644210 0000 00000000000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.......+.+++..||+.||++| |+.|+++.|+....
T Consensus 229 -----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 229 -----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp -----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred -----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11223568899999999999999 99999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.18 Aligned_cols=229 Identities=19% Similarity=0.301 Sum_probs=179.7
Q ss_pred CCCCcc-eEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHh-ccCCCCCcceeeeeeee---ccCceE
Q 005257 364 KGFSEE-NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSL-GRLKHKSLVGLRGWCKR---EKGSLM 438 (705)
Q Consensus 364 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l-~~l~Hpniv~l~g~~~~---~~~~~~ 438 (705)
++|... +.||+|+||.||+|.+..+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 789999999999999998999999999853 24577888887 55699999999998764 245689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeeccc
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFGLA 515 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFGla 515 (705)
+||||+++|+|.+++...... .+++.+++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999875433 69999999999999999999999 99999999999999998 788999999998
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+... +..++.++|||||||++|||++|+.||....... ... .....+
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------~~~-~~~~~~-- 214 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISP-GMKTRI-- 214 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------C-CSCCSS--
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------hhH-HHHHHH--
Confidence 7532 2346789999999999999999999997543210 000 000000
Q ss_pred hhhcCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 RLRAKGGFDE----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.......+. .....+.+++..||+.||++|||+.|++++
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 -RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000011111 124568899999999999999999999984
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=264.15 Aligned_cols=112 Identities=35% Similarity=0.523 Sum_probs=101.2
Q ss_pred CcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEE
Q 005257 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWI 214 (705)
Q Consensus 135 ~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I 214 (705)
||+|||||||++|++|+||++|||||||||+.|.++++ ++|.+|+.++|||
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~-----------------------------~~l~sG~~~~v~I 51 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAK-----------------------------WDWQNGKIATAHI 51 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-----------------------------CCCCTTSCEEEEE
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceee-----------------------------eEEcCCCEEEEEE
Confidence 58999999999999988999999999999999988743 3477999999999
Q ss_pred Ee--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeeeecccc
Q 005257 215 DY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 215 ~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
+| ..++|+|++++.+. ..|+|+..+||+++||++||||||||||...+.|+|++|+|++..
T Consensus 52 ~Yd~~~~~L~V~l~~~~~---~~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l 114 (133)
T 1qmo_E 52 SYNSVSKRLSVTSYYAGS---KPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL 114 (133)
T ss_dssp EEETTTTEEEEEEECSSS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred EEeCCCcEEEEEEccCCC---ccceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence 99 56689999987654 278999999999999999999999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.28 Aligned_cols=239 Identities=18% Similarity=0.199 Sum_probs=181.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--------chhHHHHHHHHHHhccCC---------CCCcce
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--------DGGTRAFLAEISSLGRLK---------HKSLVG 425 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--------~~~~~~~~~Ei~~l~~l~---------Hpniv~ 425 (705)
.++|...+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35677899999999999999998 57999999997653 223477889999988886 666666
Q ss_pred eeeee-----------------ee------------ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHH
Q 005257 426 LRGWC-----------------KR------------EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476 (705)
Q Consensus 426 l~g~~-----------------~~------------~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~ 476 (705)
+.+.+ .. ..+.+++||||+++|++.+.+.+ ..+++.++..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 65543 22 15689999999999977666633 26899999999999999
Q ss_pred HHHHHh-cCCCCCeeecCCCCCCeEEccCC--------------------CeeeeeeccceecCCCCcceeeeeeccccC
Q 005257 477 GVLYLH-EGWEKKVLHRDIKSSNVLLDKEM--------------------NGRLGDFGLARMHGHGQVASTTRVVGTVGY 535 (705)
Q Consensus 477 gL~yLH-~~~~~~iiHrDLkp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y 535 (705)
||.||| + ++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 8 9999999999999999887 8999999999876532 34899999
Q ss_pred CCccccccCCCCccccEEEEehh-HHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC----CCCHHHHHH
Q 005257 536 LAPEVFSSGRASTQTDVFGFGIL-ILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG----GFDEDEVER 610 (705)
Q Consensus 536 ~APE~~~~~~~s~ksDVwS~Gvv-l~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~----~~~~~~~~~ 610 (705)
||||++.+.. +.++||||++++ .+++++|..||... .|.... .+.+........ .........
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~------~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYL------TDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHH------HHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHH------HHhhhhhhccCcccchhhhhhcCHH
Confidence 9999998765 899999998777 77889999987421 110000 001110000001 112345678
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHH
Q 005257 611 VLHLGLLCAYPDPRARPTMRQVV 633 (705)
Q Consensus 611 l~~l~~~Cl~~dP~~RPs~~evl 633 (705)
+.+++..||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999866 888887
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=265.94 Aligned_cols=113 Identities=28% Similarity=0.480 Sum_probs=102.0
Q ss_pred CCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEE
Q 005257 134 SNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVW 213 (705)
Q Consensus 134 ~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~ 213 (705)
+||+|||||||++|.+|+||++|||||||||++|+++++ +++.+|+.++||
T Consensus 1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~-----------------------------~~l~~g~~~~v~ 51 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-----------------------------WNMQNGKVGTAH 51 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-----------------------------CCCCTTCEEEEE
T ss_pred CCCEEEEEEeCCCCcccCCCCCCeeeEecCCcccccccc-----------------------------ccccCCCEEEEE
Confidence 379999999999999999999999999999999988753 347799999999
Q ss_pred EEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeeeecccc
Q 005257 214 IDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 214 I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
|+| ..++|+|++++.+. ..|+|+..|||+++|||+||||||||||...|.|+|++|+|++..
T Consensus 52 I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 52 IIYNSVDKRLSAVVSYPNA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp EEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred EEEeCCCCEEEEEEecCCC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 999 56689999986543 568999999999999999999999999999999999999999875
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=218.61 Aligned_cols=103 Identities=24% Similarity=0.417 Sum_probs=94.5
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEeecCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVESRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
..++|+|++|+ ..||+|+|||++.+|.|+||++.. +++|||+|++||+|||+ +|++|||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~~ 80 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTPY 80 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECSS
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCCCceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecCC
Confidence 46899999998 589999999999889999999775 79999999999999999 9999999999999999887
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccC
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRT 128 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~ 128 (705)
...+||||||||+|....|. +.||||||||.+
T Consensus 81 ~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 81 TSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA 112 (113)
T ss_dssp SSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred CCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence 77789999999999877777 899999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=283.31 Aligned_cols=185 Identities=15% Similarity=0.081 Sum_probs=130.6
Q ss_pred EeecCceEEEEEEEcCCCeEEEEEEeccCC----------chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEEE
Q 005257 372 IGVGGNGKVYKGVLEGGGAEIAVKRISHEN----------DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 372 LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~----------~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.+.|+.|.+.+++....|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+ ++.+|||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLV 320 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLV 320 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEE
Confidence 456666666666555567889999986541 12346799999999999 79999999998876 7789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||++|++|.++|.+.. .++.. +|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997643 46553 589999999999999 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P 568 (705)
... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334689999999999875 567789999999999988776544
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=224.39 Aligned_cols=184 Identities=17% Similarity=0.205 Sum_probs=138.3
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++ .++.|++|.+.|+++ .++|+|+|+|+|.+... .+||||||+++|....|
T Consensus 31 ~~w~~~G~a~v~~~~IrLTp~-~~s~G~iW~~~p~~~-------~~~f~~~f~FrI~g~~~-~~gdGlAfwlt~~~~~~- 100 (256)
T 2a6y_A 31 NNWQTGEQASLEEGRIVLTSN-QNSKGSLWLKQGFDL-------KDSFTMEWTFRSVGYSG-QTDGGISFWFVQDSNIP- 100 (256)
T ss_dssp TTEEEEETCEEETBEEECCCS-TTCEEEEEESSCEEE-------SSCEEEEEEEEEESCCS-CCSCEEEEEEEECSSSC-
T ss_pred CCeEEccceEEeCCEEEECCC-CCceEEEeeCCCCcc-------cCCEEEEEEEEEecCCC-CCCCeEEEEEeCCCCcc-
Confidence 699999999999999999999 678999877777764 46899999999987643 37999999999975432
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCC------CCeeEEecCCCcccccccccccCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDID------ENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSN 189 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~ 189 (705)
..|+.+|.++ ....+||||||+.|. .|. +.|+++|.+++.+.+.. .+
T Consensus 101 -~~g~~~G~~~-------~f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~---~c------------- 153 (256)
T 2a6y_A 101 -RDKQLYNGPV-------NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFA---SC------------- 153 (256)
T ss_dssp -CCCTBTTBCT-------TCEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSE---EE-------------
T ss_pred -cCCcccCcCC-------CCCEEEEEEECCCCC---CceEEEEECCCceecccCCCccccee---cc-------------
Confidence 5788889854 346799999999873 343 66778877764343321 11
Q ss_pred CCCCCCccccceeec-CCCcceEEEEEec---CceEEEEEEEccCCCCCCCceeeeecCccc-cccce-ecccccccc--
Q 005257 190 SGTGDDEKSFKELKL-NNGKNYQVWIDYA---DSFINITMVEAGMKRPKRPLLSVPLNLSGV-LEDEM-YVGFTAATG-- 261 (705)
Q Consensus 190 ~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~---~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~-l~~~~-~vGfsastg-- 261 (705)
. ..+ ++|.+.+|||+|. ...++|.+. + . .-+++..+ ||+++ ||||||+||
T Consensus 154 ~-----------~~~rn~~~~~~v~I~Y~~~~~~~L~V~i~--~-----~----~c~~~~~v~LP~~~~~~GfSAaTG~~ 211 (256)
T 2a6y_A 154 L-----------MGYQDSSVPSTIRVTYDLEDDNLLKVQVD--N-----K----VCFQTRKVRFPSGSYRIGVTAQNGAV 211 (256)
T ss_dssp E-----------CCCTTCSSCEEEEEEEEGGGTSEEEEEET--T-----E----EEEEESCEECCSEEEEEEEEEECCSG
T ss_pred e-----------eecccCCCcEEEEEEEecCCCcEEEEEEc--C-----E----EEEEECcEEeCCCCeEEEEEEeCCCC
Confidence 1 112 3788999999996 556666663 2 1 12344444 88887 799999999
Q ss_pred -cccccceeeeeeecccc
Q 005257 262 -QLVESHKILAWSFSNTK 278 (705)
Q Consensus 262 -~~~~~h~i~~wsf~~~~ 278 (705)
...+.|.|++|+|.+..
T Consensus 212 ~~~~d~hdIls~~~~~~~ 229 (256)
T 2a6y_A 212 NNNAESFEIFKMQFFNGV 229 (256)
T ss_dssp GGCCCEEEEEEEEEEESC
T ss_pred CCCcceEEEEEEEEEecc
Confidence 88999999999999843
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=261.03 Aligned_cols=186 Identities=16% Similarity=0.182 Sum_probs=144.3
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--h------hHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--G------GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
+...++||+|+||.||+|.. .+..+++|+...... . ..+.+.+|++++++++||||+++..++.. ....
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~ 414 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNK 414 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTT
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCcc
Confidence 34567899999999999954 367899998644321 1 13458999999999999999976666664 5677
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+|||||+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++.
T Consensus 415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 999999999999999854 56899999999999998 99999999999999998 999999999998
Q ss_pred cCCCCcce------eeeeeccccCCCcccccc--CCCCccccEEEEehhHHHHhhCCCCCC
Q 005257 518 HGHGQVAS------TTRVVGTVGYLAPEVFSS--GRASTQTDVFGFGILILEVLSGRRPIE 570 (705)
Q Consensus 518 ~~~~~~~~------~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~Gvvl~ElltG~~Pf~ 570 (705)
........ .....||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 76532221 134689999999999976 567888999998888888877776663
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=214.97 Aligned_cols=103 Identities=28% Similarity=0.484 Sum_probs=92.4
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
..++|+|++|.. +||+|+|||++. +|.|+||++.. +++|||+|++||+|||+ +++++||+|+|+|.|.+.
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~~ 202 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKSP 202 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCCS
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEecC
Confidence 467999999974 699999999996 79999999763 68999999999999997 889999999999999876
Q ss_pred CCCCCCCceEEEEeeCC-CCCCCCCCCcccccccC
Q 005257 95 KGVLAGHGLVFLFVPFH-GIKGATEAQHLGLFNRT 128 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~-~~~~~~~g~~lGl~~~~ 128 (705)
+ ..+||||||||+|.. .+|.+++||||||||.+
T Consensus 203 ~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 203 D-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp S-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred C-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 3 458999999999987 58889999999999965
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.6e-22 Score=205.37 Aligned_cols=148 Identities=17% Similarity=0.140 Sum_probs=120.1
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc------------------hhHHHHHHHHHHhccCCCCC
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND------------------GGTRAFLAEISSLGRLKHKS 422 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~------------------~~~~~~~~Ei~~l~~l~Hpn 422 (705)
.....|...+.||+|+||.||+|.+ .+++.||||.++.... .....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 3445566779999999999999999 7799999999864321 13456899999999999 5
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
+++.+++.. +..++||||+++|+|.+ +. . .+...++.|++.||.|||+ .+|+||||||+|||++
T Consensus 164 -~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW--EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE--ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred -CCcCeEEec--cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE
Confidence 667775533 45699999999999988 41 1 2244799999999999998 9999999999999999
Q ss_pred cCCCeeeeeeccceecCCCCcceeeeeeccccCCCccccc
Q 005257 503 KEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542 (705)
Q Consensus 503 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~ 542 (705)
++.+||+|||+|+. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999963 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=180.77 Aligned_cols=138 Identities=20% Similarity=0.140 Sum_probs=107.7
Q ss_pred CCcceEEeecCceEEEEEEEcCCCeE--EEEEEeccCCch------------------------hHHHHHHHHHHhccCC
Q 005257 366 FSEENVIGVGGNGKVYKGVLEGGGAE--IAVKRISHENDG------------------------GTRAFLAEISSLGRLK 419 (705)
Q Consensus 366 f~~~~~LG~G~fg~Vy~~~~~~~~~~--vavK~i~~~~~~------------------------~~~~~~~Ei~~l~~l~ 419 (705)
|...+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999999667888 999987543111 1135789999999999
Q ss_pred CCCcc--eeeeeeeeccCceEEEEeeCCC-C----ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHh-cCCCCCeee
Q 005257 420 HKSLV--GLRGWCKREKGSLMLVYDYMEN-G----SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH-EGWEKKVLH 491 (705)
Q Consensus 420 Hpniv--~l~g~~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH 491 (705)
|+++. ..+. . ...+|||||+.+ | +|.++... .++.++..++.|++.||.||| + .+|+|
T Consensus 129 ~~~i~~p~~~~--~---~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYT--Y---MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVH 194 (258)
T ss_dssp HTTCCCCCEEE--E---ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred hCCCCCCeEEE--c---CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence 88752 2332 1 246899999942 4 66665422 335577899999999999999 7 99999
Q ss_pred cCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 492 RDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 492 rDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
|||||+|||++. .++|+|||+|....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999997653
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.1e-18 Score=168.92 Aligned_cols=189 Identities=16% Similarity=0.154 Sum_probs=129.1
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++ .++.|.+|.+.|+++.+ +|+++|+|+|+.+. ..+||||||++++....
T Consensus 24 ~~W~~~G~a~i~~~~IrLTp~-~~~~G~iWs~~p~~~~~-------~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~-- 92 (222)
T 2a6z_A 24 NNWQTGEQASLEEGRIVLTSN-QNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI-- 92 (222)
T ss_dssp TTEEEEETCEEETTEEESCCS-TTCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCEEEEEEEECSSS--
T ss_pred CCcEEcccEEEcCCEEEECCC-CCCeEEEEeCCCCCCCC-------CEEEEEEEEEeCCC-CCCCCEEEEEEECCCcc--
Confidence 689999999999999999999 57789999999998744 59999999998764 34799999999987431
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (705)
...|+.+|.. ....-+||+|||+.|. .++|.+.+|.-. .. |+....++...++|...++
T Consensus 93 ~~~g~~~G~~-------~~f~GL~I~~Dt~~n~------~p~i~~~~ndG~-~~------yd~~~~~~~~~~~C~~~~r- 151 (222)
T 2a6z_A 93 PRDKQLYNGP-------VNYDGLQLLVDNNGPL------GPTLRGQLNDGQ-KP------VDKTKIYDQSFASCLMGYQ- 151 (222)
T ss_dssp CCCCTBTTBC-------TTCEEEEEEEESCSTT------SSEEEEEEEESS-SC------CCGGGHHHHCSEEEECCCT-
T ss_pred cCCCcccCCC-------CCCCEEEEEEECCCCC------CceEEEEECCCC-ee------eccCCCccccccccceecc-
Confidence 1356666662 2345689999999873 356776665421 10 1000000011223332222
Q ss_pred ccccceeecCCCcceEEEEEec---CceEEEEEEEccCCCCCCCceeeeecCccccccc-eecccccccc---cccccce
Q 005257 196 EKSFKELKLNNGKNYQVWIDYA---DSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE-MYVGFTAATG---QLVESHK 268 (705)
Q Consensus 196 ~~~~~~~~l~~g~~~~~~I~Y~---~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~-~~vGfsastg---~~~~~h~ 268 (705)
+.+.+.+++|+|. ...++|.+ .+ ...+-...|+ ||+. .|+||||+|| ...+.|.
T Consensus 152 ---------n~~~~~~~rI~Y~~~~~~~l~v~i--d~----~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hd 212 (222)
T 2a6z_A 152 ---------DSSVPSTIRVTYDLEDDNLLKVQV--DN----KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFE 212 (222)
T ss_dssp ---------TEEEEEEEEEEEEGGGTSEEEEEE--TT----EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEE
T ss_pred ---------CCCCcEEEEEEEEcCCCcEEEEEE--cC----eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEE
Confidence 3456889999995 45666655 33 1111222344 5555 4799999999 8889999
Q ss_pred eeeeeec
Q 005257 269 ILAWSFS 275 (705)
Q Consensus 269 i~~wsf~ 275 (705)
|++|++.
T Consensus 213 il~~~~~ 219 (222)
T 2a6z_A 213 IFKMQFF 219 (222)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
Confidence 9999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=165.15 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=99.6
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc--------------hhHHHH--------HHHHHHhccCCCCC
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND--------------GGTRAF--------LAEISSLGRLKHKS 422 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~--------------~~~~~~--------~~Ei~~l~~l~Hpn 422 (705)
-|++.++||+|++|.||+|... +|+.||||+++.... ...... .+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3888999999999999999986 588999998753210 011112 23555555554443
Q ss_pred cceeeeeeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 423 iv~l~g~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
+....-+.. ...+|||||+++++|..+.. ..+...++.|++.+|.|||+ .+||||||||.|||++
T Consensus 175 v~vp~p~~~---~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ---SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE---ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred CCCCeeeec---cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEe
Confidence 321111111 12379999999988866531 12345688999999999998 8999999999999998
Q ss_pred cCCC----------eeeeeeccceecCCC
Q 005257 503 KEMN----------GRLGDFGLARMHGHG 521 (705)
Q Consensus 503 ~~~~----------~kL~DFGla~~~~~~ 521 (705)
+++. +.|+||+-+....+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred CCCCcccccccccceEEEEeCCcccCCCC
Confidence 8763 889999988765443
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.48 E-value=6.7e-13 Score=131.46 Aligned_cols=186 Identities=15% Similarity=0.111 Sum_probs=123.3
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++ +++.|.+|-+.|+.+- .+|+.+|+|+|+..... +||||||+++.....
T Consensus 27 ~~W~~~G~t~v~~~~IrLTp~-~s~~G~lWs~~p~~~~-------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~~-- 95 (226)
T 2a6v_A 27 SQWTLGDKVKLEEGRFVLTPG-KNTKGSLWLKPEYSIK-------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGNEG-- 95 (226)
T ss_dssp TTEEEEETCEEETTEEESCCS-TTCEEEEEESSCBCCS-------SCEEEEEEEEEESCCSC-CSCEEEEEEECSCCC--
T ss_pred CCcEEcCCeEEeCCEEEECCC-CCceEEEeeCCCCCCC-------CCeEEEEEEEEecCCCC-CCCEEEEEEECCCCC--
Confidence 589999999999899999999 9999999999999862 25999999999887433 799999999975321
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (705)
..|..+|-. .....-+||.|||+.|. ...|-+-+|.- +.. |+... +...++|...|+
T Consensus 96 -~~g~vfGg~------~d~f~GlgI~~Dt~~n~------~p~i~~~~NDG----t~~---yd~~~--~~~~g~C~~~~r- 152 (226)
T 2a6v_A 96 -DSTELFGGS------SKKFNGLMILLRLDDKL------GESVTAYLNDG----TKD---LDIES--SPYFASCLFQYQ- 152 (226)
T ss_dssp -CCCTBTTTB------CSSCEEEEEEEEEETTT------EEEEEEEEEES----SSC---CCTTT--SCCSEEEECCCS-
T ss_pred -CCccccccc------CCCccEEEEEEECCCCC------CceEEEEECCC----Ccc---cCCCC--CcccceEeEecc-
Confidence 234333310 11345689999999762 12233322211 100 11000 223344443333
Q ss_pred ccccceeecCCCcceEEEEEec---CceEEEEEEEccCCCCCCCcee-eeecCccccccce--eccccccccccccccee
Q 005257 196 EKSFKELKLNNGKNYQVWIDYA---DSFINITMVEAGMKRPKRPLLS-VPLNLSGVLEDEM--YVGFTAATGQLVESHKI 269 (705)
Q Consensus 196 ~~~~~~~~l~~g~~~~~~I~Y~---~~~~~v~~~~~~~~~~~~~~ls-~~vdl~~~l~~~~--~vGfsastg~~~~~h~i 269 (705)
+.+.+.++.|.|. ...+.|.+. + +.-+. ..|+ ||..- |+||||+||...+.|.|
T Consensus 153 ---------n~~~~t~~ri~Y~~~~~~~l~v~id--~-----~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdi 212 (226)
T 2a6v_A 153 ---------DSMVPSTLRLTYNPLDNHLLKLQMD--N-----RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEI 212 (226)
T ss_dssp ---------SCSSCEEEEEEEEGGGTSEEEEEET--T-----EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEE
T ss_pred ---------CCCCCEEEEEEEEccCCCEEEEEEc--C-----CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEE
Confidence 2456789999994 667777773 2 11121 1233 55554 99999999999999999
Q ss_pred eeeeec
Q 005257 270 LAWSFS 275 (705)
Q Consensus 270 ~~wsf~ 275 (705)
++..+.
T Consensus 213 ls~~~~ 218 (226)
T 2a6v_A 213 LKMKLY 218 (226)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 997654
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.40 E-value=3.1e-14 Score=106.06 Aligned_cols=44 Identities=32% Similarity=0.541 Sum_probs=41.3
Q ss_pred CCceeeeecCccccccceecccccccccccccceeeeeeecccc
Q 005257 235 RPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 235 ~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
+|+|+..|||+++|||+||||||||||...+.|+|++|+|++..
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~ 46 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 46 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence 47899999999999999999999999999999999999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=8.3e-11 Score=120.27 Aligned_cols=145 Identities=15% Similarity=0.077 Sum_probs=110.6
Q ss_pred HHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEE
Q 005257 361 AATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 361 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~l 439 (705)
..-.+|.....++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +.++.++++++.. .+..++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~l 87 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNL 87 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEE
Confidence 34456777778888889999999754 5789999986532222345888999999884 6677788888765 678899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG----------------------------------- 484 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------- 484 (705)
||||++|.+|.+.+. +..+...++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999987531 1123357889999999999971
Q ss_pred ---------------------CCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 485 ---------------------WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 485 ---------------------~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
....++|+|++|.|||++++..+.|.||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01559999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=110.40 Aligned_cols=136 Identities=15% Similarity=0.105 Sum_probs=96.0
Q ss_pred CCCcceEEe-ecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc--ceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIG-VGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL--VGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG-~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l~g~~~~~~~~~~lV~ 441 (705)
++.. ..++ .|..+.||++... +|..+++|..... ....+.+|+.+++.+++.++ .+++++... .+..++||
T Consensus 21 ~~~~-~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDW-AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLL 94 (264)
T ss_dssp TCEE-EECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEE
T ss_pred CCce-EecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEE
Confidence 3443 3444 4556999999754 4677999987543 23457789999999865554 447776654 56789999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW------------------------------------ 485 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------ 485 (705)
||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cC------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 21 111 2356778888888888621
Q ss_pred -------------------CCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 486 -------------------EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 486 -------------------~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
...++|+|++|.|||++++..+.|.||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.5e-09 Score=110.92 Aligned_cols=143 Identities=14% Similarity=0.189 Sum_probs=105.6
Q ss_pred cceEEeecCceEEEEEEEcCCCeEEEEEEec--cCC-chhHHHHHHHHHHhccCC--CCCcceeeeeeeecc--CceEEE
Q 005257 368 EENVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HEN-DGGTRAFLAEISSLGRLK--HKSLVGLRGWCKREK--GSLMLV 440 (705)
Q Consensus 368 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~--~~~-~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~--~~~~lV 440 (705)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.|+ +..+.+++.++.... +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567899999999998875 3578888775 221 122356788999999987 455778888776521 357899
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW----------------------------------- 485 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------- 485 (705)
|||++|..+.+.. ...++..++..++.+++..|..||...
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998875421 114678889999999999999999720
Q ss_pred --------------------CCCeeecCCCCCCeEEccCCC--eeeeeecccee
Q 005257 486 --------------------EKKVLHRDIKSSNVLLDKEMN--GRLGDFGLARM 517 (705)
Q Consensus 486 --------------------~~~iiHrDLkp~NILld~~~~--~kL~DFGla~~ 517 (705)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 58999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=3.3e-09 Score=111.07 Aligned_cols=184 Identities=17% Similarity=0.168 Sum_probs=121.1
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCc--ceeeeeeeecc--CceEEEEee
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSL--VGLRGWCKREK--GSLMLVYDY 443 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpni--v~l~g~~~~~~--~~~~lV~E~ 443 (705)
.+.++.|....||+.. ..+++|+... ......+.+|..+|+.+. +..+ .+++..+.... ...++|||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4569999999999863 3488897542 234567889999998884 3332 33444332211 134789999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG--------------------------------------- 484 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 484 (705)
++|.+|...... .++..++..++.+++..|..||+.
T Consensus 98 i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 98 IKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999888754331 467788888899999999888851
Q ss_pred ----------------CCCCeeecCCCCCCeEEcc--CCCeeeeeeccceecCCCCcceeeeeeccccC---CCcccccc
Q 005257 485 ----------------WEKKVLHRDIKSSNVLLDK--EMNGRLGDFGLARMHGHGQVASTTRVVGTVGY---LAPEVFSS 543 (705)
Q Consensus 485 ----------------~~~~iiHrDLkp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y---~APE~~~~ 543 (705)
....++|+|++|.||++++ +..+.|.||+.+.......... ....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHH
Confidence 1246899999999999998 4567899999987543211100 00011 12221110
Q ss_pred -----CC---------CCccccEEEEehhHHHHhhCCCCC
Q 005257 544 -----GR---------ASTQTDVFGFGILILEVLSGRRPI 569 (705)
Q Consensus 544 -----~~---------~s~ksDVwS~Gvvl~ElltG~~Pf 569 (705)
+. .....+.|+++.++|++.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01 112257899999999999997765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.9e-06 Score=87.69 Aligned_cols=137 Identities=17% Similarity=0.146 Sum_probs=95.3
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCC---CcceeeeeeeeccCceEEEEeeCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHK---SLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
.+.++.|....||+. +..+++|+-. .......+.+|..+|..|++. .+.+.+.++....+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 467888999999988 3558888742 223456788999999999753 244556655433556789999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG----------------------------------------- 484 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------- 484 (705)
|..|...... .++..++..++.+++..|..||+.
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9888763221 244555555666666666555531
Q ss_pred ----------------CCCCeeecCCCCCCeEEcc---CCCe-eeeeecccee
Q 005257 485 ----------------WEKKVLHRDIKSSNVLLDK---EMNG-RLGDFGLARM 517 (705)
Q Consensus 485 ----------------~~~~iiHrDLkp~NILld~---~~~~-kL~DFGla~~ 517 (705)
....++|+|++|.||+++. ++.+ .|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1245799999999999987 4554 7999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.8e-06 Score=84.94 Aligned_cols=137 Identities=15% Similarity=0.130 Sum_probs=96.9
Q ss_pred eEEeecCce-EEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCceEEEEeeCCCC
Q 005257 370 NVIGVGGNG-KVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 370 ~~LG~G~fg-~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
+.+..|..| .||+.....++..+++|+-.. ....++.+|...|+.|. +-.+.++++++.. .+..++|||++++.
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGK 105 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCc
Confidence 345556665 699988777777899997642 33456788999988884 3335667777765 56789999999998
Q ss_pred ChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 005257 448 SLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG------------------------------------------- 484 (705)
Q Consensus 448 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------- 484 (705)
++.+.... .......+..+++..|.-||..
T Consensus 106 ~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 88776532 1223345566666666666621
Q ss_pred ------------CCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 485 ------------WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 485 ------------~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
....++|+|+.+.|||++.++.+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999876677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.7e-05 Score=82.82 Aligned_cols=83 Identities=10% Similarity=0.029 Sum_probs=54.3
Q ss_pred ceEE-eecCceEEEEEEEc---C---CCeEEEEEEeccCC---chhHHHHHHHHHHhccCC-C--CCcceeeeeeeecc-
Q 005257 369 ENVI-GVGGNGKVYKGVLE---G---GGAEIAVKRISHEN---DGGTRAFLAEISSLGRLK-H--KSLVGLRGWCKREK- 434 (705)
Q Consensus 369 ~~~L-G~G~fg~Vy~~~~~---~---~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~-H--pniv~l~g~~~~~~- 434 (705)
.+.| +.|....+|+.... + ++..+++|+..... ......+.+|..+++.|. + -.+.+++.++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988764 1 15678888754322 001245678888888884 3 24566777665421
Q ss_pred -CceEEEEeeCCCCChhH
Q 005257 435 -GSLMLVYDYMENGSLDK 451 (705)
Q Consensus 435 -~~~~lV~E~~~~gsL~~ 451 (705)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=8e-05 Score=80.51 Aligned_cols=76 Identities=16% Similarity=0.006 Sum_probs=48.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-------hhHHHHHHHHHHhccCCC--CCcc-eeeeeeeeccCceE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-------GGTRAFLAEISSLGRLKH--KSLV-GLRGWCKREKGSLM 438 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-------~~~~~~~~Ei~~l~~l~H--pniv-~l~g~~~~~~~~~~ 438 (705)
.+.||.|..+.||++....+++.++||....... .....+..|.+++..+.. |..+ +++.+ . ....+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTTE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCccE
Confidence 5679999999999998765567899997643211 123456778888887742 4444 44443 2 33458
Q ss_pred EEEeeCCCC
Q 005257 439 LVYDYMENG 447 (705)
Q Consensus 439 lV~E~~~~g 447 (705)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00018 Score=75.64 Aligned_cols=143 Identities=17% Similarity=0.168 Sum_probs=80.3
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-----CCCcceee-e-eeeeccCceEEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-----HKSLVGLR-G-WCKREKGSLMLVY 441 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv~l~-g-~~~~~~~~~~lV~ 441 (705)
.+.|+.|..+.||+.... +..+++|+.... ...+..|..++..|. .|.++... | .+....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778999999874 345899988642 233444555555553 24333311 1 1112255678999
Q ss_pred eeCCCCChh--------------HHHHhcCC----C-------CcccHHHH-----------------------------
Q 005257 442 DYMENGSLD--------------KWIFQCDG----S-------MMLSCEER----------------------------- 467 (705)
Q Consensus 442 E~~~~gsL~--------------~~L~~~~~----~-------~~l~~~~~----------------------------- 467 (705)
||++|..+. ..++.... . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11221100 0 00122211
Q ss_pred --HHHHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 468 --IRVLKDVAAGVLYLHE----------GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 468 --~~i~~qia~gL~yLH~----------~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
..+..++..++.+|++ .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 1247899999999999998888899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0016 Score=66.84 Aligned_cols=79 Identities=18% Similarity=0.260 Sum_probs=55.2
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCC---CcceeeeeeeeccCceEEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHK---SLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~g~~~~~~~~~~lV~ 441 (705)
.....+.+|.|..+.||+.... +|+.+++|+-..........|.+|...|+.|.-. .+.+++++. .-++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEE
Confidence 3445678999999999999986 4788999986554444445678899988888422 233444431 237899
Q ss_pred eeCCCCCh
Q 005257 442 DYMENGSL 449 (705)
Q Consensus 442 E~~~~gsL 449 (705)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.002 Score=67.14 Aligned_cols=140 Identities=14% Similarity=0.079 Sum_probs=90.6
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC---CCCcceeeeeeeeccCceEEEEee
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK---HKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.++.. .+..++||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEEC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEe
Confidence 3456799999999999875 3567889976532 3566888999998884 2456778877765 5678999999
Q ss_pred CCCCChhH-----------HHHhcCCCC-------------------cccHHHHH---HHH----------------HHH
Q 005257 444 MENGSLDK-----------WIFQCDGSM-------------------MLSCEERI---RVL----------------KDV 474 (705)
Q Consensus 444 ~~~gsL~~-----------~L~~~~~~~-------------------~l~~~~~~---~i~----------------~qi 474 (705)
+++..+.. .|+...... .-+|.+.+ ++. ..+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99876521 223322100 01343322 111 112
Q ss_pred HHHH-HHHhc-CCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 475 AAGV-LYLHE-GWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 475 a~gL-~yLH~-~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
+..+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2122 23421 2357899999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0026 Score=69.23 Aligned_cols=32 Identities=13% Similarity=0.298 Sum_probs=28.3
Q ss_pred CCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
...++|+|++|.|||++.++ ++|.||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 48899999999999998776 999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0056 Score=63.63 Aligned_cols=159 Identities=14% Similarity=0.061 Sum_probs=86.1
Q ss_pred cCHHHHHHHhCCCCc-----ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc--cee
Q 005257 354 ITYQEIEAATKGFSE-----ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL--VGL 426 (705)
Q Consensus 354 ~~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l 426 (705)
++.+++...-..|.. .+.|+.|....+|+....+ + .+++|..... .....+..|+.++..|+...+ .++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 444555555555544 3456678889999998753 3 5889987642 122345567777777642222 222
Q ss_pred eee-----eeeccCceEEEEeeCCCCChhH--------------HHHhcC----CC-----CcccHHHHHHH--------
Q 005257 427 RGW-----CKREKGSLMLVYDYMENGSLDK--------------WIFQCD----GS-----MMLSCEERIRV-------- 470 (705)
Q Consensus 427 ~g~-----~~~~~~~~~lV~E~~~~gsL~~--------------~L~~~~----~~-----~~l~~~~~~~i-------- 470 (705)
+.. +....+..+++++|++|..+.. .++... .. ....|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 221 1111346789999998865421 112111 00 00123221110
Q ss_pred ----HHHHHHHHHHHhcC----CCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 471 ----LKDVAAGVLYLHEG----WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 471 ----~~qia~gL~yLH~~----~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
...+...+..+++. ....++|+|+.+.|||++.+..+.|.||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01234455555532 24679999999999999877556799999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0067 Score=62.58 Aligned_cols=138 Identities=12% Similarity=0.027 Sum_probs=74.7
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEEEeeC-CC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLVYDYM-EN 446 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV~E~~-~~ 446 (705)
.+.|+.|....+|+. ..+++|+....... .....+|..+++.+....+. ++++.+ ...-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCC
Confidence 678999999999999 34888876543211 11234677777777533343 455433 22346899999 65
Q ss_pred CChhHH------------------HHhcCCC--Cccc-HHHHHHHHHH--------------HHHHHH----HHh-cCCC
Q 005257 447 GSLDKW------------------IFQCDGS--MMLS-CEERIRVLKD--------------VAAGVL----YLH-EGWE 486 (705)
Q Consensus 447 gsL~~~------------------L~~~~~~--~~l~-~~~~~~i~~q--------------ia~gL~----yLH-~~~~ 486 (705)
.+|... ++..... .... +..+..+... +...+. .|. ....
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 444310 1111100 0011 1111111110 111111 111 1123
Q ss_pred CCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 487 KKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 487 ~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
..++|+|+.+.||+ ..++.+.|.||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 56999999999999 5667789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0051 Score=67.11 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=49.7
Q ss_pred ceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc-ceeeeeeeeccCceEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL-VGLRGWCKREKGSLMLV 440 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~lV 440 (705)
.+.|+.|-...+|+....+ .+..+++|+..... ....+.+|..++..|...++ .++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEE
Confidence 4568888889999998753 24678899874321 12556689999988854445 45565432 2 389
Q ss_pred EeeCCCCCh
Q 005257 441 YDYMENGSL 449 (705)
Q Consensus 441 ~E~~~~gsL 449 (705)
+||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.36 E-value=0.036 Score=57.52 Aligned_cols=144 Identities=16% Similarity=0.157 Sum_probs=80.3
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeee----eeeccCceEEEEe
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGW----CKREKGSLMLVYD 442 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~----~~~~~~~~~lV~E 442 (705)
...|+ |....||+.... +|+.+++|...... .....+..|..++..|.... +.+++.. .....+..+++||
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 34577 888899988664 35579999885331 13455667888877774222 3333332 1111445678999
Q ss_pred eCCCCChhH-----------H---HHhc----C--CCCcccHHHH----------------------HHHHHHHHHHHHH
Q 005257 443 YMENGSLDK-----------W---IFQC----D--GSMMLSCEER----------------------IRVLKDVAAGVLY 480 (705)
Q Consensus 443 ~~~~gsL~~-----------~---L~~~----~--~~~~l~~~~~----------------------~~i~~qia~gL~y 480 (705)
+++|..+.. . ++.. . ....+.+... ...+.+++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754320 1 1111 0 0111222111 1111122222222
Q ss_pred Hhc-CCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 481 LHE-GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 481 LH~-~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
+-. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 211 1246789999999999999 4 899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.007 Score=64.82 Aligned_cols=143 Identities=18% Similarity=0.142 Sum_probs=84.0
Q ss_pred ceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc-ceeeeeeeeccCceEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL-VGLRGWCKREKGSLMLV 440 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~lV 440 (705)
.+.|..|-...+|+..... ++..+++|+... .........+|..+++.|.-.++ .++++.+. + .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---ccE
Confidence 4567778888999998752 346789987532 22234566789999988854344 44555442 2 389
Q ss_pred EeeCCCCChhHH-----------------HHhcCC--CCcc--cHHHHHHHHHHHHH-------------------HHHH
Q 005257 441 YDYMENGSLDKW-----------------IFQCDG--SMML--SCEERIRVLKDVAA-------------------GVLY 480 (705)
Q Consensus 441 ~E~~~~gsL~~~-----------------L~~~~~--~~~l--~~~~~~~i~~qia~-------------------gL~y 480 (705)
|||++|..|..- |+..+. .... -+.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655311 111110 1111 24555555544322 2233
Q ss_pred Hh----c-CCCCCeeecCCCCCCeEEccC----CCeeeeeecccee
Q 005257 481 LH----E-GWEKKVLHRDIKSSNVLLDKE----MNGRLGDFGLARM 517 (705)
Q Consensus 481 LH----~-~~~~~iiHrDLkp~NILld~~----~~~kL~DFGla~~ 517 (705)
|. . .....++|+|+.+.||+++.+ +.+.|.||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 1 124579999999999999876 6899999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.015 Score=63.90 Aligned_cols=75 Identities=13% Similarity=0.018 Sum_probs=47.8
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEEEeeCCCC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.+.|+.|-...+|+....+.+..+++|+........ -+-.+|..++..|...++. ++++.+ . . .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCc
Confidence 457888889999999886545788899764322111 1125788888888655554 466554 2 2 3599999875
Q ss_pred Ch
Q 005257 448 SL 449 (705)
Q Consensus 448 sL 449 (705)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.034 Score=57.98 Aligned_cols=33 Identities=27% Similarity=0.340 Sum_probs=28.3
Q ss_pred CCCeeecCCCCCCeEEccC----CCeeeeeeccceec
Q 005257 486 EKKVLHRDIKSSNVLLDKE----MNGRLGDFGLARMH 518 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~----~~~kL~DFGla~~~ 518 (705)
...++|+|+.+.|||++.+ ..+.|.||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999874 67899999988643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.021 Score=60.67 Aligned_cols=75 Identities=9% Similarity=0.099 Sum_probs=43.3
Q ss_pred ceEEeecCceEEEEEEEcCC--------CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGG--------GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLML 439 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~l 439 (705)
.+.|+.|....+|+....+. +..+++|+..... ....+...|..+++.|...+++ ++++.. .+ ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF---NG--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec---CC--cE
Confidence 34677888889999987531 2578888764322 1111235788888887544443 455432 22 68
Q ss_pred EEeeCCCCCh
Q 005257 440 VYDYMENGSL 449 (705)
Q Consensus 440 V~E~~~~gsL 449 (705)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.04 E-value=0.24 Score=51.83 Aligned_cols=32 Identities=25% Similarity=0.311 Sum_probs=28.3
Q ss_pred CCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 486 ~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46799999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.50 E-value=0.042 Score=53.54 Aligned_cols=103 Identities=13% Similarity=0.068 Sum_probs=67.1
Q ss_pred CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCccee
Q 005257 447 GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAST 526 (705)
Q Consensus 447 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 526 (705)
-||.+.|...+. +++++++|.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|++.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 389999977654 799999999999999998776210 1111333457899999999887654 1110
Q ss_pred eeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC
Q 005257 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568 (705)
Q Consensus 527 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P 568 (705)
.....+.+||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888764 3557888999999999998874443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.88 E-value=0.14 Score=55.40 Aligned_cols=142 Identities=11% Similarity=0.114 Sum_probs=83.3
Q ss_pred ceEEeecCceEEEEEEEcCC-------CeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEGG-------GAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLV 440 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV 440 (705)
.+.|..|-...+|+...... +..+++|+..... ...-+..+|..+++.|...+++ ++++.+ .+ ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~---~~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF---PE--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc---CC--CEE
Confidence 45677788889999987631 4678888764322 1111235788888887543443 444422 22 689
Q ss_pred EeeCCCCChhH--------------H---HHh--c-----C---CCCcccHHHHHHHHHHH-------------------
Q 005257 441 YDYMENGSLDK--------------W---IFQ--C-----D---GSMMLSCEERIRVLKDV------------------- 474 (705)
Q Consensus 441 ~E~~~~gsL~~--------------~---L~~--~-----~---~~~~l~~~~~~~i~~qi------------------- 474 (705)
|||++|..|.. . |+. . . ...+..+.++.++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999866421 0 111 0 1 11112244444443322
Q ss_pred HHHHHHHhc---------------------CCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 475 AAGVLYLHE---------------------GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 475 a~gL~yLH~---------------------~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
...+.+|.+ .....++|+|+.+.||+ +.++.+.|.||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222333321 12356999999999999 7788899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.14 E-value=1.1 Score=48.06 Aligned_cols=30 Identities=27% Similarity=0.351 Sum_probs=25.1
Q ss_pred CeeecCCCCCCeEE------ccCCCeeeeeecccee
Q 005257 488 KVLHRDIKSSNVLL------DKEMNGRLGDFGLARM 517 (705)
Q Consensus 488 ~iiHrDLkp~NILl------d~~~~~kL~DFGla~~ 517 (705)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4456799999998854
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.96 E-value=0.11 Score=36.76 Aligned_cols=22 Identities=32% Similarity=0.436 Sum_probs=9.6
Q ss_pred EEEeeehhHHHHHHHHHHHHHH
Q 005257 307 IAGVTVGGLFIIVAVVLCSLFL 328 (705)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~ 328 (705)
|++.+++++++++++++.++++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~ 34 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLF 34 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeehhHHHHHHHHHHHHHHHH
Confidence 3444444444444444443333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.61 E-value=0.1 Score=36.72 Aligned_cols=23 Identities=43% Similarity=0.609 Sum_probs=10.4
Q ss_pred EEEEeeehhHHHHHHHHHHHHHH
Q 005257 306 FIAGVTVGGLFIIVAVVLCSLFL 328 (705)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~ 328 (705)
.+++.+++++++++++++..+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~ 33 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVY 33 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEeehHHHHHHHHHHHHHHHH
Confidence 34444455555444444444333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=81.12 E-value=0.69 Score=47.34 Aligned_cols=27 Identities=19% Similarity=0.142 Sum_probs=24.1
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+++..||+.||++|||+.|++++
T Consensus 275 ~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 275 QEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 457889999999999999999999873
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.11 E-value=0.16 Score=55.70 Aligned_cols=60 Identities=2% Similarity=-0.019 Sum_probs=17.0
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEE------EEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAV------KRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vav------K~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
.+.|| ||.||+|.+.....+||| |..+.. ..+....|.+|..++..++|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 44566 999999999765567888 765432 2334457889999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 705 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 4e-60 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 7e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 8e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-58 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 6e-57 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 7e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 1e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-56 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 1e-55 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 1e-55 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-55 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-54 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-54 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 6e-54 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 7e-54 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 8e-54 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-50 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 6e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 3e-36 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 3e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 4e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 1e-07 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 8e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-63
Identities = 69/299 (23%), Positives = 128/299 (42%), Gaps = 35/299 (11%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND 402
+DWE+ + IG G G VYKG G A + + ++
Sbjct: 1 DDWEIPD--------------GQITVGQRIGSGSFGTVYKGKWHGDVA-VKMLNVTAPTP 45
Query: 403 GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMML 462
+AF E+ L + +H +++ G+ L +V + E SL + +
Sbjct: 46 QQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETK--F 101
Query: 463 SCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522
+ I + + A G+ YLH K ++HRD+KS+N+ L +++ ++GDFGLA +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 523 V-ASTTRVVGTVGYLAPEVF---SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVE 578
++ G++ ++APEV S Q+DV+ FGI++ E+++G+ P N +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRD 216
Query: 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ ++ +G L L + + + L C RP Q++ +E
Sbjct: 217 QIIFMVGRGYLSPDLSK-------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-60
Identities = 71/295 (24%), Positives = 137/295 (46%), Gaps = 35/295 (11%)
Query: 343 EDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND 402
++WE+ + +G G G+V+ G G ++AVK + +
Sbjct: 6 DEWEVPR--------------ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSL-KQGS 49
Query: 403 GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMML 462
AFLAE + + +L+H+ LV L + + ++ +YMENGSL ++ G + L
Sbjct: 50 MSPDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSG-IKL 106
Query: 463 SCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522
+ + + + +A G+ ++ E + +HRD++++N+L+ ++ ++ DFGLAR+ +
Sbjct: 107 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582
+ + + APE + G + ++DV+ FGIL+ E+++ R G N V +
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ 221
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ +G + ++ E + L LC P RPT + VLE
Sbjct: 222 NLERGYRMV-----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 199 bits (508), Expect = 4e-60
Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 40/264 (15%)
Query: 25 AVDFVFNGFNS---SNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRP 75
+V F F F S ++ G A + L L + ++ GRALY +
Sbjct: 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 60
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN-SS 134
+ V F T F F + G GL F P ++LGLFN++ S
Sbjct: 61 KTESVASFYTEFTFFLKIT-GNGPADGLAFFLAP-PDSDVKDAGEYLGLFNKSTATQPSK 118
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
N V VEFD + N F + H+GI+VNS+ SV+
Sbjct: 119 NQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVAT------------------------ 154
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
K +++ + +GK I Y D I V +LS +++ L + + V
Sbjct: 155 --KRWEDSDIFSGKIATARISY-DGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRV 211
Query: 255 GFTAATGQ-LVESHKILAWSFSNT 277
G +A+TG + IL+W FS+
Sbjct: 212 GISASTGNNQFLTVYILSWRFSSN 235
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 199 bits (508), Expect = 7e-60
Identities = 76/285 (26%), Positives = 107/285 (37%), Gaps = 46/285 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVESR-ILTLTNST------TFTIGRALYPSKIPTKR 74
V F +N F N+ L G A V S L L ++GRALY + I
Sbjct: 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWD 61
Query: 75 PNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSS 134
+ V F+ SF F GL F P H G N+ S
Sbjct: 62 KETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPI----DTKPQTHAGYLGLFNENESG 117
Query: 135 NHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGD 194
+ V VEFD F+N D H+GI+VNS+ S+
Sbjct: 118 DQVVAVEFDTFRN--SWDPPNPHIGINVNSIRSIKTT----------------------- 152
Query: 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254
L N K +V I Y S + + +LS ++L L + + +
Sbjct: 153 ------SWDLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRI 206
Query: 255 GFTAATGQLV--ESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
GF+AATG + ESH +L+WSF++ S + L SFVL +
Sbjct: 207 GFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPLDLTSFVLHE 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 2e-59
Identities = 69/300 (23%), Positives = 135/300 (45%), Gaps = 20/300 (6%)
Query: 351 PHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLA 410
P Y + E + ++ +G G G+VY+GV + +AVK + E+ FL
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK 62
Query: 411 EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV 470
E + + +KH +LV L G C + ++ ++M G+L ++ +C +S + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYM 120
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVV 530
+++ + YL + K +HRD+ + N L+ + ++ DFGL+R+ +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 531 GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590
+ + APE + + S ++DV+ FG+L+ E+ + G V+EL+ + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRM 235
Query: 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI-EAGIENETE 649
+ E E+V L C +P RP+ ++ + E E+ I +E E
Sbjct: 236 E-----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 197 bits (501), Expect = 8e-59
Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 42/281 (14%)
Query: 26 VDFVFNGFNSSNLSLYGTATVESRILTLTNS------TTFTIGRALYPSKIPTKRPNSSY 79
F F FNSS+ L G ATV S L LT T ++GRA Y S I ++
Sbjct: 4 QSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGA 63
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V ++TSF + + G+ F VP + + LG+F+ NS
Sbjct: 64 VASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSN-SGFLGVFDSDVYDNS-AQTVA 121
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
VEFD F N ++ D H+GIDVNS+ S+ + G
Sbjct: 122 VEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG------------------------- 155
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
L NG+N ++ I Y + + R ++S ++++ L + + +GF+A
Sbjct: 156 ----LANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSAT 211
Query: 260 TG---QLVESHKILAWSFSNTKFSLSEELITSGLPSFVLPK 297
TG E+H +L+WSF+ +K + S+++
Sbjct: 212 TGLSEGYTETHDVLSWSFA-SKLPDDSTTEPLDIASYLVRN 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 9e-59
Identities = 80/305 (26%), Positives = 144/305 (47%), Gaps = 38/305 (12%)
Query: 355 TYQEIEAATKGFSEE---------NVIGVGGNGKVYKGVLEGGG---AEIAVKRI-SHEN 401
T+++ A + F++E VIG G G+V G L+ G +A+K + S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 402 DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM 461
+ R FL+E S +G+ H +++ L G + +M++ ++MENGSLD ++ Q DG
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-TKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 462 LSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521
+ + + +L+ +AAG+ YL + +HRD+ + N+L++ + ++ DFGL+R
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 522 Q----VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNL 576
S + + APE + ++ +DV+ +GI++ EV+S G RP
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233
Query: 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVL 636
+ M +++A++ R D + L L C D RP Q+V L
Sbjct: 234 ----YWDMTNQDVINAIEQDYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 637 EGKIE 641
+ I
Sbjct: 288 DKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-58
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 21/278 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ IG G G V+ G ++A+K I E F+ E + +L H LV
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C E+ + LV+++ME+G L ++ + + E + + DV G +
Sbjct: 65 LYGVC-LEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEG---MAYLE 118
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
E V+HRD+ + N L+ + ++ DFG+ R Q S+T V + +PEVFS R
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
S+++DV+ FG+L+ EV S + E + N V E + G L
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLY-----------KPR 225
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643
V + C P RP ++++ L E+G
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 191 bits (485), Expect = 6e-57
Identities = 73/264 (27%), Positives = 110/264 (41%), Gaps = 44/264 (16%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVES-RILTLTNST------TFTIGRALYPSKIPTKRPN 76
+ + F F FN +NL L A+V S L LTN ++GRA Y + I
Sbjct: 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT 61
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
+ V F+TSF F + GL F VP G+ G + NS+ H
Sbjct: 62 TGTVASFATSFTFNIQVPNNAGPADGLAFALVPV----GSQPKDKGGFLGLFDGSNSNFH 117
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VEFD N+++ D E H+GIDVNS+ S+ +
Sbjct: 118 TVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV-------------------- 156
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
NG+N +V I Y S + + ++S ++L VL + + VGF
Sbjct: 157 ---------NGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGF 207
Query: 257 TAATGQL---VESHKILAWSFSNT 277
+A TG VE++ +L+WSF++
Sbjct: 208 SATTGINKGNVETNDVLSWSFASK 231
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 191 bits (486), Expect = 7e-57
Identities = 71/268 (26%), Positives = 105/268 (39%), Gaps = 45/268 (16%)
Query: 23 ISAVDFVFNGFNS--SNLSLYGTATVES-RILTLTNST------TFTIGRALYPSKIPTK 73
+ + F F+ F NL+L G A + +L LT + GR LY +
Sbjct: 1 VETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW 60
Query: 74 RPNSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN 132
+ V F T F F++ PY L GLVF P K A +LG+FN + N
Sbjct: 61 DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGP-TKSKPAQGYGYLGVFNNSKQDN 119
Query: 133 SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGT 192
S VEFD F N ++ H+GIDVNS+ S+ P
Sbjct: 120 S-YQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQ-----PFQ------------- 159
Query: 193 GDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252
L+NG+ V I Y + +V ++ +++ VL D +
Sbjct: 160 -----------LDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWV 208
Query: 253 YVGFTAATG---QLVESHKILAWSFSNT 277
VG + ATG E+H + +WSF +
Sbjct: 209 DVGLSGATGAQRDAAETHDVYSWSFQAS 236
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 66/284 (23%), Positives = 123/284 (43%), Gaps = 21/284 (7%)
Query: 354 ITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEIS 413
+ E + E +G G G+V+ G G +A+K + AFL E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQ 64
Query: 414 SLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKD 473
+ +L+H+ LV L + + +V +YM GSL ++ G + + + +
Sbjct: 65 VMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQ 121
Query: 474 VAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTV 533
+A+G+ Y+ +HRD++++N+L+ + + ++ DFGLAR+ + + +
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 534 GYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDAL 593
+ APE GR + ++DV+ FGIL+ E+ + R G N V + + +G +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMP-- 234
Query: 594 DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ E + L C +P RPT + LE
Sbjct: 235 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 190 bits (484), Expect = 1e-56
Identities = 66/263 (25%), Positives = 111/263 (42%), Gaps = 40/263 (15%)
Query: 25 AVDFVFNGF--NSSNLSLYGTATVES-RILTLTNS---TTFTIGRALYPSKIPTKRPNSS 78
+ F F+ F N N+ G A+V + +L +T TT +IGRALY + I +
Sbjct: 3 DLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITG 62
Query: 79 YVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVF 138
V F+TSF F + K GL F P + + + + ++D SSN +
Sbjct: 63 KVASFATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQII 121
Query: 139 GVEFDVFKNQEFN--DIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VEFD + + +N D D H+GIDVNS+ S+ +
Sbjct: 122 AVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDW--------------------- 160
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
NG+ V I Y ++T+ + +++ ++L +L + + VGF
Sbjct: 161 --------RNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGF 212
Query: 257 TAATGQLV--ESHKILAWSFSNT 277
+ G E+H +L+W F++
Sbjct: 213 SGGVGNAAEFETHDVLSWYFTSN 235
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-56
Identities = 73/284 (25%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHENDGGTRA-FLAEISSLGRLKH 420
+ + VIG G G+VYKG+L+ + +A+K + R FL E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
+++ L G + +M++ +YMENG+LDK++ + DG S + + +L+ +AAG+ Y
Sbjct: 69 HNIIRLEGVI-SKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKY 125
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRV--VGTVGYLAP 538
L +HRD+ + N+L++ + ++ DFGL+R+ A+ T + + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598
E S + ++ +DV+ FGI++ EV++ N +++ A++ R
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------HEVMKAINDGFR 231
Query: 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642
D + L + C + RP +V +L+ I A
Sbjct: 232 LP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-56
Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
IG G G V G G ++AVK I ND +AFLAE S + +L+H +LV
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G EKG L +V +YM GSL ++ G +L + ++ DV + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
+HRD+ + NVL+ ++ ++ DFGL + + V + APE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKK 176
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
ST++DV+ FGIL+ E+ S R P + V + +G +D +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMD-----------APD 223
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
V + C + D RP+ Q+ + LE
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 9e-56
Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 25/292 (8%)
Query: 369 ENVIGVGGNGKVYKGVL---EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLV 424
VIG G G VY G L +G AVK ++ D G FL E + H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G C R +GS ++V YM++G L F + + + ++ I VA G +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG---MKFL 146
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS---TTRVVGTVGYLAPEVF 541
KK +HRD+ + N +LD++ ++ DFGLAR + S T V ++A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ + +T++DV+ FG+L+ E+++ P N ++ L+ +LL
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQ---------- 255
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDA 653
E + + + L C +P RP+ ++V + I ++A
Sbjct: 256 --PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 188 bits (478), Expect = 1e-55
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 25 AVDFVFNGFNS--SNLSLYGTATVESRILTLT------NSTTFTIGRALYPSKIPTKRPN 76
++ F F F S NL G A +++ + LT N T+GR L+ +++ +
Sbjct: 3 SLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS 62
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNR-TNDGNSSN 135
SS V F + F F++ A F+ P I + LGLF T S+N
Sbjct: 63 SSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSAN 122
Query: 136 HVFGVEFDVFKNQEFNDIDE--NHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
V VEFD F Q+ N D H+GIDVNS+ SV
Sbjct: 123 QVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK--------------------- 161
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
+G++ V + + S N+ V A R +S +++ VL + +
Sbjct: 162 --------WDRRDGQSLNVLVTFNPSTRNLD-VVATYSDGTRYEVSYEVDVRSVLPEWVR 212
Query: 254 VGFTAATGQLVESHKILAWSFSNT 277
VGF+AA+G+ ++H + +WSF++T
Sbjct: 213 VGFSAASGEQYQTHTLESWSFTST 236
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 188 bits (478), Expect = 1e-55
Identities = 68/267 (25%), Positives = 103/267 (38%), Gaps = 44/267 (16%)
Query: 24 SAVDFVFNGF------NSSNLSLYGTATVESRILTLT------NSTTFTIGRALYPSKIP 71
+ V+F + F N + ++ G AT L LT N + G+A Y +
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 72 TKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDG 131
++ F TSF F + Y G GL F P LGLF
Sbjct: 62 -LWDSTGKAASFYTSFTFLLKNY-GAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAA 118
Query: 132 N-SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNS 190
+ S N V VEFD + N+++ND H+GIDVNS+ SV+
Sbjct: 119 DPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT-------------------- 158
Query: 191 GTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLED 250
++ I Y D+ I V + + +LS ++L+ VL
Sbjct: 159 ------TRWENDDAYGSSIATAHITY-DARSKILTVLLSYEHGRDYILSHVVDLAKVLPQ 211
Query: 251 EMYVGFTAATGQLVESHKILAWSFSNT 277
++ +GF+A G E IL+W F +T
Sbjct: 212 KVRIGFSAGVG-YDEVTYILSWHFFST 237
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 187 bits (476), Expect = 1e-55
Identities = 73/268 (27%), Positives = 101/268 (37%), Gaps = 52/268 (19%)
Query: 26 VDFVFNGF--NSSNLSLYGTATVES-RILTLTN-----STTFTIGRALYPSKIPTKRPNS 77
+ F FN F N L L A + S +L LT T + GRALY + +
Sbjct: 3 ISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTT 62
Query: 78 SYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
V F T F F++ P+ GLVF P + G G + + S
Sbjct: 63 GNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-----GGGYFGIYNPLSPYP 117
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
VEFD F+N D H+GIDVNS+ S
Sbjct: 118 FVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTV------------------------- 150
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
L+NG V I Y S + +V ++ ++L VL + + VGF
Sbjct: 151 ----PFTLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGF 206
Query: 257 TAATGQ-------LVESHKILAWSFSNT 277
+AATG E+H IL+WSFS +
Sbjct: 207 SAATGDPSGKQRNATETHDILSWSFSAS 234
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 39/306 (12%)
Query: 359 IEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA-FLAEISSLGR 417
+E F + + +G G G V+K + G +A K I E R + E+ L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 418 LKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
+VG G G + + ++M+ GSLD+ + + + + +V V G
Sbjct: 61 CNSPYIVGFYGAF-YSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 116
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLA 537
+ YL E + K++HRD+K SN+L++ +L DFG++ VGT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMS 171
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
PE S Q+D++ G+ ++E+ GR PI +E+++ V+G +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 598 RAKGGFDEDEVERVLHLGLL-----------------------------CAYPDPRARPT 628
++ + + C +P R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 629 MRQVVK 634
++Q++
Sbjct: 292 LKQLMV 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+ +G G G V G G ++A+K I E F+ E + L H+ LV
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQY-DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 426 LRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW 485
L G C ++ + ++ +YM NG L ++ + ++ + + KDV + YL
Sbjct: 64 LYGVC-TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 486 EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGR 545
K+ LHRD+ + N L++ + ++ DFGL+R + S+ V + PEV +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 546 ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDE 605
S+++D++ FG+L+ E+ S + E N E + QG L
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLY-----------RPH 224
Query: 606 DEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
E+V + C + RPT + ++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 25/275 (9%)
Query: 368 EENVIGVGGNGKVYKGVL--EGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLV 424
+ +G G G V +GV ++A+K + + T + E + +L + +V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
L G C + +LMLV + G L K++ + +L V+ G+ YL E
Sbjct: 73 RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE- 127
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR--VVGTVGYLAPEVFS 542
K +HRD+ + NVLL ++ DFGL++ G T R + + APE +
Sbjct: 128 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ S+++DV+ +G+ + E LS + + V + QGK ++
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRME----------- 232
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ + L C RP V + +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 186 bits (473), Expect = 4e-55
Identities = 73/272 (26%), Positives = 104/272 (38%), Gaps = 54/272 (19%)
Query: 21 ESISAVDFVFNGF--NSSNLSLYGTATVESR-ILTLTNST------TFTIGRALYPSKIP 71
E+ S F F+ F NS L+L A+++S +L LT T + GRALY I
Sbjct: 1 ETQS---FNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIK 57
Query: 72 TKRPNSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTND 130
+ V F T F F + PY GL F VP + G
Sbjct: 58 IWDSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPP-----NSPQGEDGGNLGVFK 112
Query: 131 GNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNS 190
++ F VEFD F+N D H+GIDVNS+ S
Sbjct: 113 PPEGDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSK--------------------- 149
Query: 191 GTGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVL-- 248
+L NG V I Y + +V A LS ++L
Sbjct: 150 --------TLHFQLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPN 201
Query: 249 EDEMYVGFTAATG---QLVESHKILAWSFSNT 277
+ + VG +A TG VE+H+I++WSF+++
Sbjct: 202 SEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-55
Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 27/276 (9%)
Query: 368 EENVIGVGGNGKVYKGVLEGG--GAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSL 423
E+ +G G G V KG + +AVK + +E + LAE + + +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V + G C E S MLV + E G L+K++ Q + + I ++ V+ G+ YL E
Sbjct: 71 VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE 125
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--HGHGQVASTTRVVGTVGYLAPEVF 541
+HRD+ + NVLL + ++ DFGL++ + T V + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ + S+++DV+ FG+L+ E S + G V ++ +G+ +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMG---------- 230
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
+ L LC D RP V L
Sbjct: 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 184 bits (469), Expect = 2e-54
Identities = 68/259 (26%), Positives = 100/259 (38%), Gaps = 37/259 (14%)
Query: 24 SAVDFVFNGFNSSN--LSLYGTATVES-RILTLTN-STTFTIGRALYPSKIPTKRPNSSY 79
V F FN F+ N ++ G TV S + LTN + ++GR LY + +
Sbjct: 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGN 61
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
V F TSF F M K G++F P A G +D + H G
Sbjct: 62 VASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAG--SIGGGTLGVSDTKGAGHFVG 119
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
VEFD + N E+ND +HVGIDVNS+ SV
Sbjct: 120 VEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTV---------------------------- 151
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
+G +V + Y DS V ++ ++L L + + GF+A+
Sbjct: 152 -PWNSVSGAVVKVTVIY-DSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSAS 209
Query: 260 TGQL-VESHKILAWSFSNT 277
+ H I +WSF++T
Sbjct: 210 GSLGGRQIHLIRSWSFTST 228
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 3e-54
Identities = 70/314 (22%), Positives = 130/314 (41%), Gaps = 45/314 (14%)
Query: 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHENDGGTRA-FL 409
+E IG G G+V++ G +AVK + E +A F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 410 AEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCD------------ 457
E + + + ++V L G C + L+++YM G L++++
Sbjct: 65 REAALMAEFDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 458 ---------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508
G LSC E++ + + VAAG+ YL E +K +HRD+ + N L+ + M +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 509 LGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRR 567
+ DFGL+R ++ + + ++ PE R +T++DV+ +G+++ E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 568 PIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP 627
G + E V + G +L E+ + +L LC P RP
Sbjct: 241 QPYYGMAH--EEVIYYVRDGNILA-----------CPENCPLELYNLMRLCWSKLPADRP 287
Query: 628 TMRQVVKVLEGKIE 641
+ + ++L+ E
Sbjct: 288 SFCSIHRILQRMCE 301
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 183 bits (466), Expect = 3e-54
Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 45/261 (17%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESR-ILTLTNST---TFTIGRALYPSKIPTKRPNSSY 79
+ F FN +NL L G ATV S L LTN ++GRA Y + I
Sbjct: 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDN 61
Query: 80 VYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFG 139
+ FST+F F + + +GL F VP G + + ++LGLFN TN
Sbjct: 62 LASFSTNFTFRINAKNIENSAYGLAFALVP-VGSRPKLKGRYLGLFNTTN---------- 110
Query: 140 VEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSF 199
+ D D N + IDVNS+ ++ + +
Sbjct: 111 YDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFG----------------------- 147
Query: 200 KELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAA 259
NNG+ +V I Y ++ + ++ +S + L +ED + VGF+A
Sbjct: 148 ----HNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSAT 203
Query: 260 TG---QLVESHKILAWSFSNT 277
+G + E+H +L+WSFS+
Sbjct: 204 SGSKKETTETHNVLSWSFSSN 224
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-54
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 33/294 (11%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+ IG G G+V++G G E+AVK S + AEI L+H++++G
Sbjct: 8 QESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIA 64
Query: 429 WCKREKGS---LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE-- 483
++ G+ L LV DY E+GSL ++ + ++ E I++ A+G+ +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 484 ---GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ---VASTTRVVGTVGYLA 537
+ + HRD+KS N+L+ K + D GLA H + VGT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 538 PEVFSS------GRASTQTDVFGFGILILEVLSGRRPIEEGKP--------NLVEMVWEL 583
PEV + + D++ G++ E+ + + E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 584 MVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
M + L + + + + + + C Y + AR T ++ K L
Sbjct: 241 MRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 183 bits (465), Expect = 6e-54
Identities = 67/267 (25%), Positives = 98/267 (36%), Gaps = 42/267 (15%)
Query: 21 ESISAVDFVFNGF--NSSNLSLYGTATVES-RILTLT----NSTTFTIGRALYPSKIPTK 73
+ +S F F F N +LS G A+V +L L N T G A Y + I
Sbjct: 2 DDLS---FKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW 58
Query: 74 RPNSSYVYPFSTSFIFAM-APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN 132
N+ + F TSF F M A GL F P + GLFN T +
Sbjct: 59 NCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFNDTK-CD 116
Query: 133 SSNHVFGVEFDVFKN-QEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSG 191
SS VEFD + F D H+GIDVN + S++A
Sbjct: 117 SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK---------------- 160
Query: 192 TGDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251
+ V I Y S +T ++ ++L +L +
Sbjct: 161 -----------RYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEW 209
Query: 252 MYVGFTAATGQ-LVESHKILAWSFSNT 277
+ VGF+ +T +H++L W F++T
Sbjct: 210 VSVGFSGSTYIGRQATHEVLNWYFTST 236
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 183 bits (464), Expect = 8e-54
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 41/266 (15%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLTN-----STTFTIGRALYPSKIPTKRP 75
+ F N F N ++L G A+V S +L LT +++GRALY + +
Sbjct: 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGN 61
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ V FSTSF F + + GL F P + ++ +SSN
Sbjct: 62 TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSN 121
Query: 136 HVFGVEFDVFKNQEFNDIDEN--HVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
+ VEFD + ++ D N H+GIDVN + S+ +
Sbjct: 122 QIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAF----------- 170
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
L K + Y ++ ++L +L + +
Sbjct: 171 -----ATITYLAPNKTLIASLVYPS-------------NQTTFSVAASVDLKEILPEWVR 212
Query: 254 VGFTAATGQL--VESHKILAWSFSNT 277
VGF+AATG VE+H +L+WSF++T
Sbjct: 213 VGFSAATGYPTEVETHDVLSWSFTST 238
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-53
Identities = 54/272 (19%), Positives = 111/272 (40%), Gaps = 26/272 (9%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGL 426
+ IG G VYKG+ E+A + + F E L L+H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 427 RGWCK---REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
+ + K ++LV + M +G+L ++ + + + + + G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 130
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNG-RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
++HRD+K N+ + ++GD GLA + V+GT ++APE++
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMY- 185
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ DV+ FG+ +LE+ + P E + ++ + G +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPAS---------- 233
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
FD+ + V + C + R +++ ++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-52
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGA--EIAVKRIS-HENDGGTRAFLAEISSLGRL-KHK 421
++VIG G G+V K ++ G + A+KR+ + + R F E+ L +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM-------------LSCEERI 468
+++ L G C+ G L L +Y +G+L ++ + LS ++ +
Sbjct: 72 NIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528
DVA G+ YL +K+ +HRD+ + N+L+ + ++ DFGL+R T
Sbjct: 131 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTM 185
Query: 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGK 588
V ++A E + +T +DV+ +G+L+ E++S G ++E + QG
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGY 243
Query: 589 LLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641
L+ + + V L C P RP+ Q++ L +E
Sbjct: 244 RLE-----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-52
Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 21/275 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSL 423
+ IG G G+ K + G + K + + + + ++E++ L LKH ++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 424 VGLRGWC-KREKGSLMLVYDYMENGSLDKWIFQCDGS-MMLSCEERIRVLKDVAAGVLYL 481
V R +L +V +Y E G L I + L E +RV+ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 482 HE--GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
H VLHRD+K +NV LD + N +LGDFGLAR+ H + VGT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
+ + ++D++ G L+ E+ + P + + + +GK
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKFRR-------- 233
Query: 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ + + RP++ ++++
Sbjct: 234 ---IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 68/299 (22%), Positives = 120/299 (40%), Gaps = 39/299 (13%)
Query: 366 FSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDGGTR-AFLAEISSLGRLK 419
S +G G GKV + G +AVK + R A ++E+ L L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 420 -HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQC---------------DGSMMLS 463
H ++V L G C G +++ +Y G L ++ + D + L
Sbjct: 85 NHMNIVNLLGAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 464 CEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQ 522
E+ + VA G+ +L K +HRD+ + N+LL ++ DFGLAR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582
V ++APE + + ++DV+ +GI + E+ S G P ++
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKFYK 259
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641
++ +G + E + + C DP RPT +Q+V+++E +I
Sbjct: 260 MIKEGFRML-----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-51
Identities = 58/272 (21%), Positives = 106/272 (38%), Gaps = 28/272 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS---HENDGGTRAFLAEISSLGRLKHKS 422
F +G G G VY + +A+K + E G E+ L+H +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
++ L G+ + + L+ +Y G++ + + + + + ++A + Y H
Sbjct: 68 ILRLYGYF-HDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
K+V+HRDIK N+LL ++ DFG + + T + GT+ YL PE+
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIE 177
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ D++ G+L E L G+ P E + R +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETYKRISRVEFT 222
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
F + E L +P RP +R+V++
Sbjct: 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 6e-51
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 31/278 (11%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLK 419
K FS+ IG G G VY +A+K++S+ ++ + + E+ L +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
H + + RG + + LV +Y + D L E V G+
Sbjct: 74 HPNTIQYRGCY-LREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLA 129
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
YLH ++HRD+K+ N+LL + +LGDFG A + +A VGT ++APE
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPE 181
Query: 540 VFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596
V + G+ + DV+ GI +E+ + P+ N + ++ + Q +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIA-QNESPALQSGH 238
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
E + C P+ RPT ++K
Sbjct: 239 WS----------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 53/278 (19%), Positives = 115/278 (41%), Gaps = 26/278 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAE----IAVKRISHENDG-GTRAFLAEISSLGRLKH 420
F + V+G G G VYKG+ G + +A+K + + L E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 421 KSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
+ L G C ++ L+ M G L ++ + ++ + + +A G+ Y
Sbjct: 71 PHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPE 539
L +++++HRD+ + NVL+ + ++ DFGLA+ + + + ++A E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
+ Q+DV+ +G+ + E+++ +G P + ++ +G+ L
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLP-------- 233
Query: 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
V + + C D +RP R+++
Sbjct: 234 ---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 44/303 (14%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHENDGGTR-AFLAEISSLGRL- 418
V+G G GKV G ++AVK + + D R A ++E+ + +L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 419 KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSM------------------ 460
H+++V L G C G + L+++Y G L ++
Sbjct: 99 SHENIVNLLGAC-TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 461 --MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-M 517
+L+ E+ + VA G+ +L K +HRD+ + NVL+ ++ DFGLAR +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLV 577
V ++APE G + ++DV+ +GIL+ E+ S G P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-D 273
Query: 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
++L+ G +D E + + C D R RP+ + L
Sbjct: 274 ANFYKLIQNGFKMD-----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 638 GKI 640
++
Sbjct: 323 CQL 325
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 61/292 (20%), Positives = 129/292 (44%), Gaps = 31/292 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDGGTRA-FLAEISSLGRLK 419
+ +G G G VY+GV +G +A+K ++ R FL E S +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM-------LSCEERIRVLK 472
+V L G + +++ + M G L ++ +M S + I++
Sbjct: 82 CHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 473 DVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVG 531
++A G + K +HRD+ + N ++ ++ ++GDFG+ R ++ + +
Sbjct: 141 EIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 532 TVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591
V +++PE G +T +DV+ FG+++ E+ + +G N E V +++G LLD
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVMEGGLLD 255
Query: 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAG 643
++ + + L +C +P+ RP+ +++ ++ ++E G
Sbjct: 256 -----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 27/282 (9%)
Query: 364 KGFSEENVIGVGGNGKVYKGVLE---GGGAEIAVKRISHE---NDGGTRAFLAEISSLGR 417
K +G G G V +G + G +AVK + + F+ E++++
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 418 LKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAG 477
L H++L+ L G + +V + GSL + + G R VA G
Sbjct: 68 LDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEG 123
Query: 478 VLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--HGHGQVASTTRVVGTVGY 535
+ YL K+ +HRD+ + N+LL ++GDFGL R +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 536 LAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595
APE + S +D + FG+ + E+ + + G N +++ ++ +G+ L
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLP---- 235
Query: 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
ED + + ++ + C P RPT + L
Sbjct: 236 -------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 172 bits (436), Expect = 6e-50
Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 49/268 (18%)
Query: 21 ESISAVDFVFNGF--NSSNLSLYGTATVES-RILTLTNST-----TFTIGRALYPSKIPT 72
ES S F F F N +NL L A V S L LT ++GRALY + I
Sbjct: 2 ESTS---FSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI 58
Query: 73 KRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN 132
+++ + F+TSF F MA GL F P A LGLF +
Sbjct: 59 H--DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQAR-GGFLGLFADRA-HD 114
Query: 133 SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGT 192
+S VEFD + N D + H+GID N + S
Sbjct: 115 ASYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTP-------------------- 152
Query: 193 GDDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252
+ G+ + I Y S + +S ++L +L + +
Sbjct: 153 ---------FDMVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYV 203
Query: 253 YVGFTAATGQ---LVESHKILAWSFSNT 277
VGF+A TG +VE+H I++WSF+ +
Sbjct: 204 RVGFSATTGLNAGVVETHDIVSWSFAVS 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-49
Identities = 66/302 (21%), Positives = 116/302 (38%), Gaps = 38/302 (12%)
Query: 344 DWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVL---EGGGAEIAVKRISHE 400
D+E++ RI IG G G V++G+ E +A+K +
Sbjct: 1 DYEIQ--RERIELGR------------CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 46
Query: 401 NDGGTRA-FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGS 459
R FL E ++ + H +V L G + + ++ + G L ++ S
Sbjct: 47 TSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKYS 104
Query: 460 MMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519
L I ++ + YL K+ +HRDI + NVL+ +LGDFGL+R
Sbjct: 105 --LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEM 579
++ + ++APE + R ++ +DV+ FG+ + E+L +G N
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--ND 217
Query: 580 VWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639
V + G+ L + + L C DP RP ++ L
Sbjct: 218 VIGRIENGERLP-----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
Query: 640 IE 641
+E
Sbjct: 267 LE 268
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 171 bits (434), Expect = 1e-49
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 43/265 (16%)
Query: 24 SAVDFVFNGF--NSSNLSLYGTATVES-RILTLTN-----STTFTIGRALYPSKIPTKRP 75
++ F F F N L G A V S +L LTN ++ ++GRALY +
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+ V F TSF F + GL F P + LG+F N SN
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAP-VDTQPLDLGGMLGIFK-DGYFNKSN 119
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
+ VEFD F N ++ D H+GI+VNS+ S+ +
Sbjct: 120 QIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNW-------------------- 158
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255
NG+ V+I Y S ++T ++ +++ VL + + G
Sbjct: 159 ---------TNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFG 209
Query: 256 FTAATG---QLVESHKILAWSFSNT 277
F+A TG V+++ +L+WSF +
Sbjct: 210 FSATTGIDKGYVQTNDVLSWSFESN 234
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 58/270 (21%), Positives = 112/270 (41%), Gaps = 24/270 (8%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGW 429
+G G GKVYK + A K I +++ ++ EI L H ++V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 430 CKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKV 489
+ +L ++ ++ G++D + + + L+ + V K + YLH + K+
Sbjct: 78 F-YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 490 LHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA--- 546
+HRD+K+ N+L + + +L DFG++ + + +GT ++APEV +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190
Query: 547 --STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFD 604
+ DV+ GI ++E+ P E P + V K+ + L +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPTLAQPSRWS 242
Query: 605 EDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ C + AR T Q+++
Sbjct: 243 SN----FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 164 bits (417), Expect = 1e-47
Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 60/258 (23%)
Query: 24 SAVDFVFNGFNSSNLSLYGTATVESR-ILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYP 82
+ F+ + FN +NL L G ATV S L L+ ++ ++ RA Y + I + + V
Sbjct: 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVAS 61
Query: 83 FSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEF 142
F T+F + ++ + GL F+ VP S VEF
Sbjct: 62 FDTNFTMNIRTHRQANSAVGLDFVLVP-------------------VQPESKGDTVTVEF 102
Query: 143 DVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKEL 202
D F ++ D++ N + +
Sbjct: 103 DTFLSRISIDVNNNDIKSVPWDVH------------------------------------ 126
Query: 203 KLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQ 262
+G+N +V I Y S ++ + K +S + L + D + VGF+A +G
Sbjct: 127 -DYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGA 185
Query: 263 L---VESHKILAWSFSNT 277
E+H +L+WSFS+
Sbjct: 186 YQWSYETHDVLSWSFSSK 203
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-47
Identities = 65/272 (23%), Positives = 107/272 (39%), Gaps = 22/272 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLV 424
+ +G G G+V V +AVK + + EI L H+++V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
G RE L +Y G L I G + + R + AGV+YLH
Sbjct: 67 KFYGHR-REGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVFSS 543
+ HRDIK N+LLD+ N ++ DFGLA + + ++ GT+ Y+APE+
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 544 GRASTQ-TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ DV+ GI++ +L+G + + + + + L+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWK-------- 230
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
D L +L +P AR T+ + K
Sbjct: 231 -KIDSAPLALLHKILV--ENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (426), Expect = 4e-47
Identities = 58/293 (19%), Positives = 109/293 (37%), Gaps = 30/293 (10%)
Query: 348 EYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA 407
+Y+P + + + + +G G G V++ G A K + ++
Sbjct: 11 QYYPQPVEIKH-DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 69
Query: 408 FLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEER 467
EI ++ L+H +LV L + ++++Y++M G L + + +S +E
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEA 126
Query: 468 IRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR--LGDFGLARMHGHGQVAS 525
+ ++ V G+ ++H E +H D+K N++ + + L DFGL Q
Sbjct: 127 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183
Query: 526 TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV 585
T GT + APEV TD++ G+L +LSG P +
Sbjct: 184 VT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---------- 231
Query: 586 QGKLLDALDARLRAKGGFDEDEVERV----LHLGLLCAYPDPRARPTMRQVVK 634
+ L D+ + DP R T+ Q ++
Sbjct: 232 -----ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 7e-47
Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 36/298 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGG-----GAEIAVKRISHE-NDGGTRAFLAEISSLGRLK 419
+G G G+V + G +AVK + RA ++E+ L +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 420 HKS-LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM-------------LSCE 465
H +V L G C + G LM++ ++ + G+L ++ + L+ E
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 466 ERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVA 524
I VA G+ +L +K +HRD+ + N+LL ++ ++ DFGLAR ++
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 525 STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM 584
+ ++APE + Q+DV+ FG+L+ E+ S G + E +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRL 250
Query: 585 VQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642
+G + + + L C + +P RPT ++V+ L ++A
Sbjct: 251 KEGTRMR-----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 57/272 (20%), Positives = 113/272 (41%), Gaps = 21/272 (7%)
Query: 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS 422
K ++ IG G +G VY + G E+A+++++ + + EI + K+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
+V L +V +Y+ GSL + + + V ++ + +LH
Sbjct: 79 IVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLH 133
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+V+HRDIKS N+LL + + +L DFG Q + + +VGT ++APEV +
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVT 189
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ D++ GI+ +E++ G P N + ++ + G L+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRALYLIATNGTP------ELQNPEK 241
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
C D R + +++++
Sbjct: 242 LSAI----FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 2e-46
Identities = 61/270 (22%), Positives = 102/270 (37%), Gaps = 29/270 (10%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+G G G V++ V + G K I+ EIS + +L H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+K ++L+ +++ G L I D +S E I ++ G+ ++HE ++
Sbjct: 96 -EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 491 HRDIKSSNVLLDKEMNGR--LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
H DIK N++ + + + DFGLA ++ T + APE+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGF 207
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608
TD++ G+L +LSG P L+ L R FDED
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDD---------------LETLQNVKRCDWEFDEDAF 252
Query: 609 ERV----LHLGLLCAYPDPRARPTMRQVVK 634
V +PR R T+ ++
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 162 bits (411), Expect = 2e-46
Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 51/265 (19%)
Query: 24 SAVDFVFNGFNS-SNLSLYGTATVESR-ILTLTNSTT------FTIGRALYPSKIPTKRP 75
+ F F F++ L L G AT+ S+ L LT + ++GRA Y I K
Sbjct: 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK-- 59
Query: 76 NSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSN 135
+S+ V F+T+F F + ++ +GL F VP + + LG+FN TN+ +
Sbjct: 60 DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVP-VNSPPQKKQEFLGIFN-TNNPEPNA 117
Query: 136 HVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195
V F+ FKN D D+N + VN
Sbjct: 118 RTVAVVFNTFKN--RIDFDKNFIKPYVNENCDFH-------------------------- 149
Query: 196 EKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255
NG+ V I Y S ++ + + +S ++L +++ + VG
Sbjct: 150 --------KYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVG 201
Query: 256 FTAATG---QLVESHKILAWSFSNT 277
F+ +G E+H +L+WSFS+
Sbjct: 202 FSPTSGLTEDTTETHDVLSWSFSSK 226
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 40/295 (13%)
Query: 366 FSEENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHE-NDGGTRAFLAEISSLGR 417
+G G G+V G ++AVK + + + ++E+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 418 L-KHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMM-------------LS 463
+ KHK+++ L G C + G L ++ +Y G+L +++ + LS
Sbjct: 75 IGKHKNIINLLGAC-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 464 CEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523
++ + VA G+ YL KK +HRD+ + NVL+ ++ ++ DFGLAR H
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 524 ASTTRVV-GTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWE 582
T V ++APE + Q+DV+ FG+L+ E+ + G P VE +++
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFK 248
Query: 583 LMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
L+ +G +D + + + C + P RPT +Q+V+ L+
Sbjct: 249 LLKEGHRMD-----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 26/278 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F ++G G V E A+K + + E + RL H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
V L ++ L Y +NG L K+I + ++ + + YLH
Sbjct: 70 FVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR-MHGHGQVASTTRVVGTVGYLAPEVF 541
K ++HRD+K N+LL+++M+ ++ DFG A+ + + A VGT Y++PE+
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ A +D++ G +I ++++G P G L+ ++ +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---------------FQKIIKLEY 227
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639
F E + L D R ++ K
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 1e-41
Identities = 54/287 (18%), Positives = 115/287 (40%), Gaps = 27/287 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
+ ++G GG +V+ ++AVK + + + F E + L H +
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 423 LVGLRGWCKRE---KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
+V + + E +V +Y++ +L + ++ + I V+ D +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 125
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG--QVASTTRVVGTVGYLA 537
+ + ++HRD+K +N+++ ++ DFG+AR V T V+GT YL+
Sbjct: 126 FS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
PE ++DV+ G ++ EVL+G P + V + ++ + + + +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPVSVAYQHVREDPIPPSA---- 236
Query: 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARP-TMRQVVKVLEGKIEAG 643
E + + L +P R T ++ L ++ G
Sbjct: 237 -----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV-RVHNG 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 6e-41
Identities = 62/284 (21%), Positives = 107/284 (37%), Gaps = 26/284 (9%)
Query: 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRA-FLAEISS 414
+++ E + +V+G G +V + +A+K I+ + G EI+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 415 LGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDV 474
L ++KH ++V L G L L+ + G L I + + + R++ V
Sbjct: 61 LHKIKHPNIVALDDIY-ESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQV 116
Query: 475 AAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVG 534
V YLH+ + LD++ + DFGL++M G V ST GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPG 174
Query: 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594
Y+APEV + S D + G++ +L G P + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---------------KLFE 219
Query: 595 ARLRAKGGFDEDEVERV----LHLGLLCAYPDPRARPTMRQVVK 634
L+A+ FD + + DP R T Q ++
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-40
Identities = 49/270 (18%), Positives = 99/270 (36%), Gaps = 30/270 (11%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWC 430
+G G G V++ V K + + EIS L +H++++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 431 KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490
+ L+++++++ + + I L+ E + + V + +LH +
Sbjct: 71 E-SMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 491 HRDIKSSNVLLDKEMNGR--LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAST 548
H DI+ N++ + + +FG AR G Y APEV ST
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182
Query: 549 QTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEV 608
TD++ G L+ +LSG P ++ + A+ FDE+
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQ---------------QIIENIMNAEYTFDEEAF 227
Query: 609 ERV----LHLGLLCAYPDPRARPTMRQVVK 634
+ + + + ++R T + ++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (363), Expect = 3e-39
Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 36/285 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGT---------RAFLAEISSLG 416
+ + ++G G + V + + + E AVK I G A L E+ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 417 RLK-HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVA 475
++ H +++ L+ LV+D M+ G L ++ + LS +E ++++ +
Sbjct: 65 KVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 476 AGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGY 535
+ LH+ ++HRD+K N+LLD +MN +L DFG + G+ V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSY 175
Query: 536 LAPEVFSSGRA------STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL 589
LAPE+ + D++ G+++ +L+G P K ++ +++ G
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSGNY 232
Query: 590 LDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ + D + + L L P+ R T + +
Sbjct: 233 ------QFGSPEWDDYSDTVKDLVSRFLV--VQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (364), Expect = 2e-38
Identities = 64/275 (23%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAE---ISSLGRLK 419
FS +IG GG G+VY G A+K + + G L E +S +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
+V + L + D M G L + Q + ++ G+
Sbjct: 66 CPFIVCMSYAF-HTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGLE 121
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
++H + V++RD+K +N+LLD+ + R+ D GLA + VGT GY+APE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPE 175
Query: 540 VFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG--KLLDALDAR 596
V G A + D F G ++ ++L G P + K + + + +L D+
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
LR +E +L D R
Sbjct: 236 LR-------SLLEGLLQ-------RDVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 27/273 (9%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGR-LKHK 421
F ++G G GKV+ + A+K + + D + E L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 422 SLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYL 481
L + + K +L V +Y+ G L I C ++ G+ +L
Sbjct: 64 FLTHMFCTF-QTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119
Query: 482 HEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
K +++RD+K N+LLDK+ + ++ DFG+ + + G A T GT Y+APE+
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEIL 175
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ + D + FG+L+ E+L G+ P G+ M L+ +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAK--- 231
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
D + ++ +P R +R ++
Sbjct: 232 ----DLLVKLFV-------REPEKRLGVRGDIR 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 36/299 (12%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSL 423
+ + IG G G+V+K G ++A+K++ EN +G L EI L LKH+++
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 424 VGLRGWCK-------REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAA 476
V L C+ R KGS+ LV+D+ E+ + + E RV++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLN 128
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA---STTRVVGTV 533
G L+ K+LHRD+K++NVL+ ++ +L DFGLAR + + T V T+
Sbjct: 129 G---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 534 GYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMV 580
Y PE+ R D++G G ++ E+ + I + ++ V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLL-----CAYPDPRARPTMRQVVK 634
W + +L + L+ K + V L DP R +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 75/284 (26%), Positives = 113/284 (39%), Gaps = 27/284 (9%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRI-----SHENDGGTRAFLAEISSLGRLKHKSLV 424
+ +G G VYK + +A+K+I S DG R L EI L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
GL K ++ LV+D+ME D S++L+ + G+ YLH+
Sbjct: 64 GLLDAF-GHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSG 544
W +LHRD+K +N+LLD+ +L DFGLA+ G + T V T Y APE+
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGA 175
Query: 545 RA-STQTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMVWELMVQGKLLD 591
R D++ G ++ E+L I E E W M
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 592 ALDARLRAKGGFDEDEV-ERVLHLGLLCAYPDPRARPTMRQVVK 634
+ + +L L +P AR T Q +K
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 9e-37
Identities = 53/273 (19%), Positives = 99/273 (36%), Gaps = 25/273 (9%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLR 427
V+G+G NGKV + + + A+K + E+ R + +V +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 428 GWCK---REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
+ + L++V + ++ G L I G + E ++K + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 485 WEKKVLHRDIKSSNVLLDKEMNG---RLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
+ HRD+K N+L + +L DFG A+ +T T Y+APEV
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 542 SSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601
+ D++ G+++ +L G P + M + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
E+ V L +P R T+ + +
Sbjct: 243 EVSEE----VKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 24/289 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS-HENDGGTRAFLAEISSLGRLKHKSLV 424
++ + IG G G V +A+K+IS E+ + L EI L R +H++++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 425 GLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG 484
G+ R + Y+ + +++ + LS + L + G+ Y+H
Sbjct: 70 GINDII-RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 127
Query: 485 WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM--HGHGQVASTTRVVGTVGYLAPEVFS 542
VLHRD+K SN+LL+ + ++ DFGLAR+ H T V T Y APE+
Sbjct: 128 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 543 SGRAST-QTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMVWELMVQGKL 589
+ + T D++ G ++ E+LS R I + + ++ K
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 590 LDALDARLRAKGGFDEDEVERV----LHLGLLCAYPDPRARPTMRQVVK 634
+ L + L L +P R + Q +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 2e-36
Identities = 51/303 (16%), Positives = 99/303 (32%), Gaps = 24/303 (7%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G +Y G G E+A+K + E ++ +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIR 69
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
WC E ++V + + D + F S S + + + + + + Y+H K
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 489 VLHRDIKSSNVLLDKEMNGRL---GDFGLARMHGHGQVAS------TTRVVGTVGYLAPE 539
+HRD+K N L+ G L DFGLA+ + + + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599
S + D+ G +++ G P + K +E + + K+ ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV---- 239
Query: 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEAGIENETEDMDAYLLQQV 659
+ C +P + ++ + D +L+
Sbjct: 240 ---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296
Query: 660 KSK 662
S+
Sbjct: 297 ASR 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 62/285 (21%), Positives = 101/285 (35%), Gaps = 22/285 (7%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
F + IG G G VYK + G +A+K+I E +G + EIS L L H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L + L LV++++ + L + G+ +
Sbjct: 64 VKLLDVI-HTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFC-- 118
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
+VLHRD+K N+L++ E +L DFGLAR G T VV +
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 544 GRASTQTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMVWELMVQGKLLD 591
ST D++ G + E+++ R I E+VW +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 592 ALDARLRAKGGFD--EDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ + E L + DP R + + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 39/288 (13%)
Query: 366 FSEENV---------IGVGGNGKVYKGVLEGGGAEIAVKRI------SHENDGGTRAFLA 410
F +ENV +G G V K + G + A K I S
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 411 EISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRV 470
E+S L ++H +++ L K ++L+ + + G L ++ + + L+ EE
Sbjct: 63 EVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 118
Query: 471 LKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR----LGDFGLARMHGHGQVAST 526
LK + G ++ ++ H D+K N++L + + DFGLA G
Sbjct: 119 LKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EF 173
Query: 527 TRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQ 586
+ GT ++APE+ + + D++ G++ +LSG P G + V
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVN 232
Query: 587 GKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ D + A +D + R+L DP+ R T++ ++
Sbjct: 233 YEFEDEYFSNTSALA---KDFIRRLLV-------KDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 136 bits (344), Expect = 3e-36
Identities = 63/269 (23%), Positives = 98/269 (36%), Gaps = 29/269 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F +G G G+V+ G A+K + E E L + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
++ + G ++ + ++ DY+E G L S +V L L
Sbjct: 66 IIRMWGTF-QDAQQIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVC---LALE 118
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
K +++RD+K N+LLDK + ++ DFG A+ T + GT Y+APEV S
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVS 174
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602
+ + D + FGILI E+L+G P + + L A+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------------KTYEKILNAELR 219
Query: 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQ 631
F E V L D R Q
Sbjct: 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 134 bits (338), Expect = 3e-36
Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 30/144 (20%)
Query: 134 SNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTG 193
++ + VE D + N + D H+GID+ S+ S
Sbjct: 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKT----------------------- 37
Query: 194 DDEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253
+ + NGK I Y +S +S ++L VL + +
Sbjct: 38 ------AKWNMQNGKVGTAHIIY-NSVDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVR 90
Query: 254 VGFTAATGQLVESHKILAWSFSNT 277
VG +A+TG E++ IL+WSF++
Sbjct: 91 VGLSASTGLYKETNTILSWSFTSK 114
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 85.0 bits (210), Expect = 3e-19
Identities = 28/134 (20%), Positives = 47/134 (35%), Gaps = 19/134 (14%)
Query: 13 LLSIFLSFESISAVDFV---------FNGFNSSNLSLYGTATVESR-ILTLTNST----- 57
+LS + + S + +L L G AT + L LT +
Sbjct: 106 ILSWSFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSP 165
Query: 58 -TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFH-GIKG 115
++GRAL+ + + +S+ V F +F F + G+ F I
Sbjct: 166 QGSSVGRALFYAPVHI-WESSAVVASFEATFTFLIKS-PDSHPADGIAFFISNIDSSIPS 223
Query: 116 ATEAQHLGLFNRTN 129
+ + LGLF N
Sbjct: 224 GSTGRLLGLFPDAN 237
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-36
Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 30/290 (10%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVG 425
+++ VIG G G VY+ L G +A+K++ + R E+ + +L H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 426 LRGWC-----KREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLY 480
LR + K+++ L LV DY+ L + + + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 481 LHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAP- 538
+H + HRDIK N+LLD + +L DFG A+ G+ + + + Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPE 192
Query: 539 EVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN--LVEMVWELMVQGKLLDALDAR 596
+F + ++ DV+ G ++ E+L G+ LVE++ L +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 597 LRAKGGFDEDEVERVLHLGLLCAYP------------DPRARPTMRQVVK 634
+ F + + + P P AR T +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-35
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 29/287 (10%)
Query: 370 NVIGVGGNGKVYKGV-LEGGGAEIAVKRISHE--NDGGTRAFLAEI---SSLGRLKHKSL 423
IG G GKV+K L+ GG +A+KR+ + +G + + E+ L +H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 424 VGLRGWCK----REKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
V L C + L LV+++++ + + E ++ + G+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 130
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPE 539
+LH +V+HRD+K N+L+ +L DFGLAR++ + T VV T+ Y APE
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPE 185
Query: 540 VFSSGRASTQTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMVWELMVQG 587
V +T D++ G + E+ + I + E W V
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
+ F D E L L C +P R + +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-35
Identities = 58/274 (21%), Positives = 93/274 (33%), Gaps = 40/274 (14%)
Query: 371 VIGVGGNGKVYKGVLEGGGAEIAVKRIS------HENDGGTRAFLAEISSLGRLK--HKS 422
++G GG G VY G+ +A+K + E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
++ L W S +L+ + E G+ L E V V +
Sbjct: 71 VIRLLDWF-ERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHC- 126
Query: 483 EGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVF 541
VLHRDIK N+L+D +L DFG + T GT Y PE
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 542 SSGRASTQ-TDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600
R + V+ GIL+ +++ G P E + +++G++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQVF---------- 222
Query: 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
F + HL C P RPT ++
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (327), Expect = 3e-34
Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 26/280 (9%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
IG G G +++G ++A+K +D E + L + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVY 67
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK 488
+ +E +LV D + D S + K + A V +HE K
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 489 VLHRDIKSSNVLLDKEMNG-----RLGDFGLARM------HGHGQVASTTRVVGTVGYLA 537
+++RDIK N L+ + + + DFG+ + H + GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 538 PEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597
S + D+ G + + L G P + K + +E + + K L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637
GF E E + +H A P + +
Sbjct: 242 ---AGFPE-EFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (325), Expect = 5e-34
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 24/281 (8%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSLVGLR 427
IG G G VYK G A+K+I E++G + EIS L LKH ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 428 GWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEK 487
K L+LV++++ + L K + C+G L L + G+ Y H+ +
Sbjct: 67 DVI-HTKKRLVLVFEHL-DQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---R 119
Query: 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRAS 547
+VLHRD+K N+L+++E ++ DFGLAR G T +V + S + S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 548 TQTDVFGFGILILEVLSGRRP------------IEEGKPNLVEMVWELMVQGKLLDALDA 595
T D++ G + E+++G I W + + D
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 596 RLRAKGG--FDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634
F + E + L DP R T +Q ++
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-33
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 11/206 (5%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F ++G G GKV + G A+K + E + E L +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
L L+ + + L V +Y G L + + + + E ++ + L
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSA---LE 119
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+ V++RDIK N++LDK+ + ++ DFGL + G A+ GT YLAPEV
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 543 SGRASTQTDVFGFGILILEVLSGRRP 568
D +G G+++ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 60/286 (20%), Positives = 113/286 (39%), Gaps = 24/286 (8%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAFLAEISSLGRLKHKSL 423
+ + IG G G V+K +A+KR+ +++G + L EI L LKHK++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 424 VGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHE 483
V L L LV+++ + + C+G + + + + L
Sbjct: 64 VRLHDVL-HSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSF-----LFQLLKGLGF 116
Query: 484 GWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSS 543
+ VLHRD+K N+L+++ +L +FGLAR G + VV +F +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 544 GRASTQTDVFGFGILILEVLSGRRPIEEGKPN--LVEMVWELMVQ---------GKLLDA 592
ST D++ G + E+ + RP+ G ++ ++ L+ KL D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 593 LDARLRAKGGFDEDEVERV----LHLGLLCAYPDPRARPTMRQVVK 634
+ + V ++ L +P R + + ++
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 2e-30
Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 15/221 (6%)
Query: 366 FSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKS 422
F +G G G+V + G A+K + + L E L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 423 LVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLH 482
LV L ++ +L +V +Y+ G + + + S + YLH
Sbjct: 103 LVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH 158
Query: 483 EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFS 542
+++RD+K N+L+D++ ++ DFG A+ T + GT LAPE+
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIIL 211
Query: 543 SGRASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWE 582
S + D + G+LI E+ +G P +P + E +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 6e-30
Identities = 50/253 (19%), Positives = 100/253 (39%), Gaps = 29/253 (11%)
Query: 332 KQRRAREREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAE 391
R RE + E +E W ++ YQ + +G G +V++ + +
Sbjct: 14 NTHRPREYWDYESHVVE-WGNQDDYQLVR----------KLGRGKYSEVFEAINITNNEK 62
Query: 392 IAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCK-REKGSLMLVYDYMENGSL 449
+ VK + + EI L L+ +++ L K + LV++++ N
Sbjct: 63 VVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
Query: 450 DKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGR 508
+ L+ + + ++ + Y H ++HRD+K NV++D E R
Sbjct: 120 KQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLR 170
Query: 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRR 567
L D+GLA + GQ V + + PE+ + D++ G ++ ++ +
Sbjct: 171 LIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 568 PIEEGKPNLVEMV 580
P G N ++V
Sbjct: 229 PFFHGHDNYDQLV 241
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 50/303 (16%), Positives = 112/303 (36%), Gaps = 30/303 (9%)
Query: 355 TYQEIEAATKGFSE----ENVIGVGGNGKVYKGVLEGGGAEIAVKRI--SHENDGGTRAF 408
QE+ +G G G V V GA++A+K++ +++ +
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
E+ L ++H++++GL ++ Y+ + + + L +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528
++ + G+ Y+H ++HRD+K N+ ++++ ++ DFGLAR T
Sbjct: 125 FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTG 177
Query: 529 VVGTVGYLAPEV-FSSGRASTQTDVFGFGILILEVLSGRRP------------IEEGKPN 575
V T Y APEV + R + D++ G ++ E+++G+ I +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 576 LVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV----LHLGLLCAYPDPRARPTMRQ 631
+ + + + + + + ++L D R T +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 632 VVK 634
+
Sbjct: 298 ALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-29
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 19/228 (8%)
Query: 348 EYWPHRITYQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGT 405
+++ + + + IG G G V +A+K++S +N
Sbjct: 2 QFYSVEVGDSTFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 406 RAFLAEISSLGRLKHKSLVGLRGWCK-----REKGSLMLVYDYMENGSLDKWIFQCDGSM 460
+ E+ + + HK+++ L E + LV + M+ + D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-- 118
Query: 461 MLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520
E +L + G+ +LH ++HRD+K SN+++ + ++ DFGLAR G
Sbjct: 119 ----ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171
Query: 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP 568
+ T V T Y APEV D++ G ++ E++ +
Sbjct: 172 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-29
Identities = 66/321 (20%), Positives = 121/321 (37%), Gaps = 54/321 (16%)
Query: 326 LFLIKRKQRRAR-----EREEMEDWELEYWPHRITYQEIEAATKGFSEENVIGVGGNGKV 380
L +K + R A E+ +E++EL V+G G GKV
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIENFELL---------------------KVLGTGAYGKV 40
Query: 381 YKGVLEGG---GAEIAVKRISH----ENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE 433
+ G G A+K + + T E L ++ + + +
Sbjct: 41 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100
Query: 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRD 493
+ L L+ DY+ G L + Q + E + ++ L + +++RD
Sbjct: 101 ETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLA---LEHLHKLGIIYRD 154
Query: 494 IKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA--STQTD 551
IK N+LLD + L DFGL++ + GT+ Y+AP++ G + D
Sbjct: 155 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 214
Query: 552 VFGFGILILEVLSGRRP-IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVER 610
+ G+L+ E+L+G P +G+ N + +++ + + AK D ++R
Sbjct: 215 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK-----DLIQR 269
Query: 611 VLHLGLLCAYPDPRARPTMRQ 631
+L DP+ R
Sbjct: 270 LLM-------KDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 50/304 (16%), Positives = 105/304 (34%), Gaps = 32/304 (10%)
Query: 355 TYQEIEAATKGFSEE----NVIGVGGNGKVYKGVLEGGGAEIAVKRIS--HENDGGTRAF 408
QE+ E + +G G G V G +AVK++S ++ +
Sbjct: 5 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64
Query: 409 LAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERI 468
E+ L +KH++++GL + Y+ + + L+ +
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124
Query: 469 RVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVASTTR 528
++ + G+ Y+H ++HRD+K SN+ ++++ ++ DFGLAR T
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGY 178
Query: 529 VVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP------------IEEGKPNL 576
V + + + D++ G ++ E+L+GR I
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 577 VEMVWELMVQGKLLDALDARLRAKGGFDEDEVERV------LHLGLLCAYPDPRARPTMR 630
+ + + + + + + + L +L D R T
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV--LDSDKRITAA 296
Query: 631 QVVK 634
Q +
Sbjct: 297 QALA 300
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (254), Expect = 4e-25
Identities = 42/267 (15%), Positives = 78/267 (29%), Gaps = 44/267 (16%)
Query: 18 LSFE-SISAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPN 76
++ S V + + G A + + + S G +K +
Sbjct: 5 FEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLKSQRGSVWTKTKAAFEN-- 62
Query: 77 SSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNH 136
+ F + +G + GL + G+ G G +
Sbjct: 63 ------WEVEVTFRVTG-RGRIGADGLAIWYTENQGLDG----PVFG-------SADMWN 104
Query: 137 VFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDE 196
G+ FD F N + + + N+ H N G
Sbjct: 105 GVGIFFDSFDN--DGKKNNPAIVVVGNNGQINYDH----------------QNDGATQAL 146
Query: 197 KSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256
S + N + I Y + + M+ G K + V+ + + G
Sbjct: 147 ASCQRDFRNKPYPVRAKITYYQKTLTV-MINNGFTPDKNDYEFCAKVENMVIPTQGHFGI 205
Query: 257 TAATGQLVESHKILAWSFSNTKFSLSE 283
+AATG L + H +L++ F L+E
Sbjct: 206 SAATGGLADDHDVLSFLT----FQLTE 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (248), Expect = 2e-23
Identities = 53/313 (16%), Positives = 91/313 (29%), Gaps = 50/313 (15%)
Query: 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRG 428
+G G V+ +A+K + + T A EI L R+
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSC------------EERIRVLKDVAA 476
L+ +++ + + L ++ K +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 477 GVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDFGLARMHGHGQVASTTRVV-GTVG 534
G+ Y+H ++H DIK NVL++ L +A + T
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 535 YLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP---------------IEEGKPNLVEM 579
Y +PEV D++ LI E+++G I + L E+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 580 VWELMVQGKLLDA------------------LDARLRAKGGFDEDEVERVLHLGLLCAYP 621
L+ GK L+ L K F +DE + +
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 622 DPRARPTMRQVVK 634
DPR R +V
Sbjct: 315 DPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 4e-17
Identities = 32/161 (19%), Positives = 55/161 (34%), Gaps = 22/161 (13%)
Query: 370 NVIGVGGNGKVYKGVLEGGGAEIAVK----------RISHENDGGTRAFLAEISSLGRLK 419
++G G V+ E G E VK ++ + D G F R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 420 HKSLVGLRGWCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVL 479
++L L+G + VY + N L + I + + VL + V
Sbjct: 65 FRALQKLQGLA------VPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117
Query: 480 YLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520
+ ++H D+ NVL+ E + DF + G
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.8 bits (121), Expect = 1e-07
Identities = 25/251 (9%), Positives = 54/251 (21%), Gaps = 48/251 (19%)
Query: 26 VDFVFNGFNSSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFST 85
++ S +L +E LT T G + K + S
Sbjct: 12 LEVTDQQKELSQWTLGDKVKLEEGRFVLTPGKN-TKGSLWLKPEYSIKDAMTIEWTFRSF 70
Query: 86 SFIFAMAPYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVF 145
GL F + + N + +
Sbjct: 71 G--------FRGSTKGGLAFWLKQGNEGDSTE-----LFGGSSKKFNG----LMILLRLD 113
Query: 146 KNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLN 205
V +N T D ++ ++ +
Sbjct: 114 DK------LGESVTAYLNDGTK--------DLDIESSPYFASCLFQ-----------YQD 148
Query: 206 NGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVE 265
+ + + Y ++ ++ R + + +G +A E
Sbjct: 149 SMVPSTLRLTYNPLDNHLLKLQM----DNRVCFQTR-KVKFMGSSPFRIGTSAINDASKE 203
Query: 266 SHKILAWSFSN 276
S +IL +
Sbjct: 204 SFEILKMKLYD 214
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.3 bits (99), Expect = 8e-05
Identities = 29/252 (11%), Positives = 61/252 (24%), Gaps = 53/252 (21%)
Query: 35 SSNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94
+N A++E + LT++ + G K F+ + F Y
Sbjct: 22 PNNWQTGEQASLEEGRIVLTSNQN-SKGSLWLKQGFDLKDS-------FTMEWTFRSVGY 73
Query: 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDID 154
G G+ F FV I + +G + + D
Sbjct: 74 SG-QTDGGISFWFVQDSNIPRDKQ---------LYNGPVNYDGLQLLVDNNGP------L 117
Query: 155 ENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWI 214
+ +N + + + ++ + +
Sbjct: 118 GPTLRGQLN-------------DGQKPVDKTKIYDQSFASCLMGY----QDSSVPSTIRV 160
Query: 215 DYADSFINITMVE-AGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWS 273
Y N+ V+ + + P +G TA G + + +
Sbjct: 161 TYDLEDDNLLKVQVDNKVCFQTRKVRFPSG-------SYRIGVTAQNGAVNNNAES---- 209
Query: 274 FSNTKFSLSEEL 285
F K +
Sbjct: 210 FEIFKMQFFNGV 221
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 705 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.95 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.94 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.82 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.62 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 82.24 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 80.72 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=4.1e-54 Score=431.87 Aligned_cols=222 Identities=29% Similarity=0.492 Sum_probs=195.0
Q ss_pred eeeEEeCCCCC---CCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 25 AVDFVFNGFNS---SNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 25 ~~~f~f~~f~~---~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
+++|+|++|.+ .+|+|+|||++.++.|+||+.. ..++|||+|++||+||++.++++|||+|+|+|.|...
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~- 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT- 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC-
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEecCCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC-
Confidence 47999999974 6899999999999999999864 3589999999999999999999999999999999875
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCC-CCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDG-NSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
...+||||||||+|.... .+..|++||++|..+.+ ...+++|||||||++|.+++||++||||||+|+++|.++.+
T Consensus 80 ~~~~gDGlAFvl~p~~~~-~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~-- 156 (236)
T d1hqla_ 80 GNGPADGLAFFLAPPDSD-VKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR-- 156 (236)
T ss_dssp SSCCCCEEEEEEECTTCC-CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE--
T ss_pred CCCCCceEEEEEeCCCCC-CCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccc--
Confidence 456899999999997654 45789999999976644 35789999999999999999999999999999999987743
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
| ....+.+|+.++|||+| ..++|+|+++.. +|..|+|++.|||+++|+++|
T Consensus 157 -~-----------------------~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v 209 (236)
T d1hqla_ 157 -W-----------------------EDSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESV 209 (236)
T ss_dssp -C-----------------------CHHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEE
T ss_pred -c-----------------------ccccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcE
Confidence 2 34578899999999999 777899999764 466789999999999999999
Q ss_pred ecccccccccc-cccceeeeeeeccc
Q 005257 253 YVGFTAATGQL-VESHKILAWSFSNT 277 (705)
Q Consensus 253 ~vGfsastg~~-~~~h~i~~wsf~~~ 277 (705)
|||||||||.. .+.|+|++|+|+++
T Consensus 210 ~vGFSasTG~~~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 210 RVGISASTGNNQFLTVYILSWRFSSN 235 (236)
T ss_dssp EEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred EEEEEeECCCCCceEEEEEEeEeEec
Confidence 99999999974 67899999999975
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=2e-53 Score=428.29 Aligned_cols=222 Identities=28% Similarity=0.476 Sum_probs=194.0
Q ss_pred ceeeEEeCCCC------CCCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEE
Q 005257 24 SAVDFVFNGFN------SSNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAM 91 (705)
Q Consensus 24 ~~~~f~f~~f~------~~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 91 (705)
.+++|+|++|. ..||+|+|||++.+|.|+||+.. ..++|||+|++||+||++ +++++||+|+|+|.|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~i 80 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEETBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEcCCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEEc
Confidence 47899999995 36899999999999999999754 358999999999999995 789999999999998
Q ss_pred ecCCCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCC-CCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccc
Q 005257 92 APYKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGN-SSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSA 170 (705)
Q Consensus 92 ~~~~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~ 170 (705)
.+.+ ..+||||||||+|... +.+..|++||+++..+.++ ..+++|||||||++|.+++||++||||||+|++.|.++
T Consensus 81 ~~~~-~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~ 158 (243)
T d1leda_ 81 KNYG-APTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT 158 (243)
T ss_dssp EESS-SSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred CCCC-CCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccccc
Confidence 7664 4579999999999765 4457899999999776544 57899999999999999999999999999999999877
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccc
Q 005257 171 HAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVL 248 (705)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l 248 (705)
++ | ....+.+|+.++|||+| ..++|+|+++.. +|..|+|++.|||+++|
T Consensus 159 ~~---~-----------------------~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l 209 (243)
T d1leda_ 159 TR---W-----------------------ENDDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVL 209 (243)
T ss_dssp EE---C-----------------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHS
T ss_pred cc---c-----------------------ccCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhc
Confidence 54 2 23468899999999999 668999999864 56778999999999999
Q ss_pred ccceecccccccccccccceeeeeeecccc
Q 005257 249 EDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 249 ~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
+++||||||||||. .|.|+|++|+|+++.
T Consensus 210 ~~~vyvGFSAsTG~-~~~h~I~sWsF~s~l 238 (243)
T d1leda_ 210 PQKVRIGFSAGVGY-DEVTYILSWHFFSTL 238 (243)
T ss_dssp CSEEEEEEEEEECB-SEEEEEEEEEEEEEC
T ss_pred CCcEEEEEEcccCC-cceeeEEEEEEEeeC
Confidence 99999999999994 699999999999875
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=1.3e-51 Score=416.12 Aligned_cols=224 Identities=28% Similarity=0.398 Sum_probs=193.8
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCCC----CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC-C
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNSTT----FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY-K 95 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~~----~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 95 (705)
++++|+|++|++ +||+|+|||++. +|.||||+... .++|||+|++||+|||+.+++++||+|+|+|.|... +
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~ 81 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence 578999999974 689999999986 77999998763 488999999999999999999999999999999655 3
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCC-CCCCCCCCeeEEecCCCccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQ-EFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
...+||||||+|+|.. .|.+..|++|||+|.++ ++..+++|||||||++|+ +++||++||||||+|++.|..+.+
T Consensus 82 ~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~-- 157 (240)
T d1fx5a_ 82 PKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER-- 157 (240)
T ss_dssp GGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE--
T ss_pred CCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCcccccccc--
Confidence 4568999999999975 46778999999999754 456789999999999995 778999999999999999876643
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
| ...+.+|+.++|||+| ..++|.|++... .+|..|+++..|||+.+|+++|
T Consensus 158 -~------------------------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~~~ls~~vdLs~~l~~~v 210 (240)
T d1fx5a_ 158 -W------------------------NKRYGLNNVANVEIIYEASSKTLTASLTYP--SDQTSISVTSIVDLKEILPEWV 210 (240)
T ss_dssp -C------------------------CCCCSGGGCEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCGGGTSCSEE
T ss_pred -c------------------------ccccCCCCeEEEEEEEcCCCCEEEEEEecC--CCceeeEEeEEEchHHhCCCcE
Confidence 2 2346788899999999 666889988754 4677889999999999999999
Q ss_pred eccccccccc-ccccceeeeeeecccc
Q 005257 253 YVGFTAATGQ-LVESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsastg~-~~~~h~i~~wsf~~~~ 278 (705)
|||||||||. ..+.|+|++|+|+++.
T Consensus 211 ~vGFSasTG~~~~~~H~I~sWsFsst~ 237 (240)
T d1fx5a_ 211 SVGFSGSTYIGRQATHEVLNWYFTSTF 237 (240)
T ss_dssp EEEEEEEEETTSCEEEEEEEEEEEEES
T ss_pred EEEEEeECCCCCCceEEEEEEEeEEec
Confidence 9999999995 5689999999999864
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=3e-51 Score=412.92 Aligned_cols=222 Identities=31% Similarity=0.542 Sum_probs=193.1
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC---CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST---TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGV 97 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 97 (705)
++++|+|++|++ .||+|+|||++. ++.|+||+.. ..++|||+|++||+||++.+++++||+|+|+|.|.+++ .
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~-~ 80 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADK-S 80 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSS-S
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecCC-C
Confidence 578999999964 789999999987 6799999865 36899999999999999999999999999999997764 4
Q ss_pred CCCCceEEEEeeCCC-CCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCC--CCCCCeeEEecCCCccccccccc
Q 005257 98 LAGHGLVFLFVPFHG-IKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFN--DIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 98 ~~g~G~aF~~~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
.+||||||+|+|... .|.++.++++|++|.. ++.+.+++|||||||++|.+++ ||++||||||+|++.|.+++
T Consensus 81 ~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~--- 156 (237)
T d1qnwa_ 81 DGVDGLAFFLAPANSQIPSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV--- 156 (237)
T ss_dssp CCCCEEEEEEEETTCCCCTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE---
T ss_pred CCcceeEEEEeCCCCCCCCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccc---
Confidence 589999999999864 5677888899998854 3567899999999999998765 58999999999999987663
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
.+.+.+|+.++|||+| ..++|+|++.. ..+|..|+|+..|||+++|+++|
T Consensus 157 --------------------------~~~~~~G~~~~v~I~Yd~~~~~L~V~l~~--~~~~~~p~ls~~vDLs~~l~~~v 208 (237)
T d1qnwa_ 157 --------------------------KWDWRNGEVADVVITYRAPTKSLTVCLSY--PSDGTSNIITASVDLKAILPEWV 208 (237)
T ss_dssp --------------------------ECCCCTTCCEEEEEEEEGGGTEEEEEEEC--TTTCCEEEEEEECCHHHHSCSEE
T ss_pred --------------------------ccccCCCcEEEEEEEEcCCCcEEEEEEec--CCCCccceEEEEEChHHhCCCcE
Confidence 3457899999999999 56788888764 45788999999999999999999
Q ss_pred ecccccccccc--cccceeeeeeecccc
Q 005257 253 YVGFTAATGQL--VESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsastg~~--~~~h~i~~wsf~~~~ 278 (705)
|||||||||.. .|.|+|++|+|+++.
T Consensus 209 yvGFSasTG~~~~~q~h~I~sWsF~s~l 236 (237)
T d1qnwa_ 209 SVGFSGGVGNAAEFETHDVLSWYFTSNL 236 (237)
T ss_dssp EEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred EEEEEeECCCCCCccEeEEEEeEeEEec
Confidence 99999999975 489999999999763
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=4.8e-51 Score=411.68 Aligned_cols=221 Identities=30% Similarity=0.515 Sum_probs=191.8
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
++++|+|++|++ .||+|+|||.+. +|.||||+... +++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 478999999974 689999999987 68999998754 488999999999999999999999999999999654
Q ss_pred -CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 95 -KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 95 -~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
+...+||||||+|+|.... .+..+++||+++..+. ...++.|||||||++|. ++||+++|||||+|++.|.++.
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~-~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~-~~d~~~~HvgI~vn~~~s~~t~-- 156 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSK-PAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQ-- 156 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCC-CCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEE--
T ss_pred CCCCCCCCeEEEEECCCCCC-CCCCcccccccccCCC-CCccceEEEEEEccccC-CCCCCCCEEEEEECCccccccC--
Confidence 3456899999999998654 4567899999986554 45788999999999994 7899999999999999998774
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~ 251 (705)
.+++.+|+.++|||+| ..++|+|++.. ..+|..|+|+..|||+++|+++
T Consensus 157 ---------------------------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~--~~~~~~~~ls~~vdL~~~l~~~ 207 (239)
T d1gzca_ 157 ---------------------------PFQLDNGQVANVVIKYDAPSKILHVVLVY--PSSGAIYTIAEIVDVKQVLPDW 207 (239)
T ss_dssp ---------------------------ECCCCTTCEEEEEEEEETTTTEEEEEEEC--TTTCCEEEEEEECCHHHHSCSE
T ss_pred ---------------------------CccccCCCEEEEEEEEeCCCcEEEEEEec--CCCCcceeeeeEechHHhcCCc
Confidence 3468899999999999 55678888764 4578899999999999999999
Q ss_pred eeccccccccc---ccccceeeeeeecccc
Q 005257 252 MYVGFTAATGQ---LVESHKILAWSFSNTK 278 (705)
Q Consensus 252 ~~vGfsastg~---~~~~h~i~~wsf~~~~ 278 (705)
||||||||||. ..|.|+|++|+|+++.
T Consensus 208 vyvGFSAsTG~~~~~~~~H~V~sWsF~s~l 237 (239)
T d1gzca_ 208 VDVGLSGATGAQRDAAETHDVYSWSFQASL 237 (239)
T ss_dssp EEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEEEEcCCCCCCceeeEEEEEEeEeeC
Confidence 99999999994 5789999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-52 Score=432.40 Aligned_cols=267 Identities=24% Similarity=0.428 Sum_probs=222.5
Q ss_pred HHHHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC
Q 005257 356 YQEIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG 435 (705)
Q Consensus 356 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 435 (705)
|++++...++|+..+.||+|+||+||+|.++.+++.||||+++.. ....++|.+|+++|++++|||||+++++|.+ ++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~ 86 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EP 86 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee-CC
Confidence 334444456788899999999999999999999999999998654 3456789999999999999999999999876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+++|+|.+++.+.... .+++..++.++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~-~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeEEEeecccCcchHHHhhhcccc-chHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccce
Confidence 889999999999999999765433 79999999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
+..............||+.|||||++.+..++.++|||||||++|||++|..|+...... ..+.+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~~-------- 232 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-------- 232 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTT--------
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhcC--------
Confidence 977655544445567899999999999999999999999999999999987776544321 2222222222
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+ ...+....+.+.+++..||+.||++|||+.|+++.|+...+
T Consensus 233 -~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -YR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 22333455678999999999999999999999999986654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-51 Score=430.44 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=200.7
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCe---EEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGA---EIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+|+..++||+|+||+||+|.++.+++ .||||++... .....+.|.+|+++|++++|||||+++|+|.. ++.+++|
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv 105 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMII 105 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEE
Confidence 34556899999999999999976553 6899988665 34456789999999999999999999999976 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||++|+|.+++..... .+++.++++++.|||.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876433 69999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcce----eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHH
Q 005257 521 GQVAS----TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDA 595 (705)
Q Consensus 521 ~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~ 595 (705)
..... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+.... .+...+..+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~~-------- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQD-------- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT--------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC--------
Confidence 33221 222467999999999999999999999999999999998 89999765431 122222222
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 596 RLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 596 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+ ...+.+....+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 250 -~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 -YR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 22334456678999999999999999999999999987765
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=9.2e-51 Score=408.74 Aligned_cols=217 Identities=31% Similarity=0.494 Sum_probs=188.9
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC-
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY- 94 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 94 (705)
++++|+|++|++ +||+|+|||++. ++.||||++. .+++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 1 ~t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~ 80 (237)
T d2d3sa1 1 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 80 (237)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred CeEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCC
Confidence 478999999953 789999999986 5799999864 4699999999999999999999999999999999654
Q ss_pred CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccc
Q 005257 95 KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAG 174 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~ 174 (705)
+...+||||||+|+|... +.+..|++||+++.. ..+++|||||||++|. +||++||||||+|++.|.+..
T Consensus 81 ~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~--- 150 (237)
T d2d3sa1 81 PRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTV--- 150 (237)
T ss_dssp CSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE---
T ss_pred CCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCcccccc---
Confidence 345678999999999764 456789999998864 3578999999999997 699999999999999987653
Q ss_pred ccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccce
Q 005257 175 YWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEM 252 (705)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~ 252 (705)
.+.+.+|+.++|||+| ..++|+|++.... +|..|+++..|||+.+|+++|
T Consensus 151 --------------------------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~v 202 (237)
T d2d3sa1 151 --------------------------PFTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESV 202 (237)
T ss_dssp --------------------------ECCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEE
T ss_pred --------------------------ceeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcE
Confidence 4468899999999999 6678888887644 577789999999999999999
Q ss_pred eccccccccc-------ccccceeeeeeecccc
Q 005257 253 YVGFTAATGQ-------LVESHKILAWSFSNTK 278 (705)
Q Consensus 253 ~vGfsastg~-------~~~~h~i~~wsf~~~~ 278 (705)
|||||||||. ..|.|+|++|+|+++.
T Consensus 203 yvGFSasTG~~~~~~~~~~e~h~I~sWsFss~l 235 (237)
T d2d3sa1 203 NVGFSAATGDPSGKQRNATETHDILSWSFSASL 235 (237)
T ss_dssp EEEEEEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred EEEEEeECCCCccCccccceeeEEEEeEeEeeC
Confidence 9999999994 4699999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=426.08 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=207.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
.++|...+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++||||+++++++. .+.+++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe--ccEEEEE
Confidence 467888999999999999999875 35999998654 3456788999999999999999999999875 3568999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++...+. .+++.+++.++.|||+||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999976543 59999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCc-ceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 521 GQV-ASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 521 ~~~-~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.... ..+...+..+.... .
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p----~ 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSP----D 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCC----C
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCC----c
Confidence 332 23345689999999999864 35899999999999999999999999865432 22223333222111 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIEA 642 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 642 (705)
+ ...+...++.+.+++..||+.||++|||++|+++.|+.+.+.
T Consensus 231 ~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 L---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 112233456788999999999999999999999999876653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=419.22 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=200.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++||||++++|+|.. ++.+++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEe
Confidence 46778899999999999999987 4678999999754 3445789999999999999999999999986 6788999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.+++.... ..+++..+++++.|+|.||.|||+ ++|+||||||+|||+++++++||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred cCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999987643 268999999999999999999998 9999999999999999999999999999987765544
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
.......||+.|||||++.+..++.++|||||||++|||+|+..|+..... . ..+.+.+..+. + ...
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~-~~~~~~i~~~~---------~--~~~ 223 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-N-SEVVEDISTGF---------R--LYK 223 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-H-HHHHHHHHHTC---------C--CCC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-H-HHHHHHHHhcC---------C--CCC
Confidence 444456899999999999999999999999999999999995544433322 1 11222222221 1 222
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+..+.+.+.+++..||+.||++||||+|+++.|+++.+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 33345678899999999999999999999999987654
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=1.5e-50 Score=410.95 Aligned_cols=219 Identities=34% Similarity=0.527 Sum_probs=187.3
Q ss_pred CceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEec
Q 005257 23 ISAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAP 93 (705)
Q Consensus 23 ~~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 93 (705)
+++++|+|++|++ .||+|+|+|++. +|.|+||++. ..++|||+|++||+||++.+++++||+|+|+|.|..
T Consensus 1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~ 80 (251)
T d1g9fa_ 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA 80 (251)
T ss_dssp CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence 3579999999974 689999999986 7799999865 358999999999999999999999999999999998
Q ss_pred CCCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 94 YKGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 94 ~~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
.+...+||||||+|+|....+ +..||+||+++.. ...+++|||||||++|. +||+++|||||+|++.|..+.
T Consensus 81 ~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~-- 152 (251)
T d1g9fa_ 81 PDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTT-- 152 (251)
T ss_dssp SCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEE--
T ss_pred CCCCCCCCceEEEEecCCCCC-CCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecCccccccc--
Confidence 888889999999999986544 5678999998864 34578999999999997 699999999999999987663
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccc
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDE 251 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~ 251 (705)
.+++.+|+.++|||+| ..++|+|++... .+|..|+++..|||+.+|+++
T Consensus 153 ---------------------------~~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~l~~~vdL~~~l~~~ 203 (251)
T d1g9fa_ 153 ---------------------------SWDLANNKVAKVLITYDASTSLLVASLVYP--SQRTSNILSDVVDLKTSLPEW 203 (251)
T ss_dssp ---------------------------ECCCCTTCCEEEEEEEETTTTEEEEEEEEG--GGTEEEEEEEECCC-CCSCSE
T ss_pred ---------------------------ceEecCCCEEEEEEEEECCccEEEEEEecC--CCCcceeEEEEecchhhCCCc
Confidence 4468899999999999 667888888643 478889999999999999999
Q ss_pred eeccccccccccc--ccceeeeeeecccc
Q 005257 252 MYVGFTAATGQLV--ESHKILAWSFSNTK 278 (705)
Q Consensus 252 ~~vGfsastg~~~--~~h~i~~wsf~~~~ 278 (705)
||||||||||... |.|+|++|+|+++.
T Consensus 204 ~yvGFSAsTG~~~~~~~h~I~sWsF~s~~ 232 (251)
T d1g9fa_ 204 VRIGFSAATGLDIPGESHDVLSWSFASNL 232 (251)
T ss_dssp EEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred EEEEEEeecCCCCCCceeEEEEeEeECCC
Confidence 9999999999755 88999999999875
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=4.8e-50 Score=408.65 Aligned_cols=221 Identities=32% Similarity=0.535 Sum_probs=194.8
Q ss_pred ceeeEEeCCCCCCCeEEEcceEeecCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVESRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGV 97 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 97 (705)
...+|+|++|++.||+|+|||.+.++.|+||++.. .++|||+|++||+||++.+++++||+|+|+|.|.+.+..
T Consensus 2 ~~~sF~f~~F~~~~l~l~GdA~~~~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~~~~ 81 (253)
T d1g7ya_ 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cccEEecCCCCcccEEEEeeeEEcCCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecCCCC
Confidence 46899999999999999999999999999998653 488999999999999999999999999999999888777
Q ss_pred CCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccC
Q 005257 98 LAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWP 177 (705)
Q Consensus 98 ~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~ 177 (705)
.+||||||+|+|....+ +..||++|+++..+. ...++.|||||||++|.++ ||+++|||||+|++.|.+++
T Consensus 82 ~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~------ 152 (253)
T d1g7ya_ 82 SSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTA------ 152 (253)
T ss_dssp GCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE------
T ss_pred CCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEeceecCCC-CCCCCcEEEeeCCccccccc------
Confidence 79999999999987654 457889999986543 4567899999999999875 99999999999999987663
Q ss_pred CCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecc
Q 005257 178 DNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVG 255 (705)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vG 255 (705)
...+.+|+.++|||+| ..++|.|++.. ..+|..|+++..|||+.+||++||||
T Consensus 153 -----------------------~~~~~~g~~~~v~I~Yd~~~~~L~v~l~~--~~~~~~~~ls~~vdL~~~l~~~~yvG 207 (253)
T d1g7ya_ 153 -----------------------SWGLANGQNAEILITYNAATSLLVASLVH--PSRRTSYIVSERVDITNELPEYVSIG 207 (253)
T ss_dssp -----------------------ECCCCTTSEEEEEEEEETTTTEEEEEEEE--TTTTEEEEEEEECCHHHHSCSEEEEE
T ss_pred -----------------------CCCccCCCEEEEEEEEeCCcEEEEEEEec--CCCCCceEEEEEechhhcCCCcEEEE
Confidence 3467899999999999 66788888764 45788899999999999999999999
Q ss_pred cccccc---cccccceeeeeeecccc
Q 005257 256 FTAATG---QLVESHKILAWSFSNTK 278 (705)
Q Consensus 256 fsastg---~~~~~h~i~~wsf~~~~ 278 (705)
|||||| ...+.|+|++|+|++..
T Consensus 208 FSAsTG~~~~~~~~H~IlsWsF~s~l 233 (253)
T d1g7ya_ 208 FSATTGLSEGYTETHDVLSWSFASKL 233 (253)
T ss_dssp EEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred EEeEcCCCCCcccccEEEEEEeEEeC
Confidence 999999 45799999999998753
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=7.3e-50 Score=401.71 Aligned_cols=216 Identities=31% Similarity=0.498 Sum_probs=187.3
Q ss_pred ceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 24 SAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 24 ~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
+++||+|++|. .+||+|+|||++. +|.|+||+.. .+++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 1 ~~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~ 80 (234)
T d1f9ka_ 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP 80 (234)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred CceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECC
Confidence 46899999996 4789999999986 7899999875 3588999999999999999999999999999999765
Q ss_pred -CCCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccc
Q 005257 95 -KGVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAA 173 (705)
Q Consensus 95 -~~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~ 173 (705)
+...+||||||+|+|... |.+..|+++|+++.. ..++.|||||||++|. +||++||||||+|++.|.++.
T Consensus 81 ~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~-- 151 (234)
T d1f9ka_ 81 YAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTL-- 151 (234)
T ss_dssp CSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS----CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE--
T ss_pred CCCCCccceEEEEECCCCC-CcccccccccccCCC----CccceEEEEEeccccC--CCCCCCcEeEecCCccccccc--
Confidence 344678999999999754 667789999998864 3567899999999997 799999999999999887652
Q ss_pred cccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccc--
Q 005257 174 GYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLE-- 249 (705)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~-- 249 (705)
.+.+.+|+.++|||+| ..++++|+++... +|..|+|++.|||+.+|+
T Consensus 152 ---------------------------~~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~ 202 (234)
T d1f9ka_ 152 ---------------------------HFQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNS 202 (234)
T ss_dssp ---------------------------ECCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTC
T ss_pred ---------------------------cccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCC
Confidence 4578899999999999 6678888887654 567789999999999997
Q ss_pred cceeccccccccc---ccccceeeeeeeccc
Q 005257 250 DEMYVGFTAATGQ---LVESHKILAWSFSNT 277 (705)
Q Consensus 250 ~~~~vGfsastg~---~~~~h~i~~wsf~~~ 277 (705)
++||||||||||. ..|.|+|++|+|+++
T Consensus 203 ~~v~vGFSasTG~~~~~~~~h~I~sWsF~s~ 233 (234)
T d1f9ka_ 203 EWVNVGLSATTGYQKNAVETHEIISWSFTSS 233 (234)
T ss_dssp SEEEEEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred CEEEEEEEeecCCCCCceeeeEEEEEEeEEe
Confidence 5699999999994 568999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=414.33 Aligned_cols=246 Identities=23% Similarity=0.387 Sum_probs=209.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|+++.+++.||||++... .....+.+.+|++++++++||||+++++++.+ ++.+++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence 3588899999999999999999999999999998643 23345678999999999999999999999886 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999997644 69999999999999999999999 9999999999999999999999999999986544
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+.++.
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~------------ 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRVE------------ 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTC------------
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC------------
Confidence 32 2346799999999999999999999999999999999999999976542 12222222221
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..++....+.+.+++..||++||++|||++|+++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2233334567889999999999999999999987
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.6e-50 Score=400.88 Aligned_cols=218 Identities=34% Similarity=0.546 Sum_probs=191.7
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKG 96 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 96 (705)
.+++|+|++|++.||+|+|||++. +|.||||+... .++|||+|++||+||++.++.++||+|+|+|.|.+.+.
T Consensus 2 ~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~~ 81 (233)
T d1g8wa_ 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (233)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCSS
T ss_pred CceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCCC
Confidence 579999999999999999999986 77999998643 48999999999999999999999999999999998877
Q ss_pred CCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCccccccccccc
Q 005257 97 VLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYW 176 (705)
Q Consensus 97 ~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~ 176 (705)
..+||||||+|+|.... .+..|++||+++.. +..++.|||||||++|.++ ||+.+|||||+|+++|..+.
T Consensus 82 ~~~gDGlAF~l~~~~~~-~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~----- 151 (233)
T d1g8wa_ 82 AGPADGLAFALVPVGSQ-PKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTT----- 151 (233)
T ss_dssp CBCCEEEEEEEEETTCC-CCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE-----
T ss_pred CCCCCeEEEEEecCCCC-CCcccccCCccccC---CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeec-----
Confidence 77899999999998664 45789999998854 4567899999999999875 99999999999999887653
Q ss_pred CCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceec
Q 005257 177 PDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYV 254 (705)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~v 254 (705)
...+.+|+.++|||+| ..+.+.|++... .+|..|+++..|||+.+||++|||
T Consensus 152 ------------------------~~~~~~g~~~~~~I~yd~~~~~l~v~l~~~--~~~~~~~l~~~vdL~~~l~~~~yv 205 (233)
T d1g8wa_ 152 ------------------------RWDFVNGENAEVLITYDSSTNLLVASLVYP--SQKTSFIVSDTVDLKSVLPEWVSV 205 (233)
T ss_dssp ------------------------ECCCCTTCCEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEE
T ss_pred ------------------------cccccCCcEEEEEEEEeCCCcEEEEEEEeC--CCCCcEEEEEEechhHcCCCcEEE
Confidence 3457899999999999 566888887654 467788999999999999999999
Q ss_pred cccccccc---ccccceeeeeeeccc
Q 005257 255 GFTAATGQ---LVESHKILAWSFSNT 277 (705)
Q Consensus 255 Gfsastg~---~~~~h~i~~wsf~~~ 277 (705)
|||||||. ..|.|+|++|+|+++
T Consensus 206 GFSAsTG~~~~~~~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 206 GFSATTGINKGNVETNDVLSWSFASK 231 (233)
T ss_dssp EEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred EEEEEcCCCCCCceeeEEEEEEEEEE
Confidence 99999994 568899999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=419.47 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=210.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..+.||+|+||+||+|.++ ++..||||+++... ...+.|.+|++++++++|||||+++|+|.+ +.+++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEE
Confidence 346778899999999999999987 46889999996543 445789999999999999999999998753 56799999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++..... ..+++.++++|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999998754332 258999999999999999999998 999999999999999999999999999999876555
Q ss_pred cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 523 VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 523 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
........||+.|||||++.++.++.++|||||||++|||+||..|+...... ..+...+..+. + ..
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~~~~---------~--~~ 230 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGY---------R--MV 230 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC---------C--CC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC---------C--CC
Confidence 44444567899999999999889999999999999999999976665443321 12222222221 1 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.+....+.+.+++..||+.||++||||.+|++.|+...
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 23344567889999999999999999999999998543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=422.53 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=207.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.+ ++.+++|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence 4588899999999999999999999999999998653 23345679999999999999999999998876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++...+ .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999987654 69999999999999999999999 9999999999999999999999999999998754
Q ss_pred CCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 521 GQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 521 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
... ......+||+.|||||++.+..++.++|||||||++|||++|+.||...... .+...+..+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~----------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKIIKLE----------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTC-----------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHHHcCC-----------
Confidence 332 2334468999999999999999999999999999999999999999865431 1222222221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..++....+.+.+++..||+.||++|||++|+++
T Consensus 227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 2233334566889999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=416.48 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=198.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-cCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-KGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~lV 440 (705)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++||||+++++++.++ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999999999999999997653 34456789999999999999999999988643 4568999
Q ss_pred EeeCCCCChhHHHHhcC-CCCcccHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 441 YDYMENGSLDKWIFQCD-GSMMLSCEERIRVLKDVAAGVLYLHEGW--EKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|||+++|+|.+++.+.. ....+++.+++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 2336999999999999999999999721 13499999999999999999999999999987
Q ss_pred cCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||..... ..+...+..+..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~~~~-------- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKF-------- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCC--------
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCC--------
Confidence 754332 23446899999999999999999999999999999999999999976543 122223333322
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+....+.+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122334456889999999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=416.86 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=212.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||+||+|.+..+|+.||||+++.......+.+.+|++++++++||||+++++++.. ++.+++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEe
Confidence 579999999999999999999999999999999987665667789999999999999999999999886 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.+++.+. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+.......
T Consensus 99 ~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999988652 58999999999999999999999 9999999999999999999999999999997754433
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||.+... .+........+.. ....
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~----------~~~~ 238 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTP----------ELQN 238 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSC----------CCSS
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCC----------CCCC
Confidence 23346899999999999999999999999999999999999999976542 1222222221110 0112
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
+......+.+++.+||++||++|||+.|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334678899999999999999999999863
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=3.4e-49 Score=399.79 Aligned_cols=223 Identities=31% Similarity=0.533 Sum_probs=192.9
Q ss_pred CceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecC
Q 005257 23 ISAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPY 94 (705)
Q Consensus 23 ~~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 94 (705)
+++++|+|++|.+ .||+|+|||++. +|.||||++. +.++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 3579999999964 789999999987 6799999864 4678999999999999999999999999999999888
Q ss_pred CCCCCCCceEEEEeeCCC-CCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCC--CCCCCeeEEecCCCcccccc
Q 005257 95 KGVLAGHGLVFLFVPFHG-IKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFN--DIDENHVGIDVNSLTSVSAH 171 (705)
Q Consensus 95 ~~~~~g~G~aF~~~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgidvns~~S~~~~ 171 (705)
....+||||||+|+|... .+.++.|++||+++..+ .+..++.+||||||++|.+++ ||+++|||||+|++.|.++.
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~ 159 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV 159 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc
Confidence 777899999999999764 56678899999998654 467789999999999998764 78999999999999987664
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccc
Q 005257 172 AAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLE 249 (705)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~ 249 (705)
+ ..+.+|+.+.|||+| ..+.+.|++.. ..+|..|.++..|||+.+||
T Consensus 160 ~-----------------------------~~~~~g~~~~~~i~y~~~~~~l~v~l~~--~~~~~~~~ls~~vdL~~~l~ 208 (239)
T d1dbna_ 160 Q-----------------------------WDWINGGVAFATITYLAPNKTLIASLVY--PSNQTTFSVAASVDLKEILP 208 (239)
T ss_dssp E-----------------------------CCCCTTCCEEEEEEEEGGGTEEEEEEEE--TTTTEEEEEEEECCHHHHSC
T ss_pred c-----------------------------ceEeCCceeEEEEEEcCCCCEEEEEEEe--cCCCccEEEEEecchHHhcC
Confidence 3 245688899999999 56778887765 34677888999999999999
Q ss_pred cceecccccccccc--cccceeeeeeeccc
Q 005257 250 DEMYVGFTAATGQL--VESHKILAWSFSNT 277 (705)
Q Consensus 250 ~~~~vGfsastg~~--~~~h~i~~wsf~~~ 277 (705)
++||||||||||.. .|.|+|++|+|+++
T Consensus 209 ~~vyvGFSAsTG~~~~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 209 EWVRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp SEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred CcEEEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence 99999999999964 57899999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=412.92 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=204.1
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
++|+..+.||+|+||+||+|+++.+++.||||+++.... +..+.+.+|++++++++||||+++++++.+ ++.++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEe
Confidence 468889999999999999999999999999999976532 344678999999999999999999999886 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ 522 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 522 (705)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999643 279999999999999999999998 999999999999999999999999999998765433
Q ss_pred c-ceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 523 V-ASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 523 ~-~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... .........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~~~~~~~~---------- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTY---------- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HHHHTTCTT----------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HHHhcCCCC----------
Confidence 2 22345689999999999988775 678999999999999999999997644321111 111111100
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
..........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122356778999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=414.05 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=205.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCC----eEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGG----AEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
+.|+..++||+|+||+||+|.++.++ ..||||+++.... ....+|++|++++++++|||||+++|+|.. .+.++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceE
Confidence 45778899999999999999987654 4799999976533 345679999999999999999999999976 67889
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+.+|+|.+++..... .+++.++++++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998876443 69999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVA--STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... ......||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+...+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~--------- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDG--------- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTT---------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhcc---------
Confidence 543222 223356899999999999999999999999999999999976666543321 2222223222
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.+ ...+.+.+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 230 ~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC--CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11 23344456778999999999999999999999999987765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=416.08 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=209.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
+.|+..+.||+|+||+||+|.+..+++.||||+++.......+.+.+|+++|++++||||+++++++.. ++.+++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEec
Confidence 357889999999999999999999999999999987777777889999999999999999999999886 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.+++.+... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 91 CAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 999999999876433 69999999999999999999998 9999999999999999999999999999976533211
Q ss_pred ceeeeeeccccCCCccccc-----cCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 524 ASTTRVVGTVGYLAPEVFS-----SGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
......||+.|||||++. ...++.++|||||||++|||++|+.||....... . ...+..+...
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~-~~~i~~~~~~-------- 233 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--V-LLKIAKSEPP-------- 233 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H-HHHHHHSCCC--------
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--H-HHHHHcCCCC--------
Confidence 223468999999999984 4568899999999999999999999998654321 1 1111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
....+......+.+++..||+.||++|||+.|++++
T Consensus 234 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122344678899999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=408.18 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=203.5
Q ss_pred eEEeecCceEEEEEEEcC--CCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeCC
Q 005257 370 NVIGVGGNGKVYKGVLEG--GGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYME 445 (705)
Q Consensus 370 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~~ 445 (705)
++||+|+||+||+|.++. .++.||||+++.. .....++|.+|+++|++++||||++++++|.. +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence 579999999999998753 4578999999654 33345789999999999999999999999853 46789999999
Q ss_pred CCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcce
Q 005257 446 NGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVAS 525 (705)
Q Consensus 446 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 525 (705)
+|+|.+++.+.. .+++.++++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999997643 69999999999999999999998 999999999999999999999999999999775543322
Q ss_pred --eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 526 --TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 526 --~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||.+... ..+...+..+.. ..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~-----------~~ 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER-----------MG 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC-----------CC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCC-----------CC
Confidence 233578999999999999999999999999999999998 8999986543 222233333321 22
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK 639 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 639 (705)
.+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 3334456788999999999999999999999988754
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=1.9e-48 Score=391.98 Aligned_cols=222 Identities=28% Similarity=0.421 Sum_probs=187.3
Q ss_pred CceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC-CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCC
Q 005257 23 ISAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST-TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVL 98 (705)
Q Consensus 23 ~~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~-~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 98 (705)
+++++|+|++|.+ .+|+|+|||.+. ++.||||++. .+++|||+|++||+||++.+++++||+|+|+|.|.+.+...
T Consensus 1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~~ 80 (232)
T d1v6ia_ 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYD 80 (232)
T ss_dssp CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSB
T ss_pred CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCCC
Confidence 3579999999986 459999999986 6799999965 48999999999999999999999999999999999888788
Q ss_pred CCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCC
Q 005257 99 AGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPD 178 (705)
Q Consensus 99 ~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~ 178 (705)
+||||||+|+|...... .++..|++....+.+..++.|||||||++|.+++||+++|||||+|++.|.+..
T Consensus 81 ~gDG~AF~l~~~~~~~~--~~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~------- 151 (232)
T d1v6ia_ 81 PADGIIFFIAPEDTQIP--AGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTV------- 151 (232)
T ss_dssp CCCEEEEEEEETTCCCC--TTCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEE-------
T ss_pred CCCeEEEEEECCCCCCC--CCccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccccc-------
Confidence 99999999999864332 222233333233345678999999999999999999999999999999887652
Q ss_pred CCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceeccc
Q 005257 179 NQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGF 256 (705)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGf 256 (705)
..++.+|+.++|||+| ..++|.|++... ++..|.++..|||+.+||++|||||
T Consensus 152 ----------------------~~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~~~l~~~vdL~~~l~~~vyvGF 206 (232)
T d1v6ia_ 152 ----------------------PWNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGF 206 (232)
T ss_dssp ----------------------ECCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCEEEEEEECCHHHHSCSEEEEEE
T ss_pred ----------------------ccccCCCCEEEEEEEEeCCceEEEEEEecC---CCCcceEEEEEchhhccCCcEEEEE
Confidence 3357799999999999 666788777643 4667789999999999999999999
Q ss_pred ccccccc-cccceeeeeeecccc
Q 005257 257 TAATGQL-VESHKILAWSFSNTK 278 (705)
Q Consensus 257 sastg~~-~~~h~i~~wsf~~~~ 278 (705)
|||||.. .+.|+|++|+|+++.
T Consensus 207 SAsTG~~~~~~H~I~sWsFss~l 229 (232)
T d1v6ia_ 207 SASGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp EEECCSSBCCEEEEEEEEEEEEE
T ss_pred EEECCCCCCcccEEEEeEeEEee
Confidence 9999964 599999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=411.39 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=209.9
Q ss_pred CCCCcce-EEeecCceEEEEEEEcC--CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEEN-VIGVGGNGKVYKGVLEG--GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~-~LG~G~fg~Vy~~~~~~--~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+ +||+|+||+||+|.++. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +.++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence 3455566 49999999999998753 45689999997654 3456789999999999999999999998864 46899
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++...+. .+++.++.+++.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 vmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999865432 69999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 520 HGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+...+..+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~~------- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKR------- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCC-------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCC-------
Confidence 543322 223468999999999999999999999999999999998 99999865432 22233333322
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
...+...+..+.+++..||+.||++||||.+|++.|+...
T Consensus 231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2233445567889999999999999999999999987543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=403.72 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=214.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..++||+|+||+||+|+++ ++..||||+++.... ..++|.+|++++++++||||++++|+|.+ ++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEc
Confidence 57888999999999999999986 578899999976533 45789999999999999999999999976 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|..++..... .+++..+.+++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred cCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999999865443 58999999999999999999998 9999999999999999999999999999987665544
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+..+.. ..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~~~~~-----------~~ 221 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQGLR-----------LY 221 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHTTCC-----------CC
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHHhCCC-----------CC
Confidence 44445678999999999999999999999999999999998 89999765432 22223333211 12
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
.+....+.+.+++..||+.||++|||++++++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233445678999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=422.61 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=209.0
Q ss_pred HhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
..++|+..+.||+|+||+||+|++..+|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.. ++.+++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence 3567899999999999999999999999999999997653 3445678999999999999999999999986 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ .++|+||||||+|||+++++++||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999997654 69999999999999999999997 24899999999999999999999999999986543
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch-----------
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL----------- 589 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~----------- 589 (705)
. .....+||+.|||||++.+..++.++||||+||++|||++|+.||.................+..
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 22346899999999999999999999999999999999999999976544322221111111110
Q ss_pred ----------------hHHHHHhhhcC-CCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 590 ----------------LDALDARLRAK-GGF-DEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 590 ----------------~~~id~~l~~~-~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.+..+...... ... .......+.+++..||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111100000 000 01123467889999999999999999999883
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=403.31 Aligned_cols=246 Identities=22% Similarity=0.409 Sum_probs=201.2
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec---cCceEEEE
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE---KGSLMLVY 441 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~---~~~~~lV~ 441 (705)
+..++||+|+||+||+|.+..+++.||+|++... .....+.|.+|+++|++++||||+++++++... +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4567899999999999999999999999998754 344567799999999999999999999988642 34689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEEc-cCCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKK--VLHRDIKSSNVLLD-KEMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--iiHrDLkp~NILld-~~~~~kL~DFGla~~~ 518 (705)
||+++|+|.+++.+.. .+++.++..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999997654 68999999999999999999998 66 99999999999997 4789999999999864
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
... .....+||+.|||||++.+ +++.++|||||||++|||++|+.||..... ...+...+..+.....+
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~~~~~----- 234 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASF----- 234 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGG-----
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCCCccc-----
Confidence 432 2334689999999999865 699999999999999999999999975432 12233333333221111
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
+....+.+.+++.+||++||++|||+.|+++
T Consensus 235 -----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112345788999999999999999999986
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=3.4e-48 Score=392.14 Aligned_cols=221 Identities=29% Similarity=0.486 Sum_probs=191.2
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCC-----CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNST-----TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
.+++|+|++|.+ +||+|+|||.+. ++.||||++. .+++|||+|++||+||++.+++++||+|+|+|.|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 368999999964 799999999987 6799999863 46899999999999999999999999999999998887
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGY 175 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~ 175 (705)
...+||||||+|+|....+ +..||+||+++... .+..++.+||||||++|.++ ||+++|||||+|++.|..+.
T Consensus 82 ~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~---- 154 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTV---- 154 (237)
T ss_dssp TTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEE----
T ss_pred CCCCCCeeEEEEcCCCCCc-ccccCcccccCCCC-ccCccceEEEEeccccccCC-CCCCceEEEecCCCcccccc----
Confidence 7889999999999986544 56788999998543 35678999999999999875 99999999999999887663
Q ss_pred cCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccccee
Q 005257 176 WPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253 (705)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~ 253 (705)
...+.+|+.++|||+| ..+++.|++...+ ++..|+++..|||+.+||++||
T Consensus 155 -------------------------~~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~y 207 (237)
T d1fnya_ 155 -------------------------PWNWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVR 207 (237)
T ss_dssp -------------------------ECCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEE
T ss_pred -------------------------cccccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEE
Confidence 3356789999999999 5667888776543 6778899999999999999999
Q ss_pred cccccccc---cccccceeeeeeecccc
Q 005257 254 VGFTAATG---QLVESHKILAWSFSNTK 278 (705)
Q Consensus 254 vGfsastg---~~~~~h~i~~wsf~~~~ 278 (705)
|||||||| ...|.|+|++|+|+++.
T Consensus 208 vGFSAsTG~~s~~~e~H~I~sWsF~s~l 235 (237)
T d1fnya_ 208 FGFSATTGIDKGYVQTNDVLSWSFESNL 235 (237)
T ss_dssp EEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEECCCCCCcccccEEEEeEeEEeC
Confidence 99999999 56689999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=414.24 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=209.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-----eEEEEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-----AEIAVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
.++|+..++||+|+||+||+|++...+ ..||+|++... .....+.+.+|+.+|.++ +|||||+++++|.. .+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-CC
Confidence 356888999999999999999987544 37999998654 334567899999999998 89999999999876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC--------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG--------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIK 495 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLk 495 (705)
.+++||||+++|+|.++|+.... ...+++.+++.++.||+.||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 89999999999999999976432 1358999999999999999999999 999999999
Q ss_pred CCCeEEccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCC
Q 005257 496 SSNVLLDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGK 573 (705)
Q Consensus 496 p~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~ 573 (705)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2334678999999999999999999999999999999997 899997654
Q ss_pred ccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 005257 574 PNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLE 637 (705)
Q Consensus 574 ~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 637 (705)
.. +.+...+..+. + ...+....+.+.+|+..||+.||++|||++||+++|.
T Consensus 272 ~~--~~~~~~~~~~~---------~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD--ANFYKLIQNGF---------K--MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS--HHHHHHHHTTC---------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHHHHhcCC---------C--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 32 11222222221 1 2233344567899999999999999999999999986
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=5.9e-48 Score=388.58 Aligned_cols=218 Identities=30% Similarity=0.494 Sum_probs=188.4
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEee-cCcEEecCCCC-----CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVE-SRILTLTNSTT-----FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~-~~~l~lt~~~~-----~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
++++|+|++|++ .||+|+|||.+. +|.||||++.. +++|||||++||+||++. .++||+|+|+|.|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~~ 79 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCSS
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCCC
Confidence 478999999964 799999999987 67999998653 589999999999999864 58999999999998887
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGY 175 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~ 175 (705)
...+||||||+|+|.+..+ +..|++|||++.+.. +..++.|||||||++|. +||++||||||+|++.|.++.
T Consensus 80 ~~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~---- 151 (233)
T d1n47a_ 80 AAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTT---- 151 (233)
T ss_dssp TTSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEE----
T ss_pred CCCCCCceEEEECCCCCCC-CCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCccccccc----
Confidence 7889999999999976544 567899999986543 46788999999999998 699999999999999887663
Q ss_pred cCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccccee
Q 005257 176 WPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253 (705)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~ 253 (705)
.+.+.+|+.++|||+| ..+.+.|++.. ..+|..|.++..|||+.+||++||
T Consensus 152 -------------------------~~~l~~g~~~~v~I~Y~~~~~~l~v~l~~--~~~~~~~~ls~~vdL~~~l~~~vy 204 (233)
T d1n47a_ 152 -------------------------PFDMVYGEKANIVITYQASTKALAASLVF--PVSQTSYAVSARVDLRDILPEYVR 204 (233)
T ss_dssp -------------------------ECCCCTTSCEEEEEEEETTTTEEEEEEEE--TTTTEEEEEEEECCGGGTSCSEEE
T ss_pred -------------------------cceecCCCEEEEEEEEcCCCeEEEEEEEe--CCCCccEEEEEEechHHhcCCcEE
Confidence 3467899999999999 55677887764 346888899999999999999999
Q ss_pred cccccccc---cccccceeeeeeecccc
Q 005257 254 VGFTAATG---QLVESHKILAWSFSNTK 278 (705)
Q Consensus 254 vGfsastg---~~~~~h~i~~wsf~~~~ 278 (705)
|||||||| ...|.|+|++|+|+++.
T Consensus 205 vGFSAsTG~~~~~~~~H~I~sWsFss~l 232 (233)
T d1n47a_ 205 VGFSATTGLNAGVVETHDIVSWSFAVSL 232 (233)
T ss_dssp EEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred EEEEEecCCCCCcccccEEEEEEeEEEc
Confidence 99999999 45789999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-48 Score=408.48 Aligned_cols=246 Identities=25% Similarity=0.320 Sum_probs=207.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. ++.+++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence 4688899999999999999999999999999999653 23446789999999999999999999998876 7789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999887644 57889999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. ....+||+.|||||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~------------ 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAE------------ 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCC------------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHcCC------------
Confidence 3 23468999999999999999999999999999999999999999875431 1122222221
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 635 (705)
..++....+.+.+++.+||+.||.+|| |+++++++
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 223333445688999999999999996 78887763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=408.63 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=214.9
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCCch-hHHHHHHHHHHhccCCCCCcceeeeeee
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHENDG-GTRAFLAEISSLGRLKHKSLVGLRGWCK 431 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 431 (705)
+++...++|+..+.||+|+||+||+|++++ +++.||||+++..... ..++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999999863 4578999999765433 4567999999999999999999999998
Q ss_pred eccCceEEEEeeCCCCChhHHHHhcCC---------------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 005257 432 REKGSLMLVYDYMENGSLDKWIFQCDG---------------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVL 490 (705)
Q Consensus 432 ~~~~~~~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 490 (705)
. .+..++||||+++|+|.++++.... ...+++.+++.++.|++.||+|||+ ++||
T Consensus 87 ~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 87 V-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred c-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 6 6789999999999999999975321 1248999999999999999999998 9999
Q ss_pred ecCCCCCCeEEccCCCeeeeeeccceecCCCC-cceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCC-CC
Q 005257 491 HRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQ-VASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR-RP 568 (705)
Q Consensus 491 HrDLkp~NILld~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~-~P 568 (705)
||||||+|||++.++++||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654332 22334467899999999999999999999999999999999986 56
Q ss_pred CCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 569 IEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 569 f~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
|..... ..+...+..+.. ...+...+..+.+|+..||+.||++||||.||++.|+++.
T Consensus 243 ~~~~~~---~e~~~~v~~~~~-----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAH---EEVIYYVRDGNI-----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCH---HHHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCH---HHHHHHHHcCCC-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 665432 122233333322 1223344567889999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=405.34 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=204.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||+||+|+++++ ..||||+++.. ....+.|.+|+.++++++|||||+++++|.+ +.+++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEe
Confidence 4688899999999999999999754 67999999644 3456789999999999999999999999853 467999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|..++...... .++|.+++.++.||+.||+|||+ ++|+||||||+||||++++++||+|||+++.......
T Consensus 93 ~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999988654322 59999999999999999999998 9999999999999999999999999999987765554
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGGF 603 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~~ 603 (705)
.......||+.|+|||++..+.++.++|||||||++|||++|..|+...... ......+..+ .+ ...
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~---------~~--~~~ 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG---------YR--MPC 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT---------CC--CCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhc---------CC--CCC
Confidence 4455568999999999999999999999999999999999977776554321 1112222222 11 223
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 604 DEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 604 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+....+.+.+++.+||+.||++|||+.+|++.|+....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 44455678999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-49 Score=412.53 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=194.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
.+.|+..+.||+|+||+||+|.++.+++.||||++..... ...+.+.+|+++|++++||||+++++++.+ ++.++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 4568899999999999999999999999999999976532 334568899999999999999999998876 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc---cCCCeeeeeeccceec
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD---KEMNGRLGDFGLARMH 518 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld---~~~~~kL~DFGla~~~ 518 (705)
||+++|+|.++|...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997533 69999999999999999999998 9999999999999995 5789999999999876
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLR 598 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~ 598 (705)
..... ....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.... .....+..+...
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~-------- 227 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKAEYE-------- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTTCCC--------
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCC--------
Confidence 54332 23468999999999999999999999999999999999999999865431 222222222211
Q ss_pred cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 599 AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 599 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..........+.+.+++..||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0011122334568899999999999999999999984
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-47 Score=410.74 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=212.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
-++|+..+.||+|+||.||+|+++.+|+.||||++........+.+.+|+++|++++||||+++++++.+ ++.+++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 3579999999999999999999999999999999987766667889999999999999999999998886 778999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc--CCCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK--EMNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~--~~~~kL~DFGla~~~~~ 520 (705)
||++|+|.+++.+... .+++.++..++.||+.||.|||+ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 104 ~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999864332 69999999999999999999999 99999999999999964 67899999999998754
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+... ..
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~--------~~ 245 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDWN--------MD 245 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC--------SC
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC--------CC
Confidence 432 3446899999999999999999999999999999999999999976542 1122222222110 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
........+.+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111223567889999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=402.70 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=201.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccCCc-hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHEND-GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.++|+..+.||+|+||+||+|.+..+ +..||||.++.... ...+.|.+|++++++++||||++++++|. ++.++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEE
Confidence 35688899999999999999998643 35799999865543 34567999999999999999999999885 45789
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+||||+++|+|.+++..... .+++.+++.++.||+.||.|||+ ++|+||||||+||++++++.+||+|||+|+..
T Consensus 84 iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998876443 68999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
............||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~-------- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGER-------- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC--------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC--------
Confidence 6555545556688999999999999999999999999999999998 899997654421 1222223221
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+....+.+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12333455678999999999999999999999999986654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-48 Score=406.34 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=203.9
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc---hhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND---GGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
+.|+..+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+++|++++|||||++++++.. ++.+++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence 348889999999999999999999999999999976532 334678999999999999999999999876 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||++|+|..++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987765432 69999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcceeeeeeccccCCCcccccc---CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhh
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSS---GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARL 597 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l 597 (705)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||.+... .+.... +..+...
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~~~-i~~~~~~------- 232 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH-IAQNESP------- 232 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH-HHHSCCC-------
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHhCCCC-------
Confidence 2 23579999999999864 4689999999999999999999999976442 121111 1111110
Q ss_pred hcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 598 RAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 598 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
...+....+.+.+++..||+.||++|||+.|+++
T Consensus 233 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112223456889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-47 Score=407.34 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=214.3
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|+..+.||+|+||+||+|.+..+|+.||||+++.......+.+.+|+++|++++||||+++++++.. ++.++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 3579999999999999999999999999999999987666666788999999999999999999998876 778999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc--cCCCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD--KEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld--~~~~~kL~DFGla~~~~~ 520 (705)
||++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998875433 269999999999999999999998 9999999999999998 578999999999998765
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.... .....+..+... ..
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~--------~~ 248 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWE--------FD 248 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCC--------CC
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC--------CC
Confidence 433 34468999999999999999999999999999999999999999765421 112222222110 00
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHhc
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV--LEGK 639 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 639 (705)
..........+.+++..||+.||.+|||+.|++++ +++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11112334567899999999999999999999884 5543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=405.79 Aligned_cols=256 Identities=21% Similarity=0.383 Sum_probs=206.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe----EEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA----EIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLM 438 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 438 (705)
.+|+..++||+|+||+||+|.+..+|+ +||+|+++.. .....++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCee
Confidence 358889999999999999999987665 6899988654 34456789999999999999999999999975 4678
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
+++||+.+|+|.+++..... .+++..+++++.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999998876533 69999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCcce-eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 519 GHGQVAS-TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 519 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
....... .....||+.|||||++.++.++.++|||||||++|||+| |+.||....... +...+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~~~-------- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGE-------- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHHTC--------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC--------
Confidence 5543322 334578999999999999999999999999999999998 788887654321 122222221
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
+ ...+..+...+.+++.+||+.||++|||+.|+++.|+...
T Consensus 231 -~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 -R--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C--CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1 2233445567899999999999999999999999987653
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=1.6e-46 Score=380.72 Aligned_cols=222 Identities=29% Similarity=0.496 Sum_probs=193.2
Q ss_pred ceeeEEeCCCCC--CCeEEEcceEeecCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFNS--SNLSLYGTATVESRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~~--~~~~~~g~a~~~~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
++++|+|++|++ +||+|+|||.+.++.||||++. ..++|||+|++||+||++.+++++||+|+|+|.|...+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~ 81 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSPL 81 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECSS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEeCCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecCC
Confidence 578999999964 7899999999999999999865 46999999999999999999999999999999997764
Q ss_pred CCCCCCceEEEEeeCC-CCCCCCCCCcccccccCC-CCCCCCcEEEEEeecccCCCCC--CCCCCeeEEecCCCcccccc
Q 005257 96 GVLAGHGLVFLFVPFH-GIKGATEAQHLGLFNRTN-DGNSSNHVFGVEFDVFKNQEFN--DIDENHVGIDVNSLTSVSAH 171 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~-~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgidvns~~S~~~~ 171 (705)
..+|||+|||+.|.. ..|....|+++|+++... .+...++.|||||||++|.+.+ ||+++|||||+|++.|.++.
T Consensus 82 -~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~~ 160 (241)
T d1ukga_ 82 -SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTV 160 (241)
T ss_dssp -SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred -CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccccccc
Confidence 457999999998854 467778888999987544 4457889999999999987654 58899999999999987663
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccc
Q 005257 172 AAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLE 249 (705)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~ 249 (705)
...+.+|..++|||+| ..++|+|++... +|..|.++..|||+.+||
T Consensus 161 -----------------------------~~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~ 208 (241)
T d1ukga_ 161 -----------------------------KWDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLP 208 (241)
T ss_dssp -----------------------------ECCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSC
T ss_pred -----------------------------ccccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCC
Confidence 3467899999999999 667899988764 467788999999999999
Q ss_pred cceecccccccccccccceeeeeeecccc
Q 005257 250 DEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 250 ~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
++||||||||||...+.|+|++|+|+++.
T Consensus 209 ~~~yvGFSAsTG~~~~~H~IlsWsFss~l 237 (241)
T d1ukga_ 209 EWVRVGFSAASGEQYQTHTLESWSFTSTL 237 (241)
T ss_dssp SEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred CcEEEEEEEecCCCCceeEEEEeEEEEEe
Confidence 99999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=395.09 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=208.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC------chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN------DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||+||+|.++.+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+ ++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence 357899999999999999999999999999999986542 1235789999999999999999999999876 778
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC----Ceeeeee
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM----NGRLGDF 512 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~----~~kL~DF 512 (705)
++||||||++|+|.+++.+.+ .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999997654 69999999999999999999999 9999999999999998776 4999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch--h
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL--L 590 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~--~ 590 (705)
|+++....... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+.... .....+..+.. .
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNYEFE 236 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCCCC
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCCC
Confidence 99988754432 23357899999999999989999999999999999999999999865431 12222222221 1
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... . .....+.+++..||+.||++|||++|++++
T Consensus 237 ~~~~------~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYF------S----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHH------T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhc------C----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110 1 123467889999999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=402.93 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=205.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCC-chhHHHHHHHHHHhccC-CCCCcceeeeeeeeccC
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKG 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 435 (705)
.++|+..++||+|+||.||+|.+.. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++...+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3568889999999999999999754 34789999987543 34566788898888887 68999999999887677
Q ss_pred ceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD 502 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld 502 (705)
.+++|||||++|+|.++|+.... ...+++.+++.++.||+.||.|||+ ++|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 89999999999999999975421 2358999999999999999999999 9999999999999999
Q ss_pred cCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCC-CCCCCCCccHHHHH
Q 005257 503 KEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR-RPIEEGKPNLVEMV 580 (705)
Q Consensus 503 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~-~Pf~~~~~~~~~~v 580 (705)
+++++||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+||. .||...... +.+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999987654332 2234468999999999999999999999999999999999865 567654322 222
Q ss_pred HHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 581 WELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 581 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+..+.. ...+......+.+++.+||+.||++|||+.|++++|+.+++
T Consensus 247 ~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRRLKEGTR-----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCC-----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 233333221 22233345678899999999999999999999999997765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=396.95 Aligned_cols=251 Identities=30% Similarity=0.421 Sum_probs=200.3
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|++++++++||||++++|+|.+.++.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45677899999999999999985 678999999643 34578999999999999999999999997656778999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+++|+|.++|.+... ..+++..+++++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 999999999976432 258999999999999999999998 99999999999999999999999999999865432
Q ss_pred ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCCC
Q 005257 524 ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKGG 602 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~~ 602 (705)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||....... +...+..+. + ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~~---------~--~~ 220 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGY---------K--MD 220 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTC---------C--CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC---------C--CC
Confidence 223467999999999999999999999999999999998 677776543321 111122221 1 23
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcc
Q 005257 603 FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKI 640 (705)
Q Consensus 603 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 640 (705)
.+......+.+++.+||+.||++||||.++++.|+.+.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 34445567889999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=404.16 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=210.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|...+.||+|+||+||+|+++.+++.||||++++. .....+.+.+|+++|++++||||+++++++.+ ++.+++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccc
Confidence 5688899999999999999999999999999999754 23356778999999999999999999998886 6789999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
||||++|+|.+++.+.. .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999997654 68999999999999999999999 9999999999999999999999999999986644
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....+||+.|||||++.+..++.++||||+||++|||++|+.||...... .+...+..+.
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~~~~------------ 221 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEE------------ 221 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC------------
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHhcCC------------
Confidence 322 234468999999999999999999999999999999999999999875531 2222222221
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
..++......+.+++..||++||.+||+ +.|++++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2233334456789999999999999995 7777763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=397.95 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=207.2
Q ss_pred ceEEeecCceEEEEEEEcCCC---eEEEEEEeccC-CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEeeC
Q 005257 369 ENVIGVGGNGKVYKGVLEGGG---AEIAVKRISHE-NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDYM 444 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~---~~vavK~i~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~~ 444 (705)
.++||+|+||+||+|.+..++ ..||||+++.. .....++|.+|+++|++++||||++++|+|...++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 46999999754 44556789999999999999999999999987677899999999
Q ss_pred CCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCcc
Q 005257 445 ENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQVA 524 (705)
Q Consensus 445 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 524 (705)
++|+|.+++..... .+++.++++++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999875433 57889999999999999999998 99999999999999999999999999999876543322
Q ss_pred ---eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcCC
Q 005257 525 ---STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAKG 601 (705)
Q Consensus 525 ---~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~~ 601 (705)
......||+.|+|||.+.++.++.++|||||||++|||+||+.||...... . .+...+..+.. .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~-~~~~~i~~g~~-----------~ 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-F-DITVYLLQGRR-----------L 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC-----------C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-H-HHHHHHHcCCC-----------C
Confidence 223357899999999999999999999999999999999988887654321 1 11122222221 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 602 GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 602 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
..+....+.+.+++..||+.||++||+|.||++.|++...
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223344678899999999999999999999999987765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=398.30 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=207.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCe--EEEEEEeccC-CchhHHHHHHHHHHhccC-CCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGA--EIAVKRISHE-NDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~i~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|+..++||+|+||+||+|+++.++. .||||+++.. .....++|.+|+++|.++ +||||++++++|.. ++.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEE
Confidence 567788999999999999999988776 4788887644 344566899999999999 79999999999986 778999
Q ss_pred EEeeCCCCChhHHHHhcC-------------CCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC
Q 005257 440 VYDYMENGSLDKWIFQCD-------------GSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN 506 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~ 506 (705)
||||+++|+|.++|+... ....+++.++.+++.|||.||.|||+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999997531 23479999999999999999999999 99999999999999999999
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCC-CCCCCCccHHHHHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRR-PIEEGKPNLVEMVWELMV 585 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~-Pf~~~~~~~~~~v~~~~~ 585 (705)
+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+.+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 240 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 99999999986543222 223568999999999999999999999999999999999765 5654332 12222222
Q ss_pred hCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 586 QGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 586 ~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
++. + ...+....+.+.+++.+||+.||++||||.||++.|++.++
T Consensus 241 ~~~---------~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 QGY---------R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GTC---------C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcC---------C--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 221 1 22334455678999999999999999999999999987765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-46 Score=387.73 Aligned_cols=259 Identities=21% Similarity=0.331 Sum_probs=205.0
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHHHHHHHHhccCCCCCcceeeeeeeeccC---c
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG---S 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~ 436 (705)
.++|+..+.||+|+||+||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999997653 2345679999999999999999999998875332 4
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+|+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999987654 69999999999999999999998 999999999999999999999999999987
Q ss_pred ecCCCCc--ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 517 MHGHGQV--ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 517 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
....... ......+||+.|||||++.+..++.++|||||||++|||+||+.||..... .+.....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~~~~~~~~~~--- 234 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPP--- 234 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCCCCG---
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--HHHHHHHHhcCCCCC---
Confidence 6543322 233446899999999999999999999999999999999999999986543 222223332222110
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHh
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARP-TMRQVVKVLEG 638 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 638 (705)
........+.+.+++.+||++||++|| |++++++.|..
T Consensus 235 ------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 001112335688899999999999999 89999887764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-46 Score=399.72 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=208.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV 440 (705)
++|+..+.||+|+||.||+|.++.+|+.||||++... .....+.+.+|+++|+.++||||+++++++.. ...+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence 5789999999999999999999999999999998643 23345678999999999999999999998876 6788999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCC
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~ 520 (705)
|||+.+|+|..++.+.+ .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999997654 69999999999999999999998 9999999999999999999999999999997654
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~~------------ 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGK------------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC------------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhcCC------------
Confidence 3 2336899999999999999999999999999999999999999976542 11222222221
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARP-----TMRQVVK 634 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 634 (705)
...+......+.+++..||+.||.+|+ |+.++++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 222333445688999999999999994 8888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=389.80 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=199.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCC---CeEEEEEEeccC---CchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGG---GAEIAVKRISHE---NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~i~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|+..+.||+|+||+||+|.+... ...||||+++.. ..+..++|.+|+++|++++||||++++|+|.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cch
Confidence 4578889999999999999987533 247999998654 33456789999999999999999999999964 467
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||||+++|+|.+++..... .+++..+++++.|+|.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999998876433 69999999999999999999998 9999999999999999999999999999998
Q ss_pred cCCCCcce--eeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 518 HGHGQVAS--TTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 518 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
........ .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~~----- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGER----- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCC-----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCCC-----
Confidence 75543322 233567889999999999999999999999999999998 89999765432 222222222111
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEG 638 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 638 (705)
...+...+..+.+++.+||+.||++||||.||.+.|.+
T Consensus 234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 12223344678899999999999999999999998874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-46 Score=385.28 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch---------hHHHHHHHHHHhccCC-CCCcceeeeeeeec
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG---------GTRAFLAEISSLGRLK-HKSLVGLRGWCKRE 433 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~---------~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~ 433 (705)
++|+..+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 5788899999999999999999999999999999765321 2345889999999997 9999999999876
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeec
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFG 513 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFG 513 (705)
++.++|||||+++|+|.++|.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 778999999999999999997644 69999999999999999999998 999999999999999999999999999
Q ss_pred cceecCCCCcceeeeeeccccCCCcccccc------CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhC
Q 005257 514 LARMHGHGQVASTTRVVGTVGYLAPEVFSS------GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 514 la~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
+++....... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+..+
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~~ 230 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSG 230 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHhC
Confidence 9998765432 234689999999999853 3468899999999999999999999987543 2222333333
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... .........+.+.+++.+||++||++|||+.|++++
T Consensus 231 ~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2210 011112334578899999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=395.77 Aligned_cols=263 Identities=24% Similarity=0.390 Sum_probs=213.6
Q ss_pred HhCCCCcceEEeecCceEEEEEEEc-----CCCeEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeeeeecc
Q 005257 362 ATKGFSEENVIGVGGNGKVYKGVLE-----GGGAEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWCKREK 434 (705)
Q Consensus 362 at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 434 (705)
..++|+..++||+|+||.||+|++. .+++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.. +
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~ 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-G 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-C
Confidence 3467888999999999999999874 3567899999976543 4556799999999999 69999999999976 6
Q ss_pred CceEEEEeeCCCCChhHHHHhcCC---------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDG---------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNV 499 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NI 499 (705)
..+++||||+++|+|.++++.... ...+++.++.+++.||+.||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 678999999999999999976431 2358999999999999999999999 9999999999999
Q ss_pred EEccCCCeeeeeeccceecCCCCc-ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCC-CCCCCccHH
Q 005257 500 LLDKEMNGRLGDFGLARMHGHGQV-ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRP-IEEGKPNLV 577 (705)
Q Consensus 500 Lld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~P-f~~~~~~~~ 577 (705)
|++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.| +......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987765433 233446889999999999999999999999999999999995444 5443321
Q ss_pred HHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 578 EMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 578 ~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.+...+..+ .+ ...+......+.+|+.+||+.||++||||.|+++.|++.+.
T Consensus 255 ~~~~~~i~~~---------~~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 SKFYKMIKEG---------FR--MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHT---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcC---------CC--CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1222222222 22 22233345678999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-46 Score=398.37 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=202.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC---chhHHHH---HHHHHHhccCCCCCcceeeeeeeeccCce
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN---DGGTRAF---LAEISSLGRLKHKSLVGLRGWCKREKGSL 437 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~---~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 437 (705)
++|+..++||+|+||.||+|++..+|+.||||++.... ......+ .+|+.+++.++||||+++++++.. .+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEE
Confidence 57889999999999999999999999999999986431 1122233 345778888899999999998876 6789
Q ss_pred EEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 438 MLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 438 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
|+||||+++|+|.++|.+.. .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999997654 68999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHh
Q 005257 518 HGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDAR 596 (705)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~ 596 (705)
..... ....+||+.|||||++.. ..++.++|||||||++|||+||+.||..........+.. ..
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------~~ 221 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------MT 221 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------------HS
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hc
Confidence 65443 233579999999999975 468999999999999999999999998654321111111 11
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 005257 597 LRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVKV 635 (705)
Q Consensus 597 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 635 (705)
......++......+.+++..||+.||++||| ++|++++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11112223334466889999999999999999 6888763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=393.66 Aligned_cols=261 Identities=22% Similarity=0.410 Sum_probs=211.8
Q ss_pred hCCCCcceEEeecCceEEEEEEEcC-----CCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEG-----GGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 436 (705)
.++|...+.||+|+||+||+|.++. .+..||||+++... ......|.+|++++++++||||++++++|.. ++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCc
Confidence 3567788999999999999998852 35789999997543 3445578999999999999999999999876 668
Q ss_pred eEEEEeeCCCCChhHHHHhc-------CCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeee
Q 005257 437 LMLVYDYMENGSLDKWIFQC-------DGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRL 509 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL 509 (705)
.++||||+++|+|.+++... .....+++..+.+++.|+|.||.|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 89999999999999998643 122357999999999999999999998 99999999999999999999999
Q ss_pred eeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCC-CCCCCCCccHHHHHHHHHHhC
Q 005257 510 GDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGR-RPIEEGKPNLVEMVWELMVQG 587 (705)
Q Consensus 510 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~-~Pf~~~~~~~~~~v~~~~~~~ 587 (705)
+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||..... ..+...+.++
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i~~~ 251 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVMEG 251 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHHTT
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhC
Confidence 999999866443322 223347899999999999999999999999999999999985 56654332 1222233333
Q ss_pred chhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 588 KLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 588 ~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. ...+......+.+++..||+.||++||||.+|++.|++.++
T Consensus 252 ~~-----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22 12233344679999999999999999999999999987655
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=395.91 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=207.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC---CchhHHHHHHHHHHhc-cCCCCCcceeeeeeeeccCceEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE---NDGGTRAFLAEISSLG-RLKHKSLVGLRGWCKREKGSLML 439 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~~l 439 (705)
++|...+.||+|+||+||+|+++.+++.||||+++.. .....+.+..|..++. .++||||+++++++.+ ++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence 4688899999999999999999999999999999653 2344566777877765 6899999999999876 778999
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecC
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHG 519 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~ 519 (705)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++...
T Consensus 81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999997654 58999999999999999999999 999999999999999999999999999998665
Q ss_pred CCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhc
Q 005257 520 HGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRA 599 (705)
Q Consensus 520 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~ 599 (705)
.... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..++..+..+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~----------- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMDN----------- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-----------
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-----------
Confidence 4332 23446899999999999999999999999999999999999999986543 22223332221
Q ss_pred CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 005257 600 KGGFDEDEVERVLHLGLLCAYPDPRARPTMR-QVVK 634 (705)
Q Consensus 600 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 634 (705)
..++......+.+++..||+.||++||++. ++++
T Consensus 220 -~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 223333446688999999999999999985 6654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=391.76 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=209.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCC-------eEEEEEEeccCCc-hhHHHHHHHHHHhccC-CCCCcceeeeeeeec
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGG-------AEIAVKRISHEND-GGTRAFLAEISSLGRL-KHKSLVGLRGWCKRE 433 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~i~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 433 (705)
.++|...+.||+|+||.||+|+...++ ..||||+++.... ....++.+|...+.++ +||||++++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 356778899999999999999976543 4799999976643 4467899999999888 89999999999986
Q ss_pred cCceEEEEeeCCCCChhHHHHhcCC-------------CCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 005257 434 KGSLMLVYDYMENGSLDKWIFQCDG-------------SMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVL 500 (705)
Q Consensus 434 ~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NIL 500 (705)
++..++||||+++|+|.++|..... ...+++.++++++.||+.||+|||+ ++||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 6789999999999999999975431 2368999999999999999999999 99999999999999
Q ss_pred EccCCCeeeeeeccceecCCCCcc-eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhh-CCCCCCCCCccHHH
Q 005257 501 LDKEMNGRLGDFGLARMHGHGQVA-STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLS-GRRPIEEGKPNLVE 578 (705)
Q Consensus 501 ld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~Ellt-G~~Pf~~~~~~~~~ 578 (705)
++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||..... +
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~ 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H
Confidence 999999999999999876544322 2334578999999999999999999999999999999998 6888865443 2
Q ss_pred HHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 579 MVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 579 ~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.++..+..+.. ...+......+.+++.+||+.||++|||+.||++.|++++.
T Consensus 245 ~~~~~i~~~~~-----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCC-----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 33333333321 22233345678999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=388.97 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=210.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEe
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E 442 (705)
.++|...+.||+|+||+||+|.+..+++.||||+++... .....+.+|+++|+.++||||+++++++.+ ++.+|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence 467889999999999999999999999999999997653 334568899999999999999999998876 678999999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC--CCeeeeeeccceecCC
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE--MNGRLGDFGLARMHGH 520 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~--~~~kL~DFGla~~~~~ 520 (705)
||++|+|.+++...+ ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ ..+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999996543 258999999999999999999998 999999999999999854 5799999999987754
Q ss_pred CCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+...+..+.
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~------------ 219 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAE------------ 219 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTC------------
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------------
Confidence 432 33468899999999999999999999999999999999999999875431 2222222221
Q ss_pred CCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHhccc
Q 005257 601 GGFDED----EVERVLHLGLLCAYPDPRARPTMRQVVK--VLEGKIE 641 (705)
Q Consensus 601 ~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~ 641 (705)
..++.. ....+.+++..||..||++|||+.|+++ ++.+..+
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 111211 1345789999999999999999999998 3554433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.90 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=200.4
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccC---ceEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKG---SLMLV 440 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---~~~lV 440 (705)
+.|...+.||+|+||+||+|++. |+.||||+++... .....+..|+..+..++||||++++++|..+.. .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 34667889999999999999974 7899999986432 122223456666778899999999999986443 57999
Q ss_pred EeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 441 YDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGW-----EKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 441 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
||||++|+|.++|++. .++|.++++++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999753 5899999999999999999999631 379999999999999999999999999999
Q ss_pred eecCCCCcc---eeeeeeccccCCCccccccCC------CCccccEEEEehhHHHHhhCCCCCCCCCc------------
Q 005257 516 RMHGHGQVA---STTRVVGTVGYLAPEVFSSGR------ASTQTDVFGFGILILEVLSGRRPIEEGKP------------ 574 (705)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~------------ 574 (705)
+........ ......||+.|||||++.+.. ++.++|||||||+||||+||..|+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877544322 223468999999999987542 57789999999999999999887743111
Q ss_pred cHHHHHHHHHHhCchhHHHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 575 NLVEMVWELMVQGKLLDALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 575 ~~~~~v~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
...+........+... +.+.. ...+.+....+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~----p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLR----PNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCC----CCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccC----CCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1112222222221110 00000 00123456678999999999999999999999999986543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=391.76 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=199.9
Q ss_pred CCCCcce-EEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccC-CCCCcceeeeeeee---ccCceE
Q 005257 364 KGFSEEN-VIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRL-KHKSLVGLRGWCKR---EKGSLM 438 (705)
Q Consensus 364 ~~f~~~~-~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~---~~~~~~ 438 (705)
++|.+.+ .||+|+||+||+|.+..+++.||||+++. .+.+.+|++++.++ +||||+++++++.. .+..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5677664 69999999999999999999999999863 25577899987655 89999999998753 245689
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc---CCCeeeeeeccc
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK---EMNGRLGDFGLA 515 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~---~~~~kL~DFGla 515 (705)
+|||||++|+|.++|.+... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 99999999999999976433 369999999999999999999998 99999999999999985 457999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccH-HHHHHHHHHhCchhHHHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNL-VEMVWELMVQGKLLDALD 594 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~-~~~v~~~~~~~~~~~~id 594 (705)
+....... ....+||+.|||||++.+..++.++|||||||++|||+||+.||.+..... ..........+.
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 87655433 234589999999999999899999999999999999999999997543211 111111111111
Q ss_pred HhhhcCCCCC----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFD----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++ ....+.+.+++..||+.||++|||+.|++++
T Consensus 234 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 1234678899999999999999999999884
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=3.4e-45 Score=367.67 Aligned_cols=212 Identities=29% Similarity=0.496 Sum_probs=181.3
Q ss_pred ceeeEEeCCCCC-CCeEEEcceEee-cCcEEecCCCC------CeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCC
Q 005257 24 SAVDFVFNGFNS-SNLSLYGTATVE-SRILTLTNSTT------FTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYK 95 (705)
Q Consensus 24 ~~~~f~f~~f~~-~~~~~~g~a~~~-~~~l~lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 95 (705)
..++|+|++|+. .+|+|+|||.+. +|.||||++.. .++|||+|++||+||+ +++++||+|+|+|.|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~~~ 79 (228)
T d1ioaa_ 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRAKN 79 (228)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCBSC
T ss_pred ccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEecCC
Confidence 467999999976 569999999986 67999998764 5789999999999998 4779999999999999988
Q ss_pred CCCCCCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccc
Q 005257 96 GVLAGHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGY 175 (705)
Q Consensus 96 ~~~~g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~ 175 (705)
...+||||||+|+|+.. +.+..|++||+++.+. ++..++.|||||||+.|. +|++.+|+++++++..
T Consensus 80 ~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~--------- 146 (228)
T d1ioaa_ 80 QSISAYGLAFALVPVNS-PPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC--------- 146 (228)
T ss_dssp TTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC---------
T ss_pred CCCCCCEEEEEEeCCCC-CCCCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceeccccc---------
Confidence 78899999999999865 4456889999998654 456789999999999985 5788888888776432
Q ss_pred cCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCcccccccee
Q 005257 176 WPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMY 253 (705)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~ 253 (705)
...+.+|+.++|||+| ..+.++|++... .+|..|.++..|||+.+||++||
T Consensus 147 -------------------------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~--~~~~~~~ls~~vdL~~~l~~~vy 199 (228)
T d1ioaa_ 147 -------------------------DFHKYNGEKTDVQITYDSSNNDLRVFLHFT--VSQVKCSVSATVHLEKEVDEWVS 199 (228)
T ss_dssp -------------------------CHHHHCSSCEEEEEEEETTTTEEEEEEEET--TTCCEEEEEEECCGGGTSCSEEE
T ss_pred -------------------------ccccccCcEEEEEEEEcCCCCEEEEEEEeC--CCCceeeEEEEEchHHcCCCcEE
Confidence 2356789999999999 567888888754 47888999999999999999999
Q ss_pred cccccccc---cccccceeeeeeeccc
Q 005257 254 VGFTAATG---QLVESHKILAWSFSNT 277 (705)
Q Consensus 254 vGfsastg---~~~~~h~i~~wsf~~~ 277 (705)
|||||||| ...|.|+|++|+|+++
T Consensus 200 vGFSAsTG~~~~~~~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 200 VGFSPTSGLTEDTTETHDVLSWSFSSK 226 (228)
T ss_dssp EEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred EEEEeecCCCCCCceEEEEEEEEeEEe
Confidence 99999999 5668999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=384.02 Aligned_cols=259 Identities=26% Similarity=0.308 Sum_probs=195.2
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccCCch-----hHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDG-----GTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
.++||+|+||+||+|.++.+|+.||||+++..... ..+.+.+|++++++++||||+++++++.. ++.+++||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhhh
Confidence 57899999999999999999999999998654322 23468899999999999999999999886 6789999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCCCc
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHGQV 523 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 523 (705)
+.++++..++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 998777665532 2368999999999999999999999 9999999999999999999999999999987654432
Q ss_pred ceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCcc-HHHHHHHHHHhCchh---HHHH----
Q 005257 524 ASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPN-LVEMVWELMVQGKLL---DALD---- 594 (705)
Q Consensus 524 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~-~~~~v~~~~~~~~~~---~~id---- 594 (705)
. ....+||+.|||||++... .++.++|||||||++|||++|+.||...... ....+.+........ +...
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 2335799999999998654 5799999999999999999999999765431 111111111000000 0000
Q ss_pred HhhhcCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 595 ARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 595 ~~l~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.........+. ...+.+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000111 123568899999999999999999999873
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.2e-45 Score=368.62 Aligned_cols=215 Identities=30% Similarity=0.451 Sum_probs=187.5
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCC---CCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCC
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNS---TTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLA 99 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 99 (705)
.+++|+|++|++.||+|+|||++. +|.||||+. ...++|||+|++||+||++.+++++||+|+|+|.|.+.+...+
T Consensus 2 ~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~~ 81 (226)
T d1avba_ 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred CceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCCC
Confidence 478999999999999999999987 579999974 4578999999999999999999999999999999999888889
Q ss_pred CCceEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCC
Q 005257 100 GHGLVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDN 179 (705)
Q Consensus 100 g~G~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~ 179 (705)
||||||+|+|....+ +..|+++|+++. ++|||||+.|...+|+..||||||+|+..|..+.+.
T Consensus 82 gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~------ 144 (226)
T d1avba_ 82 AYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC------ 144 (226)
T ss_dssp CEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC------
T ss_pred CceEEEEEccCCCCC-CCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCcccccccc------
Confidence 999999999987644 467889999763 479999999977679999999999999988776543
Q ss_pred CCCCCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccc
Q 005257 180 QTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFT 257 (705)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfs 257 (705)
...+.+|+.++|||+| ..++|+|++... .+|..+.++..|||+.+||++||||||
T Consensus 145 ---------------------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~~~~~~~vdL~~~l~~~~y~GFS 201 (226)
T d1avba_ 145 ---------------------NFGHNNGEKAEVRITYDSPKNDLRVSLLYP--SSEEKCHVSATVPLEKEVEDWVSVGFS 201 (226)
T ss_dssp ---------------------CSGGGTTCEEEEEEEEEGGGTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred ---------------------ccccCCCeEEEEEEEEcCCCcEEEEEEEeC--CCCccEEEEEEecHHHccCCcEEEEEE
Confidence 2357799999999999 456788887654 467788899999999999999999999
Q ss_pred ccccc---ccccceeeeeeecccc
Q 005257 258 AATGQ---LVESHKILAWSFSNTK 278 (705)
Q Consensus 258 astg~---~~~~h~i~~wsf~~~~ 278 (705)
||||. ..|.|+|++|+|+++.
T Consensus 202 AaTG~~s~~~~~H~IlsWsF~s~~ 225 (226)
T d1avba_ 202 ATSGSKKETTETHNVLSWSFSSNF 225 (226)
T ss_dssp EEECSSGGGCEEEEEEEEEEEEEE
T ss_pred EEcCCCCCCeeeeEEEEEEeEEec
Confidence 99995 5678999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=378.44 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=201.5
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++||||+++++++.. ++.+++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence 57889999999999999999999999999999996543 2346789999999999999999999999876 77899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+.+ ++..++..... ..+++.++..++.|++.||+|||+ ++||||||||+|||++.++++||+|||+|+.....
T Consensus 81 e~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99975 55555544332 269999999999999999999998 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHHHHHhhhc
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDALDARLRA 599 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~id~~l~~ 599 (705)
... .....||+.|+|||.+.... ++.++||||+||++|||++|+.||...... +....... .+...+...+....
T Consensus 156 ~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc
Confidence 322 23357999999999976655 588999999999999999999999865421 22222111 11110000000000
Q ss_pred ----------CCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 600 ----------KGGFD-----EDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 600 ----------~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... ....+.+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0112567889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=378.00 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=198.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc------hhHHHHHHHHHHhccCC--CCCcceeeeeeeecc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND------GGTRAFLAEISSLGRLK--HKSLVGLRGWCKREK 434 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~------~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~ 434 (705)
.++|+..++||+|+||+||+|++..+++.||||++..... .....+.+|+.++++++ ||||+++++++.. .
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence 3578999999999999999999999999999999865421 12234678999999996 8999999998876 6
Q ss_pred CceEEEEeeCCC-CChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccC-CCeeeeee
Q 005257 435 GSLMLVYDYMEN-GSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKE-MNGRLGDF 512 (705)
Q Consensus 435 ~~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~-~~~kL~DF 512 (705)
+..++||||+.+ +++.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 789999999976 67878876543 69999999999999999999999 999999999999999854 78999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCC-CccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRA-STQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
|+|+...... .+...||+.|||||++.+..+ +.++||||+||++|||++|+.||.... .+..+.
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~--- 220 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQ--- 220 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCC---
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcc---
Confidence 9998764432 234689999999999987665 577899999999999999999997521 111111
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..++......+.+++.+||+.||++|||++|++++
T Consensus 221 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11222233567889999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-43 Score=370.67 Aligned_cols=263 Identities=18% Similarity=0.257 Sum_probs=204.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEEee
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVYDY 443 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~E~ 443 (705)
++|+..+.||+|+||+||+|++..+++.||||++..... .+++..|+++++.++|+|++..+..|...++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 468999999999999999999999999999998865432 345788999999999998888887777768889999999
Q ss_pred CCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEc---cCCCeeeeeeccceecCC
Q 005257 444 MENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLD---KEMNGRLGDFGLARMHGH 520 (705)
Q Consensus 444 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld---~~~~~kL~DFGla~~~~~ 520 (705)
+ +++|...+..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+....
T Consensus 85 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5577776655433 69999999999999999999999 9999999999999985 456799999999998754
Q ss_pred CCc------ceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHH
Q 005257 521 GQV------ASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALD 594 (705)
Q Consensus 521 ~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id 594 (705)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||....................... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-H
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-h
Confidence 332 123346899999999999999999999999999999999999999976443211111111111000000 0
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 595 ARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 595 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
+.+. . ..++.+.+++..||+.+|++||++.++.+.|+....
T Consensus 238 ~~~~--~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVLC--K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHT--T----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHhc--c----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0111 1 223568889999999999999999999998887643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=373.56 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=198.5
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCC-CeEEEEEEeccCC--chhHHHHHHHHHHhccC---CCCCcceeeeeeee----
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGG-GAEIAVKRISHEN--DGGTRAFLAEISSLGRL---KHKSLVGLRGWCKR---- 432 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~---- 432 (705)
.++|+..+.||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998654 6789999986542 22334566777777666 79999999998853
Q ss_pred ccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeee
Q 005257 433 EKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDF 512 (705)
Q Consensus 433 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DF 512 (705)
....++++|||++++++....... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence 234689999999887766544332 2368999999999999999999998 99999999999999999999999999
Q ss_pred ccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhH
Q 005257 513 GLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLD 591 (705)
Q Consensus 513 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~ 591 (705)
|+++...... ......||+.|||||++.+..++.++||||+||++|||++|+.||...... +....... .+....
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCG
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCch
Confidence 9998654332 234468999999999999999999999999999999999999999865431 11111111 000000
Q ss_pred -HHH-------HhhhcC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 -ALD-------ARLRAK-----GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 -~id-------~~l~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
... ...... ..+.....+.+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000000 00111223567889999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-43 Score=367.71 Aligned_cols=260 Identities=27% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|...++||+|+||+||+|.++ +++.||||+++... ....+.+.+|+.+|++++||||+++++++.. .+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEE
Confidence 57888999999999999999986 67899999997653 2335789999999999999999999999886 67899999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
||+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 999877666665332 369999999999999999999998 99999999999999999999999999999876543
Q ss_pred CcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCchhHH----H--
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKLLDA----L-- 593 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~~~~----i-- 593 (705)
.. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+... .+....... .+..... .
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCChhhccchhh
Confidence 32 22335789999999998764 579999999999999999999999976542 121111111 1110000 0
Q ss_pred ----HHhhhcCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 594 ----DARLRAKG-----GFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 594 ----d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
........ .......+.+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 001112356789999999999999999999985
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.5e-43 Score=344.27 Aligned_cols=196 Identities=29% Similarity=0.488 Sum_probs=162.4
Q ss_pred ceeeEEeCCCCCCCeEEEcceEee-cCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCc
Q 005257 24 SAVDFVFNGFNSSNLSLYGTATVE-SRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHG 102 (705)
Q Consensus 24 ~~~~f~f~~f~~~~~~~~g~a~~~-~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G 102 (705)
..++|+|++|++.||+|+|||++. +|.||||++..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+|||
T Consensus 2 ~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdG 81 (204)
T d1dhkb_ 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAVG 81 (204)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCSE
T ss_pred ccceEECCCCCccCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCCCce
Confidence 468999999999999999999986 6799999999999999999999999999999999999999999998877778999
Q ss_pred eEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCC
Q 005257 103 LVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTD 182 (705)
Q Consensus 103 ~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~ 182 (705)
|||+++|... ...++.|||||||+.| |+++|+++..+....
T Consensus 82 laf~~~~~~~-------------------~~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~~----------- 122 (204)
T d1dhkb_ 82 LDFVLVPVQP-------------------ESKGDTVTVEFDTFLS---------RISIDVNNNDIKSVP----------- 122 (204)
T ss_dssp EEEEEEEC-------------------------CCEEEEEETTTT---------EEEEEETTEEEEEEE-----------
T ss_pred EEEEecCCCC-------------------CCCCcEeeEeeEcccc---------cccCccccccccccc-----------
Confidence 9999998632 1234789999999875 667777765432221
Q ss_pred CCCCCCCCCCCCCccccceeecCCCcceEEEEEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceeccccccc
Q 005257 183 SSGSNSNSGTGDDEKSFKELKLNNGKNYQVWIDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAAT 260 (705)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsast 260 (705)
..+.+.+|+.++|||+| ..++|+|++.... +|..+.|+..+||+.+||++|||||||||
T Consensus 123 -----------------~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaT 183 (204)
T d1dhkb_ 123 -----------------WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATS 183 (204)
T ss_dssp -----------------CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEE
T ss_pred -----------------cccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeec
Confidence 13467899999999999 5668888887554 57778899999999999999999999999
Q ss_pred ccc---cccceeeeeeeccc
Q 005257 261 GQL---VESHKILAWSFSNT 277 (705)
Q Consensus 261 g~~---~~~h~i~~wsf~~~ 277 (705)
|.. .|.|+|++|+|+++
T Consensus 184 G~~~~~~e~H~IlsWsFss~ 203 (204)
T d1dhkb_ 184 GAYQWSYETHDVLSWSFSSK 203 (204)
T ss_dssp CSGGGSCCEEEEEEEEEEEE
T ss_pred CCCCCCceeeEEEEEEEEec
Confidence 953 58899999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=374.95 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=197.1
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcceeeeeeeec-----cCceEE
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KGSLML 439 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~~~l 439 (705)
+|...++||+|+||+||+|++..+++.||||++...... ..+|+++|++++||||+++++++... ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 467788999999999999999999999999999765332 24699999999999999999988532 235789
Q ss_pred EEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-Ceeeeeeccceec
Q 005257 440 VYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMH 518 (705)
Q Consensus 440 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~ 518 (705)
||||++++.+..+.........+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876555444333333479999999999999999999998 9999999999999999775 8999999999877
Q ss_pred CCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH-hCch-hHHHHH
Q 005257 519 GHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV-QGKL-LDALDA 595 (705)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~-~~~~-~~~id~ 595 (705)
...... ...+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +....... .|.. .+.+..
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhhh
Confidence 554432 23579999999999865 56899999999999999999999999765431 21111111 1111 111111
Q ss_pred hhhcC--------------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 596 RLRAK--------------GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 596 ~l~~~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10000 00011233567889999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-42 Score=362.62 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=206.8
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCC-CCcceeeeeeeeccCceEEEEe
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKH-KSLVGLRGWCKREKGSLMLVYD 442 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~~lV~E 442 (705)
++|.+.+.||+|+||+||+|++..+++.||||+++.... .+.+.+|++.+..|+| +|++.+++++.. +...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEE
Confidence 578899999999999999999999999999998865432 3456788888888865 889999987765 778899999
Q ss_pred eCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEcc-----CCCeeeeeecccee
Q 005257 443 YMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDK-----EMNGRLGDFGLARM 517 (705)
Q Consensus 443 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~-----~~~~kL~DFGla~~ 517 (705)
|+ +++|.+++..... .+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6899998876543 68999999999999999999998 99999999999999974 56799999999997
Q ss_pred cCCCCcc------eeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhH
Q 005257 518 HGHGQVA------STTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLD 591 (705)
Q Consensus 518 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~ 591 (705)
....... .....+||+.|||||++.+..++.++|||||||++|||++|+.||..............+...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543221 2334689999999999999999999999999999999999999998644322221112211111100
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhccc
Q 005257 592 ALDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGKIE 641 (705)
Q Consensus 592 ~id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 641 (705)
.. +.+. ..+ ++.+.+++..|+..+|++||+++.+.+.|++..+
T Consensus 236 ~~-~~l~--~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PL-RELC--AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CH-HHHT--TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred Ch-HHhc--CCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00 0111 112 3567888999999999999999999998887655
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=366.83 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=197.2
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeec-------c
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-------K 434 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-------~ 434 (705)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+++|++++||||+++++++... +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788999999999999999999999999999998654 334567789999999999999999999987542 3
Q ss_pred CceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeecc
Q 005257 435 GSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGL 514 (705)
Q Consensus 435 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGl 514 (705)
+.+++||||++++.+...... ...+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 468999999988766654432 2368999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCcc---eeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh
Q 005257 515 ARMHGHGQVA---STTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL 590 (705)
Q Consensus 515 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~ 590 (705)
++........ .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+............. .+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL-CGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh-cCCCC
Confidence 9876543221 12235799999999998765 6899999999999999999999999765431111111111 11110
Q ss_pred HHHHH---------hhhc--CCCCCH-H------HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 DALDA---------RLRA--KGGFDE-D------EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ~~id~---------~l~~--~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..... .+.. ...... + ....+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 0000 000001 0 12356789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=367.73 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=196.4
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccC--CchhHHHHHHHHHHhccCCCCCcceeeeeeeecc-----C
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE--NDGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK-----G 435 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~ 435 (705)
.++|+..+.||+|+||+||+|.+..+|+.||||+++.. .....+.+.+|+++|+.++||||++++++|...+ .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46789999999999999999999999999999999754 2334567899999999999999999999987532 2
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.+++||||+ +.+|..++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 579999999 55777776532 59999999999999999999999 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHH-HhCchhH--
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELM-VQGKLLD-- 591 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~-~~~~~~~-- 591 (705)
+...... +...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +...... ..+....
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCCCcHHH
Confidence 8765432 34579999999999876 45789999999999999999999999765431 1111111 0111100
Q ss_pred ----------HHHHhhhcCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ----------ALDARLRAKGG-----FDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ----------~id~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.....+..... ........+.+|+.+||..||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01111100000 011123457889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=367.39 Aligned_cols=266 Identities=23% Similarity=0.253 Sum_probs=198.7
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC-chhHHHHHHHHHHhccCCCCCcceeeeeeeecc---CceE
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN-DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREK---GSLM 438 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~---~~~~ 438 (705)
+.+|+..+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356889999999999999999999999999999997553 344567899999999999999999999886432 1234
Q ss_pred EEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceec
Q 005257 439 LVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMH 518 (705)
Q Consensus 439 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~ 518 (705)
++++|+.+|+|.+++... .+++.+++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 455667799999999643 58999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--eeeeeeccccCCCcccccc-CCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchh-----
Q 005257 519 GHGQVA--STTRVVGTVGYLAPEVFSS-GRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLL----- 590 (705)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~----- 590 (705)
...... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443221 2344679999999999854 56789999999999999999999999765432111111000000000
Q ss_pred ----HHHH--HhhhcCCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 591 ----DALD--ARLRAKGGFDED-----EVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 591 ----~~id--~~l~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
.... .........+.. ....+.+++..|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 001000111111 12457899999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=359.04 Aligned_cols=284 Identities=24% Similarity=0.311 Sum_probs=215.7
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeeccCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKREKGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~lV~ 441 (705)
++|+..+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.. ....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence 57889999999999999999999999999999986553 3446788999999999999999999999876 67889999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccceecCCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARMHGHG 521 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 521 (705)
|++.+++|..++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888775433 68999999999999999999998 99999999999999999999999999999877544
Q ss_pred CcceeeeeeccccCCCccccccCC-CCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCchhHHHHHhhhcC
Q 005257 522 QVASTTRVVGTVGYLAPEVFSSGR-ASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKLLDALDARLRAK 600 (705)
Q Consensus 522 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~~~~id~~l~~~ 600 (705)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||..+... .+..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~-------------------- 212 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-------------------- 212 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHH--------------------
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHH--------------------
Confidence 332 22346788999999987655 689999999999999999999998654321 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc---cccCCCCCcchhhHHHHHHhhccccccccccccccCCC
Q 005257 601 GGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKVLEGK---IEAGIENETEDMDAYLLQQVKSKDMWANYSRSFGYGYA 677 (705)
Q Consensus 601 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 677 (705)
..+......+.+...|...+....-... ...............+.+++..+..++|..|.++.+++
T Consensus 213 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 213 -----------KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp -----------HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred -----------HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1111111222222222221111100000 00011112233445667788888899999999999999
Q ss_pred CCCCcccccc
Q 005257 678 THPTFHDIRQ 687 (705)
Q Consensus 678 ~hp~f~~~~~ 687 (705)
+||||.+...
T Consensus 282 ~Hp~f~~~~~ 291 (292)
T d1unla_ 282 QHPYFSDFCP 291 (292)
T ss_dssp TSGGGSSCSC
T ss_pred cChhhcCCCC
Confidence 9999987653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=368.11 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=204.1
Q ss_pred CCCCcceEEeecCceEEEEEEE---cCCCeEEEEEEeccCC----chhHHHHHHHHHHhccCCC-CCcceeeeeeeeccC
Q 005257 364 KGFSEENVIGVGGNGKVYKGVL---EGGGAEIAVKRISHEN----DGGTRAFLAEISSLGRLKH-KSLVGLRGWCKREKG 435 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~---~~~~~~vavK~i~~~~----~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~ 435 (705)
++|+..+.||+|+||+||+|.. +.+|+.||||+++... ....+.+.+|++++++++| |||+++++++.. ..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CC
Confidence 5689999999999999999987 4468999999986532 2335668899999999977 899999998876 67
Q ss_pred ceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccc
Q 005257 436 SLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLA 515 (705)
Q Consensus 436 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla 515 (705)
.++++|||+.+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 8999999999999999997654 57889999999999999999998 99999999999999999999999999999
Q ss_pred eecCCCCcceeeeeeccccCCCccccccC--CCCccccEEEEehhHHHHhhCCCCCCCCCc-cHHHHHHHHHHhCchhHH
Q 005257 516 RMHGHGQVASTTRVVGTVGYLAPEVFSSG--RASTQTDVFGFGILILEVLSGRRPIEEGKP-NLVEMVWELMVQGKLLDA 592 (705)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~-~~~~~v~~~~~~~~~~~~ 592 (705)
+..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||..... .....+....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 87755444444456899999999999764 468899999999999999999999976432 2111111111
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 005257 593 LDARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPT-----MRQVVK 634 (705)
Q Consensus 593 id~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 634 (705)
......++......+.+++..||++||++||| ++|+++
T Consensus 249 ----~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 ----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11112333455677899999999999999995 778765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=359.82 Aligned_cols=257 Identities=20% Similarity=0.276 Sum_probs=200.0
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeec-cCceEEEE
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKRE-KGSLMLVY 441 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~-~~~~~lV~ 441 (705)
++|+..++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++|+.++ ||||+++++++... ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999998643 3567889999999995 99999999988642 45689999
Q ss_pred eeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCC-CeeeeeeccceecCC
Q 005257 442 DYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEM-NGRLGDFGLARMHGH 520 (705)
Q Consensus 442 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~-~~kL~DFGla~~~~~ 520 (705)
||+++++|..+.. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 58999999999999999999999 9999999999999998655 589999999987755
Q ss_pred CCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHHhCch--hHHHHH--
Q 005257 521 GQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMVQGKL--LDALDA-- 595 (705)
Q Consensus 521 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~~~~~--~~~id~-- 595 (705)
... ....+||+.|+|||.+.+. .++.++||||+||+++||++|+.||.................|.. .+....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 432 2335789999999998765 479999999999999999999999987654322211111111100 000000
Q ss_pred -----hhh----c----------CCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 005257 596 -----RLR----A----------KGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVK 634 (705)
Q Consensus 596 -----~l~----~----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 634 (705)
... . ...........+.+|+.+|++.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 00000112356788999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=363.89 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=192.6
Q ss_pred CCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec-----cCc
Q 005257 364 KGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE-----KGS 436 (705)
Q Consensus 364 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 436 (705)
++|++.++||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999999999999999997653 34456789999999999999999999998632 357
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
+|+||||+.++.+ +.+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 8999999976544 4442 158999999999999999999999 999999999999999999999999999988
Q ss_pred ecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCccHHHHHHHHHH--hCchhH---
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPNLVEMVWELMV--QGKLLD--- 591 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~~~v~~~~~--~~~~~~--- 591 (705)
...... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||...... ........ .+...+
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHT
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--HHHHHHHHhccCCCHHHHH
Confidence 765433 234457899999999999999999999999999999999999999765431 11111100 000000
Q ss_pred ----H----HHH---------------hhh-cCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 592 ----A----LDA---------------RLR-AKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 592 ----~----id~---------------~l~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
. ... ... ............+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000 000 0000012345678899999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=357.42 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=196.9
Q ss_pred hCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCC--chhHHHHHHHHHHhccCCCCCcceeeeeeeec----cCc
Q 005257 363 TKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEN--DGGTRAFLAEISSLGRLKHKSLVGLRGWCKRE----KGS 436 (705)
Q Consensus 363 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~ 436 (705)
.++|+..++||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++|||++++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999999999999999997653 33456789999999999999999999987531 233
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.+++++|+.+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 4566777889999999853 259999999999999999999998 999999999999999999999999999997
Q ss_pred ecCCCCcceeeeeeccccCCCccccccC-CCCccccEEEEehhHHHHhhCCCCCCCCCccHH-HHHHHHHHhCchhHHH-
Q 005257 517 MHGHGQVASTTRVVGTVGYLAPEVFSSG-RASTQTDVFGFGILILEVLSGRRPIEEGKPNLV-EMVWELMVQGKLLDAL- 593 (705)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~~~-~~v~~~~~~~~~~~~i- 593 (705)
..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+...... ..+... .+.....+
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~--~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL--VGTPGAELL 243 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCHHHH
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cCCCChHHh
Confidence 65322 2335789999999987665 468999999999999999999999986543211 111111 11110000
Q ss_pred -----------HHhhhcCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 594 -----------DARLRAKGGFDE-----DEVERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 594 -----------d~~l~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
...+........ .....+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000001110 122457889999999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-37 Score=330.61 Aligned_cols=264 Identities=20% Similarity=0.219 Sum_probs=194.8
Q ss_pred CCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-----------CCCcceeeeeeeec
Q 005257 365 GFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-----------HKSLVGLRGWCKRE 433 (705)
Q Consensus 365 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~g~~~~~ 433 (705)
+|+..++||+|+||+||+|++..+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5889999999999999999999999999999996542 33467788998888875 57899999887542
Q ss_pred -cCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCC------
Q 005257 434 -KGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMN------ 506 (705)
Q Consensus 434 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~------ 506 (705)
....+++++++..+..............+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 34566777777655544443333344478999999999999999999996 478999999999999986654
Q ss_pred eeeeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEehhHHHHhhCCCCCCCCCcc----HHHHHHH
Q 005257 507 GRLGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFGILILEVLSGRRPIEEGKPN----LVEMVWE 582 (705)
Q Consensus 507 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gvvl~ElltG~~Pf~~~~~~----~~~~v~~ 582 (705)
+|++|||.+....... ...+||+.|+|||++....++.++||||+||+++||++|+.||...... ..+....
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 8999999998654322 3357999999999999999999999999999999999999999753221 1111111
Q ss_pred H-HHhCchhHHH----------------------------HHhhhcCCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 005257 583 L-MVQGKLLDAL----------------------------DARLRAKGGFDEDEVERVLHLGLLCAYPDPRARPTMRQVV 633 (705)
Q Consensus 583 ~-~~~~~~~~~i----------------------------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 633 (705)
. ..-|...... ...+.............+.+++..|+..||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1 0111111100 0111112334566778889999999999999999999987
Q ss_pred HH
Q 005257 634 KV 635 (705)
Q Consensus 634 ~~ 635 (705)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 74
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.95 E-value=8.6e-29 Score=244.80 Aligned_cols=113 Identities=28% Similarity=0.487 Sum_probs=101.9
Q ss_pred CCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCCccccceeecCCCcceEEE
Q 005257 134 SNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDDEKSFKELKLNNGKNYQVW 213 (705)
Q Consensus 134 ~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~ 213 (705)
.|++|||||||++|.+++||++||||||+|++.|.++. .+++.+|+.++||
T Consensus 1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~-----------------------------~~~l~~G~~~~v~ 51 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTA-----------------------------KWNMQNGKVGTAH 51 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE-----------------------------ECCCCTTCEEEEE
T ss_pred CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCcccee-----------------------------cccccCCCEEEEE
Confidence 37999999999999999999999999999999987663 4478899999999
Q ss_pred EEe--cCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeeeecccc
Q 005257 214 IDY--ADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSFSNTK 278 (705)
Q Consensus 214 I~Y--~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~wsf~~~~ 278 (705)
|+| ..++|+|++... +|..|++++.|||+.+|+++||||||||||...+.|+|++|+|+++.
T Consensus 52 I~Yd~~~~~L~V~~~~~---~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 52 IIYNSVDKRLSAVVSYP---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp EEEETTTTEEEEEEECT---TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred EEEecCCcEEEEEEecC---CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 999 677888888643 56778999999999999999999999999999999999999999875
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=3.6e-27 Score=235.99 Aligned_cols=201 Identities=15% Similarity=0.142 Sum_probs=144.0
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.||||++..+++|+++|++|+++ .+|+|+|+|.|...+ ..+||||||+|+|+..
T Consensus 24 ~~w~~~G~a~i~~~~i~LT~~~~~~~G~v~~~~p~~~--------~~F~~~f~f~~~~~~-~~ggdG~aF~i~~~~~--- 91 (228)
T d1gv9a_ 24 PFWAHAGNAIPSADQIRIAPSLKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTENQG--- 91 (228)
T ss_dssp TTEEEEETCEECSSCEEEECSSTTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCCCCEEEEEEESSCC---
T ss_pred cceEEeeeEEEECCEEEECCCCCCCEEEEEeCCCccc--------cCcEEEEEEeccCCC-CCCCCEEEEEEecCCC---
Confidence 5789999999999999999999999999999999988 369999999997643 4589999999998642
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccc-cccccccCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVS-AHAAGYWPDNQTDSSGSNSNSGTGD 194 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (705)
..|+.+|.. ...+.+||||||+.|. ++++.+|+.+++|...... ..+.++... ..++.
T Consensus 92 -~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~-------~~~~~---- 150 (228)
T d1gv9a_ 92 -LDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQA-------LASCQ---- 150 (228)
T ss_dssp -CEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHC-------SEEEC----
T ss_pred -CCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCcccc-------cccee----
Confidence 456667662 3346799999999997 6888888888877543111 110000000 00000
Q ss_pred CccccceeecCCCcceEEEEEecCceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeeeee
Q 005257 195 DEKSFKELKLNNGKNYQVWIDYADSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAWSF 274 (705)
Q Consensus 195 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~wsf 274 (705)
.....++..+++|++|....++|++..........+.....++ ...+|+++|||||||||...+.|.|++|.+
T Consensus 151 ------~~~~~~~~~~~i~~~~~~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~ 223 (228)
T d1gv9a_ 151 ------RDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLT 223 (228)
T ss_dssp ------CCCBSCSSCEEEEEEEETTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEE
T ss_pred ------eeecCCceEEEEEEEecCCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEEEE
Confidence 0012345678899999999999999866554444444443333 556899999999999999999999999987
Q ss_pred cc
Q 005257 275 SN 276 (705)
Q Consensus 275 ~~ 276 (705)
.+
T Consensus 224 ~~ 225 (228)
T d1gv9a_ 224 FQ 225 (228)
T ss_dssp EE
T ss_pred EE
Confidence 53
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=2.6e-24 Score=212.49 Aligned_cols=104 Identities=28% Similarity=0.467 Sum_probs=91.9
Q ss_pred CceeeEEeCCCC--CCCeEEEcceEee-cCcEEecCCC------CCeEEEEEcCCCccccCCCCCcccceEEEEEEEEec
Q 005257 23 ISAVDFVFNGFN--SSNLSLYGTATVE-SRILTLTNST------TFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAP 93 (705)
Q Consensus 23 ~~~~~f~f~~f~--~~~~~~~g~a~~~-~~~l~lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 93 (705)
+.+++|+|++|+ .+||+|+|||++. +|.||||+.+ ..++|||+|++||||||+ +++++||+|+|+|.|.+
T Consensus 123 sn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~~ 201 (237)
T d1nlsa_ 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKS 201 (237)
T ss_dssp EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCC
T ss_pred cccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEec
Confidence 357999999996 4799999999996 7899999854 458999999999999996 88999999999999987
Q ss_pred CCCCCCCCceEEEEeeC-CCCCCCCCCCcccccccC
Q 005257 94 YKGVLAGHGLVFLFVPF-HGIKGATEAQHLGLFNRT 128 (705)
Q Consensus 94 ~~~~~~g~G~aF~~~~~-~~~~~~~~g~~lGl~~~~ 128 (705)
.+ ..+||||||||+|. ..+|.++.|+||||||.+
T Consensus 202 ~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T d1nlsa_ 202 PD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred CC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCC
Confidence 65 45799999999996 457889999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=1.8e-20 Score=181.43 Aligned_cols=166 Identities=19% Similarity=0.188 Sum_probs=118.0
Q ss_pred CcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCc------------------hhHHHHHHHHHHhccCCCCCcceeee
Q 005257 367 SEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHEND------------------GGTRAFLAEISSLGRLKHKSLVGLRG 428 (705)
Q Consensus 367 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~------------------~~~~~~~~Ei~~l~~l~Hpniv~l~g 428 (705)
...++||+|+||+||+|.+. +|+.||||+++.... .......+|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999986 588999998753210 01223456888999999999988776
Q ss_pred eeeeccCceEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEEccCCCee
Q 005257 429 WCKREKGSLMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEGWEKKVLHRDIKSSNVLLDKEMNGR 508 (705)
Q Consensus 429 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDLkp~NILld~~~~~k 508 (705)
+. . .+++|||+++..+.. ++......++.|++.+|.|||+ ++|+||||||+|||++++ .++
T Consensus 82 ~~---~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE---G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE---T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ec---C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 42 2 279999998765532 3445567899999999999998 999999999999999865 589
Q ss_pred eeeeccceecCCCCcceeeeeeccccCCCccccccCCCCccccEEEEe
Q 005257 509 LGDFGLARMHGHGQVASTTRVVGTVGYLAPEVFSSGRASTQTDVFGFG 556 (705)
Q Consensus 509 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~G 556 (705)
|+|||+|....+........ ..... -.|.+ ..+|+.++|+||..
T Consensus 143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~ 186 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAI 186 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHH
T ss_pred EEECCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHH
Confidence 99999998765443211000 00000 00111 34678888999853
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.6e-19 Score=178.45 Aligned_cols=194 Identities=12% Similarity=0.109 Sum_probs=124.8
Q ss_pred EEeCCCC---C--CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCc
Q 005257 28 FVFNGFN---S--SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHG 102 (705)
Q Consensus 28 f~f~~f~---~--~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G 102 (705)
|+++.+- . .+|.+.|+|.+.++.|+||++ .++.|.++++.||++++. |+++|.|+|.... ..+|||
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~~~~i~LTp~-~~~~G~~w~~~~i~~~~~-------f~~~~~F~i~g~~-~~ggdG 80 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLEEGRIVLTSN-QNSKGSLWLKQGFDLKDS-------FTMEWTFRSVGYS-GQTDGG 80 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEETTEEESCCS-TTCEEEEEESSCEECCSC-------EEEEEEEEEESCC-SCCSCE
T ss_pred ccCCCccccccCCCccEEcceeEEECCEEEECCC-CCCceEEEECCccccCCC-------eEEEEEEEEeCCC-CCCCCc
Confidence 6666652 2 689999999999999999997 578899999999999764 9999999998753 457999
Q ss_pred eEEEEeeCCCCCCCCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCC
Q 005257 103 LVFLFVPFHGIKGATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTD 182 (705)
Q Consensus 103 ~aF~~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~ 182 (705)
|||++++.... ...|+++|.. .....+||||||+.|. ....|+.++.++......... .
T Consensus 81 ~af~~~~~~~~--~~~g~~~G~~-------~~~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~-~------- 139 (221)
T d2a6za1 81 ISFWFVQDSNI--PRDKQLYNGP-------VNYDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIY-D------- 139 (221)
T ss_dssp EEEEEEECSSS--CCCCTBTTBC-------TTCEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHH-H-------
T ss_pred EEEEEEcCCCc--cccccccccC-------CCCceEEEEEECCCCC----CCceEEEecCCCccccccCCc-c-------
Confidence 99999986432 2345556652 2346799999999873 122333444333221111000 0
Q ss_pred CCCCCCCCCCCCCccccceee-cCCCcceEEEEEec---CceEEEEEEEccCCCCCCCceeeeecCccccccceeccccc
Q 005257 183 SSGSNSNSGTGDDEKSFKELK-LNNGKNYQVWIDYA---DSFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTA 258 (705)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~-l~~g~~~~~~I~Y~---~~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsa 258 (705)
....+| .+. ..++.+.+++|+|. ...+.|.+ .+. ..+ .++--.+-++++|+||||
T Consensus 140 -~~~~~~-----------~~~~~~~~~~~~~~I~y~~~~~~~l~v~i--d~~-----~c~--~~~~v~lp~~~~~fG~SA 198 (221)
T d2a6za1 140 -QSFASC-----------LMGYQDSSVPSTIRVTYDLEDDNLLKVQV--DNK-----VCF--QTRKVRFPSGSYRIGVTA 198 (221)
T ss_dssp -HCSEEE-----------ECCCTTEEEEEEEEEEEEGGGTSEEEEEE--TTE-----EEE--EESCCCCCSSEEEEEEEE
T ss_pred -ccccee-----------eecccCCCCCEEEEEEEecCccceEEEEe--cCc-----EeE--EECCeecCCCCEEEEEEE
Confidence 000111 112 23566788999993 33355554 221 011 122222225678999999
Q ss_pred ccccccccceeeee
Q 005257 259 ATGQLVESHKILAW 272 (705)
Q Consensus 259 stg~~~~~h~i~~w 272 (705)
+||...+.|.+..+
T Consensus 199 ~TG~~~~~hd~~~i 212 (221)
T d2a6za1 199 QNGAVNNNAESFEI 212 (221)
T ss_dssp ECCSGGGCCCEEEE
T ss_pred ccCCccCCCceEEE
Confidence 99999998887665
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.80 E-value=3.8e-19 Score=175.10 Aligned_cols=191 Identities=14% Similarity=0.072 Sum_probs=126.5
Q ss_pred CCeEEEcceEeecCcEEecCCCCCeEEEEEcCCCccccCCCCCcccceEEEEEEEEecCCCCCCCCceEEEEeeCCCCCC
Q 005257 36 SNLSLYGTATVESRILTLTNSTTFTIGRALYPSKIPTKRPNSSYVYPFSTSFIFAMAPYKGVLAGHGLVFLFVPFHGIKG 115 (705)
Q Consensus 36 ~~~~~~g~a~~~~~~l~lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~~~~~~~~~~ 115 (705)
.+|.+.|+|.+.++.|+||++ .++.|++|++.||++++. |+++|+|.|.... ..+||||||++.+......
T Consensus 22 ~~W~~~G~~~~~~~~i~LTp~-~~~~G~~w~~~~i~~~~~-------f~i~~~F~i~g~~-~~~~dG~afw~~~~~~~~~ 92 (218)
T d2a6va1 22 SQWTLGDKVKLEEGRFVLTPG-KNTKGSLWLKPEYSIKDA-------MTIEWTFRSFGFR-GSTKGGLAFWLKQGNEGDS 92 (218)
T ss_dssp TTEEEEETCEEETTEEESCCS-TTCEEEEEESSCBCCSSC-------EEEEEEEEEESCC-SCCSCEEEEEEECSCCCCC
T ss_pred CccEECCCEEEECCEEEECCC-CCCeeEEEeCCccccccc-------ceEEEEEEEeCCC-CCCCCcEEEEEEcCCcccC
Confidence 789999999999999999998 567899999999999864 9999999998653 4579999999997543211
Q ss_pred CCCCCcccccccCCCCCCCCcEEEEEeecccCCCCCCCCCCeeEEecCCCcccccccccccCCCCCCCCCCCCCCCCCCC
Q 005257 116 ATEAQHLGLFNRTNDGNSSNHVFGVEFDVFKNQEFNDIDENHVGIDVNSLTSVSAHAAGYWPDNQTDSSGSNSNSGTGDD 195 (705)
Q Consensus 116 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgidvns~~S~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (705)
.|+..|..+ ...-+||||||+.|. .+||.+.+|.-+ .+ +.... +...++|...+
T Consensus 93 --~~~~~G~~~-------~f~GlaV~fDt~~n~------~~~i~~~~ndGs----~~---~~~~~--d~~~g~c~~~~-- 146 (218)
T d2a6va1 93 --TELFGGSSK-------KFNGLMILLRLDDKL------GESVTAYLNDGT----KD---LDIES--SPYFASCLFQY-- 146 (218)
T ss_dssp --CTBTTTBCS-------SCEEEEEEEEEETTT------EEEEEEEEEESS----SC---CCTTT--SCCSEEEECCC--
T ss_pred --CCcccccCC-------CcceEEEEEECCCCC------CCeEEEEeCCCC----cc---ccccC--CcccceEEecc--
Confidence 122222211 123589999999874 368888766421 11 10000 00111221111
Q ss_pred ccccceeecCCCcceEEEEEecC---ceEEEEEEEccCCCCCCCceeeeecCccccccceecccccccccccccceeeee
Q 005257 196 EKSFKELKLNNGKNYQVWIDYAD---SFINITMVEAGMKRPKRPLLSVPLNLSGVLEDEMYVGFTAATGQLVESHKILAW 272 (705)
Q Consensus 196 ~~~~~~~~l~~g~~~~~~I~Y~~---~~~~v~~~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~h~i~~w 272 (705)
..++.+.++.|.|.. ..+.|.+ .+. ..+-...|+| ..++++|+||||+||...+.|.|++|
T Consensus 147 --------~~~~~~~~~~i~Y~~~~~~~l~v~i--d~~----~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~ 210 (218)
T d2a6va1 147 --------QDSMVPSTLRLTYNPLDNHLLKLQM--DNR----VCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKM 210 (218)
T ss_dssp --------SSCSSCEEEEEEEEGGGTSEEEEEE--TTE----EEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEE
T ss_pred --------cCCCCcEEEEEEEECcccceEEEEe--CCc----EEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEE
Confidence 235678899999932 2344444 221 1112223444 34567999999999999999999999
Q ss_pred eeccc
Q 005257 273 SFSNT 277 (705)
Q Consensus 273 sf~~~ 277 (705)
++.+.
T Consensus 211 ~~~~~ 215 (218)
T d2a6va1 211 KLYDG 215 (218)
T ss_dssp EEESS
T ss_pred EEEec
Confidence 98653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=2.2e-06 Score=84.59 Aligned_cols=149 Identities=15% Similarity=0.080 Sum_probs=94.7
Q ss_pred HHHHHhCCCCcceEEeecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCC-CCCcceeeeeeeeccCc
Q 005257 358 EIEAATKGFSEENVIGVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLK-HKSLVGLRGWCKREKGS 436 (705)
Q Consensus 358 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~ 436 (705)
|+...-..|+..+..+-++.+.||+... ++..+++|+...........+.+|...+..+. +-.+.+++.++.. ++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCc
Confidence 4444445555444433333468998764 35668899886554444456778888877774 3334556666554 567
Q ss_pred eEEEEeeCCCCChhHHHHhcCCCCcccHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 005257 437 LMLVYDYMENGSLDKWIFQCDGSMMLSCEERIRVLKDVAAGVLYLHEG-------------------------------- 484 (705)
Q Consensus 437 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------- 484 (705)
.++||+++++.++...... ......++.++++.|..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred eEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 8999999999887654321 111223444555555555521
Q ss_pred ------------------------CCCCeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 485 ------------------------WEKKVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 485 ------------------------~~~~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
....++|+|+.|.|||+++++..-|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012489999999999999776667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00045 Score=66.91 Aligned_cols=75 Identities=15% Similarity=0.104 Sum_probs=49.1
Q ss_pred EEeecCc-eEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCC--cceeeeeeeeccCceEEEEeeCCCC
Q 005257 371 VIGVGGN-GKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKS--LVGLRGWCKREKGSLMLVYDYMENG 447 (705)
Q Consensus 371 ~LG~G~f-g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~~lV~E~~~~g 447 (705)
.+..|.. +.||+.... ++..+++|....... ..+..|...++.|.... +.+++.++.. .+..++||++++|-
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeecc
Confidence 4555554 578988875 356688887654332 34567777777774333 4456666554 56789999999886
Q ss_pred Chh
Q 005257 448 SLD 450 (705)
Q Consensus 448 sL~ 450 (705)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00058 Score=71.18 Aligned_cols=77 Identities=14% Similarity=-0.045 Sum_probs=46.9
Q ss_pred ceEEeecCceEEEEEEEcCCCeEEEEEEeccC-------CchhHHHHHHHHHHhccCC-C-C-CcceeeeeeeeccCceE
Q 005257 369 ENVIGVGGNGKVYKGVLEGGGAEIAVKRISHE-------NDGGTRAFLAEISSLGRLK-H-K-SLVGLRGWCKREKGSLM 438 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~i~~~-------~~~~~~~~~~Ei~~l~~l~-H-p-niv~l~g~~~~~~~~~~ 438 (705)
.+.||.|....||+.....+++.++||.-... ..........|.+.|+.+. + | .+.+++.+. ....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCE
Confidence 45689999999999998877888999964321 1112233456777777662 2 3 344455432 33457
Q ss_pred EEEeeCCCCC
Q 005257 439 LVYDYMENGS 448 (705)
Q Consensus 439 lV~E~~~~gs 448 (705)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.89 E-value=0.0063 Score=61.19 Aligned_cols=137 Identities=18% Similarity=0.166 Sum_probs=76.4
Q ss_pred ceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc-----ceeee-eeeeccCceEEEEeeCCCCChh
Q 005257 377 NGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL-----VGLRG-WCKREKGSLMLVYDYMENGSLD 450 (705)
Q Consensus 377 fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni-----v~l~g-~~~~~~~~~~lV~E~~~~gsL~ 450 (705)
--.||++... +|..+++|+.+.. ....+++..|+..+..|....+ +..-+ .....++..+.++++++|..+.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4589999885 4778999987543 2235667788888888753322 11111 1112255678899999764332
Q ss_pred H----H----------HHh----c--CCCCcccHH----------------------HHHHHHHHHHHHHHHH-hcCCCC
Q 005257 451 K----W----------IFQ----C--DGSMMLSCE----------------------ERIRVLKDVAAGVLYL-HEGWEK 487 (705)
Q Consensus 451 ~----~----------L~~----~--~~~~~l~~~----------------------~~~~i~~qia~gL~yL-H~~~~~ 487 (705)
. . ++. . ..+..+.+. .....+.++...+.-+ .+....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 0 111 0 001111111 1112223333332222 222346
Q ss_pred CeeecCCCCCCeEEccCCCeeeeeecccee
Q 005257 488 KVLHRDIKSSNVLLDKEMNGRLGDFGLARM 517 (705)
Q Consensus 488 ~iiHrDLkp~NILld~~~~~kL~DFGla~~ 517 (705)
++||+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.30 E-value=0.02 Score=58.91 Aligned_cols=74 Identities=15% Similarity=0.132 Sum_probs=49.0
Q ss_pred ceEEeecCceEEEEEEEcC-------CCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCcc-eeeeeeeeccCceEEE
Q 005257 369 ENVIGVGGNGKVYKGVLEG-------GGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSLV-GLRGWCKREKGSLMLV 440 (705)
Q Consensus 369 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~lV 440 (705)
.+.|+-|-.-.+|+..... .++.|.+++.. ... ......+|..+++.+.-.++. ++++++. + .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~---g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---ceE
Confidence 4568888889999998753 23556666654 222 234456899998888544554 5666553 2 589
Q ss_pred EeeCCCCCh
Q 005257 441 YDYMENGSL 449 (705)
Q Consensus 441 ~E~~~~gsL 449 (705)
+||+++..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.62 E-value=0.12 Score=50.78 Aligned_cols=159 Identities=13% Similarity=0.084 Sum_probs=83.8
Q ss_pred cCHHHHHHHhCCCCcceEE-----eecCceEEEEEEEcCCCeEEEEEEeccCCchhHHHHHHHHHHhccCCCCCc-----
Q 005257 354 ITYQEIEAATKGFSEENVI-----GVGGNGKVYKGVLEGGGAEIAVKRISHENDGGTRAFLAEISSLGRLKHKSL----- 423 (705)
Q Consensus 354 ~~~~el~~at~~f~~~~~L-----G~G~fg~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~Ei~~l~~l~Hpni----- 423 (705)
++-+|++....+|...+.. ..|---+.|+....+ | .+++|+..... ..++...|++++..|...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4567787777888765443 355567889988753 4 48999875431 22345556777777743322
Q ss_pred ceee-e-eeeeccCceEEEEeeCCCCChhH--------------HHHhcCC----C---Cc-----------------cc
Q 005257 424 VGLR-G-WCKREKGSLMLVYDYMENGSLDK--------------WIFQCDG----S---MM-----------------LS 463 (705)
Q Consensus 424 v~l~-g-~~~~~~~~~~lV~E~~~~gsL~~--------------~L~~~~~----~---~~-----------------l~ 463 (705)
+... | .....++....++.+..+..... .++.... . .. ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 1110 1 11111345566777776543211 0110000 0 00 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeEEccCCCeeeeeeccce
Q 005257 464 CEERIRVLKDVAAGVLYLH-EGWEKKVLHRDIKSSNVLLDKEMNGRLGDFGLAR 516 (705)
Q Consensus 464 ~~~~~~i~~qia~gL~yLH-~~~~~~iiHrDLkp~NILld~~~~~kL~DFGla~ 516 (705)
.......+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222222 2235789999999999999988767899999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=82.24 E-value=0.17 Score=50.10 Aligned_cols=37 Identities=16% Similarity=0.140 Sum_probs=32.4
Q ss_pred hhHHHHHHhhccccccccccccccCCCCCCCcccccc
Q 005257 651 MDAYLLQQVKSKDMWANYSRSFGYGYATHPTFHDIRQ 687 (705)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~r~~~~~~~~hp~f~~~~~ 687 (705)
....+.++++.+..++|..|.++.++++||||.++.+
T Consensus 291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 4456778899999999999999999999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.72 E-value=0.22 Score=48.09 Aligned_cols=27 Identities=11% Similarity=-0.049 Sum_probs=23.6
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 005257 609 ERVLHLGLLCAYPDPRARPTMRQVVKV 635 (705)
Q Consensus 609 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 635 (705)
..+.+++.+|++.||.+|||++|++++
T Consensus 257 ~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 257 ATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 456788999999999999999999873
|